Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.6017810180081917,2.7794760018940665,0.0,0.0,0.0,110/284,15.16%,NLGN1;KCND2;DLG2;GRM7;NRXN1;GRID2;ASIC2;GRIA4;GRIK5;GRIK2;GABRB3;GRM5;ERC2;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;CDH8;RIMS1;GABRG3;GABRB1;CACNA1E;SYN2;PTPRN2;DTNA;SHISA6;CHRM3;SYT1;RIT2;GRIN2B;GRIA3;SYN3;AMPH;UNC13C;HCRTR2;GLRA1;GABRA2;SYT10;SNPH;SNAP25;APBA2;DLGAP2;GRM1;CAMK4;CACNB2;GRID1;CPLX1;SLC17A6;SLC1A2;SCN2B;SYN1;GRIA2;PLP1;GRIK4;GRIA1;KIF1B;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;SLC5A7;KIF5A;GABRA5;SYT5;GRM3;HOMER1;GABRB2;KCNIP2;NTSR1;RIMBP2;KCNA1;GABRG2;NSG1;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;STXBP2;SLC6A2;CHAT;PDYN;SLC12A5;NAPB;BRSK1;PCDHB16;CALM1;DOC2A;HTR1B;UNC13B;PCDHB11;PDLIM4;SLC18A3;PRKACB;GLRA3;NLGN2;OPRK1;RIC3;PRKAR1A;HRH2;CHRNA7;CHRFAM7A;HTR7;PENK
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6090416187192623,2.7343946720391545,0.0,0.0,0.0,88/224,15.16%,NLGN1;KCND2;DLG2;GRM7;NRXN1;ASIC2;GRIA4;GRIK2;GABRB3;GRM5;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;GABRG3;GABRB1;CACNA1E;SYN2;DTNA;CHRM3;SYT1;RIT2;GRIN2B;GRIA3;AMPH;UNC13C;HCRTR2;GLRA1;GABRA2;SYT10;SNAP25;APBA2;GRM1;CAMK4;CACNB2;CPLX1;SLC1A2;SCN2B;SYN1;GRIA2;PLP1;GRIK4;GRIA1;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;KIF5A;GABRA5;SYT5;GRM3;HOMER1;GABRB2;KCNIP2;NTSR1;KCNA1;GABRG2;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;SLC6A2;PDYN;SLC12A5;PCDHB16;CALM1;DOC2A;HTR1B;UNC13B;PCDHB11;SLC18A3;PRKACB;GLRA3;NLGN2;OPRK1;PRKAR1A;HRH2;CHRNA7;CHRFAM7A;HTR7;PENK
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6001085094016398,2.606247847928164,0.0,0.0,0.0,63/159,14.14%,NLGN1;LRRC4C;ROBO1;GRID2;PTPRD;LRFN5;TENM2;ADGRL3;IL1RAPL1;CDH18;KIRREL3;ROBO2;CDH8;CNTN6;GPC6;TENM3;CDH10;CNTN4;CDH2;PTPRT;DSCAM;PCDHGB4;CDH20;TENM1;TENM4;CDH11;UNC5D;NTNG1;CDH13;SLITRK1;CDH12;CDH22;CDH19;CDH7;ACVR1;NECTIN3;VCAM1;SDK1;DCHS1;FAT4;FLRT3;DSCAML1;CDH6;PCDHB6;PCDHB14;TGFB2;CDH17;ROBO3;CRB1;CDHR3;SLITRK3;CDH9;CADM3;PKD1;AMIGO2;PCDHB16;CLDN5;PCDHB11;TRO;VSTM2L;PTPRS;CDH1;CDH5
prerank,regulation of synapse assembly (GO:0051963),0.7156550798377306,2.522096484168694,0.0,0.0,0.0,17/46,7.13%,NLGN1;NRXN1;GRID2;PTPRD;LRFN5;IL1RAPL1;ROBO2;GPC6;SYNDIG1;SLITRK1;IL1RAPL2;SLIT1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6142249061410605,2.518025527455116,0.0,0.0,0.0,38/107,10.81%,NLGN1;RIMS2;LRRC4C;NRG3;GRM7;GRID2;GRIK5;GRIK2;GRM5;DLGAP1;GRIK1;RIMS1;SYT1;GRM8;CDH2;CNTNAP4;SLC8A3;SYN3;SLC12A2;DLGAP2;GRM1;GRID1;CPLX1;SNCAIP;SYN1;TMEM108;GRIK4;CLSTN2;CLSTN1;GRM3;HOMER1;BDNF;FMR1;CX3CR1;SLC8A2;CAMK2A;DLGAP3;RELN
prerank,glutamate receptor signaling pathway (GO:0007215),0.7379368675860214,2.4313191887940184,0.0,0.0,0.0,19/37,8.42%,GRM7;GRID2;GRIA4;GRIK2;GRM5;GRIN2A;GRIK1;PLCB1;GRM8;GRIN2B;GRIA3;GRIN3A;GRM1;GRIA2;GRIK4;GRM3;HOMER1;FMR1;TRPM1
prerank,synapse assembly (GO:0007416),0.6507740980014087,2.4245729837936842,0.0,0.0,0.0,29/67,14.26%,NLGN1;NRXN1;GRID2;GABRB3;ADGRL3;DNM3;KIRREL3;CDH2;DSCAM;GPM6A;GABRA2;SLITRK1;NRCAM;LRRTM3;NRXN2;SHANK3;SDK1;GABRB2;BDNF;GABRG2;FLRT3;PCDHB6;PCDHB14;DNER;CBLN4;PCDHB16;PCDHB11;CDH1;NLGN2
prerank,neurotransmitter secretion (GO:0007269),0.6971272602736992,2.3828682942544,0.0,0.0,0.0,15/44,5.48%,RIMS2;NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.856642526595149,2.359323175704995,0.0,0.0,0.0,10/18,3.39%,GRID2;GRIK5;GRIK2;GRIK1;CDH8;UNC13C;GRID1;SLC17A6;GRIA2;GRIK4
prerank,positive regulation of nervous system development (GO:0051962),0.670924014939635,2.3207601985071307,0.0,0.0,0.0,16/42,9.70%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SOX11;SYNDIG1;MME;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF;NUMB;CX3CR1;RASSF10
prerank,synapse organization (GO:0050808),0.560584249982423,2.320700397552157,0.0,0.0,0.0,37/125,9.28%,NLGN1;LRRC4C;NRXN1;PTPRD;LRFN5;ADGRL3;GRM5;CTNND2;DNM3;KIRREL3;ANK3;PPFIA2;GPC6;CDH2;GPHN;DSCAM;SLC8A3;UNC13C;GPM6A;CACNB2;NTNG1;PAK3;SLITRK1;SEMA3E;NRCAM;NRXN2;SHANK3;SDK1;BDNF;FLRT3;PCDHB6;NEDD4;CX3CR1;SLC6A1;SLC8A2;PCDHB14;DNER
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7160740595746782,2.2994632669699477,0.0,5.6395325802027803e-05,0.001,22/35,14.14%,NLGN1;CDH18;CDH8;CDH10;PCDHGB4;CDH20;CDH11;CDH13;CDH12;CDH22;CDH19;CDH7;DCHS1;CDH6;PCDHB6;PCDHB14;CDH17;CDHR3;CDH9;PCDHB16;PCDHB11;CDH5
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6395554371119538,2.29771709599868,0.0,5.205722381725644e-05,0.001,22/57,10.81%,NLGN1;DLG2;GRIA4;DLGAP1;LRRC7;GRIN2A;SHISA6;GRIN2B;DLG3;GRIA3;DLGAP2;GRIA2;GRIA1;GSG1L;SHISA9;NETO1;CACNG4;CACNG2;NEFL;CAMK2A;DLGAP3;RELN
prerank,regulation of cation channel activity (GO:2001257),0.5875354764230839,2.294367928119544,0.0,4.833885068745241e-05,0.001,32/89,12.24%,NLGN1;DLG2;FGF14;GRIA4;LRRC7;GRIN2A;FGF12;ANK3;ANK2;DMD;SHISA6;GRIN2B;DLG3;GRIA3;CACNB2;GRIA2;PDE4D;GRIA1;GSG1L;SHISA9;HOMER1;NETO1;CACNG4;CACNG2;JPH4;NEFL;PIRT;CAMK2A;RELN;KCNG1;STAC;CALM1
prerank,positive regulation of synapse assembly (GO:0051965),0.7450368846870703,2.2933442018236145,0.0,4.5116260641622244e-05,0.001,11/27,7.13%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.6508153836229059,-2.2686826073375563,0.0,0.0,0.0,23/56,12.01%,CTSB;MAPKAPK3;SFTPA2;SFTPA1;PLCG2;TLR8;CD36;TLR7;UNC93B1;ALPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;MYD88;NOD1;LY96;UBC;RPS27A;HSP90B1;CTSS
prerank,signal release from synapse (GO:0099643),0.6685454240688811,2.264353485812272,0.0,8.459298870304171e-05,0.002,14/43,5.48%,NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,neuron cell-cell adhesion (GO:0007158),0.8749401516999611,2.258199422709172,0.0,0.00011942539581605886,0.003,9/14,4.11%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1;NINJ2;NRXN2
prerank,B cell receptor signaling pathway (GO:0050853),-0.7251515154747875,-2.2528176716423065,0.0,0.0,0.0,16/32,13.68%,RFTN1;PTPRC;VAV3;PRKCB;CD38;PLCG2;SYK;TEC;BLNK;BCL2;MEF2C;NCKAP1L;LCK;ITK;PIK3CD;NFAM1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6248152831306432,-2.2526916560663026,0.0,0.0,0.0,39/72,22.33%,PTPRC;RUNX1;CD74;BIRC3;SYK;AXL;ELF1;VRK2;USP18;RNASEL;RIPK1;PIAS1;IRAK2;CFLAR;IFNAR2;RNF31;RBCK1;ABCE1;IRAK3;GAS6;CBFB;JAK1;PTPN6;OTULIN;IFNGR2;TRAF1;HSP90AB1;TRAF2;AGPAT1;IKBKB;CASP8;SOCS3;PTPN11;TRADD;IL7;STAT1;RACK1;PTPN1;IFNGR1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.6158835335899896,-2.245697745814896,0.0,0.0,0.0,35/71,15.13%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;PLCG2;SYK;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;PLD2;MYO1G;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;ARPC1B;CRK;PIK3CA;FCGR2B;HSP90AB1;ARPC1A;FCER1G;MYO10;ARPC5;BRK1
prerank,regulation of potassium ion transport (GO:0043266),0.7174758030391474,2.2375357702339356,0.0,0.00026317818707612974,0.006,9/31,6.79%,DPP10;KCNIP4;DPP6;ANK3;ANK2;KCNN2;KCNIP1;CASQ2;KCNIP2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.6128124202856461,-2.2341516298786996,0.0,0.0,0.0,34/70,15.13%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;PLCG2;SYK;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;PLD2;MYO1G;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;ARPC1B;CRK;PIK3CA;FCGR2B;HSP90AB1;ARPC1A;MYO10;ARPC5;BRK1
prerank,neurotransmitter transport (GO:0006836),0.5874123753802686,2.2262019696390443,0.0,0.00028494480405235104,0.007,28/73,13.13%,NRXN1;PPFIA2;RIMS1;SYN2;PTPRN2;SYT1;SYN3;GABRA2;SNPH;SNAP25;CPLX1;SLC17A6;SLC1A2;SYN1;SLC6A16;NRXN2;SLC1A6;SLC6A15;HRH3;SLC5A7;GLUL;SLC1A1;STXBP2;SLC6A2;CHAT;BRSK1;UNC13B;SLC18A3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.6061433185841326,-2.217313073751825,0.0,0.0,0.0,35/73,15.13%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;PLCG2;SYK;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;PLD2;MYO1G;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;ARPC1B;CRK;PIK3CA;FCGR2B;HSP90AB1;ARPC1A;FCER1G;MYO10;ARPC5;BRK1
prerank,innate immune response (GO:0045087),-0.5192945155672273,-2.203548770610504,0.0,0.0,0.0,90/217,23.17%,LYN;CYBB;CD74;FGR;SP100;MFHAS1;PLCG2;SYK;REL;TLR8;CYBA;NRROS;FES;KYNU;MALT1;PPARG;ALPK1;DHX58;TLR4;PTK2B;NLRC5;IRF5;CFP;IRAK4;CIITA;C3;PIK3CG;NUB1;RNASE7;MYD88;B2M;BST2;ATAD3A;IFITM2;OTULIN;CLEC4D;MSRB1;CHGA;APP;LCK;NCF1;CD300LB;RELA;IFIT1;NCF2;CLEC6A;CXCL16;CAMP;TRIM68;FCER1G;FRK;RNASE6;CAPZA1;DEFA6;ADAM15;PIK3CD;TRIM11;GCH1;CD40;RELB;TREML1;IKBKB;MAVS;TRIM14;ISG15;SKP2;ZAP70;HCK;TRIM39;ANG;POLR3A;NOD2;DDX3X;ZDHHC1;SLA;HMGB1;AGER;CD300E;TTC4;CYBC1;SERINC3;TRIM25;SRPK1;IFITM1;MASP1;RNF135;STYK1;ANKHD1;MEFV;RPL39
prerank,neutrophil activation involved in immune response (GO:0002283),-0.47971419346961697,-2.200002131713118,0.0,0.00015379158292178053,0.001,139/428,15.09%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CTSB;CD44;ATP8B4;CLEC12A;APAF1;FGR;ADGRE5;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;SYK;TSPAN14;CD300A;CYBA;PRKCD;FTL;OSTF1;RAC1;ANPEP;RAB7A;ROCK1;ITGB2;CD36;RAP1B;ACTR2;PTPRJ;IDH1;ANO6;RHOA;HPSE;TNFRSF1B;RAP2B;ARL8A;CRACR2A;ANXA2;PLAU;FABP5;CDK13;RAB31;C5AR1;ITGAL;S100A11;LAMP2;RAP1A;PSMB7;GYG1;SYNGR1;TCIRG1;ATG7;GNS;PLEKHO2;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;ITGAV;DERA;DNAJC13;CTSA;CFP;MAPK14;CAP1;STOM;ARSA;CD53;C3;CYB5R3;CAB39;MVP;SRP14;PRCP;GRN;PLAC8;SIRPA;TIMP2;AP2A2;B2M;VAT1;BST2;VPS35L;PLAUR;CPPED1;CTSC;HMOX2;PTPN6;GUSB;IGF2R;ADAM8;MAGT1;CD63;CTSH;CLEC4D;NCKAP1L;HK3;TMC6;PSMC3;ITGAX;EEF2;RAB3D;DGAT1;NPC2;TXNDC5;XRCC6;RAB24;DNASE1L1;LAMP1;CTSS;ACTR1B;EEF1A1;CAMP;CPNE3;PKM;RAB10;HSP90AB1;FCER1G;FRK;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;NEU1;KCMF1;COTL1;CST3;ARPC5;PGRMC1;ABCA13
prerank,neutrophil degranulation (GO:0043312),-0.4779128308535577,-2.1937027373495863,0.0,0.00013670362926380492,0.001,138/425,15.09%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CTSB;CD44;ATP8B4;CLEC12A;APAF1;FGR;ADGRE5;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;FTL;OSTF1;RAC1;ANPEP;RAB7A;ROCK1;ITGB2;CD36;RAP1B;ACTR2;PTPRJ;IDH1;ANO6;RHOA;HPSE;TNFRSF1B;RAP2B;ARL8A;CRACR2A;ANXA2;PLAU;FABP5;CDK13;RAB31;C5AR1;ITGAL;S100A11;LAMP2;RAP1A;PSMB7;GYG1;SYNGR1;TCIRG1;ATG7;GNS;PLEKHO2;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;ITGAV;DERA;DNAJC13;CTSA;CFP;MAPK14;CAP1;STOM;ARSA;CD53;C3;CYB5R3;CAB39;MVP;SRP14;PRCP;GRN;PLAC8;SIRPA;TIMP2;AP2A2;B2M;VAT1;BST2;VPS35L;PLAUR;CPPED1;CTSC;HMOX2;PTPN6;GUSB;IGF2R;ADAM8;MAGT1;CD63;CTSH;CLEC4D;NCKAP1L;HK3;TMC6;PSMC3;ITGAX;EEF2;RAB3D;DGAT1;NPC2;TXNDC5;XRCC6;RAB24;DNASE1L1;LAMP1;CTSS;ACTR1B;EEF1A1;CAMP;CPNE3;PKM;RAB10;HSP90AB1;FCER1G;FRK;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;NEU1;KCMF1;COTL1;CST3;ARPC5;PGRMC1;ABCA13
prerank,toll-like receptor signaling pathway (GO:0002224),-0.5840752623387155,-2.193206545017424,0.0,0.00012303326633742443,0.001,31/84,12.01%,RFTN1;CTSB;BIRC3;MAPKAPK3;SFTPA2;SFTPA1;PLCG2;TLR8;ITGB2;CD36;MAP3K1;PIK3AP1;TLR7;UNC93B1;RIPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;IRAK3;MYD88;EPG5;LY96;UBC;RPS27A;TNIP2;HSP90B1;TICAM1;CTSS
prerank,nervous system development (GO:0007399),0.4556187962860773,2.191923710477526,0.0,0.0004737207367370336,0.013,114/429,12.70%,LSAMP;NLGN1;RBFOX1;NRXN1;NRG1;ROBO1;ASIC2;ADGRL3;NAV3;MYT1L;NELL1;CHRM2;SPOCK1;GRIK1;FGF12;DNM3;KIRREL3;ROBO2;CNTN6;KALRN;TRPC5;CHRM3;CNTN4;EFNA5;DCLK1;ERBB4;CDH2;DSCAM;TENM1;ADAM22;LDB2;GPM6A;SERPINI1;ST8SIA2;LRCH4;APBA2;AHI1;SRRM4;DPF3;NAV2;SCN2A;SEMA6A;SH3GL2;NINJ2;SLITRK1;IL1RAPL2;SEMA5A;NRCAM;SOX6;VCAN;POU6F2;NRXN2;PAX8;PTN;POU3F2;GDNF;RBFOX2;ACVR1C;ADAM23;EPHB1;MAL;SHANK3;GPM6B;APC2;SDK1;RPS6KA6;FEZ1;DCHS1;GSS;MOG;SH3GL3;CYP51A1;FAT4;RBFOX3;YAP1;BDNF;PTS;FLRT3;NCKAP1;ADGRV1;DSCAML1;NDUFV2;DPYSL5;GFRA2;ADGRA2;PCDHB6;PTPRZ1;PCDHB14;DNER;GBX2;B3GNT5;PCDHA11;PCDHA4;NEUROD1;CHST8;RELN;GSN;MBD5;GSTP1;NBL1;RAPGEF5;DPYSL4;SMO;PKD1;HES5;TEAD1;ZIC2;TYRO3;PCDHB16;DOC2A;VLDLR;ZIC4;PCDHB11;ATXN10
prerank,cell junction assembly (GO:0034329),0.5463560641415016,2.1894241214727894,0.0,0.0004833885068745241,0.014,42/100,14.26%,NLGN1;NRXN1;ADGRL3;CDH18;CTNND2;DNM3;KIRREL3;CDH8;CDH10;CDH2;DSCAM;CDH20;CDH11;TJP1;GPM6A;SLITRK1;NRCAM;CDH12;CDH22;NRXN2;CDH19;CDH7;SHANK3;SDK1;DCHS1;TLN2;BDNF;FLRT3;CDH6;PCDHB6;PCDHB14;DNER;ARVCF;CDHR3;CDH9;FERMT2;PCDHB16;CLDN5;PCDHB11;CDH1;CDH5;NLGN2
prerank,neutrophil mediated immunity (GO:0002446),-0.4762186611090284,-2.1872604525327555,0.0,0.00011184842394311312,0.001,139/432,15.09%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CTSB;CD44;ATP8B4;CLEC12A;APAF1;FGR;ADGRE5;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;FTL;OSTF1;RAC1;ANPEP;RAB7A;ROCK1;ITGB2;CD36;RAP1B;ACTR2;PTPRJ;IDH1;ANO6;RHOA;HPSE;TNFRSF1B;RAP2B;ARL8A;CRACR2A;ANXA2;PLAU;FABP5;CDK13;RAB31;C5AR1;ITGAL;S100A11;LAMP2;RAP1A;PSMB7;GYG1;SYNGR1;TCIRG1;ATG7;GNS;PLEKHO2;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;ITGAV;DERA;DNAJC13;CTSA;CFP;IRAK4;MAPK14;CAP1;STOM;ARSA;CD53;C3;CYB5R3;CAB39;MVP;SRP14;PRCP;GRN;PLAC8;SIRPA;TIMP2;AP2A2;B2M;VAT1;BST2;VPS35L;PLAUR;CPPED1;CTSC;HMOX2;PTPN6;GUSB;IGF2R;ADAM8;MAGT1;CD63;CTSH;CLEC4D;NCKAP1L;HK3;TMC6;PSMC3;ITGAX;EEF2;RAB3D;DGAT1;NPC2;TXNDC5;XRCC6;RAB24;DNASE1L1;LAMP1;CTSS;ACTR1B;EEF1A1;CAMP;CPNE3;PKM;RAB10;HSP90AB1;FCER1G;FRK;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;NEU1;KCMF1;COTL1;CST3;ARPC5;PGRMC1;ABCA13
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6683585137450905,2.1734539645642452,0.0,0.0005536995624199094,0.017,11/34,8.14%,MPP2;GRID2;GRIN2A;GABRG3;GRIN2B;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;INSYN1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5709461694867078,2.1495541580056416,0.0,0.001088674985047841,0.035,23/72,9.53%,NLGN1;MPP2;RIMS2;NRXN1;GRIK2;GRIN2A;RIMS1;SYT1;GRIN2B;ADCY8;SLC24A2;SLC8A3;CLSTN2;PRKCZ;SHANK3;CLSTN1;TSHZ3;CACNG4;CACNG2;FMR1;ADCY1;SLC8A2;NFATC4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.7605467213523636,-2.1430909387722483,0.0,0.00041011088779141475,0.004,15/21,13.68%,LYN;PRKCH;FOXP1;RUNX1;PRKCB;ELF2;CD300A;ELF1;LPXN;CD22;STAP1;PTPN22;CBFB;FCGR2B;NFAM1
prerank,cell-cell junction organization (GO:0045216),0.5599929017205036,2.1422648612707165,0.0,0.0012688948305456256,0.043,35/79,15.43%,CADM2;CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;CDH11;TJP1;CDH13;CSF1R;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;SDK1;DCHS1;PRKCI;TLN2;CDH6;OCLN;TGFB2;CDH17;ARVCF;CDHR3;CDH9;CADM3;CLDN5;CDH1;CDH5;NLGN2;CTNND1;GJC1
prerank,regulation of dendrite development (GO:0050773),0.6449874303153165,2.129396581136309,0.0,0.0015159063575585073,0.052,19/37,14.32%,ADGRB3;CSMD3;HECW1;DCC;CDKL5;HECW2;LZTS1;PTN;MARK1;KNDC1;ALK;NEDD4;BMP7;COBL;MFSD2A;TNIK;VLDLR;SDC2;PACSIN1
prerank,B cell activation (GO:0042113),-0.5956458916534804,-2.1274292870520015,0.0,0.0006624868187399777,0.007,36/68,25.76%,PTPRC;ITGA4;BANK1;PRKCB;PLCG2;TPD52;PTPRJ;MALT1;LYL1;CD22;ITGB1;BLNK;HHEX;BCL2;KLF6;FCRL1;CEBPG;MEF2C;DNAJB9;PIK3CD;NFAM1;CD40;HDAC5;TCF3;CHRNB2;CASP8;ZAP70;LAT2;CD79A;LAX1;ZBTB7A;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6013228110893585,-2.127297813097739,0.0,0.0006151663316871221,0.007,30/67,12.05%,CYBB;NRP1;VAV3;ABI1;MAPKAPK3;PAK2;CYBA;AXL;RAC1;ROCK1;RHOA;WASF2;VAV1;MAPKAPK2;FLT1;CDC42;PTK2B;ITGAV;MAPK14;PIK3CB;NRP2;BAIAP2;VEGFA;VAV2;NCKAP1L;NCF1;CRK;NCF4;PIK3CA;NCF2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6133166541121439,2.126418336423479,0.0,0.0016137739383349494,0.056,15/46,7.55%,NLGN1;GRM7;NRXN1;GRM5;GRIK1;SYT1;GRM8;CDH2;GRM1;SHANK3;GRM3;TSHZ3;HOMER1;CACNG4;CACNG2
prerank,presynapse assembly (GO:0099054),0.7977366830981008,2.1247521524216704,0.0,0.0016542628901928156,0.058,5/16,4.04%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,axonogenesis (GO:0007409),0.46532057662594606,2.1214315769071317,0.0,0.0016435209233733818,0.06,102/237,20.29%,NRXN1;ROBO1;CTNNA2;NRXN3;UNC5C;AUTS2;NCAM1;DAB1;ANK3;ROBO2;CNTN6;KIF5C;MAP1B;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;PARD3;UNC5D;SHC3;EPHA7;TNR;DOK6;EPHA5;PLPPR4;SEMA6A;GRB10;NTNG2;NTNG1;PAK3;SLITRK1;SEMA3E;NEFH;SEMA5A;NRCAM;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;GFRA2;FYN;SPTBN4;EPHA10;SEMA3F;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SLITRK3;SEMA5B;CDK5R1;ARHGAP35;BRSK1;RET;VLDLR;EPHB4;SLITRK5;VSTM2L;ENAH;HSP90AA1;SEMA4G;KLF7;ZDHHC17;EPHB3;UNC5A;PRKCA;NRTN;EMB;EPHA3;MAP1A;CXCL12;RAB3A;PDLIM7;DOCK7;GFRA1;LAMA2;ADGRB1;S100B;EFNB2;B4GALT6;LAMA5;PPP3CB;PTK2;WNT5A;LLGL1;EFNA1;EPHA2;GLI2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.539857975083164,-2.120917594632086,0.0,0.0006561774204662636,0.008,49/112,22.42%,PTPRC;FOXP1;IGF1;CCR2;LILRB1;PLCG2;SYK;CYBA;PTPRJ;ARHGEF2;RIPK1;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;PF4;IRAK3;GAS6;SIRPA;PTPN6;LY96;SELENOS;LPL;APP;ARFGEF2;CD2;NLRC3;OAS3;NFKBIL1;ARG2;SPN;MAVS;SPHK2;RARA;LILRA5;MMP8;PTPN11;HSPB1;NOD2;LGALS9;OAS2;HMGB1;AGER;ZC3H12A;TMEM106A;IFNGR1;NR1H4;IL6
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.7020588551014859,2.1207479812748793,0.0,0.0015868477880846446,0.06,10/26,5.49%,NLGN1;RIMS2;NRXN1;RIMS1;SLC8A3;MTMR2;TMEM108;PRKCZ;SHANK3;CUX2
prerank,protein targeting to ER (GO:0045047),-0.5518134313505112,-2.118541508576583,0.0,0.0006151663316871221,0.008,53/99,25.76%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;ZFAND2A;RPL32;RPS28;RPS13;RPS15A;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;GET3;SRPRB;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;SGTA;RPLP2;CHMP4B;CHMP4A;RPL7A;RPL19;RPS15;RPL39;EDEM1;RPLP0;RPL41;RPL5;RPL13
prerank,regulation of B cell proliferation (GO:0030888),-0.6343102847513873,-2.1173344224376742,0.0,0.0006513525864922469,0.009,22/44,19.84%,LYN;PTPRC;VAV3;CD74;CD38;CD300A;SASH3;CD22;RC3H1;BCL2;TNFRSF21;AHR;MEF2C;NCKAP1L;IKZF3;FCGR2B;CD40;BST1;CHRNB2;IRS2;IL7;ATM
prerank,potassium ion transport (GO:0006813),0.5183295147581256,2.1160782479328706,0.0,0.0016241853830984009,0.063,37/120,14.00%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;NALCN;KCNMB2;KCNMB3;KCNH7;KCNH5;KCNH1;SLC24A3;KCNJ6;KCNJ3;SLC9A2;KCNJ10;KCNK2;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;TMEM175;HCN1;KCNF1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,positive regulation of cytokine production (GO:0001819),-0.47436699130727145,-2.1096944750526787,0.0,0.000751869960950927,0.011,120/292,22.48%,RFTN1;PTPRC;FOXP1;RUNX1;CD74;FGR;PAEP;CCR2;LILRB1;PLCG2;SYK;TLR8;CYBA;RAB7B;CREBBP;CGAS;HPSE;GAPDH;LY9;ARHGEF2;TLR7;MALT1;RIPK1;IL6R;HTR2B;BRCA1;STAT3;DHX58;PIBF1;IL15;CARD11;TLR4;DHX9;IL18;STAT6;RAB1A;NFKB1;TMED10;IRF5;PTGER4;PTPN22;ANXA1;IL17RA;MAPK14;BATF;C3;PIK3CG;CYRIB;CTNNB1;POLR2H;LAPTM5;SULF2;GBP5;MDK;MYD88;POLR2F;CEBPG;EIF2AK2;CD28;NOD1;HIF1A;POLR2L;LPL;POLR3G;CLEC9A;EGR1;SCRIB;ARNT;AFAP1L2;APP;AGT;XBP1;XRCC6;RELA;TICAM1;CD46;CLEC6A;CD2;ITK;SERPINE1;FCER1G;PIK3CD;TRAF2;DHX36;NFAM1;SLC7A5;CD40;AGPAT1;POU2AF1;TXK;POLR3B;MAVS;ISG15;SPHK2;IL18R1;CD226;G3BP1;HSPA1A;RARA;LILRA5;GATA3;RPS3;MMP8;PTPN11;POLR3A;NOD2;LGALS9;IL7;HMGB1;AGER;APPL1;CD274;LRRFIP1;TMEM106A;NLRP3;CEBPB;SLAMF6;NR1H4;IL6;TGFB1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5793012641341925,2.1092732565182573,0.0,0.0018119272418974093,0.074,22/59,14.06%,ROBO1;KIRREL3;ROBO2;CNTN6;TENM3;CNTN4;CDH2;PTPRT;DSCAM;CDH13;NECTIN3;SDK1;DSCAML1;PCDHB6;CDH17;ROBO3;CADM3;PKD1;AMIGO2;TRO;VSTM2L;CDH1
prerank,regulation of cation transmembrane transport (GO:1904062),0.6727444687603251,2.107810877927999,0.0,0.0017976010099396362,0.076,8/29,6.79%,DPP10;KCNIP4;DPP6;FGF12;KCNN2;KCNIP1;HOMER1;KCNIP2
prerank,positive regulation of cell communication (GO:0010647),0.6878643705755264,2.1053839169461095,0.0,0.00180465042566489,0.079,9/28,6.71%,RIMS2;GRIK2;ANK3;RIMS1;SYT1;SOX11;CLSTN2;CLSTN1;HOMER1
prerank,potassium ion transmembrane transport (GO:0071805),0.5105488728347316,2.102489017472312,0.0,0.0018311894025129028,0.083,42/135,14.00%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC12A2;NALCN;KCNT2;KCNH7;KCNH5;KCNH1;SLC24A3;SLC12A8;SLC12A1;KCNJ6;KCNJ3;SLC9A2;KCNJ10;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;ATP1A3;TMEM175;HCN1;KCNF1;ATP1B1;KCNG1;SLC12A5;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,positive regulation of phagocytosis (GO:0050766),-0.6286995136726319,-2.0978544363765534,0.0,0.001100823961966429,0.017,22/47,19.92%,DOCK2;PTPRC;CYBA;PTPRJ;ANO6;CAMK1D;CD300LF;RAB31;C4B;IL15;STAP1;C3;GAS6;SIRPA;NCKAP1L;IL2RG;FCGR2B;FCER1G;APPL2;IL2RB;PLA2G5;C2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.8572156605602081,-2.095493232511549,0.0,0.0010457827638681075,0.017,9/12,8.62%,LYN;PTPRC;RUNX1;ELF2;CD300A;ELF1;RC3H1;PTPN22;CBFB
prerank,regulation of NMDA receptor activity (GO:2000310),0.6460536202508516,2.0911291727325816,0.0,0.0020882383496979434,0.096,10/32,3.60%,NLGN1;DLG2;GRIA4;LRRC7;GRIN2A;GRIN2B;DLG3;GRIA3;GRIA2;GRIA1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.5690176023959701,-2.0827932330693084,0.0,0.0015232690117966833,0.025,29/68,22.42%,CD74;PLCG2;SYK;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;STAT3;TLR4;DHX9;IL17RA;MYD88;LPL;APP;XBP1;POU2AF1;MAVS;SPHK2;LILRA5;MMP8;PTPN11;NOD2;LGALS9;HMGB1;AGER;TMEM106A;IL6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6536377800649511,2.081179674837759,0.0,0.0023686036836851674,0.108,9/33,3.39%,NLGN1;LRRC4C;NRG3;GRID2;GRIK5;GRIK2;GRIK1;GRID1;GRIK4
prerank,adherens junction organization (GO:0034332),0.591682088139515,2.0809004286577073,0.0,0.002341168119781479,0.11,25/48,15.14%,CADM2;CDH18;CDH8;CDH10;CDH2;CDH20;CDH11;TJP1;CDH13;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;DCHS1;CDH6;CDH17;CDHR3;CDH9;CADM3;FERMT2;CDH1;CDH5;CTNND1
prerank,regulation of interferon-beta production (GO:0032648),-0.6184382902077743,-2.079863884633983,0.0,0.0014540295112604705,0.025,27/46,22.37%,LILRB1;REL;TLR8;TLR7;DHX58;TLR4;DHX9;RIOK3;IRF5;TRAF3;PPM1B;SIRPA;POLR3G;NLRC3;OAS3;RELB;YY1;RNF216;POLR3B;MAVS;ISG15;PTPN11;POLR3A;DDX3X;OAS2;RNF135;TOMM70
prerank,regulation of presynapse organization (GO:0099174),0.7451381060987773,2.0771324174417445,0.0024390243902439024,0.002394632295593796,0.118,6/18,3.25%,PTPRD;LRFN5;IL1RAPL1;GPC6;SLITRK1;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),0.7451381060987773,2.0771324174417445,0.0024390243902439024,0.002394632295593796,0.118,6/18,3.25%,PTPRD;LRFN5;IL1RAPL1;GPC6;SLITRK1;IL1RAPL2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6361024408567876,2.074445487779861,0.0,0.002487033867869426,0.126,15/37,12.04%,NLGN1;GRID2;PTPRD;TENM2;IL1RAPL1;TENM3;TENM1;TENM4;NECTIN3;VCAM1;DCHS1;FAT4;CRB1;CADM3;AMIGO2
prerank,regulation of cholesterol storage (GO:0010885),-0.799695058964305,-2.0680793856278754,0.0,0.0018187526328141,0.032,9/15,15.34%,ABCA1;MSR1;ABCG1;PPARD;PPARG;NR1H2;LPL;TTC39B;EHD1
prerank,synaptic membrane adhesion (GO:0099560),0.7959831062553325,2.067677790094555,0.0,0.0026739637404668793,0.134,6/14,3.24%,LRRC4C;PTPRD;LRFN5;GPC6;NTNG1;SLITRK1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6458019952499624,2.0658979159493973,0.0,0.002690862688268184,0.137,6/27,3.49%,PDE4B;ANK2;CTNNA3;CACNA1C;RYR2;PDE4D
prerank,axon development (GO:0061564),0.5289216333298355,2.063226216044358,0.0,0.0027384520994100945,0.142,34/78,18.42%,GRM7;CTNNA2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;PLP1;NEFH;SEMA5A;NRCAM;DSCAML1;SPTBN4;SLITRK3;CDK5R1;ARHGAP35;BRSK1;RTN4RL1;SLITRK5;DHFR;FOLR1;KLF7;ZDHHC17;EPHB3;MAP1A;RAB3A;DOCK7;ADGRB1;S100B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5509529122173982,-2.0589201104204995,0.0,0.0022043460218788545,0.04,46/87,25.76%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;RPL32;RPS28;RPS13;RPS15A;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL7A;RPL19;RPS15;RPL39;RPLP0;RPL41;RPL5;RPL13
prerank,regulation of immune response (GO:0050776),-0.5127220683351911,-2.0582693156631855,0.0,0.0021653854875386697,0.041,79/135,33.83%,LYN;ITGA4;FOXP1;FGR;SLAMF7;BIRC3;LILRB1;SYK;CD300A;SAMHD1;BCL6;ADCY7;ITGB2;RAET1E;CD300LF;ITGAL;DHX58;IL15;CD22;ITGB1;CLEC2D;PTPN22;RSAD2;TRAF3;C3;AHR;B2M;NPDC1;ITGB7;JAML;CD300LD;CD300LB;IL4I1;FCGR2B;CXADR;ULBP1;CD40;PILRA;TREML1;SPN;APPL2;GPR108;CD226;CASP8;HCST;DENND1B;CD300E;APPL1;CD300LG;IFITM1;SLAMF6;CD3E;RNF135;CD247;TREML4;CD96;ZMPSTE24;FCRLB;CD300C;SELL;CRTAM;SPINK5;CD19;RIPK3;KIR3DL2;CD8B;TKFC;XIAP;FCGR3A;FCGR3B;NCR1;KLRD1;CD8A;KLRC1;IRF4;SLA2;PLSCR1;ERAP1;CSK
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.7449414597526614,2.0572747129781876,0.0,0.0029530643329061827,0.154,7/18,5.49%,NLGN1;RIMS2;NRXN1;RIMS1;PRKCZ;SHANK3;CUX2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7209289744642154,2.054084523841833,0.0,0.00302278946298869,0.16,10/21,13.42%,AKAP6;ANK2;CACNA1C;DMD;RYR2;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.5673092834478952,-2.0493033369487477,0.0,0.0024606653267484884,0.048,33/69,22.42%,PTPRC;CCR2;PLCG2;SYK;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;LPL;APP;ARFGEF2;CD2;OAS3;SPN;MAVS;SPHK2;LILRA5;MMP8;PTPN11;HSPB1;NOD2;LGALS9;OAS2;HMGB1;AGER;TMEM106A;IFNGR1;IL6
prerank,positive regulation of immune response (GO:0050778),-0.5715098673065232,-2.0439427806273405,0.0,0.00241509745032722,0.049,28/64,19.20%,PTPRC;CD74;LILRB1;TLR8;CYBA;ITGB2;SASH3;IL15;DHX9;RIOK3;RSAD2;GRN;IFI35;GBP5;ADAM8;POLR3G;XBP1;CD46;FCGR2B;CCL5;KARS1;POLR3B;STX4;SPHK2;CD226;MYB;NOD2;LGALS9
prerank,regulation of B cell activation (GO:0050864),-0.6961316980245774,-2.0424647760376042,0.0,0.0024167248744851226,0.051,12/25,14.21%,BANK1;THEMIS2;SH3KBP1;CD22;AHR;LAPTM5;TNIP2;IKZF3;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5457225401564945,-2.041860642780046,0.0,0.0023333895339856356,0.051,47/91,25.76%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;RPL32;RPS28;RPS13;SIL1;RPS15A;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL7A;RPL19;RPS15;RPL39;RPLP0;RPL41;RPL5;RPL13
prerank,cytoplasmic translation (GO:0002181),-0.5445994443054163,-2.0407797482443937,0.0,0.0023786431491902055,0.054,47/91,25.76%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;EIF4A2;RPL12;EIF2B3;RPS14;RPL32;RPS28;RPS13;RPS15A;RPS27A;RPL28;RPS4X;EIF4A1;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPL7A;RPL19;RPS15;RPL39;RPLP0;RPL41;RPL5;RPL13
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.6010232719581055,-2.039104577439327,0.0,0.002341600875454207,0.055,28/51,22.42%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;TMED10;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;HSPB1;NOD2;LGALS9;HMGB1;AGER;TMEM106A;NLRP3;IL6
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5581150280334255,-2.0310199208531428,0.0,0.002652904805400714,0.063,34/73,22.42%,PTPRC;CCR2;PLCG2;SYK;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;ADAM8;LPL;APP;ARFGEF2;CD2;OAS3;SPN;MAVS;SPHK2;LILRA5;MMP8;PTPN11;HSPB1;NOD2;LGALS9;OAS2;HMGB1;AGER;TMEM106A;IFNGR1;IL6
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6638413983516216,2.0230677481707495,0.0,0.005207985739282915,0.257,5/25,1.90%,MPP2;GRID2;GRIN2A;GRIN2B;GLRA1
prerank,positive regulation of B cell activation (GO:0050871),-0.5927274675877428,-2.0177816893218607,0.0,0.003541866758198582,0.083,22/50,19.50%,PTPRC;VAV3;CD74;CD38;SYK;SASH3;SH3KBP1;BCL2;KMT5B;MEF2C;KMT5C;NCKAP1L;CD27;TNIP2;XBP1;CD40;BST1;CHRNB2;IRS2;SHLD2;NOD2;IL7
prerank,regulation of interleukin-6 production (GO:0032675),-0.5280083176565412,-2.017724417795645,0.0,0.003437694206486859,0.083,41/96,21.18%,CD74;PLCG2;SYK;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;IL17RA;ARRB1;IRAK3;GAS6;SIRPA;MYD88;PTPN6;SELENOS;LPL;NCKAP1L;AFAP1L2;APP;XBP1;FOXJ1;NLRC3;POU2AF1;MAVS;SPHK2;LILRA5;MMP8;PTPN11;NOD2;LGALS9;HMGB1;AGER;ZC3H12A;TMEM106A
prerank,regulation of defense response (GO:0031347),-0.5525355206359722,-2.0175716865387416,0.0,0.003339474372015806,0.083,35/76,23.55%,APOE;FOXP1;FGR;BIRC3;CCR2;SAMHD1;BCL6;SBNO2;PIK3AP1;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;TMSB4X;APPL2;BST1;CASP8;HCK;NOD2;APPL1;RNF135;SETD6;LRRC19;SEMA7A
prerank,chloride transmembrane transport (GO:1902476),0.5851716097560251,2.0129955843461684,0.0,0.005946707120741485,0.292,18/48,8.91%,GABRB3;GABRG3;GABRB1;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,heart contraction (GO:0060047),0.5900833820945259,2.009084528782043,0.00234192037470726,0.006132991680970524,0.307,12/41,11.17%,SGCZ;SGCD;DMD;RYR2;SCN2B;CASQ2;TNNI1;SGCG;TNNT2;MYH7;ATP1B1;TTN
prerank,cardiac muscle cell action potential (GO:0086001),0.6488374224109542,2.0086642251594578,0.0,0.006035450785833342,0.309,10/30,6.79%,FGF12;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;SCN2B;SCN1A;HCN2;KCNIP2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.4888292909608979,-2.0068946426882532,0.0,0.00362264617549083,0.092,68/163,21.16%,RFTN1;PTPRC;VAV3;PRKCB;CD38;PLCG2;SYK;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;CARD11;TEC;PSME3;BLNK;RC3H1;NFKB1;FBXW11;BCL2;PTPN22;PSMB9;RNF31;FYB1;RBCK1;SPG21;PIK3CB;TNFRSF21;EIF2B3;CD28;MEF2C;PSMA8;NFKBIZ;NCKAP1L;PSMC3;LCK;RELA;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;PIK3CD;LCP2;NFAM1;PSMA1;TXK;IKBKB;THEMIS;ZAP70;PSMB8;GATA3;LAT2;DENND1B;PSMD4;PSMA5;PRAM1;NFKBID;PSMB3;EIF2B1;WNK1;CD79A;PSMD3;ZC3H12A;LAX1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5185052365218379,-2.005494400800924,0.0,0.0035912412876869834,0.094,56/110,25.76%,DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;RPS14;RPL32;RPS28;RPS13;SMG8;HELZ2;RPS15A;RPS27A;RPL28;RPS4X;UPF2;RPS23;EIF3E;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RNPS1;RPL23A;RPS16;MAGOH;RPL9;RPLP2;RPL7A;RPL19;RPS15;SMG1;RPL39;RPLP0;RPL41;RPL5;RPL13
prerank,synaptic vesicle cycle (GO:0099504),0.6282329720382026,2.0039917022280482,0.0,0.006266648603121329,0.325,8/30,3.09%,NLGN1;RIMS1;PCLO;SYT10;SYNDIG1;SNAP25;CPLX1;SLC17A6
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.48824035011140005,-2.0036390891656257,0.0,0.003593866464066871,0.097,83/168,27.47%,CNOT4;DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;TUT7;CNOT1;CNOT2;RC3H1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;PATL1;RPS14;RPL32;EXOSC5;DCP2;RPS28;RPS13;SMG8;HELZ2;RPS15A;DDX5;RPS27A;RPL28;RPS4X;UPF2;MTPAP;CSDE1;RPS23;EIF3E;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;POLR2G;PAN3;CNOT6L;RPS9;RPS27;TENT4B;RPS3;RNPS1;RPL23A;EXOSC10;RPS16;MAGOH;RPL9;CNOT8;ATM;ZC3H12A;RPLP2;EXOSC4;PNLDC1;XRN2;RPL7A;RPL19;RPS15;SMG1;RPL39;RPLP0;RPL41;RPL5;RPL13;ZFP36L1;EXOSC8;CNOT3;NBDY;RPL27A
prerank,regulation of mast cell degranulation (GO:0043304),-0.7897133762284967,-1.9978582059804697,0.0,0.004069561886545577,0.108,7/14,3.01%,LYN;CD84;FGR;GAB2;SYK;CD300A;FES
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.49301229255464896,-1.9968039310467336,0.0,0.0040908561057193624,0.111,58/132,24.21%,APOE;IGF1;TFEB;MSN;P2RX7;DAPK1;ZC3HAV1;PRKCD;ROCK1;SNX9;TNFRSF1B;INSR;OPTN;ABCD2;FOXO3;CNOT1;RC3H1;ADAM9;PHKG2;PFKFB3;PIK3CB;SNX33;PLK2;ZSWIM8;ATF6;LAPTM5;HIF1A;ADAM8;DAGLB;ARNT;APP;MOV10;PFKFB4;GTPBP1;ZBTB20;FLCN;TICAM1;ABHD5;TRIM68;STK11;SH3GLB1;PIK3C2A;TRIM14;FAF1;TMEM59;IRS2;CNOT8;GSK3B;HMGB1;GRSF1;DTX3L;ZC3H12A;PTPN1;MEFV;GPLD1;PIM2;MTDH;DCN
prerank,positive regulation of defense response (GO:0031349),-0.5325355743927443,-1.9927018041999192,0.0,0.004171127809976096,0.115,32/89,18.52%,CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;IL15;TLR4;DHX9;IL18;RIOK3;PTGER4;IL17RA;GRN;IFI35;GBP5;MDK;ABCC1;MEF2C;ADAM8;LPL;POLR3G;NFKBIZ;APP;AGT;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;LILRA5;TRADD
prerank,muscle cell differentiation (GO:0042692),0.6194412993941507,1.9883983189401122,0.0,0.00778918970489184,0.384,10/32,10.68%,SGCZ;RORA;DMD;FBXO40;GLMN;MRTFA;NEBL;MYOCD;POPDC2;TBX1
prerank,axon guidance (GO:0007411),0.4430171888012447,1.987116154449526,0.0,0.0077825549606798375,0.39,61/201,12.67%,NRXN1;ROBO1;NRXN3;UNC5C;NCAM1;DAB1;ROBO2;CNTN6;KIF5C;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;UNC5D;SHC3;EPHA7;TNR;DOK6;EPHA5;SEMA6A;GRB10;NFIB;SEMA3E;SEMA5A;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;TMEFF1;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;GFRA2;FYN;SPTBN4;EPHA10;SEMA3F;PLXNA4;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SEMA5B;CDK5R1;SMO;ARHGAP35;PLXNA2;RET;VLDLR;EPHB4
prerank,neuronal action potential (GO:0019228),0.6857144804202295,1.985959702703431,0.0023923444976076554,0.007801708090197507,0.395,11/22,15.92%,ANK3;KCNMB2;KCNMB3;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1;KCNA2;CACNA1G;SCN10A
prerank,defense response to virus (GO:0051607),-0.5208842626668106,-1.9841219364821998,0.0,0.004804156114128002,0.136,45/100,22.42%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;IRF2;FLNA;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;MYD88;EXOSC5;BST2;EIF2AK2;ATAD3A;IFITM2;MOV10;RELA;IFIT1;OASL;IFIT2;RNASE6;OAS3;CD40;MAVS;ISG15;SKP2;G3BP1;MLKL;BNIP3L;ZDHHC1;OAS2;TTC4;STAT1;SERINC3;EXOSC4;IFITM1;RNF135;IL6
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.7867946882950567,-1.9830558459793708,0.0,0.004806881103415652,0.14,7/15,12.14%,OSBPL8;PLIN2;PPARG;OSBPL11;LPL;APOC4;ABHD5
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.6021419908204196,-1.9815286079185583,0.0,0.004809482229553865,0.144,26/45,22.42%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;HSPB1;NOD2;LGALS9;AGER;TMEM106A;NLRP3;IL6
prerank,regulation of innate immune response (GO:0045088),-0.5729934263263072,-1.9732520454245175,0.0,0.005331441541288392,0.162,31/57,23.13%,FGR;BIRC3;TLR8;SAMHD1;USP18;RNASEL;DHX58;DHX9;RIOK3;PTPN22;IFNAR2;ABCE1;IRAK3;IFI35;GBP5;PTPN6;ADAM8;POLR3G;PARP9;FCGR2B;NLRC3;HSP90AB1;CCL5;POLR3B;APPL2;CASP8;PTPN11;APPL1;PTPN1;RNF135;SLC15A4
prerank,central nervous system development (GO:0007417),0.4342187304926507,1.9728066405989002,0.0,0.008935526065965739,0.442,70/250,13.37%,CNTNAP2;ASIC2;ADGRL3;GRIN2A;SPOCK1;GRIK1;ROBO2;CNTN6;EML1;CNTN4;SOX11;DCLK1;CDH2;GRIN2B;ADAM22;SLC8A3;AFF2;SERPINI1;AHI1;MEIS1;EPHA7;NFIB;SH3GL2;SYNJ2;IL1RAPL2;SMARCA1;NRCAM;SOX6;VCAN;POU6F2;PAX8;SHROOM4;SLC6A17;ADAM23;SOX12;MAL;APOD;RPS6KA6;MOG;VIT;SH3GL3;PTS;NCKAP1;DSCAML1;ADGRA2;CDK5RAP3;SOX9;CX3CR1;ADGRL2;PTPRZ1;DNER;B3GNT5;ZFHX2;CHST8;RELN;GSN;GSTP1;MFSD2A;CDK5R1;SMO;EEF1AKMT4-ECE2;PKD1;HES5;ZIC2;AMIGO2;PBX1;ZIC4;CDK5RAP2;ADGRG1;PAFAH1B2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.5492822599740994,-1.9714562459192762,0.0,0.005376018811700502,0.167,23/62,15.07%,LYN;RUNX1;PRKCB;CDK6;CNOT4;CREBBP;FES;SPI1;CTR9;HSPA9;PTK2B;PF4;WDR5;PRMT1;CBFB;KMT2C;MEF2C;MOV10;KMT2D;NFE2;TNRC6C;SIN3A;PRMT6
prerank,B cell differentiation (GO:0030183),-0.5892503764300878,-1.9682764581404983,0.0,0.005497231049118964,0.175,24/46,25.76%,PTPRC;ITGA4;PLCG2;TPD52;PTPRJ;LYL1;ITGB1;BLNK;HHEX;KLF6;CEBPG;FNIP1;DNAJB9;IRF2BP2;NFAM1;HDAC5;TCF3;CD79A;ZBTB7A;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.540107172094614,1.9673507154036094,0.0,0.009351370387536247,0.465,21/57,15.93%,GRM7;CHRM2;CHRM3;ADCY2;GRM8;ADCY8;GPR37;P2RY12;ADCY5;HRH3;GNAI1;ADCY3;GABBR1;ADCY1;CORT;NPY1R;HTR1B;OPRK1;GNAL;OPRL1;OPRM1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.44323210050742756,-1.964888655960543,0.0,0.00569028856810588,0.183,135/306,25.76%,EXT1;APOE;B4GALT5;FAM111A;RBMS1;TOP3A;MEF2A;AGO2;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;BRCA1;GSPT1;POLE2;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;BLM;RAD1;RPL12;RRBP1;MRPL42;RPS14;TUFM;EEF1B2;POLR2H;MCM6;RPL32;E2F1;RPS28;RPS13;POLR2F;THAP1;RPS15A;PCLAF;POLR2L;DARS1;RPS27A;RPL28;RPS4X;MCM9;MCM3;DBF4;EEF2;EIF4EBP2;GTPBP1;TIMELESS;CDK1;RPS23;ORC5;WRN;RPL22;EXO1;RPL14;EEF1A1;FEN1;KAT7;MRPS6;TICRR;RPL34;GCNT1;RPA3;RPS11;MRPS11;RPL6;DUT;POLD2;RHNO1;EPC1;POLR2A;RFC2;LARGE1;EIF4G1;TOP1MT;RPS10;RPL18A;NFKBIB;MRPS16;TOPBP1;MCM2;BRIP1;RPL37A;POLR2G;MRPL34;RPS9;MRPS15;DNA2;RPS27;RAD9A;ABCF1;RPS3;DTX1;GTPBP2;RNPS1;RPL23A;POLR3A;RBBP8;RPS16;COPS5;RPL9;MED20;MMS19;ATM;CHEK1;RFC3;TIPIN;RPLP2;POLR2I;XAB2;NBN;MRPL51;TOPORS;INHA;CDC45;RPL7A;RPL19;SET;RPS15;RPL39;RPLP0;MCM5;RPL41;MRPL18;EEFSEC;MRPS7;RPL5;EEF1D;RECQL5;RPL13
prerank,detection of calcium ion (GO:0005513),0.772908089495161,1.9632627710198072,0.0,0.00974027841352166,0.487,9/13,13.42%,RYR2;SYT1;KCNMB2;KCNMB3;CASQ2;KCNIP2;CALM1;CALM3;CALM2
prerank,synaptic vesicle exocytosis (GO:0016079),0.5785447793106112,1.9600022652634308,0.0,0.009973068141832285,0.506,12/40,6.54%,RIMS2;RIMS1;SYT1;PCLO;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;STX2;SYT5
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.5014917831858684,-1.9568600013200272,0.0,0.00657851342457249,0.214,36/109,13.76%,LYN;VAV3;GRB2;GAB2;PLCG2;SYK;PAK2;RAC1;JUN;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;CARD11;TEC;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;PSMC3;RELA;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1
prerank,Fc receptor signaling pathway (GO:0038093),-0.5010491876779642,-1.9557504565598458,0.0,0.006520763115883494,0.215,36/110,13.76%,LYN;VAV3;GRB2;GAB2;PLCG2;SYK;PAK2;RAC1;JUN;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;CARD11;TEC;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;PSMC3;RELA;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1
prerank,action potential (GO:0001508),0.5713966711921593,1.9514780181325968,0.002277904328018223,0.010932914539965527,0.544,11/44,7.06%,KCND2;AKAP6;ANK3;DMD;KCNMB2;KCNMB3;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1
prerank,neuropeptide signaling pathway (GO:0007218),0.5425553915066962,1.9512643463853712,0.0,0.010793491846720304,0.546,20/58,16.10%,SORCS1;HCRTR2;GLRA1;SORCS3;GPR37;PNOC;OPRD1;GPR149;NTSR1;GLRA2;GALR1;CPE;PDYN;NTS;GLRA3;OPRK1;PENK;OPRL1;OPRM1;GRP
prerank,defense response to symbiont (GO:0140546),-0.5185829053583506,-1.951008150432209,0.0,0.007068381771934383,0.235,42/92,22.42%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;IRF2;FLNA;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;MYD88;EXOSC5;BST2;EIF2AK2;IFITM2;MOV10;RELA;IFIT1;OASL;IFIT2;RNASE6;OAS3;CD40;MAVS;ISG15;SKP2;G3BP1;MLKL;BNIP3L;OAS2;TTC4;STAT1;SERINC3;EXOSC4;IFITM1;IL6
prerank,positive regulation of interferon-beta production (GO:0032728),-0.6221451983717613,-1.9489509341292865,0.0,0.0071453935449811885,0.243,19/33,24.83%,TLR8;TLR7;DHX58;TLR4;DHX9;RIOK3;IRF5;POLR3G;OAS3;POLR3B;MAVS;ISG15;PTPN11;POLR3A;DDX3X;OAS2;RNF135;TOMM70;POLR3D
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6534993307438969,-1.945587279140923,0.0,0.007567706570943466,0.255,13/27,10.56%,PRKCH;ABCA1;MSR1;ABCG1;CD36;PPARG;IL18;NFKB1;ITGAV;NR1H2;PF4;LPL;AGT
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5808254899057257,-1.943462389103964,0.0017857142857142857,0.007655403238773075,0.258,18/47,13.96%,PID1;GRB2;PLCG2;SYK;XDH;CYBA;PRKCD;ITGB2;CD36;RIPK1;RNF41;TLR4;MAPK14;AGT;GADD45A;CBR1;SLC5A3;TGFBR2
prerank,positive regulation of cell junction assembly (GO:1901890),0.5244760048369714,1.9401402837385098,0.0,0.01229418102484206,0.593,13/56,7.13%,CNTNAP2;NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;TSC1;EPHB1;CUX2;CLSTN1;BDNF
prerank,excitatory postsynaptic potential (GO:0060079),0.6911689756958267,1.9388989676673272,0.0,0.012170296210785147,0.597,4/19,1.34%,MPP2;GRID2;GRIN2A;GRIN2B
prerank,plasma membrane invagination (GO:0099024),-0.6396875321200086,-1.9372339456597278,0.0,0.008522849904465219,0.282,13/29,12.50%,MSR1;ARHGAP25;MYH9;ITGB2;CD36;SNX9;RHOA;CDC42;SNX33;SH3BP1;ARHGAP12;SNX18;FCGR2B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6186812263025172,1.9367548253366509,0.0,0.0122905426167258,0.604,7/30,3.32%,FGF12;ANK2;CACNA1C;RYR2;CACNA2D1;SCN2B;SCN1A
prerank,heart process (GO:0003015),0.7531958943932898,1.9329797836499518,0.0,0.012815166415584603,0.618,5/14,9.30%,SGCZ;SGCD;RAMP3;FYN;SGCG
prerank,sensory perception of smell (GO:0007608),0.7931325400243593,1.9320798331532583,0.0,0.012815837788510817,0.622,5/11,14.33%,SLC24A4;SYT10;ADCY3;UBR3;MKKS
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5532336782402166,1.931802190512615,0.0,0.012649905387593313,0.623,16/54,8.19%,DPP10;KCNIP4;DPP6;AKAP6;KCNN2;KCNIP1;KCNMB2;KCNMB3;KCNJ6;KCNJ3;KCNJ10;KCNJ9;KCNIP2;GABBR1;KCNJ16;NEDD4
prerank,fatty acid transport (GO:0015908),-0.7190160380114824,-1.92891723982849,0.0,0.009952512437652368,0.328,7/17,10.29%,APOE;CD36;PPARD;FABP5;PPARG;SLC27A1;FABP4
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.745994261519582,1.9287742993911337,0.0024390243902439024,0.012970924934466397,0.646,8/12,13.14%,RIMS2;RIMS1;SYT1;UNC13C;SYT2;SYT5;UNC13B;SYT7
prerank,regulation of dendrite morphogenesis (GO:0048814),0.596061750659098,1.926100699604189,0.0,0.013120751322418052,0.654,13/32,12.80%,ADGRB3;PTPRD;HECW1;IL1RAPL1;CDKL5;HECW2;LZTS1;CUX2;KNDC1;NEDD4;CAPRIN2;TNIK;SDC2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5999330832462276,-1.920996945571809,0.0,0.011224087455343982,0.364,18/38,16.97%,SASH1;TLR8;CYBA;DHX58;DHX9;RIOK3;DDX60;GRN;IFI35;GBP5;PUM2;LY96;ADAM8;POLR3G;OASL;CCL5;POLR3B;ZCCHC3
prerank,regulation of cellular component size (GO:0032535),-0.632301789502808,-1.9179486973823459,0.0,0.011539671877165324,0.378,12/30,10.81%,VAV3;MSN;RIN3;RAC1;EPS8;VAV1;RARG;PICALM;PPP1CA;VAV2;MTPN;HP1BP3
prerank,regulation of cytokine production (GO:0001817),-0.4737626279982951,-1.9159464755423328,0.0,0.011781999234007592,0.39,34/126,14.85%,LYN;PTPRC;ATP2B1;FOXP1;FGR;CCR2;BCL6;TNFRSF1B;GAPDH;PLD3;HTR2B;MAPKAPK2;IL15;SRGN;PTGER4;ANXA1;MAPK14;BATF;TRAF3;PIK3CG;SIRPA;EIF2AK2;CD28;CLEC9A;AFAP1L2;AGT;CLEC6A;FCGR2B;ITK;PIK3CD;NFAM1;MAST2;AGPAT1;TXK
prerank,type I interferon signaling pathway (GO:0060337),-0.5959045817790352,-1.9159318258398863,0.0,0.011395704177154884,0.39,25/41,23.14%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,cellular response to type I interferon (GO:0071357),-0.5959045817790352,-1.9159318258398863,0.0,0.011395704177154884,0.39,25/41,23.14%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,positive regulation of type I interferon production (GO:0032481),-0.5282068616553038,-1.9156220084294415,0.0,0.01135081102338819,0.391,38/73,24.83%,TLR8;CREBBP;CGAS;GAPDH;TLR7;DHX58;TLR4;DHX9;STAT6;RIOK3;NFKB1;IRF5;PTPN22;CTNNB1;POLR2H;MYD88;POLR2F;POLR2L;POLR3G;XRCC6;RELA;OAS3;DHX36;POLR3B;MAVS;ISG15;G3BP1;PTPN11;POLR3A;DDX3X;OAS2;STAT1;LRRFIP1;RNF135;TOMM70;PRKDC;POLR3GL;POLR3D
prerank,regulation of interleukin-8 production (GO:0032677),-0.5295788856572963,-1.914262291570463,0.0016556291390728477,0.011404988498580296,0.398,26/69,19.87%,PTPRC;CD74;SYK;TLR8;ANXA4;TLR7;RIPK1;STAT3;TLR4;RAB1A;PTPN22;ANXA1;ARRB1;MYD88;MAP2K5;NOD1;AFAP1L2;RELA;CD2;SERPINE1;TMSB4X;MAVS;HSPA1A;NOD2;LGALS9;HMGB1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5946583109141408,-1.9134970090224381,0.0,0.01138057713621176,0.402,18/38,23.10%,SP100;ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;STX4;CASP8;TRADD;DDX3X;GSK3B;TMC8;SFRP1;FEM1B;HMOX1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.4103953630288783,-1.9103755828369442,0.0,0.011659768009823606,0.414,197/532,24.52%,F13A1;CD44;MAP3K8;MSN;SP100;BIRC3;GRB2;GAB2;CCR2;SYK;VIM;PAK2;MCL1;SAMHD1;BCL6;PRKCD;CBL;ITGB2;CD36;RAP1B;PTPRJ;PITPNA;TNFRSF1B;BCL2L11;CSF2RA;CANX;IRF2;ANXA2;PSME4;VAV1;GRAP2;CD300LF;RNASEL;RIPK1;SPI1;TRAF5;IL6R;IRAK2;ABL2;IL10RB;STAT3;TAB2;FOXO3;PSMB7;IL15;CCR1;CTR9;TEC;SLC27A1;CDC42;PELI1;PSME3;IL18;STAT6;ITGB1;HSPA9;PIM1;PTK2B;NFKB1;ADIPOR1;IRF5;FBXW11;BCL2;AIM2;ANXA1;IFNAR2;IL17RA;PSMB9;IRAK4;CIITA;BATF;RSAD2;PF4;STX3;TRAF3;PIK3CB;HGF;FN1;IRAK3;HNRNPDL;STAT5B;IL18RAP;STAT4;IFI35;VEGFA;MYD88;B2M;BST2;JAK1;LMNB1;NOD1;IFITM2;PTPN6;HIF1A;PSMA8;UBC;RPS27A;LCP1;GBP2;EGR1;CD27;TNIP2;IFNGR2;PSMC3;ITGAX;TRAF1;LCK;IL7R;IL2RG;IL4R;CRK;IFNAR1;RELA;PIK3CA;CSF2RB;HSP90B1;IFIT1;IL20RA;PSMD8;OASL;CCL5;IFIT2;TRIM68;FCER1G;CASP1;OAS3;CAPZA1;PSMC4;SOCS6;PSMB10;MT2A;PIK3CD;TRAF2;CNTFR;PSMA1;CD40;IL34;TMSB4X;CRKL;IKBKB;IL31RA;APPL2;IL27RA;ISG15;IL2RB;STX4;IL18R1;HCK;PSMB8;TNFRSF25;GATA3;IRS2;SOCS3;LIMS1;PTPN11;TRADD;IL1R2;NOD2;CSF1;PSMD4;IL7;PSMA5;CFL1;SLA;OAS2;PSMB3;APPL1;PSMD3;MMP1;MMP2;STAT1;PLP2;TRIM25;IFITM1;ILK;TNFSF9;IFNGR1;IL6;GSTO1;CNN2;TGFB1;SOCS5;MAP3K3;P4HB;RPS6KA5;HMOX1;TYK2;GREM2;RPLP0;IL2RA;FLT3;SHC1;ITGAM;CCL7;TNFRSF13B;MYC;PSMB1
prerank,superoxide metabolic process (GO:0006801),-0.6349862246982003,-1.9092534291728682,0.0,0.011632236090083762,0.414,10/29,14.77%,CYBB;SH3PXD2B;CYBA;NRROS;ATP7A;NCF1;PRDX1;NCF4;NCF2;PRDX2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.6934648724791307,-1.9089118170101058,0.0,0.011605526018694363,0.417,8/20,4.23%,BIRC3;SDCBP;NUPR1;OGT;PDCD6IP;RIPK1;CFLAR;PELI1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.6531037979399514,-1.9086910929753413,0.0,0.011434856518419446,0.417,10/25,11.52%,RBPJ;BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;CCDC88A
prerank,mitotic sister chromatid segregation (GO:0000070),-0.4961596115823595,-1.9059198324038042,0.0,0.011732737572467431,0.432,49/98,23.11%,RB1;PDCD6IP;CSNK2A1;EML4;NCAPG2;PIBF1;NIPBL;CHMP5;DLGAP5;KIF23;SMC4;NCAPH;KLHL22;MCPH1;CENPE;CENPK;KIFC1;KIF14;CHMP7;NAA50;CDK1;CHMP1A;KNSTRN;CHMP2A;NUSAP1;KIF2C;POGZ;INO80;SGO1;KMT5A;NCAPD3;NDC80;CEP55;KIF18B;PHF13;SMC1A;RAB11A;PRC1;PDS5B;KIF22;NCAPG;NUP62;CHMP4B;CHMP4A;VPS4A;NSL1;BECN1;SET;CCNB1
prerank,bone development (GO:0060348),-0.5926802301022819,-1.9058945598709027,0.0,0.011565127035717897,0.432,11/39,10.09%,PTPRC;AKAP13;SH3PXD2B;SLC10A7;MBTPS2;PTGER4;DYM;LRP6;SKI;SULF2;TGM2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7354133725193064,1.905011526022464,0.0,0.016888741391654326,0.751,8/15,11.40%,GRM7;GRM5;GRM8;GRM1;GRM3;HOMER1;TRPM1;HOMER3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.46023989015152766,-1.901777751536792,0.0,0.012078054455941525,0.454,73/158,27.24%,AKAP13;PRKCB;CD74;BIRC3;REL;LITAF;RHOA;GAPDH;FLNA;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;CARD11;CFLAR;PELI1;IRAK4;RNF31;RBCK1;TFG;PLK2;MYD88;BST2;WLS;NOD1;NEK6;TNIP2;PLEKHG5;RELA;TICAM1;CLEC6A;JMJD8;TRIM68;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;DDX1;MAVS;TRIM14;TNFSF10;GPRC5B;CASP8;MIER1;TRADD;SHISA5;NOD2;LGALS9;NDFIP2;TICAM2;S100A4;TMEM106A;TMED4;NUP62;TRIM25;ZDHHC13;MAP3K3;TMEM9B;HMOX1;PIM2;MTDH;UBE2N;ECT2;EEF1D;VAPA;CC2D1A;ATP2C1;CARD16
prerank,central nervous system neuron differentiation (GO:0021953),0.5889436095901478,1.900039726110412,0.0,0.017663996829469925,0.764,7/33,7.08%,MDGA2;GRID2;SPOCK1;MAP2;NTRK2;KNDC1;TOX
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5636906637241496,1.8997414781518016,0.0,0.01745032509817032,0.764,16/41,13.10%,AKAP6;ANK3;ANK2;KCNN2;KCNMB2;KCNMB3;KCNJ6;KCNJ3;KCNJ10;KCNJ9;GABBR1;KCNJ16;PIRT;STAC;KCNMA1;KCNJ12
prerank,myeloid leukocyte differentiation (GO:0002573),-0.531701712526789,-1.8972869273180533,0.0,0.01262799775324398,0.471,27/65,19.32%,FOXP1;RUNX1;SNX10;GAB2;MYH9;DEK;SBNO2;PPARG;SPI1;IL15;CDC42;MT1G;MAPK14;BATF;CBFA2T3;VEGFA;E2F1;PIK3CD;BATF3;RXRA;TGFBR2;IL31RA;CASP8;RARA;OSTM1;LGALS9;CSF1
prerank,natural killer cell mediated immunity (GO:0002228),-0.7315555964716403,-1.896902557761307,0.0,0.012505573098954646,0.473,7/15,13.98%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG;ULBP1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7111749354920222,1.8902926114361946,0.002320185614849188,0.019339625248278494,0.805,8/16,13.42%,ANK2;CACNA1C;DMD;RYR2;CASQ2;CALM1;CALM3;CALM2
prerank,receptor clustering (GO:0043113),0.6112791415707319,1.888988577508995,0.002457002457002457,0.019381193633963553,0.81,8/27,4.20%,NLGN1;DLG2;NRXN1;MAGI2;LRRC7;DLG3;NRXN2;PTN
prerank,regulation of necroptotic process (GO:0060544),-0.6652958059466658,-1.8854870864556792,0.0,0.015013383716580305,0.532,12/23,17.67%,BIRC3;SDCBP;OGT;PDCD6IP;ARHGEF2;RIPK1;CFLAR;PELI1;SLC25A4;FLOT2;CASP8;MLKL
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6815594031038684,1.883232788632963,0.0,0.020228153572606794,0.826,6/17,6.52%,ANK2;CACNA1C;CACNA2D1;CACNB2;SCN2B;HCN2
prerank,protein localization to synapse (GO:0035418),0.7697601912886209,1.8829562504790716,0.004464285714285714,0.020064542401564706,0.826,4/12,4.11%,NLGN1;NRXN1;PCLO;NRXN2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.6159318069516653,-1.8819059182417242,0.0016835016835016834,0.01573185365567867,0.553,13/29,19.50%,PTPRC;VAV3;CD74;CD38;SASH3;BCL2;MEF2C;NCKAP1L;CD40;BST1;CHRNB2;IRS2;IL7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5697514351221868,-1.8812383567135966,0.0,0.015638175694993685,0.555,20/42,21.38%,ARID2;PPP4C;ACTR2;PPP4R2;CGAS;SPIDR;ERCC6;RTEL1;WDR48;FUS;RAD51;TIMELESS;RADX;RAD51AP1;UBQLN4;WRAP53;SHLD2;MMS19;CHEK1;KDM1A
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5422107449324325,-1.8780990908694704,0.0,0.01617008643291864,0.57,22/59,15.32%,BIRC3;REL;TLR8;ROCK1;TLR7;RIPK1;IRAK2;TAB2;CARD11;TLR4;RNF31;RBCK1;LY96;UBC;RPS27A;RELA;TICAM1;NLRC3;NFKBIL1;TRAF2;RELB;IKBKB
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5941463761228831,-1.8758044286013045,0.0,0.01665681144260515,0.592,20/36,19.80%,CD74;AXL;CD300LF;RIPK1;PARP14;NLRC5;GAS6;LAPTM5;CASP4;HIF1A;PARP9;CASP1;AGPAT1;TXK;CXCR4;MAVS;HSPA1A;CSF1;IL7;TICAM2
prerank,response to muramyl dipeptide (GO:0032495),-0.7670268520470583,-1.8739317965407936,0.001763668430335097,0.017022197481874037,0.605,7/12,8.86%,VIM;ARHGEF2;CHMP5;IRF5;PTPN22;ERBIN;NOD1
prerank,regulation of platelet activation (GO:0010543),-0.6685965335583189,-1.8732107610662445,0.0,0.01693245327968804,0.608,9/21,15.04%,LYN;APOE;SYK;PLEK;TEC;TLR4;FCER1G;TXK;PLA2G4A
prerank,response to alcohol (GO:0097305),0.6199235948043309,1.8703297284040585,0.0,0.023189757969793834,0.878,6/27,1.90%,GRIN2A;GRIN2B;SLIT3;SLIT2;GRIN3A;GLRA1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.5877848396496954,-1.8698456689456535,0.0,0.01757401100646914,0.625,14/35,13.29%,LYN;CDK6;SPI1;STAT3;FOXO3;HSPA9;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A
prerank,positive regulation of response to external stimulus (GO:0032103),-0.47209528323741795,-1.867171036218872,0.0,0.0182299290975574,0.641,41/128,18.56%,SASH1;CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;DHX58;IL15;TLR4;DHX9;IL18;RIOK3;PTGER4;IL17RA;STX3;DDX60;GRN;IFI35;GBP5;MDK;PUM2;ABCC1;LY96;ADAM8;LPL;POLR3G;NFKBIZ;APP;AGT;OASL;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;STX4;ZCCHC3;LILRA5;TRADD;PDGFRB
prerank,sodium ion transmembrane transport (GO:0035725),0.4880376566995308,1.862898649388163,0.0,0.024727866276668085,0.897,26/84,10.76%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;SCN9A;HCN2;ATP1A3;SLC6A1;SLC8A2;HCN1;SLC6A13;SLC6A2;ATP1B1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5140548478652253,-1.861816257011496,0.0,0.019270270631162864,0.667,29/70,20.62%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;PSMB9;LNPEP;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3
prerank,response to exogenous dsRNA (GO:0043330),-0.694810470932699,-1.8592268548936726,0.0035650623885918,0.01971461624883015,0.678,9/18,17.19%,RFTN1;CGAS;DHX9;IRAK3;IFIT1;TICAM1;MAVS;ZCCHC3;RALB
prerank,lysosome localization (GO:0032418),-0.578539370890153,-1.858832233049753,0.0,0.01956952659861151,0.678,16/37,17.61%,TFEB;PLEKHM1;PLEKHM2;MYH9;ARL8B;MILR1;PIK3CG;BORCS6;PIP4P1;CHGA;KXD1;FLCN;PIK3CD;SPAG9;VPS33A;RAB34
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5668342762871561,1.8583404394698797,0.0,0.02577779073932689,0.909,12/39,8.73%,FGF14;HECW1;FGF12;ANK3;DMD;PRKCE;HECW2;SCN2B;PTPN3;NETO1;NEDD4;FXYD6
prerank,sodium ion transport (GO:0006814),0.48270878119602423,1.8564409783963502,0.0,0.026089345336415017,0.915,27/85,10.76%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC9B2;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SCN9A;HCN2;SLC6A1;SLC8A2;HCN1;SLC6A13;SLC5A10;SLC6A2;SLC4A11;ATP1B1
prerank,ventricular septum morphogenesis (GO:0060412),0.601020926258478,1.8549264587934002,0.0024630541871921183,0.02621311852468938,0.916,7/27,4.76%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.4831374120784798,-1.8535225382804075,0.0,0.020944267664882485,0.698,48/95,25.70%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NIPBL;NABP1;BLM;MORF4L1;MCM6;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;MCM3;GEN1;RAD54L;WRN;FEN1;RPA3;RAD51AP1;YY1;RAD54B;INO80;RAD52;ERCC4;LIG3;SLX4;MCM2;XRCC3;RBBP8;POLN;FAN1;SMC6;NBN;GINS4;PALB2;CDC45;MMS22L;MCM5;RAD51C;UBE2N;SMC5;XRCC1;AP5S1;RECQL5
prerank,negative regulation of type I interferon production (GO:0032480),-0.571728942894557,-1.85219686708664,0.0017301038062283738,0.021141923353385002,0.706,21/40,22.27%,LILRB1;REL;OTUD5;DHX58;NLRC5;PPM1B;SIRPA;UBA7;PIN1;PCBP2;NLRC3;RELB;YY1;RNF216;MAVS;NLRX1;ISG15;GPATCH3;RNF125;TRIM25;RNF135
prerank,lymphocyte differentiation (GO:0030098),-0.5163875942368563,-1.847094864808737,0.0,0.022355703735629735,0.725,32/68,25.76%,PTPRC;ITGA4;PLCG2;TPD52;AXL;PTPRJ;LYL1;IKZF1;ITGB1;BLNK;HHEX;PTPN22;KLF6;CEBPG;DNAJB9;LCK;KAT7;PIK3CD;NFAM1;HDAC5;TCF3;RELB;ZAP70;GATA3;CD79A;ZBTB7A;RABL3;CHD7;FLT3;DCAF1;MS4A1;GPS2
prerank,calcium ion transport into cytosol (GO:0060402),0.6428265517958595,1.8456173930773583,0.005012531328320802,0.02867702317033114,0.94,11/21,17.53%,GRIN2A;CACNA1C;RYR2;GRIN2B;CACNA2D1;TRPM1;JPH4;ADRA1A;ATP2B4;JPH3;TRPM2
prerank,response to cadmium ion (GO:0046686),-0.6330449202972283,-1.8453154869338342,0.0,0.022616002666070376,0.733,11/26,13.35%,JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;NCF1;MT2A
prerank,cellular response to cadmium ion (GO:0071276),-0.647283808608707,-1.8447522634155533,0.0,0.022501417376822288,0.734,11/24,13.35%,JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;NCF1;MT2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.471354831807173,1.843073960393391,0.0,0.02910834297692813,0.943,36/75,20.87%,CTNNA2;MAP2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;DCDC2;DSCAML1;SPTBN4;CDHR1;MFSD2A;SLITRK3;BRSK1;SDC2;SLITRK5;BTBD3;KLF7;ZDHHC17;MAP1A;RAB3A;DOCK7;ADGRB1;S100B;CELSR2;LLGL1;LRP4;TMEM106B;ISL1
prerank,positive regulation of chemokine production (GO:0032722),-0.5568361700699659,-1.8415149919025218,0.0,0.02325463935168901,0.756,21/44,23.10%,CD74;SYK;TLR7;IL6R;TLR4;IL18;IL17RA;EIF2AK2;HIF1A;LPL;EGR1;APP;OAS3;MAVS;LGALS9;DDX3X;IL7;HMGB1;AGER;IL6;HMOX1
prerank,cell differentiation in spinal cord (GO:0021515),0.7833847137701366,1.8410152054227387,0.004640371229698376,0.029463118992181358,0.948,3/10,4.09%,MDGA2;SOX6;SOX13
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6449833224563106,-1.8401941624601674,0.0,0.023483306053099704,0.761,13/23,22.33%,PPARG;PIAS1;PARP14;NLRC5;NR1H2;JAK1;PARP9;IFNGR2;HSP90AB1;TXK;SOCS3;STAT1;IFNGR1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.6612656779107072,-1.8389436247244877,0.0017793594306049821,0.023759972724947773,0.776,8/21,13.88%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.614760754338411,1.8388682382746306,0.002398081534772182,0.0298664209753486,0.951,7/25,11.42%,AKAP6;ANK2;TRPC1;CACNB2;RAMP3;NPSR1;CAPN3
prerank,regulation of interleukin-10 production (GO:0032653),-0.5592547981364867,-1.8387647818651849,0.0,0.023533384348371184,0.776,21/44,24.08%,LILRB1;PLCG2;SYK;STAT3;PIBF1;TLR4;TNFRSF21;CD28;TRIB2;CD46;FCGR2B;ISG15;LILRA5;MMP8;NOD2;LGALS9;HMGB1;AGER;CD274;IL6;CD47
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5787580665911237,-1.8379844079369898,0.001692047377326565,0.023596485396503927,0.783,19/37,22.97%,ADCY7;PLD3;ABCD2;STAT3;TLR4;IL17RA;MAPK14;SIRPA;GBP5;MYD88;HIF1A;TICAM1;NLRC3;APPL2;NOD2;APPL1;ZC3H12A;IL6;MEFV
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7400107863488294,1.8360994086220441,0.0,0.030461532408209587,0.953,5/13,5.23%,ANK2;CACNA1C;KCNN2;CACNB2;KCNJ3
prerank,polarized epithelial cell differentiation (GO:0030859),-0.742570209840057,-1.8328967281689825,0.0017123287671232876,0.024760444850406668,0.806,8/13,12.56%,MSN;RHOA;RAP2A;CDC42;ZDHHC7;SH3BP1;SCRIB;RAB10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6880405370126508,1.832469848495775,0.0045871559633027525,0.031217798466317788,0.957,11/15,20.50%,SCN1A;COL11A1;TMC1;KCNA1;ADGRV1;WHRN;PDZD7;MKKS;TMC2;TMEM120A;KIT
prerank,phospholipid transport (GO:0015914),-0.5321456609517043,-1.831673722641511,0.0,0.024936433156636746,0.815,14/52,11.05%,OSBPL8;APOE;ABCA1;ATP8B4;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1;ATP11C;OSBPL5;ABCC1;PRELID2;NPC2
prerank,regulation of chemokine production (GO:0032642),-0.5688404981914204,-1.8303231159272113,0.0,0.02514649310957767,0.82,17/36,23.10%,FOXP1;CD74;TLR7;IL6R;TLR4;IL18;EIF2AK2;HIF1A;LPL;EGR1;APP;LGALS9;IL7;AGER;SNAI2;IL6;HMOX1
prerank,positive regulation of immune effector process (GO:0002699),-0.6239973325483211,-1.8294322907198501,0.0016474464579901153,0.02520317819518149,0.824,12/27,19.21%,PTPRC;CCR2;LILRB1;PTPRJ;DHX58;DDX60;XBP1;CD46;APPL2;MYB;LGALS9;PLA2G5
prerank,recombinational repair (GO:0000725),-0.49216938327243465,-1.8288996956477055,0.0,0.025111089659468323,0.826,41/77,25.70%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NABP1;BLM;MORF4L1;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;GEN1;WRN;FEN1;RPA3;RHNO1;RAD51AP1;YY1;RAD54B;INO80;RAD52;ERCC4;LIG3;SLX4;XRCC3;RBBP8;POLN;FAN1;SMC6;NBN;PALB2;MMS22L;RAD51C;UBE2N;SMC5;XRCC1;AP5S1;RECQL5
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.7704346453183928,1.8286104893679136,0.00477326968973747,0.03224763420512232,0.963,7/10,19.88%,GNB5;FMR1;CALM1;CALM3;CBARP;CRHR1;GPR35
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6551794794336447,1.8284314587811488,0.004618937644341801,0.03193142240238953,0.963,9/20,13.42%,ANK2;CACNA1C;DMD;RYR2;CASQ2;ATP1B1;CALM1;CALM3;CALM2
prerank,regulation of inflammatory response (GO:0050727),-0.43395506417407037,-1.828142774142647,0.0,0.025142639774301385,0.83,50/190,12.94%,APOE;FOXP1;AOAH;BIRC3;CCR2;MFHAS1;BCL6;PRKCD;RB1;TNFRSF1B;PPARD;METRNL;SBNO2;PIK3AP1;BRD4;TLR7;USP18;PPARG;RIPK1;IL15;AREL1;TLR4;DHX9;IL18;SNX6;PTGER4;TNFAIP8L2;ANXA1;IL17RA;GRN;IFI35;SIRPA;MDK;MYD88;CASP4;ABCC1;MAPK7;DAGLB;SELENOS;LPL;OTULIN;NFKBIZ;APP;AGT;RELA;CELF1;NLRC3;CCL5;SERPINE1;CASP1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7118445206244424,-1.8281406588984301,0.00539568345323741,0.02489614330592588,0.83,9/14,19.70%,ARID2;ACTR2;ERCC6;WDR48;FUS;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5540452273129107,1.8278240976651625,0.002257336343115124,0.03187617619764617,0.964,8/38,5.23%,ANK2;CTNNA3;CACNA1C;CACNA2D1;KCND3;CACNB2;SCN2B;KCNJ3
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6775306029924346,-1.8262490099399624,0.0018214936247723133,0.02529946195171504,0.838,10/19,16.90%,RUNX1;ELF1;IRAK2;DHX9;MAP2K5;CBFB;MAPK7;PARP9;MAVS;TAF9
prerank,long-term synaptic potentiation (GO:0060291),0.632043029651491,1.824532675513884,0.00468384074941452,0.03263578494502967,0.966,9/21,9.53%,MPP2;GRIN2A;GRIN2B;SLC24A2;SLC8A3;PRKCZ;TSHZ3;SLC8A2;NFATC4
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.7061625759166943,-1.8238514126811645,0.0017421602787456446,0.025825155809095918,0.848,10/15,22.42%,STAT3;TLR4;IL17RA;GBP5;MYD88;HIF1A;TICAM1;NOD2;APPL1;IL6
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.6989959340299671,-1.8235310950796304,0.003472222222222222,0.025649506667868766,0.848,7/16,13.98%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG;ULBP1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.6792666629410533,-1.8232133484559945,0.0017761989342806395,0.025477171661381755,0.848,12/19,19.50%,ZMIZ1;SYK;AXL;GAS6;MDK;NCKAP1L;CD27;XBP1;XRCC6;ZAP70;GATA3;IL7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5929768647793923,-1.8216814408730293,0.0,0.025859982803071734,0.854,14/30,19.80%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;TNIP3;CASP8;TICAM2
prerank,T cell receptor signaling pathway (GO:0050852),-0.45425105989248576,-1.8216305278987637,0.0,0.025666106394279374,0.854,55/138,20.67%,RFTN1;PTPRC;PLCG2;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;CARD11;TEC;PSME3;RC3H1;NFKB1;FBXW11;PTPN22;PSMB9;RNF31;FYB1;RBCK1;PIK3CB;TNFRSF21;EIF2B3;CD28;PSMA8;NFKBIZ;PSMC3;LCK;RELA;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;PIK3CD;LCP2;PSMA1;TXK;IKBKB;THEMIS;ZAP70;PSMB8;GATA3;DENND1B;PSMD4;PSMA5;PRAM1;NFKBID;PSMB3;EIF2B1;WNK1;PSMD3;ZC3H12A
prerank,negative regulation of programmed cell death (GO:0043069),-0.4054050769046043,-1.8212230450101556,0.0,0.025554799540176962,0.855,158/355,30.41%,DAB2;CD44;IGF1;NOTCH2;CD74;CD38;ARHGAP10;BIRC3;TNFAIP8;PAK2;MCL1;AXL;CBL;RAB7A;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;IGF1R;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;HSPA9;PIM1;PTK2B;NFKB1;ANXA5;BCL2;ANXA1;HGF;CTNNB1;HIGD2A;GAS6;PLK2;GRK5;VEGFA;LAPTM5;BABAM2;MYD88;DNAJA1;WFS1;PLAUR;ATAD3A;CD28;SERPINB9;UBC;RPS27A;CTSH;MGMT;ZFAND6;PRDX5;NCKAP1L;TPT1;CD27;SPRY2;KIF14;XBP1;TXNDC5;CDK1;OSR1;RELA;HSP90B1;HTATIP2;WDR73;TMBIM6;CIB1;PLK3;AVEN;GREM1;GPX4;RASA1;PRDX2;AATF;IKBKB;IL31RA;CLN3;ANKLE2;BID;BNIP2;BAG3;IL2RB;STIL;TAF9;VHL;DNAJC3;HSPA1A;HCK;ATF5;BNIP3L;THOC6;CASP2;HSPB1;API5;COPS5;DDX3X;IL7;CFL1;GSK3B;CAT;NAA16;PPT1;SFRP1;KDR;HAX1;NUP62;HYPK;BCL2L2;HNRNPK;UFM1;TOPORS;MAP4K4;NR1H4;CRYAB;TCIM;IL6;PIM2;FANK1;SHC1;MTDH;LRP2;PRKDC;VDAC1;MYC;PKHD1;PSEN2;MT3;TMEM14A;SIAH2;RPS6KA3;VIP;MRE11;HIPK3;PDPN;HIGD1A;BCL2L1;NAA38;APIP;CITED2;FFAR4;LEF1;PRELID1;AQP1;GHRL;RIPK3;RIPK2;IL2;PAX2;BNIP3;NGFR;XIAP;MET;IFIT3;TRAF6
prerank,inorganic anion transmembrane transport (GO:0098661),0.49855775228299853,1.8210853204288249,0.0,0.03364921106187659,0.971,22/63,14.09%,GABRB3;GABRG3;GABRB1;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2;SLC25A11;SLC12A5;CLCN3;GLRA3
prerank,mesonephric tubule development (GO:0072164),0.6891322566098528,1.8198071116699064,0.004545454545454545,0.03373308103358217,0.973,6/15,11.52%,ROBO2;SLIT2;WT1;BMP7;SALL1;PKD1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6559739626524148,-1.8192175003699802,0.005291005291005291,0.02593764951240793,0.864,13/21,17.95%,PTPRC;PRKCH;FOXP1;PRKCB;CARD11;STAP1;LCK;RELA;RAB29;NFAM1;CD226;TESPA1;RPS3
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.5122852066246663,-1.818895394085439,0.0,0.025814817774762293,0.864,31/66,22.97%,FOXP1;IGF1;P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;SIRPA;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;HSPB1;NOD2;LGALS9;AGER;ZC3H12A;TMEM106A;NLRP3;IL6;MEFV
prerank,response to interferon-gamma (GO:0034341),-0.50311609386924,-1.81872231256845,0.0,0.025628268782608144,0.865,30/67,25.85%,CD74;SP100;DAPK1;GAPDH;KYNU;TLR4;DAPK3;CIITA;NUB1;SIRPA;GBP5;BST2;IFITM2;GBP2;CXCL16;CCL5;CASP1;GCH1;CD40;GBP3;LGALS9;GBP7;GBP6;STAT1;IFITM1;MEFV;CCL7;CD47;GBP4;IL12RB1
prerank,negative chemotaxis (GO:0050919),0.5671279582263038,1.8181103233541458,0.007389162561576354,0.03402109328274504,0.974,12/33,9.94%,ROBO1;UNC5C;SLIT3;SLIT2;SEMA6D;EPHA7;SEMA6A;SEMA3E;SLIT1;ITGB3;SEMA3F;LGR6
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.5363106766352667,-1.816122891091823,0.0017006802721088435,0.026424932513356553,0.876,19/49,19.87%,CD74;SYK;TLR8;TLR7;RIPK1;STAT3;TLR4;RAB1A;MYD88;NOD1;AFAP1L2;RELA;CD2;SERPINE1;MAVS;HSPA1A;NOD2;LGALS9;HMGB1
prerank,regulation of apoptotic process (GO:0042981),-0.3831905963178434,-1.8158966572072992,0.0,0.026279473994002496,0.877,226/676,22.42%,DAB2;CTSB;CD44;VAV3;MAP3K5;AKAP13;APAF1;IGF1;NOTCH2;CD74;CD38;ABR;CTSD;ARHGAP10;BIRC3;LILRB1;ITSN1;TNFAIP8;DAPK1;PAK2;MCL1;CRADD;BCL6;AXL;CBL;JUN;DNM2;NIBAN2;ARHGEF3;BFAR;BIRC6;CREBBP;ANO6;NUPR1;BCL2L11;ANXA4;MAP3K20;CTNNBL1;FLNA;ARHGEF2;IGF1R;SON;CALHM2;VAV1;MALT1;RIPK1;SGK1;HTR2B;FOXO3;ANP32A;AREL1;CFLAR;FGD4;NLRC4;ATG7;ITGB1;HSPA9;RYBP;PIM1;PTK2B;NFKB1;TOP2A;ANXA5;RARG;PRMT2;IRF5;BCL2;ANP32B;DAPK3;ANXA1;RPS6;STEAP3;STK3;FGD3;HGF;ARHGEF18;CTNNB1;USP36;HIGD2A;GAS6;PLK2;GRK5;ATF6;NF2;HIP1;VEGFA;NME1;E2F1;BABAM2;MYD88;DNAJA1;WFS1;PLAUR;ATAD3A;CD28;PTPN6;VAV2;SOS2;MEF2C;SERPINB9;UBC;RPS27A;CTSH;MGMT;ZFAND6;PRDX5;SUDS3;NCKAP1L;TGM2;TPT1;CD27;SCRIB;SPRY2;AGT;KIF14;IKZF3;GNA13;DUSP6;XBP1;FLCN;TXNDC5;PSENEN;OSGIN1;ARHGEF11;CDK1;PLEKHG5;OSR1;RELA;HSP90B1;GADD45A;WRN;TRIM24;STK17B;HTATIP2;EEF1E1;USP42;MLLT11;WDR73;TMBIM6;FBXO10;IFIT2;CIB1;PLK3;LGALS1;CASP1;AVEN;DFFA;TRAF2;IGFBP3;GREM1;TRIO;RASA1;TFAP4;PRDX2;MAP3K10;AATF;IKBKB;IL31RA;SHQ1;CLN3;LATS2;ANKLE2;QRICH1;BID;ARHGEF5;BNIP2;RABGGTA;KLF11;TNFSF10;BAG3;IL2RB;FAF1;SPHK2;STIL;TAF9;VHL;SKP2;CASP8;DNAJC3;HSPA1A;PHLDA1;HCK;ATF5;TNFRSF25;BNIP3L;RPS3;IFT57;RNPS1;THOC6;TRADD;PDCD5;CASP2;HSPB1;API5;RABGGTB;COPS5;DDX3X;IL7;CFL1;C1QBP;GSK3B;ATM;HMGB1;CAT;NAA16;PPT1;SFRP1;STAT1;RACK1;KDR;HAX1;NUP62;HYPK;BCL2L2;HNRNPK;CDK5;UFM1;TOPORS;MAP4K4;TNFSF9;CD3E;NR1H4;TOMM70;CRYAB;TCIM;IL6
prerank,lipoprotein biosynthetic process (GO:0042158),-0.7666066877716453,-1.8154082573696904,0.005145797598627788,0.026211435002320857,0.878,3/11,4.78%,APOE;ATG7;ATG10
prerank,T cell activation (GO:0042110),-0.5086746881180535,-1.8153517670287351,0.001692047377326565,0.025985474355749126,0.878,38/69,33.33%,PTPRC;CD44;CD74;MSN;KIF13B;DPP4;PTPN22;PIK3CG;MDK;CD28;JAML;LCP1;SCRIB;LCK;RAB29;CD2;NLRC3;ITK;CXADR;PIK3CD;CASP8;ZAP70;GATA3;CD3E;DDOST;CHD7;NCK1;CRTAM;IL2;NCK2;LAT;CD8B;ADA;CD4;CCL19;CD8A;IRF4;SLA2
prerank,phagosome maturation (GO:0090382),-0.5681739533729013,-1.8117924662258136,0.0,0.026909583637390523,0.885,14/35,20.32%,ATP6V0D2;ATP6V1E1;RAB7A;RAB31;ATP6V1A;RAB20;TCIRG1;RAB32;ATP6V1G1;ATP6V0B;RAB39A;ATP6V0E1;RAB34;ATP6V0D1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.7674893339725257,1.8117905014683575,0.004739336492890996,0.035947472188647404,0.981,6/10,7.35%,GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5718228550031443,1.8117369251248283,0.0022624434389140274,0.035565052271746896,0.981,12/31,15.51%,NLGN1;PPFIA2;TANC2;SRCIN1;SHANK3;CUX2;ABI2;CAPRIN2;RELN;CDK5R1;ARC;SIPA1L1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6264675128508113,1.81048478895752,0.002380952380952381,0.03561097688644257,0.982,9/24,15.26%,AKAP6;DMD;PDE4D;CASQ2;JPH4;CALM1;CALM3;CALM2;JPH3
prerank,negative regulation of lipid storage (GO:0010888),-0.6664310843206308,-1.8099676756689789,0.0017985611510791368,0.027484380514021252,0.892,9/19,13.03%,OSBPL8;ABCA1;ABCG1;PPARD;PPARG;ITGAV;NR1H2;ABHD5;TTC39B
prerank,positive regulation of inflammatory response (GO:0050729),-0.484364349737736,-1.8096013817179817,0.0,0.027408503282395982,0.893,27/86,18.52%,CCR2;NUPR1;TLR7;RIPK1;IL15;TLR4;DHX9;IL18;PTGER4;IL17RA;GRN;IFI35;MDK;ABCC1;ADAM8;LPL;NFKBIZ;APP;AGT;SERPINE1;KARS1;PLA2G7;GPRC5B;LILRA5;SNX4;MMP8;TRADD
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5022971882849601,-1.8072343572953098,0.0,0.027949057002984914,0.898,27/67,20.62%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;PSMB9;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7245502275084817,-1.8070742562874507,0.0034129692832764505,0.02777908129205318,0.899,9/13,12.71%,ABCA1;SYK;ITGB2;CD36;PPARG;CD9;ITGB1;LPL;FCER1G
prerank,regulation of exocytosis (GO:0017157),0.523380496370703,1.806828902989316,0.002369668246445498,0.03663581352414231,0.984,11/46,5.24%,RIMS2;CADPS;IL1RAPL1;STXBP5L;SYT1;RAB3C;CPLX1;CADPS2;RAB15;CLASP2;RAB27B
prerank,double-strand break repair (GO:0006302),-0.43881285532837866,-1.8055045739133455,0.0,0.02817663493006261,0.905,73/158,26.23%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;SMARCA5;BRCA1;DCLRE1C;NABP1;ABRAXAS1;BLM;MORF4L1;KDM2A;BABAM2;RAD51;RFWD3;NUCKS1;MCM9;RNF8;PARP9;AP5Z1;APTX;GEN1;XRCC6;DCLRE1A;BABAM1;WRN;FEN1;HMGB2;CIB1;RPA3;XRCC4;APLF;RAD51AP1;YY1;RAD54B;INO80;RAD52;ERCC4;LIG3;SLX4;DDX1;BRIP1;EYA1;DNA2;XRCC3;EYA3;BRCC3;RBBP8;POLN;ATM;HMGB1;BAP1;DTX3L;UBXN1;FAN1;SMC6;NBN;PALB2;POLB;MMS22L;DNTT;PRKDC;RAD51C;UBE2V2;UBE2N;SMC5;XRCC1;AP5S1;RECQL5;BAZ1B;DCLRE1B;VCP
prerank,regulation of RNA metabolic process (GO:0051252),-0.5230418182536389,-1.8052596070401579,0.0,0.028027578233940097,0.905,23/59,14.57%,MITF;AHNAK;MBNL1;PTBP3;TNFRSF1B;MBNL2;TRA2B;SON;RC3H1;AHNAK2;FUS;MBNL3;HNRNPH1;USP36;HNRNPL;METTL4;PCBP2;CELF1;OASL;HNRNPLL;OAS3;ZNF326;RASA1
prerank,translation (GO:0006412),-0.42446468243250646,-1.8042391847562305,0.0,0.028178586806313338,0.906,81/208,25.76%,RARS1;AGO2;RPS18;FARS2;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;NOA1;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;ABCE1;RPL12;RRBP1;MRPL42;RPS14;TUFM;EEF1B2;RPL32;RPS28;RPS13;RPS15A;DARS1;RPS27A;RPL28;RPS4X;FASTKD2;EEF2;EIF4EBP2;GTPBP1;RPS23;RPL22;RPL14;EEF1E1;EEF1A1;MRPS6;RPL34;RPS11;MRPS11;RPL6;EIF4G1;RPS10;RPL18A;KARS1;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;GTPBP2;RPL23A;RPS16;COPS5;RPL9;AARS1;DARS2;RPLP2;MRPL51;MRPL47;RPL7A;RPL19;IARS1;RPS15;RPL39;RPLP0;RPL41;MRPL18;EEFSEC;MRPS7;RPL5;EEF1D;RPL13
prerank,positive regulation of signaling (GO:0023056),0.5476874458449937,1.8037127029297797,0.0,0.03748603120011902,0.985,9/37,6.71%,RIMS2;GRIK2;RIMS1;SYT1;SOX11;CLSTN2;RAMP3;CLSTN1;HOMER1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.39559912830361044,-1.8026318471135323,0.0,0.028612616419431424,0.909,155/416,24.08%,PID1;F13A1;GRB2;GAB2;CCR2;DAPK1;SYK;VIM;MCL1;BCL6;AXL;CBL;ITGB2;CD36;PTPRJ;RHOA;TNFRSF1B;GAPDH;BCL2L11;CSF2RA;NFE2L2;ARHGEF2;SBNO2;VAV1;GRAP2;RIPK1;IL6R;IRAK2;ABL2;IL10RB;LRCH1;BRCA1;STAT3;FOXO3;CCR1;TEC;TLR4;MT1X;DHX9;IL18;STAT6;PTPN12;ITGB1;PIM1;RC3H1;NFKB1;DOCK8;IRF5;BCL2;AIM2;RIPOR2;DAPK3;ANXA1;IFNAR2;IRAK4;BATF;PF4;STX3;PIK3CB;HGF;FN1;TNFRSF21;IRAK3;STAT5B;STAT4;GAS6;VEGFA;SIRPA;GBP5;ERBIN;JAK1;IFITM2;GSDME;PTPN6;HIF1A;UBC;RPS27A;ZFAND6;GBP2;EGR1;IFNGR2;ITGAX;LCK;IL2RG;XBP1;IL4R;TPR;CRK;IFNAR1;RELA;PIK3CA;CSF2RB;HSP90B1;IFIT1;IL20RA;CCL5;CIB1;TCF7;CASP1;SOCS6;MT2A;PIK3CD;CNTFR;CD40;IL34;CRKL;CDC34;IKBKB;IL31RA;CXCR4;HCLS1;IL27RA;IL2RB;STX4;IL18R1;HCK;GATA3;RPS3;SOCS3;PTPN13;PTPN11;TRADD;IL1R2;GBP3;LGALS9;CSF1;GBP7;IL7;SLA;GSK3B;GBP6;WNK1;MMP1;ZC3H12A;MMP2;SFRP1;STAT1;HAX1;PLP2;ASAH1;SHMT1;PTPN7;IFNGR1;IL6;TGFB1;SOCS5;HMOX1;TYK2;GREM2;IL2RA;FLT3;SHC1;ITGAM;CCL7;CD47
prerank,reverse cholesterol transport (GO:0043691),-0.7353177984383199,-1.8008803115752334,0.0018050541516245488,0.029029992128663716,0.914,3/13,0.55%,APOE;ABCA1;ABCG1
prerank,regulation of phagocytosis (GO:0050764),-0.5252818259839489,-1.7996299307258274,0.0016420361247947454,0.029411732015781147,0.921,15/53,12.71%,DOCK2;PTPRC;FGR;SYK;CYBA;SNX3;CAMK1D;IL15;ITGAV;GAS6;SIRPA;TGM2;IL2RG;FCGR2B;FCER1G
prerank,positive regulation of T cell activation (GO:0050870),-0.5092947575009664,-1.7968118092886871,0.0,0.03001819459154504,0.924,33/62,31.82%,PTPRC;ZMIZ1;CCR2;IL15;DOCK8;ANXA1;CYRIB;SIRPA;MDK;CD28;NCKAP1L;LCK;XBP1;CD46;CCL5;FLOT2;ZAP70;GATA3;NOD2;LGALS9;IL7;CD274;CD3E;IL6;CD47;NCK1;TNFRSF13C;PNP;ZBTB1;NCK2;SLC7A1;CD80;CCL19
prerank,neutrophil activation (GO:0042119),-0.7441874244132388,-1.796738679097278,0.0017331022530329288,0.029833182721198732,0.924,5/12,12.71%,SYK;PRKCD;IL15;CCL5;FCER1G
prerank,regulation of neuron projection development (GO:0010975),0.4174543059126189,1.7966709821349685,0.0,0.04001075726901417,0.989,42/163,12.23%,LRRC4C;CSMD3;MAGI2;CTNNA2;IL1RAPL1;LRRC7;SPOCK1;PPFIA2;TENM3;RIT2;CDH2;DCC;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;TANC2;NCS1;NTNG2;NTNG1;PAK3;PTN;MARK1;SRCIN1;SHANK3;KNDC1;ABI2;PRKCI;TOX;BDNF;PRKD1;KANK1;TSKU;LTK;RELN;MFSD2A;CDK5R1;ARHGAP35;DPYSL3;BRSK1;RET
prerank,androgen receptor signaling pathway (GO:0030521),-0.7580869043627074,-1.795949949341068,0.0,0.029859227330351852,0.926,5/11,9.26%,ZMIZ1;KDM3A;PMEPA1;ARID1A;DDX5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7229725450179653,1.795790008092362,0.00881057268722467,0.04002359182677246,0.99,3/11,9.63%,RTP4;PKD1L3;RTP2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6703181188897166,-1.7957448436030763,0.0035714285714285713,0.029687645411648745,0.926,13/20,22.97%,P2RX7;C3AR1;ANO6;P2RX4;PSTPIP1;IL18;C3;APP;HSP90AB1;CASP1;TXNIP;NLRP3;MEFV
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.7196177032566026,-1.7956582284222782,0.0017123287671232876,0.029481380411005564,0.926,8/13,16.87%,FGR;GAB2;SYK;ITGB2;AP1G1;LAMP1;STX4;SPHK2
prerank,positive regulation of potassium ion transport (GO:0043268),0.5453780901069264,1.7955113045131863,0.0,0.03972486749494838,0.99,11/38,7.75%,AKAP6;ANK2;KCNN2;KCNMB2;KCNMB3;KCNJ6;KCNJ3;KCNJ10;KCNJ9;GABBR1;KCNJ16
prerank,negative regulation of apoptotic process (GO:0043066),-0.39351395183462884,-1.7954308184435843,0.0,0.029315219625811878,0.926,182/444,28.56%,DAB2;APOE;PRKCH;CD44;IGF1;NOTCH2;CD74;CD38;ARHGAP10;BIRC3;RNF213;TNFAIP8;PAK2;MCL1;PRKCD;RB1;AXL;CBL;ITGA5;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;CSNK2A1;IGF1R;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;ITGB1;HSPA9;PIM1;PTK2B;SNX6;NFKB1;ANXA5;BCL2;ANXA1;HGF;GRN;CTNNB1;HIGD2A;GAS6;PLK2;GRK5;VEGFA;MDK;BABAM2;MYD88;MAP2K5;DNAJA1;WFS1;PLAUR;FNIP1;ATAD3A;CD28;MEF2C;SERPINB9;ADAM8;UBC;RPS27A;CTSH;MGMT;ZFAND6;YWHAE;PRDX5;NCKAP1L;TPT1;CD27;SPRY2;KIF14;XBP1;TXNDC5;CDK1;OSR1;RELA;PIK3CA;HSP90B1;MAEA;HTATIP2;WDR73;TMBIM6;CIB1;PLK3;RETREG1;AVEN;DFFA;GREM1;RASA1;PRDX2;AATF;IKBKB;IL31RA;CLN3;HCLS1;ANKLE2;BID;BNIP2;BAG3;IL2RB;STIL;TAF9;VHL;DNAJC3;HSPA1A;HCK;ATF5;BNIP3L;THOC6;CASP2;HSPB1;API5;BEX3;COPS5;DDX3X;IL7;CFL1;GSK3B;DNAJB6;NDNF;CAT;NAA16;MAZ;CPEB4;PPT1;ZC3H12A;SFRP1;KDR;HAX1;NUP62;APOH;HYPK;BCL2L2;SFN;SNAI2;HNRNPK;UFM1;TOPORS;MAP4K4;NR1H4;CRYAB;TCIM;IL6;SET;PIM2;MAPK1;FANK1;SHC1;MTDH;LRP2;PRKDC;VDAC1;MYC;PKHD1;PSEN2;MT3;TMEM14A;SIAH2;RPS6KA3;VIP;MRE11;HIPK3;PDPN;HIGD1A;CARD16;KDM2B;BCL2L1;NAA38;POU3F4;FGF20;APIP;CITED2;FFAR4;LEF1;PRELID1;AQP1;GHRL;SLC30A10
prerank,neuron projection fasciculation (GO:0106030),0.7744284165551044,1.793989971621158,0.007177033492822967,0.04004179805856453,0.99,6/10,15.62%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.6255721854177878,-1.7924375670842452,0.003424657534246575,0.030363508341631536,0.929,13/23,22.34%,LILRB1;AXL;TLR4;GAS6;LAPTM5;RARA;LGALS9;C1QBP;HMGB1;CD274;ZC3H12A;INHA;NR1H4
prerank,mononuclear cell differentiation (GO:1903131),-0.6188802158215081,-1.7916641169703127,0.0017211703958691911,0.030457568599975737,0.932,12/24,15.58%,LYN;LILRB1;MYH9;AXL;PPARG;MT1G;IKZF1;GAS6;VEGFA;BATF3;RELB;IL31RA
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.5977575342538628,-1.7906163983977867,0.005199306759098787,0.030676897511044576,0.936,7/26,5.31%,PLCG2;CYBA;CD36;ABCB7;ABCD2;TLR4;COA8
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.63362065803064,-1.787794119570777,0.003418803418803419,0.031844960761496864,0.944,10/22,11.90%,SASH1;MFHAS1;XDH;RELL1;SPI1;MINK1;VEGFA;PRMT1;NCF1;GADD45A
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.552832178104461,-1.7873721281642705,0.0,0.03177467834975222,0.944,17/37,26.34%,SDCBP;OGT;CSNK2A1;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;SGTA;UBXN1;BAG6;EIF3H;RPL5;PML
prerank,superoxide anion generation (GO:0042554),-0.7251700544784455,-1.7871582813209064,0.0,0.03166115062510555,0.946,5/13,12.05%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5846819277594382,-1.7862363770950038,0.0016806722689075631,0.031804099348224216,0.95,13/29,19.80%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;CASP8;TICAM2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.6667604315235667,-1.7858704814464479,0.0,0.03170942481348939,0.95,11/18,24.23%,BIRC3;DHX58;DDX60;PUM2;OASL;SEC14L1;ZCCHC3;GPATCH3;C1QBP;RNF125;PUM1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49575916169897244,-1.7858551374353884,0.0,0.031486119004943684,0.95,30/67,22.79%,NEDD9;NRP1;RREB1;RSU1;CDK6;RAC1;CD36;FLNA;CDC42;PTK2B;TRIOBP;DOCK5;FN1;MYADM;UTRN;MDK;CRK;CIB1;PLEKHA2;CRKL;LIMS1;CSF1;C1QBP;GSK3B;NDNF;SFRP1;JUP;ILK;CD3E;P4HB
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.47611136103349516,-1.7858253980801706,0.0,0.031274540079478164,0.95,22/85,11.09%,LYN;DENND1A;AKAP13;IGF1;NOTCH2;GRB2;STARD8;DENND4C;MYO9B;EPS8;OGT;ARHGAP17;ARHGEF2;VAV1;RASGRP4;ARHGEF18;ERBIN;SH3BP1;SPRY2;RASAL3;KIF14;FLCN
prerank,DNA metabolic process (GO:0006259),-0.4042866458898555,-1.7855121021699436,0.0,0.03113425156483157,0.951,110/270,26.23%,SP100;SAMHD1;TOP3A;DDB2;BACH1;RAD51B;PSME4;BRCA1;UVRAG;RFC1;POLE2;TOP2A;NOC3L;NABP1;PARP4;BLM;RAD1;PRIMPOL;RTEL1;UHRF2;REXO4;PWWP3A;KMT5B;ALKBH1;MCM6;USP3;CNBP;NEIL3;RAD51;UBC;RPS27A;MGMT;KMT5C;MCM3;DBF4;GEN1;TIMELESS;XRCC6;LIG1;CDK1;DNASE1L1;PCNA;RAD54L;ORC5;GADD45A;WRN;EXO1;FEN1;HMGB2;TICRR;UHRF1;ASF1A;RPA3;ENDOG;POLD2;DOT1L;RAD51AP1;RFC2;TOP1MT;INO80;RAD52;ERCC4;UBE2T;LIG3;NSMCE3;CDC34;SLX4;TOPBP1;MCM2;USP7;PRIM1;DNA2;XRCC3;LRWD1;RAD9A;RBBP8;ADPRS;HMGB3;MMS19;SMC1A;ATM;HMGB1;CHEK1;PRIM2;RFC3;PDS5B;ALKBH3;DMC1;FAN1;NBN;CDC45;ZRANB3;NUDT15;POLB;DNTT;EID3;PRKDC;DNASE2;MCM5;POLD4;DDB1;RAD51C;UBE2V2;TSN;TRIM28;UBE2N;XRCC1;RECQL5;DCLRE1B;VCP
prerank,protein transport (GO:0015031),-0.4003102628304136,-1.7853176122190166,0.0,0.031046808381285238,0.951,148/332,26.31%,APOE;ABCA1;RAB8B;PRKCB;ABCG1;ATP6V0D2;CD74;LRP1;MYH9;ATP6V1E1;RAB7A;DNM2;CD36;SNX9;SNX27;SLC10A7;CANX;SNX8;OPTN;ARHGEF2;STX7;GOLGA4;TBC1D15;RAB31;PPARG;SGSM2;UNC93B1;TLK1;ATP6V1A;KIF3B;TBC1D2B;RAB20;TBC1D9;LAMP2;GGA3;TCIRG1;COG7;RAB1A;TOM1;SNX6;TMED10;CENPF;CTSA;STX8;TBC1D5;MACF1;ARL11;STEAP3;TBC1D1;STX3;PREB;TBC1D22A;RAB32;SNX33;GOLPH3L;TBC1D16;TBC1D22B;LAPTM5;TBC1D8B;SIL1;WLS;RAB5A;RCN3;TMED3;SYS1;RAB21;TBC1D8;ATP6V1G1;VPS26B;RAB3D;SEL1L;TBC1D17;SNX13;RAB24;RAB11B;CHMP1A;SAR1A;HSP90B1;RAB29;ARRDC4;STX5;VPS26A;RAB10;TBC1D10B;MIA2;COPA;ATP6V0B;SEC31A;ARRDC1;MIA3;CHMP2A;ARL5A;EHD1;VAMP4;TBC1D30;LMAN2L;RAB13;AP3B1;ARFIP1;STX16;AP3D1;TBC1D9B;STX4;ATP6V0E1;VPS33A;TMED2;RAB34;ARL1;SNX4;RILP;TBC1D25;ARFIP2;SNX1;PDIA4;SLU7;RAB12;TICAM2;TXNIP;ATP6V0D1;PPT1;GOLGA7;BLZF1;TMED4;TBC1D10C;TVP23A;TBC1D4;SCFD2;VMP1;RABL3;TMED5;MON1A;ARRDC2;RAB26;LRP2;ARCN1;FAM91A1;RAB19;CHMP2B;RAB1B;TANGO6;LRSAM1;AFM;NEURL1B;ATP6V0A1;SNX31;COPB2;ARFRP1;RAB22A
prerank,response to lipid (GO:0033993),-0.45530232512662855,-1.7849309322672102,0.0,0.030977416921669325,0.951,30/105,14.55%,FOXP1;ABCG1;MAPKAPK3;CD36;PPARD;OTUD5;PPARG;MAPKAPK2;STAT3;TAB2;FOXO3;TLR4;PELI1;RARG;PTPN22;ANXA1;IRAK3;CTNNB1;STAT5B;ERBIN;TRIB1;LY96;CTSH;ASXL1;IFNAR1;HMGB2;RXRA;GCH1;SPP1;TMEM161A
prerank,negative regulation of B cell activation (GO:0050869),-0.6464061853379872,-1.781723154455475,0.0,0.03216441105678381,0.958,15/21,25.62%,LYN;BANK1;CD300A;RC3H1;TNFRSF21;LAPTM5;FOXJ1;FCGR2B;SAMSN1;ID2;ATM;SFRP1;INHA;TNFRSF13B;BLK
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.5865866330989901,-1.781683394335827,0.0035335689045936395,0.03197202313065773,0.958,14/30,22.42%,PLCG2;SYK;STAT3;PIBF1;TLR4;CD28;CD46;ISG15;LILRA5;NOD2;LGALS9;HMGB1;CD274;IL6
prerank,T cell activation involved in immune response (GO:0002286),-0.725069231786841,-1.7788411777340016,0.0017241379310344827,0.03299603572378174,0.961,6/12,12.71%,CD74;LILRB1;ITGAL;MDK;LCP1;FCER1G
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5795504471057957,-1.7782646387131293,0.0,0.03303033090272055,0.964,14/30,22.17%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;SGTA;UBXN1;BAG6;EIF3H
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.632755427554702,-1.7773893389897528,0.0016750418760469012,0.033276017200135184,0.964,7/24,4.45%,ITGA4;MSN;SYK;ROCK1;ITGB2;ITGAL;ITGB1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6916255265376166,-1.7763131488806296,0.0052173913043478265,0.03351847078311016,0.965,9/15,16.29%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,DNA replication (GO:0006260),-0.4569663314802074,-1.774225446774331,0.0,0.03424827982556148,0.968,49/105,26.81%,FAM111A;RBMS1;TOP3A;BRCA1;RFC1;POLE2;BLM;RAD1;MCM6;PCLAF;MCM9;MCM3;DBF4;TIMELESS;CDK1;ORC5;WRN;EXO1;FEN1;BAZ1A;KAT7;TICRR;RPA3;DUT;POLD2;RHNO1;RFC2;MCMBP;TOP1MT;TOPBP1;MCM2;BRIP1;DNA2;RAD9A;RBBP8;ATM;CHEK1;RFC3;TIPIN;NBN;CDC45;SET;POLB;POLG2;MCM5;POLD4;RECQL5;CDK2AP1;MRE11
prerank,adipose tissue development (GO:0060612),-0.7370116874902981,-1.7733103215401376,0.0016806722689075631,0.03440936870878487,0.969,4/11,2.38%,SH3PXD2B;NAMPT;SPTLC2;ARID5B
prerank,inhibitory synapse assembly (GO:1904862),0.7164233773276486,1.773080749948289,0.009174311926605505,0.04925634102991229,0.995,8/11,21.83%,GABRB3;GABRA2;GABRB2;GABRG2;CBLN4;PLXNB1;WNT5A;LGI2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.5319682289716553,-1.7723514716065538,0.0,0.03466363058680855,0.97,22/48,20.14%,ZMIZ1;DEK;ARID1B;ATAD2;SMARCA5;ERCC6;ACTB;POLR2H;ARID1A;POLR2F;WBP2;POLR2L;ATAD2B;ASF1A;ELOF1;ZMIZ2;SPHK2;TAF1A;POLR1F;SERTAD1;CHEK1;SF3B1
prerank,regulation of acrosome reaction (GO:0060046),0.727350528510643,1.7697463412363577,0.006741573033707865,0.05061124597899264,0.996,3/10,9.66%,PLCB1;GLRA1;PLA2G10
prerank,cellular response to copper ion (GO:0071280),-0.6842513277785243,-1.7687001074280593,0.0016806722689075631,0.03598723040369665,0.974,8/16,4.22%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of programmed cell death (GO:0043068),-0.4025891849598264,-1.7670938233625413,0.0,0.036455462102019005,0.974,87/272,19.87%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;LILRB1;ITSN1;TNFAIP8;DAPK1;SYK;CRADD;BCL6;JUN;DNM2;ARHGEF3;ANO6;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;NLRC4;ATG7;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;STK3;FGD3;ARHGEF18;CTNNB1;ATF6;LAPTM5;E2F1;DNAJA1;VAV2;SOS2;UBC;RPS27A;SUDS3;TGM2;SCRIB;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;PLEKHG5;GADD45A;STK17B;HTATIP2;EEF1E1;MLLT11;IFIT2;IGFBP3;TRIO;TFAP4;MAP3K10;SHQ1;LATS2;QRICH1;BID;ARHGEF5;KLF11;TNFSF10;FAF1;SPHK2;CASP8;PHLDA1;BNIP3L;RNPS1;TRADD;PDCD5;CASP2;DDX3X;C1QBP;ATM;HMGB1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.5284771311884927,-1.7664001341601383,0.0017241379310344827,0.03652842103726949,0.976,18/45,21.00%,IGF1;CD74;CD300A;CDK6;DHX9;FN1;CTNNB1;GAS6;SKI;E2F1;MORC3;AGT;B4GALT7;NLRC3;S100A6;PARP10;SFRP1;PDGFA
prerank,sensory perception of sound (GO:0007605),0.4471728939034657,1.766168365766814,0.0,0.05172535901542143,0.996,31/88,18.30%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;TMC1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;EML2;WHRN;TBX1;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;MKKS;ATP2B2;TMC2;USP53;EPS8L2;ROR1;ALDH7A1;COL1A1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.723211934890617,-1.7651631306182807,0.003552397868561279,0.036770696958203834,0.976,8/13,10.25%,PIK3AP1;TLR7;UNC93B1;IRAK2;IRAK4;MYD88;EPG5;TNIP2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6888563132521699,-1.764280017596438,0.003430531732418525,0.03694842779695777,0.977,8/15,10.56%,PRKCH;MSR1;CD36;IL18;NFKB1;PF4;LPL;AGT
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6698632096157385,-1.7629800337062502,0.001694915254237288,0.03736848896832332,0.978,8/18,6.82%,ROCK1;RAP1B;PTK2B;RUFY3;ARFGEF1;KIF20B;RIPOR2;CYRIB
prerank,response to lipopolysaccharide (GO:0032496),-0.43726220931080034,-1.7626279685670443,0.0,0.03728211755866768,0.978,40/138,13.90%,FOXP1;MAPKAPK3;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;OTUD5;MAPKAPK2;TAB2;CTR9;TLR4;PELI1;STAP1;CHMP5;NFKB1;PTPN22;ADAM9;MAPK14;PF4;IRAK3;SIRPA;MYD88;ERBIN;TRIB1;MEF2C;LY96;SELENOS;TNIP2;XBP1;IFNAR1;RELA;TICAM1;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;GCH1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3885015738649709,1.7625573743620444,0.0,0.05294715445298953,0.996,74/268,17.60%,KCND2;ASIC2;KCNB2;KCNQ3;TRPM3;CACNA1C;RYR3;TRPC5;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;KCNH7;TRPC1;KCNH5;SLC4A4;SCN2A;KCNH1;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;KCNJ10;KCNK2;SCN9A;HCN2;KCNA1;KCNH4;KCNJ16;ATP1A3;SLC6A1;TRPM1;SLC8A2;TMEM175;HCN1;SLC6A13;SLC6A2;SLC4A11;KCNF1;ATP1B1;KCNG1;COX15;PKD1;SCARA5;KCNJ12;KCNV1;KCNH8;ATP2B4;KCNA2;KCNS3;ATP2A1;TRPV3;SLC39A6;CACNA1G;SCN10A;KCNK12;SLC39A13;UCP3;SLC6A5;KCND1;TRPM2;TRPC7;SLC6A11
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.45974953348612485,-1.761611871641632,0.0,0.03751382415319015,0.979,43/101,22.48%,LYN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;IL18;STAP1;CHMP5;NFKB1;PTPN22;ADAM9;MAPK14;PF4;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;XBP1;RELA;TICAM1;CCL5;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;HCK;NOD2;TICAM2;HMGB1;CD274;ZC3H12A;NLRP3;IL6;TGFB1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.691414391553022,-1.7604263635767405,0.0,0.03781772534188759,0.981,8/16,6.82%,ROCK1;RAP1B;PTK2B;RUFY3;ARFGEF1;KIF20B;RIPOR2;CYRIB
prerank,brain development (GO:0007420),0.4206775365094466,1.760197051252231,0.0,0.05360322514345194,0.997,41/136,14.90%,CNTNAP2;CTNNA2;ADGRL3;GRIN2A;ROBO2;EML1;CNTN4;CDH2;GRIN2B;AFF2;MEIS1;EPHA7;NFIB;SYNJ2;SMARCA1;SOX6;SHROOM4;SLC6A17;SHANK3;APOD;DSCAML1;CDK5RAP3;CX3CR1;ADGRL2;B3GNT5;ZFHX2;RELN;MFSD2A;CDK5R1;EEF1AKMT4-ECE2;HES5;ZIC2;AMIGO2;PBX1;CDK5RAP2;ADGRG1;PAFAH1B2;MKKS;UFC1;ARNT2;PAFAH1B3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.6582075508242233,-1.7592789557712807,0.005244755244755245,0.03822233474215985,0.981,5/17,4.84%,PPARD;PANK2;PRKAG2;PPARG;ADIPOR1
prerank,neuromuscular synaptic transmission (GO:0007274),0.6298799319533606,1.757542579128329,0.0,0.05448737178891247,0.997,6/18,10.85%,ERC2;DTNA;KIF1B;SLC5A7;RIMBP2;CHAT
prerank,lipoprotein catabolic process (GO:0042159),-0.7432550307021535,-1.7573893092784623,0.003590664272890485,0.03908159116850837,0.982,3/11,3.39%,APOE;CTSD;ABHD17C
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.47286521318897584,-1.7569868809119746,0.0,0.039061220246767926,0.983,23/86,10.56%,PTPRC;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;PRKCD;ITGB2;ITGA5;PTPRJ;RAP2B;ARHGEF2;IL6R;IL15;TEC;PTK2B;HGF;VEGFA;PTPN6;APP;AGT
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.617663408599331,-1.7556983475670938,0.0017513134851138354,0.03915952305497077,0.987,9/23,12.77%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;HSP90AB1;STK11
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.617663408599331,-1.7556983475670938,0.0017513134851138354,0.03915952305497077,0.987,9/23,12.77%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;HSP90AB1;STK11
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.4775756182270037,-1.7541107278974624,0.0,0.039754219528910145,0.988,29/74,20.62%,RBPJ;CREBBP;BACH1;NFE2L2;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;VHL;PSMB8;PSMD4;PSMA5;PSMB3;SIRT2;ELOC;PSMD3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.5208625890276116,-1.7532116333537904,0.0,0.039903069889319055,0.988,14/44,11.96%,LYN;APOE;CD300A;PRKCD;PTPRJ;PTPN22;PIK3CB;IRAK3;STK38;DNAJA1;SPRY2;AGT;PAQR3;AIDA
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.409528662948293,-1.7523959456065024,0.0,0.040071648722223935,0.988,81/208,23.28%,AKAP13;PRKCB;CD74;BIRC3;PLCG2;REL;LITAF;RHOA;GAPDH;OPTN;FLNA;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;CARD11;CFLAR;PELI1;RIOK3;IRAK4;RNF31;RBCK1;TRAF3;TFG;PPM1B;PLK2;MYD88;BST2;WLS;NOD1;NEK6;ZFAND6;TNIP2;TRAF1;PLEKHG5;RELA;TICAM1;CLEC6A;JMJD8;NLRC3;TRIM68;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;DDX1;MAVS;TRIM14;NLRX1;TNFSF10;TNIP3;GPRC5B;SPHK2;CASP8;TRIM39;MIER1;TRADD;SHISA5;HSPB1;NOD2;LGALS9;NDFIP2;TICAM2;S100A4;ZC3H12A;STAT1;TMEM106A;TMED4;NUP62;TRIM25;ZDHHC13;NR1H4;MAP3K3;TMEM9B;HMOX1;PIM2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5895011575970683,-1.7522974417104693,0.0016638935108153079,0.03988269119192348,0.988,8/28,6.08%,FOXP1;FGR;BIRC3;SAMHD1;CD36;DHX58;PTPN22;TRAF3
prerank,negative regulation of cytokine production (GO:0001818),-0.42545592297993223,-1.7521974728219345,0.0,0.039731259974137234,0.988,64/163,23.09%,PTPRC;CD84;ATP2B1;LILRB1;TLR8;AXL;RAC1;ADCY7;ANXA4;OTUD5;ABCD2;DHX58;PIBF1;TLR4;SRGN;NLRC5;PTGER4;SARS1;PTPN22;ANXA1;FN1;TNFRSF21;ARRB1;IRAK3;GAS6;SIRPA;LAPTM5;MAP2K5;UBA7;PTPN6;SELENOS;NCKAP1L;TRIB2;PIN1;PCBP2;FOXJ1;FCGR2B;NLRC3;VSIG4;TMSB4X;RNF216;MAVS;APPL2;NLRX1;ISG15;GPATCH3;RARA;LILRA5;MMP8;CMKLR1;LGALS9;C1QBP;HMGB1;AGER;CD274;ZC3H12A;RNF125;TRIM25;INHA;RNF135;NR1H4;IL6;MEFV;RPS6KA5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5599758235340899,1.7506082359960269,0.0047169811320754715,0.057961862629861916,0.998,4/25,1.18%,ANK2;CTNNA3;CACNA1C;RYR2
prerank,response to interferon-alpha (GO:0035455),-0.6755345706484616,-1.7501236471500243,0.006837606837606838,0.04047442938883157,0.989,10/16,21.72%,AXL;IFNAR2;GAS6;BST2;EIF2AK2;IFITM2;TPR;IFNAR1;GATA3;IFITM1
prerank,fatty acid transmembrane transport (GO:1902001),-0.6389557338425735,-1.7496046925205277,0.0034071550255536627,0.040580006311860733,0.991,6/19,4.09%,CD36;PRKAG2;ABCD2;CPT1A;SLC2A1;SLC27A1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.43023376340565767,-1.7492678461934001,0.0,0.04055927169937126,0.991,38/140,11.39%,ARHGAP15;VAV3;AKAP13;ABR;ARHGAP10;ARHGAP25;STARD8;ITSN1;ARHGAP22;MYO9B;RAC1;ARHGAP24;ARHGAP30;ARHGEF3;ARHGAP19;RHOA;ARHGAP17;ARHGEF2;VAV1;FGD4;CDC42;ITGAV;ARAP1;ARHGAP18;FGD3;RHOQ;CYRIB;ARHGEF18;SH3BP1;VAV2;SOS2;ARHGAP12;TGM2;GNA13;FLCN;TRIP10;ARHGEF11;PLEKHG5
prerank,protein sumoylation (GO:0016925),-0.5183038232092858,-1.749144466003908,0.0034602076124567475,0.04040744241621254,0.991,26/49,29.79%,NSMCE2;NUP50;PIAS1;NUP42;NUP88;RAE1;NUP205;TPR;NUP188;UBA2;UBE2I;EYA1;NUP153;NUP35;NUP107;NUP62;EGR2;TOPORS;SUMO3;SAE1;RANBP2;TRIM28;NUP37;PIAS2;AAAS;NUP133
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5974512293269547,-1.7486536711600404,0.0034071550255536627,0.04048413065516368,0.991,9/26,4.22%,SLC30A5;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,chloride transport (GO:0006821),0.4682759942533062,1.7480127651496344,0.0,0.05870287766511995,0.998,19/74,8.91%,GABRB3;GABRG3;GABRB1;SLC12A2;GLRA1;GABRA2;SLC4A10;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,response to copper ion (GO:0046688),-0.6365396390008657,-1.7478711902970157,0.006700167504187605,0.04060097789135006,0.992,8/20,4.22%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.7381821464898125,-1.7472013231865025,0.00528169014084507,0.04063496498149852,0.992,3/11,6.24%,NRP1;RAC1;HGF
prerank,microvillus organization (GO:0032528),-0.7127091832758699,-1.7471541354979487,0.003616636528028933,0.040431976151875576,0.992,6/13,3.85%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,phagosome acidification (GO:0090383),-0.5852283075743301,-1.7460481443516436,0.0017301038062283738,0.04075560986543535,0.992,11/26,20.32%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;RAB39A;ATP6V0E1;ATP6V0D1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5839657041246378,-1.7459275845341582,0.0,0.04058091811966461,0.992,11/27,9.52%,CD36;MAP3K1;IRAK2;TAB2;TLR4;IRAK4;IRAK3;MYD88;LY96;UBC;RPS27A
prerank,postsynaptic membrane organization (GO:0001941),0.6444171474108763,1.745414715847371,0.016867469879518072,0.05964574730734468,0.999,5/17,5.31%,NLGN1;NRXN1;GPHN;NRXN2;SHANK3
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5864959191129173,-1.7453350582342615,0.0017513134851138354,0.04068078325329866,0.993,10/28,12.60%,MITF;RAC1;TNFRSF1B;MFSD12;PRKAG2;ADIPOR1;C3;SIRPA;CTNS;CCL5
prerank,inflammatory response (GO:0006954),-0.4106187465665422,-1.7450492098224295,0.0,0.04060759258308863,0.993,49/195,15.66%,CYBB;CD44;ADGRE5;CCR2;MFHAS1;C3AR1;REL;CYBA;RAC1;ITGB2;NRROS;SIGLEC1;CDO1;NFX1;C5AR1;ITGAL;IL10RB;MAPKAPK2;STAT3;CCR1;TLR4;NLRC4;IL18;BLNK;NFKB1;PTGER4;TPST1;ANXA1;PARP4;CIITA;PF4;PIK3CG;NFATC3;HRH1;NOD1;ADAM8;PRDX5;AFAP1L2;RELA;FCGR2B;CCL5;CCRL2;PIK3CD;NFAM1;CD40;HDAC5;RELB;IKBKB;CXCR4
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6587774667439463,-1.7441847016811551,0.005025125628140704,0.04087072997262463,0.993,7/17,11.94%,BACH2;STAT3;TLR4;IL18;JAG1;MYO1G;CD46
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6885874737673873,-1.7440113188439403,0.0033783783783783786,0.04074495299025556,0.993,7/14,19.20%,CCR2;SYK;IL18;PTPN22;RASAL3;TGFBR2;LGALS9
prerank,neuron migration (GO:0001764),0.5035194951396437,1.744004793552825,0.004662004662004662,0.059876594021807034,0.999,18/48,11.32%,ADGRL3;ASTN2;AUTS2;SPOCK1;MAP1B;GPM6A;NTRK2;CDKL5;ASTN1;NRCAM;MARK1;TUBB2A;DCDC2;DNER;DNAAF4;PEX13;RELN;CDK5R1
prerank,gene expression (GO:0010467),-0.387591131799286,-1.7437901993330476,0.0,0.04063352637450811,0.993,145/348,27.47%,APOBEC1;RBM39;RBMS1;TSPAN14;MEF2A;AGO2;RPS18;NUP50;RPL7;RPS12;SRRM1;RNASEL;RPS21;RPS8;RPS24;GSPT1;RBPMS;MPHOSPH10;HHEX;NUP42;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;CHTOP;NUP88;MRPL42;RPS14;HNRNPH1;RAE1;POLR2H;RPL32;HNRNPL;E2F1;CDC40;RPS28;RPS13;POLR2F;THAP1;AGFG1;RPS15A;POLR2L;DARS1;RPS27A;RPL28;RPS4X;ANGPT2;FASTKD2;DUSP11;UPF2;EIF4EBP2;NUP205;HNRNPUL1;TPR;ALYREF;RPS23;TSPAN17;RPL22;RPL14;EEF1A1;MRPS6;WDR33;NUP188;RPL34;YTHDC1;RPS11;MRPS11;RPL6;RBMS2;NCBP1;EPC1;POLR2A;EIF4G1;RPS10;RPL18A;THOC2;NFKBIB;MRPS16;NUFIP1;RPL37A;POLR2G;MRPL34;RPS9;MRPS15;TFIP11;RPS27;ABCF1;RPS3;NUP153;ATXN1;DTX1;RNPS1;THOC6;RPL23A;POLR3A;NUP35;RPS16;MAGOH;COPS5;RPL9;SLU7;MED20;MMS19;NUP107;CPSF3;RPLP2;NOL9;POLR2I;DDX54;RBM3;NUP62;XAB2;HNRNPK;MRPL51;TOPORS;XRN2;RPL7A;RPL19;RPS15;SMG1;RPL39;SRSF11;RPLP0;DDX39B;RPL41;MRPL18;RANBP2;MRPS7;CPSF1;RBM15B;DEDD2;RPL5;RPL13;DHX38;NUP37;LMF1;NKX2-8;U2AF2;HNRNPF;SRSF7;RPL27A
prerank,cellular response to zinc ion (GO:0071294),-0.6833906303828238,-1.7430875948336544,0.0034542314335060447,0.040814667248672956,0.993,9/15,4.22%,P2RX4;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5529228939682986,-1.7424740931876286,0.0018281535648994515,0.04089084684345394,0.993,17/34,22.79%,NEDD9;NRP1;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;CRK;CIB1;CRKL;LIMS1;C1QBP;ILK;P4HB
prerank,macrophage activation (GO:0042116),-0.5565967531811092,-1.7423375100505931,0.0,0.040735545526406625,0.993,16/34,24.05%,FOXP1;PLCG2;SYK;ITGB2;C1QA;SBNO2;C5AR1;TLR4;IFI35;APP;CRTC3;AGER;CD93;TMEM106A;IFNGR1;ITGAM
prerank,DNA repair (GO:0006281),-0.39303710842148715,-1.7409203251981265,0.0,0.041295828981027745,0.994,120/284,26.81%,FAM111A;DDB2;BACH1;RAD51B;PSME4;SMARCA5;BRCA1;ERCC6;UVRAG;DCLRE1C;POLE2;NABP1;PARP4;ABRAXAS1;BLM;RAD1;PRIMPOL;WDR48;TEX264;REXO4;PWWP3A;KMT5B;ALKBH1;BABAM2;USP3;ATXN3;NEIL3;RAD51;UBC;RPS27A;MGMT;RFWD3;KMT5C;NUCKS1;RNF8;PARP9;APTX;TIMELESS;LIG1;CDK1;CUL4B;PCNA;FTO;DCLRE1A;RAD54L;GADD45A;BABAM1;WRN;EXO1;FEN1;CIB1;MLH3;TICRR;WDR33;ASF1A;RPA3;POLD2;XRCC4;APLF;RHNO1;DOT1L;RAD51AP1;RFC2;INO80;RAD52;ERCC4;PRMT6;UBE2T;LIG3;NSMCE3;SLX4;DDX1;TOPBP1;BRIP1;NEIL2;EYA1;DNA2;XRCC3;EYA3;RAD9A;HUWE1;BRCC3;RBBP8;ADPRS;POLN;MMS19;FAAP24;SMC1A;ATM;CHEK1;RFC3;BAP1;PDS5B;DTX3L;ALKBH3;UBXN1;EXO5;FAN1;NBN;FANCD2;ZRANB3;MLH1;POLB;EID3;PRKDC;POLD4;DDB1;RAD51C;ASCC3;CETN2;UBE2V2;TRIM28;UBE2N;XRCC1;RECQL5;BAZ1B;DCLRE1B;VCP;ASCC2;MRE11
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6695036966534997,1.7402003656564806,0.007194244604316547,0.061408467442072345,0.999,3/12,1.18%,CTNNA3;CACNA1C;RYR2
prerank,lymphocyte proliferation (GO:0046651),-0.6072076840787667,-1.7395664103304143,0.0,0.041748865582436345,0.996,7/22,14.07%,PTPRC;ELF4;MSN;BCL2;PIK3CG;MEF2C;CD40
prerank,phagosome-lysosome fusion (GO:0090385),-0.7450307276886402,-1.739490834030384,0.0017094017094017094,0.04157262522550203,0.996,8/10,19.21%,ARL8B;RAB7B;RAB7A;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6652933248560255,-1.7393985615465157,0.004934210526315789,0.04141073765448923,0.996,6/15,9.47%,APOE;SNX9;TNFRSF1B;ADAM9;SNX33;ADAM8
prerank,negative regulation of T cell activation (GO:0050868),-0.5560180215512469,-1.7385409293907979,0.0035335689045936395,0.04164395025065717,0.996,16/35,21.65%,LILRB1;TNFAIP8L2;PTPN22;RIPOR2;DUSP3;TNFRSF21;LAPTM5;NCKAP1L;SDC4;IL4I1;FCGR2B;VSIG4;SPN;CD274;LAX1;CEBPB
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.588811104036222,-1.7382674105312559,0.0017391304347826088,0.04152683428954582,0.996,9/27,11.54%,CD44;CCR2;ITGB2;RHOA;CYRIB;SIRPA;MDK;LCK;RELA
prerank,regulation of nervous system process (GO:0031644),0.6177036339000063,1.7375048717148123,0.004545454545454545,0.062476039515053525,0.999,7/18,10.80%,DLGAP1;HTR2C;SLC8A3;DLGAP2;TMEM108;SLC8A2;DLGAP3
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.6377847515385772,-1.73625024422463,0.003669724770642202,0.042431020445916776,0.997,13/18,29.07%,CCR2;NCKAP1L;IKZF3;XRCC6;CD2;IL4I1;PRKDC;ZFP36L1;TBX21;CRTAM;PRELID1;SPINK5;METTL3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.46298217295477984,-1.7345188139613896,0.0,0.04299397492161296,0.997,34/86,20.62%,CREBBP;BACH1;NFE2L2;PSME4;ATF3;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;MAPK7;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;KLF2;INO80;BAG3;VHL;HSPA1A;PSMB8;PSMD4;PSMA5;CHEK1;PSMB3;ELOC;PSMD3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5267287538477288,-1.7339994734193989,0.003424657534246575,0.043098369566258975,0.997,20/42,22.26%,NRP1;CDK6;RAC1;ROCK1;CD36;PTPRJ;RIN2;PTK2B;UTRN;VEGFA;CIB1;PLEKHA2;LIMS1;CSF1;GSK3B;SFRP1;JUP;KDR;MAP4K4;CD3E
prerank,protein deubiquitination (GO:0016579),-0.3972470144110628,-1.733103240310305,0.0,0.04327481966967329,0.997,85/242,21.29%,BIRC3;USP12;SNX3;DDB2;RHOA;USP50;OGT;ATXN7;PSME4;OTUD5;USP18;RIPK1;UCHL5;ARRB2;BRCA1;PSMB7;PSME3;ACTB;USP8;PSMB9;ABRAXAS1;MINDY2;TRAF3;WDR48;USP9X;USP36;BABAM2;USP3;ATXN3;RNF123;TGFBR1;HIF1A;PSMA8;UBC;RPS27A;OTULIN;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;USP42;RNF128;USP35;PSMC4;PSMB10;USP40;TRAF2;PSMA1;JOSD1;YY1;INO80;OTUD4;USP30;INO80E;USP7;TNIP3;MINDY1;STAMBPL1;SKP2;SMAD7;USP11;PSMB8;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMD4;PSMA5;PSMB3;BAP1;PSMD3;ZC3H12A;SMURF2;USP9Y;NLRP3;ZRANB1
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.4545963978897206,-1.7330636558920314,0.0,0.0430737647221712,0.997,39/95,21.24%,LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;STAP1;CHMP5;NFKB1;ADAM9;MAPK14;PF4;CYRIB;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;XBP1;RELA;TICAM1;FCGR2B;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;NOD2;TICAM2;HMGB1;SIRT2;CD274;ZC3H12A;NLRP3
prerank,regulation of interferon-alpha production (GO:0032647),-0.6023818883807173,-1.7326227275647839,0.005405405405405406,0.04307973634550111,0.997,10/23,20.91%,TLR8;TLR7;TLR4;DHX9;IRF5;NLRC3;DHX36;MAVS;DDX3X;STAT1
prerank,protein modification by small protein conjugation (GO:0032446),-0.38492284627424667,-1.7325713826698756,0.0,0.04289959940389804,0.997,138/361,26.23%,NSMCE2;RNF213;WWP1;ZNRF3;CBL;CNOT4;KLHL24;PEX14;BIRC6;FBXW8;NFE2L2;RNF111;NFX1;NUP50;MKRN2;PIAS1;WWP2;MYLIP;ARRB2;RNF41;FBXL17;BRCA1;AMFR;CTR9;AREL1;TNFAIP1;ATG7;RNF20;FBXO32;ATG10;NUP42;FBXW11;UBE2R2;KLHL25;UHRF2;ARRB1;NUP88;NUB1;MGRN1;UBR2;USP9X;RAE1;ZSWIM8;DET1;KCTD10;CBLL1;TRIM47;UBA7;RNF38;HIF1A;UBE2L3;SPSB2;SELENOS;UBC;RPS27A;OTULIN;RFWD3;RNF8;KLHL18;NEDD4L;DERL1;NUP205;TPR;EIPR1;CUL4B;PCNA;DCUN1D4;ARRDC4;TSPAN17;ASB5;TRIM24;FBXO10;TRIM68;UHRF1;NUP188;WAC;UBE2H;CUL2;MOCS3;TRIM11;ARRDC1;ARIH1;RNF25;RNF43;RNF34;UBE2T;UBE2G1;HLTF;CDC34;BRAP;TRIM14;USP7;UBE2C;ISG15;UBA2;VHL;MIB1;UBE2I;EYA1;FBXO7;ANAPC7;NUP153;HUWE1;DTX1;TRIM39;UBE2M;NUP35;VPS18;DTX3;RTF1;ELOC;NUP107;DTX3L;SMURF2;RACK1;NUP62;EGR2;UFM1;TOPORS;CCNF;RNF135;MEFV;TRIM72;SUMO3;SAE1;TRIM69;PRKDC;RNF187;DDB1;RANBP2;UBE2V2;TRIM28;UBE2N;RNF40;VPS11;SMURF1;NUP37;VCP
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7466355312148764,-1.728653726343243,0.008375209380234505,0.044656297689559345,0.999,5/10,8.18%,MSN;RHOA;RAP2A;CDC42;SH3BP1
prerank,regulation of synapse maturation (GO:0090128),0.7468919540198299,1.727852966816859,0.004618937644341801,0.06786435416513494,0.999,4/10,10.81%,NRXN1;ANAPC2;ARHGEF15;RELN
prerank,generation of neurons (GO:0048699),0.3901753518602142,1.726193943023404,0.0,0.0683570196017066,0.999,40/190,12.02%,PTPRD;ADGRL3;IL1RAPL1;ASTN2;AUTS2;MYT1L;SPOCK1;TAFA1;MAP1B;EML1;SOX11;GPM6A;NTRK2;SNPH;FUT9;CDKL5;ASTN1;SMARCA1;NRCAM;WNT9A;POU3F2;MARK1;TUBB2A;DCDC2;YAP1;FZD8;OLIG1;CX3CR1;TGFB2;DNER;DNAAF4;EN1;POU4F2;PEX13;NEUROD1;RELN;CDK5R1;HES5;PER2;BRSK1
prerank,response to laminar fluid shear stress (GO:0034616),-0.7482830164275415,-1.726139563556348,0.006837606837606838,0.04583732125575928,0.999,7/10,17.34%,ABCA1;NFE2L2;MAP2K5;MAPK7;KLF2;ASS1;SMAD7
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.6339926890621013,-1.7256343783842254,0.0018083182640144665,0.0459186176239147,0.999,9/19,20.91%,TLR8;TLR7;TLR4;DHX9;IRF5;DHX36;MAVS;DDX3X;STAT1
prerank,axonal fasciculation (GO:0007413),0.7070334337429038,1.7255905837267318,0.009501187648456057,0.06813527690088442,0.999,7/12,16.33%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3;EPHA3
prerank,regulation of type I interferon production (GO:0032479),-0.46402437054385537,-1.7248325879617827,0.0,0.04614630501526651,0.999,39/84,24.83%,CREBBP;CGAS;GAPDH;OTUD5;DHX58;DHX9;STAT6;NLRC5;NFKB1;IRF5;PTPN22;TRAF3;CTNNB1;POLR2H;MYD88;POLR2F;UBA7;POLR2L;POLR3G;PIN1;PCBP2;XRCC6;RELA;DHX36;RNF216;POLR3B;MAVS;NLRX1;ISG15;G3BP1;GPATCH3;POLR3A;LRRFIP1;RNF125;TRIM25;RNF135;PRKDC;POLR3GL;POLR3D
prerank,cytosolic transport (GO:0016482),-0.4411722549907816,-1.724740269233048,0.0,0.04597343052141759,0.999,47/108,22.73%,VPS13C;RAB7A;SNX2;VTI1A;VPS54;VPS13A;SNX6;KIF16B;STX8;ANKFY1;SNX5;TBC1D5;AP1G1;EPS15;LAPTM5;EEA1;RAB5A;SYS1;CORO7;VPS26B;TBC1D17;DCTN1;RAB29;LAMP1;WDR91;STX5;VPS26A;TMEM87B;TBC1D23;TBC1D10B;SNX16;CLN3;BAIAP3;STX16;SPAG9;TMEM87A;ARL1;RILP;DOP1B;SNX1;VPS51;SNX32;VPS50;TBC1D10C;PHETA1;BET1L;BECN1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.7511316471738654,-1.7230082152869157,0.003424657534246575,0.0466885006428321,0.999,7/10,14.70%,LILRB1;REL;PPM1B;SIRPA;NLRC3;RELB;YY1
prerank,regulation of protein metabolic process (GO:0051246),-0.5179004556837954,-1.7228461645928808,0.0033112582781456954,0.04655532370560466,0.999,18/44,19.31%,APOE;GSAP;TRAF3;MAP2K5;WFS1;PLAUR;MAPK7;APP;MTPN;NEDD4L;ZDHHC2;LTBP4;HSP90AB1;KLF2;SSH1;FAF1;FAM83D;LDLR
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.564200975368535,1.7216616737905028,0.006928406466512702,0.06996490881039265,0.999,7/27,6.71%,CTNNA2;IL1RAPL1;NCS1;NTNG2;NTNG1;MARK1;HOMER1
prerank,defense response to bacterium (GO:0042742),-0.4447405966074259,-1.72060790560638,0.001644736842105263,0.0475497581450553,0.999,38/105,24.66%,LYST;FGR;STAB1;SYK;PRKCD;OPTN;IL6R;TLR4;NLRC4;RAB1A;CFP;LYZL4;RNASE7;MYD88;NOD1;GBP2;CHGA;CAMP;HMGB2;SERPINE1;FCER1G;RNASE6;OAS3;DEFA6;SPN;MAVS;ISG15;ANG;NOD2;GBP7;GBP6;OAS2;PLA2G6;CEBPB;IL6;RPL39;SHC1;GBP4
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.5589751422742315,-1.720124629071002,0.001692047377326565,0.04755178251760923,0.999,13/28,24.19%,CCR2;SH3KBP1;CYRIB;SIRPA;NCKAP1L;TNIP2;LCK;XRCC6;TICAM1;NOD2;IL6;CD47;PRKDC
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5955458587642573,1.7198632971751227,0.008350730688935281,0.07053621478364136,0.999,9/20,20.07%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;MPDU1;ST6GALNAC5
prerank,regulation of autophagy (GO:0010506),-0.40078185444301917,-1.7197741517004232,0.0,0.047513730716262095,0.999,80/216,25.72%,ATP6V0D2;TFEB;PSAP;DAPK1;MCL1;GPR137B;ATP6V1E1;ROCK1;ITPR1;NUPR1;ERN1;GAPDH;OPTN;PIP4K2A;PRKAG2;ABL2;ATP6V1A;HTR2B;STAT3;TAB2;FOXO3;MTMR3;SNX6;BCL2;CTSA;PTPN22;DAPK3;SNX5;EIF4G3;PIK3CB;HGF;KLHL22;USP36;EXOC4;PLK2;ATF6;ATP6V1G1;VPS26B;FLCN;RRAGD;TICAM1;VPS26A;EEF1A1;TRIM68;STK11;ATP6V0B;SH3GLB1;RB1CC1;CAPNS1;EIF4G1;PIK3C2A;TRIM14;ATP6V0E1;RMC1;TMEM59;RHEB;HSPB1;DCAF12;GSK3B;ATM;HMGB1;SIRT2;ATP6V0D1;ZC3H12A;HAX1;PRKAG1;SNX32;GFAP;CDK5;WDR24;MEFV;PIM2;TPCN2;MTDH;VDAC1;DCN;LAMTOR1;LAMTOR3;MT3;ATP6V0A1
prerank,tryptophan metabolic process (GO:0006568),-0.7386955833361979,-1.718558478682914,0.0017331022530329288,0.047931710010621596,0.999,5/11,12.45%,KYNU;ATP7A;KMO;KYAT1;IL4I1
prerank,positive regulation of transport (GO:0051050),-0.463596446674081,-1.7174832474269357,0.003355704697986577,0.048374185640133884,0.999,23/85,17.25%,DOCK2;DAB2;APOE;LRP1;CYBA;CAMK1D;ANXA2;SGK1;IL15;DYNC1H1;ACTB;ANXA1;GAS6;SIRPA;CBLL1;NEDD4L;IL2RG;FCGR2B;FCER1G;RXRA;BID;IL2RB;KMT2A
prerank,endosome organization (GO:0007032),-0.5215699993305494,-1.716217597642414,0.0017825311942959,0.04891418896084668,0.999,13/41,8.41%,TMCC1;SNX10;CORO1C;SNX3;PI4K2A;USP50;DNAJC13;USP8;PI4K2B;WASHC4;SNX33;ALS2;EEA1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4756451890627559,-1.7150625178470598,0.0,0.04943240687228299,0.999,22/73,11.26%,DAB2;NEDD9;NRP1;FGR;SYK;PLEK;MYH9;ITGB2;ITGA5;TEC;CDC42;ITGB1;PTK2B;ITGAV;ADAM9;FYB1;FN1;ERBIN;ITGB7;ITGB1BP1;ITGB5;ZYX
prerank,myeloid cell development (GO:0061515),-0.6403882156901364,-1.714794588905544,0.005154639175257732,0.04931956253771573,0.999,5/18,10.43%,FOXP1;NRROS;ANXA2;NCKAP1L;APP
prerank,response to zinc ion (GO:0010043),-0.5951600264781834,-1.714666243869211,0.007067137809187279,0.04919660518659817,0.999,11/25,6.64%,SLC30A5;P2RX4;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CRIP1
prerank,mitotic nuclear division (GO:0140014),-0.46834771864241465,-1.7144520664402008,0.0016891891891891893,0.04913571798863085,0.999,33/71,22.63%,RHOA;EPS8;STAG1;FLNA;NCAPG2;KIF3B;PIBF1;KIF11;SMC4;ABRAXAS1;ARHGEF10;STAG2;KLHL22;CENPK;TPX2;KIFC1;CHMP7;PPP2R2D;KNSTRN;CHMP2A;NUSAP1;INO80;SGO1;UBE2C;NDC80;KIF18B;SMC1A;RAB11A;CEP192;NUP62;LSM14A;CHMP4B;NSL1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.7345250157791243,-1.712959474684028,0.008680555555555556,0.04970985334978448,0.999,4/10,9.44%,PTPRC;IRAK3;MAP2K5;MAPK7
prerank,protein modification by small protein removal (GO:0070646),-0.38851721638896686,-1.7127419340879022,0.0,0.04958680037920838,0.999,88/252,21.29%,BIRC3;USP12;SNX3;DDB2;RHOA;USP50;OGT;ATXN7;PSME4;OTUD5;USP18;RIPK1;UCHL5;ARRB2;BRCA1;PSMB7;PSME3;ACTB;USP8;PSMB9;ABRAXAS1;TRAF3;WDR48;USP9X;USP36;GPS1;SENP3;BABAM2;USP3;ATXN3;RNF123;TGFBR1;HIF1A;PSMA8;UBC;RPS27A;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;COPS6;USP42;RNF128;USP35;PSMC4;PSMB10;USP40;TRAF2;PSMA1;JOSD1;YY1;USPL1;INO80;OTUD4;USP30;INO80E;USP7;TNIP3;STAMBPL1;SKP2;SMAD7;USP11;PSMB8;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMD4;PSMA5;PSMB3;BAP1;PSMD3;ZC3H12A;COPS8;SMURF2;USP9Y;COPS4;NLRP3;ZRANB1
prerank,myoblast fusion (GO:0007520),0.6938735573137979,1.712228236143447,0.016129032258064516,0.07456694237810306,0.999,3/12,2.82%,ADGRB3;ADAM12;KCNH1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.3681172749205755,-1.7121917256514105,0.0,0.04969450330997836,0.999,184/509,24.23%,IQGAP1;LYN;SASH1;PTPRC;OSBPL8;AKAP13;PRKCB;IGF1;CD74;BCAR3;FGR;BIRC3;GRB2;GAB2;MFHAS1;PLCG2;REL;LITAF;AXL;CBL;RAC1;ROCK1;PTPRJ;CGAS;RHOA;HPSE;NUPR1;PIK3R5;GAPDH;BCL2L11;INSR;P2RX4;FLNA;IGF1R;PIK3AP1;BRD4;VAV1;TLR7;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;DHX58;TAB2;CARD11;CFLAR;TLR4;FLT1;PELI1;IL18;ITGB1;ITGAV;BCL2;IRAK4;RNF31;RPS20;RBCK1;PIK3CB;TFG;HGF;DDX60;FN1;PIK3CG;GCNT2;IFI35;GAS6;PLK2;HIP1;VEGFA;LAPTM5;MYD88;BST2;PUM2;WLS;FRS2;EIF2AK2;FNIP1;TGFBR1;CD28;NOD1;GSDME;NEK6;PTPN6;ADAM8;ITGB1BP1;FIS1;TGM2;CD27;TNIP2;SPRY2;APP;AGT;STYXL1;LCK;NCF1;STRN;FLCN;RRAGD;PLEKHG5;RELA;PIK3CA;TICAM1;F7;OASL;CLEC6A;JMJD8;HSP90AB1;CCL5;TRIM68;LGALS1;KSR1;CASP1;PIK3CD;TRAF2;DHX36;BBC3;CD40;IKBKB;DDX1;HCLS1;MAVS;TRIM14;BID;TNFSF10;GPRC5B;SPHK2;ZCCHC3;CASP8;LILRA5;GATA3;RYK;RPS3;IRS2;HCST;LIMS1;MIER1;MMP8;PTPN11;TRADD;PDGFRB;ADRB2;SHISA5;RHEB;NOD2;LGALS9;DDX3X;F10;NDFIP2;C1QBP;TICAM2;HMGB1;AGER;MAZ;S100A4;PDGFA;RACK1;KDR;TMEM106A;TMED4;HAX1;NUP62;TRIM25;ZDHHC13;ILK;HTR6;TCIM;IL6;TGFB1;MAP3K3;BECN1;TMEM9B;WDR24;RPS15;HMOX1;PIM2;LRRC19;FLT3;FGF9;SHC1;MTDH;LRP2;DCN;PUM1
prerank,regulation of myoblast fusion (GO:1901739),-0.7368258384641597,-1.7114641583075731,0.0035650623885918,0.04987746841519834,0.999,5/11,15.34%,CFLAR;RIPOR2;MAPK14;CD53;EHD1
prerank,negative regulation of chemotaxis (GO:0050922),0.5360229094731703,1.7101482187804136,0.012376237623762377,0.07518060882668326,0.999,7/31,3.42%,ROBO1;ROBO2;SLIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,cell-cell junction assembly (GO:0007043),0.4640576983500263,1.7097246644179607,0.002577319587628866,0.0747941843256712,0.999,26/63,15.81%,CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;CDH11;TJP1;CDH12;EPB41L3;CDH22;CDH19;CDH7;DCHS1;TLN2;CDH6;ARVCF;CDHR3;CDH9;CLDN5;PATJ;CDH5;CTNND1;GJC1;GJD3;PRKCA
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6397281504390484,-1.7093976334940242,0.010434782608695653,0.05099647590171041,1.0,6/17,5.25%,RBPJ;CREBBP;PLXND1;MAML1;MAML2;DLGAP5
prerank,receptor internalization (GO:0031623),-0.5188386247561466,-1.7087760739831694,0.0,0.05106420172592313,1.0,15/44,8.55%,GRB2;LILRB1;SYK;LRP1;ITGB2;DNM2;CD36;RAB31;CD9;ARRB2;GRK3;ITGB1;ARRB1;PICALM;RAB5A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5944794713292259,1.7086605140191198,0.0023752969121140144,0.07494106736905531,0.999,9/22,14.54%,AKAP6;ANK2;RYR2;ATP1B1;STAC;CALM1;CALM3;CALM2;ATP2A1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5672336955288189,-1.7079680129265615,0.0034965034965034965,0.05138922238067531,1.0,12/29,15.58%,CCR2;PIAS1;STAT3;IL15;CTR9;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,response to ionizing radiation (GO:0010212),-0.4652024146796026,-1.7078447867618805,0.001697792869269949,0.05121928370351473,1.0,35/70,27.92%,GRB2;SPIDR;BRCA1;NABP1;ANXA1;ABRAXAS1;MAPK14;BLM;RAD1;BABAM2;RAD51;RFWD3;RNF8;GADD45A;BABAM1;STK11;TICRR;XRCC4;RHNO1;RAD51AP1;INO80;TOPBP1;EYA1;EYA3;RAD9A;BRCC3;ATM;FANCD2;MYC;ECT2;EEF1D;USP28;COP1;CLOCK;UIMC1
prerank,regulation of regulated secretory pathway (GO:1903305),0.5150105307105481,1.7070704448647758,0.007009345794392523,0.07545419493161067,0.999,12/34,13.14%,RIMS2;RIMS1;SYT1;SYT10;SYN1;SYT2;RAB15;SYT5;SYT11;SYT12;DOC2A;SYT7
prerank,regulation of T cell cytokine production (GO:0002724),-0.6695325928586986,-1.7067429018061868,0.0052173913043478265,0.051626036822885496,1.0,6/15,17.34%,CCR2;TNFRSF1B;MALT1;B2M;TRAF2;SMAD7
prerank,positive regulation of apoptotic process (GO:0043065),-0.38553220798554705,-1.7065956304447498,0.0,0.05148305817257398,1.0,96/293,21.11%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;LILRB1;ITSN1;TNFAIP8;DAPK1;CRADD;BCL6;JUN;DNM2;ARHGEF3;ANO6;NUPR1;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;NLRC4;ATG7;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;STK3;FGD3;GRN;ARHGEF18;CTNNB1;ATF6;E2F1;DNAJA1;TGFBR1;VAV2;SOS2;UBC;RPS27A;SIK1;SUDS3;TGM2;SCRIB;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;PLEKHG5;FAP;GADD45A;STK17B;EEF1E1;MLLT11;IFIT2;IGFBP3;BTG1;TRIO;TFAP4;MAP3K10;SHQ1;LATS2;QRICH1;BID;ARHGEF5;KLF11;TNFSF10;FAF1;SPHK2;CASP8;PHLDA1;BNIP3L;RPS3;TRIM39;RNPS1;TRADD;PDCD5;CASP2;DDX3X;C1QBP;ATM;HMGB1;SIRT2;ZC3H12A;SFRP1;RACK1
prerank,V(D)J recombination (GO:0033151),-0.7206180027896956,-1.7065714407393895,0.015463917525773196,0.05128850282984564,1.0,8/11,24.50%,LIG1;HMGB2;XRCC4;TCF3;LIG3;HMGB1;PRKDC;DCAF1
prerank,spinal cord development (GO:0021510),0.6671173934241583,1.7054344232488603,0.021791767554479417,0.0759317581822851,0.999,5/12,11.52%,SOX11;SOX12;VIT;RELN;PKD1
prerank,Rap protein signal transduction (GO:0032486),-0.7437359277767708,-1.7042782548544957,0.008665511265164644,0.05233645868045824,1.0,5/10,7.58%,RAP1B;RAP2B;RAP2A;RAP1A;PLK2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5743990276080719,-1.703083376702133,0.005385996409335727,0.05274724078083196,1.0,9/27,14.82%,IGF1;CD74;CDK6;DHX9;FN1;GAS6;E2F1;AGT;S100A6
prerank,synaptic vesicle endocytosis (GO:0048488),0.5217077530292816,1.702921206459588,0.002347417840375587,0.07705676852546513,0.999,11/33,6.54%,NLGN1;DNAJC6;DNM3;SYT1;AMPH;SNAP91;SYNJ2;SYT2;DNM1;STON1;SYT5
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.44175290777020787,-1.7014533098834637,0.0,0.053342219540869776,1.0,34/98,14.89%,PID1;APOE;GRB2;XDH;PPARD;INSR;ANXA2;PPARG;RIPK1;IL10RB;ARRB2;RNF41;RAB1A;TBC1D5;NR1H2;MAPK14;ARRB1;VEGFA;CD63;SCRIB;AGT;CDK1;IFNAR1;RAB29;GADD45A;CCL5;CBR1;UHRF1;GREM1;TGFBR2;AGPAT1;EIF4G1;ACACB;GHITM
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4467073741005087,-1.700474862439315,0.0,0.0538127780107064,1.0,23/91,11.44%,FTL;IREB2;SLC30A5;ABCB7;ATP6V1A;FRRS1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP7A;TMEM199;HMOX2;FLVCR1;SLC31A1;ATP6V1G1;APP;LCK;CP
prerank,long-chain fatty acid transport (GO:0015909),-0.5599661310937861,-1.7002169467477877,0.0016891891891891893,0.05380896089522062,1.0,8/30,4.09%,APOE;CD36;FABP5;PRKAG2;ABCD2;PPARG;CPT1A;SLC27A1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5589698562796399,-1.6993947657142103,0.010714285714285714,0.054062567492704244,1.0,15/30,27.88%,ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;TRADD;DDX3X;GSK3B;HMOX1;BCL2L1;SCRT2
prerank,positive regulation of proteolysis (GO:0045862),-0.48352736965370746,-1.6991748398604551,0.004702194357366771,0.05397059283335018,1.0,15/55,11.23%,APOE;SNX9;TNFRSF1B;OGT;NLRC4;FBXW11;ADAM9;ASPH;SNX33;WDR48;RCN3;CTSC;ADAM8;CTSH;CLN6
prerank,phagolysosome assembly (GO:0001845),-0.6855938019701547,-1.6967734189326817,0.0034071550255536627,0.05531902381876892,1.0,8/12,19.21%,ARL8B;RAB7B;RAB7A;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,secretory granule organization (GO:0033363),-0.7248499099113365,-1.6962472334603504,0.007352941176470588,0.05542597808308268,1.0,3/10,4.44%,ABCA1;LYST;SRGN
prerank,response to ethanol (GO:0045471),0.6584209730039441,1.695326736304872,0.012135922330097087,0.0818967550313638,1.0,4/14,1.90%,GRIN2A;GRIN2B;GRIN3A;GLRA1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.7536604380293493,-1.694627796823631,0.0017825311942959,0.056190254724803955,1.0,7/10,15.95%,CD300A;ANO6;RAB31;STAP1;C3;NCKAP1L;APPL2
prerank,cardiac muscle cell contraction (GO:0086003),0.6043884410445343,1.693938378252368,0.013793103448275862,0.08213113290582563,1.0,5/19,3.32%,FGF12;CACNA1C;CACNA2D1;SCN2B;SCN1A
prerank,negative regulation of viral genome replication (GO:0045071),-0.5249962112741376,-1.6934267264375602,0.0017825311942959,0.05669614945483607,1.0,19/40,21.72%,FAM111A;ZC3HAV1;RNASEL;RSAD2;BST2;EIF2AK2;IFITM2;RESF1;IFIT1;OASL;CCL5;OAS3;SETDB1;MAVS;ISG15;PARP10;OAS2;SRPK1;IFITM1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5346523376954304,-1.6924472075871628,0.00338409475465313,0.05719289266599701,1.0,13/34,16.73%,LYN;MFHAS1;CD300A;RAB7B;CD300LF;TLR4;IRAK3;GRAMD4;LY96;TICAM1;NFKBIL1;OTUD4;GPR108
prerank,positive regulation of organelle assembly (GO:1902117),-0.5118651540909045,-1.692237303457836,0.005434782608695652,0.05709543774422915,1.0,16/44,17.26%,ASAP1;SDCBP;PDCD6IP;PIP4K2A;CNOT1;CNOT2;DYNC1H1;RAB3GAP1;CAPG;LCP1;SDC4;CCDC88A;SH3GLB1;CNOT6L;RALB;G3BP1
prerank,histone methylation (GO:0016571),-0.5789155670371897,-1.6918200509554822,0.0049586776859504135,0.05708345069744469,1.0,10/26,15.07%,CREBBP;NSD3;PRMT2;SMYD2;SMYD3;EZH2;PRMT1;SMYD1;NSD1;PRMT6
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.5226842847694414,-1.6916922469104168,0.003395585738539898,0.05693265179388236,1.0,16/41,22.34%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;ZC3H12A;NR1H4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.45604658772630424,-1.6909705002709952,0.0,0.057183292824217385,1.0,23/75,15.96%,LYN;APOE;CD300A;PRKCD;RB1;PTPRJ;IPO5;HHEX;PIK3CB;LRP6;IRAK3;PKIB;STK38;SLC8A1;INCA1;SPRY2;AGT;CDK5RAP1;PAQR3;GADD45A;TFAP4;RGS14;LATS2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.46873659493180386,-1.6907809512037117,0.0,0.057087435580564935,1.0,23/65,11.52%,BCAR3;GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;ARAP1;DUSP3;TSG101;MVP;RHBDF1;DGKD;HIP1;EPS15;RHBDF2;PLAUR;MVB12B;AFAP1L2;SPRY2;AGT;STAM2;CCDC88A
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6633319258785323,1.6907605983054157,0.020179372197309416,0.08366246582730824,1.0,8/12,16.43%,DPYD;DPYS;CDA;DPYSL5;DPYSL4;DPYSL3;CTPS1;DPYSL2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4648069207966127,-1.6904410120748967,0.0,0.057109983509853864,1.0,27/74,19.77%,IGF1;MCL1;BIRC6;ARHGEF2;RIPK1;BRCA1;CFLAR;PSME3;ITGAV;BCL2;EYA4;PF4;MAP2K5;TGFBR1;MAPK7;RELA;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;EYA1;EYA3;HSPA1A;TRADD;DDX3X;GSK3B
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5182595541542334,-1.6904288505855145,0.0017035775127768314,0.05688335659116397,1.0,17/43,22.34%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;CD274;ZC3H12A;NR1H4
prerank,lipoprotein localization (GO:0044872),-0.7100064743348387,-1.6904089876484265,0.00859106529209622,0.05666824713952596,1.0,4/11,3.24%,PRKCB;LRP1;CD36;PPARG
prerank,endocytic recycling (GO:0032456),-0.49147275809827473,-1.6897558216813287,0.0017123287671232876,0.05688108844883366,1.0,24/50,31.51%,DENND1A;RAB7A;SNX3;SNX27;EHD4;EPS15;VPS35L;RAB11B;EIPR1;VPS26A;EHD1;RAB13;ACAP2;SNX4;DENND1B;VPS51;VPS50;MICALL1;RAB35;SNX31;DENND1C;MICALL2;STX6;RAB14
prerank,inorganic cation import across plasma membrane (GO:0098659),0.45469295796068426,1.6895351401701593,0.0,0.08399493594569928,1.0,25/75,17.53%,CACNA2D1;SLC24A2;SLC8A3;SLC12A2;SLC39A10;SLC12A8;SLC12A1;KCNJ6;KCNJ3;SLC9A2;KCNJ10;KCNJ9;HCN2;KCNJ16;ATP1A3;SLC6A1;SLC8A2;ATP1B1;SLC12A5;KCNJ12;ATP2B4;TRPV3;SLC39A6;ATP1B2;TRPM2
prerank,regulation of immunoglobulin production (GO:0002637),-0.5937411991000577,-1.6893482123171257,0.008710801393728223,0.056875142885708205,1.0,11/23,31.19%,PTPRC;SASH3;CD22;DNAJB9;XBP1;FCGR2B;STX4;IL6;RBP4;IL2;VAMP3
prerank,organophosphate ester transport (GO:0015748),-0.5832504360733712,-1.6892962669664453,0.0,0.05667700429364243,1.0,9/24,11.05%,OSBPL8;PLTP;PITPNC1;PITPNA;PITPNM1;EPG5;OSBPL5;PRELID2;NPC2
prerank,regulation of interleukin-17 production (GO:0032660),-0.5525889411889088,-1.6889577855388271,0.003389830508474576,0.05669583553440146,1.0,13/31,22.48%,RFTN1;LY9;IL15;TLR4;IL18;MYD88;NCKAP1L;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1
prerank,mitotic chromosome condensation (GO:0007076),-0.5732605930302479,-1.688670424359838,0.0017482517482517483,0.056704983334043176,1.0,16/26,25.04%,RB1;CSNK2A1;NCAPG2;SMC4;NCAPH;MCPH1;CDK1;CHMP1A;NUSAP1;KMT5A;NCAPD3;PHF13;NCAPG;SET;CCNB1;AKAP8L
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3763922274081578,-1.688439764040116,0.0,0.056642805706851304,1.0,132/336,26.53%,LYN;FNIP2;VAV3;FOXP1;TAOK3;FAM111A;SUSD6;GRB2;MCL1;SAMHD1;BCL6;DDB2;CGAS;TNFRSF1B;BCL2L11;BACH1;SPIDR;RAD51B;PSME4;MAPKAPK2;BRCA1;UVRAG;DYRK2;NIPBL;POLE2;TOP2A;RNF169;BCL2;NABP1;PARP4;MAPK14;BATF;BLM;RAD1;RTEL1;CRIP1;MACROD1;WDR48;REXO4;PWWP3A;KMT5B;ALKBH1;E2F1;BABAM2;USP3;UBA7;PCLAF;RAD51;MASTL;MGMT;RFWD3;KMT5C;MCM9;RNF8;APTX;TAOK1;TIMELESS;LIG1;CDK1;CUL4B;RAD54L;GADD45A;WRN;EXO1;FEN1;CIB1;PLK3;STK11;TICRR;ASF1A;WDR76;WAC;APLF;DOT1L;RAD51AP1;RFC2;YY1;INO80;RAD52;ERCC4;UBE2T;NSMCE3;AATF;SLX4;UBQLN4;TOPBP1;BID;TAF9;XRCC3;RAD9A;RPS3;NCOA6;TAOK2;CASP2;RBBP8;ADPRS;FBXO31;MMS19;SMC1A;ATM;CHEK1;TRIP12;RFC3;PDS5B;DTX3L;ZC3H12A;ALKBH3;FAN1;SMC6;CCNK;BCL2L2;SFN;NBN;TOPORS;ZRANB3;POLB;MTREX;EID3;PRKDC;DDB1;MYC;RAD51C;TRIM28;SMC5;BLK;RECQL5;BAZ1B;USP16;RBBP5;VCP;PML;ASH2L
prerank,neuron projection morphogenesis (GO:0048812),0.3952787311036378,1.6880907720266418,0.002652519893899204,0.08445243419873512,1.0,32/137,9.03%,CNTNAP2;NLGN1;CTNNA2;MAP2;CTNND2;ANK3;MAP1B;CNTN4;DCLK1;NYAP2;DCC;MYO16;GPM6A;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;EPB41L3;EPHB1;SHANK3;DCDC2;BDNF;FLRT3;NCKAP1;DSCAML1;SPTBN4;BMP7;SRGAP2
prerank,natural killer cell activation (GO:0030101),-0.5940984711776508,-1.6863674860619067,0.0051635111876075735,0.05765054937649391,1.0,11/23,17.21%,PTPRC;ELF4;SLAMF7;AXL;SNX27;PRDX1;CD2;KAT7;PIK3CD;ULBP1;CASP8
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.4086285306560907,-1.6860841121403185,0.0,0.057580511429564725,1.0,50/149,19.20%,PRKCH;PRKCB;RAB7B;CD36;ARHGEF2;MALT1;RIPK1;TRAF5;IRAK2;STAT3;TAB2;CARD11;CFLAR;TLR4;DHX9;NLRC4;IL18;NFKB1;AIM2;RNF31;RBCK1;IRAK3;IL18RAP;MYD88;EIF2AK2;NOD1;ADAM8;UBC;RPS27A;APP;MTPN;TRAF1;AGT;RELA;TICAM1;CIB1;TRIM68;TRAF2;CD40;RNF25;IKBKB;NFKBIB;FLOT2;TRIM14;IL18R1;HSPA1A;RPS3;TRADD;NOD2;LGALS9
prerank,DNA recombination (GO:0006310),-0.5356317440998928,-1.6847938977495194,0.004991680532445923,0.05816843779090368,1.0,22/37,28.35%,RAD51B;BLM;RTEL1;RAD51;HDAC10;GEN1;RAD54L;WRN;EXO1;ENDOG;RHNO1;RAD54B;RAD52;XRCC3;HMGB3;HMGB1;DMC1;RAD51C;TSN;RECQL5;MRE11;RPAIN
prerank,regulation of actin filament-based movement (GO:1903115),0.7154793008466804,1.6845884077673734,0.021739130434782608,0.0863029294212528,1.0,3/10,3.49%,PDE4B;ANK2;PDE4D
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7166618750149918,-1.6811271315298364,0.006920415224913495,0.06037518385364257,1.0,6/11,17.25%,TET3;OGT;CTR9;KMT2D;TET2;KMT2A
prerank,positive regulation of cell projection organization (GO:0031346),0.4089352956995707,1.6802902387306116,0.0,0.08886365292059527,1.0,32/115,12.23%,ROBO1;MAGI2;PTPRD;IL1RAPL1;LRRC7;ROBO2;GRIP1;TENM3;RIT2;SLIT2;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;SLITRK1;CARMIL1;PTN;CARMIL2;CUX2;PRKCI;TOX;BDNF;PRKD1;PLXNA4;CAPRIN2;LTK;RELN;ARHGAP35;DPYSL3;PLXNA2;RET
prerank,regulation of integrin activation (GO:0033623),-0.6692615721644641,-1.6799060883305306,0.008880994671403197,0.06099467385697768,1.0,6/15,10.59%,FBLIM1;PLEK;RAP1B;PIEZO1;PTGER4;KIF14
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5930937638810075,-1.67906733858309,0.003401360544217687,0.06125199557696756,1.0,11/22,22.48%,RFTN1;LY9;IL15;IL18;MYD88;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5426973917426823,-1.6783571604798548,0.0017211703958691911,0.06147500537183113,1.0,13/29,18.46%,SAMHD1;YTHDF3;USP18;RNASEL;NLRC5;IFNAR2;ABCE1;PTPN6;HSP90AB1;OAS3;MAVS;ISG15;PTPN11
prerank,positive regulation of nervous system process (GO:0031646),0.603819686577209,1.6778497211614443,0.014218009478672985,0.09000693998003638,1.0,4/18,1.83%,RIMS2;RIMS1;TENM4;PARD3
prerank,regulation of mast cell activation (GO:0033003),-0.7238422781634284,-1.6776773062343044,0.00718132854578097,0.06172860059386283,1.0,4/10,6.43%,LYN;CD84;CD300LF;MILR1
prerank,B cell mediated immunity (GO:0019724),-0.7398838763182165,-1.6767251646205874,0.003552397868561279,0.062140981087439436,1.0,5/10,12.71%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6700739126188024,-1.675713006348544,0.003629764065335753,0.06260060655614602,1.0,6/13,9.34%,AKAP13;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,regulation of dopamine secretion (GO:0014059),0.5442844240079262,1.6753614827003098,0.00966183574879227,0.09121396829645591,1.0,11/25,16.32%,SYT1;SYT10;SYT2;GDNF;SYT5;SYT11;SYT12;SYT7;KCNA2;PRKN;SNCA
prerank,positive regulation of dendrite development (GO:1900006),0.7262893215266434,1.6751833776656742,0.01405152224824356,0.09067365805396257,1.0,6/10,14.32%,PTN;ALK;BMP7;COBL;VLDLR;PACSIN1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5935766526947147,-1.6746030282126911,0.0034071550255536627,0.06314796314459362,1.0,9/22,20.26%,CD44;GCNT2;MYADM;MAP2K5;MAPK7;LCK;FLOT2;AGER;WNK1
prerank,response to calcium ion (GO:0051592),0.4168510643822254,1.6739882003218527,0.0,0.09101707978631386,1.0,37/102,14.55%,NLGN1;RYR3;RYR2;SYT1;ADCY8;SYT10;KCNMB2;KCNMB3;TRPC1;KCNH1;SYT2;CPNE4;PDCD6;AHCYL1;CASQ2;SYT5;HOMER1;KCNIP2;ADGRV1;NEDD4;SYT11;SYT12;ADCY1;TNNT2;RYR1;TTN;CPNE8;CAPN3;CALM1;KCNMA1;PPIF;CALM3;SYT7;CALM2;CPNE5;LGMN;BRAF
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5394980452717744,-1.6734973227196521,0.009933774834437087,0.06369582017395073,1.0,11/32,10.92%,PID1;IGF1;P2RX7;NUPR1;INSR;PFKFB3;HIF1A;ARNT;APP;PFKFB4;ZBTB20
prerank,regulation of cell size (GO:0008361),-0.5807938646928484,-1.673480955700291,0.008503401360544218,0.0634752142100396,1.0,9/23,10.49%,VAV3;MSN;PLEK;RAC1;RHOA;VAV1;RARG;VAV2;MTPN
prerank,cellular response to lectin (GO:1990858),-0.4363994116601077,-1.6725829357152306,0.001607717041800643,0.06364052860585097,1.0,35/104,20.62%,LYN;PLCG2;SYK;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;PSMC3;RELA;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;RELB;IKBKB;PSMB8;KRAS;NRAS;PSMD4;PSMA5;PSMB3;PSMD3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4363994116601077,-1.6725829357152306,0.001607717041800643,0.06364052860585097,1.0,35/104,20.62%,LYN;PLCG2;SYK;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;PSMC3;RELA;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;RELB;IKBKB;PSMB8;KRAS;NRAS;PSMD4;PSMA5;PSMB3;PSMD3
prerank,nucleotide catabolic process (GO:0009166),-0.6372205902824178,-1.6722024727075089,0.0088339222614841,0.06363280534971592,1.0,5/16,9.99%,GDA;XDH;SAMHD1;DERA;NT5C2
prerank,microvillus assembly (GO:0030033),-0.6711413888222506,-1.6718424406714723,0.016100178890876567,0.06362959578624625,1.0,6/14,3.85%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5543897264424633,1.671528395173893,0.01485148514851485,0.09230391748350585,1.0,8/24,14.01%,AGBL4;TTLL11;TTLL7;TTLL10;TTLL5;NAA10;GGCX;TTLL9
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.43638645050481367,-1.6712352442651883,0.0016313213703099511,0.06387958254385696,1.0,35/105,20.62%,LYN;PLCG2;SYK;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;PSMC3;RELA;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;RELB;IKBKB;PSMB8;KRAS;NRAS;PSMD4;PSMA5;PSMB3;PSMD3
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.45675302399063267,-1.669991609442112,0.003418803418803419,0.06453050562827287,1.0,19/72,11.97%,APOE;ABCA1;NRP1;AKAP13;STARD8;MYO9B;RAC1;ARHGEF3;EPS8;ARHGEF2;ABL2;TNFAIP1;RIPOR2;ARRB1;ARHGEF18;KCTD10;CCDC125;FLCN;ITGA3
prerank,membrane depolarization during action potential (GO:0086010),0.5474021757248969,1.6697961315774947,0.0087527352297593,0.09290026539074911,1.0,7/26,6.52%,CACNA1C;SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.569155017358124,-1.6693836881920578,0.010327022375215147,0.0647357831481502,1.0,9/25,19.19%,PLCG2;MALT1;LAPTM5;B2M;TRAF2;SLC7A5;SPHK2;CD226;NOD2
prerank,regulation of neuron differentiation (GO:0045664),0.4421388272845076,1.6692730139170568,0.0,0.09267496632877115,1.0,25/76,14.76%,NLGN1;BRINP3;BRINP1;CNTN4;SOX11;NRCAM;ZEB1;VWC2;MOSMO;ALK;BDNF;CDK5RAP3;HOXD3;BMP7;ADRA2C;NEUROD1;ZFHX2;LTK;NBL1;CDK5R1;HES5;REST;CDK5RAP2;HES1;BEND6
prerank,regulation of AMPA receptor activity (GO:2000311),0.5583135202103888,1.6672967282905946,0.00966183574879227,0.0934196628385705,1.0,10/25,14.26%,NLGN1;SHISA6;GSG1L;SHANK3;SHISA9;CACNG4;CACNG2;RELN;ARC;NLGN2
prerank,regulation of interleukin-1 production (GO:0032652),-0.6451118597532073,-1.6671288050237822,0.018612521150592216,0.06605568188751791,1.0,6/15,7.80%,FOXP1;TLR4;TMED10;ANXA1;GAS6;SIRPA
prerank,positive regulation of autophagy (GO:0010508),-0.4456088632280474,-1.666960604013725,0.0,0.06596947416035494,1.0,31/81,24.21%,TFEB;DAPK1;ROCK1;GNAI3;OPTN;FOXO3;PIK3CB;CAMKK2;PLK2;ATF6;FLCN;SESN1;TICAM1;TRIM68;PLK3;STK11;WAC;SH3GLB1;PIK3C2A;TRIM14;FBXO7;TMEM59;BNIP3L;GSK3B;HMGB1;ZC3H12A;KDR;MEFV;PIM2;MTDH;DCN
prerank,membrane assembly (GO:0071709),0.5155497047509574,1.6665921635156267,0.007142857142857143,0.09334266350619887,1.0,7/34,4.57%,NLGN1;NRXN1;PTPRD;IL1RAPL1;ANK3;NRXN2;STX2
prerank,positive regulation of viral transcription (GO:0050434),-0.5638009517382718,-1.6663222647096474,0.00684931506849315,0.06622418261474344,1.0,13/25,26.55%,MDFIC;NELFB;DHX9;POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;NELFE
prerank,mesenchymal cell development (GO:0014031),0.5916875432467589,1.6661717195500971,0.0024330900243309003,0.09309517979296995,1.0,4/18,4.92%,NRG1;SOX11;CDH2;PDCD6
prerank,myeloid cell differentiation (GO:0030099),-0.4882081568824716,-1.6660050975509357,0.0,0.06616842097722966,1.0,10/47,9.16%,LYN;RUNX1;MFHAS1;SPI1;RASGRP4;IKZF1;HSPA9;RPS14;ACIN1;FLVCR1
prerank,lipoprotein transport (GO:0042953),-0.7228702263354659,-1.6633078503471332,0.005244755244755245,0.06791522944971136,1.0,4/10,3.24%,PRKCB;LRP1;CD36;PPARG
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6746946939342481,-1.6628890764060102,0.0034129692832764505,0.06799638519581656,1.0,8/13,19.89%,ZMIZ1;ARID1B;SPI1;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.4833013962677215,-1.662788599166765,0.008849557522123894,0.06784037098395745,1.0,29/55,31.82%,PTPRC;IGF1;CCR2;SYK;IL15;IL18;ANXA1;CD28;NCKAP1L;CD46;CCL5;IL27RA;RPS3;HMGB1;AGER;CD274;TNFSF9;CD3E;IL6;IL12RB1;NCK1;TNFRSF13C;PNP;IL2;NCK2;SLC7A1;IGFBP2;CD80;CCL19
prerank,kinetochore organization (GO:0051383),-0.680551824830411,-1.662258950410842,0.010135135135135136,0.0679340826358594,1.0,8/13,17.75%,CENPF;DLGAP5;CENPA;CENPE;POGZ;NUF2;NDC80;CENPH
prerank,nucleosome assembly (GO:0006334),-0.5370823570734441,-1.6614718431185151,0.008264462809917356,0.068321910713001,1.0,13/31,18.73%,SMARCA5;ANP32B;UBN1;ASF1B;HMGB2;ASF1A;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,regulation of RNA splicing (GO:0043484),-0.473765235033312,-1.6613771023098323,0.0016666666666666668,0.06812381757548325,1.0,36/69,25.42%,AHNAK;MBNL1;PTBP3;RBM39;ERN1;MBNL2;TRA2B;SON;AHNAK2;FUS;MBNL3;HNRNPH1;HNRNPL;RPS13;CWC22;METTL4;DYRK1A;CELF1;HNRNPLL;TMBIM6;YTHDC1;ZNF326;POLR2A;SRSF10;HSPA1A;SNRNP70;SLC38A2;GRSF1;HNRNPH2;SRPK1;RBM38;HNRNPK;RBM22;ESRP1;CLK4;LARP7
prerank,immunoglobulin mediated immune response (GO:0016064),-0.7126704659929014,-1.6606175553723181,0.011342155009451797,0.06844043629501141,1.0,5/10,12.71%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.4808986570286721,-1.6601858629617543,0.0017094017094017094,0.06856039336521218,1.0,20/55,20.67%,PID1;GRB2;XDH;RAC1;RIPK1;RNF41;BRCA1;MAPK14;AGT;BCO2;GADD45A;CBR1;TGFBR2;MPV17;AATF;BST1;SPHK2;PDGFRB;SIRT2;ZC3H12A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5700246190622065,1.6587076292853196,0.009456264775413711,0.09831716589122749,1.0,9/23,13.17%,KIF5C;KIF1B;DYNC1I1;KIF5A;HOOK3;HOOK1;MAP6D1;F8A1;DYNC1I2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6624402821049523,-1.6585653607892057,0.013201320132013201,0.06935368369568513,1.0,3/13,17.22%,NAMPT;PARP9;PARP10
prerank,inorganic ion transmembrane transport (GO:0098660),0.6769785890400076,1.6581698555713835,0.023965141612200435,0.09806207234875934,1.0,1/12,0.21%,ASIC2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.566435851696435,-1.6577521905034345,0.015358361774744027,0.06970065487832451,1.0,11/25,15.58%,CCR2;PIAS1;STAT3;CTR9;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.43062933288674315,-1.6576803892900482,0.001736111111111111,0.06952216509059973,1.0,42/94,27.57%,FNIP2;MAP3K5;APAF1;MCL1;PRKCD;ITPR1;TNFRSF1B;ERN1;BCL2L11;BRCA1;BCL2;CRIP1;E2F1;CASP4;DDX5;ATP2A3;MLLT11;STK11;STK24;TRAF2;CUL2;BBC3;QRICH1;CASP2;DDX3X;C1QBP;ATM;BAG6;CEBPB;BCL2L2;SFN;TOPORS;RRP8;ERO1A;CYP1B1;PRKDC;ERN2;PML;DIABLO;CUL3;BCL2L1;MYBBP1A
prerank,neuron differentiation (GO:0030182),0.3824969797341788,1.656913436189936,0.0,0.09836122686436435,1.0,29/165,12.26%,PTPRD;TENM2;IL1RAPL1;MYT1L;SPOCK1;PHOX2A;TENM3;SOX11;TENM1;TENM4;NTRK2;SNPH;FUT9;RORB;ATP8A2;EPHA5;SMARCA1;WNT9A;POU3F2;ALK;FZD8;OLIG1;TGFB2;EN1;POU4F2;NEUROD1;CDK5R1;BRSK1;PBX1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5399777251827561,-1.6567539539586642,0.006993006993006993,0.06989123651805283,1.0,12/34,24.45%,PTPRC;SASH3;PTPN22;LAPTM5;DNAJB9;XBP1;SLC7A5;STX4;SPHK2;NOD2;IL6;RBP4
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.4840768330442248,-1.65629794826293,0.0088339222614841,0.06997517022941015,1.0,19/49,18.76%,RUNX1;CNOT4;RAB7B;PF4;WDR5;PRMT1;CBFB;KMT2C;MEF2C;MOV10;KMT2D;NFE2;HMGB2;CIB1;TNRC6C;SIN3A;PRMT6;KMT2A;PITHD1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.6638504707941881,-1.65568913343969,0.013582342954159592,0.07023666770205493,1.0,7/14,12.23%,MSN;RHOA;RAP2A;CDC42;SH3BP1;SCRIB;FOXJ1
prerank,oligosaccharide metabolic process (GO:0009311),0.4766621327147671,1.655131954592003,0.004597701149425287,0.09916615892125338,1.0,20/46,20.07%,B3GALT1;ST8SIA2;FUT9;B3GALT5;ST8SIA3;GAL3ST3;ST6GAL2;FUT8;AMY1A;AMY1B;AMY1C;ST6GALNAC3;ST3GAL6;B4GALNT2;ST8SIA5;IDUA;ST8SIA1;B3GALT4;MPDU1;ST6GALNAC5
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.610449084372678,-1.655059547846167,0.010434782608695653,0.0704633810933162,1.0,7/18,15.45%,DOCK2;PLCG2;SYK;SBNO2;IFI35;FCER1G;KARS1
prerank,regulation of leukocyte activation (GO:0002694),-0.6581987522174015,-1.6550586884226324,0.008818342151675485,0.07022771761139876,1.0,4/14,1.41%,LYN;CD74;MFHAS1;GPR137B
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5642467002601204,1.6542767370717637,0.014598540145985401,0.0991636994102595,1.0,7/22,7.13%,MAGI2;NTRK3;NTRK2;SH3GL2;WASF1;TMEM108;BDNF
prerank,carbohydrate biosynthetic process (GO:0016051),0.5705173021340239,1.6542384873210476,0.006423982869379015,0.09851196479018004,1.0,9/21,20.07%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;MPDU1;ST6GALNAC5
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.6571528495335333,-1.6539284406282002,0.010327022375215147,0.0708712625192344,1.0,3/14,4.27%,CD84;PAEP;IL18
prerank,regulation of T cell differentiation (GO:0045580),-0.5269838030150347,-1.6534039169871309,0.008665511265164644,0.07098324595401038,1.0,19/33,29.33%,ZMIZ1;RUNX1;CCR2;MDK;CBFB;XBP1;CD2;TCF7;ZAP70;GATA3;IL7;IL2RA;TBX21;CRTAM;PRELID1;SPINK5;METTL3;IL2;ZBTB1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6848900984885025,-1.6518756534206414,0.010638297872340425,0.07166891461615796,1.0,6/12,18.45%,PLCG2;CYBA;CD36;TLR4;SLC5A3;MMP8
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5835364500929247,-1.651639791083746,0.011627906976744186,0.07159886420223778,1.0,8/22,9.47%,APOE;ROCK1;SNX9;TNFRSF1B;ADAM9;SNX33;TIMP2;ADAM8
prerank,regulation of interleukin-12 production (GO:0032655),-0.4943070529540935,-1.6513351073397822,0.005226480836236934,0.07162640617235977,1.0,20/47,19.88%,FOXP1;LILRB1;PLCG2;SYK;TLR8;PIBF1;TLR4;IRF5;MAPK14;IRAK3;LAPTM5;MDK;CD40;MAST2;LILRA5;CMKLR1;LGALS9;C1QBP;HMGB1;AGER
prerank,activation of GTPase activity (GO:0090630),-0.4392353511713369,-1.6497054367939081,0.0016,0.0726017287718349,1.0,33/89,19.46%,ABR;CORO1C;ARHGAP25;ARHGAP22;ARHGAP24;SIPA1;TBC1D15;SGSM2;TBC1D2B;TBC1D9;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;TBC1D16;TBC1D22B;SIPA1L3;TBC1D8B;TBC1D8;SCRIB;TBC1D17;CCDC125;FOXJ1;TBC1D10B;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;TBC1D9B;TBC1D25;GPR65;PIP5K1A
prerank,regulation of p38MAPK cascade (GO:1900744),-0.531604027121803,-1.648941805177111,0.005172413793103448,0.07291932412730488,1.0,11/35,11.90%,SASH1;MFHAS1;XDH;RELL1;SPI1;MINK1;PTPN22;VEGFA;PRMT1;NCF1;GADD45A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.6971562001128789,-1.6479986682308765,0.006932409012131715,0.07339114678948708,1.0,7/11,19.89%,ZMIZ1;ARID1B;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,cellular response to interferon-gamma (GO:0071346),-0.4394752433168374,-1.647996309898048,0.005076142131979695,0.07315286384536537,1.0,36/88,26.34%,CD44;SP100;DAPK1;PRKCD;GAPDH;IRF2;TLR4;IRF5;DAPK3;CIITA;SIRPA;GBP5;B2M;JAK1;GBP2;IFNGR2;OASL;CCL5;TRIM68;CASP1;OAS3;MT2A;HCK;GBP3;LGALS9;GBP7;GBP6;OAS2;STAT1;TRIM25;IFNGR1;CCL7;CD47;GBP4;IL12RB1;PML
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6553502607389814,-1.6477470096299622,0.015384615384615385,0.07311918780001496,1.0,7/13,19.51%,NUPR1;MBTPS2;NR1H2;WFS1;FCGR2B;MANF;LPCAT3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5209668226723772,-1.6475684644644832,0.006980802792321117,0.07301825916373983,1.0,18/32,21.71%,TAOK3;BRCA1;ABRAXAS1;BLM;RINT1;BABAM2;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3891149684629439,-1.6464884930150587,0.0,0.07366567371283538,1.0,66/193,21.46%,RNF213;ZNRF3;CBL;CNOT4;RNF150;BFAR;BIRC6;RNF19A;RNF149;RNF111;MYLIP;AMFR;AREL1;ANAPC1;RNF166;RC3H1;RNF20;UBE2R2;KLHL25;ARRB1;UBE3B;NUB1;KCTD10;ATXN3;UBE2L3;SPSB2;UBC;RPS27A;RNF8;UBE4B;NEDD4L;XBP1;WDR91;RNF128;FBXO10;UHRF1;BUB1B;UBE2H;RNF185;PCYOX1;ARRDC1;ARIH1;RNF43;RNF34;UBE2G1;CDC34;UBQLN4;UBE2C;ISG15;MIB1;UBE2I;AURKA;FBXO7;ANAPC7;NDFIP2;FBXO22;TRIP12;ELOC;DTX3L;PSMD3;UBE3C;SMURF2;RNF125;FBXW4;BAG6;TRIM25
prerank,actin nucleation (GO:0045010),-0.5936484675139474,-1.6459941511100726,0.008787346221441126,0.07378052606324394,1.0,9/21,16.29%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,stress-activated MAPK cascade (GO:0051403),-0.46536613752893435,-1.6443477054091078,0.005119453924914676,0.07472010734211185,1.0,24/61,19.20%,MAP3K8;MAP3K5;MAP4K3;MAP3K20;IRAK2;MINK1;TAB2;NFKB1;FBXW11;PTGER4;MAPK14;GPS1;TRIB1;NOD1;UBC;RPS27A;TNIP2;CRKL;MAP3K10;IKBKB;MAP2K3;TAOK2;NOD2;LGALS9
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7056661342358554,-1.6442843390555486,0.010380622837370242,0.07452524604260549,1.0,7/11,17.21%,BIRC3;NUPR1;ARHGEF2;RIPK1;PELI1;SLC25A4;CASP8
prerank,osteoclast differentiation (GO:0030316),-0.5736104484134775,-1.6434529246994198,0.014705882352941176,0.0748901539286913,1.0,6/22,5.83%,FOXP1;SNX10;GAB2;ANXA2;SBNO2;MAPK14
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5955471131312757,-1.6430401710732652,0.013888888888888888,0.07503082517685146,1.0,7/18,9.98%,CD74;RAC1;CAMK1D;RIPOR2;MDK;ADAM8;NCKAP1L
prerank,DNA-dependent DNA replication (GO:0006261),-0.41001082582106924,-1.642866188103477,0.0016025641025641025,0.07494161954919017,1.0,51/128,24.52%,PSME4;PSMB7;RFC1;PSME3;POLE2;NOC3L;PSMB9;BLM;PRIMPOL;GINS3;MCM6;RAD51;PSMA8;UBC;RPS27A;MCM3;PSMC3;DBF4;SSBP1;ORC5;PSMD8;WRN;BAZ1A;PSMC4;PSMB10;RPA3;PSMA1;POLD2;RFC2;MCMBP;CDC34;TOPBP1;MCM2;PRIM1;DNA2;LRWD1;PSMB8;PSMD4;PSMA5;PSMB3;PRIM2;RFC3;PSMD3;GINS4;CDC45;TWNK;POLB;POLG2;MCM5;POLD4;PSMB1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7002387344313912,-1.641409993116298,0.012411347517730497,0.07582795556437677,1.0,3/10,1.00%,LYN;FGR;LILRB1
prerank,pinocytosis (GO:0006907),-0.7075186311460446,-1.6408960221091193,0.01436265709156194,0.07599136196383302,1.0,5/10,6.73%,DOCK2;MAPKAPK3;MAPKAPK2;SNX5;SNX33
prerank,positive regulation of behavior (GO:0048520),0.6878659955813049,1.640884527901653,0.04100227790432802,0.10890126658431308,1.0,2/10,0.95%,NLGN1;SGIP1
prerank,response to molecule of bacterial origin (GO:0002237),-0.45344053650403665,-1.6398916765512843,0.0017211703958691911,0.07656513955760844,1.0,19/69,13.90%,FOXP1;MAPKAPK3;OTUD5;C4B;MAPKAPK2;TAB2;TLR4;PELI1;IRF5;PTPN22;CYRIB;IRAK3;ERBIN;TRIB1;LY96;IFNAR1;FCGR2B;HMGB2;GCH1
prerank,dendrite self-avoidance (GO:0070593),0.5964413040335881,1.6387508850825545,0.03508771929824561,0.10993028067937675,1.0,7/16,16.18%,CNTN6;CNTN4;DSCAM;DSCAML1;ROBO3;VSTM2L;EMB
prerank,peptide biosynthetic process (GO:0043043),-0.3994747232041545,-1.6384711719076126,0.0030959752321981426,0.07734231406301831,1.0,64/153,25.76%,AGO2;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;MRPL42;RPS14;RPL32;RPS28;RPS13;RPS15A;DARS1;RPS27A;RPL28;RPS4X;EIF4EBP2;RPS23;RPL22;RPL14;EEF1A1;MRPS6;RPL34;RPS11;MRPS11;RPL6;EIF4G1;RPS10;RPL18A;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;RPL23A;RPS16;COPS5;RPL9;RPLP2;MRPL51;RPL7A;RPL19;RPS15;RPL39;RPLP0;RPL41;MRPL18;FURIN;MRPS7;RPL5;RPL13
prerank,sensory perception of mechanical stimulus (GO:0050954),0.41449994017839126,1.637060438954674,0.0,0.11063642485421389,1.0,28/85,18.30%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;EML2;WHRN;TBX1;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;ATP2B2;USP53;EPS8L2;ROR1;ALDH7A1;COL1A1
prerank,regulation of striated muscle contraction (GO:0006942),0.5280274512163946,1.6366694792410008,0.015730337078651686,0.11019795070468344,1.0,9/27,15.92%,ANK2;DMD;RYR2;SLC8A3;TNNI1;CALM1;CALM3;CALM2;SCN10A
prerank,establishment of epithelial cell polarity (GO:0090162),-0.6077577792856015,-1.6362840374467222,0.008445945945945946,0.07877567863598384,1.0,7/19,8.18%,MSN;RHOA;RAP2A;CYTH1;CDC42;SIPA1L3;SH3BP1
prerank,ventricular septum development (GO:0003281),0.5065791138263385,1.636243700392108,0.013089005235602094,0.10983155568550214,1.0,8/37,5.17%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1;MATR3
prerank,B cell homeostasis (GO:0001782),-0.7228618168734618,-1.6356743970330265,0.007155635062611807,0.07903458957384579,1.0,5/10,9.98%,LYN;DOCK10;DOCK11;MEF2C;NCKAP1L
prerank,regulation of dendrite extension (GO:1903859),0.5847177139173909,1.6353626027787282,0.018518518518518517,0.10997088531395421,1.0,4/18,3.71%,RIMS2;RIMS1;SYT1;SYT2
prerank,sister chromatid segregation (GO:0000819),-0.5386761093154858,-1.6348686510004595,0.012280701754385965,0.07950075506297277,1.0,15/31,22.63%,RB1;NCAPG2;TOP2A;SMC4;KLHL22;CENPK;KIFC1;KNSTRN;NUSAP1;INO80;SGO1;NDC80;KIF18B;SMC1A;NSL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.6207352374030946,-1.6344552013159446,0.011986301369863013,0.07954763155533229,1.0,12/18,28.74%,LYN;C3AR1;C5AR1;SPG21;FCER1G;CMKLR1;LAX1;BAG6;GPLD1;BLK;FPR2;CD19
prerank,macrophage activation involved in immune response (GO:0002281),-0.6501125314833202,-1.6338086406381078,0.01549053356282272,0.079839532189209,1.0,5/13,7.47%,PLCG2;SYK;SBNO2;GRN;IFI35
prerank,zinc ion homeostasis (GO:0055069),-0.5592937047792683,-1.6336656140524672,0.006968641114982578,0.079700724184271,1.0,9/28,4.22%,SLC30A5;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,calcium ion import across plasma membrane (GO:0098703),0.6377422344818852,1.6329836473946182,0.015765765765765764,0.11125669874224044,1.0,8/14,19.09%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,regulation of organelle assembly (GO:1902115),-0.4467884205052208,-1.6327513345874243,0.0033613445378151263,0.08013666774490047,1.0,27/72,17.65%,MSN;PDCD6IP;TBC1D15;ATG5;TBC1D2B;IFT20;CEP295;MTMR3;TBC1D5;TBC1D1;SDCCAG8;TSG101;TBC1D22A;TBC1D16;PLK2;TBC1D22B;RNF4;RAB5A;TBC1D8;CEP295NL;TBC1D17;TBC1D10B;DYNLT2B;TBC1D24;TBC1D9B;STIL;HCK
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5879321195480173,-1.63228652336362,0.015280135823429542,0.08021469796163386,1.0,9/22,12.50%,CD300A;PTPRJ;DGKZ;LPXN;CD22;PTPN22;DUSP3;LAPTM5;FCGR2B
prerank,positive regulation of lipid storage (GO:0010884),-0.583502680889814,-1.6319079942283432,0.015517241379310345,0.0803108966719533,1.0,8/21,15.34%,MSR1;PLIN2;NFKB1;C3;OSBPL11;LPL;APOC4;EHD1
prerank,regulation of monocyte differentiation (GO:0045655),-0.644555287320257,-1.63158123314545,0.017889087656529516,0.0802875695736667,1.0,9/14,26.25%,FOXP1;CD74;CDK6;FES;ACIN1;IL34;CSF1;MYC;ZFP36L1
prerank,regulation of muscle contraction (GO:0006937),0.5487764745065082,1.631499054068733,0.021739130434782608,0.11168877369992368,1.0,7/26,7.48%,KCNB2;CHRM2;TNNI1;PLCE1;ENO1;KCNA1;PPP1R12B
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.43917347823313746,-1.630788489897943,0.0016750418760469012,0.08066831751906792,1.0,33/80,22.39%,RAB7B;RAB7A;SNX2;SNX3;VTI1A;VPS54;SNX8;SGSM2;SNX6;ANKFY1;SNX5;TBC1D5;VPS26B;TBC1D17;DCTN1;RAB29;STX5;VPS26A;TMEM87B;TBC1D23;TBC1D10B;BAIAP3;STX16;SPAG9;TMEM87A;ARL1;SNX1;VPS51;SNX32;VPS50;TBC1D10C;PHETA1;BET1L
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.46058073560089857,-1.6303429502614029,0.005145797598627788,0.08077337143149468,1.0,30/58,27.92%,NSMCE2;BRCA1;ERCC6;UVRAG;DCLRE1C;ABRAXAS1;KDM2A;BABAM2;RNF8;XRCC6;DCLRE1A;BABAM1;HMGB2;XRCC4;ERCC4;LIG3;BRCC3;ATM;HMGB1;NBN;ZBTB7A;POLB;DNTT;PRKDC;UBE2V2;UBE2N;SMC5;DCLRE1B;MRE11;UIMC1
prerank,negative regulation of bone mineralization (GO:0030502),-0.665979909633368,-1.6299744101111273,0.018211920529801324,0.08079307277181826,1.0,6/13,18.99%,CCR1;SRGN;PTK2B;GREM1;ENPP1;RFLNB
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6229017745426334,1.6299388891325561,0.022058823529411766,0.11225327958240061,1.0,3/15,1.68%,NLGN1;CNTNAP4;SYN3
prerank,regulation of T cell activation (GO:0050863),-0.5022946707355733,-1.6289933306506374,0.008503401360544218,0.08133784327089369,1.0,23/42,31.08%,CCR2;TNFRSF1B;TNFAIP8L2;PTPN22;DUSP3;CYRIB;SIRPA;LAPTM5;LCK;CD2;IL4I1;CCL5;LAX1;TNFSF9;CD47;TBX21;CRTAM;PRELID1;SPINK5;METTL3;IL27;LAT;CD4
prerank,regulation of ion transport (GO:0043269),0.42413641791248036,1.6286405726007829,0.0,0.11273782560267141,1.0,20/76,8.78%,NKAIN2;ANK3;SYT1;NKAIN3;SYT10;SYT2;GDNF;KCNJ6;KCNJ3;KCNJ10;CA2;ITGB3;KCNJ9;SYT5;KCNJ16;NEDD4;TOR1A;SPTBN4;SYT11;SYT12
prerank,regulation of glycolytic process (GO:0006110),-0.4523176700491704,-1.6283686440679064,0.004909983633387889,0.08166333053146546,1.0,21/68,12.98%,IGF1;P2RX7;NUPR1;OGT;INSR;NUP50;PRKAG2;NUP42;PFKFB3;CBFA2T3;NUP88;RAE1;HIF1A;ARNT;APP;PFKFB4;ZBTB20;NUP205;TPR;JMJD8;NUP188
prerank,positive regulation of innate immune response (GO:0045089),-0.5388274415449852,-1.6271040735227995,0.008710801393728223,0.08244324096236552,1.0,12/30,15.91%,TLR8;SPI1;DHX9;RIOK3;NLRC5;IFI35;GBP5;ADAM8;POLR3G;CCL5;POLR3B;MAVS
prerank,transferrin transport (GO:0033572),-0.5205024693403336,-1.626348931732631,0.001763668430335097,0.08281813241742843,1.0,11/33,20.32%,ATP6V0D2;ATP6V1E1;DNM2;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;RAB11B;ATP6V0B;ATP6V0E1;ATP6V0D1
prerank,positive regulation of dendrite extension (GO:1903861),0.5847200326235528,1.6250879788679784,0.02336448598130841,0.11496985211806603,1.0,4/17,3.71%,RIMS2;RIMS1;SYT1;SYT2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5550544103484994,-1.6250676405377134,0.014925373134328358,0.0835827765118255,1.0,8/24,12.55%,APOE;UCHL5;PSME3;PTK2B;NUB1;RHBDF1;CTSC;UBE3A
prerank,positive regulation of DNA recombination (GO:0045911),-0.5346436784209623,-1.6245942405695286,0.012048192771084338,0.08370604461521476,1.0,12/27,19.70%,ARID2;ACTR2;ERCC6;WDR48;FUS;KMT5B;KMT5C;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19
prerank,receptor metabolic process (GO:0043112),-0.47138942449341803,-1.6241980008013315,0.006825938566552901,0.08383219775220106,1.0,20/53,13.82%,GRB2;LILRB1;SYK;LRP1;ITGB2;DNM2;CD36;RAB31;CD9;ARRB2;GRK3;UVRAG;ITGB1;KIF16B;PICALM;SNX25;RAB11B;ARFGEF2;FCER1G;SH3GLB1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.6630210104453302,-1.6231642077489281,0.011299435028248588,0.08445406317360749,1.0,8/13,19.50%,CD74;AXL;DHX9;GAS6;AGPAT1;MAVS;TAF9;IL7
prerank,positive regulation of cell killing (GO:0031343),-0.650978538794706,-1.6225361106140146,0.021238938053097345,0.08476382264780398,1.0,3/13,1.51%,SYK;CYBA;RAC1
prerank,defense response to protozoan (GO:0042832),-0.663595422850026,-1.6219226006963468,0.012389380530973451,0.0850181329682243,1.0,9/12,24.66%,LYST;BATF;PF4;MYD88;GBP2;CD40;GBP7;GBP6;GBP4
prerank,regulation of cholesterol efflux (GO:0010874),-0.5399082585074,-1.6218031320676018,0.010416666666666666,0.08485015959322723,1.0,9/30,13.88%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;TTC39B;RXRA
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.40850740581313233,-1.6209241741802716,0.0016286644951140066,0.08531610286802961,1.0,38/121,18.46%,LYN;PTPRC;NEDD9;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;ITGA5;PTPRJ;ARHGEF2;IL6R;STAT3;PIBF1;IL15;TEC;IL18;PARP14;PTK2B;HGF;GAS6;VEGFA;PARP9;AGT;CLEC6A;CCL5;GREM1;CD40;IL34;CSPG4;IL31RA;HCLS1;GPRC5B;LILRA5;SOCS3;PTPN11
prerank,dendrite morphogenesis (GO:0048813),0.5020254537619743,1.6209130571766484,0.009501187648456057,0.11796915239582681,1.0,15/35,15.62%,CTNNA2;MAP2;CTNND2;PAK3;PTN;EPHB1;SHANK3;PHACTR1;DCDC2;SDC2;ARC;BTBD3;CHRNA7;KLF7;EPHB3
prerank,tryptophan catabolic process (GO:0006569),-0.6983191053192894,-1.6196701991204816,0.017361111111111112,0.0860346457543978,1.0,4/11,12.45%,KYNU;KMO;KYAT1;IL4I1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.45602777622000373,-1.6186856017675864,0.0050335570469798654,0.0866500668006878,1.0,30/63,27.24%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;RFWD3;CDK1;PCNA;GADD45A;PLK3;WAC;E2F8;CNOT6L;AURKA;CASP2;MDM4;FBXO31;CNOT8;ATM;CDC25C;SFN;GTSE1;CCNB1;PCBP4;PRKDC;RBL2;PML;CNOT3
prerank,cholesterol transport (GO:0030301),-0.48265158393897545,-1.6185104071448524,0.005263157894736842,0.0865921524655059,1.0,9/45,11.17%,APOE;ABCA1;MSR1;ABCG1;CD36;OSBPL5;LIMA1;NPC2;STARD5
prerank,regulation of intracellular signal transduction (GO:1902531),-0.3544703971661604,-1.6173339316040323,0.0,0.08734658862720922,1.0,126/420,19.89%,ARHGAP15;LYN;VAV3;AKAP13;TAOK3;ABR;SGMS1;ARHGAP10;BIRC3;ARHGAP25;STARD8;ITSN1;PLCG2;PAK2;ARHGAP22;MYO9B;RAC1;TOP3A;ARHGAP24;ARHGAP30;ARHGEF3;ARHGAP19;RHOA;ARHGAP17;BRD7;OPTN;PHF20;ARHGEF2;CSNK2A1;PIP4K2A;MOB3B;PRKAG2;VAV1;VRK2;GNA12;TRAF5;MINK1;SGK1;RNF41;BRCA1;DYRK2;FGD4;CDC42;CHD3;ITGAV;ARAP1;PTPN22;ARHGAP18;STK3;MAPK14;FGD3;RPL11;SMYD2;BLM;TRAF3;RAD1;RHOQ;TAF6;ARHGEF18;NF2;VEGFA;RCN3;PIP4P1;VAV2;SOS2;ZFAND6;ARHGAP12;TPX2;SPRED1;PIN1;TRAF1;STYXL1;GNA13;TAOK1;FLCN;TRIP10;ARHGEF11;CDK1;PLEKHG5;CRK;RELA;WRN;EXO1;FAM13B;CLEC6A;PLK3;STK11;RPA3;TRAF2;TRIO;ARHGAP36;RHNO1;RFC2;RACGAP1;TAF4B;TMSB4X;RNF34;PAK1IP1;TOPBP1;BST1;ARHGEF5;KMT5A;BRIP1;USP7;RBBP4;ARHGAP31;SPHK2;TAF9;AURKA;DNA2;RAD9A;TAF3;PTPN13;FAM83D;TAOK2;CMKLR1;MDM4;HSPB1;RBBP8;PAK6;TAF4;AKAP7;PIP5K1A;ATM;AGER;CHEK1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.442655903816316,-1.6159265202364865,0.003424657534246575,0.08834559671704972,1.0,28/73,20.62%,RUNX1;PSME4;SPI1;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;TCF3;KMT2A;PSMB8;GATA3;MYB;TCF12;LMO2;PSMD4;PSMA5;PSMB3;PSMD3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.4562980821504427,-1.6154402093755917,0.005226480836236934,0.08843016018002381,1.0,22/63,22.42%,PTPRC;VAV3;CD74;CD38;SASH3;IL15;IL18;BCL2;ANXA1;CD28;MEF2C;NCKAP1L;CD46;CCL5;CD40;BST1;CHRNB2;IRS2;IL7;CD274;CD3E;IL6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4766763817575274,-1.6150188724078016,0.008695652173913044,0.0885665249546825,1.0,30/44,39.78%,CD44;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;CAST;FNIP1;YWHAE;CST7;BEX3;DDX3X;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;TNF;KLF4;LTF;USP47;NGF;LAMP3;TRIAP1;RAF1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5424973527758816,-1.6147458042758587,0.01549053356282272,0.0885318190229721,1.0,9/29,10.09%,LYN;IGF1;NOTCH2;GRB2;VAV1;RASGRP4;ITGAV;ERBIN;TGM2
prerank,cellular response to interleukin-12 (GO:0071349),-0.4820414757471303,-1.6143366820467204,0.01658374792703151,0.08861514329525648,1.0,26/48,27.89%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;SIRPA;JAK1;LMNB1;LCP1;CAPZA1;CFL1;GSTO1;CNN2;P4HB;TYK2;RPLP0;CD47;MTAP;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,cellular response to fluid shear stress (GO:0071498),-0.6685187425809537,-1.6132159079546475,0.01721170395869191,0.08932698974784857,1.0,7/12,16.30%,MTSS1;NFE2L2;MAP2K5;MEF2C;MAPK7;KLF2;ASS1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.6160086560182596,-1.6129516324370552,0.015254237288135594,0.08931456947901097,1.0,3/16,1.57%,APOE;LRP1;ROCK1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.41116638490814406,-1.6125920757915844,0.0,0.08938813568258126,1.0,43/107,26.65%,MAP3K5;NIBAN1;JUN;ITPR1;ERN1;BCL2L11;ATF3;MBTPS2;ATG10;BCL2;PPP1R15B;ATF6;CREB3L2;WFS1;RCN3;CASP4;DNAJB9;ATP2A3;SELENOS;DERL1;SEL1L;HSP90B1;UBXN6;TRAF2;RNF185;BBC3;TMEM259;QRICH1;HYOU1;PDIA4;GSK3B;ERP44;ERLEC1;BAG6;CEBPB;UFM1;P4HB;ERO1A;PDIA3;ERN2;VCP;NCK1;ALOX15
prerank,negative regulation of protein transport (GO:0051224),-0.552839293653135,-1.6125312314101252,0.013223140495867768,0.08921454009180592,1.0,7/25,8.05%,APOE;SNX3;WWP2;PKDCC;RSAD2;RHBDF1;RHBDF2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.5374909204699005,-1.6123235490127124,0.017391304347826087,0.0891307662800008,1.0,11/27,17.86%,VPS13C;OPTN;VPS13A;IFT20;COG7;TMED10;GBP5;SYS1;PAQR3;ARL5A;ARL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.6889343088174662,-1.6114957974786794,0.015463917525773196,0.08963024574537189,1.0,5/11,17.34%,PTPRC;LILRB1;AHR;IL4I1;SMAD7
prerank,positive regulation of neurogenesis (GO:0050769),0.42356736401613665,1.6091105852949195,0.009828009828009828,0.12835856377762905,1.0,17/68,9.70%,ROBO1;PTPRD;IL1RAPL1;ROBO2;SOX11;SLIT2;NTRK2;CDKL5;SLITRK1;MME;SHANK3;CUX2;NUMB;CX3CR1;PLXNA4;CAPRIN2;RASSF10
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.6776661572856522,-1.6089090362068743,0.023931623931623933,0.09162239762221788,1.0,3/11,1.24%,LYN;MFHAS1;CYBA
prerank,regulation of humoral immune response (GO:0002920),-0.48874769427308307,-1.6088230608303211,0.011217948717948718,0.09143778124658503,1.0,17/44,28.74%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2;C6;C7;C8G;CD19
prerank,snRNA transcription (GO:0009301),-0.4415153227458061,-1.6083597716591729,0.004975124378109453,0.09166316345617068,1.0,29/70,22.65%,GTF2A1;INTS8;NABP1;SRRT;INTS11;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;NCBP1;POLR2A;USPL1;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;ELL2;GTF2A2;GTF2F2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4654410711502846,-1.6070409887577148,0.00510204081632653,0.0924502300229189,1.0,26/49,33.21%,SGMS1;MCL1;NUPR1;BCL2L11;BCL2;PLAUR;GSDME;FIS1;STYXL1;LCK;BBC3;BID;DDX3X;RACK1;BCL2L2;BECN1;P4HB;URI1;RTKN2;BCL2L1;EIF2AK3;NOC2L;PTPMT1;NDUFS3;CAV1;MMP9
prerank,regulation of hemopoiesis (GO:1903706),-0.6941244014739955,-1.6066218523783002,0.025735294117647058,0.09260102152450904,1.0,4/10,8.62%,RUNX1;PRKCB;CREBBP;CBFB
prerank,negative regulation of viral process (GO:0048525),-0.4610067813690307,-1.6063910406610373,0.0034542314335060447,0.09255990418464001,1.0,24/57,26.34%,FAM111A;ZC3HAV1;UBP1;RNASEL;RSAD2;BST2;EIF2AK2;IFITM2;IFIT1;OASL;CCL5;OAS3;TRIM11;MAVS;TRIM14;ISG15;PARP10;OAS2;STAT1;SRPK1;IFITM1;TRIM28;LARP7;PML
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5323959557866391,-1.604893528019859,0.013468013468013467,0.0937593728577916,1.0,8/30,9.07%,PTPRC;CD300A;PRKCD;PIBF1;PARP14;MVP;NF2;PTPN6
prerank,regulation of programmed cell death (GO:0043067),-0.3910312665539154,-1.604878054327581,0.0,0.09351528512102285,1.0,63/161,24.81%,CTSB;APAF1;BIRC3;DAPK1;CRADD;BCL6;CREBBP;ACER3;BCL2L11;MALT1;RIPK1;SGK1;ANP32A;NLRC4;RARG;ANP32B;DAPK3;STEAP3;USP36;NF2;HIP1;NME1;WFS1;PTPN6;TGM2;TPT1;AGT;IKZF3;OSGIN1;WRN;TRIM24;HTATIP2;USP42;FBXO10;LGALS1;CASP1;DFFA;TRAF2;IGFBP3;PRDX2;BID;RABGGTA;SKP2;TNFRSF25;BNIP3L;RPS3;IFT57;CASP2;RABGGTB;ATM;STAT1;HAX1;NUP62;ASAH1;CDK5;TNFSF9;CD3E;TOMM70;ZBTB7A;FANK1;FLT3;ACTN1;TARDBP
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6671323121819085,-1.604419525034252,0.015817223198594025,0.09374802372570289,1.0,7/12,20.49%,DHRS3;CNOT1;EZH2;ASXL1;KLF2;TRIM16;CYP26C1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5560432157716502,-1.6044141677212498,0.015544041450777202,0.0934986498953462,1.0,8/24,9.44%,RBPJ;NFE2L2;ATF3;MBTPS2;ATF6;VEGFA;HIF1A;MAPK7
prerank,neural crest cell development (GO:0014032),0.4597992254382205,1.6043460429780287,0.009828009828009828,0.13210709504913534,1.0,14/44,11.23%,NRG1;SOX11;ERBB4;CDH2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;PDCD6;SEMA3F;TBX1;SEMA5B;TAPT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5264914024111325,-1.6042177800518707,0.015544041450777202,0.09342259876971042,1.0,12/27,24.23%,AGO2;RIPK1;STAT3;DHX9;PUM2;DDX5;MAP2K1;EIF4G1;DDX6;IL6;TGFB1;PUM1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.49170686683202275,-1.6038567276809854,0.010380622837370242,0.09353167024836481,1.0,24/41,31.21%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;PRKAG1;NUP62;ZBTB7A;RANBP2;NUP37;EP300;AAAS;NUP133;EIF6;PGAM1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6340443001255793,-1.60385365587658,0.018050541516245487,0.09328158556855634,1.0,3/15,1.12%,APOE;ABCG1;PLTP
prerank,indolalkylamine catabolic process (GO:0046218),-0.7034310213487045,-1.6034042644316848,0.019130434782608695,0.09346919265831691,1.0,4/10,12.45%,KYNU;KMO;KYAT1;IL4I1
prerank,histone H4-K5 acetylation (GO:0043981),-0.6300206747549049,-1.6031869846476898,0.016423357664233577,0.09319525163919971,1.0,6/15,12.66%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,histone H4-K8 acetylation (GO:0043982),-0.6300206747549049,-1.6031869846476898,0.016423357664233577,0.09319525163919971,1.0,6/15,12.66%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,phosphorylation (GO:0016310),-0.3536396500925401,-1.6030027513627034,0.0,0.09308866183201954,1.0,118/384,19.98%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;PAK2;PRKCD;CDK6;ROCK1;MAP4K3;BIRC6;MAP3K1;RUNX3;ERN1;MAP3K20;INSR;PEAK1;CSNK2A1;PANK2;DGKZ;CDK13;PRKAG2;VRK2;RNASEL;MAML1;TLK1;MINK1;NADK;SGK1;HTR2B;MAPKAPK2;GRK3;STAT3;TEC;DYRK2;PIM1;PTK2B;DAPK3;STK3;PIK3CB;PIK3CG;CDK18;IRAK3;CAMKK2;DGKD;GAS6;PLK2;GRK5;STK38;COQ8A;EIF2AK2;JAK1;TRIB1;CDK14;TGFBR1;NEK6;FGGY;MORC3;SIK1;TRIB2;POMK;RSKR;APP;LCK;TAOK1;DYRK1A;GNPTAB;CDK1;PIK3CA;MAP2K1;PPP4R1;STK17B;STK11;FRK;STK24;ACVR2A;GMFG;MKNK1;PIK3CD;IGFBP3;MARK2;TGFBR2;MAST2;TXK;CCNE1;IKBKB;MKNK2;DGKG;LATS2;GMFB;STRADA;SPHK2;CDKL4;AURKA;PGK1;RARA;ZAP70;HCK;RYK;PKN3;HCST;BRD2;TAOK2;STK10;IP6K3;MAK;BMPR2;PAK6;GSK3B;ATM;CDK16;CHEK1;CDC42BPG
prerank,negative regulation of protein binding (GO:0032091),-0.4465884371175609,-1.602362882320334,0.005076142131979695,0.09342737216862994,1.0,27/71,21.38%,DAB2;ITGA4;CTSZ;PRKCD;ROCK1;PEX14;ARRB2;ACTB;PPP1CA;B2M;ATP2A3;ITGB1BP1;NES;PIN1;IFIT1;TMBIM6;IFIT2;ADAM15;TFIP11;RALB;AURKA;ADRB2;GSK3B;TMC8;DISC1;RACK1;KDM1A
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5984665257643415,-1.6016958645284214,0.0072992700729927005,0.09378696384200456,1.0,4/18,4.10%,LILRB3;LILRB1;GPR137B;TLR4
prerank,actin filament organization (GO:0007015),-0.3919289369368337,-1.6014086524197846,0.0,0.0938152874969778,1.0,34/151,11.81%,MYO5A;NEDD9;CORO1C;ABI1;ARHGAP25;RAC1;MYO1F;RHOA;EPS8;ARHGAP17;FLNA;ARHGEF2;GAS2L3;SVIL;CDC42;RUFY3;MYO1G;TRIOBP;TPM3;WASL;TPM4;CAPG;NRAP;BAIAP2;HIP1;MARCKSL1;SH3BP1;LCP1;CORO7;MYO1E;ARHGAP12;CDC42EP2;MYO7A;BAIAP2L2
prerank,calcium ion transport (GO:0006816),0.39203871699436876,1.6012539288117829,0.0027397260273972603,0.13423194688383025,1.0,16/113,3.17%,ANK2;TRPM3;CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;SLC24A4;SLC24A2;GRIN3A;SLC8A3;NALCN;TRPC1;CACNB2;SLC24A3
prerank,protein ubiquitination (GO:0016567),-0.3471144694763255,-1.6007076394383486,0.0,0.09421707173216431,1.0,145/471,21.11%,SASH1;RNF213;WWP1;ZNRF3;CBL;CNOT4;KLHL24;PEX14;BFAR;DDB2;BIRC6;RNF19A;FBXW8;NFE2L2;RNF111;NFX1;PSME4;MKRN2;WWP2;MYLIP;ARRB2;RNF41;FBXL17;BRCA1;AMFR;PSMB7;CTR9;AREL1;RNF166;TNFAIP1;PELI1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;PSMB9;KLHL25;RNF31;LNPEP;FBXL20;RBCK1;UHRF2;KLHL22;ARRB1;UBE3B;NUB1;MGRN1;UBR2;USP9X;CTNNB1;HERC6;ZSWIM8;DET1;KCTD10;TPP2;RNF4;CBLL1;TRIM47;CBFB;RNF38;HIF1A;HECTD2;PSMA8;UBE2L3;SPSB2;SELENOS;UBC;RPS27A;OTULIN;RFWD3;RNF8;UBE4B;KLHL18;PSMC3;NEDD4L;DERL1;EIPR1;CUL4B;PCNA;ARRDC4;TSPAN17;PSMD8;ASB5;TRIM24;FBXO10;UBE3A;TRIM68;UHRF1;PSMC4;PSMB10;WAC;UBE2H;TRAF2;FBXW2;CUL2;RNF185;TRIM11;PSMA1;TNKS2;ARRDC1;ARIH1;RNF25;RNF43;RNF34;UBE2T;UBE2G1;HLTF;CDC34;BRAP;TRIM14;USP7;UBE2C;ISG15;ASB4;VHL;KLHL42;MIB1;FBXL8;SKP2;FBXO7;ANAPC7;PSMB8;HUWE1;DTX1;TRIM39;PSMD4;PSMA5;FBXO31;VPS18;FBXO22;TRIP12;PSMB3;DTX3;RTF1;ELOC;DTX3L;PSMD3;UBE3C;SMURF2;RNF125;FBXW4;RACK1
prerank,presynaptic endocytosis (GO:0140238),0.5324004037217893,1.6005106957711739,0.019656019656019656,0.13407369736344038,1.0,7/24,6.54%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.680401905085138,1.5996765556953447,0.04408352668213457,0.13404861332273996,1.0,4/10,8.19%,HECW1;PRKCE;HECW2;NEDD4
prerank,platelet degranulation (GO:0002576),-0.3999890617291335,-1.5994262568979962,0.0016207455429497568,0.09515000911003946,1.0,42/118,22.48%,F13A1;LYN;IGF1;PSAP;PLEK;PHACTR2;CD36;FLNA;TAGLN2;CD9;CYB5R1;LAMP2;LHFPL2;SRGN;ANXA5;TLN1;PF4;HGF;FN1;PROS1;CYRIB;TEX264;GAS6;VEGFA;CD63;WDR1;APP;SERPINE1;ABCC4;MANF;TMSB4X;LGALS3BP;APLP2;ENDOD1;GTPBP2;FAM3C;F5;PDGFA;APOH;FERMT3;TUBA4A;TGFB1
prerank,regulation of immune effector process (GO:0002697),-0.48729944073563136,-1.5976492302555976,0.011235955056179775,0.09652985021390426,1.0,13/41,19.92%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5393994161840567,-1.5973617181595228,0.012681159420289856,0.09649642883960695,1.0,9/27,15.09%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA;ABCA13
prerank,regulation of viral genome replication (GO:0045069),-0.46101909774642386,-1.5962287191369409,0.007054673721340388,0.0971675938936887,1.0,29/56,34.39%,FAM111A;ZC3HAV1;RNASEL;RSAD2;BST2;EIF2AK2;CD28;IFITM2;IFIT1;OASL;CCL5;OAS3;MAVS;ISG15;VAPB;PARP10;DDX3X;OAS2;SRPK1;IFITM1;DDB1;HACD3;ISG20;PPID;ADARB1;PLSCR1;TNF;RAD23A;LTF
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6956435376244199,-1.5958252981090932,0.012477718360071301,0.09726940095245058,1.0,3/10,4.27%,ROCK1;IL15;IL18
prerank,regulation of cellular component movement (GO:0051270),-0.4724729705891659,-1.5957894458809208,0.010050251256281407,0.09705041622482506,1.0,15/49,8.81%,DIAPH1;LYN;SP100;CDK6;ROCK1;RHOA;FES;CD9;ABL2;ARAP1;DAPK3;ARHGAP18;ZSWIM8;VEGFA;TGFBR1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4704397277003789,1.5956733788542128,0.007142857142857143,0.13708956294540642,1.0,17/44,15.46%,AKAP6;ANK2;KCNN2;KCNMB2;KCNMB3;KCNJ6;KCNJ3;KCNJ10;KCNJ9;KCNIP2;GABBR1;KCNJ16;ATP1B1;KCNMA1;KCNJ12;WNK4;WNK3
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.4918275195812826,-1.5956500669086633,0.007194244604316547,0.09693693007649669,1.0,27/41,35.24%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;PRKAG1;NUP62;ZBTB7A;RANBP2;NUP37;EP300;AAAS;NUP133;EIF6;PGAM1;SCARB2;SLC2A6;SEC13
prerank,regulation of response to external stimulus (GO:0032101),-0.4018029752422627,-1.5940242342054989,0.001564945226917058,0.09805120387265355,1.0,44/121,25.20%,FOXP1;FGR;BIRC3;CCR2;SAMHD1;BCL6;CD36;P2RX4;SBNO2;PIK3AP1;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;CYRIB;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;STK24;TMSB4X;CXCR4;APPL2;BST1;CASP8;HCK;PPEF1;NOD2;APPL1;RNF135;SETD6;NMT1;LRRC19;SEMA7A;GUCY2F;GUCY2D;ZMPSTE24
prerank,regulation of endocytosis (GO:0030100),-0.4452419519029288,-1.5940179526110423,0.006666666666666667,0.09780358016112087,1.0,15/61,10.66%,DAB2;APOE;MCTP1;LILRB1;LRP1;ROCK1;ABL2;CD22;SNX33;PICALM;HIP1;CBLL1;RAB5A;NEDD4L;PACSIN2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6691324905270368,-1.5934895711853567,0.011725293132328308,0.09803742620703546,1.0,6/12,11.55%,PLEK;SH3BP1;LIMA1;WDR1;MTPN;PIK3CA
prerank,iron ion transport (GO:0006826),-0.47317523794605,-1.5918937702081812,0.0,0.09928440225509105,1.0,15/47,20.32%,ATP6V0D2;ATP6V1E1;IREB2;DNM2;ABCB7;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;RAB11B;CP;ATP6V0B;ATP6V0E1;SLC11A2;ATP6V0D1
prerank,nucleosome organization (GO:0034728),-0.45207912209281575,-1.59152754596877,0.010050251256281407,0.09934467855986855,1.0,18/55,18.73%,ARID2;BPTF;SMARCA5;SMARCD3;ANP32B;SMARCC2;ARID1A;RNF8;NFE2;HMGB2;ASF1A;SPTY2D1;PADI4;SART3;INO80;CHAF1A;BRD2;RSF1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.6675457783063556,-1.5914519375397544,0.026622296173044926,0.09917104220043686,1.0,6/11,17.21%,RFTN1;UNC93B1;RIPK1;TNIP2;TICAM1;CASP8
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.6569909934959699,-1.5913689755586824,0.02264808362369338,0.09897032068632966,1.0,5/12,5.66%,ABCA1;ABCG1;PPARG;ITGAV;NR1H2
prerank,positive regulation of glycolytic process (GO:0045821),-0.574175465318217,-1.591263131375862,0.016863406408094434,0.09857808618678711,1.0,9/20,10.92%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;APP;PFKFB4;ZBTB20
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.574175465318217,-1.591263131375862,0.016863406408094434,0.09857808618678711,1.0,9/20,10.92%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;APP;PFKFB4;ZBTB20
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.46844259367503294,1.590570754458147,0.009174311926605505,0.1413016969143167,1.0,14/41,10.81%,GRM5;DLG3;NTRK2;DOCK3;TGFA;CSF1R;EGF;SRCIN1;PRNP;BDNF;FYN;FBXW7;AREG;RELN
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.35192162983499764,-1.5901419093905398,0.0,0.09941642957355641,1.0,135/341,27.58%,RNF213;WWP1;ZNRF3;CBL;CNOT4;RNF150;BFAR;BIRC6;RNF19A;RNF149;NFE2L2;RNF111;PSME4;WWP2;MYLIP;ARRB2;FBXL17;AMFR;PSMB7;AREL1;ANAPC1;RNF166;TNFAIP1;PELI1;PSME3;RC3H1;RNF20;FBXW11;UBE2R2;PSMB9;KLHL25;RBCK1;TSG101;UBAP1;KLHL22;ARRB1;UBE3B;NUB1;USP9X;CTNNB1;TBL1XR1;ZFAND2A;ZSWIM8;KCTD10;ATXN3;RNF4;MVB12B;TGFB1I1;ATE1;PSMA8;UBE2L3;SPSB2;RNF8;UBE4B;PSMC3;KIF14;NEDD4L;PCBP2;XBP1;SPSB3;MAEA;PSMD8;WDR91;RNF128;FBXO10;UHRF1;BUB1B;PSMC4;PSMB10;UBE2H;RNF185;PSMA1;ARRDC1;ARIH1;RNF43;RNF34;UBE2G1;CDC34;UBQLN4;RNF216;UBE2C;FAF1;KLHL42;MIB1;SKP2;UBE2I;AURKA;FBXO7;ANAPC7;PSMB8;HUWE1;NDFIP2;PSMD4;PSMA5;FBXO22;TRIP12;PSMB3;SIRT2;ELOC;DTX3L;PSMD3;UBE3C;SMURF2;UBXN1;RNF125;FBXW4;ZRANB1;BAG6;TRIM25;VPS4A;FEM1B;TOPORS;HECTD3;TRIM72;RNF115;KCTD2;ZNRF1;RNF187;DDB1;PSMB1;RNF19B;SPOP;RNF40;SIAH2;SMURF1;FBXL19;VCP;PML;CUL3;DCAF11;UBE4A;COP1;CLOCK;TBX21;PSMA7
prerank,centromere complex assembly (GO:0034508),-0.5031775163325474,-1.5895896429465726,0.018803418803418803,0.09969077988155657,1.0,17/36,25.48%,SMARCA5;KNL1;MIS18BP1;CENPF;DLGAP5;CENPA;CENPE;CENPK;CENPN;CENPL;POGZ;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6821864916777618,1.5876830093531369,0.030232558139534883,0.14350596297837434,1.0,4/10,8.19%,HECW1;PRKCE;HECW2;NEDD4
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6274412769458484,1.5872721927139222,0.03686635944700461,0.14306125985348486,1.0,3/13,3.42%,B3GALT1;B3GALT5;GAL3ST3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.6565981133486467,-1.587114623533637,0.01864406779661017,0.10181079493453254,1.0,6/12,14.78%,NOTCH2;DOCK10;DOCK11;PTK2B;FCGR2B;POU2AF1
prerank,positive regulation of viral process (GO:0048524),-0.4513077839315309,-1.586957394602112,0.001694915254237288,0.1017228028173377,1.0,23/60,26.55%,MDFIC;AXL;RAB7A;NELFB;DHX9;POLR2H;POLR2F;CD28;POLR2L;IFIT1;CCL5;POLR2A;POLR2G;VAPB;RSF1;DDX3X;POLR2I;SRPK1;VPS4A;GTF2F2;DDB1;GTF2F1;NELFE
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.4449079539757497,-1.5868059978083349,0.006666666666666667,0.1016474591241823,1.0,18/67,12.61%,LYN;FGR;ABI1;SYK;INSR;IGF1R;FES;ABL2;PIBF1;IL15;TEC;FLT1;PTK2B;PKDCC;PTPN6;LCK;DYRK1A;ITK
prerank,ureteric bud development (GO:0001657),0.5831879485202802,1.5867344396125347,0.037296037296037296,0.1428486967821152,1.0,5/17,10.57%,ROBO2;SLIT2;WT1;BMP7;SALL1
prerank,regulation of DNA repair (GO:0006282),-0.47778246692461845,-1.585671982253989,0.010135135135135136,0.10246173876046151,1.0,25/44,26.34%,DEK;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;RNF8;PCNA;BABAM1;KAT7;RADX;TMEM161A;RAD52;EYA1;EYA3;RPS3;WRAP53;BRCC3;TRIP12;UBE2V2;TRIM28;UBE2N;PML
prerank,calcium ion transmembrane transport (GO:0070588),0.39804963007871136,1.5846335433408023,0.0024691358024691358,0.14433641595268465,1.0,13/86,3.17%,GRIN2A;TRPM3;CACNA1C;RYR3;TRPC5;GRIN2B;CACNA2D1;SLC24A4;SLC24A2;SLC8A3;NALCN;TRPC1;SLC24A3
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.5378457278568322,-1.5839846690768788,0.010309278350515464,0.10384007678878622,1.0,11/29,19.88%,CCR2;ANO6;CCR1;GAS6;CCL5;SERPINE1;PLA2G7;LGALS9;C1QBP;HMGB1;AGER
prerank,protein ADP-ribosylation (GO:0006471),-0.5206604175974632,-1.5830574098019816,0.022304832713754646,0.10445706134608422,1.0,11/28,20.16%,ZC3HAV1;PARP11;PARP14;TIPARP;PARP4;SIRT3;PARP8;PARP9;TNKS2;PARP10;SIRT2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5462372792835786,-1.582890148435154,0.020942408376963352,0.10439085470344663,1.0,13/24,25.36%,RFC1;UBC;RPS27A;LIG1;PCNA;RPA3;POLD2;RFC2;LIG3;RFC3;POLB;POLD4;XRCC1
prerank,potassium ion import across plasma membrane (GO:1990573),0.47936493443620437,1.5826630144706573,0.0072992700729927005,0.14530714724614108,1.0,13/41,13.10%,SLC12A2;SLC12A8;SLC12A1;KCNJ6;KCNJ3;KCNJ10;KCNJ9;HCN2;KCNJ16;ATP1A3;ATP1B1;SLC12A5;KCNJ12
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.5736233940244426,-1.582642235198449,0.02292768959435626,0.10440036063401889,1.0,6/19,9.98%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.5410305639131949,-1.5819511965511943,0.028368794326241134,0.10486405047732558,1.0,13/25,24.19%,STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;STAT1;PRKDC
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6702079122221516,1.5818567558111547,0.04265402843601896,0.14527696714236127,1.0,3/10,3.76%,UPP2;DPYD;DPYS
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.4924119525733279,-1.58169154323412,0.012195121951219513,0.1048783575242191,1.0,14/40,20.05%,SLC16A7;SLC38A6;SLC38A10;SLC27A1;SLC38A7;SLC7A7;SLC36A4;ABCC1;SLC7A5;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.44086173926111133,-1.5807310089720308,0.010221465076660987,0.10553021260810763,1.0,35/61,27.92%,BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;HGF;RTEL1;USP9X;BABAM2;CEBPG;RAD51;RNF8;PCNA;BABAM1;WRN;DHX36;APLF;TMEM161A;OTUD4;USP7;EYA1;EYA3;RPS3;PDGFRB;WRAP53;BRCC3;HMGB1;NBN;MYC;TRIM28;FGFR4;UBE2N;PML;MRE11;UIMC1
prerank,vesicle organization (GO:0016050),-0.465741956489209,-1.580473255770635,0.01192504258943782,0.10555179203792728,1.0,14/46,11.45%,SNX10;PI4K2A;USP50;SRGN;DNAJC13;USP8;PI4K2B;WASL;WASHC4;SNX33;ALS2;EPS15;ARFGEF2;SAR1A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5391109443541326,-1.580292121298696,0.018900343642611683,0.1055047496514824,1.0,12/26,24.70%,SPTLC2;ACER3;CYB5R3;CYB5B;GCH1;ARG2;SPHK2;SPTLC3;ASAH1;CYP1B1;NQO1;ABCA2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.42015334715325103,-1.5800406276394952,0.001652892561983471,0.10550251179335518,1.0,25/93,13.44%,SASH1;MAP3K5;TAOK3;SDCBP;MFHAS1;XDH;RELL1;RIPK1;SPI1;TRAF5;MINK1;PTK2B;AXIN1;TRAF3;VEGFA;PRMT1;EIF2AK2;CD27;APP;TRAF1;NCF1;TAOK1;GADD45A;FCGR2B;TRAF2
prerank,positive regulation of endocytosis (GO:0045807),-0.4797681563096163,-1.579874755016987,0.005067567567567568,0.10539355706735996,1.0,21/45,15.95%,DAB2;APOE;LRP1;AXL;CBL;ANO6;RAB31;CDC42;STAP1;ANKFY1;C3;HIP1;CBLL1;B2M;RAB21;NCKAP1L;NEDD4L;SERPINE1;ABCA13;CLN3;APPL2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.5557029528888952,-1.5788382483790497,0.012280701754385965,0.10608957444206134,1.0,8/22,23.65%,CCR2;LILRB1;TNFRSF1B;LAPTM5;SLC7A5;SPHK2;NOD2;TRIL
prerank,response to estrogen (GO:0043627),-0.5106400745496054,-1.577946214566265,0.01877133105802048,0.10662883082576782,1.0,18/31,34.07%,BRCA1;WBP2;SERPINB9;KMT2D;TRIM24;RARA;GATA3;ARID5A;SFRP1;TRIM25;RBBP5;ASH2L;CITED2;GHRL;ESR1;EP300;CAV1;CRHBP
prerank,regulation of dendritic spine development (GO:0060998),0.5638061570614351,1.5773761990103405,0.03414634146341464,0.14900034010177138,1.0,9/19,13.93%,NLGN1;PPFIA2;GRIN3A;TANC2;SHANK3;FMR1;CPEB3;ARF6;PTPRS
prerank,Golgi to endosome transport (GO:0006895),-0.6114980128670249,-1.5772811191488483,0.02564102564102564,0.1069300366691936,1.0,6/16,9.74%,VPS13C;VPS13A;KIF16B;EPS15;SYS1;CORO7
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.6012736272005634,-1.5769061559555198,0.019642857142857142,0.10704187806836443,1.0,9/17,21.65%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,mitotic recombination (GO:0006312),-0.6144009984585797,-1.5763228036175265,0.03356890459363958,0.10737874787772927,1.0,10/15,25.20%,NSMCE2;TEP1;RAD51;GEN1;RAD54B;RAD52;XRCC3;DMC1;SMC6;SMC5
prerank,neuromuscular process controlling balance (GO:0050885),0.630723663243347,1.5759440676879353,0.03110047846889952,0.14967641726862763,1.0,2/12,0.23%,NRXN1;PCDH15
prerank,cellular response to ionizing radiation (GO:0071479),-0.4669789336227201,-1.5750807221601788,0.017361111111111112,0.10833356729520958,1.0,22/47,25.41%,GRB2;MAP3K20;SPIDR;NIPBL;MAPK14;BLM;RAD1;RAD51;NUCKS1;XRCC6;GADD45A;WRN;RHNO1;RAD51AP1;INO80;TMEM109;RAD9A;ATM;KDM1A;CRYAB;ECT2;EEF1D
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.7078026211280343,-1.5750732969455232,0.0273972602739726,0.10808559912150086,1.0,5/10,18.18%,KYNU;ATP7A;KYAT1;IL4I1;QDPR
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.43445286968097563,-1.5749487812314849,0.008278145695364239,0.10798423276697916,1.0,28/69,22.65%,GTF2A1;INTS8;NABP1;SRRT;INTS11;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;NCBP1;POLR2A;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;ELL2;GTF2A2;GTF2F2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.660770769255991,1.5744976374466526,0.048723897911832945,0.15048708176686107,1.0,5/10,13.10%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,response to tumor necrosis factor (GO:0034612),-0.415154217959535,-1.574444674783159,0.0066555740432612314,0.10822574845723865,1.0,30/91,21.79%,PID1;MAP4K3;NFE2L2;ARHGEF2;RIPK1;BRCA1;DHX9;ADAM9;TNFRSF21;YTHDC2;NUB1;ERBIN;GSDME;ZFAND6;GBP2;RELA;CXCL16;CCL5;CIB1;GCH1;CD40;IKBKB;CASP8;GATA3;RPS3;TRADD;GBP3;ZC3H12A;SFRP1;ASAH1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5614883923020468,1.573589580978114,0.03990610328638498,0.1506462530119117,1.0,7/19,10.56%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;CRB1
prerank,negative regulation of bone remodeling (GO:0046851),-0.6466421436453659,-1.5726990422863198,0.02847571189279732,0.10975435827413581,1.0,7/11,22.42%,P2RX7;GPR137B;GREM1;CALCA;UBASH3B;SFRP1;IL6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.45243156375782656,-1.5716349030847812,0.00865051903114187,0.11039780764666782,1.0,18/55,18.26%,PAK2;CRADD;NUPR1;BCL2L11;RIPK1;BCL2;TGFBR1;GSDME;FIS1;AGT;STYXL1;LCK;TRAF2;BBC3;BID;TNFSF10;RPS3;TRIM39
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5102703108768968,1.5712411218986837,0.030226700251889168,0.15228638932585778,1.0,10/27,13.14%,RIMS2;RIMS1;SYT1;SYT10;SYT2;SYT5;SYT11;SYT12;VAMP7;SYT7
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6860629629259031,-1.5709791217609064,0.02608695652173913,0.11081926127877471,1.0,4/10,12.58%,RB1;C5AR1;EGR1;HSP90AB1
prerank,negative regulation of RNA splicing (GO:0033119),-0.5878205329719904,-1.5708645416545046,0.02030456852791878,0.11065807447801762,1.0,9/19,27.41%,PTBP3;RPS13;TMBIM6;SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,cardiac muscle contraction (GO:0060048),0.48697692935943604,1.570120770284586,0.01904761904761905,0.15258873850524082,1.0,10/34,11.17%,DMD;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;GSN;TTN
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.39463627826846204,-1.5694438295936306,0.0,0.11176525460223234,1.0,47/136,21.72%,SP100;RB1;PEX14;NUPR1;ANXA4;FLNA;SPI1;IRAK2;WWP2;ARRB2;PIM1;NLRC5;PRMT2;AIM2;RBCK1;TRAF3;MDFI;ARRB1;IRAK3;GAS6;BHLHE40;ERBIN;MAP2K5;EGLN1;WFS1;CEBPG;TRIB1;OTULIN;SIK1;FOXJ1;NLRC3;NFKBIL1;ID2;TMSB4X;MAP3K10;USP7;PARP10;SMAD7;TAF3;CMKLR1;ID1;SUFU;ZC3H12A;NLRP3;KDM1A;ID3;HEYL
prerank,cellular response to estrogen stimulus (GO:0071391),-0.6143044366801407,-1.5693338181140113,0.03140495867768595,0.11162264619431633,1.0,6/14,20.84%,WBP2;SERPINB9;TRIM24;RARA;ARID5A;SFRP1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.5145574697704132,-1.569218021399218,0.013445378151260505,0.1114949725430887,1.0,14/33,17.95%,CD300A;PTPRJ;DGKZ;CARD11;RC3H1;PTPN22;DUSP3;LAPTM5;LCK;RELA;RAB29;CD226;TESPA1;RPS3
prerank,DNA conformation change (GO:0071103),-0.5898467681553482,-1.5685542977462923,0.022071307300509338,0.11191185649835864,1.0,8/17,20.41%,TOP3A;HHEX;TOP2A;HMGB2;TOP1MT;HMGB3;HMGB1;PRM1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6654782055183835,-1.5685239021188346,0.020370370370370372,0.11167613087436011,1.0,7/11,17.22%,PARP11;PARP14;TIPARP;PARP4;PARP8;PARP9;PARP10
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.43879729339970197,-1.568449789889853,0.008090614886731391,0.11148684942976707,1.0,20/63,20.18%,IGF1;SP100;PAK2;BIRC6;RIPK1;CFLAR;PSME3;ITGAV;TGFBR1;TRAF1;AGT;RELA;TRAF2;BID;TNFSF10;STX4;DEPTOR;CASP8;TRADD;TMC8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4145316798431429,-1.5682150262362302,0.005042016806722689,0.11144551249410424,1.0,38/80,30.78%,CD44;MAP3K5;CTSD;DAPK1;SYK;CSNK2A1;MALT1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;NOD1;GRAMD4;YWHAE;FIS1;CASP1;TNFSF10;PDCD5;BEX3;DDX3X;DNAJB6;HMGB1;NLRP3;SFN;SOX7;CYCS;MYC;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;F2R;BCL10
prerank,calcium ion import into cytosol (GO:1902656),0.6001667265461488,1.5667208414116391,0.03695652173913044,0.15543679697554905,1.0,8/15,19.09%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,mitotic cytokinesis (GO:0000281),-0.4611400571446535,-1.566202359452049,0.01658374792703151,0.11327808281154195,1.0,26/47,27.00%,ROCK1;SNX9;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;ARL3;CKAP2;RASA1;RACGAP1;NUSAP1;KIF20A;CEP55;JTB;CHMP4B;KLHDC8B;RAB35;ECT2;MITD1;STAMBP
prerank,nucleic acid metabolic process (GO:0090304),-0.4317031357472365,-1.5661313633601468,0.00966183574879227,0.11311177364696484,1.0,32/69,25.70%,HNRNPA3;HNRNPH1;POLR2H;HNRNPL;POLR2F;POLR2L;DUSP11;PCBP2;DNASE1L1;WRN;FEN1;METTL14;NCBP1;POLR2A;DDX1;TOPBP1;WTAP;POLR2G;DNA2;HNRNPA1;ENPP1;MMS19;HNRNPH2;POLR2I;DDX54;HNRNPK;XRN2;GTF2F2;DNTT;DNASE2;GTF2F1;RECQL5
prerank,receptor-mediated endocytosis (GO:0006898),-0.39465513238724204,-1.5658258242857268,0.0016750418760469012,0.11315127932886142,1.0,35/132,12.71%,DAB2;MRC1;APOE;MSR1;GRB2;CD163;LILRB1;STAB1;SYK;LRP1;ITGB2;DNM2;CD36;SNX9;CANX;INSR;RAB31;CD9;ARRB2;GRK3;ITGB1;DNAJC13;AP1G1;FCHO2;LRP6;PICALM;PI4KB;EPS15;AP2A2;IGF2R;CLEC9A;HSP90B1;CXCL16;FCGR2B;FCER1G
prerank,regulation of complement activation (GO:0030449),-0.4819030556195967,-1.5653377501683206,0.01610305958132045,0.11337277273685262,1.0,16/40,28.74%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;C1QC;C1QBP;C2;C6;C7;C8G;CD19
prerank,membrane raft organization (GO:0031579),-0.6176635270964203,-1.5651692585328165,0.021164021164021163,0.11325212166359917,1.0,7/15,20.56%,RFTN1;ANXA2;MYADM;NPC1;FLOT2;CLN3;PPT1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.6882927295815396,-1.5649391638938364,0.0176678445229682,0.11327430112997974,1.0,7/10,23.52%,TNFRSF1B;DPP4;FAP;CHADL;CST3;TGFB1;ADTRP
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.46244804125284317,1.5645165646761952,0.009324009324009324,0.157041976199123,1.0,8/41,1.66%,HTR2C;GRIN2A;RYR3;RYR2;GRIN2B;CACNA2D1;SLC24A2;SLC8A3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.4699347543020565,-1.5641845750052825,0.0180623973727422,0.11385030829110851,1.0,24/46,27.89%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;JAK1;LMNB1;LCP1;CAPZA1;CFL1;GSTO1;CNN2;P4HB;TYK2;RPLP0;MTAP;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5254030672191241,-1.5640526343978876,0.015437392795883362,0.1137293963096508,1.0,11/27,18.39%,MAP3K8;MAP3K5;MAP3K20;NFKB1;FBXW11;UBC;RPS27A;TNIP2;KAT7;IKBKB;TAOK2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6931084738775652,-1.5628500560187009,0.025906735751295335,0.11480888042549928,1.0,8/10,29.11%,NPL;ST3GAL1;GNPDA1;ST6GAL1;GNPDA2;AMDHD2;RENBP;GNE
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.39764707331392857,-1.5624661593544926,0.0050933786078098476,0.11487989324913084,1.0,39/108,21.24%,MAP3K5;APAF1;CTSD;DAPK1;SYK;XDH;CRADD;MALT1;PPARG;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;GRAMD4;ATP2A3;FIS1;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;RPS3;IFT57;TRADD;PDCD5;CASP2;BEX3;LGALS9;DDX3X;HMGB1;RACK1;NLRP3
prerank,nucleosome disassembly (GO:0006337),-0.6111993747440447,-1.5624363511608474,0.02422145328719723,0.11439616589521329,1.0,5/14,11.92%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,chromatin disassembly (GO:0031498),-0.6111993747440447,-1.5624363511608474,0.02422145328719723,0.11439616589521329,1.0,5/14,11.92%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,chromosome condensation (GO:0030261),-0.4936304294468873,-1.561623582655415,0.02901023890784983,0.11496744706883033,1.0,20/36,26.04%,RB1;CSNK2A1;NCAPG2;TOP2A;INCENP;SMC4;NCAPH;MCPH1;ACIN1;CDK1;CHMP1A;NUSAP1;KMT5A;NCAPD3;PHF13;NCAPG;SET;CCNB1;AKAP8L;ERN2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3571976767087288,-1.5612524838771844,0.0,0.1151196789614226,1.0,81/234,23.67%,PRKCH;PRKCB;PLCG2;RAB7B;CD36;CAMK1D;ARID5B;ARHGEF2;MALT1;PPARG;RIPK1;TRAF5;IRAK2;STAT3;MBTPS2;TAB2;CARD11;CFLAR;TLR4;DHX9;NLRC4;IL18;NFKB1;AIM2;RNF31;STK3;RBCK1;LRP6;IRAK3;CTNNB1;IL18RAP;VEGFA;MYD88;CEBPG;EIF2AK2;NOD1;ADAM8;UBC;RPS27A;APP;MTPN;TRAF1;AGT;RELA;TICAM1;CIB1;TRIM68;TRAF2;CRTC3;NFAM1;CD40;HDAC5;RNF25;TCF3;IKBKB;NFKBIB;FLOT2;HCLS1;MAVS;TRIM14;ARHGEF5;IL18R1;HSPA1A;RPS3;PPARGC1B;TRADD;COPS5;NOD2;LGALS9;AGER;JUP;NLRP3;KDM1A;TRIM25;PLPP3;IL6;ESR2;ZBTB7A;RPS6KA5;DVL2;FANK1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6790593626147685,-1.5611387713916258,0.025225225225225224,0.11498962479154214,1.0,4/10,9.98%,RUNX1;RUNX3;CBFB;NCKAP1L
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6442950279356239,-1.561067600973652,0.0375,0.11481377118277566,1.0,5/13,7.24%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,phospholipid homeostasis (GO:0055091),-0.6480722358126729,-1.5608071489190947,0.02555366269165247,0.1147802383831087,1.0,4/11,9.87%,ABCA1;ABCG1;RCN3;TLCD2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.6473612556213371,-1.5600320491770483,0.02292768959435626,0.11530362669070678,1.0,4/12,8.75%,LYN;FOXP1;BCL6;FNIP1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.542181630872167,1.559301012997338,0.049107142857142856,0.16202067238495105,1.0,6/19,10.81%,PTPRD;IL1RAPL1;CDKL5;CUX2;CAPRIN2;RELN
prerank,response to X-ray (GO:0010165),-0.6250154732957178,-1.5585670326074483,0.040280210157618214,0.11656995487894958,1.0,8/14,19.84%,NIPBL;ANXA1;BLM;NUCKS1;XRCC6;XRCC4;BRCC3;ATM
prerank,positive regulation of catalytic activity (GO:0043085),-0.48292265440667426,-1.5583508263622954,0.020618556701030927,0.11654359954160425,1.0,16/37,25.54%,ABL2;ATP7A;MAPK14;CHTOP;SSBP1;PSENEN;WRN;CIB1;SLC5A3;XRCC4;STX4;NOD2;PHACTR4;FGFR4;PSEN2;MT3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6132915077834104,1.5582198757705448,0.02745995423340961,0.16230020057700958,1.0,8/14,18.82%,ANK3;DMD;TESC;ATP1B1;GLRX;WNK4;WNK3;WNK2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4922086992683853,-1.5581940808001447,0.02112676056338028,0.1164633978389238,1.0,13/36,20.43%,SGMS1;CRADD;RB1;CSNK2A1;BCL2;TGFBR1;TRAF1;STYXL1;TMBIM6;DEPTOR;RPS3;TRIM39;MAZ
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6772672906971653,-1.5581586585952782,0.02608695652173913,0.11622739987569557,1.0,6/10,20.93%,DHX58;RIOK3;SEC14L1;GPATCH3;C1QBP;RNF125
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.5736358874299614,-1.5579970962083791,0.024263431542461005,0.11616435668622803,1.0,6/17,9.98%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6519037920349974,-1.5578984300821066,0.02376599634369287,0.11601849383186799,1.0,5/11,22.48%,RIPK1;DDX5;MAP2K1;IL6;TGFB1
prerank,regulation of axonogenesis (GO:0050770),0.44133162798237385,1.5577748549503208,0.013089005235602094,0.16189259059746897,1.0,9/51,3.24%,LRRC4C;ROBO1;ROBO2;CDH2;SLIT2;NTRK2;LINGO1;PAK3;SLITRK1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.4259146613037855,-1.5575060156696656,0.010471204188481676,0.11619154687457374,1.0,30/79,15.49%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;CTSS;SEC24D;ACTR1B;FCGR2B;FCER1G;CAPZA1;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,positive regulation of cation channel activity (GO:2001259),0.46089686112186184,1.5574061543140005,0.022556390977443608,0.16136135458075124,1.0,12/40,14.11%,AKAP6;ANK3;ANK2;SHANK3;KCNIP2;PIRT;RELN;STAC;CALM1;CALM3;CALM2;ARC
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.416700515972451,-1.557322401708132,0.008223684210526315,0.11611030987583486,1.0,23/87,11.55%,IQGAP2;IQGAP1;NOTCH2;LRP1;PRKCD;RAC1;ROCK1;RHOA;EPS8;ARHGAP17;ABL2;PTK2B;DAPK3;ARHGAP18;RHOQ;BAIAP2;MDK;SH3BP1;BST2;TAOK1;CRK;CCDC88A;PIK3CA
prerank,regulation of defense response to virus by host (GO:0050691),-0.5167633316508045,-1.5573070733393561,0.01867572156196944,0.11587230414735225,1.0,14/30,22.37%,LILRB1;CGAS;DHX9;AIM2;PTPN22;PARP9;SIN3A;RNF216;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70
prerank,cellular response to dsRNA (GO:0071359),-0.6167402872427141,-1.5571820530095595,0.02772963604852686,0.11574161876010493,1.0,7/15,17.19%,CGAS;DHX9;RIOK3;IFIT1;MAVS;ZCCHC3;RALB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.45145519917607563,-1.5570948698232276,0.00847457627118644,0.11557437456571808,1.0,26/54,27.24%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;CNOT6L;AURKA;CASP2;MDM4;CNOT8;ATM;CDC25C;SFN;GTSE1;CCNB1;PCBP4;RBL2;PML;CNOT3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.4271330848801402,-1.556335961480958,0.008802816901408451,0.1158704068615997,1.0,30/78,15.49%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;CTSS;SEC24D;ACTR1B;FCGR2B;FCER1G;CAPZA1;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.4271330848801402,-1.556335961480958,0.008802816901408451,0.1158704068615997,1.0,30/78,15.49%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;CTSS;SEC24D;ACTR1B;FCGR2B;FCER1G;CAPZA1;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.4151596136981889,-1.555527944365992,0.0,0.11642319213527029,1.0,22/87,12.10%,LYN;PTPRC;APOE;P2RX7;CD300A;PRKCD;PTPRJ;TLR4;PIK3CB;DUSP3;IRAK3;SIRPA;STK38;ITGB1BP1;SPRY2;SPRED1;PIN1;AGT;PAQR3;DUSP6;FLCN;SPRED2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.6653745230349193,-1.5553163437400972,0.03914590747330961,0.11637159332676134,1.0,8/11,25.62%,LYN;CD300A;RC3H1;TNFRSF21;FCGR2B;ATM;TNFRSF13B;BLK
prerank,cAMP-mediated signaling (GO:0019933),0.5217123171824779,1.5547394418851517,0.023752969121140142,0.1634482078067416,1.0,7/24,8.83%,RIMS2;AKAP6;ADCY2;EPHA5;PDE4D;SOX9;ADCY1
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.372414547621596,-1.5539983341672283,0.0,0.1174482381064569,1.0,54/175,22.23%,PID1;BIRC3;TNFRSF1B;NFE2L2;ARHGEF2;PSME4;RIPK1;TRAF5;BRCA1;FOXO3;PSMB7;PSME3;DHX9;PTK2B;AIM2;PSMB9;TRAF3;TNFRSF21;ERBIN;GSDME;PSMA8;ZFAND6;GBP2;CD27;PSMC3;TRAF1;RELA;PSMD8;CCL5;CIB1;PSMC4;PSMB10;TRAF2;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;GATA3;RPS3;LIMS1;TRADD;GBP3;PSMD4;PSMA5;PSMB3;PSMD3;ZC3H12A;SFRP1;STAT1;ASAH1;ILK;TNFSF9
prerank,intracellular cholesterol transport (GO:0032367),-0.6071081025381313,-1.5537166022050442,0.03508771929824561,0.11747582751967227,1.0,7/15,21.84%,ABCA1;ABCG1;LRP6;NPC2;NPC1;LDLR;VPS4A
prerank,regulation of mRNA catabolic process (GO:0061013),-0.39213054153884785,-1.5536891016890617,0.003169572107765452,0.11725775568196697,1.0,39/121,21.23%,VIM;ZC3HAV1;PRKCD;YTHDF3;DCP1A;PSME4;MAPKAPK2;CNOT1;PSMB7;ANP32A;PSME3;RC3H1;PSMB9;EXOSC5;DCP2;PUM2;PSMA8;UBC;RPS27A;ZC3H14;PSMC3;MOV10;GTPBP1;PSMD8;PSMC4;PSMB10;DHX36;PSMA1;EIF4G1;HSPA1A;PSMB8;HSPB1;PSMD4;PSMA5;CNOT8;PSMB3;PSMD3;ZC3H12A;EXOSC4
prerank,anterior/posterior axis specification (GO:0009948),-0.6068716598889087,-1.5534740501932898,0.04912280701754386,0.11723089237837557,1.0,4/15,19.06%,SKI;WLS;RIPPLY2;HOXD8
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5599632890861294,1.553339613843598,0.035046728971962614,0.16420991924708095,1.0,7/18,10.81%,NLGN1;NRXN1;SHANK3;TSHZ3;CACNG4;CACNG2;RELN
prerank,small GTPase mediated signal transduction (GO:0007264),-0.4034295890373127,-1.5531059524748456,0.0032679738562091504,0.11731338995949639,1.0,34/103,18.74%,IGF1;ABR;RREB1;GRB2;GNB1;RB1;RAC1;JUN;ARHGAP30;USP50;GRAP2;RGS19;RIN2;RGL2;USP8;ARHGAP18;PLD2;MAPK14;ARHGEF18;PLK2;CCDC88A;KSR1;ARL3;SETDB1;CRKL;BRAP;GRAP;ARHGAP31;RALB;G3BP1;KRAS;NRAS;ARFIP2;RHEB
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6251806330416362,-1.552257326515732,0.03304347826086956,0.11790428460150143,1.0,6/12,13.07%,FOXP1;CD74;TLR4;MAP2K5;LPL;OAS3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.38300640940226116,-1.551870586982477,0.001639344262295082,0.11801091889682935,1.0,50/148,21.94%,TOP3A;BRD7;PHF20;CSNK2A1;PIP4K2A;PRKAG2;SGK1;BRCA1;DYRK2;CHD3;RPS20;MAPK14;RPL11;SMYD2;BLM;RAD1;TAF6;PIP4P1;TPX2;PIN1;CDK1;WRN;EXO1;PLK3;STK11;RPA3;RHNO1;RFC2;TAF4B;RNF34;PAK1IP1;TOPBP1;KMT5A;BRIP1;USP7;RBBP4;TAF9;AURKA;DNA2;RAD9A;TAF3;MDM4;RBBP8;TAF4;ATM;CHEK1;RFC3;PRKAG1;NBN;CDK5
prerank,positive regulation of heart rate (GO:0010460),0.5696588822087146,1.5518340509826574,0.03611738148984198,0.16502472230222315,1.0,8/17,16.33%,RYR2;PDE4D;ADRA1B;EDN1;ADRA1A;ADRA1D;ADRB1;TPM1
prerank,endothelial tube morphogenesis (GO:0061154),-0.6868100221805555,-1.5516394584835145,0.03135313531353135,0.11800596165199817,1.0,3/10,7.18%,RBPJ;RHOA;CTNNB1
prerank,negative regulation of binding (GO:0051100),-0.4158511377556072,-1.5512695048533391,0.010101010101010102,0.11819447372423766,1.0,29/81,21.38%,DAB2;SP100;CTSZ;PRKCD;JUN;ROCK1;PEX14;ACTB;MDFI;PPP1CA;E2F1;ITGB1BP1;NES;PIN1;IFIT1;TMBIM6;IFIT2;TFAP4;BTAF1;TFIP11;RALB;AURKA;RSF1;PLN;GSK3B;TMC8;DISC1;RACK1;KDM1A
prerank,regulation of interferon-gamma production (GO:0032649),-0.42802380833593145,-1.550839172424498,0.0017152658662092624,0.11840536230238909,1.0,29/71,22.34%,CCR2;LILRB1;TLR8;AXL;TLR7;TLR4;IL18;PTPN22;CYRIB;GAS6;SIRPA;LAPTM5;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226;RARA;LGALS9;C1QBP;HMGB1;CD274;ZC3H12A;SLAMF6;INHA;NR1H4
prerank,proteasomal protein catabolic process (GO:0010498),-0.3632310826675087,-1.5506580427963297,0.0,0.11831998776270264,1.0,86/201,27.58%,WWP1;BFAR;NFE2L2;PSME4;WWP2;ARRB2;RNF41;FBXL17;PSMB7;AREL1;TNFAIP1;PELI1;PSME3;FBXW11;PSMB9;RBCK1;DDI2;KLHL22;ARRB1;CTNNB1;TBL1XR1;ZFAND2A;ZSWIM8;KCTD10;ATXN3;RNF4;RCN3;ATE1;PSMA8;SPSB2;UBE4B;PSMC3;KIF14;NEDD4L;PCBP2;DERL1;SEL1L;SPSB3;CUL4B;MAEA;PSMD8;UBXN6;PSMC4;SOCS6;PSMB10;RNF185;PSMA1;RNF34;UBE2G1;CDC34;RNF216;FAF1;KLHL42;SKP2;PSMB8;HUWE1;PSMD4;PSMA5;PSMB3;SIRT2;ERLEC1;PSMD3;SMURF2;UBXN1;BAG6;FEM1B;TOPORS;HECTD3;TRIM72;KCTD2;ZNRF1;RNF187;DDB1;PSMB1;SPOP;SIAH2;SMURF1;FBXL19;VCP;PML;CUL3;DCAF11;COP1;CLOCK;TBX21;PSMA7
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.6554488337987624,-1.5504150075061542,0.03597122302158273,0.11831442793477445,1.0,6/12,17.19%,CGAS;DHX9;IFIT1;MAVS;ZCCHC3;RALB
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.4028796760008613,-1.5500287933298202,0.003395585738539898,0.11845468948204002,1.0,34/100,22.52%,DAB2;SDCBP;HECTD1;RNF19A;OGT;GNA12;UCHL5;PIAS1;RYBP;CBFA2T3;RPL11;NUB1;DET1;TRIB1;TRIB2;RNF180;HSP90AB1;WAC;ARIH1;GABARAP;UBQLN4;USP7;TAF9;SMAD7;HSPA1A;TRIM39;GSK3B;FBXO22;SIRT2;UBXN1;RACK1;BAG6;EIF3H;SOCS5
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6142048568424829,-1.5494136911242644,0.022336769759450172,0.11880623129479424,1.0,7/15,21.14%,IGF1R;TEC;PTK2B;DYRK1A;ITK;TXK;KDR
prerank,ether lipid metabolic process (GO:0046485),-0.6200103052746889,-1.5493442399960833,0.027573529411764705,0.11863922111108784,1.0,9/14,25.69%,NCEH1;TMEM86B;AGMO;PLAAT3;PLA2G7;PEX7;PAFAH1B1;PLA2G6;LIPE
prerank,striated muscle tissue development (GO:0014706),0.49873473260782725,1.5486651131674039,0.02830188679245283,0.16753887582710358,1.0,8/29,11.29%,SGCZ;SGCD;NDUFV2;BMP7;ZBTB18;SGCG;POPDC2;PGM5
prerank,regulation of T cell proliferation (GO:0042129),-0.4429081504841683,-1.548113067758082,0.0142602495543672,0.11964222548424004,1.0,28/61,31.82%,PTPRC;LILRB1;TNFRSF1B;IL15;ANXA1;TNFRSF21;CD28;NCKAP1L;SDC4;CD46;IL4I1;CCL5;VSIG4;SPN;CD274;CEBPB;TNFSF9;CD3E;IL6;NCK1;TNFRSF13C;PNP;RIPK3;NCK2;IL27;SLC7A1;CD80;CCL19
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5635430112480142,1.5472216257059517,0.04367816091954023,0.1683133339436731,1.0,2/17,1.49%,ANK2;CACNA2D1
prerank,DNA replication initiation (GO:0006270),-0.484014515589877,-1.5472084068068914,0.019469026548672566,0.12031892417286681,1.0,20/37,35.25%,POLE2;NOC3L;MCM6;MCM3;DBF4;ORC5;RPA3;CDC34;TOPBP1;MCM2;PRIM1;LRWD1;PRIM2;CDC45;MCM5;ORC3;ORC6;MCM7;POLE;POLA2
prerank,regulation of cell adhesion (GO:0030155),-0.3888297893386886,-1.547099149769325,0.004672897196261682,0.12019540025585544,1.0,39/129,15.88%,LYN;PLXNC1;RSU1;ROCK1;PTPRJ;SIPA1;PLXNA1;PLAU;PLXND1;CYTH1;FES;LPXN;CYTIP;ABL2;MINK1;IL18;PTK2B;ITGAV;TGFBI;RIPOR2;STX3;PIK3CG;MYADM;VEGFA;MDK;ATXN3;CBLL1;ADAM8;ITGB1BP1;TGM2;KIF14;ZDHHC2;FLCN;CCL5;PPP1R12A;MIA3;RASA1;CXCR4;SPN
prerank,regulation of translational initiation (GO:0006446),-0.43946433730073214,-1.5470088110536744,0.0067226890756302525,0.12001933026472325,1.0,32/63,27.83%,YTHDF3;AGO2;ATF3;PPP1R15B;KLHL25;EIF4G3;EIF4A2;EIF5;ALKBH1;EIF4EBP1;EIF4EBP2;TPR;CSDE1;EIF3E;CCL5;BOLL;NCBP1;EIF4G1;DDX1;POLR2G;DNAJC3;HSPB1;EIF5B;DDX3X;CEBPB;EIF3H;EIF1;MIF4GD;NCK1;EIF1B;EIF2AK3;EIF2B2
prerank,regulation of viral transcription (GO:0046782),-0.47589593532782404,-1.5450545737873422,0.015280135823429542,0.12181049719452174,1.0,17/39,26.55%,MDFIC;NELFB;UBP1;DHX9;POLR2H;POLR2F;POLR2L;TRIM11;POLR2A;TRIM14;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;LARP7;NELFE
prerank,positive regulation of immune system process (GO:0002684),-0.6042771822233914,-1.5448552040938175,0.017825311942959002,0.12177274146145205,1.0,9/16,19.20%,IL15;ANXA1;RSAD2;PIK3CB;VEGFA;NCKAP1L;PIK3CD;MIA3;LGALS9
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.43999449215878944,-1.5431456652679476,0.009900990099009901,0.12320902814647788,1.0,28/56,27.00%,ROCK1;SNX9;RHOA;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;BIN3;ARL3;CKAP2;RASA1;RACGAP1;NUSAP1;KIF20A;CEP55;JTB;CHMP4B;VPS4A;RAB35;ECT2;MITD1;STAMBP
prerank,response to cytokine (GO:0034097),-0.380566085151478,-1.5428626715089244,0.0015723270440251573,0.12320867017945335,1.0,52/141,23.32%,PID1;CD74;SP100;MAPKAPK3;REL;MCL1;MAP4K3;RHOA;KYNU;RIPK1;IL6R;IRAK2;MAPKAPK2;STAT3;PTPN12;BCL2;ANXA1;ADAM9;IFNAR2;CIITA;YTHDC2;NUB1;IRAK3;TIMP2;MYD88;BST2;EIF2AK2;IFITM2;PTPN6;APP;RELA;CXCL16;CASP1;GCH1;CD40;RELB;CXCR4;HCLS1;ISG15;IL18R1;TAF9;CASP8;PTPN13;PTPN11;LGALS9;CD274;STAT1;HAX1;IFITM1;PTPN7;MEFV;DDOST
prerank,erythrocyte differentiation (GO:0030218),-0.4637490264486892,-1.5427568514021262,0.016544117647058824,0.12306577512731033,1.0,12/44,15.86%,LYN;MFHAS1;IKZF1;HSPA9;RPS14;VEGFA;ACIN1;CEBPG;FLVCR1;NCKAP1L;ID2;HCLS1
prerank,protein autophosphorylation (GO:0046777),-0.37513746537000847,-1.5420814142461083,0.0015552099533437014,0.12358479477273013,1.0,48/157,19.84%,LYN;TAOK3;FGR;MAPKAPK3;DAPK1;PAK2;ERN1;INSR;PEAK1;IGF1R;FES;VRK2;RIPK1;MINK1;MAPKAPK2;TEC;FLT1;PIM1;PTK2B;DAPK3;ULK2;CAMKK2;GRK5;EIF2AK2;EIF2AK1;NEK6;SIK1;TAOK1;DYRK1A;STK17B;HTATIP2;ITK;STK11;STK24;MKNK1;MARK2;TXK;MAP3K10;MKNK2;AURKA;HCK;TAOK2;STK10;PDGFRB;MAK;STK16;GSK3B;ATM
prerank,intracellular pH reduction (GO:0051452),-0.4931509809821296,-1.5419836815402461,0.02072538860103627,0.12342677354554818,1.0,10/33,17.12%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;RAB39A;ATP6V0E1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.44561637052375613,-1.5413179068852774,0.01864406779661017,0.12387585779779588,1.0,26/52,26.04%,ERN1;TATDN2;TLN1;PREB;WFS1;DNAJB9;XBP1;DCTN1;SERP1;SEC31A;TPP1;VAPB;SRPRB;DNAJC3;HYOU1;CXXC1;ATP6V0D1;GFPT1;ACADVL;EDEM1;LMNA;SHC1;PPP2R5B;KLHDC3;PDIA5;ERN2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.54682130444596,-1.5410539533977459,0.03098106712564544,0.12386919800588636,1.0,9/22,20.05%,LYN;MFHAS1;RAB7B;PTPN22;IFI35;APPL2;WDFY1;TICAM2;APPL1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4199760805706595,-1.5408067436966817,0.008460236886632826,0.12386751605081905,1.0,30/76,23.52%,SASH1;RHOA;TLR7;SPI1;TLR4;ADIPOR1;PTPN22;IFI35;PPM1B;LAPTM5;EIF2AK2;NOD1;CD27;APP;RELA;NLRC3;TMSB4X;RPS3;LIMS1;MMP8;TRADD;NOD2;LGALS9;DDX3X;AGER;ZC3H12A;NLRP3;ILK;TCIM;LRRC19
prerank,positive regulation of peptidase activity (GO:0010952),-0.5593940253928679,-1.540510301857115,0.028960817717206135,0.12395972165623034,1.0,5/20,11.28%,PSME3;GRN;RCN3;CTSH;PSENEN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.44793026583366224,-1.5401329445771808,0.010752688172043012,0.12412799119221031,1.0,20/48,27.42%,FNIP2;MCL1;TNFRSF1B;BCL2L11;BRCA1;DYRK2;BCL2;CRIP1;E2F1;TMEM109;CASP2;ATM;BAG6;BCL2L2;SFN;TOPORS;PRKDC;PML;USP28;BCL2L1
prerank,regulation of cellular metabolic process (GO:0031323),-0.46218470189534255,-1.5399671171754765,0.019639934533551555,0.12405936377867854,1.0,13/45,15.27%,PID1;ABCG1;PANK2;RNF41;KIF16B;TBC1D16;BCO2;NPC2;AGPAT1;MPV17;ACACB;RNF34;SSH1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.6110990490853847,-1.5398385678814295,0.029574861367837338,0.12396890854250543,1.0,8/14,22.42%,CD74;IL18;RSAD2;RARA;NOD2;DENND1B;NLRP3;IL6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5369922176280291,-1.5396241451839194,0.03697478991596639,0.12392783092334395,1.0,10/23,10.92%,IGF1;P2RX7;INSR;NFKB1;PFKFB3;HIF1A;ARNT;APP;PFKFB4;ZBTB20
prerank,regulation of lymphocyte migration (GO:2000401),-0.6831858897841491,-1.5395636459591124,0.025252525252525252,0.1237548332075942,1.0,7/10,23.52%,MSN;WASL;MIA3;SPN;STK10;SLC8B1;ADTRP
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6634523984160275,-1.5392849722495534,0.03169014084507042,0.1237509603910594,1.0,4/10,7.36%,LYN;STAT3;STAT6;STAT5B
prerank,regulation of coagulation (GO:0050818),0.6386440887797014,1.539245850135684,0.05813953488372093,0.17675062791418789,1.0,1/11,0.53%,HS3ST5
prerank,regulation of response to interferon-gamma (GO:0060330),-0.6169958750582498,-1.5382395509887001,0.023608768971332208,0.12466558888091103,1.0,8/14,22.33%,PIAS1;JAK1;PARP9;IFNGR2;HSP90AB1;SOCS3;STAT1;IFNGR1
prerank,histone modification (GO:0016570),-0.39460679313587266,-1.5381873682524225,0.004846526655896607,0.12448972733616193,1.0,34/109,18.35%,RCOR1;MIDEAS;PRKCD;CREBBP;PHF20;ATXN7;NSD3;PRMT2;INCENP;EYA4;MORF4L1;TAF6;USP36;TBL1XR1;EZH2;USP3;PRMT1;SUDS3;HDAC10;NAA50;RBM14;UHRF1;MTA3;PADI4;HDAC5;SIN3A;NSD1;PRMT6;MRGBP;PHF20L1;EYA1;EYA3;HUWE1;MIER1
prerank,regulation of protein kinase activity (GO:0045859),-0.3955580147592064,-1.5381467824075674,0.0031746031746031746,0.12427573245901735,1.0,28/106,13.71%,IQGAP1;PTPRC;FGR;PAK2;RB1;SNX9;RAP2B;PRKAG2;C5AR1;CEP85;UVRAG;TAB2;RAP1A;PTK2B;LRP6;CAMKK2;GAS6;ALS2;CENPE;SMG8;TRIB1;ITGB1BP1;TRIB2;SPRED1;XRCC6;CACUL1;LCP2;CAMKK1
prerank,histone H3-K9 demethylation (GO:0033169),-0.6566596857601799,-1.5380615545415888,0.03633217993079585,0.12411101837522273,1.0,6/11,21.38%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,B cell proliferation (GO:0042100),-0.5808138432840388,-1.5376334752692908,0.018315018315018316,0.12432886222655723,1.0,8/17,28.74%,PTPRC;BCL2;MEF2C;CD40;CD79A;MS4A1;GAPT;CD19
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.434413918137459,-1.5367516847427827,0.013513513513513514,0.12505969660651142,1.0,14/61,8.10%,LYN;AKAP13;IGF1;NOTCH2;GRB2;RAC1;ARHGEF3;VAV1;RASGRP4;PIK3CB;PIK3CG;ARRB1;ALS2;ERBIN
prerank,regulation of ATP metabolic process (GO:1903578),-0.44253580744591403,-1.5366430743498278,0.010657193605683837,0.12494497697288263,1.0,28/54,31.21%,OGT;NUP50;PRKAG2;ATP7A;NUP42;NUP88;RAE1;HIF1A;FIS1;NUP205;TPR;JMJD8;NUP188;SPHK2;NUP153;COX7A2;NUP35;NUP107;PRKAG1;NUP62;ZBTB7A;RANBP2;NUP37;EP300;AAAS;NUP133;EIF6;PGAM1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5799283120758679,1.5365038192988203,0.037296037296037296,0.17924901835388274,1.0,2/17,0.68%,AKAP6;ANK3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.31474028767555556,-1.536464618926844,0.0,0.12491000424776678,1.0,310/1082,22.14%,PID1;RBPJ;MDFIC;DAB2;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;ELF4;FLI1;RUNX1;IGF1;TFEB;NAMPT;CD74;CD38;SP100;TCF4;RREB1;ELF2;LILRB1;REL;LITAF;TET3;JUN;DNM2;NIBAN2;ACTR2;CREBBP;MEF2A;RUNX3;OGT;PPARD;BPTF;AGO2;TOX2;NFE2L2;BRD7;RNF111;IRF2;ARHGEF2;SBNO2;BRD4;NFIC;NFYA;ARID1B;ATF3;ATAD2;ELF1;NSD3;PAXBP1;UBP1;RNASEL;SMARCA5;PPARG;RIPK1;KDM3A;MAML1;ELK3;SPI1;BRCA1;ETV1;ERCC6;STAT3;FOXO3;E2F2;LYL1;MAML2;TLR4;DHX9;IL18;STAT6;USF2;ACTR3;RYBP;NLRC5;NFKB1;RNF20;HHEX;RUNX2;SMARCD3;RARG;PRMT2;IRF5;NFATC2IP;FBXW11;MLXIP;CRLF3;MEF2B;KLF6;TCF20;SMARCC2;SNX5;NR1H2;CIITA;JAG1;SS18;AXIN1;PF4;BLM;NRF1;HGF;RHOQ;WASL;NFATC3;ARRB1;TAF6;LRP6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;STAT5B;CAMKK2;EDF1;PLAC8;NR2F1;ATF6;DPF2;SKI;VEGFA;CREB3L2;E2F1;FIZ1;MAP2K5;RNF4;CNBP;ATMIN;ARID1A;HELZ2;CEBPG;E2F3;KMT2C;TGFBR1;TGFB1I1;WBP2;MEF2D;HIF1A;TFEC;SLC9A1;MEF2C;ATAD2B;MAPK7;UBC;RPS27A;ITGB1BP1;ASXL1;EGR1;MRTFB;PARP9;ARNT;TNIP2;AFAP1L2;APP;PIN1;PSMC3;AGT;NCF1;DYRK1A;XBP1;FLCN;XRCC6;ALYREF;ARHGEF11;OSR1;RELA;MAP2K1;KLF10;KMT2D;MLLT10;MED4;NFE2;PRDM2;SPIN1;HTATIP2;FOXJ1;RBM14;MLLT6;MLLT11;IL4I1;FOSL2;HMGB2;KAT7;ZBED4;SERPINE1;UHRF1;CHD8;ASF1A;FOXJ3;ACVR2A;WAC;CALCOCO1;DHX36;ELOF1;E2F8;CRTC3;GREM1;IER2;RXRA;TET2;DR1;PPP1R12A;CD40;HDAC5;SIN3A;KLF2;ID2;EPC1;CKAP2;DOT1L;SPP1;TCF3;NSD1;TFAM;TFAP4;YY1;ZMIZ2;POU2AF1;POGZ;INO80;TXK;AATF;IKBKB;KARS1;DNAJC2;IL31RA;HCLS1;HMGN1;MAVS;NUFIP1;TFCP2;QRICH1;NR4A1;NRIP1;FOXJ2;SOX10;TNIP3;AGRN;TAF9;VHL;KMT2A;MAP2K3;SMAD7;GPATCH3;RARA;MED6;TFE3;ATF5;CSRNP1;GATA3;MYB;SERTAD1;NCOA6;PLAG1;SSBP4;PPARGC1B;CXXC1;TRIM16;NFATC1;TCF12;NR3C1;HAS3;RSF1;PITHD1;MEIS3;BMPR2;HOXD8;COPS5;NOD2;DDX3X;LMO2;CHP2;MMS19;RASL11A;ATM;HMGB1;CHEK1;EHF;SIRT2;CASZ1;RLF;NAA16;GLMP;MAZ;DTX3L;ZC3H12A;RAI1;SFRP1;JUP;STAT1;ZSCAN21;MAX;POU3F1;NLRP3;HAX1;HOXB2;CCNK;KDM1A;NUP62;MAML3;CEBPB;HEYL;EGR2;MTF1;ILK;ZNF296;BARX2;MYRFL
prerank,amino sugar biosynthetic process (GO:0046349),-0.6340616044790846,-1.5357735302912157,0.03832752613240418,0.12541478745775703,1.0,8/12,30.02%,GNPDA1;UAP1L1;UAP1;GFPT1;GNPDA2;AMDHD2;RENBP;GNPNAT1
prerank,actin filament-based transport (GO:0099515),-0.5492967221685644,-1.5350929022001853,0.044444444444444446,0.12597505397027842,1.0,7/21,11.48%,MYO5A;MYO1F;MYO1G;WASL;SUN2;MYO1E;MYO7A
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.44082986653227485,1.5350767464398094,0.013921113689095127,0.18004894441134864,1.0,14/48,16.32%,AKAP6;ANK2;DMD;TRPC1;PDE4D;CASQ2;JPH4;NPSR1;CAPN3;CALM1;CALM3;CALM2;JPH3;SNCA
prerank,negative regulation of endocytosis (GO:0045806),-0.5301473166022025,-1.5347145962738458,0.034129692832764506,0.1261413494346087,1.0,7/24,6.90%,MCTP1;LILRB1;CD300A;RAC1;NR1H2;SNX33;PICALM
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6165174994282412,1.532846713894374,0.059602649006622516,0.18171969321680623,1.0,6/12,16.32%,MAP2;ARHGEF7;TUBB4A;EML2;CDH5;SNCA
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.6190735509569867,-1.5325643949118488,0.030716723549488054,0.12820018665047092,1.0,6/13,11.88%,AXL;IL18;AP1G1;GAS6;TICAM1;LAMP1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.38809486160454987,-1.5324117671182111,0.004784688995215311,0.12812355950368653,1.0,37/113,21.11%,FNIP2;ABCA1;ASAP1;SYK;PLEK;CD36;RAP1B;DDB2;USP50;BCL2L11;SPIDR;PIEZO1;TLR4;CAPG;VEGFA;GBP5;MYD88;FNIP1;LCP1;CDC42EP2;PSMC3;CUL4B;PSMC4;RPA3;SH3GLB1;EIF4G1;ERCC4;BRK1;BID;ISG15;FAF1;RPS3;DDX3X;GSK3B;ATM;MMP1;RACK1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3179689583964002,-1.5323518344654516,0.0,0.1279427211930124,1.0,237/834,22.07%,PID1;RBPJ;DAB2;MITF;ZMIZ1;ZEB2;ELF4;RUNX1;IGF1;TFEB;NAMPT;TCF4;RREB1;LILRB1;REL;LITAF;TET3;JUN;ACTR2;CREBBP;MEF2A;OGT;PPARD;BPTF;AGO2;TOX2;NFE2L2;RNF111;IRF2;ARHGEF2;SBNO2;BRD4;NFIC;PLXND1;ATF3;ATAD2;ELF1;CDK13;PAXBP1;UBP1;RNASEL;SMARCA5;PPARG;RIPK1;MAML1;ELK3;SPI1;BRCA1;ETV1;STAT3;FOXO3;E2F2;MAML2;TLR4;EAPP;DHX9;IL18;STAT6;USF2;ACTR3;NLRC5;NFKB1;HHEX;RUNX2;SMARCD3;RARG;IRF5;NFATC2IP;MLXIP;CRLF3;DLGAP5;MEF2B;KLF6;TCF20;NR1H2;CIITA;JAG1;SS18;PF4;NRF1;HGF;RHOQ;WASL;NFATC3;ARRB1;TAF6;LRP6;MED24;AHR;CTNNB1;TBL1XR1;STAT5B;PLAC8;NR2F1;ATF6;DPF2;SKI;VEGFA;E2F1;FIZ1;MAP2K5;RNF4;CNBP;ATMIN;HELZ2;CEBPG;E2F3;KMT2C;WBP2;MEF2D;HIF1A;TFEC;SLC9A1;MEF2C;ATAD2B;MAPK7;UBC;RPS27A;ITGB1BP1;ASXL1;EGR1;MRTFB;ARNT;TNIP2;APP;PIN1;PSMC3;XBP1;FLCN;XRCC6;OSR1;RELA;KLF10;KMT2D;MLLT10;MED4;PRDM2;HTATIP2;FOXJ1;RBM14;MLLT6;IL4I1;FOSL2;MICAL2;HMGB2;KAT7;ZBED4;SERPINE1;UHRF1;CHD8;FOXJ3;ACVR2A;CALCOCO1;DHX36;E2F8;CRTC3;GREM1;IER2;RXRA;TET2;DR1;PPP1R12A;CD40;HDAC5;SIN3A;KLF2;EPC1;CKAP2;DOT1L;TCF3;YY1;ZMIZ2;POU2AF1;POGZ;INO80;TXK;AATF;IKBKB;HCLS1;MAVS;NUFIP1;TFCP2;NR4A1;NRIP1;FOXJ2;TNIP3;AGRN;TAF9;KMT2A;SMAD7;RARA;MED6;TFE3;ATF5;CSRNP1;GATA3;MYB;NCOA6;PLAG1;SSBP4;PPARGC1B;NFATC1;TCF12;NR3C1;RSF1;MEIS3;BMPR2;HOXD8;COPS5;NOD2;DDX3X;LMO2;CHP2;ATM;HMGB1;EHF;SIRT2;CASZ1;RLF;GLMP;ZC3H12A;JUP;STAT1;ZSCAN21;MAX;NLRP3;HAX1;HOXB2;CCNK;KDM1A;MAML3;CEBPB;HEYL;EGR2;MTF1;ZNF296;BARX2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.492724442155267,-1.53197522164345,0.0313588850174216,0.12807786731557547,1.0,21/33,32.32%,RAB7B;FES;STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;PITHD1;STAT1;PRKDC;HOXA5;ETS1;MTURN;ANKRD54;HSPA1B
prerank,cation transport (GO:0006812),0.35668260670325935,1.5299741238777689,0.0,0.18424786749720962,1.0,38/167,14.00%,KCNB2;TRPM3;KCNN2;KCND3;SLC8A3;SLC12A2;KCNMB2;KCNMB3;SLC4A4;SCN2A;KCNH1;SCN1A;SLC9B2;SCN3A;SLC47A1;SLC6A17;KCNJ6;KCNJ3;KCNJ10;SCN9A;KCNIP2;KCNA1;KCNH4;KCNJ16;SLC1A1;PKD1L3;TRPM1;SLC8A2;SLC5A10;SLC4A11;KCNF1;ATP1B1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNA2;KCNS3
prerank,cellular protein metabolic process (GO:0044267),-0.3356683503966159,-1.5299166012711434,0.0,0.1299799138367836,1.0,141/396,25.79%,APOE;IGF1;FAM20C;SFTPA2;SFTPA1;ST3GAL1;PPP4R2;ST8SIA4;AGO2;CSF2RA;RPS18;RPL7;RPS12;RIPK1;RPS21;ABL2;RPS8;WWP2;RPS24;GSPT1;CCDC59;SARS1;RPL36;MSRA;PARP4;RPS6;RPS20;RPL11;RPL10A;RPL12;FN1;RRBP1;C3;MRPL42;RPS14;GAS6;STK38;RPL32;RPS28;RPS13;WFS1;RPS15A;UBA7;DARS1;UBE2L3;RPS27A;CTSH;RPL28;RPS4X;MSRB1;KLK3;APP;UBL5;ZDHHC2;EIF4EBP2;B4GALT7;PSENEN;CP;CSF2RB;HSP90B1;RPS23;SEPHS1;SERP1;RPL22;RPL14;EEF1A1;MRPS6;LGALS1;RPL34;RPS11;MRPS11;IGFBP3;FBXW2;RPL6;PADI4;MIA3;SPP1;DENND3;EIF4G1;MFGE8;CST3;FDXR;RPS10;UBE2G1;PIGH;CDC34;RPL18A;MRPS16;HM13;APLP2;RPL37A;RABGGTA;MRPL34;RPS9;TTF1;MAN2B1;MRPS15;UBE2I;DNAJC3;RPS27;GNMT;ABCF1;RPS3;RPL23A;UBE2M;SHISA5;RPS16;RABGGTB;COPS5;RPL9;RAB12;CSF1;IGFALS;FBXO22;F5;BAP1;MMP1;MMP2;RPLP2;CSNK1G3;MANBA;MRPL51;IL6;RPL7A;RPL19;P4HB;ERO1A;RPS15;RPL39;RPLP0;PRKDC;RPL41;MRPL18;PSEN2;FURIN;MRPS7;D2HGDH;RPL5;RPL13;SIAH2;QSOX1
prerank,kidney development (GO:0001822),0.40721145418916804,1.5297193448079207,0.017326732673267328,0.18364274653668075,1.0,20/65,11.52%,ROBO2;PCSK5;MME;PAX8;GREB1L;GDNF;HNF1B;WT1;TRAF3IP1;FGF10;BMP7;TGFB2;TFAP2A;CITED1;AGTR1;HAS2;SALL1;CEP290;PYGO2;PKD1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5288104806418895,-1.5296317342584638,0.03202846975088968,0.13005631689572578,1.0,13/23,33.01%,LILRB1;RAET1E;ARRB2;AP1G1;LAMP1;CD226;LGALS9;SLAMF6;CRTAM;KLRC2;NCR1;KLRD1;KLRC1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4493308358723125,-1.5295197198321593,0.01896551724137931,0.12993208569699607,1.0,22/50,23.52%,SASH1;RHOA;TLR7;TLR4;IFI35;LAPTM5;EIF2AK2;NOD1;CD27;APP;RELA;RPS3;LIMS1;MMP8;TRADD;NOD2;LGALS9;DDX3X;AGER;ILK;TCIM;LRRC19
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5583567179740093,-1.529063218604597,0.031932773109243695,0.130142377826367,1.0,7/20,11.54%,RBPJ;NFE2L2;RUNX2;VEGFA;HIF1A;XBP1;RELA
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6200228888710375,-1.5284431279233766,0.032423208191126277,0.1305819676976309,1.0,7/12,32.84%,NELFB;EAPP;RNF8;LARP7;RECQL5;NELFE;NELFA
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.5408576032508665,-1.5284185186185302,0.027777777777777776,0.13036136202956017,1.0,12/24,22.37%,LILRB1;CGAS;AIM2;PTPN22;PARP9;SIN3A;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.42180643479496355,-1.5280062238430903,0.01020408163265306,0.13056963865946208,1.0,25/70,20.62%,RUNX1;PSME4;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;KMT2A;PSMB8;GATA3;MYB;TCF12;LMO2;PSMD4;PSMA5;PSMB3;PSMD3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.643774441273997,-1.5277662801121195,0.03496503496503497,0.1305833533077324,1.0,8/11,30.02%,GNPDA1;UAP1L1;UAP1;GFPT1;GNPDA2;AMDHD2;RENBP;GNPNAT1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.637258397865353,1.5272106571003758,0.05489260143198091,0.1859190717399927,1.0,5/10,15.91%,TGFA;EGF;FBXW7;AREG;ADAM17
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.44576633382851916,-1.5271244333454665,0.013136288998357963,0.13105373040434515,1.0,32/54,35.95%,APOE;P2RX4;PPARG;MAPK14;PRCP;VEGFA;SH3BP1;HIF1A;MEF2C;ANGPT2;GADD45A;CD40;TMSB4X;MAP2K3;HSPB1;HMGB1;JUP;KDR;TGFB1;ATP5F1B;FGF18;ETS1;NUS1;AGTR2;CSNK2B;FGF2;PLCG1;TNF;ATP5F1A;GATA2;HRG;PDGFB
prerank,positive regulation of protein kinase activity (GO:0045860),-0.3784840659120786,-1.526973771176294,0.0,0.13097809881017758,1.0,55/148,19.32%,IQGAP1;PTPRC;NEDD9;TAOK3;PAK2;PRKCD;SNX9;RHOA;INSR;PRKAG2;IL6R;MINK1;TAB2;RAP1A;SLC27A1;PTK2B;INCENP;STK3;AXIN1;CAB39;EZH2;GAS6;ALS2;VEGFA;CENPE;EGR1;TPX2;AGT;KIF14;TAOK1;XRCC6;CCDC88A;MAP2K1;CACUL1;HSP90AB1;CCL5;CIB1;STK11;LCP2;CAMKK1;MARK2;TGFBR2;CALCA;IL34;STRADA;GPRC5B;RALB;MAP2K3;LILRA5;TAOK2;ADRB2;JTB;PAK6;DDX3X;CSF1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5535867503718328,-1.5269574606341034,0.02888086642599278,0.13074489861615884,1.0,6/18,17.01%,TLR4;CLEC4D;TNIP2;CD2;KARS1;CD226
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.608162600818726,-1.5265055125509026,0.032148900169204735,0.13099914900537293,1.0,7/13,26.65%,BFAR;PPP1R15B;WFS1;DNAJB9;RACK1;PTPN1;NCK1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5109111310834012,-1.5261923556687087,0.02847571189279732,0.13107436910162037,1.0,12/27,21.75%,CD44;CD74;SMYD2;DDX5;SPRED1;DYRK1A;SPRED2;EEF1E1;KMT5A;ATM;KDM1A;SNAI2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6438896569859924,-1.5261232194623606,0.027633851468048358,0.13089539213752324,1.0,5/12,21.47%,MBNL1;LRP6;SKI;FBXW4;MEGF8
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5794741670319847,-1.526062958936941,0.03333333333333333,0.13071708549913436,1.0,6/17,15.00%,ANXA4;PTPN22;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.4783187735581196,-1.525785584418883,0.02280701754385965,0.13078781164751407,1.0,16/38,25.48%,SMARCA5;KNL1;MIS18BP1;UBN1;CENPA;ASF1B;CENPK;CENPN;CENPL;ASF1A;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5990284987623129,-1.5257280371604034,0.03130434782608696,0.13058282628115184,1.0,7/15,12.57%,CD36;USP50;TLR4;GBP5;MYD88;EIF2AK2;NLRC3
prerank,mitotic spindle organization (GO:0007052),-0.37295375327137853,-1.525065856388358,0.0,0.1310040807431581,1.0,64/153,24.53%,RHOA;STAG1;FLNA;EML4;KIF3B;PIBF1;KIF11;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;KIF23;CENPA;ABRAXAS1;EFHC2;ARHGEF10;STAG2;KIF4A;SUN2;PLK2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;TPX2;BUB1;KIFC1;TAOK1;TBCE;BUB1B;MAP4;SPC25;KIF2C;TTK;DYNC1LI2;SGO1;MAD1L1;STIL;NUF2;AURKA;RPS27;NDC80;CENPH;PCNT;RCC1;ERCC6L;SMC1A;RAB11A;PAFAH1B1;PRC1;NUP107;CEP192;LSM14A;PPP1CC;NSL1;CCNB1;CENPO;SPC24;CENPP;RANBP2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.49872803505760355,-1.5246414025021195,0.02385008517887564,0.1311653536068646,1.0,12/28,22.92%,MAP3K5;ITPR1;ERN1;BCL2;CASP4;ATP2A3;TRAF2;BBC3;QRICH1;BAG6;CEBPB;ERO1A
prerank,positive regulation of vacuole organization (GO:0044090),-0.6525706345146971,-1.5239005510826342,0.036297640653357534,0.1317049431243609,1.0,6/10,17.19%,ANXA2;PIP4K2A;RAB3GAP1;GRN;SH3GLB1;RALB
prerank,mitochondrion distribution (GO:0048311),-0.6399075559293832,-1.5230787494416411,0.039723661485319514,0.13233594830882636,1.0,3/12,2.65%,TRAK1;MEF2A;MTM1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.45527660256633584,-1.5228803614511264,0.029159519725557463,0.1323369464222008,1.0,17/44,20.67%,ZC3HAV1;ROCK1;YTHDF3;AGO2;CNOT1;RC3H1;MOV10;GTPBP1;FTO;CELF1;TNRC6C;METTL14;DHX36;POLR2G;TOB1;CNOT8;ZC3H12A
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.5592709832262586,-1.5226473792630368,0.04584040747028863,0.13233567086603634,1.0,10/21,14.21%,BANK1;PIBF1;TNFAIP8L2;PTPN22;DUSP3;LAPTM5;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5518382988971874,-1.522585613398151,0.035842293906810034,0.13215540133327103,1.0,13/19,32.57%,GNPDA1;MPI;UAP1L1;NANS;PMM2;UAP1;GFPT1;GNPDA2;AMDHD2;RENBP;PMM1;GNPNAT1;UGP2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6156783268390481,-1.5222313451675153,0.040998217468805706,0.13231504069493893,1.0,5/13,7.87%,CD74;LILRB1;PLCG2;IRAK3;LAPTM5
prerank,positive regulation of GTPase activity (GO:0043547),-0.3680532185000961,-1.5220643875057045,0.0,0.13223254267366305,1.0,66/188,22.80%,BCAR3;ABR;CORO1C;ARHGAP25;RSU1;ARHGAP22;ARHGAP24;SNX9;DOCK10;SIPA1;DOCK11;TBC1D15;SGSM2;RGS1;TBC1D2B;TBC1D9;RAP1A;ITGB1;DOCK8;ARAP1;RAB3GAP1;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;PICALM;TBC1D16;EZH2;ALS2;TBC1D22B;SIPA1L3;SH3BP1;TBC1D8B;TBC1D8;TGM2;SCRIB;PIN1;TBC1D17;CCDC125;FLCN;SNX13;FOXJ1;SNX18;CCL5;TBC1D10B;CD40;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;AGRN;TBC1D9B;TBC1D25;LIMS1;GPR65;MMUT;PIP5K1A;GSK3B;SFRP1;RACK1;TBC1D10C;RAP1GAP2;MAP4K4;RAP1GDS1;TBC1D4
prerank,sterol transport (GO:0015918),-0.5563465895254126,-1.5217028622081696,0.032148900169204735,0.13241173619999513,1.0,13/19,36.93%,MSR1;CD36;OSBPL5;NPC2;NPC1;LDLR;LDLRAP1;CAV1;STARD3;ARV1;ABCG8;LCAT;APOA2
prerank,DNA geometric change (GO:0032392),-0.5290169589942424,-1.5215625538677666,0.036395147313691506,0.132336110753724,1.0,17/24,26.81%,DHX9;ANXA1;BLM;RTEL1;MCM9;WRN;HMGB2;DHX36;DDX1;DNA2;HMGB3;HMGB1;NBN;ZRANB3;ASCC3;RECQL5;MRE11
prerank,potassium ion export across plasma membrane (GO:0097623),0.6061896417238571,1.5212890320035135,0.05104408352668213,0.1922055240289111,1.0,3/13,6.79%,KCND3;KCNT2;KCNIP2
prerank,regulation of hydrolase activity (GO:0051336),-0.4189642930627111,-1.5212472271591928,0.01794453507340946,0.1324718037768867,1.0,20/71,13.05%,ARHGAP15;VAV3;PLXNC1;GPR137B;FGD6;PLXNA1;PLXND1;VAV1;TBC1D15;FGD4;FBXW11;RAB3GAP1;FGD3;VAV2;ITGB1BP1;ARHGAP12;ADAP1;CRK;WRN;TBC1D10B
prerank,purine nucleotide catabolic process (GO:0006195),-0.6112218676175906,-1.520841791817017,0.047957371225577264,0.13267647480827938,1.0,3/13,9.99%,GDA;XDH;NT5C2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6137883669270151,1.5207122949117429,0.06619385342789598,0.19196062043499879,1.0,5/12,9.58%,NFIB;MYCBP2;EPHB1;SPTBN4;TSKU
prerank,cAMP metabolic process (GO:0046058),0.5952963454118972,1.5203684894471665,0.05568445475638051,0.191423782276339,1.0,6/13,8.83%,ADCY2;ADCY8;PDE4D;ADCY5;ADCY3;ADCY1
prerank,ERBB2 signaling pathway (GO:0038128),0.48108875600687917,1.5202455212180372,0.0327455919395466,0.19062966875134402,1.0,7/31,6.67%,NRG1;ERBB4;PTPRR;EGF;GAB1;SOS1;NRG2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.488355869559259,-1.520015497195249,0.03395585738539898,0.13334121708802174,1.0,11/35,7.95%,IQGAP2;NRP1;NOTCH2;FES;ABL2;CDC42;PTK2B;STAP1;DAPK3;BAIAP2;MDK
prerank,cytoplasmic translational initiation (GO:0002183),-0.5771156492476516,-1.5195057732761763,0.035211267605633804,0.13360162295403114,1.0,6/17,14.71%,EIF4A2;EIF2B3;EIF3A;EIF5;EIF4A1;EIF4G1
prerank,neuromuscular junction development (GO:0007528),0.5121961149678881,1.5189501041491273,0.04428904428904429,0.1912806609901056,1.0,4/24,2.55%,ANK3;GPHN;UNC13C;CACNB2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6014550778520799,1.5186710423505307,0.05752212389380531,0.19074510481268717,1.0,6/13,13.42%,ANK3;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,regulation of postsynapse organization (GO:0099175),0.4958339476816646,1.5177533267050274,0.05183585313174946,0.19092139944460615,1.0,8/28,6.71%,IL1RAPL1;PPFIA2;CDKL5;TANC2;SRCIN1;SHANK3;ABI2;HOMER1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.4536531603309083,-1.5175054597682238,0.02533783783783784,0.13561965863828376,1.0,18/48,20.16%,APOE;CD84;ROCK1;SNX3;FLNA;NFKB1;ITGAV;IRAK3;AZIN1;EIF2AK1;SF3B3;PIN1;HSP90AB1;FLOT2;RILP;MDM4;LDLR;SIRT2
prerank,methylguanosine-cap decapping (GO:0110156),-0.6583899169694098,-1.5165085590384793,0.04512635379061372,0.13642676115390354,1.0,3/10,8.19%,DCP1A;PATL1;DCP2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.4508126154762351,-1.5164739841879549,0.02030456852791878,0.13622269898684616,1.0,16/46,19.89%,TLR8;CRADD;MAP3K1;PIEZO1;TLR7;TLR4;NFKB1;PTGER4;MYD88;SLC9A1;GADD45A;CASP1;CD40;CASP8;CASP2;CHEK1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5657148867133245,-1.51618797196384,0.032534246575342464,0.13630534139259848,1.0,6/18,11.68%,DAB2;MSN;SNX3;DNAJC13;RAB21;MAP2K1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.347137678238396,-1.5156009163490318,0.0,0.13661339503369735,1.0,102/264,27.41%,CTNNBL1;TRA2B;DDX46;CDK13;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;SNRPG;FUS;GCFC2;HNRNPH1;COIL;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;CWC22;RBM19;SPEN;RALY;DDX5;POLR2L;SF3B3;PRPF8;SF3B5;UBL5;SART1;PCBP2;HNRNPUL1;ALYREF;NUDT21;SNRPA;RBM14;CWC15;SMN1;WDR33;RBM10;METTL14;YTHDC1;NCBP1;SART3;ZRSR2;PSPC1;POLR2A;GEMIN7;SNUPN;PDCD7;DDX1;SF3A1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;WBP11;TXNL4A;RNPS1;SNRNP70;HNRNPA1;SCNM1;MAGOH;PAPOLA;SLU7;WDR77;BUD13;SF3B1;CPSF3;LSM5;HNRNPH2;TGS1;POLR2I;GEMIN6;PPIL1;XAB2;SRPK1;HNRNPK;SNU13;NONO;SYF2;GTF2F2;RBM22;MTREX;SRSF11;DHX35;DDX39B;PRPF6;GTF2F1;CPSF1;RBM15B;DHX38;ISY1;HSPA8;WDR83;U2AF2;HNRNPF;SRSF7
prerank,protein polyubiquitination (GO:0000209),-0.33873181601318775,-1.515363435387644,0.0,0.13660668503838444,1.0,108/297,26.06%,SASH1;RNF213;WWP1;HECTD1;BFAR;DDB2;RNF19A;FBXW8;PSME4;TRAF5;WWP2;MYLIP;RNF41;FBXL17;BRCA1;AMFR;PSMB7;AREL1;ANAPC1;RNF166;PELI1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;PSMB9;RNF31;LNPEP;FBXL20;RBCK1;TRAF3;UBE3B;UBR2;CTNNB1;HERC6;TPP2;RNF4;CBFB;FBXO38;HECTD2;ANKRD39;PSMA8;UBE2L3;UBC;RPS27A;RNF8;UBE4B;PSMC3;TRAF1;NEDD4L;PSMD8;FBXO10;UBE3A;TRIM68;PSMC4;PSMB10;UBE2H;TRAF2;FBXW2;PSMA1;TNKS2;ARIH1;RNF34;UBE2T;UBE2G1;CDC34;RNF216;TRIM14;UBE2C;KLHL42;FBXL8;SKP2;FBXO7;ANAPC7;PSMB8;HUWE1;PSMD4;PSMA5;FBXO31;FBXO22;TRIP12;PSMB3;DTX3L;PSMD3;UBE3C;SMURF2;RNF125;FBXW4;RUSC1;TOPORS;CCNF;RNF135;RNF115;ZNRF1;TRIM69;RNF187;PSMB1;UBE2V2;RNF19B;SPOP;UBE2N;LRSAM1;SIAH2;SMURF1;FBXL19
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6170889975969808,-1.5146254347713946,0.029876977152899824,0.13722839480839824,1.0,8/13,28.91%,RUNX1;RUNX3;CBFB;NCKAP1L;TGFBR2;ZBTB7B;PNP;NKAP
prerank,regulation of DNA binding (GO:0051101),-0.45672504424679367,-1.514257030834361,0.030716723549488054,0.13742309630726487,1.0,22/44,23.76%,IGF1;SP100;JUN;PPARG;MDFI;EDF1;SKI;NME1;E2F1;CEBPG;PLAUR;HMGB2;DOT1L;TFAP4;MMP8;RSF1;HMGB1;SIRT2;KDM1A;TGFB1;ZBTB7A;SUMO3
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4593799398005183,1.5140646394424297,0.03341288782816229,0.1946645603059888,1.0,8/35,3.88%,RIMS2;HTR2C;AKAP6;ADCY2;EPHA5;GUCY1B1;PDE4D;PDE9A
prerank,regulation of DNA recombination (GO:0000018),-0.49277171474682274,-1.5124767742353664,0.022375215146299483,0.13916160934069288,1.0,13/32,22.53%,PPP4C;PPP4R2;SPIDR;BLM;RTEL1;RAD51;IL7R;ALYREF;RAD51AP1;SHLD2;CHEK1;KDM1A;ZRANB3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.44366934121158225,-1.5119233235673692,0.02079722703639515,0.13953200542220953,1.0,14/47,12.66%,NEDD9;NRP1;CORO1C;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;ITGB1BP1;CRK;CIB1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4582326527966878,-1.5117749862371412,0.020689655172413793,0.13945448574662406,1.0,19/45,22.33%,CD44;SP100;PRKCD;IRF2;IRF5;CIITA;B2M;JAK1;GBP2;IFNGR2;OASL;TRIM68;OAS3;MT2A;HCK;OAS2;STAT1;TRIM25;IFNGR1
prerank,cell part morphogenesis (GO:0032990),-0.6127561539807147,-1.511321577557023,0.04498269896193772,0.13965696184415244,1.0,4/13,10.66%,PID1;MTM1;FIS1;PACSIN2
prerank,retrograde axonal transport (GO:0008090),0.5540253195459336,1.5110627778436514,0.06060606060606061,0.19741868206293545,1.0,5/16,8.93%,DLG2;TMEM108;DST;KIF5A;NEFL
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.48262003177375934,-1.5107026548672307,0.025380710659898477,0.14008340835326324,1.0,13/32,22.46%,RB1;BACH1;BRD4;CDK18;E2F1;CDK14;PCNA;ID2;CCNE1;KLF11;CDK16;CDK5;CDC45
prerank,positive regulation of T cell differentiation (GO:0045582),-0.48473793208497146,-1.5094940261588465,0.03140495867768595,0.14131404989322402,1.0,19/36,29.33%,ZMIZ1;BCL6;MDK;ADAM8;NCKAP1L;SART1;XBP1;CD46;IL4I1;TESPA1;ZAP70;GATA3;IL7;TNFSF9;IL12RB1;PNP;LEF1;NKAP;ZBTB1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5386745472131422,-1.5084302921149266,0.03559322033898305,0.14230340602083905,1.0,8/21,21.44%,CNOT4;TUT7;CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,fibrinolysis (GO:0042730),-0.6084314597349898,-1.5083598060556682,0.028622540250447227,0.14211535706354983,1.0,3/13,12.69%,PLAU;PLAUR;SERPINE1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5813427512460989,-1.507927174230754,0.03664921465968586,0.14232219656162803,1.0,10/18,23.52%,TNFAIP8L2;PTPN22;DUSP3;LAPTM5;IL4I1;MIA3;ASS1;WNK1;LAX1;ADTRP
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6629680970266931,-1.5072298894925646,0.03893805309734513,0.14278994392134442,1.0,4/10,7.54%,LYN;LILRB1;AXL;GAS6
prerank,regulation of mRNA stability (GO:0043488),-0.3705421761963653,-1.506671215203689,0.0015748031496062992,0.14319777114662124,1.0,52/145,26.88%,VIM;PRKCD;ROCK1;YTHDF3;DCP1A;PSME4;MAPKAPK2;PSMB7;ANP32A;PSME3;RC3H1;PSMB9;FUS;E2F1;EXOSC5;DCP2;PUM2;PSMA8;UBC;RPS27A;ZC3H14;TENT5A;PSMC3;FTO;CELF1;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;EIF4G1;FASTKD3;HSPA1A;PSMB8;TENT5C;HSPB1;PSMD4;PSMA5;PSMB3;PSMD3;EXOSC4;SET;PCBP4;PUM1;PSMB1;TENT5D;ZFP36L1;VIP;HSPA8;EXOSC8;TBRG4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5864267304147006,-1.5064725299922173,0.040492957746478875,0.14320555074111913,1.0,5/15,15.34%,RIPOR2;ADAM9;MAPK14;CD53;EHD1
prerank,epithelial cell migration (GO:0010631),-0.4790469276309699,-1.5064566490846554,0.01864406779661017,0.14296809697405466,1.0,10/37,11.75%,NRP1;ZEB2;ROCK1;RHOA;PLXND1;LPXN;DPP4;PLEKHG5;PIK3CA;FAP
prerank,neuron development (GO:0048666),0.35667151528883634,1.5062584293108137,0.0,0.2027354749933535,1.0,26/141,8.25%,CNTNAP2;NLGN1;TENM2;MYT1L;MAP2;TENM3;CNTN4;TENM1;TENM4;GPM6A;RASGRF1;NTRK2;ATP8A2;SRRM4;EPHA5;SH3GL2;PLP1;TMEM108;BICDL1;POU3F2;GDNF;GPM6B;ALK;FLRT3;NEDD4;TOR1A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5274164171969697,1.5055592017872064,0.04794520547945205,0.2026164758262278,1.0,6/21,8.83%,ADCY2;ADCY8;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.6717523506040697,-1.5055439261543746,0.05102040816326531,0.14375997000156332,1.0,7/10,27.52%,MALT1;RC3H1;NFKBIZ;SMAD7;NFKBID;ZC3H12A;TBX21
prerank,actin filament capping (GO:0051693),-0.5641500650785835,-1.5054898162984167,0.04308797127468582,0.14332198688371067,1.0,9/18,21.67%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;ADD3;CAPZA1;TWF2;FLII
prerank,barbed-end actin filament capping (GO:0051016),-0.5641500650785835,-1.5054898162984167,0.04308797127468582,0.14332198688371067,1.0,9/18,21.67%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;ADD3;CAPZA1;TWF2;FLII
prerank,positive regulation of lipid transport (GO:0032370),-0.6154482118815592,-1.5048855733080924,0.04601769911504425,0.14375881813034158,1.0,2/12,1.16%,APOE;LRP1
prerank,telomere maintenance (GO:0000723),-0.4410577060139812,-1.5047848468680083,0.015280135823429542,0.14360135796811413,1.0,23/50,26.81%,NSMCE2;SP100;TEP1;BLM;RTEL1;RAD51;XRCC6;PCNA;WRN;RPA3;POLD2;TEN1;ERCC4;DNA2;XRCC3;ATM;SMC6;NBN;PRKDC;POLD4;SMC5;DCLRE1B;MRE11
prerank,negative regulation of anoikis (GO:2000811),-0.6040682419244133,-1.5046008114585725,0.043795620437956206,0.14353810119258723,1.0,5/14,11.55%,MCL1;ITGA5;ITGB1;BCL2;PIK3CA
prerank,negative regulation of axon extension (GO:0030517),0.4817211961878012,1.5043896635260687,0.052763819095477386,0.20314621723450454,1.0,10/30,15.05%,MAP2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;TRIM46;SEMA3F;SEMA5B;PTPRS;SEMA4G
prerank,regulation of B cell differentiation (GO:0045577),-0.5644948015888891,-1.5043222499733004,0.03496503496503497,0.14358980897210913,1.0,10/17,26.25%,SYK;NCKAP1L;CD27;IKZF3;XBP1;IL4I1;ID2;SFRP1;INHA;ZFP36L1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3944255778078264,-1.5042057100791333,0.011475409836065573,0.14346315233907503,1.0,33/94,20.62%,MAP3K8;PSME4;IRAK2;TAB2;PSMB7;PELI1;PSME3;NFKB1;FBXW11;PSMB9;IRAK4;IRAK3;MYD88;NOD1;PSMA8;UBC;RPS27A;EGR1;TNIP2;PSMC3;RELA;PSMD8;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;IL1R2;NOD2;PSMD4;PSMA5;PSMB3;PSMD3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5962048635061156,-1.5026623303152578,0.0410958904109589,0.14494843455301834,1.0,6/13,26.55%,NELFB;EAPP;RNF8;LARP7;RECQL5;NELFE
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5610381060305019,1.5019950235941617,0.06205250596658711,0.2053659958506186,1.0,8/17,17.36%,CACNA1C;RYR2;GJC3;ATP1A3;ATP1B1;GJC1;GJD3;ATP1B2
prerank,regulation of interleukin-4 production (GO:0032673),-0.5393101484214553,-1.501894633899403,0.04013961605584642,0.14560839092878794,1.0,9/21,21.65%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4360858255583248,-1.5012517523931697,0.02891156462585034,0.1460951451459214,1.0,15/56,10.94%,LYN;FGR;ABI1;SYK;INSR;FES;ABL2;TEC;FLT1;PTK2B;TPST1;PKDCC;PTPN6;LCK;DYRK1A
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6281295045344193,-1.5009603742824633,0.03866432337434095,0.14620102027428497,1.0,2/11,1.81%,RUNX1;ETV6
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.6076738470159937,-1.5006871464277614,0.042704626334519574,0.14625605825020802,1.0,8/13,20.67%,ZC3HAV1;CNOT1;RC3H1;MOV10;GTPBP1;NUDT21;CNOT8;ZC3H12A
prerank,cardiac muscle tissue development (GO:0048738),0.41837984143240287,1.4997431955266138,0.0364963503649635,0.20749738025187803,1.0,10/50,11.17%,SGCZ;NRG1;SGCD;CBY1;MSX1;NDUFV2;BMP7;SGCG;MYOCD;TTN
prerank,secondary alcohol metabolic process (GO:1902652),-0.45952574236426136,-1.4996960771745698,0.017482517482517484,0.14707514232428187,1.0,12/42,13.88%,APOE;ABCA1;ABCG1;IDH1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA
prerank,RNA metabolic process (GO:0016070),-0.3739955426290287,-1.4995297504707414,0.006589785831960461,0.14700484158616586,1.0,50/127,25.80%,APOBEC1;RBM39;RBMS1;AGO2;RNASEL;HNRNPA3;DHX9;RBPMS;MPHOSPH10;RNASE4;HNRNPH1;POLR2H;ALKBH1;HNRNPL;POLR2F;POLR2L;FASTKD2;DUSP11;PCBP2;HNRNPUL1;FTO;METTL14;RNASE6;DHX36;RBMS2;NCBP1;POLR2A;NUFIP1;WTAP;POLR2G;TFIP11;ATXN1;HNRNPA1;PAPOLA;DDX3X;ZC3H12A;HNRNPH2;NOL9;POLR2I;DDX54;RBM3;HNRNPK;XRN2;GTF2F2;MTREX;DDX39B;SND1;GTF2F1;DEDD2;RNASEH2B
prerank,glial cell differentiation (GO:0010001),0.4876871704058791,1.4992838341401011,0.03526448362720403,0.20717301761612858,1.0,11/28,17.15%,SOX11;CDH2;SLC8A3;NFIB;FGF10;SOX9;PTPRZ1;RELN;HES5;ERBB3;GPR157
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.48791202919480725,-1.498830009347241,0.0328719723183391,0.14756877792029244,1.0,10/31,24.45%,PTPRC;SASH3;KMT5B;DNAJB9;KMT5C;XBP1;STX4;SHLD2;IL6;RBP4
prerank,platelet aggregation (GO:0070527),-0.48704411920326857,-1.497699204019038,0.025547445255474453,0.14860496831539982,1.0,9/33,6.51%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG
prerank,DNA double-strand break processing (GO:0000729),-0.5523439934365655,-1.4973037042970117,0.043782837127845885,0.14886399633948674,1.0,11/18,26.81%,BRCA1;BLM;RAD52;SLX4;DNA2;RBBP8;ATM;NBN;UBE2V2;UBE2N;MRE11
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5136929776200394,-1.4968577323453587,0.026785714285714284,0.14913880203744645,1.0,17/25,34.20%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJB12;DNAJC18
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5094097603991757,1.4967024452579492,0.04271356783919598,0.20963810631376895,1.0,12/25,18.82%,ANK3;ANK2;DMD;TCAF1;PIRT;ATP1B1;STAC;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.5034639215412062,-1.4964193941948418,0.03350970017636684,0.14941060107314386,1.0,7/26,13.90%,APOE;POR;HTR2B;ATP7A;PIK3CB;HIF1A;GCH1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5124194221446957,-1.496165725846578,0.025,0.14945118506043328,1.0,8/25,18.45%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8
prerank,regulation of sodium ion transport (GO:0002028),0.45662787662489,1.4948868385894536,0.02702702702702703,0.2110017938404879,1.0,15/34,20.13%,NKAIN2;FGF12;ANK3;NKAIN3;AHCYL1;NEDD4;SPTBN4;ATP2B4;WNK4;WNK3;CNKSR3;NKAIN4;WNK2;NKAIN1;PER1
prerank,cellular response to glucagon stimulus (GO:0071377),0.5435254971140127,1.4947695559297351,0.05896805896805897,0.21017462480667906,1.0,7/17,14.74%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5834441805876334,-1.4945624969009528,0.050788091068301226,0.15108443680893519,1.0,5/14,21.52%,BFAR;BCL2L11;DNAJB9;COPS5;PTPN1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.6029288683823486,-1.4945149545561955,0.030874785591766724,0.15088427582143737,1.0,5/13,11.15%,P2RX7;ANO6;C3;AZIN1;ACSL5
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.509718666196105,-1.4941076549066983,0.04085257548845471,0.15110177845806136,1.0,14/24,29.68%,PID1;DAB2;RHOQ;PICALM;ITGB1BP1;PPFIA1;TMEM59;TGFB1;LZTFL1;INPP5K;PPP2R5A;GDI1;BCL2L1;ABI3
prerank,protein autoubiquitination (GO:0051865),-0.42199689089140774,-1.493646867366912,0.018900343642611683,0.1514277779554652,1.0,20/61,16.67%,RNF213;CNOT4;KLHL24;BFAR;DDB2;NFX1;WWP2;RNF41;BRCA1;AMFR;UHRF2;RNF4;RNF8;UBE3A;TRIM68;UHRF1;TRAF2;RNF185;UBE2T;ASB4
prerank,pyroptosis (GO:0070269),-0.5870786228442858,-1.4934469463767994,0.038869257950530034,0.15142555856913775,1.0,7/15,17.21%,DHX9;NLRC4;AIM2;CASP4;GSDME;CASP1;CASP8
prerank,positive regulation of protein import (GO:1904591),-0.49525509621644515,-1.4932274653093989,0.0429042904290429,0.15142334659311524,1.0,16/30,25.08%,PRKCD;IPO5;FLNA;TPR;HCLS1;MAVS;ARHGEF5;BAG3;PDCD5;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.47001653295723117,1.4931300411894624,0.03225806451612903,0.21121616049687247,1.0,11/31,15.79%,SYT1;SYT10;SYT2;SYT5;SYT11;SYT12;DOC2A;REST;SYT7;CBARP;CACNA1G
prerank,cholesterol efflux (GO:0033344),-0.5366851249931726,-1.492934597274299,0.03866432337434095,0.15152161915785506,1.0,3/20,0.55%,APOE;ABCA1;ABCG1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4997781471331239,-1.4927576556765871,0.024305555555555556,0.15149673614034537,1.0,11/29,20.84%,ADIPOR1;SDHAF2;SPRY2;SPRED1;SPRED2;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.589206907078774,-1.4916895820006901,0.06148282097649186,0.15251424419319431,1.0,4/14,7.36%,LYN;STAT3;STAT6;STAT5B
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.44322221773882925,-1.4908484747182156,0.021505376344086023,0.15326313157880553,1.0,19/43,21.71%,TAOK3;BRCA1;NABP1;ABRAXAS1;BLM;RINT1;BABAM2;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,response to unfolded protein (GO:0006986),-0.4475537867614094,-1.49051435532385,0.025510204081632654,0.1534514081622052,1.0,19/48,21.52%,ERN1;OPTN;HSPA9;DNAJA1;DERL1;HSPE1;DNAJC4;TMBIM6;HSP90AB1;HSPA4;HSPH1;BAG3;HSPA1A;HSPB1;HSPA2;STT3B;ERP44;HSPA13;PTPN1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6157937520680101,-1.490200051505115,0.04931972789115646,0.15310648829209272,1.0,3/12,5.25%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6157937520680101,-1.490200051505115,0.04931972789115646,0.15310648829209272,1.0,3/12,5.25%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6157937520680101,-1.490200051505115,0.04931972789115646,0.15310648829209272,1.0,3/12,5.25%,NSMCE2;RB1;DLGAP5
prerank,protein mannosylation (GO:0035268),0.5159719887066239,1.4899793020245438,0.04830917874396135,0.21438748075214373,1.0,7/22,5.26%,TMTC2;TMTC1;CRPPA;DPY19L1;TMTC3;POMT2;DPY19L2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.617880000908435,-1.4899669692195823,0.043706293706293704,0.15315011013511992,1.0,4/13,8.76%,APOE;PLEK;NFKB1;ERLIN1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6534230780549357,-1.4895770592916322,0.04056437389770723,0.15335924927652259,1.0,3/10,9.55%,APOE;ABCA1;ZDHHC8
prerank,vesicle transport along actin filament (GO:0030050),-0.5467951745552109,-1.4894567293675391,0.06013745704467354,0.1532732296521294,1.0,6/19,11.48%,MYO5A;MYO1F;MYO1G;WASL;MYO1E;MYO7A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43556203802273225,-1.4894443504878379,0.013816925734024179,0.15304250967992256,1.0,27/50,34.96%,CD44;PAK2;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;PLAUR;FNIP1;YWHAE;RNF34;BEX3;DDX3X;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;MMP9;TNF;KLF4;USP47
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3971762776391875,-1.4893416939169393,0.006622516556291391,0.15292311280645754,1.0,44/95,29.62%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRY2;SPRED1;PIN1;FLCN;LTBP4;ITGA3;SPRED2;HTRA3;HSP90AB1;STK11;TGFBR2;LDLRAD4;LATS2;VASN;SMAD7;HSPA1A;IL17RD;SMURF2;EID2;TGFB1;ZBTB7A;SKIL;SMURF1;SMAD4;ENG;BCL9;CITED2;DKK3;WFIKKN1;EP300;NREP
prerank,regulation of cell cycle (GO:0051726),-0.3402868913735923,-1.4890950515435966,0.0,0.15294660730794601,1.0,87/271,24.84%,IQGAP1;PTPRC;NOTCH2;BIRC3;SDCBP;LILRB1;CDK6;RB1;JUN;RUNX3;NUPR1;ERN1;MAP3K20;APBB2;SIPA1;CSNK2A1;SON;FBXL17;BRCA1;STAT3;RNF20;CENPF;KIF20B;CRLF3;DLGAP5;DAPK3;UHRF2;TAF6;LRP6;GRK5;NF2;THAP1;RPS15A;TGFBR1;PCLAF;NEK6;MASTL;SIK1;AFAP1L2;CDKN3;CDC25A;CHMP1A;MAP2K1;FAP;MAEA;GADD45A;HSP90AB1;STK11;PRR11;LIN37;ID2;TFAP4;GADD45GIP1;PPP1R9B;NR4A1;RBBP4;FBXL8;SKP2;RARA;DYNLT3;CDKN2C;GATA3;FBXL6;ATM;CHEK1;SIRT2;BAP1;SFRP1;LIN9;RACK1;GAS2L1;NBN;CDK5;INHA;TGFB1;PHACTR4;WDR12;RRP8;CCNB1;PIM2;PUM1;NUDT6;MYC;CKS2;SND1;TARDBP;CCNB2
prerank,regulation of organelle organization (GO:0033043),-0.39814941872519244,-1.4889009874749408,0.011784511784511785,0.1529139189045852,1.0,19/80,16.12%,DIAPH1;MYO5A;ZEB2;MSN;CLIC4;PAK2;MTM1;PREB;ARMH3;FIS1;TAOK1;SAR1A;STX5;SPEF1;MARK2;PRMT6;CLN3;MAVS;ARHGEF5
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5744145333453723,-1.4885895282782704,0.050966608084358524,0.1530253757509312,1.0,6/15,10.56%,IGF1;ROCK1;MEF2A;SLC9A1;MTPN;AGT
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4144553831541914,-1.4873053860538863,0.018803418803418803,0.15437079797434305,1.0,26/62,24.53%,AGO2;NUP50;PPARG;STAT3;DHX9;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;TGFB1;PUM1;RANBP2
prerank,response to hydrogen peroxide (GO:0042542),-0.45221644623791823,-1.487288994124795,0.032423208191126277,0.15414054275336966,1.0,22/45,30.54%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;ADAM9;SIRPA;MAPK7;APTX;RELA;STK24;RPS3;CAT;HP;IL6;HMOX1;CYP1B1;ECT2;AQP1;RIPK3;PAX2;RHOB
prerank,rRNA processing (GO:0006364),-0.35846443480651774,-1.4869900269246386,0.003169572107765452,0.15425942786659114,1.0,67/172,27.49%,RPL7;RPS24;ESF1;RIOK3;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;RPL12;DDX49;RPS14;NOP14;RPL32;SENP3;EXOSC5;WDR36;RPS28;NOL6;NVL;RPL28;DHX37;KRR1;SART1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;RPL37A;RPS9;UTP6;LSM6;RPS27;RPL23A;EXOSC10;RPS16;RPL9;THUMPD1;RPLP2;NOL9;DDX54;EXOSC4;SNU13;XRN2;RPL7A;RPL19;WDR12;RPS15;RPL39;MTREX;RPLP0;C1D;PRKDC;RPL41;NHP2;RCL1;MRM2;RPL5;PDCD11;RPL13;IMP4;EXOSC8;RPL27A;WDR3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.34479797104902965,-1.4869706456480059,0.0016366612111292963,0.15402810891037752,1.0,93/241,27.41%,CTNNBL1;TRA2B;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;SNRPG;FUS;GCFC2;HNRNPH1;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;CWC22;RBM19;SPEN;RALY;DDX5;POLR2L;SF3B3;PRPF8;SF3B5;UBL5;SART1;PCBP2;HNRNPUL1;ALYREF;NUDT21;SNRPA;RBM14;CWC15;WDR33;RBM10;METTL14;YTHDC1;NCBP1;SART3;ZRSR2;PSPC1;POLR2A;GEMIN7;PDCD7;SF3A1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;WBP11;TXNL4A;RNPS1;SNRNP70;HNRNPA1;MAGOH;PAPOLA;SLU7;BUD13;SF3B1;CPSF3;LSM5;HNRNPH2;POLR2I;GEMIN6;PPIL1;XAB2;HNRNPK;SNU13;NONO;SYF2;GTF2F2;RBM22;MTREX;SRSF11;DHX35;DDX39B;PRPF6;GTF2F1;CPSF1;RBM15B;DHX38;ISY1;HSPA8;WDR83;U2AF2;HNRNPF;SRSF7
prerank,rRNA metabolic process (GO:0016072),-0.3637391242928894,-1.486443361668589,0.0016260162601626016,0.15441865569859708,1.0,64/160,27.49%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;RPL12;DDX49;RPS14;NOP14;RPL32;SENP3;EXOSC5;WDR36;RPS28;NOL6;NVL;RPL28;DHX37;KRR1;RPL22;RPL14;RPL34;RPL6;NIFK;NOLC1;EMG1;RPL18A;RPL37A;RPS9;UTP6;RPS27;RPL23A;EXOSC10;RPS16;RPL9;RPLP2;NOL9;DDX54;EXOSC4;SNU13;XRN2;RPL7A;RPL19;WDR12;RPS15;RPL39;MTREX;RPLP0;C1D;RPL41;RCL1;MRM2;DEDD2;RPL5;PDCD11;RPL13;ERN2;IMP4;EXOSC8;RPL27A;WDR3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5678679213755131,1.4863282151998491,0.05963302752293578,0.21846100528437262,1.0,5/16,10.57%,PAX8;GDNF;WT1;CITED1;SALL1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5470384694777757,-1.4861207001160475,0.04671280276816609,0.15456821803296042,1.0,10/18,24.70%,STX7;ACTB;STX8;ZDHHC7;ZDHHC2;CLN3;APPL1;VPS4A;CDK5;ABCA2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.4885201819676547,-1.485316417330923,0.02727272727272727,0.1552553227463737,1.0,17/30,34.20%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJB12;DNAJC18
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.4092435328226991,-1.4847580907663736,0.017713365539452495,0.15563411963916124,1.0,24/70,22.48%,P2RX7;MCL1;CRADD;TNFRSF1B;RIPK1;IL6R;RNF41;ITGAV;BCL2;CD27;MLLT11;CIB1;TRAF2;GABARAP;BID;BAG3;CASP8;TRADD;CASP2;DDX3X;GSK3B;APPL1;BCL2L2;TGFB1
prerank,mitotic spindle assembly (GO:0090307),-0.4487105649547285,-1.4846077657606467,0.030821917808219176,0.1555720162471442,1.0,19/42,21.65%,RHOA;STAG1;FLNA;KIF3B;PIBF1;KIF11;KIF23;ABRAXAS1;ARHGEF10;STAG2;KIF4A;TPX2;KIFC1;RACGAP1;SMC1A;RAB11A;PRC1;CEP192;LSM14A
prerank,cellular response to insulin stimulus (GO:0032869),-0.37252914431670847,-1.4845652054747773,0.00859106529209622,0.15537428285994515,1.0,36/124,20.32%,MYO5A;RAB8B;ATP6V0D2;NAMPT;BCAR3;GRB2;DENND4C;ATP6V1E1;INSR;IGF1R;RAB31;PPARG;ATP6V1A;SLC27A1;TCIRG1;AP3S1;RHOQ;ZDHHC7;BAIAP2;SELENOS;ATP6V1G1;XBP1;ZNF106;PKM;RAB10;ATP6V0B;HDAC5;PIK3C2A;RAB13;ATP6V0E1;IRS2;ENPP1;RAB12;GSK3B;APPL1;ATP6V0D1
prerank,metal ion transport (GO:0030001),0.37885727358282306,1.4844506214056532,0.015544041450777202,0.21990468876984684,1.0,30/86,20.42%,CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;GRIN3A;SLC8A3;TRPC1;NIPA1;RAMP3;FYN;SLC8A2;RYR1;CAMK2A;MMGT1;ATP2A1;ATP2B2;NDFIP1;CHRNA7;SELENOK;RAMP2;NIPAL4;TRPM2;TUSC3;CCR5;NIPAL2;SLC24A1;MRS2;CACNB3
prerank,regulation of amyloid-beta formation (GO:1902003),-0.47443516201766356,-1.4833985454614977,0.027210884353741496,0.1564507524002875,1.0,10/34,11.54%,APOE;IGF1;ABCG1;GSAP;ROCK1;GGA3;TMED10;PICALM;PIN1;RELA
prerank,substrate-dependent cell migration (GO:0006929),-0.5869090771957736,-1.4830427579905563,0.050933786078098474,0.15662115182223613,1.0,3/14,0.97%,PTPRC;NRP1;SDCBP
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.4156734775602129,-1.4830369254226705,0.020618556701030927,0.15637175508366571,1.0,24/57,22.14%,TAOK3;BRCA1;ABRAXAS1;BLM;RINT1;BABAM2;RFWD3;FOXN3;TAOK1;CDK1;BABAM1;TICRR;WAC;TOPBP1;RAD9A;TRIM39;TAOK2;BRCC3;FBXO31;ATM;CHEK1;TIPIN;NBN;FANCD2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.4301382214383048,-1.482779667310288,0.032148900169204735,0.1564048173228425,1.0,17/54,18.52%,BIRC3;SYK;RIPK1;CFLAR;RNF31;RBCK1;GAS6;LAPTM5;CASP4;OTULIN;TRAF1;CASP1;TRAF2;IKBKB;CASP8;HSPA1A;TRADD
prerank,cellular response to interleukin-6 (GO:0071354),-0.5061923948405578,-1.4823565240852374,0.054817275747508304,0.15664087713743613,1.0,10/26,11.54%,PID1;CBL;SBNO2;SPI1;IL6R;STAT3;CTR9;NFKB1;JAK1;RELA
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.4058290165652892,-1.482157815148246,0.010135135135135136,0.1566344118016532,1.0,29/77,28.42%,IGF1;MCL1;RB1;BIRC6;CSNK2A1;RIPK1;CFLAR;PSME3;ITGAV;BCL2;SLC35F6;HGF;PLAUR;TGFBR1;RELA;TMBIM6;GHITM;HSPA1A;ACAA2;DDX3X;MAZ;BCL2L2;TMEM14A;SIAH2;URI1;RTKN2;BCL2L1;NOC2L;PRELID1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.37861959206586826,-1.482103404004047,0.009787928221859706,0.15644886786720116,1.0,33/108,19.77%,IQGAP2;IQGAP1;DIAPH1;CLIC4;P2RX7;LRP1;PAK2;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;KATNBL1;TAOK1;CRK;CCDC88A;SPEF1;MARK2;CLN3;BST1;RND2;ARHGEF5;CDK2AP2;TWF2;TAOK2;PDGFRB;RHOBTB1;GSK3B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5132047493298503,-1.4811484658258103,0.04201680672268908,0.15739317285105772,1.0,13/26,27.41%,DAB2;FOXP1;BRCA1;CNOT1;CNOT2;VPS18;SFRP1;HEYL;ZBTB7A;VPS11;NCOR1;PIAS2;CLOCK
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.49630250298646383,-1.480742769372539,0.04340567612687813,0.1576320061722815,1.0,11/27,12.57%,TLR4;PTPN22;ARRB1;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NCKAP1L;FOXJ1;NLRC3
prerank,negative regulation of viral life cycle (GO:1903901),-0.5752592335771369,-1.48063435937158,0.054481546572934976,0.1574961436341767,1.0,5/15,13.74%,SNX3;CIITA;BST2;IFITM2;TRIM11
prerank,intermediate filament organization (GO:0045109),-0.5550023358827522,-1.4804053888748032,0.057391304347826085,0.15755028789809525,1.0,7/17,24.85%,VIM;KLHL24;MTM1;DNAJB6;GFAP;BFSP2;DSP
prerank,spindle assembly (GO:0051225),-0.4082503279661336,-1.4803268186733136,0.00847457627118644,0.15738600848934642,1.0,26/67,21.65%,GOLGA8B;RHOA;STAG1;FLNA;KIF3B;PIBF1;KIF11;HAUS5;ABRAXAS1;ARHGEF10;STAG2;HAUS6;STARD9;TUBGCP4;NEK6;TPX2;KIFC1;HAUS4;HAUS7;INO80;RPS3;RCC1;SMC1A;RAB11A;CEP192;LSM14A
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.5682808118305135,-1.4798747941378967,0.037162162162162164,0.15768506512766237,1.0,4/16,6.82%,PTPRC;LILRB1;STX7;CYRIB
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.45047488817782155,-1.479566150340244,0.033783783783783786,0.15780027244469944,1.0,20/43,24.99%,FOXP1;IGF1;JUN;ERN1;IL6R;IL18;MEF2D;CCL5;ID2;FOXJ2;PDGFRB;RBPMS2;ADAMTS1;MMP2;STAT1;IL6;P2RY6;HMOX1;FGF9;CCN4
prerank,positive regulation of bone resorption (GO:0045780),-0.6290494115442014,-1.479113006645752,0.053691275167785234,0.1581227383758152,1.0,4/11,14.46%,PLEKHM1;SYK;ADAM8;SPP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.31703431633065177,-1.4788898311188887,0.0,0.15812557848168543,1.0,154/572,21.75%,RBPJ;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;SP100;RREB1;SDCBP;BCL6;RB1;JUN;ZNF568;ETV6;CREBBP;MEF2A;RUNX3;PPARD;BPTF;BACH1;ARID5B;DNMT3A;IRF2;ZNF148;NFIC;NFX1;ATF3;GATAD2A;PPARG;SPI1;PHF21A;WWP2;ZNF3;STAT3;FOXO3;CNOT1;CTR9;NIPBL;CHD3;CNOT2;NFKB1;HHEX;ZBTB21;RARG;SAP30;SARS1;NR1H2;CIITA;SMYD2;CUX1;MDFI;NFATC3;ZBTB2;USP9X;MCPH1;RPS14;TBL1XR1;EZH2;NR2F1;DPF2;SKI;VEGFA;EED;BHLHE40;E2F1;MAP2K5;CNBP;WFS1;CBFB;THAP1;FNIP1;SPEN;DDX5;TFEC;SAP130;MEF2C;UBC;RPS27A;SUDS3;PARP9;HDAC10;NEDD4L;FLCN;TPR;TCF25;OSR1;RELA;KLF10;GADD45A;PRDM2;FOXJ1;ZFP57;PLK3;UHRF1;FRK;CHD8;IRF2BP2;MTA3;SP2;E2F8;BATF3;RXRA;DR1;LIN37;HDAC5;SIN3A;KLF2;ID2;TGIF1;EPC1;TCF3;NSD1;YY1;KLF8;ZNF177;KMT5A;NRIP1;KLF11;SOX10;BAG3;VHL;UXT;UBE2I;SMAD7;HSPA1A;RARA;TAF3;GATA3;MYB;ARID5A;ATXN1;RIPPLY2;MIER1;NR3C1;ID1;MDM4;SUFU;C1QBP;HMGB1;SIRT2;RTF1;MAZ;SMURF2;GTF2IRD1;STAT1;LRRFIP1;MAX;KDM1A;ID3;CEBPB;TBX2;SNAI2
prerank,carboxylic acid metabolic process (GO:0019752),-0.46970909181336473,-1.4776619395069073,0.04492512479201331,0.1593587424032481,1.0,19/33,33.06%,TBXAS1;ST3GAL1;SLC2A1;CYB5R3;ST6GAL1;AGXT;PLA2G4A;SLC23A1;SLC23A2;GNMT;CARNMT1;ACOT4;GSTO1;CYB5A;PON3;GNE;CYP2S1;DAO;SLC2A3
prerank,positive regulation of protein catabolic process (GO:0045732),-0.39345071243439317,-1.4774553981030811,0.015228426395939087,0.1593673051318467,1.0,21/84,12.77%,APOE;MSN;WWP1;RAB7A;SNX9;TNFRSF1B;CSNK2A1;WWP2;RNF41;AREL1;ATG7;ADAM9;TIPARP;AXIN1;SNX33;PLK2;ADAM8;NEDD4L;ASB5;STX5;PLK3
prerank,sulfation (GO:0051923),0.6065436089667541,1.4774063857867703,0.08158508158508158,0.22874251756170488,1.0,4/11,18.32%,HS3ST5;CHST5;SULT4A1;SULT2B1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4638248703033092,1.4772601221933335,0.03009259259259259,0.22795245871649333,1.0,9/32,17.68%,AKAP6;TRPC1;NPSR1;CAPN3;CALM1;CALM3;CALM2;SNCA;HAP1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.614391803261262,-1.4770886713590479,0.048465266558966075,0.159543961259389,1.0,5/12,15.88%,RHOA;DOCK8;APP;CCL5;SPN
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.47722324212478856,-1.476687142325602,0.052805280528052806,0.15975249698851623,1.0,16/33,30.54%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;SIRPA;MAPK7;RELA;RPS3;IL6;CYP1B1;ECT2;AQP1;RIPK3;PAX2;RHOB
prerank,interstrand cross-link repair (GO:0036297),-0.43292875840877526,-1.4762585769504086,0.035897435897435895,0.1600003824304493,1.0,22/53,22.14%,DCLRE1C;WDR48;NEIL3;RAD51;UBC;RPS27A;RFWD3;NUCKS1;MCM9;RNF8;DCLRE1A;RPA3;RAD51AP1;ERCC4;UBE2T;SLX4;XRCC3;POLN;FAAP24;EXO5;FAN1;FANCD2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6214241097405051,-1.4759531058840676,0.04475043029259897,0.16008396434852762,1.0,7/12,27.32%,DAB2;FOXP1;SFRP1;HEYL;ZBTB7A;NCOR1;PIAS2
prerank,histone H4-K16 acetylation (GO:0043984),-0.5498615087374251,-1.4757618771979943,0.04316546762589928,0.16007425388336288,1.0,7/19,17.25%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7;KMT2A
prerank,negative regulation of ossification (GO:0030279),-0.5264338395322664,-1.4751656018763681,0.041025641025641026,0.16055367323034128,1.0,9/23,20.84%,RBPJ;CCR1;SRGN;PTK2B;MDK;MEF2C;GREM1;ENPP1;SFRP1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5130837762381559,-1.4747648998779261,0.05862068965517241,0.16081015756146008,1.0,9/23,23.15%,SP100;ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,metanephros development (GO:0001656),0.4846371948676699,1.474747208937048,0.041758241758241756,0.23048312395890366,1.0,8/26,11.52%,ROBO2;PAX8;GDNF;WT1;FGF10;BMP7;CITED1;PKD1
prerank,aminoglycan biosynthetic process (GO:0006023),0.4225321269573709,1.4745733411229305,0.0407673860911271,0.22974393577627886,1.0,9/49,3.84%,B3GALT1;HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;B3GALT5;PXYLP1;HS3ST1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6261008590828601,-1.4743936120574994,0.054817275747508304,0.16101104647644968,1.0,6/11,19.19%,LILRB1;AXL;GAS6;SELENOS;HCLS1;NOD2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4818866220539836,-1.474342539324576,0.03488372093023256,0.16082825547043478,1.0,19/33,34.06%,APOE;RHOA;PPARG;MAP2K5;MEF2C;ITGB1BP1;ANGPT2;GADD45A;HDAC5;HMGB1;JUP;TGFB1;CARD10;TBXA2R;AGTR2;CSNK2B;FGF2;TNF;KLF4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.40281640093164034,-1.474150235787067,0.014354066985645933,0.1608099430612431,1.0,30/72,27.24%,SP100;CRADD;CNOT4;CNOT1;CNOT2;BATF;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;TFAP4;CNOT6L;AURKA;CASP2;MDM4;CNOT8;ATM;CDC25C;SFN;NBN;GTSE1;CCNB1;PCBP4;RBL2;PML;CNOT3
prerank,regulation of platelet aggregation (GO:0090330),-0.5585003971618361,-1.4741267869946484,0.04882154882154882,0.16058851245201164,1.0,4/17,3.28%,LYN;SYK;PRKCD;CD9
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.4417751437423542,-1.4738575984352609,0.025684931506849314,0.16069459443002534,1.0,25/48,31.21%,OGT;NUP50;PRKAG2;NUP42;NOA1;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;PRKAG1;NUP62;ZBTB7A;RANBP2;NUP37;EP300;AAAS;NUP133;EIF6;PGAM1
prerank,protein-DNA complex disassembly (GO:0032986),-0.5591386125496985,-1.473229085027808,0.05181347150259067,0.16124109715794288,1.0,5/16,11.92%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,Golgi to lysosome transport (GO:0090160),-0.63280631571482,-1.4731834802922446,0.04512635379061372,0.1610424932301292,1.0,5/11,15.85%,ANKFY1;AP1G1;LAPTM5;LAMP1;CLN3
prerank,regulation of anoikis (GO:2000209),-0.5398263316100349,-1.4713856479987226,0.047619047619047616,0.16288258202409903,1.0,6/19,11.55%,MCL1;ITGA5;ITGB1;BCL2;SIK1;PIK3CA
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5980261665313709,-1.4711920879274227,0.052346570397111915,0.16285945203560256,1.0,6/13,26.68%,DAB2;RBPMS;TGFBR1;TGFB1;SH2B1;SMAD4
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.546685351254141,-1.4706949284327075,0.03716814159292035,0.16324091060457452,1.0,11/20,39.05%,CYP46A1;FDXR;TSPOAP1;FDX1;HSD17B10;HSD3B2;FDX2;STARD3;AKR1C1;AKR1D1;TSPO
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.5702378484101432,-1.4705665242707402,0.053726169844020795,0.16313354909042702,1.0,7/17,19.87%,CCR2;ANO6;CCR1;CCL5;SERPINE1;PLA2G7;HMGB1
prerank,triglyceride catabolic process (GO:0019433),-0.5434758654513275,-1.4704674211500062,0.06216696269982238,0.16299120026876315,1.0,3/19,10.29%,FABP5;LPL;FABP4
prerank,negative regulation of translation (GO:0017148),-0.3926864712608236,-1.4704235232889733,0.018425460636515914,0.16280288822094394,1.0,29/87,21.96%,DAPK1;ROCK1;YTHDF3;GAPDH;AGO2;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;EIF4EBP1;EIF4EBP2;TPR;FTO;EIF3E;CELF1;METTL14;DHX36;UNK;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;CPEB4;RACK1;LSM14A;SHMT1
prerank,response to glucagon (GO:0033762),0.5180105172928098,1.4700636756890892,0.05693069306930693,0.23499025908254598,1.0,10/19,22.84%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A;PRKAR2B;CRY1;PRKAR1B
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5873924560977037,-1.4696521256819404,0.05952380952380952,0.16344339443310046,1.0,8/14,22.97%,LILRB1;TLR8;PIBF1;IRAK3;LILRA5;CMKLR1;C1QBP;MEFV
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5804058227281089,1.4694834037631848,0.06206896551724138,0.23471283436197557,1.0,5/13,8.87%,GRIK2;SHISA6;SLC4A10;SHISA9;SLC8A2
prerank,transition metal ion homeostasis (GO:0055076),-0.4903764951190504,-1.4694499558749818,0.044722719141323794,0.16346033254402687,1.0,7/28,11.44%,FTL;IREB2;ABCB7;PICALM;B2M;HMOX2;CP
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6232922014537406,-1.4693710848696233,0.06390328151986183,0.16332019535073602,1.0,4/10,8.60%,ZEB2;MFSD12;ATP7A;CTNS
prerank,regulation of protein import into nucleus (GO:0042306),-0.4751962275093422,-1.4688276826329925,0.04132231404958678,0.16374491883117698,1.0,17/36,25.08%,MDFIC;PRKCD;IPO5;FLNA;TPR;HCLS1;MAVS;BAG3;SUFU;CHP2;ZC3H12A;JUP;UFM1;TGFB1;RBM22;TRIM28;ECT2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.44234137136553797,-1.4684589778763448,0.03161397670549085,0.16395840373289702,1.0,20/46,25.08%,PRKCD;IPO5;FLNA;DHX9;ANP32B;GAS6;YWHAE;TPR;HCLS1;MAVS;BAG3;CHP2;GSK3B;ZC3H12A;JUP;TGFB1;GTSE1;RBM22;TRIM28;ECT2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4274700014496785,-1.4680761811101537,0.0313588850174216,0.1641326301058663,1.0,22/53,19.84%,PRKCD;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;DDX5;RNF8;SPRED1;PCNA;BABAM1;SPRED2;EEF1E1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;ATM
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6238077629448768,1.467842729714315,0.0748792270531401,0.23607283010200703,1.0,4/10,8.08%,BMPR1B;SOX5;SOX6;SOX9
prerank,regulation of heart contraction (GO:0008016),0.37383095741506234,1.4676416246912425,0.015384615384615385,0.23536378051551496,1.0,30/90,17.49%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;PDE4D;ADORA3;CORIN;AHCYL1;CASQ2;KCNIP2;APLN;ATP1A3;FXYD6;SLC8A2;TGFB2;TNNT2;RYR1;ATP1B1;CALM1;CALM3;KCNJ12;CALM2;ATP2B4;ATP2A1;ATP2B2;SCN10A;TPM1;ATP1B2;CELF2
prerank,mitotic metaphase plate congression (GO:0007080),-0.4322532516135611,-1.4673759067540064,0.024549918166939442,0.16456342083723324,1.0,27/51,29.36%,PDCD6IP;EML4;PIBF1;CHMP5;CENPE;KIFC1;KIF14;CHMP7;CHMP1A;CHMP2A;KIF2C;MAD1L1;NUF2;NDC80;CEP55;RAB11A;KIF22;NUP62;CHMP4B;CHMP4A;VPS4A;BECN1;CCNB1;CHMP2B;CUL3;SPDL1;NUDC
prerank,postreplication repair (GO:0006301),-0.4363790218803017,-1.4664159712428708,0.044905008635578586,0.16553933459724815,1.0,20/45,26.23%,BRCA1;RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;WDR33;RPA3;POLD2;RFC2;ISG15;PARP10;POLN;RFC3;TRIM25;POLD4;UBE2V2;UBE2N;VCP
prerank,positive regulation of viral life cycle (GO:1903902),-0.5167184503091645,-1.466151203486954,0.03484320557491289,0.16560424117191538,1.0,11/22,24.62%,CD74;AXL;TSG101;LGALS1;TRIM11;CHMP2A;LGALS9;VPS4A;P4HB;DDB1;CHMP2B
prerank,"phototransduction, visible light (GO:0007603)",-0.5756956312410646,-1.4654852207617677,0.07167832167832168,0.1661497535078279,1.0,7/14,34.55%,GNB1;GNA11;ABCA4;RP1;GNAQ;CNGB1;SAG
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5244565235628691,-1.4641385979834642,0.048214285714285716,0.16754429254472053,1.0,5/21,13.49%,MITF;JUN;MED24;MED4;DHX36
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5027027740025873,1.4638671742867013,0.07294117647058823,0.23959999393247844,1.0,7/23,13.81%,METAP2;FNTB;GRK4;CAMKMT;FNTA;CALM1;METAP1
prerank,cellular response to starvation (GO:0009267),-0.3565368227275116,-1.463467780938652,0.0064,0.16812176869874096,1.0,44/147,23.49%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;PRKAG2;ATG5;ATP6V1A;LAMP2;FOXO3;TCIRG1;ATG7;MTMR3;EIF2AK2;FNIP1;ATP6V1G1;SIK1;XBP1;FLCN;RRAGD;SESN1;KLF10;WRN;STK24;ATP6V0B;XPR1;SH3GLB1;GABARAP;ATP6V0E1;RALB;HNRNPA1;RHEB;BMPR2;ATP6V0D1;CPEB4;ZC3H12A;SFRP1;GAS2L1;PRKAG1;CEBPB;BECN1;RRP8;WDR24;KPTN;MAPK1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5738742829810711,-1.4633212850950328,0.051601423487544484,0.16806052978694927,1.0,7/14,24.23%,DHX58;DDX60;PUM2;OASL;ZCCHC3;ZDHHC5;PUM1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5536413967290629,-1.4632675930578363,0.0506108202443281,0.16786498934005253,1.0,6/17,19.19%,LYN;TAOK3;EIF2AK2;TAOK1;TAOK2;NOD2
prerank,positive regulation of macroautophagy (GO:0016239),-0.4297323078461143,-1.4628923204312123,0.04355400696864112,0.1680492875473431,1.0,20/48,27.25%,SPTLC2;GNAI3;OPTN;PIP4K2A;UVRAG;RAB3GAP1;SESN1;WAC;SH3GLB1;SLC25A4;BAG3;RALB;BNIP3L;ADRB2;KDR;VDAC1;DCN;LRSAM1;VPS13D;TSC2
prerank,peripheral nervous system development (GO:0007422),0.48925148936724816,1.4620052370653274,0.06310679611650485,0.2412665918150228,1.0,12/23,25.49%,ASIC2;SERPINI1;GDNF;BDNF;ADGRB2;ERBB3;ADGRB1;GPC1;NF1;GFRA3;ALDH3A2;SCN8A
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.576717032364046,-1.4616197604469687,0.06643356643356643,0.16939995635669325,1.0,9/14,22.52%,MALT1;IL18;ANXA1;NFKBIZ;RARA;MYB;NFKBID;NLRP3;SOCS5
prerank,detection of visible light (GO:0009584),-0.5637324106281333,-1.4615474245828939,0.05486725663716814,0.1692449230363091,1.0,8/16,41.72%,GNA11;ABCA4;RP1;REEP6;GNAQ;CNGB1;CACNA2D4;PDE6B
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4981633724240418,-1.4614877363105552,0.035653650254668934,0.1690722784677708,1.0,9/26,21.18%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8;TMEM106A
prerank,negative regulation of autophagy (GO:0010507),-0.4222230903318476,-1.4602534957496567,0.03225806451612903,0.17048405819187123,1.0,13/54,7.21%,MCL1;NUPR1;HTR2B;STAT3;TAB2;ATG7;BCL2;CTSA;PTPN22;EIF4G3;HGF;KLHL22;USP36
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.6116967800627882,-1.4600865651284716,0.060498220640569395,0.1704235909465747,1.0,4/11,16.56%,UBN1;ASF1B;ASF1A;RBBP4
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5231616381988995,1.4592216825825217,0.061274509803921566,0.24424864644271982,1.0,4/18,3.23%,NLGN1;RIMS2;RIMS1;SYN1
prerank,histone mRNA metabolic process (GO:0008334),-0.4949836568041278,-1.4590616382207302,0.04529616724738676,0.17153247628268722,1.0,11/27,21.23%,TUT7;SNRPG;SNRPF;DCP2;MTPAP;NCBP1;TENT4B;EXOSC10;ATM;CPSF3;EXOSC4
prerank,regulation of catecholamine secretion (GO:0050433),0.46032622566459364,1.4583171372742203,0.03299492385786802,0.2445477104414789,1.0,11/29,16.32%,SYT1;SYT10;SYT2;HRH3;SYT5;SYT11;SYT12;SYT7;KCNA2;PRKN;SNCA
prerank,cellular response to interleukin-2 (GO:0071352),-0.6290485366637961,-1.457620086351353,0.05641025641025641,0.1727935866658769,1.0,8/11,24.04%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6290485366637961,-1.457620086351353,0.05641025641025641,0.1727935866658769,1.0,8/11,24.04%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1
prerank,"transcription, DNA-templated (GO:0006351)",-0.3436069452070937,-1.4575470172934282,0.0015527950310559005,0.1726316114788359,1.0,77/207,27.19%,RREB1;AFF4;DEK;MEF2A;NELFB;NFIC;NFX1;NFYA;SMARCA5;GTF2A1;ARRB2;ERCC6;FOXO3;KLF13;CTR9;NFKB1;MAF;TAF6;POLR2H;E2F1;POLR2F;CBFB;THAP1;DDX5;POLR2L;SNAPC2;POLR3G;XBP1;MED4;TRIM24;SMN1;GTF2E2;NCBP1;EPC1;TFAM;POLR2A;TAF4B;NFKBIB;POLR2G;TAF9;TTF1;TAF1A;TAF3;DTX1;SNAPC3;NCOA6;RNPS1;POLR3A;RSF1;GMEB2;TAF4;MED20;MMS19;GTF3C5;RTF1;ELOC;GTF3A;PKNOX1;POLR2I;CCNK;XAB2;GTF2A2;TOPORS;TWNK;GTF2F2;POLR3GL;DRAP1;TRIP11;DEAF1;GTF2F1;SSRP1;BRF1;NELFE;NKX2-8;ZBTB7B;HIPK3;UBTF
prerank,cellular response to chemokine (GO:1990869),-0.4404649322757533,-1.456621917077107,0.03529411764705882,0.17349300000374862,1.0,8/46,5.98%,CCR2;RHOA;LRCH1;CCR1;PTK2B;DOCK8;RIPOR2;PF4
prerank,intracellular protein transport (GO:0006886),-0.3280876792160722,-1.4565623849514557,0.0,0.17334476530777176,1.0,111/304,24.39%,CD74;SYK;TRAK1;RAB7A;SNX9;SNX27;KIF13B;IPO5;SNX8;ARHGEF2;STX7;NUP50;TBC1D15;RAB31;SGSM2;UNC93B1;TLK1;TBC1D2B;RAB20;TBC1D9;LAMP2;STAT3;GGA3;COG7;RAB1A;SNX6;NUP42;TMED10;CTSA;STX8;XPO6;TBC1D5;ARL11;TBC1D1;FUT10;RPL11;STX3;PREB;TBC1D22A;RAB32;NUP88;TBC1D16;TBC1D22B;LAPTM5;TBC1D8B;BCS1L;SIL1;WLS;RAB5A;E2F3;TMED3;AP1S3;RAB21;TBC1D8;XPO5;VPS26B;TBC1D17;TPR;SNX13;RAB24;SAR1A;RAB29;STX5;VPS26A;NUP188;TBC1D10B;COPA;SEC31A;GABARAP;ARL5A;EHD1;TBC1D30;APPL2;AP3B1;ARFIP1;STX16;STRADA;CCHCR1;MAIP1;AP3D1;TBC1D9B;BAG3;STX4;VPS33A;TMED2;ARL1;NUP153;TBC1D25;ARFIP2;SNX1;SLU7;FAM53A;TICAM2;APPL1;TNPO3;NUP107;NXT2;TMED4;NUP62;TBC1D10C;EGR2;SPRN;TGFB1;TBC1D4;HPS4;SCFD2;RABL3;TMED5;ARCN1;FAM91A1;RAB19
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6083132003454665,-1.4557213202714239,0.05244755244755245,0.1741099027756204,1.0,3/12,3.77%,INSR;IGF1R;UVRAG
prerank,purine nucleotide metabolic process (GO:0006163),-0.49892945464001703,-1.4549016003825417,0.05862068965517241,0.17488885025654383,1.0,5/24,9.99%,GDA;XDH;GUK1;HPRT1;NT5C2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.5378237685993608,-1.454519476380329,0.05583756345177665,0.17510016235897752,1.0,7/19,20.40%,CYBA;PRDX5;PRDX1;PRDX2;ACOX1;CAT;PXDNL
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5127136843562559,-1.4537600677675433,0.05289256198347107,0.1757831135151669,1.0,10/22,20.01%,NFE2L2;PSME4;PSMB7;PSMB9;PSMA8;PSMB10;PSMA1;PSMB8;PSMA5;PSMB3
prerank,ncRNA processing (GO:0034470),-0.34476907741716606,-1.4535329694187646,0.0031446540880503146,0.1757904273307301,1.0,78/200,29.18%,AGO2;FARS2;RPL7;ADAT1;RPS24;TUT7;ESF1;MPHOSPH10;INTS8;SARS1;RPL36;RPS6;RPL11;RPL10A;RPL12;DDX49;SRRT;INTS11;RPS14;NOP14;RPL32;SENP3;EXOSC5;WDR36;RPS28;NOL6;NVL;RPL28;INTS6;DHX37;KRR1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;KARS1;RPL37A;INTS1;RPS9;UTP6;RPS27;RPL23A;EXOSC10;RPS16;RPL9;AARS1;INTS5;RPLP2;NOL9;DDX54;EXOSC4;SNU13;XRN2;RPL7A;RPL19;WDR12;RPS15;RPL39;MTREX;RPLP0;C1D;RPL41;RCL1;MRM2;RPL5;PDCD11;RPL13;IMP4;EXOSC8;RPL27A;WDR3;PIH1D2;THG1L;METTL3;WDR46
prerank,actin filament polymerization (GO:0030041),-0.49707844866057405,-1.4534809517464806,0.04964539007092199,0.17560299118859216,1.0,9/29,9.89%,DIAPH1;GAS7;RAC1;PSTPIP2;PSTPIP1;WASL;CORO7;MSRB1;DIAPH3
prerank,regulation of extracellular matrix organization (GO:1903053),-0.5629782012706037,-1.453459242490383,0.05673758865248227,0.1753772038304916,1.0,5/15,11.75%,RUNX1;LRP1;RB1;AGT;FAP
prerank,engulfment of apoptotic cell (GO:0043652),0.5630124160812726,1.4534144494121368,0.06474820143884892,0.2509844804823143,1.0,4/15,6.44%,XKR4;XKR6;RHOBTB2;XKR8
prerank,positive regulation of exosomal secretion (GO:1903543),-0.5653323969328334,-1.4525378840119436,0.06284658040665435,0.17634003262327635,1.0,6/15,14.36%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4859881159459497,-1.4525087994977492,0.06129597197898424,0.1761297001752788,1.0,11/26,23.48%,MFHAS1;CYBA;PTPN22;RSAD2;IFI35;WDFY1;DDX3X;TICAM2;HMGB1;SLC15A4;TREML4
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4835979375239021,1.4525010370393219,0.06459948320413436,0.251243354808258,1.0,4/24,1.33%,NRG1;CTNNA2;OLFM2;CDH2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.37170463804806514,-1.4524781126871324,0.011419249592169658,0.17591292900659813,1.0,43/110,26.41%,APOE;PAEP;WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;IL18;ATG7;RAB1A;TIPARP;NR1H2;AXIN1;PLK2;MAP2K5;WFS1;PRMT1;MAPK7;APP;MTPN;AGT;NEDD4L;ASB5;STX5;UHRF1;KLF2;EIF4G1;SLC6A9;HUWE1;RILP;CSF1;GSK3B;SMURF2;TGFB1;OAZ3;DDB1;ABCA2;RAB1B;SMURF1;VCP;RANBP9;VIP
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.5045413315370442,-1.4520596781905517,0.043795620437956206,0.17616078836001484,1.0,8/23,9.98%,CD74;MPP1;RAC1;CAMK1D;DPP4;RIPOR2;MDK;NCKAP1L
prerank,cardiolipin metabolic process (GO:0032048),-0.5890282214393914,-1.4510198828430065,0.04817275747508306,0.17728725105957083,1.0,9/13,34.45%,TAMM41;SLC27A1;PLA2G4A;PLA2G5;PLA2G6;PNPLA8;LCLAT1;PTPMT1;PGS1
prerank,regulation of cell cycle process (GO:0010564),-0.3756576844175826,-1.45072720475139,0.013223140495867768,0.17745708428010307,1.0,34/104,21.06%,ZFYVE26;BIRC6;CSNK2A1;CDK13;CEP85;UVRAG;KIF11;CDC42;DYNC1H1;KIF20B;DAPK3;CTNNB1;PLK2;BUB1;PIN1;DBF4;FLCN;PLK3;MKI67;KNSTRN;SH3GLB1;RACGAP1;KIF20A;MAD1L1;AURKA;ATF5;RCC1;HORMAD1;RAB11A;CHEK1;PRC1;TIPIN;SFRP1;CDC25C
prerank,adenine nucleotide transport (GO:0051503),-0.5479411157788533,-1.4505372284254963,0.044563279857397504,0.17744092186939953,1.0,6/17,15.29%,LRRC8D;LRRC8C;SLC25A24;SLC25A42;ABCC4;SLC25A4
prerank,lipid transport (GO:0006869),-0.37549516941858874,-1.450523083210236,0.01192504258943782,0.17720460378999753,1.0,23/97,15.85%,OSBPL8;APOE;ABCA1;ABCG1;PLTP;PITPNC1;CD36;PITPNA;PPARD;FABP5;ABCD2;SLC27A1;PITPNM1;GLTP;OSBPL5;PRELID2;NPC2;STARD5;ABCC4;ABCA9;RXRA;ABCA13;CLN3
prerank,T cell proliferation (GO:0042098),-0.58542483267732,-1.45040747428243,0.07482993197278912,0.17711031348632897,1.0,4/13,6.51%,MSN;LILRB1;DOCK8;PIK3CG
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5312782065593875,-1.4503083725820685,0.06525573192239859,0.1770023488473918,1.0,9/19,22.19%,NRP1;RAC1;ROCK1;PTPRJ;VEGFA;LIMS1;SFRP1;KDR;MAP4K4
prerank,regulation of leukocyte migration (GO:0002685),-0.5462263694394803,-1.4502266826022094,0.06271186440677966,0.17685814509013362,1.0,8/16,23.52%,RAC1;ANXA1;VEGFA;NCKAP1L;MIA3;BST1;HMOX1;ADTRP
prerank,pulmonary valve morphogenesis (GO:0003184),0.5220729279231995,1.4501806005341051,0.06419753086419754,0.2537963185170642,1.0,3/17,1.35%,ROBO1;ROBO2;SLIT2
prerank,entry into host (GO:0044409),-0.6037244722919294,-1.4490410035644825,0.06506849315068493,0.17814799903739267,1.0,5/13,8.22%,GRB2;CBL;ITGAV;CTNNB1;CBLL1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6371834706735963,-1.4487571215715167,0.05,0.17827850000622897,1.0,7/10,28.25%,JUN;BAG3;VHL;HSPA1A;SIRT2;NCK1;CITED2
prerank,lymphocyte migration (GO:0072676),-0.4737030458482289,-1.4486949651263024,0.028716216216216218,0.17810364949521806,1.0,17/32,39.30%,MSN;CKLF;MYO1G;ADAM8;CCL5;ZAP70;GATA3;CCL7;TBX21;CRTAM;CCL24;CCL4;CCL19;CCL25;CCL8;MSMP;CCL14
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5267905812746254,1.448340521665134,0.0705596107055961,0.25570840619188384,1.0,3/17,3.78%,NLGN1;SYT10;RAB15
prerank,regulation of G0 to G1 transition (GO:0070316),-0.45954887155636315,-1.4483003102862537,0.04118616144975288,0.17838785363514414,1.0,15/38,21.11%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;RHNO1;EPC1;RBBP4;PHC3;UXT;RBBP8;CHEK1;MAX
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.31481870060282224,-1.447875429299503,0.0,0.1787144593316776,1.0,139/476,22.48%,MDFIC;APOE;MITF;ZMIZ1;MAP3K5;ELF4;FLI1;RUNX1;IGF1;TFEB;CD74;CD38;SP100;TCF4;RREB1;ELF2;JUN;DNM2;NIBAN2;CREBBP;RUNX3;PPARD;BRD7;RNF111;BRD4;NFYA;ARID1B;ATAD2;ELF1;NSD3;PPARG;KDM3A;BRCA1;STAT3;FOXO3;LYL1;RYBP;NFKB1;RNF20;HHEX;RUNX2;SMARCD3;PRMT2;FBXW11;CRLF3;KLF6;SMARCC2;SNX5;NR1H2;CIITA;AXIN1;BLM;LRP6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;CAMKK2;EDF1;CREB3L2;E2F1;RNF4;CNBP;ATMIN;ARID1A;TGFBR1;TGFB1I1;WBP2;HIF1A;MEF2C;EGR1;PARP9;AFAP1L2;AGT;NCF1;DYRK1A;XRCC6;ARHGEF11;RELA;MAP2K1;MED4;NFE2;SPIN1;MLLT11;HMGB2;CHD8;WAC;CALCOCO1;RXRA;KLF2;ID2;EPC1;SPP1;TCF3;NSD1;TFAM;TFAP4;IKBKB;KARS1;DNAJC2;IL31RA;QRICH1;SOX10;VHL;KMT2A;MAP2K3;GPATCH3;RARA;TFE3;ATF5;GATA3;MYB;NCOA6;CXXC1;TRIM16;NFATC1;HAS3;RSF1;PITHD1;MMS19;EHF;CASZ1;RLF;NAA16;MAZ;DTX3L;RAI1;SFRP1;STAT1;POU3F1;NUP62;CEBPB;EGR2;ILK;MYRFL;NR1H4;IL6;TGFB1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6288850649364325,-1.4477845431613614,0.07718696397941681,0.17859150022614886,1.0,3/10,3.64%,PTPRC;LILRB1;ARRB2
prerank,dendritic cell differentiation (GO:0097028),-0.5164990593794222,-1.4477130583001785,0.05676126878130217,0.17844648452900558,1.0,11/22,25.62%,LYN;LILRB1;AXL;BATF;GAS6;BATF3;TGFBR2;LGALS9;FLT3;PRTN3;BLK
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5785898150720853,1.4472314650141005,0.08928571428571429,0.2563626367132417,1.0,2/12,2.99%,B3GALT1;B3GALT5
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.397884844219946,-1.4468583946079865,0.03459637561779242,0.17934464593032254,1.0,23/72,20.69%,BIRC3;REL;PSME4;MALT1;PSMB7;PSME3;FBXW11;PSMB9;PSMA8;PSMC3;RELA;PSMD8;PSMC4;PSMB10;TRAF2;PSMA1;RELB;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3;COPS8
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.3903315930075429,-1.446265259252871,0.01721170395869191,0.17982102312400547,1.0,39/87,31.58%,CD44;GRB2;CBL;KIF16B;HNRNPH1;GALNT3;CEP57;POLR2H;POLR2F;FRS2;POLR2L;ITGB1BP1;SPRED1;SPRED2;CCL5;SHCBP1;NCBP1;POLR2A;NR4A1;POLR2G;HNRNPA1;PTPN11;NDNF;SFRP1;POLR2I;GTF2F2;MAPK1;FGF9;FGFR4;ESRP1;GTF2F1;ZFP36L1;HNRNPF;FGF20;FGF18;FIBP;FGF16;RAB14;FGF2
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.43116518873909926,-1.4459298596377987,0.039316239316239315,0.18001122461823582,1.0,18/45,27.00%,ERN1;RIPK1;NFKB1;DIMT1;DDX5;DYRK1A;RELA;MAP2K1;HNRNPLL;POLR2A;HSPA1A;SLC38A2;GRSF1;IL6;TGFB1;RBM22;BUD23;U2AF2
prerank,regulation of cell junction assembly (GO:1901888),-0.4856201329177621,-1.4453613229145699,0.06643356643356643,0.1805247582439276,1.0,7/27,9.38%,PRKCH;RUNX1;ROCK1;RAP1B;RAP1A;CBFB;MEF2C
prerank,focal adhesion assembly (GO:0048041),0.4941541091390328,1.445082810462826,0.08027522935779817,0.2584876188811526,1.0,7/21,12.11%,SORBS1;ARHGEF7;DLC1;PTPRK;THSD1;TESK2;FERMT2
prerank,protein-DNA complex assembly (GO:0065004),-0.36735681590052927,-1.444202550459936,0.0112,0.18185651478826312,1.0,37/116,20.89%,TCF4;DDB2;PSME4;SMARCA5;PSMB7;PSME3;ANP32B;PSMB9;MCM6;RAD51;PSMA8;UBC;RPS27A;MCM3;PSMC3;CUL4B;ORC5;PSMD8;HMGB2;ASF1A;PSMC4;PSMB10;RPA3;SPTY2D1;PADI4;PSMA1;SART3;CHAF1A;MCM2;PSMB8;BRD2;RSF1;PSMD4;PSMA5;PSMB3;PSMD3;DMC1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5447307722700513,-1.4441653339164877,0.06143344709897611,0.18165178256574394,1.0,10/17,24.99%,NRP1;IGF1;S100A11;DOCK5;MDK;CCL5;PDGFRB;ADAMTS1;FGF9;CCN4
prerank,negative regulation of immune effector process (GO:0002698),-0.5898061487891977,-1.444136313000099,0.06028368794326241,0.1814305540017703,1.0,4/13,7.13%,LILRB1;CD300A;RC3H1;GRN
prerank,replication fork processing (GO:0031297),-0.45274476182340717,-1.4440795470161014,0.044596912521440824,0.181249131682098,1.0,12/38,12.06%,FAM111A;SAMHD1;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;GEN1;ALYREF;PCNA;WRN
prerank,negative regulation of phagocytosis (GO:0050765),-0.5466755638498039,-1.443965571760589,0.047217537942664416,0.18115329646866088,1.0,10/17,25.21%,CD300A;SNX3;CD300LF;SIRPA;FCGR2B;HMGB1;APPL1;RACK1;CD47;PRTN3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.444158691869406,-1.4436196234859684,0.0411663807890223,0.18137550528627047,1.0,11/40,13.94%,APOE;RUNX1;PLCG2;VIM;CYBA;CD36;TLR4;MTPN;ZBTB20;CCL5;SLC5A3
prerank,cellular defense response (GO:0006968),-0.4487907179312181,-1.4432014668420639,0.038397328881469114,0.18167007256855583,1.0,26/40,36.19%,ZNF148;C5AR1;TCIRG1;ITGB1;PTK2B;LY96;NCF1;RELA;NCF2;ITK;LGALS3BP;CD5L;SPN;LSP1;BECN1;PRF1;CD300C;ADORA2A;KLRC2;KIR3DL2;TRAT1;CXCR2;NCR1;ADORA2B;FOSL1;CXCL9
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5012325023757387,-1.4426883881221606,0.06324786324786325,0.18212651698736917,1.0,5/23,6.91%,PTPRC;CBL;SNX6;TSG101;MVP
prerank,positive regulation of vasoconstriction (GO:0045907),0.5672318436020405,1.4423884959151738,0.10043668122270742,0.2615728949170255,1.0,5/13,12.90%,SMTNL2;ADRA1B;OXTR;ADRA1A;ADRA1D
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.51333402274532,-1.4422183483722342,0.0627177700348432,0.18254616653029743,1.0,5/20,6.90%,PID1;DAB2;PKDCC;RHOQ;PICALM
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5222320532429955,-1.4421859174188378,0.06118881118881119,0.18233428670162613,1.0,9/20,13.57%,NRP1;IGF1;LRP1;PLAU;S100A11;TRIB1;CCL5;SERPINE1;IGFBP3
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.6269774244515518,-1.4417853125317215,0.08305084745762711,0.18208250185291278,1.0,7/10,21.71%,BLM;WRN;EXO1;SLX4;DNA2;XRCC3;NBN
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.6269774244515518,-1.4417853125317215,0.08305084745762711,0.18208250185291278,1.0,7/10,21.71%,BLM;WRN;EXO1;SLX4;DNA2;XRCC3;NBN
prerank,t-circle formation (GO:0090656),-0.6269774244515518,-1.4417853125317215,0.08305084745762711,0.18208250185291278,1.0,7/10,21.71%,BLM;WRN;EXO1;SLX4;DNA2;XRCC3;NBN
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5478992105904401,-1.4412222526568466,0.07445008460236886,0.18257161870724117,1.0,5/16,13.90%,APOE;HTR2B;PIK3CB;HIF1A;GCH1
prerank,synaptic vesicle localization (GO:0097479),0.5781626004111013,1.4411891973266377,0.07494145199063232,0.2623387855183065,1.0,5/13,8.25%,NLGN1;KIF5C;SYNDIG1;KIF5A;TOR1A
prerank,positive regulation of binding (GO:0051099),-0.38838193854491443,-1.4405455563417484,0.01652892561983471,0.18311814812570248,1.0,28/84,20.54%,APOE;IGF1;LRP1;PPARG;AMFR;DHX9;STK3;RPL11;EDF1;SKI;NME1;B2M;CEBPG;PLAUR;NVL;PARP9;APP;PIN1;DERL1;HMGB2;NCBP1;RALB;RARA;MMP8;GSK3B;HMGB1;SIRT2;DTX3L
prerank,histone exchange (GO:0043486),-0.4505237431699243,-1.4398164041602608,0.051194539249146756,0.18381739899674354,1.0,15/37,25.48%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RNF8;SPTY2D1;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6146565930678147,-1.4392589252303971,0.08793103448275862,0.18432559395934459,1.0,6/10,22.26%,PIEZO1;DPP4;CCL5;WNK1;FERMT3;CD3E
prerank,CENP-A containing chromatin organization (GO:0061641),-0.47625999254054496,-1.4389728438972365,0.06872852233676977,0.18421936237269282,1.0,13/29,25.48%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.47625999254054496,-1.4389728438972365,0.06872852233676977,0.18421936237269282,1.0,13/29,25.48%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5005494674722468,-1.4389677662536484,0.06830122591943957,0.18397807822763074,1.0,11/26,26.25%,IQGAP1;PTPN12;DUSP3;STAT5B;EEF1A1;KNSTRN;PTPN11;SNAI2;INPP5K;PDE8A;ZFP36L1
prerank,regulation of actin filament-based process (GO:0032970),-0.3984868991157227,-1.43896257889823,0.02364864864864865,0.183732452499754,1.0,26/70,22.46%,IQGAP2;IQGAP1;LRP1;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;TAOK1;CRK;CCDC88A;BST1;RND2;ARHGEF5;TWF2;TAOK2;PDGFRB;RHOBTB1;PDGFA;RHOF;CNN2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.44483769710809656,-1.438421819956347,0.04340567612687813,0.18422735283492772,1.0,13/40,12.06%,FAM111A;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;MCM9;GEN1;TIMELESS;ALYREF;PCNA;WRN
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.42365025893581126,-1.4382263401830355,0.03739837398373984,0.18428922173535425,1.0,14/49,15.86%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,transcription by RNA polymerase II (GO:0006366),-0.32277873074233476,-1.438188607686206,0.0,0.18408230676884346,1.0,93/305,22.86%,RBPJ;NOTCH2;RREB1;AFF4;CREBBP;DEK;PPARD;NELFB;NFIC;NFX1;NFYA;CDK13;C5AR1;PPARG;MAML1;GTF2A1;ARRB2;ERCC6;KLF13;E2F2;CTR9;MAML2;INTS8;NFKB1;RARG;NABP1;MAF;NR1H2;SRRT;INTS11;TAF6;SNRPG;TBL1XR1;NR2F1;SNRPF;POLR2H;SSU72;POLR2F;CBFB;E2F3;DDX5;POLR2L;NRBF2;SNAPC2;INTS6;INTS14;HDAC10;XBP1;NUDT21;MED4;TRIM24;RPRD2;WDR33;ELOF1;GTF2E2;RXRA;NCBP1;HDAC5;POLR2A;TAF4B;TAF8;TFCP2;NR4A1;INTS1;POLR2G;ELP4;TAF9;RARA;TAF1A;TAF3;DTX1;SNAPC3;NR3C1;GMEB2;PAPOLA;TAF4;MED20;PHAX;RTF1;ELOC;INTS5;MAZ;CPSF3;PKNOX1;POLR2I;CCNK;MAML3;ELL2;GTF2A2;NR1H4;MED18;GTF2F2;ESR2
prerank,aortic valve morphogenesis (GO:0003180),0.44782163755732973,1.4373786007533944,0.05623471882640587,0.2673674198611237,1.0,7/30,10.06%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6329678260296965,-1.4373639358448353,0.05235602094240838,0.18491419719919497,1.0,5/10,14.23%,CD36;TLR4;MYD88;TICAM1;MIA3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4007409709086234,-1.437122264216738,0.029605263157894735,0.18500465956316342,1.0,31/72,24.21%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;FLT1;IL18;PIK3CB;HGF;FN1;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;CCL5;PIK3CD;HCLS1;IRS2;HCST;PDGFRB;MAZ;PDGFA;KDR;HAX1;BECN1;FLT3;DCN
prerank,regulation of JUN kinase activity (GO:0043506),-0.4579914106211761,-1.4370648507644754,0.04770017035775128,0.18482238929064237,1.0,10/33,17.95%,SASH1;MAP3K5;TAOK3;PTPN22;DNAJA1;AIDA;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,regulation of neutrophil migration (GO:1902622),-0.6199844637507443,-1.4367284368643987,0.07317073170731707,0.1850166342832612,1.0,4/10,16.05%,MPP1;RAC1;NCKAP1L;BST1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5303619144115815,-1.4363482829282317,0.05087719298245614,0.18523177062077778,1.0,5/18,15.04%,TBXAS1;CD74;DAGLB;CBR1;PLA2G4A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5537505525709514,1.4358408475281879,0.07407407407407407,0.2686982208470259,1.0,5/15,10.76%,KCNN2;KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,phospholipid translocation (GO:0045332),-0.4807028005338831,-1.435140096003229,0.06197654941373534,0.18656810562640427,1.0,6/28,9.30%,ABCA1;ATP8B4;P2RX7;ANO6;ATP11C;ABCC1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5004704891191909,-1.4348956390887835,0.06688963210702341,0.18668368072072028,1.0,11/23,24.57%,DDB2;GPS1;UBC;RPS27A;CUL4B;COPS6;COPS5;COPS8;COPS4;DDB1;CETN2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5179248724723446,-1.4347083889805143,0.06493506493506493,0.1866857570097543,1.0,14/21,26.25%,IGF1;HTR2B;ITGAV;PTGER4;CTSH;CDK1;MAP2K1;KARS1;LGALS9;KDR;MAPK1;MYC;MT3;ZFP36L1
prerank,regulation of GTPase activity (GO:0043087),-0.34846220360132873,-1.4345449600561455,0.011111111111111112,0.1866583391036901,1.0,41/177,13.05%,ARHGAP15;VAV3;PLXNC1;BCAR3;RSU1;GPR137B;FGD6;SNX9;DOCK10;PLXNA1;PLXND1;DOCK11;VAV1;TBC1D15;SGSM2;RGS1;LRCH1;RAP1A;FGD4;ITGB1;DOCK8;ARAP1;ARFGEF1;RAB3GAP1;FGD3;PICALM;EZH2;ALS2;SH3BP1;VAV2;ITGB1BP1;ARHGAP12;ADAP1;TGM2;PIN1;FLCN;SNX13;CRK;SNX18;CCL5;TBC1D10B
prerank,positive regulation of JNK cascade (GO:0046330),-0.3962063004462121,-1.434465795309681,0.021922428330522766,0.1865230127934097,1.0,24/70,19.88%,MAP3K5;TAOK3;SDCBP;MFHAS1;RIPK1;TRAF5;MINK1;PTK2B;AXIN1;TRAF3;CD27;APP;TRAF1;NCF1;TAOK1;GADD45A;FCGR2B;TRAF2;MAP3K10;TAOK2;MMP8;NOD2;HMGB1;AGER
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4685209963747668,-1.4343705908252098,0.05862646566164154,0.1863749746522044,1.0,9/29,18.98%,RPS21;RPS8;RPS14;NOP14;DHX37;MRPS11;NGDN;UTP6;RPS16
prerank,defense response to fungus (GO:0050832),-0.5387270031973918,-1.433957190412829,0.07692307692307693,0.1866646357551194,1.0,5/17,12.25%,PLCG2;GAPDH;RNASE7;CLEC4D;CLEC6A
prerank,regulation of lamellipodium organization (GO:1902743),-0.5725664838048926,-1.433859244952268,0.06946983546617916,0.18654450504252085,1.0,4/14,4.13%,CD44;RAC1;CAPZB;CDC42
prerank,protein K48-linked ubiquitination (GO:0070936),-0.41917342959164955,-1.433574604820306,0.029556650246305417,0.18669158969793626,1.0,22/54,24.41%,BFAR;AMFR;PELI1;UBE2R2;RNF4;FBXO38;RNF8;NEDD4L;UBE3A;UBE2H;RNF34;UBE2T;UBE2G1;CDC34;RNF216;UBE2C;SKP2;DTX3L;TOPORS;RNF115;ZNRF1;RNF187
prerank,synaptic vesicle recycling (GO:0036465),0.44162807101747026,1.4331388696272676,0.047619047619047616,0.27183013113650145,1.0,7/31,6.54%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5
prerank,regulation of endothelial cell migration (GO:0010594),-0.383901536870118,-1.4330387926432324,0.029900332225913623,0.18711783293827838,1.0,17/85,10.56%,SASH1;APOE;NRP1;FOXP1;SP100;RAC1;RIN2;PTK2B;PIK3CB;PIK3CG;PRCP;GRN;NRP2;VEGFA;SH3BP1;ITGB1BP1;AGT
prerank,vacuolar acidification (GO:0007035),-0.5105659994072332,-1.4325955788753706,0.0737410071942446,0.1874828957102491,1.0,9/21,20.56%,ATP6V0D2;TCIRG1;TMEM199;GRN;CLN6;CLN3;ATP6V0E1;ATP6V0D1;PPT1
prerank,intracellular sterol transport (GO:0032366),-0.586756135213067,-1.431700769473895,0.061946902654867256,0.18840461765304567,1.0,4/13,14.81%,ABCA1;ABCG1;NPC2;NPC1
prerank,alcohol catabolic process (GO:0046164),-0.6216564143039516,-1.4313956566100825,0.08787346221441125,0.18858895213129287,1.0,3/10,14.87%,APOE;CYP27A1;CYP46A1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.4459248121212157,-1.431035701428363,0.0466786355475763,0.18883585468432998,1.0,16/39,22.29%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG;TJP2;HSPB1;CLIC1;UBASH3B;FERMT3;ILK;PLPP3
prerank,Notch signaling involved in heart development (GO:0061314),-0.6071636547066726,-1.4307378506278705,0.0846286701208981,0.18895294041561375,1.0,3/11,5.75%,RBPJ;NOTCH2;JAG1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.38060565739394525,-1.4306001280157197,0.022838499184339316,0.18889556992264198,1.0,29/84,23.23%,SASH1;NRP1;FOXP1;RAC1;P2RX4;RIN2;PTK2B;MAPK14;PIK3CB;PIK3CG;GRN;NRP2;VEGFA;HIF1A;ITGB1BP1;AGT;PIK3CD;CD40;TMSB4X;MAP2K3;GATA3;HSPB1;BMPR2;HMGB1;ZC3H12A;KDR;PLPP3;TGFB1;GPLD1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4856498202715103,-1.4297560829842897,0.06283662477558348,0.1897675406440065,1.0,8/25,8.84%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;CD28
prerank,positive regulation of T cell migration (GO:2000406),-0.520958154949172,-1.4292161510326993,0.06598984771573604,0.19018048075381408,1.0,7/20,20.26%,CCR2;RHOA;DOCK8;APP;CCL5;SPN;WNK1
prerank,actin filament network formation (GO:0051639),0.5696374637663365,1.4283688709114915,0.09285714285714286,0.2780860477683893,1.0,6/11,14.81%,CARMIL1;CARMIL2;SPIRE1;COBL;FHOD3;PLS3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.37092301129849325,-1.4279238907179341,0.024390243902439025,0.19165242044274355,1.0,38/100,24.21%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;PIP4K2A;FLT1;IL18;PIK3CB;HGF;FN1;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;NLRC3;CCL5;PIK3CD;HCLS1;IRS2;HCST;PTPN13;PDGFRB;PIP5K1A;MAZ;PDGFA;KDR;HAX1;PIP5K1C;BECN1;MAPK1;FLT3;PPP2R5B;DCN
prerank,NAD biosynthetic process (GO:0009435),-0.5140671322906734,-1.4278521867287248,0.0576271186440678,0.1914811477961498,1.0,8/20,35.11%,NAMPT;KYNU;PARP9;PARP10;NADSYN1;NMNAT3;NUDT12;HAAO
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3451862550533491,1.427799237625703,0.013623978201634877,0.2778838075785722,1.0,36/118,16.22%,ADGRB3;LRRC4C;HECW1;PPFIA2;EFNA5;CDH2;TANC2;HECW2;LZTS1;PAK3;CLASP2;GDNF;WARS1;SRCIN1;SHANK3;KNDC1;ABI2;ADGRA2;TSPAN12;NEDD4;TBX1;EMP2;CDK5R1;SH3D19;TNIK;ARHGAP35;BRSK1;FERMT2;SDC2;WTIP;ARC;SIPA1L1;EPHB3;BMPER;SPARC;PDZD8
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5170111575635224,-1.427664456965755,0.07705192629815745,0.19146411275499503,1.0,11/20,33.37%,MBTPS2;NFKB1;ADAM9;PSENEN;RELA;HM13;TGFB1;PSEN2;NGFR;TRAF6;RHBDD1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3601078715030209,-1.427466653372177,0.013377926421404682,0.19146952079234422,1.0,39/122,21.26%,IGF1;NAMPT;BCAR3;VIM;NIBAN1;YTHDF3;INSR;DYRK2;TLR4;DHX9;NLRC5;NFKB1;CIITA;HGF;PRMT1;LARP4B;PCIF1;CD28;LARP4;RPS4X;MTPN;EEF2;XBP1;PCNA;EIF3E;KAT7;PPP1R3E;METTL14;HSPH1;FAF1;SLC6A9;DNA2;IRS2;PDGFRB;NOD2;DDX3X;KDR;TMEM106A;RBM3
prerank,protein localization to membrane (GO:0072657),0.3206435514459072,1.4274293072277298,0.005277044854881266,0.27737661190471974,1.0,22/187,4.33%,NLGN1;DLG2;DPP10;KCNIP4;NRXN1;DPP6;MAGI2;LRRC7;KCNB2;ANK3;ANK2;DLG3;RAB3C;MAP7;CACNB2;FRMPD1;TESC;RAB15;EPB41L3;NRXN2;PTN;CLASP2
prerank,regulation of adaptive immune response (GO:0002819),-0.5278921630032942,-1.4270504771482169,0.075,0.1917848947006283,1.0,6/18,14.21%,ADCY7;SASH3;AHR;IL4I1;FCGR2B;SAMSN1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5287784601232047,-1.4269558055459504,0.06473594548551959,0.19167178624626538,1.0,7/18,15.33%,ERN1;BCL2L11;ATXN3;XBP1;FCGR2B;RNF185;TMEM259
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4112104641098841,-1.4268005410952853,0.035830618892508145,0.19163706188181703,1.0,15/57,15.86%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;NF2;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,mitotic DNA replication (GO:1902969),-0.6240020333129017,-1.4262907940237692,0.06227758007117438,0.19207355086418326,1.0,6/10,22.46%,GINS3;MCM6;MCM3;LIG1;MCM2;CDC45
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.36155596521747885,-1.4261693357639782,0.009538950715421303,0.19199229941559168,1.0,38/109,19.46%,PLCG2;INPP4A;PLEK;PI4K2A;PIK3R5;PLBD1;MTM1;PIP4K2A;MTMR10;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;PIK3CG;PI4KB;RAB5A;IMPA1;PIP4P1;MTMR6;PIK3CA;PLCB3;PIK3CD;PLCD1;PLAAT3;PLEKHA2;PLA2G4A;PIK3C2A;PGAP3;PTPN13;PLEKHA4;PDGFRB;IP6K3;PLA2G5;PLA2G12A;PIP5K1A
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5452140484371961,-1.4259479861942408,0.0706896551724138,0.19201285931326223,1.0,10/17,21.94%,NRP1;FES;CDC42;STAP1;BAIAP2;BAIAP2L2;HCLS1;HCK;HAX1;CDK5
prerank,mitochondrion morphogenesis (GO:0070584),-0.6097895442329458,-1.425575857483737,0.06007067137809187,0.19225216249411614,1.0,3/11,9.92%,PID1;MTM1;FIS1
prerank,error-prone translesion synthesis (GO:0042276),-0.5155496886910215,-1.4251086674982356,0.06890756302521009,0.19259535672956588,1.0,8/21,14.54%,RFC1;POLE2;PRIMPOL;UBC;RPS27A;PCNA;RPA3;RFC2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5211735656560781,1.4250707935934126,0.07808564231738035,0.2799436462897635,1.0,9/16,23.55%,ANK2;RYR2;BCAP29;TAPT1;BCAP31;GABARAPL2;HSPA5;LRRK2;SEC16A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.6062679729701506,-1.4249172374089956,0.0773286467486819,0.19258975973826345,1.0,8/11,26.82%,LYN;ANXA1;PIK3CB;MEF2C;PIK3CD;LGALS9;BLK;RAPGEF2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.4398400045566069,-1.4248225217979626,0.048576214405360134,0.19247835903134677,1.0,12/42,16.56%,ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCC2;ARID1A;RNF8;CHD8;SPTY2D1;INO80;RBBP4
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4531888087833047,-1.4245110470723636,0.04436860068259386,0.1926827138809541,1.0,15/34,18.86%,NRP1;ERN1;MAPKAPK2;FLT1;MT1G;ANXA1;MAPK14;VEGFA;ITGB1BP1;SPRY2;RELA;PIK3CA;NR4A1;MAP2K3;HSPB1
prerank,pentose-phosphate shunt (GO:0006098),-0.6034906471705412,-1.4238654431326045,0.0745697896749522,0.19328037789335822,1.0,7/11,28.99%,PGD;DERA;RPE;TKT;PGLS;TALDO1;PGM2
prerank,positive regulation of DNA binding (GO:0043388),-0.4597400491185304,-1.4238125817328888,0.06076388888888889,0.19308985564014608,1.0,15/31,22.48%,IGF1;RB1;NIBAN2;PPARG;EDF1;SKI;NME1;CEBPG;PLAUR;HMGB2;GATA3;MMP8;HMGB1;SIRT2;TGFB1
prerank,cell differentiation in hindbrain (GO:0021533),0.5851165988551644,1.4236860598719587,0.07641921397379912,0.2810268129966312,1.0,2/11,5.59%,GRID2;KNDC1
prerank,purine ribonucleotide transport (GO:0015868),-0.5497723079259551,-1.4236238667605539,0.057971014492753624,0.19308209153949826,1.0,6/16,15.29%,LRRC8D;LRRC8C;SLC25A24;SLC25A42;ABCC4;SLC25A4
prerank,cell-substrate junction assembly (GO:0007044),0.4386600990093256,1.4231477355928388,0.0625,0.2807095533836515,1.0,9/33,12.11%,SORBS1;ARHGEF7;DST;DLC1;PTPRK;THSD1;CD151;TESK2;FERMT2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5481241847636253,-1.4224529250629587,0.0570409982174688,0.19451496635872143,1.0,7/16,20.28%,LILRB1;TNFRSF21;TRIB2;FCGR2B;MMP8;AGER;CD274
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.630228907108904,-1.4211384794204527,0.07394366197183098,0.19584203669898878,1.0,5/10,21.11%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.630228907108904,-1.4211384794204527,0.07394366197183098,0.19584203669898878,1.0,5/10,21.11%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,actin polymerization or depolymerization (GO:0008154),-0.42528634747966526,-1.4210443840023366,0.045,0.19571981930259025,1.0,15/50,12.60%,DIAPH1;GAS7;ABI1;RAC1;PSTPIP2;PSTPIP1;SVIL;WASL;CAPG;CORO7;MSRB1;DIAPH3;WDR1;MICAL1;MICAL2
prerank,protein polyglutamylation (GO:0018095),0.5883685426240177,1.420994813257102,0.09263657957244656,0.2832485814185896,1.0,3/11,5.23%,TTLL11;TTLL7;TTLL5
prerank,renal system development (GO:0072001),0.39263586539217343,1.4205617140228894,0.0399002493765586,0.28277608914870855,1.0,16/52,11.52%,PCSK5;MME;PAX8;GREB1L;HNF1B;WT1;TRAF3IP1;TGFB2;TFAP2A;AGTR1;MYOCD;HAS2;SALL1;CEP290;PYGO2;PKD1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4960371413916186,-1.4202569270687238,0.06884681583476764,0.19654095896643384,1.0,7/23,17.95%,SASH1;MAP3K5;TAOK3;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,regulation of phosphorylation (GO:0042325),-0.3538996480129314,-1.4197628702366456,0.021922428330522766,0.19693587206023247,1.0,47/120,26.38%,LYN;FNIP2;NRP1;CORO1C;SDCBP;ROCK1;OGT;NUP50;PRKAG2;STAP1;NLRC5;NUP42;FN1;NUP88;RAE1;FNIP1;HIF1A;NCKAP1L;APP;PIN1;NUP205;FLCN;TPR;CCDC88A;JMJD8;CCL5;NUP188;IKBKB;ANKLE2;CDKN2C;NUP153;ANG;NUP35;HSPB1;SIRT2;NUP107;PRKAG1;NUP62;ILK;INHA;ZBTB7A;RANBP2;STAT2;CCDC88C;NUP37;PML;FZD7
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.5555984982237834,-1.4195681010296757,0.0855614973262032,0.19696847249062552,1.0,8/15,23.15%,ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,regulation of secretion (GO:0051046),0.5434391561236477,1.4195358891646992,0.07847533632286996,0.28326720570897107,1.0,8/13,20.64%,NRG1;EGF;MYO6;FGF10;OPRK1;ERBB3;ACSL3;POFUT2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.570918772291715,-1.4194168425755795,0.08900523560209424,0.1969356630945679,1.0,8/13,23.14%,CANX;STAT3;JAK1;OASL;IL27RA;OAS2;STAT1;TYK2
prerank,nucleocytoplasmic transport (GO:0006913),-0.4386139731161416,-1.4192634017786632,0.050505050505050504,0.1968765278948672,1.0,17/40,21.22%,BACH2;MALT1;ANP32A;SNRPG;SNRPF;NUP205;HTATIP2;SMN1;NCBP1;GEMIN7;SNUPN;RGS14;ATXN1;HNRNPA1;PHAX;NXT2;GEMIN6
prerank,sensory perception (GO:0007600),0.4108627797350149,1.4191200805288802,0.03818615751789976,0.28279838947182573,1.0,20/45,16.45%,PCDH15;TMEM150C;MME;PNOC;TTC8;SCN9A;ADGRV1;WHRN;PDYN;CLRN1;KCNA2;USH2A;OPRK1;GNAL;CHRNA7;PENK;OPRL1;SCN10A;OPRM1;NIPSNAP1
prerank,monocyte chemotaxis (GO:0002548),-0.45558352405546176,-1.4190994893195221,0.05123674911660778,0.1968346082433337,1.0,18/32,42.42%,IL6R;FLT1;ANXA1;CCL5;CALCA;PTPRO;IL6;CCL7;CCL24;CCL4;CCL19;CCL25;PDGFB;CCL8;MSMP;CCL14;RPS19;TNFRSF11A
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.46265112399202757,-1.4190339504150862,0.06713780918727916,0.19666263304467121,1.0,15/31,25.62%,LYN;LILRB1;CD300A;RC3H1;TNFRSF21;SDC4;IL4I1;FCGR2B;VSIG4;SPN;ATM;CD274;CEBPB;TNFRSF13B;BLK
prerank,midbody abscission (GO:0061952),-0.5343623257894003,-1.4184451480943507,0.07381370826010544,0.19720143349743782,1.0,12/17,26.68%,PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;CHMP4B;CHMP4A;VPS4A;CHMP2B;MITD1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.38421370408923766,-1.4183543074308091,0.041025641025641026,0.19705415986630953,1.0,25/73,19.17%,APAF1;XDH;CRADD;PPARG;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;ATP2A3;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;IFT57;TRADD;CASP2;BEX3
prerank,response to muscle stretch (GO:0035994),0.533498415122332,1.4181365312779475,0.08254716981132075,0.2833149591924133,1.0,5/15,11.17%,DMD;RYR2;CDH2;GSN;TTN
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5327888552170692,-1.4180818918031821,0.07583774250440917,0.1971897537692587,1.0,4/17,8.76%,APOE;ABCG1;MBTPS2;ERLIN1
prerank,protein phosphorylation (GO:0006468),-0.3077525979771455,-1.4178636231454576,0.0,0.19721400037951514,1.0,129/478,19.98%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;ABI1;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;PRKCD;CDK6;ROCK1;MAP4K3;BIRC6;CAMK1D;MAP3K1;RUNX3;ERN1;MAP3K20;INSR;PEAK1;CSNK2A1;IGF1R;FES;CDK13;PRKAG2;VRK2;TLR7;RNASEL;RIPK1;MAML1;TLK1;ABL2;MINK1;SGK1;MAPKAPK2;GRK3;TEC;DYRK2;TLR4;FLT1;PIM1;PTK2B;INCENP;DAPK3;PKDCC;STK3;MAPK14;ULK2;CAB39;CDK18;IRAK3;CAMKK2;GAS6;PLK2;GRK5;VRK3;STK38;COQ8A;EIF2AK2;EIF2AK1;JAK1;TRIB1;CDK14;TGFBR1;NEK6;PTPN6;MORC3;MASTL;SIK1;TRIB2;RSKR;APP;LCK;TAOK1;DYRK1A;CDK1;MAP2K1;PPP4R1;STK17B;HTATIP2;STK11;FRK;STK24;ACVR2A;GMFG;MKNK1;PIK3CD;IGFBP3;MARK2;TGFBR2;MAST2;TXK;CCNE1;MAP3K10;IKBKB;TTK;MKNK2;LATS2;GMFB;STRADA;CDKL4;PNCK;AURKA;SMAD7;RARA;ZAP70;HCK;RYK;PKN3;HCST;BRD2;TAOK2;STK10;PDGFRB;IP6K3;MAK;BMPR2;PAK6;STK16;GSK3B;ATM;CDK16;CHEK1;CDC42BPG
prerank,regulation of membrane repolarization (GO:0060306),0.5679835126787525,1.4174266959555701,0.09544468546637744,0.2834384669041569,1.0,3/13,5.78%,AKAP6;CACNA2D1;CASQ2
prerank,presynapse organization (GO:0099172),0.5996644646718922,1.417275786846493,0.09382151029748284,0.28261091055680654,1.0,2/10,4.04%,NLGN1;LRRTM3
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6149503725006119,-1.4169924015982798,0.08061749571183534,0.19793899471530685,1.0,4/10,20.26%,MYADM;MAP2K5;MAPK7;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6149503725006119,-1.4169924015982798,0.08061749571183534,0.19793899471530685,1.0,4/10,20.26%,MYADM;MAP2K5;MAPK7;WNK1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.47098488463402716,-1.4169864506801535,0.054982817869415807,0.19770263183631598,1.0,17/29,36.78%,STX7;RAET1E;SPI1;STAP1;AP1G1;CYRIB;LAMP1;CD226;SLAMF6;ITGAM;IL12RB1;CRTAM;KLRC2;KLRD1;IL12A;NOS2;IL12B
prerank,iron ion homeostasis (GO:0055072),-0.39486079765615223,-1.4169762796349443,0.028764805414551606,0.19746379022968324,1.0,12/58,11.44%,FTL;IREB2;ABCB7;ATP6V1A;FRRS1;TMEM199;PICALM;B2M;HMOX2;FLVCR1;ATP6V1G1;CP
prerank,cellular response to purine-containing compound (GO:0071415),0.6061755126843176,1.4168678802015036,0.10476190476190476,0.282125547917335,1.0,4/10,9.81%,RYR3;RYR2;CASQ2;RYR1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.601238197809929,-1.4167849868060591,0.08214285714285714,0.19743698298265067,1.0,5/11,28.45%,DHX9;NCBP1;SRPK1;PTCD2;SAFB
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.48332883224723416,-1.4164719944792685,0.06791171477079797,0.1976168281287146,1.0,3/24,1.57%,PRKCH;RUNX1;ROCK1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5318936276408068,-1.4162090577272177,0.07304347826086957,0.19771216645890555,1.0,10/18,22.42%,CBL;SPI1;IL6R;STAT3;CTR9;JAK1;SOCS3;PTPN11;STAT1;IL6
prerank,sterol metabolic process (GO:0016125),-0.3989565762212125,-1.4149615838985425,0.03523489932885906,0.1990879743026333,1.0,15/60,14.99%,APOE;ABCA1;LIPA;ABCG1;PPARD;PRKAG2;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA;CYP46A1;FDXR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5957042875966337,-1.4147963683986495,0.07363013698630137,0.19908063137059753,1.0,6/11,20.91%,CANX;STAT3;STAT4;JAK1;IL27RA;STAT1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3604957958063789,-1.4144956771421275,0.01610305958132045,0.19927277886525244,1.0,36/114,22.23%,BIRC3;TNFRSF1B;PSME4;RIPK1;TRAF5;FOXO3;PSMB7;PSME3;PTK2B;AIM2;PSMB9;TRAF3;PSMA8;CD27;PSMC3;TRAF1;RELA;PSMD8;PSMC4;PSMB10;TRAF2;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;LIMS1;TRADD;PSMD4;PSMA5;PSMB3;PSMD3;STAT1;ILK;TNFSF9
prerank,manganese ion transport (GO:0006828),0.546943532322253,1.414019263040532,0.10218978102189781,0.2856069958197451,1.0,2/14,2.25%,TRPC5;TRPC1
prerank,cellular response to chemical stress (GO:0062197),-0.3679330372847627,-1.4135234591056598,0.023090586145648313,0.20035412328584631,1.0,29/96,20.67%,CYBB;LRRC8D;CYBA;NFE2L2;VRK2;FOXO3;ATG7;SLC25A24;NUDT2;MSRA;GSR;SELENOS;PRDX5;NCF1;PRDX1;NCF4;PIK3CA;NCF2;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;DDX3X;ATM;CAT;SIRT2;RBM11;ZC3H12A
prerank,positive regulation of neuron projection development (GO:0010976),0.36563007989489643,1.4130615059164429,0.023923444976076555,0.286037092467885,1.0,24/85,12.48%,MAGI2;LRRC7;TENM3;RIT2;NTRK3;SERPINI1;NTRK2;FUT9;PTN;CUX2;PRKCI;ALK;TOX;BDNF;PRKD1;BMP7;COBL;CAPRIN2;LTK;RELN;ARHGAP35;DPYSL3;RET;VLDLR
prerank,translesion synthesis (GO:0019985),-0.42795355149599745,-1.4125029721263298,0.06972789115646258,0.201555830986554,1.0,18/42,26.23%,RFC1;POLE2;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;RPA3;POLD2;RFC2;ISG15;PARP10;POLN;RFC3;TRIM25;POLDIP2;POLD4;VCP
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.41467194264302254,-1.4121675323981042,0.05583756345177665,0.2017533180051057,1.0,16/48,17.01%,CCR2;LILRB1;TLR8;TLR7;TLR4;IL18;PTPN22;CYRIB;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4368919625478108,-1.4120902269486664,0.06924315619967794,0.2016230379924679,1.0,9/40,9.09%,DAB2;SDCBP;JAG1;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1
prerank,endomembrane system organization (GO:0010256),-0.33868775142751584,-1.4108591557105212,0.0144,0.20304272256448014,1.0,77/178,30.82%,MYOF;ATP8B4;TMCC1;SNX10;PLEKHM2;GOLGA8B;GOLGA5;PI4K2A;USP50;FBXW8;OPTN;CDC42;SYNGR1;COG7;SRGN;RAB1A;TMED10;DNAJC13;USP8;ARFGEF1;PI4K2B;TRAPPC11;WASHC4;DYM;SNX33;GOLPH3L;SUN2;ALS2;TJAP1;TMED3;TLCD2;ARFGEF2;RAB29;SERP1;COG2;SEC31A;MIA3;LEMD2;LMAN2L;VAPB;AP3D1;TMED2;LAPTM4B;ARL1;HUWE1;DOP1B;TICAM2;VPS18;VPS51;REEP3;BLZF1;TMED4;VPS4A;PHETA1;TLCD1;COG4;VMP1;TMED5;CHMP2B;TRIP11;LAMTOR1;VPS11;RAB22A;OTOF;VAPA;EIF2AK3;RNF26;TRAPPC8;SYNGR2;HACE1;ATP8B2;GAK;MAPK15;REEP6;ANXA8L1;ANXA8;RAB2A
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4730800784531589,-1.4107121365705502,0.06779661016949153,0.20299128627005453,1.0,11/28,26.36%,CRADD;SPI1;BCL2;GABARAP;BID;BAG3;CASP8;TRADD;DDX3X;DEDD2;DIABLO
prerank,telomere maintenance via recombination (GO:0000722),-0.6042122608957154,-1.4103181756240541,0.0875,0.20329322508706252,1.0,7/11,25.20%,NSMCE2;TEP1;RAD51;ERCC4;XRCC3;SMC6;SMC5
prerank,regulation of cellular response to stress (GO:0080135),-0.3569750711185759,-1.4100358983509593,0.01935483870967742,0.20347229524798316,1.0,39/115,23.49%,MCL1;CREBBP;NUPR1;ATF3;NUP50;MAPKAPK2;AMFR;MBTPS2;NUP42;ARMT1;NUP88;RAE1;NEK6;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;MANF;EIF4G1;DNAJC2;HSPH1;CLN3;BAG3;HSPA1A;NUP153;NUP35;SLC38A2;GSK3B;DNAJB6;ATM;DNAJC7;NUP107;NUP62;CEBPB;CRYAB;SMG1;MAPK1
prerank,cAMP biosynthetic process (GO:0006171),0.6025975619589096,1.409936572077258,0.11188811188811189,0.29008274943082585,1.0,5/10,8.83%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1
prerank,nuclear export (GO:0051168),-0.3818691021221401,-1.4098908561431505,0.02622950819672131,0.20344160484521853,1.0,41/80,33.53%,SRRM1;MALT1;NUP42;XPO6;WASHC4;CHTOP;RAE1;CDC40;XPO5;TPR;ALYREF;NUP188;NCBP1;THOC2;STRADA;CCHCR1;NUP153;ATXN1;RNPS1;THOC6;HNRNPA1;MAGOH;SLU7;PHAX;NUP62;EGR2;TGFB1;SRSF11;DDX39B;DHX38;SMURF1;U2AF2;SRSF7;XPO7;EIF4E;CSE1L;SRSF5;U2AF1L4;EIF4A3;ANKLE1;SARNP
prerank,regulation of Notch signaling pathway (GO:0008593),-0.38146477578856247,-1.409813853948314,0.03231292517006803,0.20330420021471055,1.0,16/76,11.94%,RBPJ;ZMIZ1;TSPAN14;NIBAN2;CREBBP;MAML1;WWP2;STAT3;MAML2;JAG1;ARRB1;POFUT1;ITGB1BP1;ENHO;RFNG;CD46
prerank,regulation of establishment of protein localization (GO:0070201),-0.5809302126547989,-1.408565659005128,0.07557117750439367,0.2047369695066532,1.0,4/13,8.28%,CTSD;SPIDR;CEP295;DNAJA1
prerank,positive regulation of coagulation (GO:0050820),-0.6129025630107106,-1.40841389270248,0.07719928186714542,0.20445251595226738,1.0,6/10,32.05%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,positive regulation of hemostasis (GO:1900048),-0.6129025630107106,-1.40841389270248,0.07719928186714542,0.20445251595226738,1.0,6/10,32.05%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5276827600481103,-1.4082241382534917,0.06408094435075885,0.2044552451146696,1.0,9/18,24.35%,MDFIC;MFHAS1;FLCN;SIN3A;LATS2;SUFU;GSK3B;UFM1;CTNNA1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6011816986771837,-1.4076915086502189,0.08216783216783216,0.2049797004510606,1.0,5/10,25.28%,OGT;SELENOS;USP7;GNMT;ZNF692
prerank,metal ion homeostasis (GO:0055065),0.4244670899894242,1.4067854564015545,0.05092592592592592,0.29433674918514957,1.0,11/40,16.32%,ANK3;TMTC2;SLC12A2;SLC12A8;SLC12A1;KCNA1;LETM1;SLC12A5;FAM20A;COX11;SNCA
prerank,regulation of Golgi organization (GO:1903358),-0.5319302405541061,-1.4062583171468583,0.08287292817679558,0.20668244934739444,1.0,6/17,23.49%,MYO5A;ARMH3;MAP2K1;STX5;CAMSAP2;MAPK1
prerank,negative regulation of developmental growth (GO:0048640),0.4446538266091036,1.4059048068388795,0.08018867924528301,0.2947051188658703,1.0,7/30,15.47%,MAP2;DCC;TRIM46;DUSP10;WWC1;PTPRS;GDF15
prerank,epithelial cell differentiation (GO:0030855),-0.3744336886245115,-1.4058994036692003,0.03262642740619902,0.20691809298244004,1.0,22/88,17.91%,DAB2;CTSB;ANXA4;TAGLN2;PPARG;CPT1A;ANXA1;MAF;JAG1;EDF1;ZDHHC7;VEGFA;SCRIB;CDK1;PCNA;RAB10;CBR1;E2F8;TPP1;TDRD7;PGK1;GATA3
prerank,Golgi organization (GO:0007030),-0.363148996105941,-1.4056388856960143,0.018272425249169437,0.20701166290042672,1.0,37/112,23.59%,ATP8B4;PLEKHM2;VTI1A;GOLGA8B;GOLGA5;PI4K2A;FBXW8;OPTN;CDC42;COG7;RAB1A;TMED10;ARFGEF1;PI4K2B;TRAPPC11;DYM;GOLPH3L;TJAP1;TMED3;CDK1;RAB29;STX5;PLK3;COG2;VAMP4;LMAN2L;STX16;TMED2;ARL1;HUWE1;TICAM2;VPS51;BLZF1;TMED4;COG4;VMP1;TMED5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.49046454930688765,-1.4053699012144272,0.05799648506151142,0.2072031951109729,1.0,6/24,7.75%,NRP1;RAC1;ROCK1;PTPRJ;DUSP3;VEGFA
prerank,amyloid fibril formation (GO:1990000),-0.4143167541720947,-1.404619714820734,0.03951890034364261,0.20802131828712644,1.0,14/51,14.94%,TSPAN14;CD36;RIPK1;GGA3;TGFBI;USP9X;B2M;UBC;RPS27A;APP;PSENEN;CALCA;MFGE8;CST3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.31275471778855934,-1.4030438130603666,0.0,0.20992532517365511,1.0,85/390,12.86%,LYN;NEDD9;CYBB;NRP1;VAV3;MTSS1;IGF1;ATP6V0D2;NAMPT;BCAR3;FGR;ABI1;GRB2;MAPKAPK3;ARPC2;SDCBP;ITSN1;SYK;PAK2;CYBA;AXL;CBL;ATP6V1E1;RAC1;ROCK1;ACTR2;PTPRJ;RHOA;INSR;IGF1R;WASF2;FES;VAV1;ATP6V1A;MAPKAPK2;RASGRP4;STAT3;FLT1;CDC42;TCIRG1;ACTR3;PTK2B;BLNK;STAP1;ACTB;ITGAV;KIF16B;AP3S1;ARPC3;MAPK14;PIK3CB;HGF;RHOQ;WASL;MVP;HNRNPH1;NRP2;GALNT3;CEP57;BAIAP2;POLR2H;VEGFA;SULF2;AP2A2;POLR2F;FRS2;VAV2;POLR2L;ANGPT2;ATP6V1G1;NCKAP1L;SPRED1;LCK;NCF1;PSENEN;ARPC1B;CRK;NCF4;PIK3CA;ZNF106;NCF2;SPRED2;ARPC1A;SHCBP1;FRK
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3383264695196681,-1.4029451155143042,0.01437699680511182,0.20982952991720216,1.0,44/166,19.31%,ZEB2;IGF1;BCAR3;VIM;NIBAN1;YTHDF3;CD36;INSR;P2RX4;DYRK2;SLC27A1;TLR4;DHX9;ATP7A;NR1H2;HGF;PAOX;PRMT1;LARP4B;PCIF1;CD28;LARP4;HIF1A;RPS4X;EGR1;ARNT;EEF2;PCNA;EIF3E;HSP90AB1;CCL5;KAT7;PPP1R3E;METTL14;KLF2;ASS1;FAF1;SLC6A9;DNA2;IRS2;MMP8;PDGFRB;DDX3X;LDLR
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.516043802642863,1.4026071411056802,0.09777777777777778,0.2991673019103419,1.0,4/17,6.63%,SLIT2;TWSG1;DOK5;PCSK6
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.5186312979556159,-1.4025084870652549,0.0748663101604278,0.2101574010051991,1.0,8/18,22.15%,GINS3;MCM3;LIG1;PCNA;POLD2;LIG3;RFC3;GINS4
prerank,regulation of histone deacetylation (GO:0031063),-0.5737788528223389,-1.4018340859745178,0.10120068610634649,0.21091332585545877,1.0,9/13,34.75%,AKAP8;NIPBL;PRMT6;SPHK2;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.547729804224887,-1.4016996848193983,0.08287292817679558,0.21084179835454595,1.0,13/16,38.44%,ITGB2;RHOA;MDK;RELA;IL6;FUT4;ST3GAL4;ETS1;TRAF6;TNF;SELE;SELP;FUT7
prerank,inner ear morphogenesis (GO:0042472),0.47400952791134554,1.4011385307328834,0.07061503416856492,0.3004305519703006,1.0,7/22,17.28%,PAX8;MYO6;SOX9;TFAP2A;TBX1;TMIE;TTC39C
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.47426739237917476,-1.400904271941048,0.07049180327868852,0.21170868167966161,1.0,14/28,25.08%,PRKCD;IPO5;FLNA;TPR;HCLS1;MAVS;BAG3;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,lymphocyte mediated immunity (GO:0002449),-0.5846216414967614,-1.400646521090754,0.10457516339869281,0.21180581999367767,1.0,8/12,33.33%,JAG1;MYO1G;CD46;GNL1;KLRC2;KLRD1;CD8A;SLA2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.40509648537353027,-1.3998365625889846,0.03986710963455149,0.2126635895401536,1.0,17/52,21.44%,CNOT4;DCP1A;TUT7;CNOT1;CNOT2;RC3H1;PATL1;EXOSC5;DCP2;PAN3;CNOT6L;LSM6;CNOT8;DDX6;LSM5;EXOSC4;PNLDC1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5820105964928195,1.3993883958445739,0.09414758269720101,0.3021456482560642,1.0,8/12,18.82%,ANK3;DMD;ATP1B1;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.29298871041670566,-1.3991410473059207,0.0,0.21339142541780456,1.0,219/807,23.09%,RBPJ;MDFIC;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;CD38;SP100;RCOR1;RREB1;SDCBP;MIDEAS;WWP1;BCL6;RB1;JUN;PEX14;NIBAN2;ZNF568;ETV6;CREBBP;MEF2A;RUNX3;PPARD;BPTF;BACH1;ARID5B;DNMT3A;BRD7;IRF2;ZNF148;FLNA;SBNO2;NFIC;NFX1;ATF3;GATAD2A;PPARG;ELK3;SPI1;PHF21A;WWP2;ZNF3;BRCA1;STAT3;FOXO3;CNOT1;CTR9;IKZF1;NIPBL;CHD3;SNX6;CNOT2;NFKB1;HHEX;ZBTB21;RUNX2;RARG;PRMT2;SAP30;FBXW11;CENPF;SARS1;SMARCC2;NR1H2;CIITA;CBFA2T3;SMYD2;CUX1;MDFI;ZBTB2;AHR;USP9X;MCPH1;GCFC2;CTNNB1;RPS14;TBL1XR1;JARID2;PBXIP1;EZH2;GAS6;NR2F1;DPF2;KDM2A;SKI;VEGFA;EED;BHLHE40;E2F1;MAP2K5;CNBP;WFS1;CBFB;THAP1;FNIP1;SPEN;DDX5;TFEC;SAP130;MEF2C;UBC;RPS27A;PRDX5;FOXN3;SUDS3;PARP9;HDAC10;CIART;NEDD4L;TIMELESS;FLCN;TPR;MAF1;XRCC6;TCF25;CHMP1A;OSR1;RELA;KLF10;GADD45A;PRDM2;FOXJ1;ZFP57;CCDC85B;HMGB2;KAT7;PLK3;UHRF1;FRK;CHD8;IRF2BP2;MTA3;SP2;E2F8;BATF3;RXRA;DR1;CALCA;LIN37;HDAC5;SIN3A;KLF2;ID2;TGIF1;EPC1;TCF3;NSD1;PSPC1;TFAP4;YY1;PRMT6;MAP3K10;KLF8;ZNF177;BTAF1;KMT5A;NRIP1;KLF11;PHC3;IKZF4;SOX10;VHL;UXT;UBE2I;SMAD7;RARA;TAF3;ATF5;GATA3;MYB;SAMD1;ARID5A;ATXN1;RIPPLY2;LIMS1;MIER1;NR3C1;ID1;RSF1;MDM4;SUFU;C1QBP;HMGB1;CBFA2T2;SIRT2;RTF1;BAP1;MAZ;SMURF2;CIC;SFRP1;GTF2IRD1;STAT1;LRRFIP1;MAX;KDM1A;ID3;CEBPB;TBX2;HEYL;SNAI2;CDK5;GATAD2B;NR1H4;NONO;CRYAB;EID2;TGFB1;HOXD9;ESR2;SOX7;SET;ZBTB7A;HDAC8;RPS6KA5
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.46797746575189836,-1.398916158055803,0.08333333333333333,0.21347152615984694,1.0,5/25,10.02%,NELFB;BRD4;CDK13;EAPP;RNF8
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.34180475466812377,-1.3988362948632997,0.012102874432677761,0.2133461361100461,1.0,33/150,12.58%,OSBPL8;GRB2;GAB2;MFHAS1;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;P2RX4;IGF1R;PIK3AP1;VAV1;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;TGFBR1;CD28;ADAM8;ITGB1BP1;SPRY2;LCK;STRN;PIK3CA;F7;HSP90AB1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5300341925610703,1.3986534415399343,0.09156626506024096,0.30226447504545567,1.0,5/16,9.22%,SOX5;SOX6;PTN;SOX9;TGFB2
prerank,cell projection organization (GO:0030030),-0.4537770092250155,-1.3977845497258299,0.07216494845360824,0.21456708712898398,1.0,9/30,10.66%,PLEK;RAC1;PARVB;CDC42;ITGB1;RHOQ;CAPG;NCKAP1L;PACSIN2
prerank,O-glycan processing (GO:0016266),-0.4038607917828675,-1.3975234922661761,0.04690117252931323,0.2146893924084389,1.0,15/54,13.14%,B4GALT5;ST3GAL1;GALNT7;GALNT10;GALNT3;POFUT1;XXYLT1;GALNT1;ST6GAL1;C1GALT1;B3GNT2;GXYLT1;POMGNT1;GALNT12;GCNT1
prerank,regulation of ion transmembrane transport (GO:0034765),0.44133262824825026,1.3970234926144984,0.07407407407407407,0.30384529467114496,1.0,10/33,8.19%,AKAP6;CHRM3;KCNJ6;KCNJ3;KCNJ10;AHCYL1;CASQ2;KCNJ9;KCNJ16;NEDD4
prerank,regulation of neuron migration (GO:2001222),0.46484693412187206,1.3968980314206427,0.07766990291262135,0.30293034399464974,1.0,9/26,13.27%,CTNNA2;SEMA6A;NTNG2;NTNG1;PHACTR1;SRGAP2;NEXMIF;CAMK2A;ADGRG1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.36551114213335356,-1.396780711203964,0.030944625407166124,0.21544849154854964,1.0,45/96,33.53%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;UPF2;NUP205;TPR;ALYREF;WDR33;NUP188;YTHDC1;NCBP1;THOC2;NUP153;RNPS1;THOC6;NUP35;MAGOH;SLU7;NUP107;CPSF3;NUP62;SMG1;SRSF11;DDX39B;RANBP2;CPSF1;RBM15B;DHX38;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4E;SRSF5;U2AF1L4;EIF4A3;ALKBH5;SARNP
prerank,organelle organization (GO:0006996),-0.307775149736036,-1.3965665432281982,0.0014792899408284023,0.21548773082073597,1.0,122/388,24.65%,DIAPH1;APOE;NEDD9;ATP8B4;TMCC1;VPS13C;ARHGAP10;PLEKHM2;FGD6;RAB7A;YTHDF3;PEX14;GOLGA8B;GOLGA5;PI4K2A;FBXW8;PDCD6IP;SIPA1;OPTN;ATXN7;STX7;CAPZB;RAB31;ABCD2;SH3KBP1;FGD4;CDC42;COG7;RAB1A;PYROXD2;CHMP5;ATP7A;TMED10;ARFGEF1;RAB3GAP1;PI4K2B;PLD2;TRAPPC11;FGD3;NRF1;WASL;DYM;RAB32;GOLPH3L;KIF4A;EPS15;SIPA1L3;MDK;TJAP1;BCS1L;ATAD3A;LARP4;TMED3;SIRT3;DIAPH3;CHGA;PACSIN2;CHMP7;SSBP1;SYNE3;SPRYD3;TMEM11;CHMP1A;SAR1A;MICAL1;FMNL2;RAB29;WDR73;MICAL2;CXADR;COG2;SEC31A;AFG1L;MIA3;MAST2;CHMP2A;PLAAT3;TFAM;ZMYM6;LMAN2L;PEX7;NIPSNAP2;VAPB;ODF2;STX4;ABCD3;TMED2;RAB34;CEP55;ARL1;HUWE1;DOP1B;TTC17;PAK6;CFL1;TICAM2;VPS18;VPS51;CYP26C1;FAF2;BLZF1;TMED4;ZRANB1;HAX1;CHMP4B;CHMP4A;VPS4A;CNN2;TWNK;MAST3;MTX1;COG4;VMP1;POLG2;TMED5;CCL7;CYCS;PTCD2;ATP5F1B;MYC;CHMP2B;TRIP11
prerank,mitotic cell cycle phase transition (GO:0044772),-0.32900399973623756,-1.3965451581094805,0.00641025641025641,0.21527031484730824,1.0,74/203,24.84%,CDK6;RB1;DNM2;EPS8;OPTN;FBXL17;GSPT1;ANAPC1;CNTRL;GPR132;CCND3;DYNC1H1;FBXW11;CCNY;CRLF3;HAUS5;SDCCAG8;HAUS6;CEP57;PLK2;E2F1;CKAP5;E2F3;CDK14;MASTL;YWHAE;NES;DBF4;EIF4EBP1;CEP70;CDKN3;CHMP7;PPP2R2D;HAUS4;CDC25A;CDK1;CUL4B;DCTN1;HAUS7;CACUL1;PLK3;CUL2;PPP1R12A;CHMP2A;CCNE1;CDC34;LATS2;NINL;UBE2C;ODF2;FBXL8;SKP2;AURKA;WEE1;PHLDA1;ANAPC7;PCNT;CDKN2C;RCC1;FBXL6;PAFAH1B1;CEP192;CDC25C;MAX;CHMP4B;TUBA4A;CCNF;CEP41;CCNB1;PIM2;PPP1CB;MYC;CETN2;CCNB2
prerank,protein-containing complex subunit organization (GO:0043933),-0.36196318558601853,-1.3957330313569118,0.03764320785597381,0.2161716329773341,1.0,33/109,18.82%,MITF;SKAP2;CD74;WIPF1;PEX14;SNX9;CREBBP;LPXN;SLC2A1;PTK2B;TAPBP;WASL;CAPG;PICALM;DET1;TUBGCP4;DARS1;NCKAP1L;REPS2;TRAF1;NUP205;TPR;CAPZA1;KPNA3;TRAF2;NIFK;CD40;TFAP4;ST13;IL2RB;KMT2A;NUP35;MDM4
prerank,regulation of protein kinase A signaling (GO:0010738),0.49351651872705826,1.3957111661579644,0.095,0.30386811607669334,1.0,9/20,22.84%,AKAP6;RAMP3;ADGRV1;PJA2;PRKAR1A;IAPP;PRKAR2B;LRRK2;PRKAR1B
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4484796595294445,-1.3956645651723523,0.07475083056478406,0.21599900570645347,1.0,13/33,21.30%,RUNX1;CD74;FES;RIPK1;CCR1;PF4;ACIN1;ID2;IL34;HCLS1;CASP8;CSF1;HAX1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5417900911167548,-1.3949523272473572,0.0726643598615917,0.21674190952467265,1.0,6/16,18.14%,INSR;IGF1R;GSPT1;IRAK3;CLN3;TBC1D25
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.3734805643803087,-1.3947992362866586,0.02321724709784411,0.21671555416062602,1.0,32/83,23.28%,CDK6;RB1;BACH1;BRD4;GSPT1;GPR132;CRLF3;CDK18;PLK2;E2F1;E2F3;CDK14;DBF4;EIF4EBP1;CDKN3;CDC25A;CUL4B;PCNA;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;KLF11;CDKN2C;RCC1;CDK16;MAX;CDK5;CDC45;PIM2
prerank,chromatin remodeling at centromere (GO:0031055),-0.4561683114658443,-1.39454176078345,0.08981001727115717,0.21681533737424918,1.0,13/31,25.48%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPO;CENPP;HJURP
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5855985390142009,-1.3945212545600996,0.08940397350993377,0.2165848671600175,1.0,3/11,5.31%,ABCB7;ABCD2;COA8
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.44742845035800755,-1.393981031660212,0.06844741235392321,0.217070584500191,1.0,14/36,21.11%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;EPC1;RBBP4;PHC3;UXT;RBBP8;CHEK1;MAX
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5717608516151195,-1.3939020117943326,0.08061749571183534,0.21693133101259682,1.0,6/13,21.95%,MDFIC;SP100;TPR;NUP153;SUFU;UFM1
prerank,cellular iron ion homeostasis (GO:0006879),-0.3942110944389349,-1.3928977015016335,0.03484320557491289,0.21812947129513519,1.0,31/55,41.88%,FTL;IREB2;ABCB7;ATP6V1A;FRRS1;TMEM199;HMOX2;FLVCR1;ATP6V1G1;CP;SLC11A2;ATP6V0D1;CYB561A3;HMOX1;MYC;FTH1;SMAD4;LCN2;ATP13A2;ATP6AP1;SLC11A1;ABCB6;TFR2;HAMP;CCDC115;NEDD8;CUL1;GLRX3;ACO1;NUBP1;HFE
prerank,protein import (GO:0017038),-0.371459864726943,-1.3928178791084345,0.030206677265500796,0.21799650736667112,1.0,28/84,22.26%,APOE;RAB8B;SYK;PEX14;IPO5;NUP50;ABCD2;LAMP2;STAT3;PEX26;SNX33;NUP88;E2F3;FIS1;TPR;NUP188;HSPA4;APPL2;ABCD3;NUP153;TOMM22;FAM53A;APPL1;TNPO3;NUP107;NXT2;NUP62;SPRN
prerank,mRNA destabilization (GO:0061157),-0.4321126282968064,-1.3925730808977124,0.048027444253859346,0.2180969701274744,1.0,10/38,13.49%,ROCK1;YTHDF3;TUT7;CNOT1;RC3H1;MOV10;FTO;CELF1;METTL14;DHX36
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5850389025179916,-1.3923164675243378,0.08771929824561403,0.21820294738025414,1.0,4/12,10.97%,ERN1;BCL2L11;ATF6;XBP1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3911550457049136,-1.3921819651257337,0.04942339373970346,0.21811486761545965,1.0,22/67,16.72%,RAC1;P2RX4;CAPZB;TBC1D15;ATG5;TBC1D2B;IFT20;CDC42;TBC1D5;TBC1D1;SDCCAG8;TBC1D22A;TBC1D16;TBC1D22B;RAB5A;TBC1D8;TBC1D17;TBC1D10B;MYO10;DYNLT2B;TBC1D24;TBC1D9B
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5783738391704473,-1.391944691004517,0.09347442680776014,0.21816465276350147,1.0,3/13,1.59%,SYK;PRKCD;ITGB2
prerank,protein O-linked mannosylation (GO:0035269),0.5040675154326791,1.3913858218230513,0.10904872389791183,0.31003676278949444,1.0,8/18,16.62%,TMTC2;TMTC1;CRPPA;TMTC3;POMT2;FKTN;POMGNT2;DPM2
prerank,actin crosslink formation (GO:0051764),-0.5769663414248504,-1.3902112551246706,0.0821917808219178,0.2203097546941049,1.0,6/12,11.81%,EPS8;FLNA;GAS2L3;BAIAP2;LCP1;BAIAP2L2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5570809884911285,-1.3899190783714759,0.08718861209964412,0.2204942113285528,1.0,7/14,26.99%,ABCG1;DYRK1A;PSENEN;CLN3;ADAM19;PSEN2;BACE1
prerank,striated muscle contraction (GO:0006941),0.3884264919773267,1.3895281412796752,0.03917050691244239,0.3121744461329315,1.0,11/53,12.08%,DMD;DTNA;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;TTN;STAC
prerank,mRNA processing (GO:0006397),-0.3143075098190281,-1.389514151020714,0.00933125972006221,0.22083399589219796,1.0,105/287,27.41%,ERN1;CTNNBL1;TRA2B;SON;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;CHTOP;SRRT;SNRPG;FUS;GCFC2;HNRNPH1;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;CWC22;RBM19;SPEN;RALY;DDX5;POLR2L;SF3B3;PRPF8;CMTR2;SF3B5;UBL5;SART1;PCBP2;HNRNPUL1;ALYREF;NUDT21;SNRPA;CELF1;RPRD2;RBM14;CWC15;WDR33;RBM10;METTL14;YTHDC1;NCBP1;SART3;ZRSR2;PSPC1;POLR2A;GEMIN7;PDCD7;SF3A1;THOC2;SRSF10;PRPF18;POLR2G;RBM4B;TFIP11;LSM6;WBP11;TXNL4A;RNPS1;THOC6;SNRNP70;HNRNPA1;MAGOH;PAPOLA;SLU7;BUD13;SF3B1;CPSF3;LSM5;HNRNPH2;POLR2I;GEMIN6;PPIL1;XAB2;HNRNPK;SNU13;NONO;SYF2;GTF2F2;RBM22;MTREX;SRSF11;DHX35;DDX39B;PRPF6;GTF2F1;AKAP8L;CPSF1;RBM15B;DHX38;RAMAC;ISY1;HSPA8;TBRG4;WDR83;U2AF2;HNRNPF;SRSF7
prerank,histone mRNA catabolic process (GO:0071044),-0.5471016454658233,-1.388860714390823,0.10320284697508897,0.22152553521074586,1.0,7/15,21.23%,TUT7;DCP2;MTPAP;TENT4B;EXOSC10;ATM;EXOSC4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.47482812097527854,-1.3888415448751659,0.09407665505226481,0.22129022751056035,1.0,11/25,26.95%,TRA2B;SRRM1;MPHOSPH10;SF3B3;PRPF8;SRSF10;TXNL4A;SLU7;SF3B1;PRPF6;WDR83
prerank,Golgi to plasma membrane transport (GO:0006893),-0.4105943613761674,-1.388532464593709,0.06070826306913996,0.22142855149232435,1.0,20/47,21.04%,OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;EXOC4;OSBPL5;VPS35L;SYS1;ARFGEF2;RABEP1;RAB10;ARL3;VAMP4;EXOC2;RAB34;EXOC6;GOLGA7;BLZF1
prerank,negative regulation of receptor binding (GO:1900121),-0.6154987336122562,-1.3882185363697057,0.10416666666666667,0.22157366739935233,1.0,3/10,13.27%,B2M;ATP2A3;ADAM15
prerank,regulation of MAP kinase activity (GO:0043405),-0.3648484162514795,-1.3878217517927542,0.031198686371100164,0.22187898810909074,1.0,25/92,15.42%,LYN;APOE;CD300A;PRKCD;PTPRJ;PIK3R5;HTR2B;FLT1;PIK3CB;TSG101;PIK3CG;IRAK3;EZH2;VEGFA;STK38;TRIB1;ADAM8;TRIB2;SPRY2;AGT;PAQR3;KSR1;CD40;IL34;RGS14
prerank,regulation of blood coagulation (GO:0030193),-0.46828787889324275,-1.3877624833438398,0.0759493670886076,0.22169118762435358,1.0,13/27,36.75%,APOE;HPSE;TFPI;FAP;SERPINE1;APOH;ADTRP;ST3GAL4;F2R;F12;CAV1;HRG;FOXA2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5747430735295419,-1.3871433785155336,0.08041958041958042,0.22233443615079937,1.0,8/12,26.10%,NPL;GNPDA1;IL4I1;ACOT4;GNPDA2;AMDHD2;RENBP;PON3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.4051561627087104,-1.3864817323367153,0.06806282722513089,0.22274536491426875,1.0,23/50,26.00%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,regulation of gene silencing by RNA (GO:0060966),-0.4051561627087104,-1.3864817323367153,0.06806282722513089,0.22274536491426875,1.0,23/50,26.00%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5221431882776933,-1.38639601933597,0.09464285714285714,0.22261393427071272,1.0,8/16,20.51%,RB1;NIPBL;NAA50;MAU2;POGZ;SGO1;SMC1A;PDS5B
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.42831481700589163,-1.3860391101607918,0.048252911813643926,0.2229074955915635,1.0,15/40,9.61%,DAB2;CBL;INSR;ANXA2;ARRB2;TBC1D5;WASL;C3;ARRB1;DGKD;HIP1;VEGFA;B2M;CD63;RAB21
prerank,positive regulation of cellular respiration (GO:1901857),-0.591796607053238,-1.3857727898128154,0.08771929824561403,0.22299462427610914,1.0,5/11,28.42%,NUPR1;IL10RB;IFNAR1;VCP;PRELID1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.36640241358588466,-1.385769004570169,0.03577235772357724,0.22274933560833743,1.0,36/88,28.20%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;SPEF1;PSMA1;VANGL2;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;PKHD1;AP2S1;PFN1;SMURF1;FZD1;FZD7;DAAM1;PSMA7;CELSR1;AP2A1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5041485312850794,1.3856639375751256,0.08863636363636364,0.3178648663035505,1.0,2/17,1.18%,ANK2;RYR2
prerank,regulation of protein binding (GO:0043393),-0.3541306706072968,-1.3852722056712623,0.024115755627009645,0.2232414011039299,1.0,33/114,21.38%,DAB2;CTSZ;LRP1;PRKCD;ROCK1;PEX14;AMFR;ACTB;STK3;RPL11;PPP1CA;B2M;NVL;ITGB1BP1;NES;APP;PIN1;DERL1;CRK;IFIT1;TMBIM6;IFIT2;MARK2;HDAC5;TFIP11;RALB;AURKA;GSK3B;TMC8;DTX3L;DISC1;RACK1;KDM1A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5372291384823327,-1.3843365115350519,0.09800362976406533,0.22437981274886518,1.0,6/15,16.45%,SAMHD1;YTHDF3;USP18;NLRC5;OAS3;ISG15
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4351472269258001,-1.3837682429639433,0.06654676258992806,0.22495166731972255,1.0,13/36,22.17%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;BAG6;EIF3H
prerank,stem cell development (GO:0048864),0.5185835678767085,1.3837118955193857,0.09273182957393483,0.32020934253180783,1.0,4/16,4.92%,NRG1;SOX11;CDH2;PDCD6
prerank,intestinal lipid absorption (GO:0098856),-0.5827840692119368,-1.3836778235492473,0.08468468468468468,0.2248229755259268,1.0,3/11,19.31%,CD36;LIMA1;LDLR
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5999341228772707,-1.382550144645836,0.08756567425569177,0.22618665233593602,1.0,6/10,29.33%,CCR2;TNFRSF1B;HMGB1;AGER;RIPK3;ZBTB1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.48572775665835904,-1.3824864260040695,0.08844765342960288,0.22601350836714795,1.0,7/22,10.56%,IGF1;ROCK1;MEF2A;P2RX4;SLC9A1;MTPN;AGT
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.27664158119280363,-1.382469453069124,0.0,0.22577512109842685,1.0,424/1668,22.07%,PID1;RBPJ;DAB2;APOE;MITF;FNIP2;ZMIZ1;ZEB2;FOXP1;ELF4;FLI1;RUNX1;PRKCB;IGF1;TRPS1;BACH2;TFEB;NAMPT;SP100;TCF4;RCOR1;RREB1;ELF2;SDCBP;LILRB1;REL;LITAF;TRAK1;MIDEAS;TET3;BCL6;RB1;JUN;ZNF568;ETV6;ACTR2;CREBBP;DEK;MEF2A;RUNX3;OGT;PPARD;BPTF;AGO2;ANXA4;TOX2;BACH1;ARID5B;ZBTB34;NFE2L2;DNMT3A;BRD7;CCNL1;RNF111;IRF2;ZNF148;PHF20;ARHGEF2;SBNO2;BRD4;NFIC;NFX1;NFYA;ARID1B;ATF3;ZSCAN12;ATAD2;ELF1;CDK13;GATAD2A;PAXBP1;UBP1;RNASEL;SMARCA5;PPARG;RIPK1;KDM3A;MAML1;PIAS1;ELK3;SPI1;PHF21A;WWP2;ZNF3;BRCA1;JMJD1C;ETV1;STAT3;FOXO3;CNOT1;KLF13;E2F2;LYL1;ZSCAN26;CTR9;MAML2;TLR4;DHX9;IKZF1;IL18;STAT6;USF2;NIPBL;ACTR3;CHD3;CNOT2;NLRC5;NFKB1;HHEX;ZBTB21;RUNX2;SMARCD3;RARG;IRF5;NFATC2IP;SAP30;MLXIP;SARS1;CRLF3;MEF2B;KLF6;MAF;TCF20;SMARCC2;NR1H2;CIITA;JAG1;MAPK14;SS18;BATF;PF4;SMYD2;CUX1;NRF1;TEF;HGF;KDM7A;RHOQ;ETV3;WASL;MDFI;NFATC3;ARRB1;TAF6;LRP6;KDM3B;ZBTB2;MYNN;MED24;FUS;AHR;USP9X;KLF3;MCPH1;CTNNB1;RPS14;TBL1XR1;STAT5B;STAT4;EZH2;PLAC8;NR2F1;ATF6;DPF2;KDM2A;SKI;VEGFA;EED;BHLHE40;CREB3L2;E2F1;FIZ1;MAP2K5;RNF4;CNBP;ATMIN;ARID1A;SSU72;WFS1;HELZ2;CEBPG;SP110;CBFB;THAP1;E2F3;FNIP1;KMT2C;SPEN;WBP2;MEF2D;HIF1A;DDX5;TFEC;SLC9A1;SAP130;MEF2C;ATAD2B;MAPK7;UBC;RPS27A;OLIG2;ITGB1BP1;ASXL1;NUCKS1;EGR1;SUDS3;MRTFB;PARP9;ARNT;SP140;TNIP2;HDAC10;PROX2;APP;PIN1;PSMC3;MOV10;NEDD4L;IKZF3;BAZ2B;ZBTB20;XBP1;FLCN;TPR;XRCC6;CCNL2;TCF25;ZNF319;ZNF569;CDK1;OSR1;CRK;RELA;KLF10;KMT2D;MLLT10;MED4;GADD45A;NFE2;PRDM2;SALL3;ARID3B;HTATIP2;FOXJ1;ZFP57;RBM14;MLLT6;IL4I1;FOSL2;BAZ1A;HMGB2;KAT7;TCF7;ZBED4;SERPINE1;ZFP41;PLK3;UHRF1;FRK;CHD8;ZFX;TNRC6C;IRF2BP2;MTA3;MED31;FOXJ3;SP2;ACVR2A;CALCOCO1;CREG1;DHX36;E2F8;CRTC3;BATF3;GREM1;IER2;RXRA;TET2;DR1;PPP1R12A;LIN37;CD40;HDAC5;SIN3A;KLF2;ID2;TGIF1;EPC1;PPIL4;CKAP2;DOT1L;TCF3;NSD1;RELB;TFAP4;YY1;ZMIZ2;POU2AF1;POGZ;INO80;TXK;ZBTB46;AATF;IKBKB;MED13L;KLF8;ZNF177;MRGBP;HR;HCLS1;MAVS;NUFIP1;TFCP2;KMT5A;NR4A1;BRIP1;ZBTB12;NRIP1;ELP4;KLF11;FOXJ2;IRX5;IKZF4;SOX10;TNIP3;AGRN;TAF9;VHL;PHF20L1;UXT;ZBTB25;UBE2I;KMT2A;SMAD7;RARA;MED6;ZBTB24;TFE3;TAF3;ATF5;CSRNP1;REPIN1;GATA3;MYB;ARID5A;ATXN1;RIPPLY2;HTATSF1;NCOA6;PLAG1;SSBP4;PPARGC1B;MIER1;BRD2;NFATC1;TCF12;NR3C1;ID1;RSF1;GMEB2;MDM4;RBBP8;MEIS3;BMPR2;HOXD8;COPS5;NOD2;DDX3X;MED20;HMGB3;LMO2;WDR77;LCORL;SUFU;DBX2;CHP2;BRD9;C1QBP;SP9;ATM;HMGB1;EHF;SIRT2;RTF1;CASZ1;ZFP28;RLF;ELOC;GLMP;MAZ;ATF7;KDM5B;ZC3H12A;SMURF2;CIC;RAI1;GTF2IRD1;PKNOX1;JUP;STAT1;LRRFIP1;LIN9;ZFP2;ZSCAN21;MAX;POU3F1;ZKSCAN1;NLRP3;HAX1;HOXB2;CCNK;KDM1A;MAML3;ID3;CEBPB;TBX2;HEYL;SNAI2;HNRNPK;EGR2;MTF1;TADA1;ZNF296;BARX2
prerank,regulation of MAPK cascade (GO:0043408),-0.33730893640383397,-1.3822020907914017,0.01594896331738437,0.22594599034320476,1.0,25/157,9.07%,IQGAP1;LYN;PTPRC;TAOK3;IGF1;CD74;BCAR3;P2RX7;PLCG2;SYK;PAK2;ROCK1;PTPRJ;INSR;IGF1R;VRK2;MINK1;RNF41;FLT1;STK3;DUSP3;FN1;LAPTM5;GSDME;PTPN6
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.40604789404584607,-1.3820776832505455,0.04455445544554455,0.22587124204863562,1.0,28/48,35.95%,P2RX4;ANXA1;MAPK14;VEGFA;HIF1A;CIB1;CD40;TMSB4X;PIK3C2A;MAP2K3;HSPB1;HMGB1;KDR;TGFB1;MAP3K3;HMOX1;ATP5F1B;FGF18;ETS1;NUS1;FGF2;PLCG1;ATP5F1A;HDAC7;HDAC9;GATA2;SRPX2;PDGFB
prerank,RNA biosynthetic process (GO:0032774),-0.44834572261027106,-1.3818995088136887,0.08407871198568873,0.22587599427262015,1.0,10/31,20.14%,SMARCA5;TAF6;SMN1;POLR2A;PRIM1;TTF1;NCOA6;RSF1;TAF4;PRIM2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.34725880694141154,-1.38181904850975,0.009950248756218905,0.22574588573638404,1.0,50/125,24.53%,EML4;KIF3B;KIF11;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;CENPA;EFHC2;KIF4A;SUN2;PLK2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;BUB1;TAOK1;TBCE;BUB1B;MAP4;SPC25;NUSAP1;KIF2C;TTK;DYNC1LI2;SGO1;MAD1L1;STIL;NUF2;AURKA;RPS27;NDC80;CENPH;PCNT;RCC1;ERCC6L;PAFAH1B1;NUP107;PPP1CC;NSL1;CCNB1;CENPO;SPC24;CENPP;RANBP2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5226991138009276,1.3813673123218655,0.1187648456057007,0.3229778900547781,1.0,7/16,16.43%,UPP2;DPYD;DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.6102472882115213,-1.3812710704154225,0.10278745644599303,0.22629928045912384,1.0,1/10,1.14%,GNB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5521179434361543,1.381260572324751,0.11963882618510158,0.32196214993791844,1.0,5/12,15.44%,PDE4D;CALM1;CALM3;CALM2;GJD3
prerank,Ras protein signal transduction (GO:0007265),-0.3456429483273233,-1.3812485089500912,0.02009273570324575,0.22608021548594304,1.0,38/137,18.23%,IGF1;RREB1;GRB2;GNB1;RB1;MYO9B;RAC1;JUN;ROCK1;ARHGEF3;RAP1B;RHOA;USP50;RAP2B;EPS8;RAP2A;GRAP2;GNA12;RAP1A;RGL2;USP8;MAPK14;PLK2;CDC42EP2;GNA13;ARHGEF11;PLEKHG5;KSR1;SETDB1;CRKL;BRK1;BRAP;GRAP;CDC42EP3;RALB;G3BP1;KRAS;NRAS
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4664698890054886,-1.3811846564112475,0.08188153310104529,0.22591706429258349,1.0,17/25,33.11%,LYST;CHMP5;TMEM50A;CHMP7;CHMP1A;UBXN6;CHMP2A;LEPROTL1;LAPTM4B;RILP;CHMP4B;CHMP4A;CHMP2B;VCP;MVB12A;VPS4B;VTA1
prerank,mitotic cytokinetic process (GO:1902410),-0.5041148944655687,-1.3810401774468657,0.08566433566433566,0.2258594604387101,1.0,14/20,26.68%,RHOA;PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;CHMP4B;CHMP4A;VPS4A;KLHDC8B;CHMP2B;MITD1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4175869719044079,-1.3804821652305246,0.06690777576853527,0.22644894747715907,1.0,13/43,11.41%,GRB2;CBL;RAB7A;PTPRJ;SH3KBP1;CDC42;SNX6;DUSP3;TSG101;MVP;EPS15;SPRY2;STAM2
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5596081120083848,-1.3803151519447532,0.10416666666666667,0.22641987371358205,1.0,6/13,24.53%,KPNA4;IPO5;KPNA3;CBLB;NUP35;RANBP2
prerank,mitochondrial genome maintenance (GO:0000002),-0.587206028583234,-1.3802092868132922,0.0890909090909091,0.22629845225839182,1.0,4/11,15.29%,TOP3A;MEF2A;MPV17;SLC25A4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.419445776817545,1.3787096353507429,0.07334963325183375,0.32544491569486994,1.0,10/39,8.73%,FGF12;ANK2;CHRM3;SCN2B;TCAF1;AHCYL1;PTPN3;HOMER1;NEDD4;FXYD6
prerank,regulation of neurotransmitter transport (GO:0051588),0.5172338310150773,1.3784525698452403,0.1050228310502283,0.324716930056015,1.0,6/16,10.53%,RIMS1;CPLX1;SNCAIP;SYN1;FMR1;CAMK2A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.36967847507845736,1.3782505599330983,0.05489260143198091,0.32388670340363734,1.0,9/65,5.82%,KCND2;RORA;SLC8A3;SCN2A;TIGAR;SUV39H1;FMN2;TSC1;OPRD1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.48289064405375304,-1.3779379656356507,0.08869565217391304,0.22938057647538024,1.0,9/22,24.06%,BRD4;CDK13;ERCC6;EAPP;ALYREF;KAT7;HMGN1;CCNK;DDX39B
prerank,regulation of developmental growth (GO:0048638),-0.46213376763718833,-1.3777719697992714,0.1001727115716753,0.22938135011248942,1.0,9/29,15.96%,APOE;IGF1;DNM2;INSR;NIPBL;STAT5B;APP;SIN3A;LATS2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.442641013610853,-1.3777282708602687,0.07625649913344887,0.22894348768346848,1.0,17/32,29.79%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,tRNA export from nucleus (GO:0006409),-0.442641013610853,-1.3777282708602687,0.07625649913344887,0.22894348768346848,1.0,17/32,29.79%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.38400461136034797,-1.3765542836916886,0.042105263157894736,0.23039865083123237,1.0,32/72,31.58%,GRB2;CBL;KIF16B;HNRNPH1;GALNT3;CEP57;POLR2H;POLR2F;FRS2;POLR2L;SPRED1;SPRED2;SHCBP1;NCBP1;POLR2A;POLR2G;HNRNPA1;PTPN11;POLR2I;GTF2F2;MAPK1;FGF9;FGFR4;ESRP1;GTF2F1;HNRNPF;FGF20;FGF18;FIBP;FGF16;RAB14;FGF2
prerank,regulation of catabolic process (GO:0009894),-0.5011539030143257,-1.3763706777193363,0.09722222222222222,0.23039691722828845,1.0,12/18,35.19%,ITGB1;ZDHHC7;NEDD4L;ZDHHC2;FAP;FAF1;FAM83D;FURIN;CENATAC;RARRES2;TMEM9;HGS
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4896393413487141,-1.376220672163507,0.08718861209964412,0.23034591943326937,1.0,11/20,29.68%,PID1;DAB2;RHOQ;PICALM;PPFIA1;TMEM59;TGFB1;LZTFL1;PPP2R5A;BCL2L1;ABI3
prerank,embryonic limb morphogenesis (GO:0030326),-0.444108256445526,-1.3755374792590085,0.08080808080808081,0.23115626783104565,1.0,9/34,11.39%,MBNL1;CREBBP;MAP3K20;NIPBL;RARG;LRP6;CTNNB1;SKI;OSR1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.42401125106202553,-1.3750274256380814,0.059964726631393295,0.23161797561473468,1.0,12/39,11.41%,GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;DUSP3;TSG101;MVP;EPS15;SPRY2;STAM2
prerank,positive regulation of developmental growth (GO:0048639),0.3835210477768279,1.3749439779461528,0.055415617128463476,0.32832547238403864,1.0,9/49,10.17%,RIMS2;RIMS1;PLCB1;SYT1;CDKL5;SYT2;BDNF;POU4F2;GHRH
prerank,T-helper cell differentiation (GO:0042093),-0.5448862689148857,-1.374928012624765,0.10243055555555555,0.23148668141231307,1.0,4/14,5.90%,FOXP1;ATP7A;PTGER4;BATF
prerank,retinoic acid metabolic process (GO:0042573),-0.5414803306848062,-1.3748426548294328,0.09661016949152543,0.23135159052153562,1.0,8/14,31.38%,BCO2;CYP26C1;ALDH8A1;CYP2S1;SCPEP1;UGT1A7;UGT1A8;UGT1A1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3915686905787157,-1.3741306453367708,0.04647160068846816,0.23215451886399538,1.0,23/61,24.78%,PANK2;PSME4;PRKAG2;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3;NR1H4;OAZ3;NQO1;PSMB1;FGFR4
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5136466266871554,1.3738803637096921,0.11286681715575621,0.3289654570289297,1.0,3/15,5.03%,MAGI2;ACVR1;IGSF1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4969991116530881,1.3731143813380726,0.10739856801909307,0.3291029801928478,1.0,7/18,10.81%,ADCY8;EPHA5;OPRD1;PRKD1;CD200;ADCY1;RELN
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3810349233289863,-1.3726019625530845,0.04707792207792208,0.23431923483593523,1.0,23/74,22.48%,DAB2;SDCBP;ADIPOR1;GCNT2;CTNNB1;EZH2;SDHAF2;MDK;TGFBR1;TGFB1I1;SPRY2;SPRED1;SPRED2;GREM1;TGFBR2;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1;IL6;TGFB1
prerank,negative regulation of cell junction assembly (GO:1901889),0.4588332420286595,1.3725450106273014,0.0893719806763285,0.32891680680794927,1.0,6/25,5.43%,ROBO2;ARHGAP6;SLIT1;CLASP2;DLC1;APOD
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5223043054050398,-1.372030653486157,0.0907563025210084,0.23490526980479046,1.0,5/17,7.87%,PTPRJ;DGKZ;PTPN22;DUSP3;LAPTM5
prerank,pre-replicative complex assembly (GO:0036388),-0.3813638362518327,-1.37149523585374,0.05218855218855219,0.2354520309208208,1.0,21/64,20.62%,PSME4;PSMB7;PSME3;PSMB9;MCM6;PSMA8;UBC;RPS27A;MCM3;PSMC3;ORC5;PSMD8;PSMC4;PSMB10;PSMA1;MCM2;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5250412066827626,-1.3713343061131242,0.08391608391608392,0.23541900616736555,1.0,5/17,13.37%,SASH1;CD36;TRIB1;LY96;NFKBIL1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.33873570891586435,-1.3701750639836916,0.025796661608497723,0.23685595646554003,1.0,64/151,26.82%,IQGAP1;NRP1;CD44;ERN1;MAPKAPK2;RAP1A;FLT1;MT1G;PTPN12;RUNX2;ANXA1;MAPK14;DUSP3;HGF;CTNNB1;STAT5B;VEGFA;MAP2K5;TGFBR1;MEF2C;MAPK7;ITGB1BP1;SPRY2;RELA;EEF1A1;CPNE3;CCL5;CIB1;ACVR2A;KNSTRN;TGFBR2;CRKL;EHD1;APPL2;STMN2;ACAP2;NR4A1;MAP2K3;SMAD7;TWF2;LIMS1;PTPN11;NR3C1;PDCD5;HSPB1;BMPR2;NDNF;APPL1;SIRT2;SFRP1;RACK1;KDR;SNAI2;TGFB1;SHC1;LRP2;RAB35;INPP5K;PDE8A;ZFP36L1;URI1;BMP2;SMAD4;RAPGEF2
prerank,cell chemotaxis (GO:0060326),-0.3913434093557777,-1.3701612484249468,0.07167832167832168,0.23662001144518308,1.0,16/60,19.46%,NRP1;CCR2;PRKCD;ARRB2;CCR1;HGF;VEGFA;ABCC1;PLEKHG5;HMGB2;CCRL2;CXCR4;RAB13;NR4A1;PDGFRB;PIP5K1A
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5420563011154108,1.3700549924364744,0.11009174311926606,0.33197408508500914,1.0,9/13,25.85%,SAR1B;INSIG1;TMEM30A;GCC2;TM9SF4;CD81;SORL1;SEC16A;BRSK2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.37350355356906784,-1.3700126838979867,0.04983388704318937,0.23656150382212882,1.0,31/72,26.45%,ERCC6;RFC1;GPS1;POLR2H;POLR2F;POLR2L;UBC;RPS27A;LIG1;CUL4B;PCNA;COPS6;RPA3;POLD2;POLR2A;RFC2;ERCC4;LIG3;HMGN1;USP7;POLR2G;COPS5;RFC3;COPS8;POLR2I;COPS4;XAB2;POLD4;DDB1;XRCC1;ISY1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5978811959425955,-1.3699907789499768,0.09557522123893805,0.23634393672645174,1.0,3/10,4.35%,LRP1;PTPRJ;PTPN12
prerank,cellular response to interleukin-1 (GO:0071347),-0.3371926072590517,-1.3695131695890836,0.02145214521452145,0.23673729606089497,1.0,48/143,25.07%,MAP3K8;PSME4;IRAK2;TAB2;PSMB7;PELI1;PSME3;RC3H1;NFKB1;FBXW11;PSMB9;IRAK4;IRAK3;SIRPA;MYD88;NOD1;HIF1A;PSMA8;UBC;RPS27A;GBP2;EGR1;TNIP2;PSMC3;RELA;PSMD8;CCL5;PSMC4;PSMB10;PSMA1;CD40;IKBKB;PSMB8;IL1R2;GBP3;NOD2;PSMD4;PSMA5;PSMB3;PSMD3;ZC3H12A;SFRP1;MAP3K3;RPS6KA5;CCL7;CD47;PSMB1;UBE2N
prerank,response to histamine (GO:0034776),0.5680321129529022,1.3693209390625043,0.13658536585365855,0.3320923452479495,1.0,4/10,7.35%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.5244296800913967,-1.3692546014517353,0.11734693877551021,0.23687134402768317,1.0,4/16,5.71%,ABCB7;ABCD2;COA8;CIITA
prerank,JNK cascade (GO:0007254),-0.4253648144080055,-1.368619329576486,0.0782608695652174,0.23753757083464902,1.0,11/40,9.52%,MAP3K5;MAP4K3;IRAK2;MINK1;TAB2;PTGER4;GPS1;TRIB1;NOD1;UBC;RPS27A
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6006921932153839,-1.3685294963856787,0.09913043478260869,0.23741525245127515,1.0,4/10,21.14%,NAMPT;TLR4;NOD2;KDR
prerank,tRNA transport (GO:0051031),-0.43059506400347947,-1.3683464558465965,0.0726643598615917,0.23743005355364927,1.0,18/35,29.79%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;TOMM20L;RANBP2;NUP37;AAAS;NUP133
prerank,negative regulation of inflammatory response (GO:0050728),-0.32750861528990644,-1.3682553261946464,0.020537124802527645,0.2372839946104791,1.0,31/182,9.64%,LYN;APOE;AOAH;IGF1;FGR;CD163;MFHAS1;PLCG2;SYK;GNB1;PRKCD;MYH9;RB1;ADCY7;TNFRSF1B;PPARD;METRNL;PPARG;PTGER4;TNFAIP8L2;MAPK14;GNG2;GRN;PLK2;SIRPA;MDK;RHBDF2;CYSLTR1;MAPK7;SELENOS;OTULIN
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.50243702479526,-1.3680700636458332,0.10714285714285714,0.2373363919807646,1.0,6/19,10.48%,APOE;IGF1;ROCK1;GGA3;PICALM;PIN1
prerank,mammary gland development (GO:0030879),0.48469876501701686,1.367954539809583,0.11838790931989925,0.333482241775022,1.0,6/21,14.68%,NRG1;ERBB4;APLN;OXTR;ARHGAP35;JAK2
prerank,myoblast differentiation (GO:0045445),-0.5550204259466682,-1.3679281712371907,0.10207612456747404,0.23728837658529608,1.0,6/14,9.26%,MBNL1;PLEKHM3;IGF1;RB1;JAG1;DDX5
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5116889755189843,-1.3677343972648799,0.11806797853309481,0.237319281556744,1.0,4/17,3.81%,APOE;IGF1;ROCK1;GGA3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5016676944302183,-1.3675326174464388,0.0851063829787234,0.2373834799193432,1.0,9/20,22.42%,MALT1;IL18;RSAD2;B2M;TRAF2;IL18R1;DENND1B;NLRP3;IL6
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5139357298582701,-1.3672836291213577,0.1111111111111111,0.23753284934773952,1.0,9/18,29.05%,PTBP3;RPS13;TMBIM6;SHQ1;ZC3H12A;TGFB1;NUDT16;NCOR1;ESR1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5690114808277875,-1.366730143941832,0.11129848229342328,0.23812662610374427,1.0,4/12,6.90%,APOE;ROCK1;TMED10;PICALM
prerank,mRNA export from nucleus (GO:0006406),-0.3530427997253348,-1.3665919965239086,0.032362459546925564,0.2380474238883804,1.0,46/102,33.53%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;UPF2;NUP205;TPR;ALYREF;WDR33;NUP188;YTHDC1;NCBP1;THOC2;NUP153;RNPS1;THOC6;NUP35;MAGOH;SLU7;NUP107;CPSF3;NUP62;SMG1;SRSF11;DDX39B;RANBP2;CPSF1;RBM15B;DHX38;NUP37;ENY2;U2AF2;SRSF7;AAAS;NUP133;EIF4E;SRSF5;U2AF1L4;EIF4A3;ALKBH5;SARNP
prerank,regulation of macroautophagy (GO:0016241),-0.3520913810025453,-1.3661142031448887,0.03565640194489465,0.23852775564246714,1.0,38/105,25.79%,ATP6V0D2;ATP6V1E1;ERN1;GAPDH;GNAI3;PRKAG2;ATP6V1A;SNX6;SNX5;USP36;EXOC4;ATP6V1G1;VPS26B;RRAGD;SESN1;PIK3CA;VPS26A;WAC;ATP6V0B;SH3GLB1;RB1CC1;CAPNS1;CLN3;ATP6V0E1;BNIP3L;TBC1D25;RHEB;ATP6V0D1;KDR;PRKAG1;SNX32;CDK5;SMG1;DCN;LAMTOR1;LAMTOR3;ATP6V0A1;QSOX1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4511059086877138,1.365990869681465,0.10697674418604651,0.33592380403735045,1.0,5/25,3.24%,B3GALT1;FUT9;NDST4;B3GALT5;NDST3
prerank,plasma membrane tubulation (GO:0097320),-0.5608828681848566,-1.365871426011132,0.11604095563139932,0.23866064673997475,1.0,9/13,31.93%,SNX9;SNX33;PACSIN2;BIN3;CHMP4A;MICALL1;PACSIN3;WHAMM;CAVIN2
prerank,innate immune response in mucosa (GO:0002227),-0.6023725834797891,-1.365705352585289,0.11190053285968028,0.238644763009365,1.0,6/10,39.78%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3
prerank,embryonic organ morphogenesis (GO:0048562),0.3999609206421272,1.3652649799772025,0.06791569086651054,0.33618555141184203,1.0,12/42,17.34%,RYR2;HOXC4;SOX11;ACVR1;DSCAML1;HOXD3;NEUROD1;TBX1;HOXC9;HES1;FUZ;ALDH1A3
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.38811531487928635,-1.3651857311233284,0.06303236797274275,0.2391030352108857,1.0,28/64,22.26%,CORO1C;CDK6;ROCK1;CD36;RHOA;PEAK1;PLAU;MINK1;PTK2B;DAPK3;MACF1;JAG1;PIK3CB;DUSP3;UTRN;NF2;SLC9A1;CIB1;ADAM15;RASA1;PLEKHA2;BST1;CSF1;GSK3B;SFRP1;JUP;MAP4K4;CD3E
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4643987794199018,-1.3649023547944095,0.09636363636363636,0.23929573421124736,1.0,4/26,4.10%,LILRB3;CDK6;GPR137B;TLR4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.39085867300174365,-1.3641416691656945,0.07389162561576355,0.24023203352469064,1.0,19/55,20.62%,PSME4;PSMB7;PSME3;GPR132;PSMB9;PSMA8;PSMC3;PSMD8;AVEN;PSMC4;PSMB10;PSMA1;AURKA;PSMB8;ATF5;PSMD4;PSMA5;PSMB3;PSMD3
prerank,RNA export from nucleus (GO:0006405),-0.35235116639054376,-1.364072390202596,0.04451510333863275,0.24006800089118732,1.0,47/100,33.53%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;XPO5;UPF2;NUP205;TPR;ALYREF;WDR33;NUP188;YTHDC1;NCBP1;THOC2;NUP153;RNPS1;THOC6;HNRNPA1;NUP35;MAGOH;SLU7;NUP107;CPSF3;NUP62;SMG1;SRSF11;DDX39B;RANBP2;CPSF1;RBM15B;DHX38;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4E;SRSF5;U2AF1L4;EIF4A3;ALKBH5;SARNP
prerank,cellular response to superoxide (GO:0071451),-0.617005436772512,-1.3639853444560393,0.0984182776801406,0.23994388041756418,1.0,5/10,25.54%,ATP7A;PRDX1;PRDX2;ADPRS;MT3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5881852054600955,-1.3639046609019558,0.11744386873920552,0.23956616544803733,1.0,6/10,36.02%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5881852054600955,-1.3639046609019558,0.11744386873920552,0.23956616544803733,1.0,6/10,36.02%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,hyaluronan catabolic process (GO:0030214),-0.5068596438139641,-1.3638561801801556,0.08431703204047218,0.23938119942065933,1.0,5/18,9.34%,CD44;HEXA;LYVE1;GUSB;SLC9A1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5344785564008737,-1.3632515139674477,0.11367673179396093,0.23999759183160896,1.0,7/14,16.69%,CD74;LILRB1;PLCG2;LAPTM5;TICAM1;MAVS;GPRC5B
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5332674235749002,-1.3627713454488701,0.11724137931034483,0.24041329836872624,1.0,7/14,44.62%,ADAM8;IL6;PTGER3;TNF;IL1B;IL6ST;OSM
prerank,regulation of cell killing (GO:0031341),-0.518970933451636,-1.3625323304090247,0.09481216457960644,0.2404992446166197,1.0,2/16,1.51%,CYBA;RAC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4817687173383868,-1.3622856930654796,0.09106239460370995,0.240598096645511,1.0,6/22,13.44%,STX7;MALT1;CYRIB;B2M;FBXO38;TRAF2
prerank,protein deacetylation (GO:0006476),-0.4263554432789757,-1.3622407048034457,0.07082630691399663,0.2404182466963401,1.0,12/41,14.09%,RCOR1;MIDEAS;FLNA;MORF4L1;TBL1XR1;SIRT3;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,I-kappaB phosphorylation (GO:0007252),-0.5873535503148571,-1.3616421372418734,0.1054421768707483,0.24109948902430506,1.0,2/10,4.10%,TLR7;TLR4
prerank,diol biosynthetic process (GO:0034312),-0.5335089592479464,-1.361528197919019,0.12781954887218044,0.24102777896758337,1.0,8/15,24.70%,SPTLC2;ACER3;GCH1;SPHK2;QDPR;SPTLC3;ASAH1;ABCA2
prerank,heart development (GO:0007507),0.32329924722547315,1.3612735573401331,0.013550135501355014,0.34188772195241035,1.0,35/150,13.25%,SGCZ;FGF12;CACNA1C;SGCD;PCSK5;ERBB4;NTRK3;ZFPM2;SCUBE1;PRICKLE4;ACVR1;DLC1;WT1;PLCE1;APLN;CACYBP;FLRT3;NDUFV2;SOX9;BMP7;TGFB2;SGCG;DNAAF4;MYH7;POU4F2;MYOCD;POPDC2;SALL1;TBX1;EEF1AKMT4-ECE2;PKD1;ALPK2;EPHB4;PDLIM4;FLRT2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.32337736711159426,-1.3604234437275655,0.01088646967340591,0.24237292804772748,1.0,58/182,22.66%,APOBEC1;APOE;FOXP1;MSR1;RUNX1;IGF1;NOTCH2;SDCBP;RIN3;REL;XDH;RB1;AGO2;OPTN;ZNF148;SPI1;WWP2;CCR1;PARP14;NFKB1;PTPN22;TIPARP;MYADM;PICALM;VEGFA;CD28;HIF1A;MEF2C;PARP9;APP;MOV10;FLCN;MAP2K1;CD46;CELF1;HSP90AB1;TNRC6C;SETDB1;SLC7A5;ID2;YY1;CRKL;FLOT2;VHL;PARP10;AURKA;MMP8;LGALS9;LDLR;NDFIP2;ZC3H12A;SFRP1;RACK1;KDR;ANXA7;CD3E;TGFB1;APLNR
prerank,plasma membrane repair (GO:0001778),-0.5493998380189181,-1.3601075083702174,0.13333333333333333,0.24259165661289556,1.0,4/13,6.13%,MYOF;MYH9;ARL8B;AHNAK2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5690860581353048,-1.3597117985992557,0.09298245614035087,0.24293347624137257,1.0,3/11,7.62%,ATF3;MBTPS2;ATF6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.582596429768192,-1.359596188811652,0.11774744027303755,0.24283544784505823,1.0,3/11,0.83%,CD44;CORO1C;RREB1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.5258292020361691,-1.3591686324850647,0.09572649572649573,0.2431840760869225,1.0,10/15,36.41%,KYNU;KMO;KYAT1;IL4I1;QDPR;IDO2;HGD;FAH;HAAO;TAT
prerank,regulation of sensory perception of pain (GO:0051930),0.5499073069149067,1.3585189484748608,0.14672686230248308,0.34576679190795767,1.0,4/11,10.66%,CCN3;SPX;TMEM100;ZFHX2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.42452714914363465,1.358393763787482,0.08215962441314555,0.3447975094419563,1.0,8/32,10.53%,RIMS2;RIMS1;CPLX1;SNCAIP;SYN1;FMR1;SYT11;CAMK2A
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.49619975445342723,-1.3569679739813252,0.09183673469387756,0.24632711946656458,1.0,13/21,36.70%,ROCK1;CCR1;SRGN;PTK2B;GAS6;GREM1;ENPP1;TGFB1;HEY2;ASPN;ROCK2;HEY1;FGF23
prerank,modulation by symbiont of host process (GO:0044003),-0.5845843554713666,-1.3569275742221834,0.1285475792988314,0.24614164772166539,1.0,4/10,9.52%,MRC1;B2M;UBC;RPS27A
prerank,electron transport chain (GO:0022900),-0.5270968493196149,-1.356771684168326,0.11826086956521739,0.24610146325519702,1.0,2/15,1.78%,ENOX2;POR
prerank,cyclooxygenase pathway (GO:0019371),-0.5879111541793319,-1.3566208800120565,0.10412926391382406,0.2460484395474463,1.0,2/10,12.78%,TBXAS1;CBR1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.38352758754034266,-1.3566187612675717,0.06543624161073826,0.24579154751503907,1.0,26/65,25.91%,NRROS;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRY2;SPRED1;PIN1;SPRED2;HTRA3;TGFBR2;LDLRAD4;VASN;SMAD7;HSPA1A;IL17RD;SMURF2;EID2;TGFB1;ZBTB7A;SKIL;SMURF1
prerank,membrane protein proteolysis (GO:0033619),-0.422689029636913,-1.3565928708459518,0.08277027027027027,0.2455687251192278,1.0,18/37,33.82%,MYH9;MBTPS2;NFKB1;ADAM9;CTSH;PSENEN;RELA;HM13;ADAM19;TGFB1;PSEN2;PRTN3;BACE1;NGFR;TRAF6;DAG1;RHBDD1;ERAP1
prerank,regulation of cellular response to heat (GO:1900034),-0.3655002761843765,-1.3565806685271036,0.05752961082910321,0.24532446815746295,1.0,32/77,29.79%,CREBBP;NUP50;MAPKAPK2;NUP42;NUP88;RAE1;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;DNAJC2;HSPH1;BAG3;HSPA1A;NUP153;NUP35;GSK3B;DNAJB6;ATM;DNAJC7;NUP107;NUP62;CRYAB;MAPK1;RANBP2;NUP37;HSPA8;EP300;AAAS;NUP133
prerank,positive regulation of integrin activation (GO:0033625),-0.5841215588414643,-1.3561997423340324,0.12105263157894737,0.24566114063618477,1.0,3/11,2.84%,PLEK;RAP1B;PIEZO1
prerank,regulation of autophagosome maturation (GO:1901096),-0.5620762487489779,-1.3560700587335996,0.10877192982456141,0.24559214108364183,1.0,5/13,18.66%,UVRAG;UBQLN4;CLN3;TBC1D25;ADRB2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.436893972465187,-1.3550907461110082,0.10296684118673648,0.2468499386504838,1.0,8/30,19.05%,NIBAN2;DCP2;TEN1;ERCC4;TENT4B;HNRNPA1;EXOSC10;BMPR2
prerank,negative regulation of defense response (GO:0031348),-0.3710811157515563,-1.3547903166818445,0.0564373897707231,0.24704284462148893,1.0,18/77,10.86%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;PTGER4;TNFAIP8L2;IRAK3;PPM1B;SIRPA;MAPK7;SELENOS;OTULIN;PCBP2
prerank,regulation of vacuole organization (GO:0044088),-0.48245569159389323,-1.3547202566608472,0.11882998171846434,0.24688419125738295,1.0,5/20,8.55%,ANXA2;MTM1;IFT20;MTMR3;RAB5A
prerank,glucose import (GO:0046323),-0.5428356087344297,-1.3543072961042466,0.1111111111111111,0.24721876930027736,1.0,3/13,7.56%,SLC2A1;SLC27A1;ZDHHC7
prerank,insulin secretion (GO:0030073),0.4796875059077382,1.3539676055424488,0.11337868480725624,0.3517854858208588,1.0,4/19,10.51%,RIMS2;PTPRN2;MAFA;NEUROD1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5865626138255924,-1.35386654005144,0.11711711711711711,0.24758206719262274,1.0,9/10,38.83%,CDC42;KNSTRN;RACGAP1;SIRT2;CCNB1;ECT2;RCC2;APC;NEK2
prerank,cellular protein modification process (GO:0006464),-0.2785920134566551,-1.3538344097646613,0.0,0.24736713355887271,1.0,277/982,22.52%,F13A1;LYN;PTPRC;APOE;PRKCH;FNIP2;PPM1H;MAP3K5;B4GALT5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;ZC3HAV1;PAK2;PRKCD;CDK6;ROCK1;MAP4K3;ST3GAL1;DDB2;BIRC6;PTPRJ;PPP4R2;MAP3K1;RUNX3;ERN1;FBXW8;ST8SIA4;DAPP1;MAP3K20;MAN2A1;INSR;MTM1;PEAK1;CSNK2A1;PSME4;CDK13;PRKAG2;VRK2;RNASEL;MAML1;TLK1;ATG5;ABL2;MINK1;SGK1;WWP2;MAPKAPK2;GRK3;PSMB7;TEC;ALG5;DYRK2;PSME3;ATG7;PTPN12;PARP14;MTMR3;COG7;RAB1A;PIM1;PTK2B;PTPRE;FBXO32;ATG10;FBXW11;PTPN22;UBXN7;DAPK3;ANXA1;MSRA;TIPARP;PARP4;PSMB9;KLHL25;STK3;FUT10;FBXL20;TRIOBP;DCAF10;FN1;C3;MACROD1;KLHL22;GCNT2;CDK18;NUB1;IRAK3;LRRC41;CAMKK2;DCAF8;PPM1B;GAS6;PLK2;GRK5;GPS1;PPP1CA;SDHAF2;STK38;COQ8A;WFS1;WDR5;EIF2AK2;RAB5A;JAK1;TRIB1;CDK14;UBA7;TGFBR1;MPI;NEK6;PTPN6;HIF1A;MORC3;MTMR6;ATE1;SIRT3;PSMA8;UBE2L3;SPSB2;SUMF2;PARP8;SIK1;TRIB2;PTP4A2;TGM2;PARP9;DUSP11;RSKR;APP;UBL5;PSMC3;B3GNT2;LCK;TAOK1;DYRK1A;DUSP6;B4GALT7;SPSB3;RAB11B;CDK1;CP;CUL4B;HSP90B1;MAP2K1;SEPHS1;PSMD8;ASB5;SERP1;PPP4R1;COPS6;STK17B;FBXO10;STK11;FRK;LGALS1;PSMC4;SOCS6;STK24;PSMB10;ACVR2A;GMFG;MKNK1;PIK3CD;IGFBP3;FBXW2;PADI4;CUL2;METAP1D;PSMA1;MARK2;TGFBR2;PPP1R12A;TNKS2;MIA3;MAST2;SPP1;LARGE1;NPC1;TXK;MFGE8;CCNE1;CST3;PIGH;CDC34;SSH1;IKBKB;MKNK2;APLP2;LATS2;GMFB;RAB13;ISG15;RABGGTA;STRADA;ASB4;VHL;KLHL42;FBXL8;CDKL4;MAN2B1;WSB2;SKP2;UBE2I;PARP10;DNAJC3;AURKA;RARA;ZAP70;FBXO7;GNMT;HCK;PSMB8;RYK;PKN3;PTPRO;HCST;SOCS3;PTPN13;PMM2;BRD2;TAOK2;STK10;DUSP5;UBE2M;SHISA5;IP6K3;MAK;PPEF1;BMPR2;PAK6;RABGGTB;COPS5;CSF1;PSMD4;PSMA5;FBXO31;STT3B;GSK3B;ATM;CDK16;RAB11A;CHEK1;FBXO22;CDC42BPG;PSMB3;SIRT2;F5;WNK1;ELOC;BAP1;PSMD3;COPS8;FBXW4;CSNK1G3;COPS4;PRKAG1;GRK6;SRPK1;PTPN1;ILKAP;MANBA;FEM1B;CDK5;ILK;CCNF;MAP4K4;PTPN7;IL6;CD247;TGFB1;PPP1CC;FUT4;SOCS5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43805752656374297,1.353304892334373,0.10311750599520383,0.35173939121258146,1.0,8/28,17.31%,MAP2;MAP1B;MAPRE3;CLASP2;GAS2L2;ARL2;MAP1A;PRUNE1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.37152392268455625,-1.3531166805747596,0.05536912751677853,0.24821450972096795,1.0,28/76,24.58%,ANXA4;SPI1;IRAK2;ARRB2;NLRC5;PRMT2;AIM2;RBCK1;TRAF3;ARRB1;IRAK3;ERBIN;MAP2K5;OTULIN;FOXJ1;NLRC3;NFKBIL1;TMSB4X;NFKBIB;USP7;FAF1;PARP10;CMKLR1;ZC3H12A;NLRP3;SETD6;CYP1B1;PKHD1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3599476296739299,-1.3530317500631657,0.05245346869712352,0.24808478822523375,1.0,19/92,10.56%,SASH1;NRP1;FOXP1;RREB1;PLCG2;RAC1;RIN2;PTK2B;ADAM9;PIK3CB;DOCK5;PIK3CG;GRN;NRP2;VEGFA;HIF1A;CTSH;ITGB1BP1;AGT
prerank,tRNA modification (GO:0006400),-0.38298282861499133,-1.3529679773078633,0.06291390728476821,0.24794259894104995,1.0,19/62,20.76%,OSGEP;METTL1;ELP5;PUS7;ALKBH1;ANKRD16;PUS1;TRMT44;QTRT1;METTL6;MOCS3;TRMT6;ADAT2;TYW5;THUMPD1;AARS1;BCDIN3D;METTL2A;METTL2B
prerank,neuron projection development (GO:0031175),0.3091944294287475,1.3523805651811043,0.02168021680216802,0.3522359344949503,1.0,37/168,12.70%,CNTNAP2;NLGN1;GRM7;MAP2;CTNND2;CNTN4;DCLK1;NYAP2;MYO16;GPM6A;RASGRF1;SH3GL2;PAK3;PLP1;NEFH;TMEM108;EPB41L3;BICDL1;GDNF;EPHB1;SHANK3;GPM6B;BDNF;FLRT3;NCKAP1;ADGRV1;NEDD4;TOR1A;BMP7;SRGAP2;TSKU;WHRN;NBL1;CDK5R1;TNIK;FRY;ATXN10
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.43863902260625565,-1.3521373170619564,0.08108108108108109,0.24899159450845526,1.0,10/33,11.52%,BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;NCF1;CCDC88A
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3300943729043837,-1.3520496294714341,0.01729559748427673,0.24884367820116363,1.0,49/153,23.49%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;ERN1;CSNK2A1;VRK2;RIPK1;TLK1;SGK1;MAPKAPK2;DYRK2;MAPK14;ULK2;CAB39;GAS6;PLK2;VRK3;STK38;TGFBR1;NEK6;MORC3;MASTL;DYRK1A;CDK1;MKNK1;MARK2;TGFBR2;MAST2;MAP3K10;IKBKB;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;GSK3B;ATM;WNK1;CSNK1G3;CDK5;MAST3;SMG1;RPS6KA5;MAPK1
prerank,regulation of cell-cell adhesion (GO:0022407),0.41295359275978,1.3519322264351143,0.10796915167095116,0.35189759417994876,1.0,7/39,4.13%,PTPRG;TENM3;EFNA5;PTPRR;FUT9;EPHA7;AFDN
prerank,cellular response to oxidative stress (GO:0034599),-0.3379683798685066,-1.3519304162104866,0.0380794701986755,0.24875447307563656,1.0,37/118,24.23%,CYBB;DAPK1;CYBA;PRKCD;JUN;NFE2L2;VRK2;FOXO3;SLC25A24;NUDT2;MSRA;GSR;CAMKK2;HIF1A;SELENOS;PRDX5;ARNT;NCF1;PRDX1;NCF4;NCF2;MPV17;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;RPS3;CAT;SIRT2;RBM11;ZC3H12A;SRXN1;ERO1A;HMOX1;MAPK1;CYCS
prerank,cellular response to peptide (GO:1901653),-0.3889417006443196,-1.3518139684024684,0.066006600660066,0.2486819408726609,1.0,18/56,12.50%,ITGA4;IGF1;VIM;LRP1;CD36;ARHGEF2;IGF1R;TLR4;SNX6;CHMP5;PTPN22;CASP4;NOD1;ABCC1;APP;XBP1;TIMELESS;FCGR2B
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4410745149777665,1.351614023944077,0.09154929577464789,0.3513198612463058,1.0,6/27,5.31%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1;SHANK3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5543852810856473,-1.350913918607896,0.1128747795414462,0.24985636274297693,1.0,5/12,14.41%,CBL;PTPRJ;IFT20;F7;CBLB
prerank,negative regulation of translational initiation (GO:0045947),-0.5447393487062194,-1.3507061038075705,0.10869565217391304,0.24995372568845203,1.0,6/13,11.94%,AGO2;EIF2AK1;EIF4EBP1;EIF4EBP2;TPR;EIF3E
prerank,prostanoid biosynthetic process (GO:0046457),-0.5252907411089444,-1.3502972906171788,0.10124333925399645,0.25036068449891763,1.0,4/15,15.04%,TBXAS1;CD74;DAGLB;PLA2G4A
prerank,negative regulation of gene expression (GO:0010629),-0.3036295363536002,-1.350016486731412,0.010687022900763359,0.2505356465999187,1.0,87/302,22.66%,APOE;PTBP3;ATP2B1;FOXP1;MSR1;RUNX1;IGF1;NOTCH2;DAPK1;REL;XDH;RB1;ERN1;GAPDH;AGO2;DNMT3A;ZNF148;SPI1;WWP2;CNOT1;CCR1;PARP14;SRGN;NFKB1;PTGER4;PTPN22;DAPK3;TIPARP;PUS7;MYADM;PICALM;JARID2;EZH2;VEGFA;EED;DCP2;RPS13;EIF2AK2;PCIF1;CD28;HIF1A;MEF2C;PARP9;APP;MOV10;FLCN;MAP2K1;CD46;CELF1;FCGR2B;TMBIM6;TNRC6C;DHX36;SETDB1;SLC7A5;ID2;EPC1;YY1;CRKL;NCL;FLOT2;SHQ1;RBBP4;VHL;PARP10;LSM6;AURKA;TOB1;HSPA1A;RPS3;MMP8;LGALS9;DDX3X;NDFIP2;CNOT8;DDX6;LSM5;ZC3H12A;SFRP1;RACK1;KDR;LSM14A;ANXA7;SHMT1;CD3E;TGFB1;APLNR
prerank,regulation of autophagosome assembly (GO:2000785),-0.4253244484527956,-1.3498788537694124,0.0873440285204991,0.2505108728188531,1.0,13/33,25.40%,NUPR1;MTM1;PIP4K2A;IFT20;MTMR3;RAB3GAP1;RAB5A;SH3GLB1;RALB;CHMP4B;CHMP4A;RAB1B;LRSAM1
prerank,monocyte differentiation (GO:0030224),-0.5722072820639094,-1.349851189692783,0.11284722222222222,0.25030462531241465,1.0,5/10,15.58%,MYH9;PPARG;MT1G;VEGFA;IL31RA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.46770774425218237,1.349739035982995,0.11190476190476191,0.35350348982193663,1.0,10/22,20.42%,PDE4B;DMD;CACNB2;GNB5;FMR1;STAC;CBARP;CRHR1;GPR35;CACNB3
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.4975244961434788,-1.3495710286885851,0.1022530329289428,0.25047910754942754,1.0,6/22,12.45%,RUNX1;BCL6;MDK;CBFB;CD46;IL4I1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5465408887299699,1.3492452065105258,0.15186915887850466,0.3532214537750386,1.0,2/11,6.79%,AKAP6;KCNIP2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5685350278881716,-1.3487648030073756,0.10956521739130434,0.25150364696023075,1.0,3/12,10.65%,CD44;GCNT2;LCK
prerank,positive regulation of cellular component organization (GO:0051130),-0.34431240563545196,-1.3481382892352631,0.0361247947454844,0.25222950650650083,1.0,14/107,2.68%,DAB2;APOE;FNIP2;RUNX1;PLEKHM2;ASAP1;SYK;LRP1;RB1;BCL2L11;SPIDR;INSR;ABCB7;IGF1R
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.3016905036707582,-1.347964879813431,0.01020408163265306,0.2522257286406795,1.0,116/314,27.58%,WWP1;RB1;BFAR;NFE2L2;PSME4;WWP2;ARRB2;FBXL17;AMFR;PSMB7;AREL1;ANAPC1;TNFAIP1;PELI1;PSME3;RHBDD2;FBXW11;PSMB9;FBXL20;RBCK1;KLHL22;ARRB1;UBR2;CTNNB1;TBL1XR1;ZFAND2A;ZSWIM8;KCTD10;ATXN3;RNF4;WFS1;ERLIN1;FBXO38;DNAJB9;PSMA8;SPSB2;SELENOS;UBC;RPS27A;UBE4B;PSMC3;DNAJB14;KIF14;NEDD4L;PCBP2;DERL1;SEL1L;SPSB3;CDK1;CUL4B;HSP90B1;MAEA;PSMD8;BUB1B;PSMC4;PSMB10;CUL2;RNF185;PSMA1;RNF34;UBE2G1;CDC34;RNF216;UBE2C;FAF1;KLHL42;FBXL8;SKP2;AURKA;ANAPC7;PSMB8;RNF121;HUWE1;FBXL6;PSMD4;PSMA5;FBXO31;STT3B;DCAF12;PSMB3;SIRT2;FOXRED2;PSMD3;SMURF2;SGTA;UBXN1;FBXW4;FAF2;BAG6;TRIM25;FEM1B;TOPORS;CCNF;HECTD3;CCNB1;TRIM72;EDEM1;KCTD2;ZNRF1;RNF187;DDB1;PSMB1;SPOP;MAN1B1;SIAH2;SMURF1;FBXL19;VCP;PML;CUL3;DCAF11;UBE4A;COP1;CLOCK;TBX21;PSMA7
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.335461095704133,-1.3474185154077774,0.025210084033613446,0.2528139228164935,1.0,50/145,24.57%,RAD51B;BRD4;PSME4;PSMB7;CNTRL;PSME3;GPR132;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;CKAP5;PSMA8;YWHAE;TPX2;PSMC3;CEP70;KIF14;HAUS4;CDC25A;CDK1;DCTN1;PSMD8;HAUS7;AVEN;PSMC4;PSMB10;PSMA1;NINL;ODF2;AURKA;PSMB8;PCNT;PSMD4;PSMA5;RAB11A;PAFAH1B1;PSMB3;PSMD3;CEP192;CDC25C;TUBA4A;CEP41;CCNB1;RAD51C;PSMB1;CETN2
prerank,RNA modification (GO:0009451),-0.38860340682044914,-1.3472832978298686,0.0630048465266559,0.2527619479020097,1.0,25/54,35.28%,NSUN3;METTL1;ELP5;PUS7;ALKBH1;NSUN4;ANKRD16;QTRT1;TRMT6;ADAT2;TYW5;THUMPD1;AARS1;BCDIN3D;RBM15B;MRM2;THG1L;CTU2;METTL3;FTSJ1;CTU1;TRMT61A;ADARB1;PUS7L;CDKAL1
prerank,nucleotide-excision repair (GO:0006289),-0.34715811332908436,-1.346957956718559,0.04201680672268908,0.2530329941238224,1.0,39/101,25.36%,DDB2;RNF111;ERCC6;RFC1;GPS1;POLR2H;ATXN3;POLR2F;POLR2L;UBC;RPS27A;LIG1;CUL4B;PCNA;COPS6;RPA3;POLD2;POLR2A;RFC2;ERCC4;LIG3;SLX4;HMGN1;BRIP1;USP7;POLR2G;COPS5;MMS19;RFC3;COPS8;POLR2I;COPS4;FAN1;XAB2;POLB;POLD4;DDB1;CETN2;XRCC1
prerank,lipid catabolic process (GO:0016042),-0.4887642688407823,-1.3465943943914882,0.11454545454545455,0.2533384989047113,1.0,8/18,29.44%,LPL;PLAAT3;SIRT2;PPT1;MT3;LIPE;LIPH;HSD17B14
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.46668634466352027,-1.346241702163147,0.10553633217993079,0.25359342062357293,1.0,10/24,21.11%,NR1H2;TXNDC12;WFS1;SELENOS;XBP1;TMBIM6;HSPA1A;LPCAT3;UBXN1;RACK1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4555862940132507,-1.3458449646368593,0.09911504424778761,0.2539364191940186,1.0,5/27,4.73%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.5827688569202079,-1.3456772481316026,0.10843373493975904,0.25393467833971023,1.0,5/11,20.40%,PRDX5;PRDX1;PRDX2;CAT;PXDNL
prerank,nucleoside catabolic process (GO:0009164),0.5510733175710899,1.3456588228655033,0.1391509433962264,0.35873807287352133,1.0,3/11,3.76%,UPP2;DPYD;DPYS
prerank,insulin receptor signaling pathway (GO:0008286),-0.3712467417823495,-1.3454796508208962,0.04409171075837742,0.2539889784282769,1.0,22/69,20.32%,ATP6V0D2;NAMPT;BCAR3;GRB2;ATP6V1E1;INSR;IGF1R;ATP6V1A;TCIRG1;AP3S1;RHOQ;BAIAP2;ATP6V1G1;PIK3CA;ZNF106;ATP6V0B;PIK3C2A;ATP6V0E1;IRS2;GSK3B;APPL1;ATP6V0D1
prerank,melanocyte differentiation (GO:0030318),-0.5689261106627408,-1.345471402756997,0.13175675675675674,0.2537446046650873,1.0,5/11,18.94%,MITF;LRMDA;MEF2C;SLC24A5;ENPP1
prerank,regulation of JNK cascade (GO:0046328),-0.35136270648253043,-1.3452771115369218,0.038397328881469114,0.25378034564612556,1.0,30/101,19.88%,MAP3K5;TAOK3;SDCBP;MFHAS1;IGF1R;RAP2A;RIPK1;TRAF5;MINK1;PTK2B;AXIN1;TRAF3;DUSP3;SIRPA;CD27;APP;TRAF1;NCF1;TAOK1;GADD45A;AIDA;FCGR2B;TRAF2;MAP3K10;TAOK2;MMP8;COPS5;NOD2;HMGB1;AGER
prerank,sphingosine metabolic process (GO:0006670),-0.49673910805665233,-1.3452510242209317,0.12280701754385964,0.2535689547583711,1.0,12/17,41.75%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;PLPP3;ABCA2;ACER2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4956016174591658,-1.345125501164213,0.10104529616724739,0.2535105413901434,1.0,9/19,23.49%,MPP1;CAMK1D;MDK;CCL5;IL34;BST1;CMKLR1;CSF1;MAPK1
prerank,regulation of exosomal secretion (GO:1903541),-0.49002895401278407,-1.3447089924922637,0.12454873646209386,0.2538747466170286,1.0,6/19,14.36%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3124691089244154,1.3445472826762248,0.02077922077922078,0.3596235303365444,1.0,40/152,17.20%,ADGRB3;ADGRL3;CHRM2;ADCY2;GRM8;ADCY8;GNAO1;LGR5;GPR37;P2RY12;ADCY5;RAMP3;GNAI1;ADRA1B;ADCY3;GABBR1;PTH1R;ADGRL2;ADCY1;CORT;GPR3;GHRH;CALCB;LPAR2;NPY1R;LGR4;GNAZ;HTR1B;ADRA1D;ADGRG1;PRKACB;GPR26;OPRK1;GNAL;ADGRB2;OPRL1;IAPP;RAMP2;ADGRL4;CRHR1
prerank,cellular response to oxygen levels (GO:0071453),-0.5697120778507477,-1.3445106470691452,0.13824057450628366,0.25391763939897644,1.0,9/10,41.39%,ATP6V1A;TMEM199;ATP6V1G1;ATP6V0D1;CPEB4;ATP6AP1;PICK1;CCDC115;NDUFS2
prerank,mesenchymal to epithelial transition (GO:0060231),0.5598869343673963,1.3441410226415555,0.15207373271889402,0.3591925809815121,1.0,4/10,10.57%,PAX8;WT1;CITED1;SALL1
prerank,positive regulation of dendritic spine development (GO:0060999),0.4749484008768811,1.3438430837594812,0.11778290993071594,0.3585456907580682,1.0,7/20,11.02%,NLGN1;SHANK3;CUX2;FMR1;CAPRIN2;RELN;CPEB3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5730178644942087,-1.343655427250438,0.12478336221837089,0.254995409219799,1.0,3/11,5.13%,CD44;CD74;BCL2
prerank,regulation of interleukin-13 production (GO:0032656),-0.5385516978016828,-1.3436127983009303,0.09013605442176871,0.2548085650631014,1.0,7/13,19.20%,IL18;TNFRSF21;SPHK2;RARA;LILRA5;GATA3;LGALS9
prerank,outflow tract septum morphogenesis (GO:0003148),0.4545826582915377,1.3420311259551891,0.09852216748768473,0.36061457108430484,1.0,6/24,10.68%,ROBO1;ROBO2;ZFPM2;ACVR1;TGFB2;TBX1
prerank,telomere capping (GO:0016233),-0.5053264136024169,-1.3420007695678033,0.12087912087912088,0.25707288876776246,1.0,8/16,26.81%,DCLRE1C;DCLRE1A;TEN1;TFIP11;NBN;PRKDC;DCLRE1B;MRE11
prerank,cellular glucose homeostasis (GO:0001678),-0.41280669212407156,-1.3419732044250638,0.08528428093645485,0.2568584486419612,1.0,10/41,10.97%,LRRC8D;ERN1;IGF1R;TRA2B;GAS6;HIF1A;NUCKS1;HK3;ZBTB20;XBP1
prerank,regulation of double-strand break repair (GO:2000779),-0.4151850167989462,-1.3418537024714667,0.07692307692307693,0.25678360458344013,1.0,16/39,21.38%,PPP4C;ACTR2;PPP4R2;DEK;SPIDR;RNF169;RTEL1;RAD51;MGMT;TIMELESS;RAD51AP1;WRAP53;SHLD2;CHEK1;TRIP12;KDM1A
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4486894807453863,-1.341252474734839,0.0843585237258348,0.2574471098110606,1.0,6/26,9.34%,PLEK;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,homologous chromosome segregation (GO:0045143),0.4727673417035343,1.341169319060473,0.13333333333333333,0.361042875784582,1.0,6/20,14.28%,ZCWPW1;FMN2;PTTG1;IHO1;MEIKIN;MEIOB
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.39299273628137965,-1.3409617630623047,0.06972789115646258,0.25765452103677927,1.0,21/47,26.87%,RREB1;PPARD;METRNL;PPARG;PIM1;MEDAG;LPL;XBP1;WDFY2;ID2;TFE3;CMKLR1;GDF3;ZC3H12A;SFRP1;CEBPB;ADIG;ZBTB16;ZFP36L1;BMP2;ZBTB7B
prerank,regulation of protein kinase B signaling (GO:0051896),-0.3169837117674344,-1.3405952036331086,0.02046783625730994,0.25792536786733233,1.0,40/193,12.66%,OSBPL8;BANK1;GRB2;GAB2;MFHAS1;XDH;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;P2RX4;IGF1R;PIK3AP1;VAV1;ARRB2;RNF41;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;RCN3;TGFBR1;CD28;ADAM8;ITGB1BP1;SPRY2;LCK;STRN;FLCN;PIK3CA;F7;HSP90AB1;CIB1
prerank,dendritic cell migration (GO:0036336),-0.5192306679849661,-1.3400283925495327,0.10608695652173913,0.2586372695983376,1.0,7/16,19.87%,CCR2;EPS8;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5763156887990057,1.3399681452599779,0.15764705882352942,0.3620959607792614,1.0,5/10,21.13%,ADGRV1;TSKU;WHRN;PDZD7;PLS1
prerank,AMP metabolic process (GO:0046033),-0.5346771136735045,-1.3398595299526979,0.12152777777777778,0.25866151187221986,1.0,3/13,9.66%,XDH;NUDT2;ADSS1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47726202382577043,1.3395000368068215,0.1258741258741259,0.3618598659649509,1.0,5/20,8.19%,HECW1;PRKCE;HECW2;CASQ2;NEDD4
prerank,protein localization to vacuole (GO:0072665),-0.5480640451864183,-1.3393480228517818,0.13660245183887915,0.25920354741183294,1.0,8/13,34.00%,MFSD1;RNF128;SH3GLB1;GLMP;LMBRD1;KPTN;ATP13A2;SH3BP4
prerank,regulation of smooth muscle contraction (GO:0006940),0.4758355070232896,1.3387484366136537,0.13317757009345793,0.36202914682664106,1.0,7/20,14.79%,KCNB2;CHRM2;CHRM3;PLCE1;MYOCD;ZDHHC21;SETD3
prerank,mesenchymal cell differentiation (GO:0048762),-0.3950144388551064,-1.3384405662108878,0.07023411371237458,0.26042082141244677,1.0,23/51,29.06%,RBPJ;ROCK1;HTR2B;FBXL17;HGF;LRP6;CTNNB1;TGFBR1;HIF1A;DDX5;MEF2C;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4224335161422598,-1.3384204172072383,0.1153184165232358,0.2601915335897144,1.0,7/37,4.86%,APOE;SDCBP;RIN3;OPTN;BRCA1;NFKB1;ITGAV
prerank,response to prostaglandin E (GO:0034695),-0.5778775860153229,-1.3383282152070715,0.11891891891891893,0.2600908603555731,1.0,3/10,6.86%,GNB1;PTGER4;GNG2
prerank,regulation of synapse organization (GO:0050807),0.4349110520641825,1.3375076024203083,0.10352422907488987,0.363159359188211,1.0,3/26,2.20%,CTNNA2;IL1RAPL1;CDKL5
prerank,regulation of secretion by cell (GO:1903530),0.3753820783866987,1.3368599104715004,0.07635467980295567,0.3632219029984702,1.0,9/54,3.78%,RIMS2;RIMS1;STXBP5L;SYT1;RAB3C;CPLX1;SNCAIP;SYN1;RAB15
prerank,protein targeting to lysosome (GO:0006622),-0.47462163612673286,-1.3367655625279398,0.12007168458781362,0.2622291287630804,1.0,7/20,15.71%,RAB7A;LAMP2;GGA3;LAPTM5;AP3M1;GNPTAB;SNX16
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.35343356238206414,-1.3366522226499393,0.05460750853242321,0.2621327282166735,1.0,30/88,23.38%,FNIP2;SDCBP;SYK;PLEK;RAB7A;BCL2L11;PDCD6IP;SPIDR;TSG101;VEGFA;FNIP1;CDC42EP2;SDC4;CHGA;TPR;SH3GLB1;CHMP2A;BRK1;SLX4;BID;FAF1;RPS3;HAS3;SYNPO;GSK3B;MMP1;RACK1;VPS4A;TGFB1;BIK
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.42421412036822886,-1.3360808114683325,0.0880281690140845,0.2627119235449111,1.0,16/39,24.97%,RPS24;RIOK3;RPS6;ERAL1;RPS14;NOP14;RPS28;MRPS11;EMG1;LSM6;RPS27;SURF6;RPS16;SNU13;RPS15;MRPS7
prerank,positive regulation of neuron differentiation (GO:0045666),0.39873948065225967,1.3357889523507491,0.10194174757281553,0.36398055957408765,1.0,12/40,14.76%,BRINP3;BRINP1;SOX11;NRCAM;ZEB1;VWC2;HOXD3;ADRA2C;NEUROD1;NBL1;REST;BEND6
prerank,positive regulation of cell migration (GO:0030335),-0.3082215823855831,-1.3353468879006727,0.01059001512859304,0.26356837953446904,1.0,75/253,21.79%,DAB2;PTPRC;NEDD9;NRP1;IGF1;FGR;RREB1;CCR2;SDCBP;PLCG2;MGAT5;AGO2;INSR;ARHGEF2;IGF1R;PLAU;S100A11;STAT3;CCR1;FLT1;NIPBL;ITGB1;PTK2B;RUFY3;KIF20B;ADAM9;ELP5;SEMA4A;DOCK5;HGF;FN1;GCNT2;MYADM;GRN;SUN2;VEGFA;MDK;CBLL1;TGFBR1;HIF1A;CTSH;NCKAP1L;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CPNE3;CCL5;CIB1;SEMA4B;PIK3CD;MIA3;CRKL;SEMA3D;STX4;SPAG9;CLDN1;TRADD;PDGFRB;BMPR2;CSF1;F10;C1QBP;ATM;RAB11A;MAZ;SMURF2;PDGFA;RACK1;KDR;SEMA3B;SNAI2;FERMT3
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5261468184421373,-1.3345783860113698,0.13443830570902393,0.2645190935382693,1.0,11/15,40.58%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1;SAMD8;ORMDL2;ORMDL3;TNF;SPHK1;ORMDL1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3719094332223282,-1.334501389626797,0.06020066889632107,0.2643552942478666,1.0,26/72,24.43%,DDB2;DCP1A;RFC1;RNASE4;REXO4;UBC;RPS27A;DNASE1L1;CUL4B;PCNA;FEN1;RNASE6;RPA3;POLD2;RFC2;ERCC4;DDX1;DNA2;ENPP1;HORMAD1;RFC3;ZC3H12A;FAN1;XRN2;POLD4;DDB1
prerank,mitochondrial protein processing (GO:0034982),0.560262502508813,1.3339023056456984,0.16113744075829384,0.36642945068982813,1.0,4/11,11.47%,OMA1;ATP23;IMMP1L;PMPCB
prerank,regulation of cell division (GO:0051302),-0.36455403085219895,-1.3337822378116053,0.07377049180327869,0.2652645708251161,1.0,26/72,24.58%,ZFYVE26;BIRC6;HTR2B;UVRAG;BLM;PLK2;PIN1;FLCN;CIB1;PLK3;SH3GLB1;KIF20A;AURKA;KIF18B;CDK2AP2;CSPP1;RAB11A;TXNIP;SIRT2;PRC1;RACK1;SFN;BECN1;MYC;CETN2;SMYD5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4155775722316727,-1.3334500435166483,0.09059233449477352,0.265552047326773,1.0,14/37,27.42%,NUPR1;BCL2L11;BCL2;GSDME;FIS1;STYXL1;LCK;BBC3;BID;RPS3;RACK1;BECN1;NCK1;BCL2L1
prerank,activation of protein kinase A activity (GO:0034199),0.485917312089418,1.3332563421287147,0.13947990543735225,0.3664218983436605,1.0,7/16,14.74%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5816520149089517,-1.3329858801900172,0.14669051878354203,0.2659913890817061,1.0,6/11,27.52%,RC3H1;ANXA1;SMAD7;ZC3H12A;SOCS5;TBX21
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4072177320702288,-1.332981417632022,0.10391822827938671,0.26573976950628886,1.0,17/42,26.23%,RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;WRN;RPA3;POLD2;RFC2;ISG15;PARP10;POLN;RFC3;TRIM25;POLD4;VCP
prerank,RNA processing (GO:0006396),-0.32211934215475435,-1.3327472398554272,0.020602218700475437,0.26583637274363187,1.0,58/176,25.32%,APOBEC1;MBNL1;RBM39;RBMS1;SON;SRRM1;RNASEL;TUT7;RBPMS;MPHOSPH10;SMU1;SNRNP35;SNRPG;FUS;HNRNPH1;SNRPF;HNRNPL;SF3B3;TSEN54;PRPF8;FASTKD2;DUSP11;HNRNPUL1;MTPAP;NUDT21;CELF1;RBMS2;NCBP1;ZRSR2;PDCD7;PPIG;SF3A1;PPP1R9B;PRPF18;NUFIP1;TFIP11;LSM6;TENT4B;ATXN1;RNPS1;SCNM1;MAGOH;SLU7;SF3B1;LSM5;NOL9;DDX54;RBM3;SRPK1;HNRNPK;XRN2;NONO;SRSF11;DDX39B;TARDBP;PRPF6;AKAP8L;DEDD2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5239390625858666,-1.3315732758028191,0.13275862068965516,0.26740315471644394,1.0,4/15,7.45%,DAB2;PIK3CB;WASL;DGKD
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5667451520048984,-1.331206040176703,0.12563667232597622,0.26776184048228263,1.0,6/10,27.73%,SMARCD3;CTNNB1;VEGFA;DISC1;KDM1A;DCT
prerank,cellular response to metal ion (GO:0071248),0.32254192697611955,1.3307998180975111,0.056910569105691054,0.36990691538540105,1.0,34/123,14.55%,NLGN1;DLG2;ANK3;RYR3;SYT1;ADCY8;SLC12A2;GLRA1;SYT10;KCNH1;SYT2;TIGAR;CPNE4;PRNP;SYT5;KCNA1;ADGRV1;SYT11;SYT12;ADCY1;GLRA2;SLC13A5;TFAP2A;RYR1;CPNE8;CAPN3;HSF1;PPIF;SYT7;PRKN;CDH1;CPNE5;LGMN;BRAF
prerank,ribosome biogenesis (GO:0042254),-0.3186830764240501,-1.3299635607080034,0.029411764705882353,0.26951989955142125,1.0,72/187,28.38%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;ABCE1;RPL12;DDX49;RPS14;NOP14;RPL32;SENP3;EXOSC5;WDR36;RPS28;NOL6;NVL;RPL28;DHX37;KRR1;CUL4B;RPL22;RPL14;RPL34;RPL6;NOLC1;DDX31;EMG1;PAK1IP1;RPL18A;EIF2A;RPL37A;RPS9;UTP6;RPS27;SURF6;MRPL22;RPL23A;EXOSC10;RPS16;RPL9;GTF3A;RPLP2;NOL9;DDX54;EXOSC4;NIP7;SNU13;XRN2;RPL7A;RPL19;WDR12;RPS15;RPL39;MTREX;RPLP0;C1D;RPL41;RCL1;MRM2;RPL5;PDCD11;RPL13;IMP4;EXOSC8;RPL27A;WDR3;PIH1D2;NOC2L
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4968082867127479,-1.3298894682897955,0.1141396933560477,0.2693682876629974,1.0,5/18,16.85%,APOE;MSN;CTSC;RNF128;FAF1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4146334365365292,-1.3295397449194828,0.11036789297658862,0.2696266822804207,1.0,14/39,26.31%,FXYD5;JAG1;MYADM;NF2;VEGFA;MAP2K5;MAPK7;MIA3;ASS1;WNK1;TGFB1;ADTRP;SPINT2;BMP2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.39792241263052835,-1.3291474075053311,0.07214765100671142,0.2699853999753938,1.0,20/46,26.41%,FOXP1;IGF1;PPARG;IL6R;IL18;CTNNB1;TRIB1;XRCC6;CCL5;IGFBP3;ID2;ANG;PDGFRB;RBPMS2;STAT1;IL6;HMOX1;PRKDC;CCN4;VIP
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5708928009132835,-1.3289308438478138,0.12374581939799331,0.2701059857963532,1.0,7/11,32.44%,MAP3K5;PRKCD;STK24;CYP1B1;DIABLO;GSKIP;STK25
prerank,regulation of protein localization to nucleus (GO:1900180),-0.40026751872025423,-1.328521450444286,0.08880994671403197,0.2705162496435002,1.0,21/43,31.18%,MFHAS1;NVL;PARP9;PIN1;FLCN;TPR;CDK1;KAT7;SIN3A;LATS2;GSK3B;DTX3L;TGFB1;GTSE1;CARD10;SUMO3;CTNNA1;EIF2AK3;ATP13A2;NGFR;ORMDL3
prerank,granulocyte differentiation (GO:0030851),-0.4964270751763654,-1.3281869866651537,0.10664335664335664,0.2707557666366653,1.0,9/18,29.58%,DEK;SPI1;CBFA2T3;E2F1;RXRA;RARA;PML;LEF1;EP300
prerank,chromosome organization (GO:0051276),-0.34504580068133506,-1.3279300485028984,0.05360134003350084,0.2709027523868117,1.0,32/99,24.57%,DDB2;HHEX;TOP2A;PWWP3A;RAE1;EZH2;GPS1;UBC;RPS27A;RFWD3;NUCKS1;HDAC10;CUL4B;COPS6;HMGB2;PADI4;HDAC5;DOT1L;HMGN1;NUF2;LRWD1;NDC80;CENPH;COPS5;COPS8;COPS4;MTHFR;ZBTB7A;HDAC8;DDB1;MYC;CETN2
prerank,regulation of chromosome segregation (GO:0051983),-0.5157303139425397,-1.3277698676046672,0.12020905923344948,0.27088102854760276,1.0,9/16,25.20%,CSNK2A1;PUM2;BUB1;MKI67;KIF2C;HORMAD1;SMC6;PUM1;SMC5
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5355676600706826,-1.3275939927994398,0.11206896551724138,0.27087486025863855,1.0,2/14,1.91%,ITGA4;ANO6
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5037069962417414,-1.3275084344188695,0.11092985318107668,0.27075544655645467,1.0,7/18,15.88%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.476918384151849,-1.32726602265742,0.1284722222222222,0.270880424938875,1.0,3/20,1.70%,IGF1;RB1;NIBAN2
prerank,hemopoiesis (GO:0030097),-0.34985104394703137,-1.3272580426987475,0.054365733113673806,0.27063273012941813,1.0,30/87,25.02%,PTPRC;RUNX1;NOTCH2;PLEK;ETV6;RUNX3;CDK13;RASGRP4;LYL1;FLT1;RUNX2;JAG1;FUT10;MFAP5;LCK;FLCN;TET2;TGFBR2;MKNK2;KMT2A;NCOA6;ARMC6;SFRP1;KDR;TGFB1;FLT3;PRRC2C;TNFRSF13B;KITLG;ZBTB16
prerank,cellular response to calcium ion (GO:0071277),0.3594269354594355,1.3270621736974044,0.0645933014354067,0.3756926461871549,1.0,21/67,14.55%,NLGN1;RYR3;SYT1;ADCY8;SYT10;KCNH1;SYT2;CPNE4;SYT5;ADGRV1;SYT11;SYT12;ADCY1;RYR1;CPNE8;CAPN3;PPIF;SYT7;CPNE5;LGMN;BRAF
prerank,negative regulation of innate immune response (GO:0045824),-0.42634690137610914,-1.3270087902254502,0.10288808664259928,0.27076709539200194,1.0,10/34,13.10%,SAMHD1;YTHDF3;USP18;DHX58;NLRC5;IRAK3;GRN;NLRC3;OAS3;VSIG4
prerank,sphingoid biosynthetic process (GO:0046520),-0.5584565622701179,-1.3260393224780997,0.16455696202531644,0.2717599600210713,1.0,6/11,24.70%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5584565622701179,-1.3260393224780997,0.16455696202531644,0.2717599600210713,1.0,6/11,24.70%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4310714122976595,1.324592588640331,0.11483253588516747,0.3793527984639867,1.0,4/26,4.06%,EFNA5;ADCY8;EPHA5;ADCY5
prerank,cellular response to increased oxygen levels (GO:0036295),-0.55552484434641,-1.324100716164516,0.12681159420289856,0.2746391715797617,1.0,4/11,9.84%,ATP6V1A;ATG7;TMEM199;ATP6V1G1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3384477540134921,-1.3231389231771915,0.05203252032520325,0.2758941067438901,1.0,37/110,22.48%,APOE;FNIP2;ABCA1;SYK;FBLIM1;RB1;CD36;BCL2L11;SPIDR;CDC42;RIOK3;PREB;VEGFA;EIF2AK2;FNIP1;CDC42EP2;SAR1A;AIDA;TRAF2;SH3GLB1;ANKRA2;BRK1;BID;FAF1;TFIP11;RALB;HCK;RPS3;PTPN11;DDX3X;GSK3B;TMC8;MMP1;RACK1;GFAP;CRYAB;TGFB1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4052085576889227,1.3230032403073293,0.09111111111111111,0.38132148548412137,1.0,9/34,13.42%,PDE4B;ANK2;RYR2;PDE4D;ATP1B1;CALM1;ADRA1A;CALM3;CALM2
prerank,protein localization to cell junction (GO:1902414),0.459016686968161,1.3229496873147846,0.11512415349887133,0.380188283246859,1.0,3/22,1.75%,NLGN1;TJP1;PCLO
prerank,DNA alkylation (GO:0006305),-0.47849754293724606,-1.3229004545256466,0.12186379928315412,0.27574579669276816,1.0,2/19,3.12%,DNMT3A;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),-0.47849754293724606,-1.3229004545256466,0.12186379928315412,0.27574579669276816,1.0,2/19,3.12%,DNMT3A;GATAD2A
prerank,keratinocyte differentiation (GO:0030216),-0.42738396050580196,-1.322886196680837,0.09523809523809523,0.27550832246490337,1.0,9/29,25.66%,CLIC4;ANXA1;ADAM9;JAG1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3
prerank,ureteric bud morphogenesis (GO:0060675),0.49977232196508625,1.3224738029305017,0.15246636771300448,0.37995315655035056,1.0,5/16,10.57%,PAX8;GDNF;WT1;CITED1;SALL1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.45353393895085625,-1.3223661227967964,0.12564543889845095,0.27609585061494296,1.0,9/24,22.53%,NIBAN2;BLM;RTEL1;DFFA;ERCC4;KMT2A;RPS3;BMPR2;ZRANB3
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5455113747259603,-1.3210823344889064,0.13989637305699482,0.2778406986421825,1.0,5/12,21.72%,SNX3;CIITA;IFITM2;TRIM11;IFITM1
prerank,protein deacylation (GO:0035601),-0.46217058828161495,-1.3207745420386676,0.12028725314183124,0.27803869899694544,1.0,8/23,21.75%,ABHD17C;SIRT3;HDAC10;HDAC5;SIN3A;SIRT2;PPT1;LYPLA1
prerank,positive regulation of ruffle assembly (GO:1900029),0.5245576030467556,1.3205824230236942,0.15671641791044777,0.3824243541026972,1.0,4/13,5.48%,NLGN1;FAM98A;P2RY12;CARMIL2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.46817310652459565,-1.3197327927646068,0.11,0.27943607154667227,1.0,8/21,9.34%,CORO1C;ROCK1;RHOA;PEAK1;DAPK3;MACF1;DUSP3;SLC9A1
prerank,histone H3-K4 methylation (GO:0051568),-0.44722493211351744,-1.319509552079719,0.13126079447322972,0.27953816169447826,1.0,13/26,28.24%,TET3;OGT;CTR9;WDR5;KMT2C;KMT2D;TET2;KMT2A;CXXC1;RBBP5;ASH2L;KDM6A;WDR5B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5817137530083292,-1.3190464682444405,0.15016501650165018,0.2800251229618368,1.0,5/10,26.12%,LRP6;CTNNB1;RYK;WNT3;FZD1
prerank,import into nucleus (GO:0051170),-0.3602028710621233,-1.318525312727106,0.0734094616639478,0.28060146620492954,1.0,26/73,22.26%,BACH2;SYK;IPO5;NUP50;STAT3;NUP88;SNRPG;SNRPF;E2F3;TPR;HTATIP2;SMN1;NUP188;GEMIN7;SNUPN;APPL2;NUP153;HNRNPA1;FAM53A;APPL1;TNPO3;NUP107;NXT2;GEMIN6;NUP62;SPRN
prerank,DNA methylation (GO:0006306),-0.46072625570717873,-1.318495410572073,0.11090909090909092,0.2803764095474786,1.0,4/23,12.29%,DNMT3A;GATAD2A;METTL4;ZFP57
prerank,regulation of focal adhesion assembly (GO:0051893),-0.38110859328692753,-1.3180257625035954,0.06996587030716724,0.2808974727947702,1.0,13/54,9.65%,NRP1;CORO1C;RAC1;ROCK1;PTPRJ;RHOA;PEAK1;DAPK3;MACF1;DUSP3;VEGFA;SLC9A1;ITGB1BP1
prerank,regulation of protein modification process (GO:0031399),-0.3881338331116286,-1.317903721390566,0.07560137457044673,0.28081641330872614,1.0,13/50,12.10%,LYN;FNIP2;CORO1C;ATG7;ATG10;FN1;PUM3;FNIP1;SPRED1;PIN1;FLCN;CCDC88A;SPRED2
prerank,positive regulation of cell population proliferation (GO:0008284),-0.28828068658276856,-1.3172607476543783,0.004366812227074236,0.28154521389361326,1.0,107/423,21.14%,PID1;RBPJ;LYN;PTPRC;PRKCH;FOXP1;IGF1;NAMPT;CD74;GAB2;SDCBP;CDK6;ACER3;HPSE;INSR;CSNK2A1;IGF1R;CDK13;C5AR1;IL6R;HTR2B;IL15;FLT1;EAPP;DHX9;IL18;TCIRG1;PIM1;DPP4;PTK2B;ITGAV;BCL2;KIF20B;RPS6;STX3;SLC35F6;FN1;CHTOP;GCNT2;GRN;EZH2;GAS6;GRK5;VEGFA;NME1;MDK;E2F1;CNBP;BST2;PRMT1;RPS15A;TGFBR1;PTPN6;MEF2C;CTSH;TBC1D8;ITGB1BP1;RPS4X;NES;ITGAX;AGT;KIF14;IL7R;XBP1;OSR1;RELA;KMT2D;CACUL1;CCL5;CIB1;GLP2R;GREM1;TGFBR2;ID2;CAPNS1;DOT1L;IL34;S100A6;CRKL;TTK;IL31RA;HCLS1;BST1;STX4;CNOT6L;RPS9;RARA;HCK;SERTAD1;IRS2;KRAS;PDGFRB;MEIS3;NOD2;CSF1;WDR77;RBPMS2;IL7;CNOT8;CHP2;PRC1;MAZ;TIPIN;SFRP1;STAT1;PDGFA;KDR
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.4422056445509476,-1.317136965289201,0.12755102040816327,0.2814566898742609,1.0,8/29,11.69%,RUNX1;BRCA1;CNOT1;CNOT2;AXIN1;CBFB;WBP2;KMT2D
prerank,regulation of superoxide anion generation (GO:0032928),-0.5389789115212158,-1.3170617912657894,0.15236427320490367,0.2813216859890354,1.0,8/14,28.25%,SYK;PRKCD;ITGB2;AATF;TGFB1;ITGAM;CD177;FPR2
prerank,microglial cell activation (GO:0001774),-0.4709010163418749,-1.316118947199556,0.12562814070351758,0.28257805256577884,1.0,8/21,24.05%,ITGB2;C1QA;C5AR1;GRN;APP;AGER;IFNGR1;ITGAM
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4539809148889955,-1.315952890325947,0.11931818181818182,0.28256329772697697,1.0,8/24,18.67%,DCP2;TNKS2;TEN1;ERCC4;SLX4;TENT4B;HNRNPA1;EXOSC10
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3034559442827461,-1.3158295703994223,0.027950310559006212,0.2824974038262556,1.0,43/245,12.92%,IQGAP1;PTPRC;APOE;NRP1;CD44;TAOK3;IGF1;NOTCH2;CD74;BCAR3;MFHAS1;PLCG2;ROCK1;CD36;PTPRJ;PIK3R5;INSR;IGF1R;C5AR1;HTR2B;ARRB2;RAP1A;CCR1;FLT1;PTK2B;PTPN22;PIK3CG;ARRB1;GCNT2;EZH2;GAS6;VEGFA;LAPTM5;EIF2AK2;GSDME;ADAM8;SPRY2;APP;TAOK1;MAP2K1;CCL5;CIB1;KSR1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.42645150057586906,-1.3154489908915235,0.1020066889632107,0.28283709810997143,1.0,19/32,35.74%,RHOA;ANXA1;VEGFA;MAP2K5;ITGB1BP1;CIB1;HDAC5;PIK3C2A;KDR;MAP3K3;HMOX1;CARD10;TBXA2R;FGF2;KLF4;HDAC7;HDAC9;GATA2;SRPX2
prerank,mRNA modification (GO:0016556),-0.47062848856535144,-1.315247636460886,0.12666666666666668,0.2828883000454946,1.0,8/22,16.18%,PUS7;CBLL1;PCIF1;PUS1;METTL14;VIRMA;TRMT6;WTAP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5519157596771789,-1.3151367545266495,0.14893617021276595,0.2828118497691024,1.0,3/12,5.13%,CD44;CD74;BCL2
prerank,nitric oxide metabolic process (GO:0046209),-0.5237852756906975,-1.3150200744005518,0.13192182410423453,0.2827320679508672,1.0,6/14,23.87%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,regulation of protein catabolic process (GO:0042176),-0.34162781280078214,-1.3149241755757841,0.05,0.28261424152844106,1.0,39/99,26.41%,WWP1;RAB7A;SNX3;FLNA;CSNK2A1;WWP2;RNF41;AREL1;ATG7;CTSA;TIPARP;AXIN1;IRAK3;PLK2;AZIN1;SF3B3;PIN1;NEDD4L;ZDHHC2;ASB5;WDR91;STX5;EEF1A1;FAF1;HUWE1;RILP;FAM83D;MDM4;GSK3B;SIRT2;SMURF2;GFAP;OAZ3;RAB26;DDB1;FURIN;SMURF1;VCP;VIP
prerank,ESCRT complex disassembly (GO:1904896),-0.5737958579332902,-1.314829303684541,0.12050359712230216,0.2822567968490507,1.0,9/10,33.36%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;VTA1;IST1
prerank,ESCRT III complex disassembly (GO:1904903),-0.5737958579332902,-1.314829303684541,0.12050359712230216,0.2822567968490507,1.0,9/10,33.36%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;VTA1;IST1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5500151256270545,-1.314226863895469,0.14113597246127366,0.2829972874240506,1.0,2/12,4.27%,PAEP;IL18
prerank,regulation of gene expression (GO:0010468),-0.2721349584214131,-1.313934063707468,0.0013333333333333333,0.2832313424904208,1.0,268/903,25.07%,PID1;RBPJ;LYN;PTPRC;APOE;MITF;AHNAK;MBNL1;PTBP3;FOXP1;MSR1;RUNX1;IGF1;NOTCH2;TFEB;CD74;MSN;RREB1;LILRB1;P2RX7;PLCG2;REL;XDH;AFF4;BCL6;CDK6;RB1;ROCK1;DNM2;CD36;CREBBP;RUNX3;AGO2;BACH1;NFE2L2;INSR;MBNL2;IRF2;APBB2;ZNF148;SBNO2;TRA2B;SON;NFX1;NFYA;NSD3;FOXN2;SPI1;AFF1;WWP2;BRCA1;JMJD1C;STAT3;CCR1;LYL1;ZSCAN26;CTR9;TLR4;PARP14;CHD3;RYBP;RC3H1;STAP1;NFKB1;RNF20;SAP30;PTPN22;DAPK3;TIPARP;GPBP1L1;CIAO3;MAPK14;TAPBP;RPL11;PF4;TRAF3;PIK3CB;ZC3H7B;AHNAK2;FN1;GON4L;CRIP1;SRRT;GCNT2;MYADM;PICALM;FUS;AHR;GCFC2;MBNL3;HNRNPH1;USP36;REXO4;HNRNPDL;POFUT1;EDF1;EZH2;GAS6;VEGFA;SIRPA;BHLHE40;HNRNPL;E2F1;MYD88;CNBP;PUM2;THAP1;TGFBR1;CD28;LARP4;METTL4;HIF1A;SLC8A1;MEF2C;SERPINB9;UBE2L3;CTSH;NFKBIZ;FOXN3;EGR1;PARP9;HDAC10;SPRY2;APP;PIN1;ITGAX;MOV10;HP1BP3;PCBP2;MYOM1;FLCN;OSR1;RELA;NUDT21;MAP2K1;KMT2D;TICAM1;CD46;CELF1;PRDM2;SPIN1;HNRNPLL;MLLT6;KAT7;TCF7;TRIM68;TNRC6C;YTHDC1;ZNF326;PIK3CD;CALCOCO1;DHX36;SPTY2D1;SETDB1;RPL6;TRIM11;SLC7A5;HDAC5;BTG1;ANKRA2;SART3;ID2;TCF3;NSD1;PSPC1;POLR2A;ZNF628;YY1;POGZ;TXK;CRKL;SRSF10;FLOT2;NKAPL;DTNBP1;HCLS1;TRIM14;VHL;TDRD7;CASP8;PARP10;ADAM19;AURKA;TOB1;HSPA1A;ATF5;TOB2;MARF1;GATA3;MYB;RPS3;ATXN1;KRAS;PLAG1;TRIM39;LIMS1;PPARGC1B;SNRNP70;CXXC1;MMP8;NR3C1;PDCD5;NUP35;PAK6;SLC38A2;LGALS9;DDX3X;CSF1;NDFIP2;SUFU;NFKBID;GSK3B;WNT3;ATM;UBAP2;CASZ1;GRSF1;MAZ;ATF7;NUP107;ZC3H12A;ZFPL1;SFRP1;GTF2IRD1;HNRNPH2;ZSCAN21;RACK1;POU3F1;KDR;PRKAG1;MEGF8;RBM38;CEBPB;SNAI2;HNRNPK;ANXA7;CD3E;IFNGR1;NONO;IL6;TGFB1;APLNR;ESR2;SOX7;MEFV;RPS6KA5;MAPK1;ADTRP;LRRC19;DVL2;C1D;ZNF395;PAX6;HES6;CHD7;PCBP4;FGF9;PUM1;DRAP1;RNF187;MYC;GZF1;FGFR4;TARDBP;TADA3;ESRP1;CCN4;CLK4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5497486228839565,1.3130682661244257,0.15456674473067916,0.39619099657500806,1.0,2/11,2.55%,CACNA2D1;CACNB2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.45375665085792255,-1.3129540836656406,0.11442786069651742,0.2845812442240915,1.0,9/26,20.05%,BIRC3;CD36;IRAK3;NFKBIL1;OTUD4;FLOT2;APPL2;GPR108;APPL1
prerank,regulation of cellular catabolic process (GO:0031329),-0.36684627417576243,-1.3121855421686475,0.07653061224489796,0.2855752882111548,1.0,10/62,5.36%,PSAP;DAPK1;GPR137B;ROCK1;ITPR1;NUPR1;PIP4K2A;ABL2;MTMR3;DAPK3
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2944136163681639,-1.3118711305521162,0.004594180704441042,0.285824675199607,1.0,96/348,23.55%,IQGAP1;LYN;DAB2;PTPRC;FNIP2;NRP1;CD44;BANK1;IGF1;CD74;BCAR3;SDCBP;PLCG2;PAK2;NIBAN1;RAC1;ITGA5;SNX9;PTPRJ;INSR;ARHGEF2;RAP2A;PRKAG2;RIPK1;IL6R;TAB2;RAP1A;IL15;TEC;RBPMS;CCND3;PTK2B;AXIN1;HGF;C3;ARRB1;CAB39;CAMKK2;GAS6;ALS2;VEGFA;CENPE;PLAUR;FNIP1;TGFBR1;SPRY2;APP;PIN1;AGT;FLCN;XRCC6;WDFY2;CLEC6A;CACUL1;HSP90AB1;CIB1;ACVR2A;LCP2;CAMKK1;RB1CC1;CD40;IL34;EIF4G1;CRKL;CSPG4;TTK;HCLS1;MAVS;RALB;MAP2K3;KRAS;TAOK2;PTPN11;JTB;BMPR2;RSPO1;DDX3X;CSF1;GDF3;AGER;PDGFA;RACK1;KDR;HAX1;PRKAG1;NBN;ILK;INHA;S1PR2;IL6;TGFB1;APLNR;RPS6KA5;MAPK1;ADTRP;DVL2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.49514157781685386,-1.3114669866581297,0.12607944732297063,0.2861873247087849,1.0,9/18,24.88%,CD300A;SKI;MORC3;B4GALT7;NLRC3;PARP10;SFRP1;MYC;FTH1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.40773269210690677,-1.3113734373906079,0.10374149659863946,0.286068412011832,1.0,20/39,26.14%,PI4K2A;ITPKB;PIP4K2A;PI4K2B;PIK3CB;TMEM150A;PIK3CG;PI4KB;TTC7A;PIK3CA;SOCS6;PIK3CD;PIK3C2A;SOCS3;IP6K3;SOCS5;SMG1;ITPKC;PIK3C2G;IP6K1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.40757786133416307,-1.3109379048432106,0.10782608695652174,0.2865482611747815,1.0,6/36,9.13%,APOE;DNM2;HTR2B;PIK3CB;WASL;HIF1A
prerank,regulation of cholesterol esterification (GO:0010872),-0.5666192393271392,-1.3107604709142613,0.15412186379928317,0.28656097338026426,1.0,2/10,0.55%,APOE;ABCG1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.38271022887930073,-1.310461106411426,0.10135135135135136,0.2868231619543095,1.0,19/50,24.52%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.35829966595503987,1.3102007018276531,0.07894736842105263,0.40062603013481907,1.0,10/53,15.93%,HTR2C;CHRM2;CHRM3;HRH3;OPRD1;NPY1R;HTR1B;HRH2;HTR7;OPRM1
prerank,protein catabolic process (GO:0030163),-0.3788525897699288,-1.3100945935197432,0.09644670050761421,0.2871214530079829,1.0,25/59,26.50%,APOE;CTSD;RIPK1;RNF41;LAMP2;DDI2;ATE1;PSMA8;CLN6;CUL4B;TRIM24;SOCS6;DENND3;UBE2G1;TPP1;RAB12;STT3B;PPT1;BAG6;MANBA;DDB1;LRSAM1;SIAH2;VCP;HSPA8
prerank,ceramide metabolic process (GO:0006672),-0.3785947465818515,-1.3100696971550563,0.07719298245614035,0.2868948422282337,1.0,24/49,40.58%,SGMS1;SPTLC2;ACER3;SPTSSA;CLN6;SPTLC3;SAMD8;ASAH1;PLPP3;DEGS2;ABCA2;CERS3;ORMDL2;PLA2G15;CERK;ORMDL3;ACER2;CERS2;PNPLA1;FUT7;PPP2CA;PLPP2;PLPP1;ORMDL1
prerank,histone ubiquitination (GO:0016574),-0.4618474023424074,-1.3095582351460398,0.12212389380530973,0.2874287646352811,1.0,13/21,32.78%,CTR9;RNF20;UBR2;RNF8;UHRF1;WAC;HUWE1;DTX3L;UBE2N;RNF40;UBE2E1;UBE2U;UBE2A
prerank,ion transport (GO:0006811),0.32249531368995765,1.3094768689485141,0.02557544757033248,0.400839647319928,1.0,18/111,8.87%,TRPM3;GABRB1;KCNN2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;GLRA1;SLC17A6;SLC1A2;SLC24A3;SLC1A6;SLC12A1;SLC26A3;SLC9A2;SLC1A1;PKD1L3;SLC8A2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.44737545501193654,1.3092526145210233,0.12698412698412698,0.39997884118924554,1.0,5/21,3.24%,HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.5199845396293467,-1.3089926869620536,0.15753424657534246,0.2879845024347784,1.0,7/14,17.95%,CARD11;LCK;RELA;RAB29;CD226;TESPA1;RPS3
prerank,ion homeostasis (GO:0050801),0.4153364836852226,1.3089817146349843,0.1136890951276102,0.39926209316507427,1.0,10/30,21.63%,UNC80;SLC4A10;SLC4A4;SLC4A11;SLC12A5;WNK4;WNK3;WNK2;SLC30A3;P2RY2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5618850987508983,-1.308804353285908,0.14620938628158844,0.28801518051135794,1.0,6/11,20.28%,RUNX1;RUNX3;CBFB;LGALS9;HMGB1;CD274
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4932418296698036,-1.3081415767526112,0.13582342954159593,0.2888174628336494,1.0,5/18,9.38%,ITGA4;PPARG;FLT1;MDK;MEF2C
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5672284171833647,-1.3076929019922268,0.1606837606837607,0.2892498446498615,1.0,3/10,8.28%,SNX3;WWP2;DNAJA1
prerank,calcium ion homeostasis (GO:0055074),0.3267682268690947,1.307379631126207,0.04656862745098039,0.40114571418137634,1.0,23/95,16.47%,HTR2C;ANK2;TMTC2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC24A3;TMEM203;PTH1R;SLC8A2;EDN1;CALCB;ATP1B1;ATP2B4;CDH5;FAM20A;ATP2A1;ATP2B2;CHRNA7;ATP13A5;SNCA;CXCL12
prerank,negative regulation of response to stimulus (GO:0048585),-0.37096439054267843,-1.3069242654011732,0.10032894736842106,0.2901994627826629,1.0,20/60,25.93%,LYN;MCTP1;VPS13C;CDK6;NR1H2;MAP2K5;WFS1;MAPK7;FCGR2B;IGFBP3;BRAP;APPL2;LPCAT3;UBASH3B;PTPN1;SOCS5;MAP3K3;KIF26A;FCRLB;CASK
prerank,cellular response to reactive oxygen species (GO:0034614),-0.37578765162823996,-1.3067753679998826,0.09417808219178082,0.2901519397881167,1.0,12/59,11.54%,MAP3K5;PRKCD;JUN;NFE2L2;RIPK1;ANXA1;CAMKK2;SIRPA;MAPK7;PRDX5;NCF1;RELA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4387901080125926,-1.3067559117851497,0.12056737588652482,0.28990946548286894,1.0,5/28,4.73%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,positive regulation of blood coagulation (GO:0030194),-0.49617542477223486,-1.306647022822747,0.1431095406360424,0.2898283099500057,1.0,11/17,45.08%,ANO6;HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12;HRG;THBD;F3;ENPP4
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.26234190714889427,-1.3063049996559655,0.0,0.29012647709726763,1.0,443/1646,23.85%,RBPJ;MDFIC;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;FOXP1;ELF4;FLI1;RUNX1;PRKCB;IGF1;TRPS1;BACH2;TFEB;CD74;CD38;SP100;TCF4;RCOR1;RREB1;ELF2;REL;LITAF;TRAK1;MIDEAS;WWP1;BCL6;RB1;JUN;DNM2;PEX14;NIBAN2;ZNF568;ETV6;CREBBP;DEK;MEF2A;RUNX3;OGT;PPARD;BPTF;ANXA4;TOX2;BACH1;ARID5B;ZBTB34;NFE2L2;BRD7;CCNL1;INSR;RNF111;IRF2;APBB2;ZNF148;PHF20;SBNO2;BRD4;NFIC;NFX1;NFYA;ARID1B;ATF3;ZSCAN12;ATAD2;ELF1;NSD3;GATAD2A;UBP1;SMARCA5;PPARG;KDM3A;FOXN2;PIAS1;ELK3;SPI1;WWP2;ZNF3;BRCA1;JMJD1C;ETV1;ERCC6;STAT3;FOXO3;KLF13;E2F2;LYL1;ZSCAN26;CTR9;DHX9;IKZF1;STAT6;USF2;NIPBL;CHD3;RYBP;SNX6;CNOT2;NFKB1;RNF20;HHEX;ZBTB21;RUNX2;SMARCD3;PRMT2;IRF5;SAP30;FBXW11;CENPF;MLXIP;CRLF3;MEF2B;KLF6;DAPK3;MAF;TCF20;SMARCC2;GPBP1L1;SNX5;NR1H2;CIITA;MAPK14;AXIN1;BATF;CBFA2T3;BLM;CUX1;NRF1;TEF;KDM7A;ETV3;GON4L;NFATC3;SRRT;ARRB1;LRP6;KDM3B;ZBTB2;PICALM;CDK18;MYNN;MED24;FUS;AHR;KLF3;GCFC2;CTNNB1;TBL1XR1;JARID2;REXO4;POFUT1;STAT5B;CAMKK2;PBXIP1;STAT4;EDF1;EZH2;GAS6;NR2F1;ATF6;DPF2;KDM2A;VEGFA;EED;BHLHE40;CREB3L2;E2F1;RNF4;CNBP;ATMIN;ARID1A;CEBPG;SP110;CBFB;THAP1;E2F3;CDK14;TGFBR1;SPEN;METTL4;TGFB1I1;WBP2;MEF2D;HIF1A;DDX5;TFEC;POLR2L;MEF2C;UBE2L3;OLIG2;NUCKS1;POLR3G;FOXN3;EGR1;SUDS3;PARP9;ARNT;SP140;HDAC10;AFAP1L2;PROX2;CIART;AGT;IKZF3;NCF1;BAZ2B;HP1BP3;ZBTB20;DYRK1A;TIMELESS;XRCC6;CCNL2;ZNF319;ARHGEF11;ZNF569;CHMP1A;OSR1;CRK;RELA;PCNA;MAP2K1;KLF10;KMT2D;MED4;NFE2;PRDM2;SPIN1;SALL3;ARID3B;HTATIP2;FOXJ1;ZFP57;MLLT6;MLLT11;FOSL2;BAZ1A;CCDC85B;HMGB2;KAT7;TCF7;ZFP41;CHD8;ZFX;IRF2BP2;MTA3;MED31;FOXJ3;SP2;WAC;ZNF326;CALCOCO1;CREG1;DHX36;SPTY2D1;RPL6;E2F8;BATF3;RXRA;CALCA;HDAC5;SIN3A;BTG1;KLF2;ID2;TGIF1;EPC1;SPP1;TCF3;NSD1;PSPC1;TFAM;POLR2A;RELB;TFAP4;ZNF628;YY1;ZMIZ2;CCNE1;ZBTB46;PRMT6;MAP3K10;AATF;IKBKB;RGS14;MED13L;KARS1;KLF8;SRSF10;DNAJC2;IL31RA;ZNF177;BTAF1;MRGBP;HR;HCLS1;TFCP2;QRICH1;KMT5A;NR4A1;BRIP1;ZBTB12;ELP4;KLF11;FOXJ2;IRX5;PHC3;IKZF4;SOX10;VHL;PHF20L1;UXT;ZBTB25;UBE2I;KMT2A;MAP2K3;SMAD7;GPATCH3;RARA;MED6;ZBTB24;TFE3;ATF5;CSRNP1;REPIN1;GATA3;MYB;SAMD1;ARID5A;ATXN1;HTATSF1;NCOA6;PLAG1;LIMS1;PPARGC1B;BRD2;CXXC1;TRIM16;NFATC1;TCF12;NR3C1;HAS3;ID1;RSF1;PITHD1;NUP35;GMEB2;MDM4;RBBP8;MEIS3;HOXD8;PAK6;MED20;HMGB3;WDR77;LCORL;SUFU;DBX2;MMS19;BRD9;SP9;CDK16;HMGB1;EHF;CBFA2T2;SIRT2;CASZ1;ZFP28;RLF;ELOC;NAA16;BAP1;MAZ;ATF7;NUP107;DTX3L;KDM5B;SMURF2;ZFPL1;CIC;RAI1;SFRP1;GTF2IRD1;PKNOX1;STAT1;LRRFIP1;LIN9;ZFP2;ZSCAN21;MAX;POU3F1;ZKSCAN1;HOXB2;CCNK;KDM1A;NUP62;ID3;CEBPB;TBX2;HEYL;SNAI2;HNRNPK;EGR2;CDK5;MTF1;ILK;TADA1;ZNF296;BARX2;MYRFL;NR1H4;NONO;MED18;CRYAB;TCIM;IL6;EID2;CDC45;TGFB1;HOXD9;E2F5;HES7;RRP8;ESR2;SOX7;ZNF32;SET;ZBTB7A;RPS6KA5;ZNF394;PIM2;VRTN;RFX5;DVL2;SCMH1;MAFF;FANK1;BBX;ZNF395;PAX6;HES6;TSC22D4;CHD7
prerank,positive regulation of organelle organization (GO:0010638),-0.42436227935349613,-1.3062068746449451,0.11282051282051282,0.29002039323798623,1.0,11/32,19.77%,P2RX7;ANXA2;UVRAG;SYNJ1;ANXA1;RAB3GAP1;KATNBL1;SHCBP1L;ADRB2;PLA2G5;GSK3B
prerank,sensory perception of chemical stimulus (GO:0007606),0.4947765995255371,1.3053867469307148,0.1580188679245283,0.40394300899376157,1.0,6/15,14.41%,SLC24A4;SYT10;ADCY3;UBR3;MKKS;GNAL
prerank,error-free translesion synthesis (GO:0070987),-0.46083048673809834,-1.3048526221591414,0.1342512908777969,0.2919808755945268,1.0,9/22,26.23%,RFC1;UBC;RPS27A;PCNA;RPA3;RFC2;RFC3;POLDIP2;VCP
prerank,cellular protein catabolic process (GO:0044257),-0.37522296552986467,-1.3048167342391968,0.09540034071550256,0.2917581530541052,1.0,19/59,19.29%,CTSB;CTSZ;RAB7A;MALT1;RIPK1;MYLIP;TCIRG1;AP2A2;RNF123;CTSC;CTSH;FAP;CTSS;AFG1L;DENND3;UBE2G1;CASP8;BNIP3L;RAB12
prerank,activation of adenylate cyclase activity (GO:0007190),0.4016943409104834,1.3043325179612137,0.1201923076923077,0.404938568051769,1.0,9/35,13.22%,ADCY2;ADCY8;LGR5;ADORA3;ADCY5;ADCY3;ADCY1;LGR4;ADRB1
prerank,regulation of receptor recycling (GO:0001919),-0.5008906640541204,-1.3040227956581494,0.14558058925476602,0.29285638834493205,1.0,6/16,11.83%,OPTN;ANXA2;KIF16B;TBC1D16;SCRIB;RAB29
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.45576435836488594,-1.303971839778951,0.10745233968804159,0.29266707231754313,1.0,10/23,21.24%,SPI1;ADIPOR1;IFI35;PPM1B;RELA;NLRC3;TMSB4X;DDX3X;ZC3H12A;NLRP3
prerank,actin cytoskeleton reorganization (GO:0031532),-0.36964906379206486,-1.3039371692712203,0.07993197278911565,0.29246684623107,1.0,11/63,5.38%,NEDD9;NRP1;GRB2;PLEK;MYH9;RHOA;FLNA;RAP2A;MINK1;PARVB;ANXA1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4684759554919663,-1.303823629919793,0.13926174496644295,0.29238844498903693,1.0,5/19,9.38%,RBPJ;RUNX1;PIM1;TGFBR1;MEF2C
prerank,leukocyte tethering or rolling (GO:0050901),-0.5039815547760441,-1.3031399980832015,0.13725490196078433,0.293269734063904,1.0,7/17,15.88%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4963699607894876,1.3027650032517106,0.14769975786924938,0.4067915944358123,1.0,6/14,20.57%,UPP2;DPYD;DPYS;DHODH;CAD;NT5M
prerank,negative regulation of cell motility (GO:2000146),0.32626513239610233,1.3026640348073846,0.059895833333333336,0.40574419100149567,1.0,16/108,5.38%,ROBO1;MAGI2;NAV3;TMEFF2;SLIT2;PTPRT;SPOCK3;FRMD5;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;DLC1;PODN;PTPRK
prerank,protein localization to lysosome (GO:0061462),-0.4329736502463929,-1.302641695841868,0.12920353982300886,0.29383172868449675,1.0,11/28,23.23%,RAB7A;GGA3;LAPTM5;MFSD1;AP3M1;RNF128;SNX16;GLMP;LMBRD1;VPS4A;KPTN
prerank,negative regulation of cation channel activity (GO:2001258),0.42278333915093824,1.3021431324730395,0.11486486486486487,0.40554497757326263,1.0,13/26,25.72%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;UBQLN1;GPR35;KCNAB1;EPO;PKD2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4391241801567922,1.3018024354964621,0.14849187935034802,0.4049252958331252,1.0,5/24,5.07%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1
prerank,neural tube development (GO:0021915),0.49333376820815455,1.3017760606421545,0.1261682242990654,0.40377822830779864,1.0,4/15,11.95%,SOX11;ARL13B;PKD1;HES5
prerank,negative regulation of immune response (GO:0050777),-0.3184938608271188,-1.3013802043986955,0.03987240829346093,0.29563648988160807,1.0,29/154,14.21%,LYN;FGR;CCR2;CD163;LILRB1;PLCG2;SYK;GNB1;CD300A;MYH9;ADCY7;SPI1;DHX58;RC3H1;PTGER4;MAPK14;GNG2;IRAK3;PPM1B;PLK2;RHBDF2;CYSLTR1;PCBP2;FCGR2B;NLRC3;GLP2R;CALCA;ADCYAP1R1;SAMSN1
prerank,embryonic skeletal system development (GO:0048706),0.398138567151703,1.3009117795155514,0.1261682242990654,0.40425123655209216,1.0,14/35,21.23%,PCSK5;HOXC4;SOX11;WNT9A;KIAA1217;DSCAML1;HOXD3;HOXC9;FUZ;UCMA;COL1A1;WNT5A;SULF1;DYNC2I1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.562581114795851,-1.3007014988953227,0.14948453608247422,0.2964463021447663,1.0,2/10,1.61%,CD84;SARAF
prerank,RNA catabolic process (GO:0006401),-0.3940993435500966,-1.3005764108624434,0.09420289855072464,0.29639486317043806,1.0,27/46,41.37%,ERN1;DCP2;FEN1;RNASE6;NCBP1;LSM6;DNA2;HSPA1A;LSM5;XRN2;MTREX;SND1;RNASEH2B;NUDT16;ZC3H12D;ISG20;METTL3;NUDT12;HSPA1B;AGO3;SLFN14;ZFP36;RNASE3;DXO;RNASEH2A;YTHDF2;METTL16
prerank,tRNA processing (GO:0008033),-0.36670439406076316,-1.3005068251746603,0.07166123778501629,0.2962551574666026,1.0,29/61,35.28%,FARS2;ADAT1;METTL1;SARS1;ELP5;TSEN54;ANKRD16;QTRT1;TRMT6;ADAT2;DDX1;KARS1;TYW5;THUMPD1;AARS1;ELAC2;RPP40;CPSF1;ZBTB8OS;THG1L;CTU2;FTSJ1;POP1;CTU1;TRMT61A;TRNT1;RTCB;TRMT10B;CDKAL1
prerank,regulation of vasoconstriction (GO:0019229),0.42955423302818196,1.3001979587620915,0.13452914798206278,0.40448290427254635,1.0,11/27,14.86%,CHRM3;KCNMB2;SMTNL2;ADRA1B;OXTR;AGTR1;PER2;ADRA1A;ADRA1D;ZDHHC21;ECE1
prerank,nuclear pore complex assembly (GO:0051292),-0.5727025154159865,-1.2998837444278604,0.1519434628975265,0.2970063278246354,1.0,4/10,20.52%,NUP205;TPR;NUP153;NUP107
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4711494563353796,-1.2998739235831047,0.137546468401487,0.2967624905500736,1.0,7/20,12.66%,CDK6;CTR9;HSPA9;PTK2B;PF4;PRMT1;CIB1
prerank,pulmonary valve development (GO:0003177),0.4654451501136959,1.2995140941646008,0.13691931540342298,0.4047172451232659,1.0,3/18,1.35%,ROBO1;ROBO2;SLIT2
prerank,post-translational protein modification (GO:0043687),-0.29006536354094675,-1.2991006640362686,0.02748091603053435,0.29781858548528534,1.0,92/332,22.79%,APOE;FAM20C;DDB2;FBXW8;PSME4;ATG5;PSMB7;PSME3;RAB1A;FBXO32;FBXW11;UBXN7;PSMB9;KLHL25;FBXL20;DCAF10;FN1;C3;KLHL22;NUB1;LRRC41;DCAF8;GAS6;GPS1;WFS1;WDR5;RAB5A;HIF1A;PSMA8;SPSB2;SUMF2;PTP4A2;APP;PSMC3;SPSB3;RAB11B;CP;CUL4B;HSP90B1;PSMD8;ASB5;COPS6;FBXO10;LGALS1;PSMC4;SOCS6;PSMB10;IGFBP3;FBXW2;CUL2;PSMA1;MIA3;SPP1;MFGE8;CST3;APLP2;RAB13;RABGGTA;ASB4;VHL;KLHL42;FBXL8;WSB2;SKP2;DNAJC3;FBXO7;PSMB8;SOCS3;UBE2M;SHISA5;RABGGTB;COPS5;CSF1;PSMD4;PSMA5;FBXO31;STT3B;RAB11A;FBXO22;PSMB3;ESCO2;F5;ELOC;PSMD3;COPS8;FBXW4;COPS4;FEM1B;CCNF;IL6;SOCS5;P4HB
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.4007812780204934,-1.2980716368015737,0.10792580101180438,0.29924164411769494,1.0,11/38,20.67%,RAC1;CD36;INSR;P2RX4;TLR4;SIRPA;HSP90AB1;KLF2;ASS1;MMP8;ZC3H12A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4397925936821084,-1.2979920937299945,0.12521739130434784,0.29911892248883615,1.0,8/25,24.06%,ERCC6;ALYREF;KAT7;ZNF326;HMGN1;HTATSF1;CCNK;DDX39B
prerank,positive regulation of cell cycle process (GO:0090068),-0.347411946142106,-1.2978531995901623,0.0625,0.2991110016805789,1.0,29/91,21.92%,IGF1;RHOA;MAP3K20;INSR;SVIL;CDC42;CEP295;DYNC1H1;KIF20B;KIF23;CD28;DBF4;KIF14;GEN1;TPR;FEN1;E2F8;RHNO1;RACGAP1;NUSAP1;INO80;AURKA;XRCC3;NDC80;PDGFRB;CSPP1;SIRT2;NUP62;RANBP1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4763660680787895,1.2974103147550062,0.15348837209302327,0.40661198247518165,1.0,4/16,5.43%,ARHGAP6;CLASP2;DLC1;APOD
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4763660680787895,1.2974103147550062,0.15348837209302327,0.40661198247518165,1.0,4/16,5.43%,ARHGAP6;CLASP2;DLC1;APOD
prerank,neural crest cell differentiation (GO:0014033),0.46729343619467234,1.2973369655119416,0.15404040404040403,0.4055347596048246,1.0,4/18,4.92%,NRG1;SOX11;CDH2;PDCD6
prerank,regulation of protein sumoylation (GO:0033233),-0.4881299366914654,-1.29728823934419,0.15332197614991483,0.29982328991250506,1.0,4/17,9.94%,ZMIZ1;PIAS1;CTNNB1;EGR1
prerank,regulation of cardiac conduction (GO:1903779),0.3657342886811831,1.29721938763719,0.09313725490196079,0.40454626357730233,1.0,16/54,14.63%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;CORIN;AHCYL1;CASQ2;ATP1A3;FXYD6;SLC8A2;RYR1;ATP1B1;ATP2B4;ATP2A1;ATP2B2
prerank,regulation of glucose import (GO:0046324),-0.43588495142189887,-1.2972152352482629,0.12886597938144329,0.2996681737636589,1.0,12/30,20.05%,PID1;OSBPL8;IGF1;INSR;PRKAG2;RHOQ;SELENOS;APPL2;IRS2;PTPN11;ENPP1;APPL1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4761154679639879,-1.2970708721387476,0.1408695652173913,0.2996298251188271,1.0,4/19,4.27%,IGF1;TNFRSF1B;NUPR1;IL18
prerank,negative regulation of platelet activation (GO:0010544),-0.5021334853590727,-1.2968913214307938,0.16308243727598568,0.29966470048577226,1.0,3/16,3.28%,APOE;PRKCD;CD9
prerank,neutrophil migration (GO:1990266),-0.375930030835296,-1.2968372156567582,0.09572649572649573,0.2994736014026163,1.0,27/58,36.34%,SYK;ITGB2;CKLF;IRAK4;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD;PPIB;PIP5K1C;CCL7;PRTN3;PECAM1;CCL24;CD177;CCL4;CXCR2;CCL19;CCL25;EDN3;CCL8;CXCL9;EDN2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4889506727468354,-1.296709006909075,0.16501650165016502,0.2994178285632536,1.0,5/17,11.09%,PID1;NUPR1;CBFA2T3;FIS1;FLCN
prerank,granulocyte chemotaxis (GO:0071621),-0.3793407222862104,-1.2961371617566557,0.11013986013986014,0.3001702180981992,1.0,12/55,13.42%,SYK;ITGB2;CKLF;ANXA1;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,nuclear pore organization (GO:0006999),-0.5205923060457303,-1.2959801069651362,0.15370705244122965,0.30014815732485783,1.0,5/14,20.52%,NUP205;TPR;NUP153;NUP35;NUP107
prerank,maturation of SSU-rRNA (GO:0030490),-0.4196644923980281,-1.2956450987454708,0.1295971978984238,0.3004362020223279,1.0,12/34,22.31%,RPS8;RIOK3;RPS14;NOP14;RPS28;DHX37;MRPS11;NGDN;UTP6;LSM6;RPS16;SNU13
prerank,lipid homeostasis (GO:0055088),-0.3753636102585113,-1.2955949613887563,0.09183673469387756,0.30023865311650083,1.0,19/57,26.33%,APOE;ABCA1;ABCG1;PPARG;USF2;RCN3;TLCD2;ZBTB20;XBP1;ABHD5;ACOX1;IRS2;DDX3X;TLCD1;ACOXL;PNPLA8;ABCA2;THADA;ORMDL2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.4114869025643384,-1.2943730558709527,0.11993243243243243,0.3020802634387108,1.0,9/32,23.17%,GAPDH;PF4;RNASE7;CAMP;RNASE6;DEFA6;ANG;CXCL14;RPL39
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5764540101690545,-1.294231251536303,0.17747440273037543,0.30204886981126317,1.0,4/10,18.22%,PIBF1;PARP14;NF2;SOCS3
prerank,myeloid dendritic cell activation (GO:0001773),-0.5321483326769815,-1.294138244570723,0.14716312056737588,0.30195376170015076,1.0,5/12,19.87%,DOCK2;BATF;BATF3;TGFBR2;HMGB1
prerank,regulation of translation (GO:0006417),-0.31242134606341465,-1.2931570480412742,0.04590163934426229,0.30335829135843845,1.0,51/173,22.42%,DAPK1;VIM;NIBAN1;YTHDF3;GAPDH;GSPT1;FOXO3;CNOT1;NSUN3;DHX9;DAPK3;KLHL25;EIF4G3;PUS7;EIF4A2;PUM3;EIF5;ALKBH1;EIF2AK2;LARP4B;PCIF1;CD28;LARP4;RPS4X;APP;MTPN;EEF2;CSDE1;EIF3E;METTL14;DHX36;NOLC1;NCBP1;EIF4G1;DDX1;NCL;EIF2A;RBM4B;TOB1;RPS3;HSPB1;EIF5B;DDX3X;CNOT8;DDX6;RACK1;RBM3;LSM14A;SHMT1;EIF3H;IL6
prerank,regulation of stem cell differentiation (GO:2000736),-0.34263051475934936,-1.2930862459284331,0.07155025553662692,0.30320621074852405,1.0,28/89,20.62%,RUNX1;NELFB;PSME4;PSMB7;PSME3;PSMB9;JAG1;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;NUDT21;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;KMT2A;PSMB8;GATA3;MYB;TCF12;LMO2;PSMD4;PSMA5;PSMB3;PSMD3
prerank,antibacterial humoral response (GO:0019731),-0.5031568861580211,-1.2924815244893395,0.13580246913580246,0.30399743695832593,1.0,7/16,23.17%,RNASE7;CAMP;RNASE6;DEFA6;ANG;PLA2G6;RPL39
prerank,connective tissue development (GO:0061448),-0.4159958157839556,-1.2923892516531907,0.1232876712328767,0.3038527270912999,1.0,9/35,10.97%,CD44;SH3PXD2B;NAMPT;SPTLC2;ARID5B;ATP7A;SULF2;CREB3L2;XBP1
prerank,protein polymerization (GO:0051258),-0.37952095015561593,-1.2923865923501001,0.08762886597938144,0.30359443610571785,1.0,19/55,22.27%,DIAPH1;GAS7;RAC1;PSTPIP2;PSTPIP1;WASL;CKAP5;CORO7;MSRB1;DIAPH3;PIN1;CHMP2A;GPX4;UBE2C;ANG;TTC17;CHMP4B;CHMP4A;RNF135
prerank,glycolipid metabolic process (GO:0006664),-0.3825765195333696,-1.2923051655250668,0.10945273631840796,0.3034634652720671,1.0,20/47,31.02%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;GBGT1;NEU1;PGAP3;ASAH1;PGAP1;ABCA2;B4GALNT1;CPTP;CERK;ST3GAL4;B3GALNT1;ST8SIA6
prerank,regulation of peptide hormone secretion (GO:0090276),0.34899849301323527,1.2918665530739257,0.10158013544018059,0.4141812880965045,1.0,16/67,16.10%,HTR2C;CACNA1C;CACNA1E;KCNC2;SNAP25;PAX8;RAPGEF4;ADRA2C;NEUROD1;FFAR1;PER2;SYT7;KCNS3;RFX3;PRKCA;GRP
prerank,cellular response to interleukin-7 (GO:0098761),-0.4911982051463001,-1.2918472049342211,0.13986013986013987,0.30370985591485494,1.0,7/17,19.50%,STAT3;STAT5B;JAK1;IL7R;IL2RG;IRS2;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4911982051463001,-1.2918472049342211,0.13986013986013987,0.30370985591485494,1.0,7/17,19.50%,STAT3;STAT5B;JAK1;IL7R;IL2RG;IRS2;IL7
prerank,aorta morphogenesis (GO:0035909),-0.48794081668036576,-1.2916191318266823,0.146218487394958,0.3038190895835393,1.0,3/17,5.75%,RBPJ;LRP1;JAG1
prerank,positive regulation of filopodium assembly (GO:0051491),0.43799094743974765,1.291494684408992,0.14146341463414633,0.41371012119952,1.0,4/24,1.82%,NLGN1;TENM2;TENM1;GPM6A
prerank,early endosome to late endosome transport (GO:0045022),-0.4734903138833225,-1.291159642504498,0.1486725663716814,0.30431390278765075,1.0,8/20,18.03%,RAB7A;KIF16B;STX8;EEA1;RAB5A;WDR91;SNX16;RILP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4935780109935063,1.2907911983790121,0.16502463054187191,0.413958278247414,1.0,6/15,13.91%,CELF4;RAI2;STOX2;TGFB2;UBR3;NR5A2
prerank,amino acid transmembrane transport (GO:0003333),-0.39434322742104955,-1.2904700043110486,0.10252100840336134,0.30528581901195073,1.0,11/45,14.61%,LRRC8D;SLC38A6;SLC6A6;MFSD12;SLC38A10;SLC38A7;SLC7A7;SLC36A4;SFXN2;SLC7A5;SFXN1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4071313854486591,-1.2904486308346428,0.12416107382550336,0.3050496160884783,1.0,10/35,11.97%,ARHGAP24;ABL2;TNFAIP1;RIPOR2;KCTD10;SPRY2;RASAL3;CCDC125;FLCN;ITGA3
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.3940413738004632,-1.2904290127392755,0.13175675675675674,0.304804048687865,1.0,21/42,43.06%,CCR2;CCR1;PTK2B;PF4;CCL5;CIB1;WNK1;CCL7;CCL24;CCL4;CCL19;CCL25;ACKR3;CCL8;CXCL9;CXCL1;CCL14;SH2B3;RBM15;CXCL10;OXSR1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.468785264846571,1.2895206214462147,0.1511627906976744,0.41534413233351514,1.0,6/19,6.90%,HS3ST5;HS6ST3;HS6ST2;NDST4;NDST3;GLCE
prerank,nucleus organization (GO:0006997),-0.38436660215323587,-1.2893095816078883,0.12141652613827993,0.30647336886035853,1.0,18/47,21.84%,PDCD6IP;ATXN7;CHMP5;USP36;SUN2;CHMP7;NUP205;TPR;CHMP1A;WDR73;CHMP2A;LEMD2;CEP55;NUP35;REEP3;CHMP4B;CHMP4A;VPS4A
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5394463672219395,1.2892564508338094,0.19103773584905662,0.4147015441976904,1.0,3/10,10.80%,DLGAP1;DLGAP2;DLGAP3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5571092913516906,-1.2886907364892342,0.15467625899280577,0.307278295051314,1.0,7/11,22.48%,RIPK1;PF4;ID2;IL34;CASP8;CSF1;TGFB1
prerank,epithelial cell morphogenesis (GO:0003382),-0.4894219566953228,-1.2886634403710129,0.16351118760757316,0.307058512972131,1.0,12/17,35.71%,SIPA1L3;COL22A1;COL18A1;RILPL1;PKHD1;CCDC88C;RILPL2;GRHL2;MET;TNMD;CNMD;POF1B
prerank,cellular response to sterol (GO:0036315),0.5092364923873455,1.2886461484768965,0.16783216783216784,0.4148282324852063,1.0,5/13,12.52%,RORA;OSBPL7;INSIG1;SMO;RORC
prerank,cardiocyte differentiation (GO:0035051),0.5350614983658712,1.2886327873500607,0.16458852867830423,0.41366168203668097,1.0,5/10,11.39%,NRG1;CBY1;TGFB2;MYOCD;EEF1AKMT4-ECE2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.44531549523155256,-1.288522826012893,0.15716753022452504,0.3070004906913645,1.0,8/24,15.68%,LYN;CCR2;ANO6;CCR1;CCL5;SERPINE1;GREM1;PLA2G7
prerank,aortic valve development (GO:0003176),0.39064539584772495,1.287837731235088,0.12106537530266344,0.4140829248984579,1.0,7/34,10.06%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,ncRNA transcription (GO:0098781),-0.521921429237634,-1.287779285154554,0.16666666666666666,0.3079878662974766,1.0,8/13,26.25%,SNAPC2;SPIN1;NIFK;USPL1;SNAPC3;ANG;GTF3A;BRF1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5387095161849212,1.2877692559201623,0.16371681415929204,0.41302111103968797,1.0,4/11,10.76%,KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,regulated exocytosis (GO:0045055),-0.3076437757850831,-1.287251645859048,0.039936102236421724,0.3085324031708393,1.0,39/173,12.81%,F13A1;LYN;IGF1;PSAP;PLEK;MYH9;PHACTR2;CD36;ARHGAP17;FLNA;TAGLN2;RAB31;CD9;CYB5R1;RAB11FIP5;LAMP2;LHFPL2;SYNGR1;SRGN;ANXA5;TMED10;TLN1;PF4;HGF;FN1;PROS1;CYRIB;TEX264;GAS6;RIMS3;VEGFA;SYT4;CD63;WDR1;APP;RAB11B;RAB10;SERPINE1;ABCC4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.35538147052828817,-1.2871648797313984,0.0868824531516184,0.30839330587651165,1.0,20/73,17.73%,DEK;DNMT3A;SMARCA5;SPI1;ERCC6;ACTB;JARID2;EZH2;POLR2H;EED;POLR2F;WBP2;POLR2L;ZFP57;HDAC5;EPC1;RBBP4;SPHK2;TAF1A;POLR1F
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3378416052716613,1.2868886704621232,0.08521303258145363,0.41361534610097495,1.0,20/76,15.93%,GRM5;HTR2C;CHRM2;GRM1;P2RY12;OPRD1;PLCE1;ADRA1B;HOMER1;TRHR;PTH1R;CX3CR1;CCKBR;AGTR1;F2RL2;ADRA1A;ADRA1D;OPRK1;OPRL1;OPRM1
prerank,negative regulation of neuron differentiation (GO:0045665),0.44396955404106236,1.286823856684282,0.14390243902439023,0.41259792689967023,1.0,8/22,17.38%,CNTN4;SOX9;BMP7;POU4F2;HES5;REST;HES1;HES3
prerank,basement membrane organization (GO:0071711),0.49065370576854794,1.2862936359783996,0.18138424821002386,0.41244147876583526,1.0,7/14,22.23%,NTNG2;NTNG1;FLRT2;NID2;RAMP2;NID1;NTN4
prerank,actin filament bundle assembly (GO:0051017),-0.40664908160019253,-1.2859662405504435,0.10294117647058823,0.31018413226350133,1.0,8/33,11.81%,NEDD9;EPS8;BAIAP2;LCP1;LIMA1;MICAL1;HSP90B1;BAIAP2L2
prerank,regulation of macrophage differentiation (GO:0045649),-0.5120224011146225,-1.2855329921228849,0.13824057450628366,0.31071884278053946,1.0,8/15,22.16%,RIPK1;PF4;ID2;IL34;C1QC;CASP8;CSF1;INHA
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5187023507163033,-1.2855199713912078,0.15985790408525755,0.31046184261811094,1.0,8/13,30.02%,GNPDA1;UAP1L1;UAP1;GFPT1;GNPDA2;AMDHD2;RENBP;GNPNAT1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.5322096709681797,-1.2854568910177737,0.16106194690265488,0.3102989395178334,1.0,6/12,17.44%,NABP1;PLK2;ZWILCH;BUB1;BUB1B;WEE1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.523800245118538,-1.2844422403984708,0.16639209225700163,0.311743066841753,1.0,6/13,23.87%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,pore complex assembly (GO:0046931),-0.4701587983116834,-1.2838081676644146,0.15669014084507044,0.3125571482878924,1.0,7/19,20.52%,P2RX7;ANO6;NUP205;TPR;PDZD11;NUP153;NUP107
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4200824077882559,-1.2836163101818905,0.12006861063464837,0.31262044407789963,1.0,13/33,22.41%,PLCG2;PSME3;EZH2;E2F1;PTPN6;KIF14;ID2;INO80;APPL2;TRIM39;FAM83D;APPL1;TCIM
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.49725993053692796,-1.2833416709097694,0.15268456375838926,0.3128198563950807,1.0,6/16,18.22%,PIBF1;PARP14;ADIPOR1;NF2;VHL;SOCS3
prerank,protein-containing complex disassembly (GO:0032984),-0.37713243524610207,-1.28313626901156,0.11371237458193979,0.312903175722472,1.0,25/54,32.14%,TECPR1;LAMP2;UVRAG;AXIN1;TSG101;LRP6;CTNNB1;PPP1CA;EPG5;LIX1;GABARAP;CLN3;VPS33A;GSK3B;VPS4A;DVL2;VPS16;MYC;FZD1;VCP;HSPA8;FRAT1;GABARAPL1;STX17;CAV1
prerank,negative regulation of hemostasis (GO:1900047),-0.5392838546044602,-1.282924623471415,0.17122040072859745,0.3129863500205728,1.0,5/12,23.52%,APOE;TFPI;SERPINE1;APOH;ADTRP
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.37488273949937784,-1.282180157519501,0.12582781456953643,0.3140183406002533,1.0,21/57,23.03%,RPL7;RPS24;RPS6;RPL11;NOP14;RPS28;NVL;DHX37;CUL4B;RPL14;DDX31;EMG1;PAK1IP1;SHQ1;SURF6;RPS16;GTF3A;TGS1;NIP7;WDR12;RPS15
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.46211842289882954,-1.2820242482432724,0.14821124361158433,0.3140116807328162,1.0,8/20,16.02%,PLEK;ROCK1;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13
prerank,Rho protein signal transduction (GO:0007266),-0.36581437242948595,-1.2818697996111432,0.09967320261437909,0.31402105238420336,1.0,11/53,11.39%,MYO9B;ROCK1;ARHGEF3;RHOA;EPS8;GNA12;CDC42;CDC42EP2;GNA13;ARHGEF11;PLEKHG5
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.479734480038536,-1.2817999662833055,0.15853658536585366,0.3138799507928858,1.0,3/17,5.75%,RBPJ;NOTCH2;JAG1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.42396364385360563,-1.2815729373624642,0.13194444444444445,0.313968315168473,1.0,17/31,34.20%,ERN1;OPTN;HSPA9;ATXN3;DNAJB14;TMBIM6;BAG3;HSPA1A;HSPA2;HSPA13;PTPN1;HSPA8;STUB1;HSPA1B;DNAJB12;RHBDD1;DNAJC18
prerank,response to organophosphorus (GO:0046683),-0.4911623519347732,-1.281136295000252,0.15436241610738255,0.3144400068428165,1.0,5/16,20.91%,P2RX7;P2RX4;TRIM16;RFC3;STAT1
prerank,positive regulation of DNA repair (GO:0045739),-0.38655047668604325,-1.28054108864523,0.12758620689655173,0.3151737649397419,1.0,21/46,19.87%,SPIDR;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;MGMT;RNF8;HDAC10;TIMELESS;PCNA;BABAM1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;HMGB1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34224671095258075,-1.280308404211197,0.08485856905158069,0.3152980003057738,1.0,28/87,22.48%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;USP9X;ARHGEF18;SKI;TGFBR1;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;APPL2;FMOD;SMAD7;ID1;APPL1;USP9Y;EID2;TGFB1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.39289729227600395,-1.279848585440071,0.14814814814814814,0.31582044489290517,1.0,10/42,13.20%,OPTN;IL6R;TLR4;RNASE7;CHGA;CAMP;HMGB2;SERPINE1;RNASE6;DEFA6
prerank,macrophage migration (GO:1905517),-0.5196771733772689,-1.2797266605353375,0.17028380634390652,0.31578042971463605,1.0,4/13,12.60%,CCR2;P2RX4;CKLF;CCL5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3383003103692768,-1.279484579127239,0.08040201005025126,0.31592609405916605,1.0,29/88,18.07%,MYO5A;VPS13C;FTL;DNM2;VPS13A;KIF16B;AP1G1;ARRB1;EXOC4;EPS15;OSBPL5;VPS35L;AP1S3;SYS1;CORO7;APP;TXNDC5;ARFGEF2;RABEP1;RAB10;CLINT1;ARL3;CHMP2A;RP2;DTNBP1;STX4;EXOC2;AP1S2;DOP1B
prerank,axonemal dynein complex assembly (GO:0070286),0.41858321564441436,1.2790247832059938,0.12527472527472527,0.42614563989044285,1.0,6/27,10.18%,DNAAF3;DNAI4;ODAD3;DNAH17;DNAAF4;CFAP73
prerank,positive regulation of cartilage development (GO:0061036),0.4694002126570594,1.2787292624405484,0.1750599520383693,0.4255022511649681,1.0,6/17,11.23%,BMPR1B;SOX5;SOX6;SOX9;BMP1;TAPT1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.42849149022363986,1.2784373875551678,0.1566265060240964,0.42488558887235256,1.0,8/27,15.26%,ANK2;DMD;CACNB2;PDE4D;JPH4;CALM1;CALM2;JPH3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.48282503413291067,-1.278392175455884,0.1549053356282272,0.3174989476964403,1.0,12/17,42.94%,SELENOS;DERL1;SEL1L;HSP90B1;HM13;FAF2;VCP;AUP1;RHBDD1;OS9;HERPUD1;SYVN1
prerank,protein import into peroxisome membrane (GO:0045046),-0.4512325088344045,-1.2780052293297828,0.1574539363484087,0.31790864272241276,1.0,5/22,9.92%,RAB8B;PEX14;ABCD2;PEX26;FIS1
prerank,positive regulation of neuron migration (GO:2001224),-0.5471181998111188,-1.277687224799336,0.16695352839931152,0.31817058570172907,1.0,4/11,7.95%,ARHGEF2;NIPBL;KIF20B;MDK
prerank,regulation of insulin secretion (GO:0050796),0.32100140689416784,1.2763584992261865,0.08549222797927461,0.4279111171322929,1.0,24/101,15.81%,CACNA1C;CACNA1E;EFNA5;KCNC2;SNAP25;EPHA5;ADCY5;CCN3;RAPGEF4;NR1D1;ADRA2C;NEUROD1;CAPN10;FFAR1;PER2;REST;SYT7;PRKN;KCNS3;INHBB;IRS1;NLGN2;RFX3;PRKCA
prerank,androgen metabolic process (GO:0008209),-0.46930528647941894,-1.275817119738006,0.15944540727902945,0.32111154020655674,1.0,10/18,37.77%,HSD17B7;SPP1;SRD5A1;SRD5A2;HSD17B10;HSD3B2;SRD5A3;HSD17B3;AKR1D1;CYP19A1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.47158418482650066,-1.2757168914942767,0.16666666666666666,0.32101016110720065,1.0,5/18,17.31%,APOE;ABCG1;PSENEN;CLN3;ADAM19
prerank,positive regulation of neuron death (GO:1901216),-0.3847132227888241,-1.2753118199790732,0.127208480565371,0.3214882463220737,1.0,11/46,12.50%,MAP3K5;ITGB2;C1QA;NUPR1;FOXO3;TLR4;PICALM;GRN;CTNNB1;EGR1;FCGR2B
prerank,RNA methylation (GO:0001510),-0.3647049669467535,-1.2752618855435878,0.10034013605442177,0.321303430865971,1.0,26/60,34.22%,NSUN3;METTL1;NSUN4;DIMT1;CBLL1;PCIF1;TRMT44;METTL14;METTL6;VIRMA;TRMT6;WTAP;BCDIN3D;METTL2A;METTL2B;TGS1;THADA;BUD23;RBM15B;MRM2;METTL3;FTSJ1;ZCCHC4;TRMT61A;METTL5;TRMT61B
prerank,multivesicular body assembly (GO:0036258),-0.42042619686342947,-1.2750586909694674,0.12522686025408347,0.32138964719531293,1.0,17/30,35.19%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;CHMP4B;CHMP4A;VPS4A;CHMP2B;MVB12A;VPS4B;VTA1;IST1;HGS
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.28687336127334806,-1.274904185974665,0.02627511591962906,0.3213841514849866,1.0,59/308,14.27%,DAB2;APOE;PRKCH;ABCA1;B4GALT5;FGR;RREB1;CCR2;SDCBP;SYK;LRP1;ROCK1;CD36;NIBAN2;OGT;GAPDH;AGO2;IGF1R;FABP5;KDM3A;HTR2B;IL15;SLC27A1;IL18;STAT6;DYNC1H1;ADIPOR1;PTGER4;BATF;UCP2;PIK3CG;GCNT2;CTNNB1;EZH2;GAS6;PLAC8;VEGFA;KMT5B;MDK;EIF2AK2;RBM19;TGFBR1;CD28;TGFB1I1;KMT5C;CLEC9A;FABP4;ITGAX;AGT;XBP1;IL4R;FOXJ1;CLEC6A;ITK;SERPINE1;PIK3CD;NFAM1;TGFBR2;AGPAT1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.45399428114357804,1.2743325308376279,0.16105769230769232,0.43085646571557357,1.0,3/20,1.22%,CHRM2;PLCB1;CHRM3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5126596680381104,1.2737580054250035,0.1945080091533181,0.43085711192603876,1.0,6/13,14.99%,ADCY8;SHANK3;ADCY1;RELN;LGMN;CHRNA7
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.37737208463813054,-1.273485111304223,0.09866220735785954,0.323604831193279,1.0,19/51,23.49%,CCR2;ANO6;IL6R;CCR1;GAS6;VEGFA;MDK;F7;CCL5;SERPINE1;IL34;PLA2G7;CMKLR1;LGALS9;CSF1;C1QBP;HMGB1;IL6;MAPK1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.47599956175640473,-1.2733793599877794,0.15985790408525755,0.32352915972232354,1.0,10/18,32.34%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C;RCC2;VPS4B
prerank,regulation of myotube differentiation (GO:0010830),-0.44475405030324355,-1.2729763918135768,0.15492957746478872,0.32395750789416816,1.0,7/24,14.08%,PIEZO1;MAML1;MAPK14;SIK1;XBP1;SMYD1;HDAC5
prerank,peptidyl-lysine modification (GO:0018205),-0.33236113466687406,-1.2728689544504042,0.08291873963515754,0.32384180745904634,1.0,36/99,29.79%,NSMCE2;NUP50;PIAS1;ATP7A;NUP42;NUP88;RAE1;SENP3;SIRT3;HDAC10;NUP205;TPR;NUP188;USPL1;UBA2;UBE2I;EYA1;NUP153;NUP35;SIRT2;NUP107;NUP62;EGR2;TOPORS;PLOD3;METTL21A;SUMO3;SAE1;RANBP2;TRIM28;NUP37;PIAS2;PLOD1;EP300;AAAS;NUP133
prerank,endodermal cell differentiation (GO:0035987),-0.40724133184117517,-1.272557981864861,0.14716312056737588,0.32415283342500073,1.0,7/31,10.39%,ITGA4;ITGB2;ITGA5;CTR9;ITGAV;FN1;ITGB5
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4010518114833008,-1.2723653017405825,0.12280701754385964,0.32421935763563764,1.0,10/36,12.50%,MSR1;ARHGAP25;MYH9;RAC1;ITGB2;CD36;CDC42;SH3BP1;ARHGAP12;FCGR2B
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.49727673769954645,-1.272361420318575,0.15641476274165203,0.3239499381104205,1.0,5/15,8.88%,RBPJ;PTPN12;RHBDF1;RHBDF2;MVB12B
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.3033861992025479,-1.2721893957054218,0.050156739811912224,0.32401129510234583,1.0,55/184,20.84%,PSME4;PSMB7;ANAPC1;CNTRL;PSME3;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;E2F1;CENPE;CKAP5;NEK6;PTPN6;PSMA8;UBC;RPS27A;YWHAE;TPX2;KLHL18;PSMC3;CEP70;KIF14;HAUS4;CDK1;DCTN1;PSMD8;HAUS7;BUB1B;PSMC4;PSMB10;PSMA1;ID2;TFAP4;INO80;PPP1R9B;APPL2;NINL;UBE2C;ODF2;AURKA;ANAPC7;PSMB8;PCNT;PSMD4;PSMA5;PAFAH1B1;PSMB3;APPL1;SIRT2;PSMD3;CEP192
prerank,activation of protein kinase activity (GO:0032147),-0.3284813083329982,-1.2721774568339206,0.08095238095238096,0.323753998294345,1.0,27/106,14.04%,OSBPL8;TAOK3;IGF1;PAK2;PRKCD;ADCY7;INSR;MALT1;PRRC1;MINK1;PIBF1;IL18;PTK2B;STK3;AXIN1;GAS6;VEGFA;ITGB1BP1;TPX2;KIF14;TAOK1;CCDC88A;STK11;TRAF2;MARK2;TGFBR2;CALCA
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3884178484842517,-1.2710559326075919,0.13153153153153152,0.3253515070303916,1.0,14/40,26.34%,CSNK2A1;GNA12;PTK2B;AXIN1;RPL11;NUB1;LAPTM5;UBE3A;UBQLN4;TRIM39;SGTA;RPL5;SMURF1;PML
prerank,T cell differentiation (GO:0030217),-0.38959355875759194,-1.27063078875071,0.1254180602006689,0.3258358807630776,1.0,11/40,17.91%,PTPRC;SPI1;PTPN22;ANXA1;CD28;LCK;TCF7;FCER1G;PIK3CD;ZAP70;GATA3
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3869380915593784,-1.270619130467428,0.12251655629139073,0.3255766508239166,1.0,9/42,8.12%,CORO1C;RSU1;RAC1;RHOA;MINK1;PIK3CB;GCNT2;MYADM;ATXN3
prerank,renal filtration (GO:0097205),-0.5505398998746289,-1.2702717713566656,0.19649122807017544,0.3259663343442823,1.0,5/10,18.37%,SULF2;TBC1D8B;MYO1E;ITGA3;XPNPEP3
prerank,metal ion export (GO:0070839),0.3995193031528019,1.2701376644428706,0.13921113689095127,0.43720317914185536,1.0,9/31,17.36%,KCND3;KCNT2;SLC4A4;KCNIP2;ATP1A3;ATP1B1;ATP2B4;KCNE4;ATP1B2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3907082707558527,-1.269881372546278,0.12687813021702837,0.3263553590590345,1.0,8/39,5.75%,RBPJ;ZMIZ1;TSPAN14;CREBBP;MAML1;STAT3;MAML2;JAG1
prerank,neurotransmitter uptake (GO:0001504),0.5153429680296638,1.2695002507555802,0.19339622641509435,0.437364234096459,1.0,3/12,7.16%,SNAP25;SLC1A6;GLUL
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.478664047748525,-1.2692833112896067,0.17689530685920576,0.3271157360069442,1.0,10/17,36.78%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A;IL12B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4671566312074216,-1.268795953026339,0.1634446397188049,0.32762772483014596,1.0,12/18,35.74%,ANXA1;VEGFA;CIB1;PIK3C2A;KDR;MAP3K3;HMOX1;FGF2;HDAC7;HDAC9;GATA2;SRPX2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4321086169728875,-1.2681533691678524,0.1503623188405797,0.32849985850090924,1.0,8/26,10.24%,CCR2;HPSE;BRCA1;SARS1;C3;SULF2;HIF1A;ARNT
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.5420152965969952,-1.2679872304017004,0.18588640275387264,0.32852162425369,1.0,6/11,16.84%,ITGB2;SPI1;STAP1;TICAM1;MAVS;STX4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.48529231769870484,1.267874145298663,0.20048899755501223,0.4395735244927487,1.0,4/13,15.79%,SYT1;SYT10;HYAL3;CACNA1G
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.42534525591054395,-1.2670640612747133,0.1611785095320624,0.32986896431422635,1.0,6/26,6.90%,LYN;USP50;STAT3;PSME3;AIM2;PICALM
prerank,potassium ion homeostasis (GO:0055075),0.4294038986340427,1.2669684069580405,0.15349887133182843,0.4402077751066675,1.0,7/23,12.69%,SLC12A2;SLC12A8;SLC12A1;ATP1A3;ATP1B1;SLC12A5;KCNMA1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.336082411944099,1.2669526320022269,0.10026385224274406,0.4390225726152392,1.0,18/75,12.24%,METAP2;KCTD8;PLCB1;RGS6;FRMPD1;GIT2;RAMP3;RGS20;PLCE1;FNTB;GNG7;GRK4;CAMKMT;EDN1;CAMK2A;MRAP;FNTA;CALM1
prerank,digestive tract development (GO:0048565),0.39080474543859633,1.266656901496623,0.13768115942028986,0.43837258393959194,1.0,13/32,20.50%,PCSK5;CLMP;RARB;COBL;TGFB2;SALL1;SMO;PKD1;GLI3;EPHB3;BBS7;GLI2;KIT
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.37455688379046703,-1.2664218392067903,0.1323024054982818,0.33068217008620465,1.0,11/48,7.54%,PTPRC;SAMHD1;YTHDF3;USP18;PPARG;PARP14;STAP1;NLRC5;NR1H2;IRAK3;GAS6
prerank,stem cell differentiation (GO:0048863),-0.3854868156841979,-1.266054672014531,0.13781512605042018,0.3310783841420314,1.0,9/39,11.39%,PTPRC;NELFB;HTR2B;FBXL17;BATF;LRP6;JARID2;MEF2C;OSR1
prerank,neuromuscular process (GO:0050905),0.4758551610420413,1.2659443501163519,0.17464114832535885,0.43865530714359807,1.0,4/16,9.60%,NRXN1;MYCBP2;KCNA1;PRRT2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3965350228111542,-1.2658834527367857,0.13829787234042554,0.3311020438847378,1.0,18/39,27.07%,APOE;MSN;ROCK1;CD36;RAP1B;RAP1A;AGT;TRAF2;SPTY2D1;ANKRA2;PARP10;PTPN11;GFAP;HJURP;VPS11;HSPA8;RAPGEF2;BBS10
prerank,response to acidic pH (GO:0010447),-0.5091452656794745,-1.2657470578611543,0.18706293706293706,0.33108024896580496,1.0,5/13,18.59%,RAB11FIP5;SLC9A1;RAB11B;CTSS;GPR65
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4041938669517987,-1.2654542605638852,0.12542372881355932,0.3313441587724316,1.0,12/33,21.14%,NUPR1;NFE2L2;GAS6;MDK;WFS1;CAST;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,energy reserve metabolic process (GO:0006112),-0.46813201692237527,-1.2650345446349514,0.1509090909090909,0.3317745560764229,1.0,9/19,25.54%,PID1;PRKAG2;PHKG2;GBE1;GSK3B;GFPT1;PYGL;MYC;MT3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.40803075513860554,-1.2647471757326312,0.141156462585034,0.33200655617039276,1.0,10/33,12.69%,LYN;SYK;PLAU;DPP4;ADAM9;PIK3CG;ITGB1BP1;NCKAP1L;CIB1;SERPINE1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5482742699300842,1.2647190126803423,0.19221967963386727,0.4400233643776401,1.0,1/10,0.68%,ANK3
prerank,positive regulation of macrophage activation (GO:0043032),-0.4713024207605905,-1.2645940712920367,0.17421602787456447,0.33200465198779566,1.0,5/17,18.45%,TLR4;STAP1;TNIP2;KARS1;MMP8
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.37504266600087877,-1.2641855027111455,0.11231884057971014,0.3324786440721221,1.0,12/48,7.95%,NEDD9;NRP1;RREB1;RAC1;FBXW8;FLNA;CDC42;TRIOBP;CUX1;DOCK5;MYADM;MDK
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.31078239900784704,1.263871796123116,0.06234413965087282,0.44054169329979226,1.0,30/110,17.20%,ADGRB3;ADGRL3;ADCY2;ADCY8;LGR5;ADCY5;RAMP3;ADRA1B;ADCY3;GPR101;PTH1R;ADGRL2;ADCY1;GPR3;ADRA2C;GHRH;CALCB;LPAR2;LGR4;ADRA1A;ADRA1D;ADRB1;ADGRG1;GPR26;GNAL;ADGRB2;IAPP;RAMP2;ADGRL4;CRHR1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.37667750952017715,-1.2636674311136882,0.12947189097103917,0.33318086336827146,1.0,15/47,24.44%,TAOK3;IGF1R;RAP2A;EIF2AK2;TAOK1;MAP2K1;GREM1;TAOK2;COPS5;NOD2;LGALS9;AGER;MAP4K4;MAPK1;MYC
prerank,keratan sulfate metabolic process (GO:0042339),-0.4093710606439737,-1.263490715780061,0.14742451154529307,0.3332149253084695,1.0,8/31,10.64%,B4GALT5;HEXA;ST3GAL1;GNS;GALNS;SLC35D2;PRELP;B3GNT2
prerank,regulation of protein ubiquitination (GO:0031396),-0.3264530070386743,-1.2633756464478743,0.08240887480190175,0.3331546049745752,1.0,42/108,32.32%,SASH1;BIRC3;OGT;MALT1;ARRB2;BRCA1;AXIN1;ARRB1;LAPTM5;DNAJA1;WFS1;TGFBR1;UBE2L3;PRMT3;SPRY2;DERL1;UBE3A;HSP90AB1;NSMCE3;ISG15;TBC1D7;SMAD7;HSPA1A;RPS3;HUWE1;NDFIP2;UBXN1;HDAC8;UBE2N;CUL3;U2AF2;RIPK2;XIAP;PTTG1IP;TRAF6;BCL10;SQSTM1;HSPBP1;CAV1;STUB1;FANCI;HSPA1B
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5130472203953407,-1.263056115044478,0.21465968586387435,0.33343142043328533,1.0,7/12,31.23%,MCM6;MCM3;MCM2;GINS4;CDC45;MCM5;MCM7
prerank,calcium ion import (GO:0070509),0.4060958180383412,1.2629700917109172,0.15639810426540285,0.4413241714415103,1.0,7/28,15.79%,CACNA1C;CACNA1E;CACNB2;SLC25A23;MICU3;ATP2A1;CACNA1G
prerank,muscle cell development (GO:0055001),0.3941226740354461,1.2629565862371075,0.14918414918414918,0.4401424050463835,1.0,9/30,14.06%,SGCZ;ANK2;DMD;SDC1;NEBL;TTN;DYSF;ALPK2;HES1
prerank,regulation of cilium assembly (GO:1902017),-0.3608584994336286,-1.2628786257017819,0.10996563573883161,0.3334723539090559,1.0,19/62,16.72%,TBC1D15;ATG5;TBC1D2B;IFT20;TBC1D5;TBC1D1;SDCCAG8;TBC1D22A;TBC1D16;TBC1D22B;TBC1D8;TBC1D17;CCDC88A;TBC1D10B;TBC1D30;DYNLT2B;TBC1D7;TBC1D24;TBC1D9B
prerank,histone lysine demethylation (GO:0070076),-0.4372649713851026,-1.2627802671743993,0.14261168384879724,0.3333802656781013,1.0,11/25,30.51%,KDM3A;JMJD1C;KDM7A;KDM3B;KDM2A;HR;KDM5B;KDM1A;KDM2B;KDM6A;RIOX2
prerank,oligodendrocyte differentiation (GO:0048709),0.4535830128087889,1.2625874567492092,0.1897810218978102,0.4397194262477609,1.0,6/19,11.95%,SLC8A3;SOX6;SOX13;SOX9;PTPRZ1;HES5
prerank,regulation of cytokinesis (GO:0032465),-0.3428013033673261,-1.2625352837125101,0.10526315789473684,0.33353971067941585,1.0,26/78,25.08%,ZFYVE26;BIRC6;RHOA;SVIL;UVRAG;CDC42;KIF20B;KIF23;PLK2;PIN1;KIF14;FLCN;PLK3;E2F8;SH3GLB1;RACGAP1;KIF20A;AURKA;CSPP1;RAB11A;PRC1;ZFYVE19;VPS4A;BECN1;CETN2;ECT2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5159710680724524,-1.2624401679698531,0.1936619718309859,0.3334272989351203,1.0,3/12,13.56%,APOBEC1;RESF1;SETDB1
prerank,muscle tissue morphogenesis (GO:0060415),0.4694285856600263,1.262383714931365,0.17715617715617715,0.43894566246802225,1.0,5/16,20.54%,TBX1;TTN;MYLK;TGFBR3;EFEMP2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49845412935294425,-1.2623729796048082,0.17565217391304347,0.33327018585276513,1.0,4/14,7.13%,PTPRC;IGF1;TNFRSF1B;GRN
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.436736816566088,1.2615071577883525,0.16511627906976745,0.43961761207723826,1.0,2/21,1.49%,ANK2;CACNA2D1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.3558942470509729,-1.2611246068459638,0.10702341137123746,0.335197865249917,1.0,21/61,18.51%,CDK6;RB1;GSPT1;GPR132;CRLF3;PLK2;E2F1;E2F3;DBF4;EIF4EBP1;CDKN3;CDC25A;CUL4B;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;CDKN2C;RCC1
prerank,carbohydrate derivative transport (GO:1901264),-0.46995295349871224,-1.261070789451248,0.16607773851590105,0.33501408440536445,1.0,7/18,17.15%,ABCG1;PLTP;SLC10A7;SLC15A3;NPC2;CLN3;SLC29A1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.38974543938191747,-1.2610672687925044,0.12956810631229235,0.33474309012213443,1.0,11/39,21.14%,ITGA4;ANO6;NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;CD40;GATA3;NDNF;KDR
prerank,myotube differentiation (GO:0014902),0.4754932846611861,1.260882540516652,0.1773049645390071,0.43984696050394523,1.0,3/17,2.82%,ADGRB3;ADAM12;KCNH1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4810308514031595,1.2604725996493193,0.1820388349514563,0.43949135812759793,1.0,8/15,22.91%,HMGCS1;NUDT7;ACACA;MVK;ACAT1;MLYCD;ACSS1;MVD
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.33482423487514357,-1.2602474436613342,0.1,0.33592759007845396,1.0,25/87,20.62%,CDK6;RB1;BRD7;PSME4;PSMB7;PSME3;GPR132;PRMT2;PSMB9;PSMA8;PSMC3;PSMD8;AVEN;PSMC4;PSMB10;PSMA1;AURKA;WEE1;PSMB8;CDKN2C;CDK2AP2;PSMD4;PSMA5;PSMB3;PSMD3
prerank,response to amino acid starvation (GO:1990928),-0.34716184342066336,-1.2602444426541133,0.100169779286927,0.3356562890098345,1.0,24/72,27.48%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;FLCN;RRAGD;SESN1;ATP6V0B;SH3GLB1;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;WDR24;KPTN;MAPK1;LAMTOR1;LAMTOR3;MIOS;EIF2AK3
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.34122899819831876,-1.2599784999101042,0.10714285714285714,0.3358564540781315,1.0,16/76,11.81%,NRP1;P2RX7;PLEK;SNX9;FES;CDC42;PTK2B;STAP1;DYNC1H1;BAIAP2;KATNBL1;NES;NCKAP1L;WDR1;CDC42EP2;BAIAP2L2
prerank,cell projection assembly (GO:0030031),-0.4454692527819909,-1.2596333572801168,0.16112084063047286,0.3362216182346342,1.0,6/22,9.98%,RAC1;PARVB;CDC42;RHOQ;CAPG;NCKAP1L
prerank,cellular response to amino acid starvation (GO:0034198),-0.34736984438251384,-1.2592128112563663,0.1054421768707483,0.33671995667717686,1.0,24/71,27.48%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;FLCN;RRAGD;SESN1;ATP6V0B;SH3GLB1;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;WDR24;KPTN;MAPK1;LAMTOR1;LAMTOR3;MIOS;EIF2AK3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5263170220497474,1.258896708128899,0.22249388753056235,0.4416026890907496,1.0,7/10,27.43%,SARDH;BHMT;SMOX;ALDH7A1;HNMT;LRTOMT;SLC44A1
prerank,regulation of mitochondrial translation (GO:0070129),-0.4462006497105194,-1.2587116089354993,0.1695205479452055,0.3373582289166938,1.0,7/21,19.74%,NSUN3;ALKBH1;FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,negative regulation of phosphorylation (GO:0042326),-0.3345129002311818,-1.2586110477623504,0.08709677419354839,0.33726797670765396,1.0,14/85,7.80%,PID1;LYN;CORO1C;XDH;NIBAN1;ROCK1;NUPR1;IBTK;STAP1;PPP1R15B;CBFA2T3;LRP6;MYADM;SIRPA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4608619590622139,1.2585062106616158,0.1775,0.44126242965076184,1.0,4/18,5.48%,CHRM2;PLCB1;CHRM3;HRH3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3799935069319888,-1.2583718521705578,0.14358108108108109,0.33742454592366045,1.0,7/43,5.55%,PID1;PRKCB;PRKCD;OGT;PIP4K2A;PTPRE;SNX5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.33592777422571146,-1.257517111871767,0.10666666666666667,0.3386556314084668,1.0,26/84,20.62%,RB1;PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;UBC;RPS27A;PSMC3;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;PSMA1;UBE2C;SKP2;AURKA;ANAPC7;PSMB8;PSMD4;PSMA5;FBXO31;PSMB3;PSMD3
prerank,regulation of neuron projection arborization (GO:0150011),0.4768772359226886,1.2574747484162194,0.18333333333333332,0.44232452396726935,1.0,7/15,19.60%,GRIP1;NTNG2;NTNG1;MFSD2A;MAP3K13;FZD4;WNT5A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.49080834247594896,-1.2570680444808933,0.1844331641285956,0.3391640592291067,1.0,3/15,5.66%,PPARD;PPARG;NR1H2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48310405892076685,-1.2570540361766491,0.1953405017921147,0.3389072337591901,1.0,9/16,35.67%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A
prerank,membrane depolarization (GO:0051899),0.3992985674390621,1.256507260429653,0.16105769230769232,0.443130107371588,1.0,7/32,7.55%,CACNA1E;SCN2A;SCN1A;SCN3A;SCN9A;CACNG4;CACNG2
prerank,positive regulation of lipid localization (GO:1905954),-0.5323239056762482,-1.2559553542526005,0.1936619718309859,0.3406157337147605,1.0,4/11,9.57%,LRP1;NFKB1;C3;LPL
prerank,regulation of centrosome duplication (GO:0010824),-0.4157318501453856,-1.2557427973488435,0.14938488576449913,0.3407387181656374,1.0,14/29,24.62%,PDCD6IP;CEP295;CHMP5;PLK2;CEP295NL;GEN1;CHMP1A;CHMP2A;STIL;XRCC3;CHMP4B;CCNF;PKHD1;CHMP2B
prerank,negative regulation of blood coagulation (GO:0030195),-0.39079458120698884,-1.2556434314172906,0.1415929203539823,0.3406341464833791,1.0,13/38,27.99%,APOE;PLAU;TFPI;PLAUR;F7;SERPINE1;F10;PDGFA;APOH;ADTRP;A2M;SERPINB2;F11
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4112895822007826,-1.2555500098438368,0.16140350877192983,0.3405237146274151,1.0,11/31,19.88%,PLCG2;SYK;TLR4;IRF5;MAPK14;LAPTM5;MDK;CD40;LGALS9;HMGB1;AGER
prerank,regulation of multicellular organismal development (GO:2000026),-0.4231306433830504,-1.255310489895402,0.1675213675213675,0.34067057748617424,1.0,11/25,21.36%,HPSE;INSR;NIPBL;DUSP6;CDK1;DHX36;RACGAP1;GATA3;OAS2;TRIP12;BAG6
prerank,cGMP metabolic process (GO:0046068),0.5076778674753482,1.2551386984178594,0.21951219512195122,0.4447485380316535,1.0,2/12,3.88%,GUCY1B1;PDE9A
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.536312191766313,-1.2542269508210742,0.18196994991652754,0.34236264309850495,1.0,5/11,12.60%,LYN;SYK;PLAUR;JAK1;CCL5
prerank,translational elongation (GO:0006414),-0.32422697624009233,-1.2538244872683,0.07251264755480608,0.34276646860841475,1.0,42/101,33.27%,MRPS10;ERAL1;MRPL42;TUFM;EEF1B2;CHCHD1;EEF2;GTPBP1;EEF1A1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;GTPBP2;MRPL17;MRPL15;RACK1;MRPL51;MRPL47;MRPL18;EEFSEC;MRPS7;EEF1D;MRPS25;MRPL54;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPS35;MRPS28
prerank,axon extension (GO:0048675),0.42502651934300856,1.2537750803186065,0.15517241379310345,0.4463565877759902,1.0,6/23,4.08%,AUTS2;MAP1B;SLIT3;SLIT2;SEMA5A;SLIT1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.50039193609671,-1.2537370992649368,0.18262411347517732,0.3426606714440461,1.0,3/15,5.13%,CD44;CD74;BCL2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.45473789476400367,-1.2536909998073569,0.1989342806394316,0.3424499325910481,1.0,5/19,18.15%,PRKCD;ABCD2;DAGLB;ABHD5;IRS2
prerank,cellular response to retinoic acid (GO:0071300),0.37067634595913607,1.2536397063965166,0.1674641148325359,0.44546399301851275,1.0,17/42,20.52%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;TBX1;LTK;RET;EPHA3;BRINP2;FZD4;ADNP2;SNW1;WNT5A;WNT5B;FZD10
prerank,icosanoid secretion (GO:0032309),-0.5379383438447305,-1.2536166202707768,0.19618055555555555,0.34230755479399755,1.0,7/12,38.95%,ANXA1;ABCC4;PLA2G5;PNPLA8;ACE;NOS2;NMUR2
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4064175418478185,-1.2534331898622573,0.1494057724957555,0.34234531073780927,1.0,8/32,4.43%,CORO1C;RREB1;ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,neutrophil chemotaxis (GO:0030593),-0.3698197104793639,-1.2527287723575866,0.1426056338028169,0.34336068045236434,1.0,11/53,13.42%,SYK;ITGB2;CKLF;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,endothelial cell development (GO:0001885),-0.4360184389679923,-1.2526556928016375,0.17301038062283736,0.3432059363889467,1.0,13/25,33.77%,MSN;RAP1B;RAP1A;MYADM;COL22A1;COL18A1;PECAM1;MARVELD2;RAPGEF2;MET;TNMD;CNMD;EZR
prerank,negative regulation of endopeptidase activity (GO:0010951),0.35804450557059037,1.2525958440295546,0.12028301886792453,0.44653670169713683,1.0,5/47,4.81%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4559884863438878,-1.2525757192852283,0.17688266199649738,0.3430644044914535,1.0,3/20,6.72%,BRD7;BRCA1;ARRB1
prerank,response to peptide hormone (GO:0043434),-0.3767790119016011,-1.251180890062965,0.155668358714044,0.34528812992727637,1.0,9/43,7.44%,ROCK1;OGT;STAT3;SLC27A1;STAT6;ANXA1;EIF2B3;STAT5B;STAT4
prerank,lipid translocation (GO:0034204),-0.4510863604969816,-1.2506393040109864,0.19458544839255498,0.3459862679090775,1.0,4/21,9.30%,ABCA1;ATP8B4;ATP11C;ABCC1
prerank,limb development (GO:0060173),0.4064232587994255,1.250557946442711,0.1796116504854369,0.4496838616101924,1.0,13/28,21.38%,PCSK5;BMPR1B;LNPK;KREMEN2;FGF10;IQCE;SALL1;KDF1;GLI3;KAT2A;SMOC1;LRP4;INTU
prerank,cholesterol homeostasis (GO:0042632),-0.34573109998400287,-1.250368074075132,0.12046204620462046,0.3461829882630364,1.0,15/64,15.34%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LPL;LIMA1;XBP1;NPC2;TTC39B;NPC1;EHD1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5168994697265022,1.2503501180046612,0.22535211267605634,0.4488712687694628,1.0,5/11,19.43%,FYN;REST;PRKN;LANCL1;UBQLN1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2794374305644807,-1.250079255652854,0.04294478527607362,0.34642113069385627,1.0,94/327,23.85%,MITF;ZMIZ1;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;FOXN2;SPI1;JMJD1C;STAT3;LYL1;ZSCAN26;CTR9;CHD3;RYBP;RNF20;SAP30;DAPK3;GPBP1L1;GON4L;SRRT;FUS;AHR;GCFC2;REXO4;POFUT1;EDF1;EZH2;BHLHE40;E2F1;CNBP;THAP1;TGFBR1;RALY;HIF1A;MEF2C;UBE2L3;FOXN3;HDAC10;HP1BP3;RELA;KMT2D;PRDM2;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;RPL6;BTG1;TCF3;NSD1;PSPC1;POLR2A;ZNF628;SRSF10;HCLS1;VHL;ATF5;MYB;ATXN1;PLAG1;PPARGC1B;CXXC1;NR3C1;NUP35;PAK6;SUFU;CASZ1;ATF7;NUP107;ZFPL1;GTF2IRD1;ZSCAN21;CEBPB;SNAI2;NONO;ESR2;SOX7;RPS6KA5;DVL2;ZNF395;HES6;CHD7
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4717815904554074,-1.2500211012374112,0.1724137931034483,0.3462537428490358,1.0,6/17,12.66%,SYK;PIEZO1;ADAM9;NCKAP1L;CCL5;CIB1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.4701910015426759,-1.249742511117678,0.16188870151770657,0.34653807769576767,1.0,7/18,11.97%,ABL2;TNFAIP1;RIPOR2;KCTD10;CCDC125;FLCN;ITGA3
prerank,positive regulation of double-strand break repair (GO:2000781),-0.386134957243949,-1.2496990198377103,0.1453287197231834,0.34633220061228176,1.0,16/39,20.54%,ARID2;ACTR2;SPIDR;ERCC6;WDR48;FUS;KMT5B;MGMT;KMT5C;PARP9;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19;DTX3L
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.5239303166676965,-1.2493223740793589,0.20477815699658702,0.34674578380961374,1.0,6/12,39.05%,FDXR;TSPOAP1;FDX1;FDX2;STARD3;TSPO
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4823515288759213,1.2491666200040634,0.21709006928406466,0.45022248747719806,1.0,5/14,14.86%,CORIN;OXTR;AGTR1;EDN1;ECE1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.2683946339989207,-1.2490224075437784,0.015580736543909348,0.3469864747705645,1.0,130/497,23.09%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;DAPK1;MIDEAS;WWP1;BCL6;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;GAPDH;ARID5B;BRD7;ZNF148;SBNO2;GATAD2A;PPARG;ELK3;SPI1;WWP2;S100A11;BRCA1;CNOT1;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;PRMT2;FBXW11;CENPF;DAPK3;SMARCC2;NR1H2;CIITA;PUS7;CBFA2T3;AHR;GCFC2;CTNNB1;JARID2;PBXIP1;EZH2;GAS6;DPF2;EED;BHLHE40;E2F1;EIF2AK2;EIF2AK1;PCIF1;SPEN;SELENOS;FOXN3;SUDS3;HDAC10;CIART;TIMELESS;XRCC6;CHMP1A;RELA;KLF10;CCDC85B;HMGB2;KAT7;CHD8;MTA3;DHX36;CALCA;HDAC5;SIN3A;ID2;EPC1;PSPC1;TFAP4;PRMT6;MAP3K10;NCL;BTAF1;KMT5A;PHC3;IKZF4;UBE2I;TOB1;RARA;ATF5;GATA3;MYB;SAMD1;RPS3;ARID5A;ATXN1;LIMS1;NR3C1;ID1;RSF1;ENPP1;BMPR2;DDX3X;CNOT8;DDX6;GSK3B;CBFA2T2;SIRT2;BAP1;SMURF2;CIC;SFRP1;RACK1;KDM1A;ID3;LSM14A;TBX2;HEYL;CDK5;SHMT1;NONO;CRYAB;EID2;TGFB1;SOX7;SET;ZBTB7A;RPS6KA5
prerank,regulation of macrophage activation (GO:0043030),-0.40271779489933635,-1.2490139923585992,0.15817223198594024,0.34672040391031794,1.0,11/30,22.42%,CD74;MFHAS1;GPR137B;TLR4;TNIP2;FCGR2B;KARS1;IL31RA;MMP8;ZC3H12A;IL6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4628320112030954,-1.2484278020645023,0.1783783783783784,0.3474953550872229,1.0,8/18,29.05%,RIPK1;DDX5;MAP2K1;ZC3H12A;IL6;TGFB1;NCOR1;ESR1
prerank,sensory perception of light stimulus (GO:0050953),0.3208181016872297,1.2483726588431163,0.0906801007556675,0.4506036595317721,1.0,20/87,13.91%,PCDH15;GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;ABLIM1;IMPG2;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;EML2;WHRN;PRPH2;ZIC2;CLRN1;USH2A
prerank,positive regulation of growth (GO:0045927),-0.3562777331770604,-1.247956461189833,0.12307692307692308,0.3480804640160875,1.0,16/64,14.82%,RFTN1;SDCBP;INSR;CSNK2A1;CDC42;BCL2;DDX49;KLHL22;WFS1;TGFBR1;MTPN;CXCL16;CIB1;NCBP1;EIF4G1;INO80
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3290816516557726,-1.2479201124542791,0.10277324632952692,0.3478733540083972,1.0,28/88,22.01%,PSME4;FBXL17;PSMB7;PSME3;FBXW11;PSMB9;FBXL20;FBXO38;PSMA8;PSMC3;KIF14;CUL4B;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;FBXL8;SKP2;PSMB8;FBXL6;PSMD4;PSMA5;FBXO31;PSMB3;PSMD3;FBXW4;CCNF
prerank,signal transduction in response to DNA damage (GO:0042770),-0.375707086737976,-1.2475927528402546,0.13131313131313133,0.3481880871088322,1.0,17/49,21.71%,GRB2;MAP3K20;ERCC6;MAPK14;BATF;RAD1;E2F1;GADD45A;RHNO1;DOT1L;BID;BRIP1;RAD9A;MDM4;ATM;CHEK1;NBN
prerank,ncRNA export from nucleus (GO:0097064),-0.389450016646876,-1.2475326925275103,0.17697594501718214,0.3480156994711506,1.0,18/36,29.79%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;PHAX;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5351743635022691,-1.2473157216701933,0.1794425087108014,0.3481733168074734,1.0,4/11,11.45%,DAB2;MSN;RAB21;EIPR1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.47969427557216876,1.2467296714354636,0.1941747572815534,0.45289852503856604,1.0,6/15,16.47%,NTRK3;CDH13;VEGFD;PGF;SCG2;CXCL12
prerank,regulation of defense response to virus (GO:0050688),-0.4935934257518282,-1.2463104276024592,0.19652173913043477,0.34974394197960457,1.0,8/14,27.73%,DHX9;TRAF3;PPM1B;PCBP2;RNF216;C1QBP;ZMPSTE24;RNF26
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.554347096763453,-1.2459908617722446,0.19826086956521738,0.35003946966817834,1.0,4/10,14.82%,DBF4;SSBP1;E2F8;INO80
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.473144724936161,-1.2457342140899155,0.189419795221843,0.35024517187571125,1.0,6/18,11.74%,LYN;CAMK1D;IL6R;PTK2B;MDK;F7
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3122976767451037,-1.2456051320338786,0.0896,0.3501944719863097,1.0,46/119,26.75%,PLCG2;INPP4A;PI4K2A;PIK3R5;ITPKB;MTM1;PIP4K2A;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;DPM3;TMEM150A;PIK3CG;PI4KB;TTC7A;RAB5A;IMPA1;MTMR6;PIK3CA;SOCS6;PIK3CD;PLEKHA2;PIGH;PIK3C2A;PGAP3;SOCS3;PTPN13;PLEKHA4;IP6K3;PIP5K1A;MPPE1;VAC14;PIP5K1C;SOCS5;SMG1;RAB4A;ITPKC;PIK3C2G;INPP5K;PIGZ;IP6K1;PGAP2
prerank,regulation of primary metabolic process (GO:0080090),-0.3115677842517547,-1.2448673489342843,0.09177215189873418,0.3513614410751469,1.0,36/126,21.01%,APOE;PSAP;CREBBP;PPARD;NFYA;PSME4;PPARG;PSMB7;PSME3;ADIPOR1;SMARCD3;PSMB9;TBL1XR1;EDF1;AZIN1;HELZ2;PSMA8;PSMC3;PSMD8;PSMC4;IDI1;PSMB10;PSMA1;RXRA;SIN3A;ID2;ACACB;PSMB8;IRS2;NCOA6;LDLR;PSMD4;PSMA5;PSMB3;PSMD3;TGS1
prerank,negative regulation of cell migration (GO:0030336),0.29829660144925363,1.244862552954973,0.07614213197969544,0.45558751551187865,1.0,18/137,5.38%,ROBO1;MAGI2;NAV3;PTPRG;TMEFF2;SLIT2;PTPRR;PTPRT;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;CLASP2;ACVR1C;DLC1;PODN;PTPRK
prerank,renal water homeostasis (GO:0003091),0.4147191793217512,1.2447835639209206,0.1778846153846154,0.454552754447078,1.0,7/23,14.74%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.40851440181721327,-1.2447539915030048,0.165,0.35126683234290373,1.0,13/30,29.58%,DAB2;FOXP1;PRMT2;DDX5;KLK3;TRIM68;SFRP1;KDM1A;HEYL;ZBTB7A;NCOR1;PIAS2;EP300
prerank,cellular response to cAMP (GO:0071320),0.3928069736273404,1.2447197524171385,0.14798206278026907,0.45352683836922525,1.0,6/30,9.26%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;HCN1
prerank,P-body assembly (GO:0033962),-0.5140426921902344,-1.2445228647059146,0.20898100172711573,0.3513886856123075,1.0,5/12,21.65%,RC3H1;DYNC1H1;PATL1;DDX6;LSM14A
prerank,histone deubiquitination (GO:0016578),-0.4542167525365593,-1.2444538690043476,0.18996415770609318,0.35124041525561417,1.0,10/18,28.76%,ATXN7;USP36;USP3;USP7;BRCC3;USP16;ENY2;UIMC1;EPOP;USP51
prerank,neuron fate commitment (GO:0048663),0.4774804082744669,1.2444485709075903,0.20506912442396313,0.45290388477474897,1.0,2/14,4.46%,MYT1L;POU3F2
prerank,positive regulation of histone modification (GO:0031058),-0.4079356084111843,-1.2444052700339874,0.17487266553480477,0.35105524569280905,1.0,13/33,26.87%,BRD7;BRCA1;AKAP8;NIPBL;CHTOP;ARRB1;SART3;KDM1A;APLNR;RPS6KA5;AKAP8L;UBE2N;ZBTB7B
prerank,RNA splicing (GO:0008380),-0.3285271995108147,-1.2440712171424513,0.09602649006622517,0.3513927732046316,1.0,31/95,24.92%,MBNL1;TRA2B;SRRM1;MPHOSPH10;SMU1;SNRNP35;SNRPG;FUS;SNRPF;SF3B3;PRPF8;NCBP1;ZRSR2;PDCD7;PPIG;SRSF10;PPP1R9B;PRPF18;LSM6;TXNL4A;RNPS1;SCNM1;MAGOH;SLU7;SF3B1;SRPK1;NONO;SRSF11;DDX39B;TARDBP;PRPF6
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4078851145332761,-1.243950553090787,0.16782006920415224,0.35130436883996335,1.0,10/30,24.06%,CD44;CD74;RTEL1;TPT1;DYRK1A;TMEM161A;RPS3;KDM1A;SNAI2;DDX39B
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.48619182366051794,1.2431665076764002,0.19012345679012346,0.4545039932262099,1.0,3/13,8.69%,NR3C2;PGR;BMP7
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.48085177990573025,-1.2421509807046918,0.19901315789473684,0.35422954218624525,1.0,7/16,22.97%,ADCY7;ABCD2;SIRPA;NLRC3;APPL2;ZC3H12A;MEFV
prerank,T cell mediated immunity (GO:0002456),-0.5018627679085541,-1.2421493647089774,0.21392190152801357,0.35395394608262737,1.0,4/13,11.94%,JAG1;MYO1G;CTSH;CD46
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.40345336745269894,-1.2419889556515304,0.15985790408525755,0.35395132809447793,1.0,10/34,18.56%,IGF1;NSMCE2;RB1;INSR;DLGAP5;CD28;NUSAP1;AURKA;ANAPC7;PDGFRB
prerank,hyaluronan metabolic process (GO:0030212),-0.4434418819847954,-1.2419140777033335,0.1724137931034483,0.35381935911166246,1.0,5/23,9.34%,CD44;HEXA;LYVE1;GUSB;SLC9A1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.31150508039020114,-1.241633185466194,0.07861635220125786,0.3541074277659269,1.0,49/132,26.45%,DHX9;RPL11;CRNKL1;ERAL1;EIF3A;SNRPG;GCFC2;RPS14;COIL;EIF5;SNRPF;RPS28;SART1;NUDT21;CELF1;HSP90AB1;SMN1;YTHDC1;MRPS11;RPL6;NCBP1;SART3;ZRSR2;GEMIN7;SNUPN;DDX1;SRSF10;SHQ1;PRPF18;RPS27;TXNL4A;RPL23A;WDR77;SF3B1;TGS1;GEMIN6;XAB2;SRPK1;BRIX1;RPS15;RPLP0;EIF2S2;DDX39B;PRKDC;PRPF6;MRPS7;RPL5;RAMAC;ISY1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5026408449414294,-1.241313347961472,0.17739130434782607,0.3544445657402574,1.0,2/13,0.63%,CD44;CD74
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.4224476178231231,-1.241292766260532,0.17647058823529413,0.3542077282571724,1.0,11/24,25.64%,PID1;COX10;LYRM7;SDHAF4;GFPT1;SLC25A13;ACADVL;CYCS;MYC;MT3;COQ10B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.3011537427079685,-1.2411386162761873,0.0842433697347894,0.3542049205982319,1.0,49/152,22.48%,ZEB2;DKK2;CSNK2A1;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;PSMB9;MACF1;AXIN1;TBL1XR1;PPM1B;SKI;SULF2;LRRK1;WLS;PSMA8;PIN1;PSMC3;PSMD8;SPIN1;PSMC4;PSMB10;PSMA1;TNKS2;RSPO3;GPRC5B;JRK;PSMB8;PLEKHA4;RSPO1;DDX3X;PSMD4;PSMA5;PSMB3;TMEM198;WNK1;PSMD3;SMURF2;DISC1;SFRP1;JUP;CSNK1G3;ZRANB1;ILK;TGFB1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.5259689618671433,-1.241131284532692,0.20578231292517007,0.35393958180822327,1.0,4/11,21.18%,CIITA;PF4;XBP1;TMEM106A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4331164802070729,1.241104689881119,0.195,0.4577825500449835,1.0,7/20,15.05%,SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B;SEMA4G
prerank,DNA duplex unwinding (GO:0032508),-0.3677419758154872,-1.2407323178164755,0.1315345699831366,0.35436387915818507,1.0,22/50,26.81%,DDB2;DHX9;ANXA1;BLM;RTEL1;MCM6;RAD51;UBC;RPS27A;MCM9;SSBP1;CUL4B;WRN;DDX1;MCM2;NBN;TWNK;DDB1;ASCC3;CETN2;RECQL5;MRE11
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.33507426818862357,-1.240304531886001,0.12106135986733002,0.35485231463216116,1.0,17/80,13.02%,ABCG1;GSAP;VIM;NIBAN1;PRKCD;YTHDF3;PICALM;LARP4B;PCIF1;CD28;LARP4;SIRT3;RPS4X;EEF2;RELA;EIF3E;METTL14
prerank,ribosome assembly (GO:0042255),-0.376407900752735,-1.2401353431718904,0.14629948364888123,0.3548683391001085,1.0,19/47,25.39%,RPL11;ERAL1;RPS14;RPS28;DHX37;EFL1;MRPS11;RPL6;EIF2A;RPS27;MRPL22;RPL23A;DDX3X;C1QBP;BRIX1;RPS15;RPLP0;MRPS7;RPL5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.35197634894855795,-1.2400038618940175,0.13220338983050847,0.3548283264068222,1.0,19/62,21.75%,MCL1;NFE2L2;ARHGEF2;BCL2;TXNDC12;DNAJA1;PLAUR;MAPK7;SELENOS;TPT1;XBP1;TMBIM6;TMEM161A;HSPA1A;HYOU1;HSPB1;DDX3X;BCL2L2;SNAI2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.35696375709405015,-1.239880104486804,0.1256544502617801,0.3547507427735478,1.0,13/59,13.15%,MITF;JUN;NFKB1;RUNX2;MED24;CTNNB1;CBFB;MOV10;CDK1;RELA;MED4;TNRC6C;MED31
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.5402413240060161,-1.2395257806231386,0.18,0.3550994618083595,1.0,7/11,37.61%,LRP6;CTNNB1;RYK;FZD1;LMX1A;NR4A2;WNT2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.30661439286939807,-1.239439548606356,0.08928571428571429,0.35499481060835864,1.0,49/150,22.48%,PID1;LYN;PTPRC;CORO1C;XDH;PAK2;NIBAN1;PRKCD;RB1;IBTK;PRKAG2;CEP85;PMEPA1;PPP1R15B;LRP6;MYADM;MVP;SIRPA;TRIB1;PTPN6;SNX25;ITGB1BP1;TRIB2;SPRY2;SPRED1;PAQR3;SPRED2;CIB1;IGFBP3;GREM1;SAMSN1;EIF4G1;CRKL;LDLRAD4;DTNBP1;DEPTOR;DNAJC3;SMAD7;PTPN13;HSPB1;ENPP1;SIRT2;UBASH3B;ZC3H12A;SFRP1;RACK1;SFN;PLPP3;TGFB1
prerank,retina homeostasis (GO:0001895),-0.4317277439145143,-1.2393839917781813,0.1782178217821782,0.3548267848751946,1.0,5/23,11.29%,POTEF;ACTB;B2M;SLC28A2;PRDX1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.34883204010775337,-1.2392377719908896,0.12020033388981637,0.35479658058247526,1.0,27/68,26.35%,MTHFS;PANK2;SLC2A1;MTHFD1L;TPK1;CYB5R3;ABCC1;PDZD11;MTR;MTHFD2L;ACP5;PDXK;SLC23A1;SLC23A2;MMUT;ENPP1;PNPO;LMBRD1;SLC52A2;SHMT1;MTHFR;GSTO1;AASDHPPT;HLCS;CYB5A;FPGS;SLC52A1
prerank,positive regulation of translation (GO:0045727),-0.32314744636743026,-1.2390204785267183,0.11658456486042693,0.354890417947694,1.0,26/94,19.74%,VIM;NIBAN1;YTHDF3;AGO2;DHX9;CNBP;LARP4B;PCIF1;CD28;LARP4;RPS4X;FASTKD2;EEF2;EIF3E;PKM;CCL5;METTL14;BOLL;DHX36;NGRN;FASTKD3;POLR2G;RPS9;RMND1;DDX3X;C1QBP
prerank,stress granule assembly (GO:0034063),-0.4433325872626531,-1.2390204567106737,0.18214285714285713,0.3546133762475006,1.0,10/20,24.17%,YTHDF3;DYNC1H1;CSDE1;RPS23;G3BP1;DDX3X;DDX6;LSM14A;ATXN2L;PRRC2C
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5445351550249775,-1.2390038175400215,0.19689119170984457,0.3543674770813388,1.0,5/10,22.06%,MTHFS;MTHFD1L;MTHFD2L;SHMT1;MTHFR
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5481355822285097,-1.2386587580588626,0.2326007326007326,0.3546791110997075,1.0,5/10,18.94%,PID1;PRKCB;SELENOS;APPL2;ENPP1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3978812769475033,-1.2384976709675952,0.18043844856661045,0.3547162136462992,1.0,11/34,15.96%,MFHAS1;SPI1;RIPOR2;SNX33;PICALM;DNAJA1;NEDD4L;FLCN;SIN3A;LEPROTL1;LATS2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.474413427367778,-1.2382772963356408,0.19897084048027444,0.35477815233620175,1.0,10/16,33.92%,BLM;MCM6;RAD51;SSBP1;WRN;MCM2;TWNK;RECQL5;MCM7;RECQL
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.5470597055893527,-1.2381382190319303,0.1934931506849315,0.35473858314142503,1.0,6/10,26.68%,BRCA1;HDAC5;SPHK2;KMT2A;CHEK1;SMAD4
prerank,glycoprotein catabolic process (GO:0006516),0.4554243234797421,1.2379041841742564,0.17339667458432304,0.46347438393658325,1.0,5/17,10.94%,MMP12;FBXO44;FBXO2;FBXO27;ADAMTS12
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3445115532410008,-1.2377376037666072,0.1404399323181049,0.3552095631157482,1.0,22/65,21.84%,PSME4;PSMB7;PSME3;GPR132;NABP1;PSMB9;PSMA8;PSMC3;PSMD8;AVEN;PSMC4;PSMB10;PSMA1;AURKA;PSMB8;PSMD4;PSMA5;CHEK1;PSMB3;PSMD3;ZFYVE19;VPS4A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5223877319215657,1.2375095910577487,0.22705314009661837,0.4631310756614323,1.0,5/10,17.01%,PRKCE;PTH1R;IRS1;SNCA;AKT2
prerank,plasma membrane organization (GO:0007009),-0.34818550798864467,-1.2372086147431898,0.14189189189189189,0.3558364690192986,1.0,18/61,16.84%,MYOF;P2RX7;MYH9;ARL8B;SNX9;ANO6;ABCD2;AHNAK2;SNX33;TLCD2;PACSIN2;SERP1;BIN3;ANXA6;CXCR4;CLN3;PLSCR4;STX4
prerank,eye morphogenesis (GO:0048592),-0.4543294573892111,-1.2371900607002184,0.18327402135231316,0.3555928653277047,1.0,6/19,9.62%,STAT3;NIPBL;RARG;SKI;VEGFA;MFAP5
prerank,establishment of endothelial barrier (GO:0061028),-0.41098469420820505,-1.2370640194131173,0.17525773195876287,0.3555337123426336,1.0,6/29,6.84%,MSN;RAP1B;RAP2B;RAP1A;RAB1A;MYADM
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.41848599387383795,-1.2367311783825823,0.17421602787456447,0.3558596660205937,1.0,12/26,31.02%,B4GALT5;GBGT1;TPI1;GCNT1;LARGE1;TKT;ALG6;GAL3ST4;ALG11;GK5;ST3GAL4;ST8SIA6
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4447333332663517,-1.2364223060315624,0.16407599309153714,0.35616987880848416,1.0,13/21,33.21%,IGF1;JUN;ERN1;MEF2D;FOXJ2;ADAMTS1;MMP2;P2RY6;FGF9;LDLRAP1;FGF2;GJA1;MMP9
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.46971946917462337,-1.2362028564905172,0.22592592592592592,0.3563035780864753,1.0,7/16,21.52%,NRP1;PTPRJ;PIK3C2A;RGS14;PDGFRB;PDGFA;PTPN1
prerank,cellular response to nutrient levels (GO:0031669),-0.34556346747415445,-1.235634536547132,0.13666666666666666,0.3570104019374638,1.0,17/62,21.64%,TFEB;LAMP2;ATG7;FNIP1;LPL;XBP1;FLCN;RRAGD;KLF10;WRN;STK24;EIF4G1;RALB;BMPR2;SFRP1;GAS2L1;KCNB1
prerank,purine-containing compound catabolic process (GO:0072523),-0.5023503387971496,-1.2355685492417865,0.1993006993006993,0.35685727646382503,1.0,3/13,9.99%,GDA;XDH;NT5C2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5432398218873368,-1.2355308150895534,0.2103448275862069,0.3563752945045615,1.0,3/10,39.21%,REEP6;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5432398218873368,-1.2355308150895534,0.2103448275862069,0.3563752945045615,1.0,3/10,39.21%,REEP6;CNGB1;CACNA2D4
prerank,cellular lipid catabolic process (GO:0044242),-0.41161776136379696,-1.2355281242959506,0.18453427065026362,0.35610452873888276,1.0,5/27,7.25%,AOAH;PPARD;PLBD1;ABHD12;PLBD2
prerank,positive regulation of gene expression (GO:0010628),-0.2685737771582206,-1.2348118003604516,0.03901734104046243,0.3571308122016033,1.0,87/442,14.53%,PID1;RBPJ;MITF;IGF1;CD74;FGR;MSN;LILRB1;P2RX7;PLCG2;VIM;NIBAN1;ROCK1;YTHDF3;CD36;DEK;ERN1;GAPDH;AGO2;NFE2L2;SMARCA5;RIPK1;HTR2B;BRCA1;ERCC6;STAT3;IL15;TLR4;STAP1;ACTB;PTGER4;PTPN22;MAPK14;BATF;RPL11;PF4;PIK3CB;FN1;PIK3CG;GAS6;POLR2H;VEGFA;E2F1;MYD88;POLR2F;EIF2AK2;LARP4B;PCIF1;TGFBR1;CD28;LARP4;WBP2;HIF1A;DDX5;POLR2L;MEF2C;SERPINB9;CTSH;RPS4X;CLEC9A;EGR1;SPRY2;APP;ITGAX;MOV10;AGT;EEF2;DYRK1A;MYOM1;OSR1;MAP2K1;TICAM1;EIF3E;CD46;CELF1;HNRNPLL;CLEC6A;ITK;TNRC6C;METTL14;PIK3CD;CALCOCO1;DHX36;NFAM1;ID2;AGPAT1;POLR2A
prerank,positive regulation of DNA replication (GO:0045740),-0.4765602007790729,-1.2344187344117772,0.20909090909090908,0.3575545465811175,1.0,6/16,17.36%,BCAR3;DHX9;PCNA;KAT7;FAF1;DNA2
prerank,cellular response to glucose starvation (GO:0042149),-0.3695241546101821,-1.2327625717136201,0.1646655231560892,0.3602340275140922,1.0,16/41,27.57%,PRKAG2;FOXO3;MTMR3;SIK1;XBP1;SESN1;SH3GLB1;HNRNPA1;CPEB4;ZC3H12A;PRKAG1;BECN1;RRP8;KPTN;EIF2AK3;MYBBP1A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.33587547923419897,-1.2326016806910962,0.1264957264957265,0.36025028642202767,1.0,36/78,34.36%,DAB2;HECTD1;RNF19A;NFE2L2;PIAS1;CBFA2T3;NUB1;DET1;TRIB1;TRIB2;RNF180;PLK3;ARIH1;GABARAP;SMAD7;HSPA1A;GSK3B;FBXO22;SIRT2;SGTA;RACK1;SOCS5;RNF19B;VCP;COP1;CDC20;KEAP1;HSPBP1;CAV1;STUB1;HSPA1B;USP5;CSNK1D;UBQLN2;NOP53;RAD23A
prerank,maintenance of blood-brain barrier (GO:0035633),0.3901092727375921,1.2325302433834682,0.17937219730941703,0.4726100501678028,1.0,11/30,18.32%,DMD;TJP1;SLC12A2;SLC1A1;OCLN;MFSD2A;CLDN5;CDH5;WNK3;MBP;LAMA2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.42236140500064384,1.2324798301284756,0.17452830188679244,0.47151015447386985,1.0,5/23,7.73%,ANK2;CACNA2D1;CASQ2;PRNP;FYN
prerank,regulation of macrophage migration (GO:1905521),0.5275623872624012,1.2323438863338498,0.21739130434782608,0.4705991483741587,1.0,4/10,8.40%,CD200R1;P2RY12;CD200;CX3CR1
prerank,axoneme assembly (GO:0035082),0.3924749158133107,1.2318242600876512,0.18683651804670912,0.47054721794871945,1.0,4/30,3.44%,DNAAF3;CFAP74;DNAI4;RSPH1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5083612303822876,1.2316352741011665,0.22666666666666666,0.4697284590636326,1.0,2/11,4.30%,DDX11;NOL11
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.39984524980385083,-1.2301359862095955,0.18100358422939067,0.36441074912254456,1.0,11/30,24.22%,PTPRC;PLEK;FLT1;BATF;ARMC6;SFRP1;KDR;TGFB1;FLT3;PRRC2C;TNFRSF13B
prerank,heme catabolic process (GO:0042167),-0.4802923315058148,-1.2301270993190185,0.2130281690140845,0.3638730064561454,1.0,7/14,31.53%,BLVRB;HMOX2;ABCC1;HMOX1;UGT1A4;UGT1A1;SLCO1B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4802923315058148,-1.2301270993190185,0.2130281690140845,0.3638730064561454,1.0,7/14,31.53%,BLVRB;HMOX2;ABCC1;HMOX1;UGT1A4;UGT1A1;SLCO1B1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.543913709431546,-1.229930512350294,0.2146690518783542,0.36394389497961843,1.0,4/10,16.45%,TUT7;UBC;RPS27A;ISG15
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.40813476813437094,1.229474661430625,0.20967741935483872,0.4731987257313685,1.0,10/26,19.88%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;UBQLN1;GPR35
prerank,negative regulation of growth (GO:0045926),-0.31403743103563325,-1.2292497664533457,0.10806451612903226,0.3649296584623514,1.0,35/121,21.11%,NOTCH2;BCL6;RB1;PTPRJ;APBB2;SIPA1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CRLF3;BST2;FLCN;OSGIN1;CCDC85B;STK11;ADAM15;MT2A;BTG1;PPP1R9B;EI24;SPHK2;HSPA1A;CDKN2C;ENPP1;BMPR2;DDX3X;NME6;PPT1;SFRP1;RACK1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.43230299994515076,-1.2289284354839163,0.20166666666666666,0.3652470141581594,1.0,10/22,26.36%,LYN;ABCG1;GSAP;PICALM;RELA;AGER;IFNGR1;ABCA2;EFNA3;RANBP9
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3329452103279729,-1.228860453774555,0.1174496644295302,0.36508547448570994,1.0,19/80,14.75%,KLC1;KIF3B;UVRAG;KIF11;COG7;RAB1A;TMED10;KIF23;KIF15;TAPBP;GOLPH3L;KIF4A;RINT1;CENPE;TMED3;COPA;RER1;RACGAP1;KIF2C
prerank,sterol homeostasis (GO:0055092),-0.3387254311400112,-1.228602764063789,0.13377926421404682,0.3652622881248327,1.0,15/65,15.34%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LPL;LIMA1;XBP1;NPC2;TTC39B;NPC1;EHD1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.4129237849396731,-1.2284668759671769,0.18871252204585537,0.3652201687831435,1.0,11/28,21.65%,LILRB1;RC3H1;TNFRSF21;SCRIB;SDC4;IL4I1;VSIG4;SPN;LGALS9;CD274;CEBPB
prerank,cellular potassium ion homeostasis (GO:0030007),0.4841161515790736,1.2282143248234147,0.20465116279069767,0.47480115245239873,1.0,5/13,17.36%,SLC12A2;ATP1A3;ATP1B1;KCNMA1;ATP1B2
prerank,positive regulation of cell division (GO:0051781),-0.3827699417893148,-1.2282057505040234,0.19487179487179487,0.3653900459510625,1.0,10/38,20.16%,RHOA;SVIL;HTR2B;CDC42;KIF20B;KIF23;KIF14;RACGAP1;CSPP1;SIRT2
prerank,motor neuron axon guidance (GO:0008045),0.47262145565020486,1.2281528382424969,0.2018348623853211,0.4737478064934185,1.0,3/15,5.41%,SLIT2;SLIT1;TMEFF1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5274346749862546,-1.2280453037646808,0.23869801084990958,0.36539661951063196,1.0,5/10,24.21%,BCL2;MLLT11;RACK1;KDR;DCN
prerank,Notch signaling pathway (GO:0007219),-0.35017307803461284,-1.2277655492494874,0.13898305084745763,0.365671908692172,1.0,19/59,21.75%,RBPJ;NOTCH2;CREBBP;PLXND1;MAML1;MAML2;DLGAP5;JAG1;POFUT1;MDK;PSENEN;MIB1;DTX1;DTX3;DTX3L;STAT1;MAML3;HEYL;SNAI2
prerank,glycosphingolipid metabolic process (GO:0006687),-0.37275991166689293,-1.2277562102296093,0.15,0.36540786540795783,1.0,11/42,14.65%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;CLN6;NEU1;LARGE1
prerank,positive regulation of cell death (GO:0010942),-0.3504708563433612,-1.2276997252189725,0.15384615384615385,0.36522462508394027,1.0,19/59,21.74%,MAP3K5;LRP1;ITGB2;C1QA;CD36;SLC6A6;RIPK1;RARG;PICALM;EGR1;CELF1;HTATIP2;FCGR2B;EIF4G1;FAF1;GSK3B;ZC3H12A;HPR;HP
prerank,lipid modification (GO:0030258),0.36773406656785285,1.2270267781481967,0.16625916870415647,0.4750522852275413,1.0,4/37,2.70%,DGKB;PLPP4;PLPPR1;PLPPR4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.37631294018404254,-1.2269416147819152,0.1597222222222222,0.366342994388418,1.0,15/46,18.74%,RBPJ;RB1;IL15;TLR4;NR1H2;LNPEP;PLCL2;TLE3;FLCN;ACOT13;STK11;IL18R1;TFE3;ID1;RHEB
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5297114891412331,-1.2266328119562357,0.22123893805309736,0.3666438011083752,1.0,3/10,4.09%,CD36;SLC2A1;SLC27A1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.26817120943396855,-1.2263794604973932,0.047345767575322814,0.366840613484834,1.0,139/417,29.21%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;MIDEAS;WWP1;BCL6;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;ARID5B;BRD7;ZNF148;SBNO2;GATAD2A;PPARG;ELK3;SPI1;WWP2;BRCA1;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;PRMT2;FBXW11;CENPF;SMARCC2;NR1H2;CIITA;CBFA2T3;EIF4A2;AHR;GCFC2;CTNNB1;JARID2;PBXIP1;EZH2;GAS6;DPF2;EED;BHLHE40;E2F1;SPEN;FOXN3;SUDS3;HDAC10;CIART;TIMELESS;XRCC6;CHMP1A;RELA;KLF10;CCDC85B;HMGB2;KAT7;CHD8;MTA3;CALCA;HDAC5;SIN3A;ID2;EPC1;PSPC1;TFAP4;PRMT6;MAP3K10;BTAF1;KMT5A;PHC3;IKZF4;UBE2I;RARA;ATF5;GATA3;MYB;SAMD1;ARID5A;ATXN1;LIMS1;NR3C1;ID1;RSF1;CBFA2T2;SIRT2;BAP1;SMURF2;CIC;SFRP1;KDM1A;ID3;TBX2;HEYL;CDK5;NONO;CRYAB;EID2;TGFB1;SOX7;SET;ZBTB7A;RPS6KA5;SCMH1;TSC22D4;SHC1;GZF1;TRIM28;DEAF1;ZBTB16;RBM15B;DEDD2;INPP5K;MT3;NCOR1;ERN2;BMP2;PML;HSPA8;SMAD4;CLOCK;DEPDC1;TBX21;MYBBP1A;UIMC1;CITED2;DKK3;CREBZF;LEF1;RCOR2;ZMYND15;NKAP;MLX;CTBP2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5120756548804307,-1.2262663879230804,0.2452504317789292,0.3667649631624608,1.0,6/12,20.56%,TMEM199;GRN;CLN6;CLN3;VPS33A;PPT1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4177523834126894,-1.2261949852041891,0.1602112676056338,0.3666233004869802,1.0,5/25,4.03%,PLCG2;PLEK;ITPR1;P2RX4;CD22
prerank,response to fatty acid (GO:0070542),-0.46673719237512723,-1.2260378748008753,0.19031719532554256,0.36662703510411493,1.0,4/17,9.57%,PID1;CD36;FOXO3;LPL
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.2901643971097212,-1.2256530720266356,0.09119496855345911,0.36710411201635407,1.0,45/190,17.26%,LYN;BANK1;ARHGAP25;P2RX7;XDH;MCL1;PLEK;PTPRJ;ITPR1;RIPK1;SPI1;ARRB2;CD22;RIOK3;ADIPOR1;BCL2;MAPK14;PIK3CB;DUSP3;CYRIB;MYADM;MGRN1;UBR2;DGKD;IFI35;PPM1B;SH3BP1;PLAUR;FNIP1;ARHGAP12;SPRED1;FLCN;RELA;NLRC3;CIB1;TMSB4X;RNF34;CDC34;DGKG;NLRX1;TBC1D7;TNIP3;DEPTOR;CASP8;MAP2K3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3776671593600936,-1.2255019228499655,0.15570934256055363,0.36710190231570633,1.0,12/41,15.18%,HECTD1;BFAR;TRAF5;WWP2;PELI1;TRAF3;RNF4;RNF8;TRAF1;TRAF2;UBE2T;UBE2G1
prerank,membrane organization (GO:0061024),-0.2845204940457256,-1.2253198494685893,0.0672,0.3671916226928514,1.0,64/227,16.71%,DAB2;MYOF;TMCC1;CORO1C;GRB2;ARPC2;ITSN1;CBL;DNM2;SNX3;ACTR2;SNX9;NEMP1;PDCD6IP;SH3KBP1;ARRB2;SYNJ1;SYNGR1;ACTR3;CHMP5;ACTB;ARPC3;GLTP;FCHO2;WASL;ARRB1;MYADM;PICALM;SUN2;HIP1;EPS15;AP2A2;RAB5A;AGFG1;IGF2R;FNBP1;UBC;RPS27A;TLCD2;REPS2;PACSIN2;IL7R;CHMP7;TRIP10;CHMP1A;STAM2;SAR1A;CCDC88A;BAIAP2L2;RABEP1;SERP1;ARPC1A;SH3GLB1;CHMP2A;TOR1AIP1;LEMD2;NPC1;ARPC5;PIK3C2A;VAMP4;CLN3;KIF20A;VAPB;AP3D1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3764038721351889,-1.2248841303930513,0.1689419795221843,0.367666266610378,1.0,11/43,11.54%,JUN;PPARD;PPARG;SPI1;STAT3;FOXO3;NFATC3;HIF1A;DDX5;EGR1;RELA
prerank,positive regulation of reproductive process (GO:2000243),0.38998812125116356,1.2247867556229255,0.17882352941176471,0.4788569199914212,1.0,10/31,17.13%,PLCB1;GLRA1;CFAP69;PLA2G10;HYAL3;TACR3;INHBB;SYDE1;INHBA;PDE3A
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4872517697128009,-1.2245463891446224,0.20738137082601055,0.36797423469174856,1.0,7/15,15.58%,CD84;CD300A;CD300LF;MILR1;GRN;FCGR2B;IL31RA
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4365020916506134,-1.2243876984197908,0.19964349376114082,0.36798897908502504,1.0,10/21,33.82%,MYH9;ADAM9;PSENEN;HM13;ADAM19;PSEN2;PRTN3;BACE1;DAG1;ERAP1
prerank,peptidyl-serine modification (GO:0018209),-0.29462429991139494,-1.2227499396317063,0.07389937106918239,0.3706245227869741,1.0,50/166,23.49%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;CSNK2A1;VRK2;TLK1;SGK1;MAPKAPK2;DYRK2;MAPK14;ULK2;CAB39;GALNT3;GAS6;PLK2;VRK3;STK38;TGFBR1;NEK6;GALNT1;MORC3;MASTL;DYRK1A;CDK1;MKNK1;MARK2;TGFBR2;MAST2;MAP3K10;IKBKB;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;GSK3B;ATM;NDNF;WNK1;CSNK1G3;CDK5;MAST3;SMG1;RPS6KA5;MAPK1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.42306659204846175,-1.2226433351303767,0.19864176570458403,0.37054382103297046,1.0,8/23,19.32%,LYN;MSN;MDK;CCL5;IL34;STK10;CMKLR1;CSF1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.46037416568915174,-1.2220430336126888,0.21454545454545454,0.3712997928055345,1.0,4/18,6.50%,PRKCB;PRKAG2;SLC2A1;C3
prerank,carnitine shuttle (GO:0006853),-0.5217894113855189,-1.2210809898548398,0.24666666666666667,0.3728332859682483,1.0,3/11,14.88%,PRKAG2;CPT1A;ACACB
prerank,protein stabilization (GO:0050821),-0.29496790667783485,-1.221077320475051,0.07753164556962025,0.3725563600207778,1.0,53/168,25.81%,IGF1;PRKCD;GAPDH;FLNA;LAMP2;COG7;ATP1B3;COA8;STK3;RPL11;USP9X;GRN;USP36;CCT7;HIP1;MFSD1;WFS1;MORC3;RAB21;TNIP2;PIN1;SEL1L;LAMP1;HSP90AB1;FLOT2;USP7;BAG3;TAF9;VHL;CRTAP;SMAD7;HSPA1A;CCT4;TRIM39;MDM4;PPIB;NAA16;GLMP;GOLGA7;BAG6;HYPK;PLPP3;CRYAB;GTSE1;HPS4;PIM2;RABL3;P3H1;RPL5;AFM;PFN1;MT3;RASSF2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3161991520519479,-1.2208924463843709,0.13043478260869565,0.3726478423076261,1.0,21/108,12.00%,MDFIC;RUNX1;LRP1;SNX3;CSNK2A1;HHEX;CCNY;MACF1;AXIN1;MDFI;CTNNB1;SKI;PPP1CA;SULF2;WLS;CBFB;CDK14;OTULIN;APP;ITGA3;SPIN1
prerank,cellular response to unfolded protein (GO:0034620),-0.41716883588827597,-1.2206670540494637,0.1975736568457539,0.3727769730398862,1.0,9/26,21.52%,ERN1;OPTN;HSPA9;TMBIM6;BAG3;HSPA1A;HSPA2;HSPA13;PTPN1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.36047262756131704,-1.2193813751554545,0.1490787269681742,0.3748766529025028,1.0,11/46,10.59%,ITGA4;NRP1;RAC1;RHOA;PEAK1;LPXN;PARVB;ITGAV;FN1;ITGB7;KIF14
prerank,cellular calcium ion homeostasis (GO:0006874),0.2905318544677223,1.2190555167306032,0.08883248730964467,0.49035889717514247,1.0,30/133,16.47%,HTR2C;ANK2;TRPC5;RYR2;ADCY8;SLC24A4;SLC24A2;SLC8A3;HCRTR2;TRPC1;SLC24A3;LETM1;TMEM203;PTH1R;CCDC47;SLC8A2;RYR1;EDN1;CALCB;ATP1B1;MICU3;ATP2B4;CDH5;ATP2A1;ATP2B2;CHRNA7;SELENOK;ATP13A5;PDZD8;CXCL12
prerank,protein modification process (GO:0036211),-0.33092023481167826,-1.218876068315684,0.12947189097103917,0.3755238471222326,1.0,29/76,22.92%,ST3GAL1;PPP4R2;ST8SIA4;ABL2;WWP2;MSRA;PARP4;STK38;UBA7;UBE2L3;UBL5;B4GALT7;SEPHS1;SERP1;FBXW2;PADI4;PIGH;CDC34;RABGGTA;MAN2B1;UBE2I;GNMT;UBE2M;RABGGTB;FBXO22;BAP1;CSNK1G3;MANBA;ERO1A
prerank,response to cAMP (GO:0051591),0.37305504852457233,1.2188249377423916,0.15587529976019185,0.4896778220911954,1.0,7/37,9.65%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;HCN1;CITED1
prerank,cellular response to interleukin-15 (GO:0071350),-0.501929236984641,-1.2186921607616046,0.21631205673758866,0.3752964857051754,1.0,6/13,10.71%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.501929236984641,-1.2186921607616046,0.21631205673758866,0.3752964857051754,1.0,6/13,10.71%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,fatty acid biosynthetic process (GO:0006633),0.32915958795455036,1.2186691645064665,0.1675,0.4887711870925555,1.0,19/63,20.99%,ELOVL7;ABHD3;ACSM5;OLAH;HACD1;NDUFAB1;CYP1A1;ACACA;ABCD1;DECR2;LTA4H;TECRL;HSD17B8;MLYCD;ACSM3;ASAH2;ACOT7;ELOVL6;ELOVL2
prerank,protein kinase B signaling (GO:0043491),-0.43363912901049667,-1.2184274156355681,0.21503496503496503,0.375465393307179,1.0,12/23,29.49%,IGF1;GAS6;CCL5;PLK3;SIRT2;KDR;TGFB1;ADTRP;MT3;ZFP36L1;TSC2;PAX2
prerank,positive regulation of developmental process (GO:0051094),0.28485954263660823,1.2178708063253632,0.06233062330623306,0.48936085521980477,1.0,34/164,14.32%,NLGN1;NRXN1;GRIP1;PLCB1;ENPP2;BMPR1B;ARHGEF7;SOX5;SOX6;PTN;CLASP2;GDNF;ACVR1;SHANK3;ANAPC2;SPIRE1;WT1;MIEF1;ALK;SOX9;FMR1;BMP7;COBL;POU4F2;NEUROD1;RELN;CPEB3;BMP1;TAPT1;VLDLR;REST;PRKN;SYDE1;PACSIN1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.470276518032202,-1.217585440328763,0.222011385199241,0.37647446066963725,1.0,5/15,17.35%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.470276518032202,-1.217585440328763,0.222011385199241,0.37647446066963725,1.0,5/15,17.35%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,cholesterol metabolic process (GO:0008203),-0.3390450202073686,-1.2174889758221576,0.1354515050167224,0.3763920164362934,1.0,15/68,14.87%,APOE;ABCA1;ABCG1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;IDI1;HSD17B7;RXRA;ACAT2;CYP46A1
prerank,primary neural tube formation (GO:0014020),-0.3999665832327657,-1.2170807222856037,0.19047619047619047,0.37684338829760267,1.0,19/30,30.78%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;TGFB1;PHACTR4;DVL2;LRP2;DEAF1;TSC2;GRHL3;CELSR1;IFT122;GRHL2;PAX2;BCL10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3061725866992234,-1.216341069130327,0.10756302521008404,0.3779197748786335,1.0,37/128,22.48%,ZMIZ1;CBL;JUN;NRROS;RHOA;RNF111;LPXN;ARRB2;ITGB1;RUNX2;ADAM9;GCNT2;USP9X;SLC33A1;ARHGEF18;SKI;TGFBR1;TGFB1I1;DDX5;UBC;RPS27A;ITGB5;ZYX;ACVR2A;TGFBR2;ZMIZ2;APPL2;SMAD7;ID1;BMPR2;GDF3;APPL1;SMURF2;USP9Y;MEGF8;EID2;TGFB1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.43663473565084654,-1.215963828510834,0.21202003338898165,0.37828159069399264,1.0,7/20,26.34%,SP100;SUN2;MORC3;TAF8;TAF3;TOPORS;PML
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4718997094488494,-1.215439170779315,0.2205128205128205,0.37898538952133004,1.0,7/16,8.18%,ARHGAP24;OGT;ARHGAP17;PIK3CB;PIK3CG;ALS2;SH3BP1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5000146101745356,-1.215381936261793,0.2333965844402277,0.3788073792850095,1.0,5/12,17.22%,PARP11;TIPARP;PARP8;TNKS2;PARP10
prerank,cellular response to fatty acid (GO:0071398),-0.5045408506301354,-1.2153469915479749,0.23440134907251264,0.378592239605601,1.0,5/12,26.29%,PID1;LPL;ZC3H12A;NR1H4;KCNK4
prerank,response to ketone (GO:1901654),0.4113159890113394,1.2153159639228834,0.2128146453089245,0.4936605720299451,1.0,5/24,9.22%,SLIT3;SLIT2;YAP1;CATSPERD;TGFB2
prerank,photoperiodism (GO:0009648),-0.4026847271651392,-1.2150852076919436,0.17398945518453426,0.3787957317571907,1.0,13/28,28.08%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;RBM4B;FBXL8;FBXL6;PPP1CC;PPP1CB;PML;CLOCK;FBXL3
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.38227676455285897,1.2149152413089486,0.21100917431192662,0.49333801668587424,1.0,8/31,15.71%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;TBX1;HOXC9;FUZ
prerank,positive regulation of heart contraction (GO:0045823),0.4285731873617103,1.2148095322834087,0.1981981981981982,0.4923766965928144,1.0,5/19,12.89%,RYR2;APLN;TGFB2;EDN1;ADRA1A
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5106490242395954,-1.2142758669082212,0.21568627450980393,0.379959693172701,1.0,2/12,1.90%,IREB2;IDH1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.45102228472527817,1.2141543660221108,0.2146341463414634,0.49267286739631794,1.0,6/16,20.07%,RORA;PDK3;RORC;PRKN;MLYCD;SIRT1
prerank,cellular component assembly (GO:0022607),-0.2817130016394912,-1.2140328109028593,0.07894736842105263,0.3801418526641839,1.0,57/253,17.25%,MITF;NEDD9;SKAP2;CD74;WIPF1;FBLIM1;RAC1;YTHDF3;PEX14;SNX9;CREBBP;RHOA;EPS8;FLNA;STX7;LPXN;PARVB;SLC2A1;CDC42;PTK2B;ACTB;TAPBP;RHOQ;WASL;CAPG;PICALM;GAS6;BAIAP2;DET1;SH3BP1;TUBGCP4;CCDC40;DARS1;LCP1;LIMA1;TLCD2;NCKAP1L;REPS2;SPAG16;TRAF1;MICAL1;BAIAP2L2;FOXJ1;CAPZA1;KPNA3;SPEF1;TRAF2;NIFK;CD40;TFAP4;CHAF1A;ST13;DNAJB13;ESPN;RBBP4;IL2RB;KMT2A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.41863606542488807,-1.2137493910324986,0.19197207678883071,0.3803673910535669,1.0,8/24,21.75%,CD44;CD74;BCL2;TPT1;TMEM161A;TAF9;KDM1A;SNAI2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4856568623300909,-1.2136583471260387,0.23498233215547704,0.38025366418429607,1.0,2/13,2.29%,CCR2;GNAI3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5047804240251128,1.2136382651507855,0.24700239808153476,0.49266956620651486,1.0,2/11,2.58%,NECAB1;ITM2A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.4421892174726545,-1.213328592369365,0.22473867595818817,0.3805614146652423,1.0,6/20,15.96%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,cellular response to pH (GO:0071467),-0.46239837093989966,-1.213104601878511,0.22183098591549297,0.3806745436927048,1.0,6/17,26.29%,RAB11FIP5;SLC9A1;RAB11B;ASIC1;GPLD1;KCNK4
prerank,acylglycerol metabolic process (GO:0006639),-0.3774092910524376,-1.2128728515675358,0.165,0.38079475923693384,1.0,14/37,27.54%,APOE;DGKZ;ABHD12;DGKD;LPL;SEL1L;DGAT1;PLAAT3;DGKG;APOBR;APOH;LMF1;DGKA;GK5
prerank,protein targeting to peroxisome (GO:0006625),-0.4028906779316808,-1.212700562820624,0.17677642980935876,0.38084503660283564,1.0,8/29,17.21%,RAB8B;PEX14;ABCD2;PEX26;ZFAND6;FIS1;PEX7;ABCD3
prerank,cell cycle G2/M phase transition (GO:0044839),-0.30417964343581694,-1.212154300192367,0.10578512396694215,0.38156879958081885,1.0,45/129,25.30%,DNM2;OPTN;FBXL17;CNTRL;AKAP8;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;MASTL;YWHAE;NES;CEP70;HAUS4;CDC25A;CDK1;DCTN1;HAUS7;PLK3;PPP1R12A;NINL;ODF2;FBXL8;SKP2;AURKA;WEE1;PHLDA1;PCNT;FBXL6;PAFAH1B1;CEP192;CDC25C;TUBA4A;CEP41;CCNB1;PPP1CB;CETN2;CCNB2;AKAP8L;CEP72
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5286413101216791,-1.2121079471056084,0.24242424242424243,0.3813678440475808,1.0,1/10,0.16%,APOE
prerank,protein-containing complex assembly (GO:0065003),-0.2796170934976485,-1.2121050738763801,0.0677710843373494,0.3810912485197379,1.0,62/259,17.58%,MITF;SKAP2;SH3PXD2B;CD74;WIPF1;CTSZ;P2RX7;PEX14;SNX9;CREBBP;ANO6;LPXN;RIPK1;SLC2A1;DHX9;RAB1A;PTK2B;TMED10;AIM2;AXIN1;TAPBP;BLM;TFG;FN1;PREB;WASL;CAPG;PICALM;CTNNB1;DET1;TUBGCP4;CTSC;TLE3;SLC9A1;DARS1;ITGB1BP1;NCKAP1L;REPS2;DNAJB14;TRAF1;PPP6R3;PDZD11;SEC24A;KMT2D;STX5;SEC24D;TCF7;CAPZA1;KPNA3;TRAF2;SEC31A;NIFK;CD40;TFAP4;TRAPPC5;ST13;TLE4;IL2RB;CASP8;KMT2A;CLDN1;TMED2
prerank,artery morphogenesis (GO:0048844),-0.40471460127507963,-1.211969257740139,0.2078853046594982,0.38109147750441213,1.0,14/30,31.83%,NRP1;LRP1;JAG1;VEGFA;TGFBR1;SMAD7;PDGFRB;BMPR2;TBX2;LRP2;ENG;GJA5;ADAMTS9;HEY2
prerank,peptide cross-linking (GO:0018149),-0.41534341014503845,-1.2119346889768665,0.21269296740994853,0.38086965051464794,1.0,4/25,10.09%,F13A1;ANXA1;FN1;TGM2
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3819710233330013,-1.2117691627299962,0.1799660441426146,0.38092776984425747,1.0,19/36,29.01%,MAP3K20;ERCC6;RAD1;E2F1;TIMELESS;RHNO1;DOT1L;BRIP1;DNA2;RAD9A;ATM;CHEK1;TIPIN;NBN;CDC45;USP28;CLOCK;CEP63;DONSON
prerank,positive regulation of signal transduction (GO:0009967),-0.28254713566132067,-1.2114514603093807,0.07727975270479134,0.3812517000874465,1.0,45/238,12.25%,RBPJ;SASH1;PTPRC;NRP1;ZMIZ1;PRKCB;IGF1;CD74;TSPAN14;CRADD;AXL;ITGA5;CREBBP;MGAT5;ERN1;FLNA;CSNK2A1;MAML1;UCHL5;STAT3;MAML2;PTK2B;HHEX;ITGAV;SNX5;MACF1;JAG1;C3;GAS6;SKI;SULF2;WLS;TGFBR1;HIF1A;LY96;CD63;ITGB1BP1;ASXL1;ARNT;IL7R;XBP1;ENHO;F7;SPIN1;CLEC6A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4382555711675179,-1.2111819022576567,0.21477663230240548,0.381199720245926,1.0,9/21,17.43%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;EYA3;HSPA1A
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4382555711675179,-1.2111819022576567,0.21477663230240548,0.381199720245926,1.0,9/21,17.43%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;EYA3;HSPA1A
prerank,mitochondrial translation (GO:0032543),-0.31502235625068487,-1.2111495129284908,0.11258278145695365,0.38097682617054834,1.0,42/104,34.34%,NOA1;MRPS10;ERAL1;MRPL42;TUFM;FASTKD2;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPS25;MRPL54;EARS2;MRPL39;MRPL53;MRPL11;MTRF1;MRPL33;GATB;MRPL28;MRPL30;MRPL43;MRPS17;MTIF3;MRPS5;MRPS35;MRPS28;RARS2;MRPL1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3104204464846666,-1.2110440164012661,0.12643678160919541,0.38089355762546556,1.0,32/112,20.99%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;USP9X;ARHGEF18;SKI;TGFBR1;MEF2C;MAPK7;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;CRKL;APPL2;SMAD7;LIMS1;NR3C1;ID1;PDCD5;APPL1;SFRP1;USP9Y
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4041079686499803,1.2110079857856801,0.20045045045045046,0.49727700957179705,1.0,6/24,8.17%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4175120784371661,-1.2109355203555174,0.1958762886597938,0.3808220853298091,1.0,5/26,8.76%,PRKAG2;BRCA1;ADIPOR1;NR1H2;ERLIN1
prerank,cellular metal ion homeostasis (GO:0006875),0.2987076304707691,1.210669130920905,0.10126582278481013,0.49682015294520365,1.0,24/102,16.47%,HTR2C;ANK2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;SLC24A3;ATP1A3;LETM1;TMEM203;PTH1R;SLC8A2;EDN1;CALCB;ATP1B1;KCNMA1;ATP2B4;CDH5;ATP2A1;ATP2B2;CHRNA7;ATP13A5;CXCL12
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.519671271136755,-1.2102575209718933,0.23711340206185566,0.38181951831983457,1.0,5/11,25.85%,MALT1;NFKBIZ;CLEC6A;NFKBID;IL12RB1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4841190094020147,-1.2102305853086175,0.22491349480968859,0.38159323535784906,1.0,4/13,14.41%,CBL;SNX6;TSG101;CBLB
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3313577327537493,-1.2101278676825478,0.15719063545150502,0.38150079954281674,1.0,15/70,10.59%,ITGA4;NRP1;RB1;RAC1;RHOA;PEAK1;LPXN;SPI1;PARVB;ITGAV;FN1;SIPA1L3;ITGB7;MEF2C;KIF14
prerank,apoptotic process (GO:0006915),-0.28519166146894465,-1.2099136987978172,0.09147286821705426,0.38158400424718136,1.0,52/203,19.07%,APAF1;NOTCH2;PAEP;DAPK1;PRKCD;ITGB2;OGT;PPARD;GAPDH;BCL2L11;RIPK1;CFLAR;TNFAIP1;NUDT2;PTK2B;BCL2;DAPK3;STK3;TNFRSF21;AHR;DPF2;HIP1;MYD88;CASP4;FASTKD2;APP;PIK3CA;FAP;GADD45A;CD2;CASP7;IFIT2;CIB1;PLK3;STK11;CASP1;ADAM15;BBC3;TGFBR2;MAP3K10;CXCR4;BID;MCM2;BNIP2;CASP8;TNFRSF25;CSRNP1;IFT57;TAOK2;TRADD;CASP2;PAK6
prerank,acylglycerol catabolic process (GO:0046464),-0.3981812420258814,-1.2099013300926766,0.1996615905245347,0.3813288582925175,1.0,4/30,10.29%,FABP5;ABHD12;LPL;FABP4
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.47974463399476125,-1.2096938434791717,0.2525083612040134,0.3814871745343567,1.0,2/15,1.09%,CCR2;SYK
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5235544207208617,-1.2096715839433407,0.22202797202797203,0.3812548066757034,1.0,5/10,24.88%,LILRB1;FN1;HSP90AB1;LAPTM4B;FURIN
prerank,positive regulation of axonogenesis (GO:0050772),0.35332168437274436,1.2094249628209,0.15829145728643215,0.49847419814631194,1.0,10/43,11.94%,ROBO1;ROBO2;SLIT2;NTRK2;CDKL5;SLITRK1;BDNF;PLXNA4;POU4F2;PLXNA2
prerank,regulation of histone acetylation (GO:0035065),-0.3924717520670062,-1.2093821202655375,0.18524590163934426,0.38149508810198635,1.0,10/33,23.09%,BRD7;SPI1;BRCA1;ARRB1;FLCN;HDAC5;KMT2A;CHEK1;SET;RPS6KA5
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4182159708744819,-1.2091391160692502,0.23154362416107382,0.38163509554628927,1.0,9/25,12.63%,ITGA4;ITGB2;ITGA5;ITGB1;ITGAV;ITGB7;ITGAX;CD2;CXADR
prerank,regulation of cell migration (GO:0030334),-0.2685188575172722,-1.2090836735725496,0.036127167630057806,0.38143611282612067,1.0,77/382,13.42%,DAB2;SASH1;MITF;NEDD9;PLXNC1;IGF1;MCTP1;CD74;FGR;CORO1C;CLIC4;SDCBP;ARID2;RAC1;ROCK1;YTHDF3;PTPRJ;RHOA;MGAT5;RAP2B;INSR;DOCK10;PLXNA1;FLNA;IGF1R;PLAU;PLXND1;RAP2A;GNA12;MINK1;SGK1;RNF41;STAT3;FOXO3;CCR1;FLT1;ITGB1;PTK2B;RNF20;RUFY3;ANXA1;ADAM9;ELP5;MACF1;JAG1;SEMA4A;DUSP3;HGF;GCNT2;CYRIB;MYADM;GRN;SUN2;NF2;VEGFA;MDK;CBLL1;BST2;TGFBR1;CTSH;SPRY2;ITGAX;KIF14;XBP1;FLCN;OSGIN1;ARHGEF39;F7;CXCL16;CPNE3;CCL5;CIB1;SERPINE1;SEMA4B;STK24;ADAM15;PIK3CD
prerank,actomyosin structure organization (GO:0031032),0.31582639416760067,1.2089354918713318,0.13624678663239073,0.49838682921167854,1.0,16/75,12.96%,SORBS1;TJP1;FRMD5;CDC42BPA;EPB41L4B;EPB41L3;EPB41L4A;PHACTR1;FRMD3;CSRP1;TNNT2;TTN;PGM5;CAPN3;MYH10;FHOD3
prerank,regulation of lymphocyte activation (GO:0051249),-0.49985474362368587,-1.208753769651335,0.23559322033898306,0.38178353987285196,1.0,8/12,31.08%,THEMIS2;IKZF3;LCK;CCL5;CRTAM;CD19;LAT;CD4
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4346370734425796,-1.2085658591367903,0.2135593220338983,0.3818811926794687,1.0,13/20,36.49%,APOE;MBTPS2;TTC39B;FMO5;LPCAT3;NR1H4;ACADVL;ABCA2;LDLRAP1;SREBF1;ARV1;DGKQ;GNB3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4323622272039505,-1.2083443925758433,0.2129783693843594,0.38200361338844346,1.0,4/23,9.87%,PLEK;NUPR1;CBFA2T3;SIK1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4622855021361673,-1.2081830681222148,0.21052631578947367,0.3820325154767014,1.0,9/17,26.55%,CTR9;RNF20;ZC3H14;NUDT21;NCBP1;VIRMA;RNF40;ZC3H3;NELFE
prerank,regulation of nuclear division (GO:0051783),-0.42775172775899817,-1.2081637082891077,0.19550173010380623,0.38178688283776857,1.0,7/20,21.06%,CDK13;KIF20B;DAPK3;PIN1;MKI67;RCC1;CDC25C
prerank,dendritic cell chemotaxis (GO:0002407),-0.4867790561899871,-1.208099438296526,0.22797927461139897,0.38163214860932776,1.0,6/14,19.87%,CCR2;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,telomere organization (GO:0032200),-0.3663920806842337,-1.2078095640681195,0.1996527777777778,0.38190253248774586,1.0,17/43,26.81%,SP100;BLM;RTEL1;XRCC6;PCNA;WRN;RPA3;POLD2;DOT1L;ERCC4;DNA2;ATM;NBN;PRKDC;POLD4;DCLRE1B;MRE11
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.26666946218970955,-1.2075874788186476,0.06354009077155824,0.3820307016731547,1.0,107/366,23.85%,MITF;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;FOXN2;SPI1;JMJD1C;STAT3;FOXO3;LYL1;ZSCAN26;CTR9;CHD3;RYBP;RNF20;SAP30;DAPK3;GPBP1L1;PUM3;GON4L;SRRT;FUS;AHR;GCFC2;REXO4;POFUT1;EDF1;EZH2;BHLHE40;E2F1;CNBP;THAP1;PCIF1;TGFBR1;HIF1A;MEF2C;UBE2L3;NUCKS1;FOXN3;HDAC10;APP;MTPN;HP1BP3;CCDC88A;RELA;KMT2D;ORC5;PRDM2;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;RPL6;NOLC1;BTG1;TCF3;NSD1;PSPC1;POLR2A;ZNF628;SRSF10;HCLS1;EIF2A;VHL;RBM4B;ATF5;MYB;ATXN1;PLAG1;PPARGC1B;CXXC1;NR3C1;NUP35;PAK6;SUFU;ESCO2;CASZ1;ATF7;NUP107;ZFPL1;GTF2IRD1;PDGFA;ZSCAN21;RBM3;CEBPB;SNAI2;NONO;ESR2;SOX7;RPS6KA5;RABL3;DVL2;ZNF395;HES6;CHD7
prerank,regulation of microtubule polymerization (GO:0031113),0.36728242358947855,1.2073238771203696,0.17727272727272728,0.5007351823217011,1.0,12/40,17.31%,NAV3;MAP2;MAPRE3;TUBB4A;OCLN;EML2;CDK5R1;CDK5RAP2;CDH5;ARL2;SNCA;PRUNE1
prerank,regulation of cell aging (GO:0090342),-0.5115163389223719,-1.2070943848955533,0.253781512605042,0.3825962560258322,1.0,4/11,34.75%,NEK6;LMNA;NEK4;ING2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.42920632505918943,-1.2069615513142464,0.22145328719723184,0.3825635329278025,1.0,12/22,34.31%,ROCK1;MGAT5;MASTL;NCKAP1L;STYXL1;IKBKB;GSK3B;FKBP1B;BOD1L1;PTPA;TNF;ROCK2
prerank,response to interferon-beta (GO:0035456),-0.4244175521487686,-1.2069187928586333,0.2108843537414966,0.38236810978385993,1.0,16/22,45.54%,AIM2;IFNAR2;BST2;IFITM2;CDC34;STAT1;IFITM1;IRGC;PLSCR1;IKBKE;TRIM6;XAF1;IFITM3;SHFL;UBE2K;HTRA2
prerank,regulation of biomineral tissue development (GO:0070167),-0.4103300964582833,-1.206858407129313,0.1839863713798978,0.3821906446137359,1.0,11/26,34.85%,ROCK1;GAS6;ANKH;ENPP1;CEBPB;TGFB1;NOTUM;HEY2;ROCK2;BMP2K;HEY1
prerank,multivesicular body organization (GO:0036257),-0.3947152940883241,-1.2065985060612725,0.18181818181818182,0.3824232507186626,1.0,17/31,35.19%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;CHMP4B;CHMP4A;VPS4A;CHMP2B;MVB12A;VPS4B;VTA1;IST1;HGS
prerank,T cell migration (GO:0072678),-0.49137087823767184,-1.2062953524789954,0.2495755517826825,0.38274289966538594,1.0,6/13,17.51%,MSN;MYO1G;PIK3CG;CXCL16;PIK3CD;ZAP70
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.34171072464952684,-1.206159252128924,0.1552901023890785,0.3827004871856741,1.0,23/66,25.42%,PRKCD;IPO5;FLNA;CCT7;PARP9;TPR;CDK1;KAT7;HCLS1;MAVS;BAG3;CCT4;CHP2;DTX3L;ZC3H12A;JUP;TGFB1;GTSE1;RBM22;CARD10;TRIM28;ECT2;LARP7
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5169459254663966,-1.2052662526092282,0.23507462686567165,0.3841916446624313,1.0,3/10,13.84%,LYN;MAP2K1;GREM1
prerank,phosphate ion homeostasis (GO:0055062),-0.5142621120189733,-1.2051134041814788,0.2549019607843137,0.38416586978703576,1.0,4/10,36.70%,XPR1;ENPP1;FGFR4;FGF23
prerank,N-terminal protein amino acid modification (GO:0031365),0.47368056901682415,1.2051048105849786,0.24881516587677724,0.5044647094562743,1.0,5/14,15.48%,METAP2;NAA10;NAA60;METAP1;PDF
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3432377445774503,-1.2048717203983195,0.1680960548885077,0.3843372666329183,1.0,23/57,24.44%,MAP3K5;CTSD;DAPK1;SYK;USP50;MALT1;NLRC4;AIM2;ASPH;NOD1;GRAMD4;FIS1;CASP1;TNFSF10;CASP8;PDCD5;DDX3X;HMGB1;NLRP3;SOX7;MEFV;CYCS;MYC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.33307895111026786,-1.2044343497646426,0.15333333333333332,0.38485843446259715,1.0,28/71,22.73%,CTSB;CTSZ;PDCD6IP;MALT1;RNF41;FBXL17;DDI2;USP9X;ATXN3;RNF123;CTSC;ATE1;PSMA8;UBC;RPS27A;CTSH;CUL4B;FAP;CTSS;SOCS6;HM13;ISG15;CASP8;ZRANB1;BAG6;CHMP4B;VPS4A;RSPRY1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.42833515558662233,1.2039613741196962,0.20347394540942929,0.5059340706360655,1.0,3/19,9.06%,TJP1;AFDN;NEXMIF
prerank,macroautophagy (GO:0016236),-0.3043714691938222,-1.2033156134281942,0.14052287581699346,0.386693556098525,1.0,37/118,24.62%,PLEKHM1;ARL8B;CSNK2A1;TECPR1;PIP4K2A;PRKAG2;ATG5;LAMP2;UVRAG;TCIRG1;ATG7;MTMR3;MTMR14;ATG10;TBC1D5;TSG101;EPG5;LIX1;HDAC10;STAM2;UBXN6;RB1CC1;GABARAP;CHMP2A;CLN3;EI24;VPS33A;TOMM22;PRKAG1;CHMP4B;CHMP4A;VPS4A;TOMM70;BECN1;VDAC1;VPS16;CHMP2B
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.4278088901857346,-1.2031721840439484,0.22998296422487224,0.38667660719031427,1.0,9/21,27.48%,BCL2L11;TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A;NCK1;BCL2L1;EIF2AK3
prerank,sulfur compound transport (GO:0072348),-0.40703424119192194,-1.2027711307742344,0.1996527777777778,0.3871590114798757,1.0,4/27,4.09%,LRRC8D;SLC6A6;SLC26A11;SLC27A1
prerank,cholesterol biosynthetic process (GO:0006695),0.3867818462720499,1.2026783904486529,0.21354166666666666,0.5076758374817408,1.0,10/31,14.61%,DHCR24;HMGCS1;INSIG1;CYP51A1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,cellular senescence (GO:0090398),-0.39889699534293427,-1.2023475627748608,0.20833333333333334,0.38768018993998066,1.0,10/27,26.34%,NSMCE2;PRKCD;SPI1;MAPK14;MAP2K1;ID2;SMC6;TBX2;SMC5;PML
prerank,endothelial cell migration (GO:0043542),-0.3813965336165298,-1.2022870993309798,0.20508474576271185,0.3875013343386235,1.0,12/37,16.16%,NRP1;MYH9;RHOA;PLXND1;LPXN;DPP4;VEGFA;PLEKHG5;PIK3CA;FAP;RAB13;NR4A1
prerank,peroxisomal membrane transport (GO:0015919),-0.4015868887502637,-1.2022092491480232,0.19796954314720813,0.38736389037170144,1.0,7/27,17.21%,RAB8B;PEX14;ABCD2;PEX26;FIS1;PEX7;ABCD3
prerank,icosanoid metabolic process (GO:0006690),-0.372966102675602,-1.202192084619214,0.18493150684931506,0.38712075980141214,1.0,14/40,29.83%,TBXAS1;MAPKAPK2;ALOX5AP;ABCC1;DAGLB;GPX4;PLA2G4A;PON2;CYP1B1;PNPLA8;PON3;ALOX15;CYP2S1;PTGR1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.37433342304475525,1.2016704827601525,0.19480519480519481,0.5087067855695887,1.0,8/31,10.56%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;ANK1;CRB1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.30269244988551386,-1.2012134808779833,0.1254180602006689,0.3885271627522773,1.0,44/128,25.30%,DNM2;BACH1;OPTN;FBXL17;CNTRL;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;MASTL;YWHAE;NES;CEP70;HAUS4;CDC25A;CDK1;DCTN1;HAUS7;PLK3;PPP1R12A;NINL;ODF2;FBXL8;SKP2;AURKA;WEE1;PHLDA1;PCNT;FBXL6;PAFAH1B1;CEP192;CDC25C;TUBA4A;CEP41;CCNB1;PPP1CB;CETN2;CCNB2;CEP72
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.49190634505850905,-1.2006691223829085,0.2535211267605634,0.38921940808485284,1.0,6/12,21.71%,BLM;METTL4;KAT7;TICRR;TIPIN;NBN
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.5176029168019503,-1.2006658812730677,0.24057450628366248,0.38894753601617427,1.0,4/10,17.08%,DCLRE1C;RTEL1;DCLRE1A;TFIP11
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.34471675234569077,-1.200629037471798,0.16428571428571428,0.388738002502983,1.0,19/56,26.92%,DAB2;SDCBP;PMEPA1;RBPMS;TGFBR1;SNX25;PIN1;ACVR2A;GREM1;TTK;LDLRAD4;SMAD7;BMPR2;GDF3;INHA;TGFB1;BMP2;SMAD4;ENG
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28717936125985705,1.2002000535740942,0.0925,0.5107246436243309,1.0,19/124,8.27%,CNTNAP2;NLGN1;MAP2;CNTN4;GPM6A;RASGRF1;SH3GL2;CSF1R;PLP1;TMEM108;BICDL1;CARMIL1;GDNF;GPM6B;KIFAP3;FLRT3;NEDD4;TOR1A;FAM161A
prerank,chromatin remodeling (GO:0006338),-0.31314069225166974,-1.2001504108775012,0.14991762767710048,0.38940333981076314,1.0,22/100,18.73%,RB1;BPTF;ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCD3;SMARCC2;JARID2;ARID1A;BAZ2B;BAZ1A;CHD8;PADI4;DR1;HDAC5;INO80;RBBP4;INO80C;MYB;RSF1
prerank,snRNA processing (GO:0016180),-0.45989944624165224,-1.2000036974595192,0.24914675767918087,0.38941248672373246,1.0,6/16,20.38%,INTS8;INTS11;INTS6;INTS14;INTS1;INTS5
prerank,negative regulation of secretion (GO:0051048),0.5155403103512985,1.1991649407804663,0.25813953488372093,0.5117996090925544,1.0,5/10,16.04%,NRG1;EGF;SPX;VAMP8;ERBB3
prerank,sensory perception of taste (GO:0050909),0.5082669776101789,1.198850364784387,0.24528301886792453,0.511322420207248,1.0,3/10,10.48%,ASIC2;PKD1L3;TAS1R1
prerank,cation transmembrane transport (GO:0098655),0.347151946463039,1.1983488226293764,0.1702127659574468,0.5112465057445282,1.0,10/44,17.53%,ASIC2;TRPM3;SLC25A19;TRPM1;SFXN3;ATP1B1;SLC25A38;SLC22A5;SLC6A5;TRPM2
prerank,prostaglandin metabolic process (GO:0006693),-0.40442690593659125,-1.1982201231451322,0.21660649819494585,0.3924691538263577,1.0,9/26,29.83%,TBXAS1;CD74;DAGLB;PLA2G4A;ACOX1;PNPLA8;CYP2S1;PTGES;PTGR1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.46789474596020647,-1.198113288011639,0.2270363951473137,0.39239258925168524,1.0,10/15,42.94%,SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;AUP1;OS9;HERPUD1;SYVN1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.42210963478093194,-1.1980905382948548,0.21023765996343693,0.3921552766815535,1.0,3/21,8.81%,DAB2;RBPMS;TGFBR1
prerank,toxin transport (GO:1901998),-0.5242466754116206,-1.197961321636023,0.24775583482944344,0.3921372568065562,1.0,7/10,42.03%,ANTXR2;RAB29;SLC22A3;SLC22A2;ANTXRL;SLC29A4;ADAM10
prerank,mRNA transport (GO:0051028),-0.31018034058023003,-1.1971918103340227,0.12807881773399016,0.39331225959862054,1.0,46/101,33.53%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;UPF2;NUP205;TPR;ALYREF;WDR33;NUP188;YTHDC1;NCBP1;THOC2;NUP153;RNPS1;THOC6;NUP35;MAGOH;SLU7;NUP107;CPSF3;NUP62;SMG1;SRSF11;DDX39B;RANBP2;CPSF1;RBM15B;DHX38;NUP37;ZFP36L1;U2AF2;SRSF7;AAAS;NUP133;EIF4E;SRSF5;U2AF1L4;EIF4A3;ALKBH5;SARNP
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4956859039448174,1.1970888849570775,0.24942263279445728,0.512997360913019,1.0,3/10,6.70%,YOD1;UBE2J1;INSIG1
prerank,triglyceride metabolic process (GO:0006641),-0.3571892523968324,-1.196633436042497,0.17264957264957265,0.39413247014838776,1.0,21/48,39.41%,APOE;FABP5;AGMO;LPL;FABP4;SEL1L;DGAT1;PLAAT3;APOBR;APOH;LMF1;LIPH;GK5;GPAT2;LPIN3;CAV1;PNPLA1;APOA2;SLC27A5;LIPG;FABP7
prerank,lytic vacuole organization (GO:0080171),-0.38465136450667503,-1.1965725337507747,0.1913477537437604,0.39397783644017825,1.0,16/32,31.92%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.4528043575559535,-1.1964390713902529,0.218213058419244,0.39394212163499603,1.0,6/17,21.75%,CD44;CD74;DYRK1A;RNF34;KDM1A;SNAI2
prerank,positive regulation of lyase activity (GO:0051349),0.4581702593040144,1.196184156905537,0.23653395784543327,0.5137677724593805,1.0,5/14,23.52%,CACNA1C;GUCA1A;FXN;NF1;NOS1
prerank,negative regulation of metabolic process (GO:0009892),-0.35138810410254395,-1.1960997118864125,0.18057921635434412,0.39432638063090236,1.0,17/54,18.74%,RBPJ;RB1;IL15;TLR4;NR1H2;LNPEP;PLCL2;ZDHHC7;TLE3;FIS1;FLCN;ACOT13;STK11;IL18R1;TFE3;ID1;RHEB
prerank,cardiac cell development (GO:0055006),-0.5065918650420848,-1.1960880458575813,0.2681660899653979,0.3940646503969431,1.0,4/11,12.63%,JAG1;VEGFA;SLC8A1;CXADR
prerank,somite development (GO:0061053),0.503109358227918,1.1960281188079545,0.24641148325358853,0.5128973941187758,1.0,3/11,19.16%,SOX11;SMO;MEOX2
prerank,nerve growth factor signaling pathway (GO:0038180),0.5104327299089624,1.1958911092335711,0.2357142857142857,0.511989972355346,1.0,2/10,7.13%,MAGI2;BDNF
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.41072043679064435,-1.1957925933037608,0.22202797202797203,0.39434712445372894,1.0,9/26,20.20%,TET3;OGT;CTR9;KMT5B;KMT5C;KMT2D;TET2;KMT2A;EEF2KMT
prerank,cytosolic calcium ion transport (GO:0060401),0.3798748404930873,1.1955775099158803,0.1820388349514563,0.5115221686865159,1.0,10/28,15.26%,CACNA1C;RYR2;CACNA2D1;SLC25A23;TRPM1;JPH4;SLC8A2;ADRA1A;MICU3;JPH3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31818282869318565,-1.195515016742479,0.16612903225806452,0.3946101938288378,1.0,35/85,28.20%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;VANGL2;PSMB8;RYK;PSMD4;PSMA5;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;AP2S1;PFN1;SMURF1;FZD1;FZD7;DAAM1;PSMA7;CELSR1;AP2A1
prerank,dendritic spine morphogenesis (GO:0060997),0.4589810317601631,1.195500024154239,0.24069478908188585,0.5104789477909544,1.0,4/15,5.31%,CTNND2;PAK3;EPHB1;SHANK3
prerank,steroid hormone biosynthetic process (GO:0120178),-0.39273352432106573,-1.1952199391582297,0.2179054054054054,0.39487030380974303,1.0,14/29,39.05%,HSD17B7;FDXR;SRD5A1;SRD5A2;TSPOAP1;FDX1;HSD3B2;HSD17B14;FDX2;SRD5A3;STARD3;HSD17B3;CYP19A1;TSPO
prerank,intracellular lipid transport (GO:0032365),-0.42916145214468604,-1.1945882729135873,0.2363013698630137,0.39570552716127155,1.0,6/21,17.21%,PRKAG2;ABCD2;CPT1A;NPC2;ACACB;ABCD3
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.4938194023080436,-1.1942925162812763,0.25773195876288657,0.3960274442417788,1.0,3/12,4.64%,NUPR1;IL18;STAP1
prerank,mRNA catabolic process (GO:0006402),-0.35819721014233896,-1.1940150630928494,0.2033898305084746,0.3962894616108478,1.0,26/44,43.51%,ERN1;TUT7;RC3H1;DCP2;DDX5;LSM6;HSPA1A;EXOSC10;LSM5;EXOSC4;XRN2;NUDT16;NBDY;ZC3H12D;METTL3;DHX34;NUDT12;HSPA1B;AGO3;SLFN14;ZFP36;DXO;YTHDF2;METTL16;RNH1;XRN1
prerank,cellular response to radiation (GO:0071478),-0.36583323987697564,-1.1939270011865752,0.18561872909698995,0.39617400540308256,1.0,12/40,17.57%,GRB2;SPIDR;MAPK14;BLM;RAD1;RAD51;GADD45A;RHNO1;RAD51AP1;INO80;NSMCE3;RAD9A
prerank,regulation of tissue remodeling (GO:0034103),-0.44197651896622453,-1.1938208208411938,0.23201438848920863,0.3960896840822384,1.0,4/18,7.95%,RUNX1;IL15;IL18;MDK
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.29881483812145176,-1.193762850384528,0.11801242236024845,0.39593927822440034,1.0,46/124,28.40%,GNB1;RAC1;RHOA;AGO2;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;GNG2;CTNNB1;AP2A2;VANGL1;PSMA8;PSMC3;MOV10;PSMD8;TNRC6C;PSMC4;PLCB3;PSMB10;PSMA1;VANGL2;PSMB8;RYK;NFATC1;PSMD4;PSMA5;PSMB3;PSMD3;SMURF2;SFRP1;DVL2;PSMB1;AP2S1;PFN1;CCDC88C;SMURF1;FZD1;FZD7;DAAM1;PSMA7;CELSR1;AP2A1;LEF1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.34489327090156213,1.1935339248604913,0.155,0.5137020132353268,1.0,17/44,15.25%,OSBPL6;SLC27A2;OSBPL7;INSIG1;SQLE;DHCR7;ACOX2;SC5D;EBP;PER2;HSD3B7;OSBPL2;PSAT1;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4042784015527327,-1.193062018719451,0.2276707530647986,0.3969824707472483,1.0,13/26,28.55%,DHX58;IRAK3;PPM1B;TRIB1;PCBP2;NLRC3;NFKBIL1;C1QBP;SIRT2;CARD16;MAPKBP1;RNF26;SIGIRR
prerank,regulation of microtubule-based movement (GO:0060632),0.500449081312082,1.1922654409660098,0.2448512585812357,0.5153295214211353,1.0,5/11,18.58%,MAP2;NEFH;CFAP298;HAP1;TTC21B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5028887895108696,-1.1920857452852895,0.26534296028880866,0.3984758158143317,1.0,4/11,10.17%,STAT3;DHX9;PUM2;XPO5
prerank,RNA 3'-end processing (GO:0031123),-0.3303627225993624,-1.1918255502295483,0.17687074829931973,0.3987273077512129,1.0,29/69,33.53%,SRRM1;TUT7;CHTOP;CDC40;MTPAP;ALYREF;NUDT21;RPRD2;WDR33;NCBP1;THOC2;TENT4B;RNPS1;THOC6;MAGOH;PAPOLA;SLU7;CPSF3;SRSF11;DDX39B;CPSF1;DHX38;U2AF2;SRSF7;TUT1;SRSF5;U2AF1L4;EIF4A3;SARNP
prerank,exit from mitosis (GO:0010458),-0.4861972100024209,-1.1917401924639524,0.24772313296903462,0.3986063485662974,1.0,6/12,21.70%,EPS8;CHMP7;PPP2R2D;CHMP2A;UBE2C;CHMP4B
prerank,carboxylic acid transport (GO:0046942),-0.3459500789855031,-1.190942792318539,0.17569786535303777,0.3998564020413879,1.0,15/55,20.05%,SLC16A7;PSAP;SLC38A6;SLC6A6;SLC36A4;SLC66A1;SLC7A5;SLC16A6;CLN3;SLC23A1;SLC23A2;SLC6A9;SLC38A2;SLC25A10;SLC16A1
prerank,peptide metabolic process (GO:0006518),0.3189451438317563,1.190553030428857,0.1486810551558753,0.5180076083839507,1.0,18/75,17.89%,DMD;PCSK5;MME;MGAT3;TRHDE;IDE;SEC11C;ABCB9;GSTZ1;GSTP1;PCSK1;CPE;GGT1;GSTK1;LTA4H;GSTM5;DNPEP;GSTA4
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.48715081363449564,1.1904768459305102,0.2684085510688836,0.5169590590180777,1.0,4/12,11.06%,PLCB1;SLIT2;CCN3;NBL1
prerank,Golgi ribbon formation (GO:0090161),-0.4780000696584104,-1.1900166607417255,0.27101200686106347,0.40128280143647266,1.0,6/13,24.65%,VTI1A;OPTN;VAMP4;STX16;TMED5;TRIP11
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3684160939092128,-1.1899532452762855,0.22185430463576158,0.40112352728587175,1.0,10/39,11.48%,MYO5A;TRAK1;MYO1F;RAB1A;FBXW11;MYO1G;WASL;SYT4;MYO1E;MYO7A
prerank,regulation of bone mineralization (GO:0030500),-0.3406344052029555,-1.1899158307194315,0.18412162162162163,0.4009071900774912,1.0,16/55,19.05%,ATP2B1;P2RX7;ANO6;CCR1;SRGN;PTK2B;PKDCC;SLC8A1;MEF2C;OSR1;ACVR2A;GREM1;ISG15;ANKH;ENPP1;BMPR2
prerank,lysosome organization (GO:0007040),-0.37579171145283813,-1.189851248097813,0.19831932773109243,0.40075096117525855,1.0,17/36,31.92%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS33A;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,positive regulation of cilium assembly (GO:0045724),0.43345065431408386,1.1889502390574964,0.25565610859728505,0.5194032842363644,1.0,7/18,22.31%,TAPT1;SEPTIN9;ARHGAP35;FUZ;HAP1;BBS4;HTT
prerank,protein localization to plasma membrane (GO:0072659),0.2862817503056505,1.1886786430445968,0.1134020618556701,0.5188483799214783,1.0,16/129,5.86%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;AFDN;CLASP2;NECTIN3;RAMP3
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3748476983103058,-1.1886487117343514,0.2045060658578856,0.4028063034430078,1.0,21/39,29.24%,ABCA1;RAB8B;CANX;STEAP3;PREB;RCN3;RAB3D;SEL1L;RAB10;MIA2;MIA3;RAB13;PDIA4;RAB12;TVP23A;MON1A;TANGO6;AFM;PPY;COPG1;LTBP2
prerank,cell-cell junction maintenance (GO:0045217),0.48060198511086233,1.1884330563269874,0.23933649289099526,0.5182000012043794,1.0,5/11,18.57%,TJP1;CSF1R;FERMT2;NLGN2;PARD6A
prerank,sphingolipid metabolic process (GO:0006665),-0.3037399526893464,-1.1881634648701265,0.14023372287145242,0.4033887096056742,1.0,40/108,31.90%,SGMS1;HEXA;PSAP;TEX2;SPTLC2;ACER3;CTSA;GLTP;ARSA;ESYT1;ESYT2;SPTSSA;SUMF2;PRKD3;NEU1;KDSR;VAPB;SPHK2;SPTLC3;PPT1;SAMD8;ASAH1;PLPP3;ELOVL5;DEGS2;ABCA2;B4GALNT1;CERS3;ORMDL2;PLA2G15;VAPA;HACD4;CPTP;CERK;HACD3;B3GALNT1;ORMDL3;SERINC1;ACER2;ALDH3B1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4254776871320757,-1.1880399628712905,0.22895622895622897,0.4033325477541138,1.0,4/21,5.31%,ABCB7;ABCD2;BRCA1;COA8
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.471038922627768,-1.1877141937972477,0.254416961130742,0.40366584182420523,1.0,6/14,14.23%,RAB1A;SEC24A;SAR1A;SEC24D;SEC31A;MIA3
prerank,regulation of lipid catabolic process (GO:0050994),0.4268889760928094,1.1875415386197572,0.2482758620689655,0.519129017010891,1.0,5/19,14.97%,ALK;APOC1;ANGPTL3;ABCB11;ABCD1
prerank,negative regulation of reproductive process (GO:2000242),-0.4441745229653219,-1.1869752435038519,0.23344947735191637,0.4047590116591776,1.0,2/17,0.74%,IGF1;PAEP
prerank,regulation of dephosphorylation (GO:0035303),0.4553417618869685,1.1865989054428596,0.24324324324324326,0.5199705562735922,1.0,8/15,22.71%,MTMR2;CDK5RAP3;SMG5;PPP1R16B;MTMR9;MTMR4;PPP1R17;SMG7
prerank,regulation of spindle assembly (GO:0090169),-0.40687177446707423,-1.186306848428615,0.22791519434628976,0.40578770642031897,1.0,14/25,33.73%,PDCD6IP;CHMP5;DYNC1H1;RNF4;TPR;CHMP1A;CHMP2A;HSPA1A;CHMP4B;CHMP2B;HSPA1B;VPS4B;DRG1;NUMA1
prerank,regulation of centrosome cycle (GO:0046605),-0.4258743463046698,-1.186160506297025,0.2465986394557823,0.405794662006912,1.0,12/21,27.32%,PDCD6IP;CHMP5;GEN1;CHMP1A;CHMP2A;AURKA;XRCC3;ATF5;CHMP4B;PKHD1;CHMP2B;MARK4
prerank,translational termination (GO:0006415),-0.3100670663963519,-1.184859075732197,0.16501650165016502,0.4079988733644392,1.0,36/95,33.27%,GSPT1;ABCE1;MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPS25;MRPL54;MRPL39;MRPL53;MRPL11;MTRF1;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPS35;MRPS28
prerank,liver development (GO:0001889),-0.3837188681357151,-1.184846786387534,0.21922428330522767,0.4077478679141404,1.0,15/32,30.14%,ARID5B;ANXA1;CEBPG;CCDC40;XBP1;GFER;E2F8;AURKA;CEBPB;IL6;LSR;DNAAF1;NKX2-8;CITED2;MET
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2981072872654218,-1.1847394323710083,0.14729950900163666,0.4076762432934089,1.0,39/137,21.11%,BCAR3;PSAP;RSU1;SNX9;RHOA;DOCK10;DOCK11;SGSM2;RGS1;RAP1A;ITGB1;DOCK8;ARAP1;RAB3GAP1;PICALM;EZH2;ALS2;SH3BP1;RCN3;CTSH;TGM2;PIN1;FLCN;SNX13;WRN;SNX18;CCL5;HMGB2;CD40;TBC1D30;TBC1D7;AGRN;RPS3;LIMS1;MMUT;CHP2;GSK3B;SFRP1;RACK1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.42838620868933064,-1.1846253074900244,0.25,0.40759454235102405,1.0,3/19,1.57%,PRKCH;RUNX1;ROCK1
prerank,positive regulation of cellular process (GO:0048522),-0.25293498504866496,-1.1839506964332516,0.053824362606232294,0.4086026287412728,1.0,172/565,27.10%,DOCK2;LYN;IGF1;NAMPT;GAB2;SDCBP;P2RX7;LRP1;CYBA;PRKCD;RAC1;CD36;SLC6A6;PTPRJ;CAMK1D;ACER3;TNFRSF1B;NUPR1;INSR;P2RX4;CSNK2A1;IGF1R;CDK13;IL6R;HTR2B;IL15;TLR4;FLT1;CDC42;EAPP;TCIRG1;DPP4;PTK2B;DYNC1H1;ITGAV;BCL2;KIF20B;RPS6;STX3;SLC35F6;FN1;CHTOP;DDX49;KLHL22;GCNT2;LRP6;GRN;EZH2;GAS6;GRK5;VEGFA;SIRPA;MDK;CNBP;PRMT1;RPS15A;TGFBR1;PTPN6;ADAM8;CTSH;TBC1D8;ITGB1BP1;RPS4X;TGM2;MTPN;ITGAX;KIF14;IL7R;IL2RG;XBP1;FLCN;RELA;KMT2D;CELF1;CXCL16;FCGR2B;CACUL1;HSP90AB1;CCL5;CIB1;FCER1G;GLP2R;DHX36;CST7;GREM1;NCBP1;TGFBR2;CAPNS1;AGPAT1;DOT1L;IL34;EIF4G1;INO80;ACACB;CRKL;TTK;IL31RA;HCLS1;BST1;IL2RB;STX4;FAF1;CNOT6L;RPS9;VHL;RARA;LILRA5;TFE3;HCK;SERTAD1;IRS2;KRAS;PDGFRB;MEIS3;PLA2G5;DDX3X;CSF1;WDR77;IL7;CNOT8;CSPP1;CHP2;C1QBP;ATM;CHEK1;SIRT2;PRC1;MAZ;TIPIN;ZC3H12A;SFRP1;PDGFA;KDR;EXOSC4;SMC6;TBX2;HPR;HP;EGR2;S1PR2;IL6;TGFB1;P4HB;DVL2;LMNA;FLT3;FGF9;SHC1;CD47;ECHDC3;RNF187;MYC;PKHD1;KITLG;FGFR4;FKBP1B;SMC5;PRTN3;MT3;CCN2;RPS6KA3;ZFP36L1;CDCA7L;FZD7;VIP;ASH2L;CUL3;RTKN2;TBRG4;STAMBP;PDPN;TSPAN31
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5116614488122653,-1.1837512520279343,0.2508896797153025,0.40867789881872585,1.0,5/10,19.20%,IL18;SPHK2;RARA;GATA3;LGALS9
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5085752984887006,-1.183205458415049,0.2660098522167488,0.4094570796498051,1.0,4/11,16.01%,PLEK;NES;WDR1;STMN2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4862703822993758,-1.1831227210619193,0.25261324041811845,0.409330408720422,1.0,9/11,44.96%,UQCRC1;UQCRC2;CYCS;UQCRQ;UQCRB;UQCC3;UQCRFS1;UQCR10;UQCR11
prerank,positive regulation of TOR signaling (GO:0032008),-0.3641920935654027,-1.182801120919606,0.2158154859967051,0.4096686665731232,1.0,16/40,26.87%,GPR137B;KLHL22;GAS6;FNIP1;PIP4P1;NCKAP1L;FLCN;RRAGD;PIK3CA;RHEB;HTR6;WDR24;SIK3;LAMTOR1;LAMTOR3;MIOS
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3258357820125268,1.182388348110844,0.1722488038277512,0.5283770357652389,1.0,10/52,8.22%,RBFOX1;KHDRBS3;KHDRBS2;SRRM4;CELF4;CELF5;RBFOX2;NOVA1;RBFOX3;FMR1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.30842142177181914,-1.1823778706801353,0.1625615763546798,0.41016859042147463,1.0,21/101,13.02%,MSN;VIM;NIBAN1;YTHDF3;OGT;ATG7;ATG10;FBXW11;NR1H2;ASPH;LARP4B;PCIF1;CD28;LARP4;RPS4X;AGT;EEF2;CLN6;EIF3E;UHRF1;METTL14
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.28148128225001473,-1.1818217308238543,0.1282051282051282,0.4109260464696174,1.0,53/170,25.31%,PTPRC;APOE;FOXP1;IGF1;TFEB;AFF4;CDK6;AFF1;MTMR3;KIF16B;CIAO3;TAPBP;CRIP1;AHR;HNRNPDL;TBC1D16;SIRPA;HIF1A;SLC8A1;NFKBIZ;APP;PIN1;PCBP2;PRDM2;TRIM68;TRIM11;ANKRA2;SART3;RASA1;POGZ;TXK;NKAPL;TRIM14;TOB1;TOB2;MARF1;TRIM39;RSPO1;LDLR;NFKBID;UBAP2;ZC3H12A;MEGF8;HNRNPK;APLNR;MEFV;C1D;PCBP4;RNF187;MYC;LAMTOR1;TARDBP;ZUP1
prerank,protein localization to cell-cell junction (GO:0150105),-0.4587586676128102,-1.1816568176615918,0.25252525252525254,0.4109749596687765,1.0,6/15,13.54%,PAK2;ACTB;ARHGEF18;JAK1;SCRIB;TJP2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.43718968930343016,-1.18158436899378,0.24338624338624337,0.4108207167047359,1.0,2/17,1.09%,RUNX1;VIM
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.40620060836657534,-1.18149601147916,0.23591549295774647,0.41072058036381925,1.0,6/25,10.43%,SDCBP;RIN3;RAC1;ITGAV;PICALM;APP
prerank,regulation of viral entry into host cell (GO:0046596),-0.3874151933666131,-1.1812392560197784,0.22621184919210055,0.41094036651590116,1.0,12/30,22.79%,CD74;SNX3;CIITA;IFITM2;TRIM68;LGALS1;TRIM11;TRIM14;LGALS9;TRIM25;IFITM1;P4HB
prerank,cellular response to UV (GO:0034644),-0.3133305001389233,-1.181132541655281,0.1721311475409836,0.4108377623861127,1.0,36/76,35.52%,PRKCD;DDB2;CREBBP;CRIP1;CDC25A;CUL4B;PCNA;STK11;DHX36;RHNO1;TMEM161A;YY1;INO80;ERCC4;NSMCE3;CHEK1;MMP1;MMP2;KDM1A;DDB1;MYC;USP28;CARD16;NOC2L;AQP1;METTL3;ZBTB1;EP300;COPS9;PPID;ATF4;MMP9;RHBDD1;EIF2S1;USP47;MAPK13
prerank,early endosome to Golgi transport (GO:0034498),-0.5008010649895792,-1.1805409076268838,0.2572463768115942,0.411702588655097,1.0,4/11,18.48%,SNX2;SNX8;STX5;SNX1
prerank,positive regulation of cell motility (GO:2000147),-0.2779077884733061,-1.1804501734408122,0.10697674418604651,0.4116088423037505,1.0,60/205,22.90%,DAB2;NEDD9;IGF1;FGR;SDCBP;MGAT5;INSR;IGF1R;PLAU;STAT3;CCR1;FLT1;ITGB1;PTK2B;RUFY3;ADAM9;ELP5;SEMA4A;HGF;GCNT2;MYADM;GRN;SUN2;VEGFA;MDK;CBLL1;TGFBR1;CTSH;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CPNE3;CCL5;CIB1;SEMA4B;PIK3CD;CFAP20;SEMA3D;STX4;SPAG9;CLDN1;TRADD;PDGFRB;CSF1;F10;ATM;MAZ;PDGFA;RACK1;KDR;CCDC25;SEMA3B;SNAI2;FERMT3;MAP4K4;TGFB1;GTSE1
prerank,negative regulation of cell cycle process (GO:0010948),-0.3367782918177401,-1.1804120033849286,0.18363939899833054,0.4113968903501986,1.0,19/61,21.84%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;E2F8;CHMP2A;EPC1;RBBP4;PHC3;UXT;RBBP8;CHEK1;NME6;MAX;ZFYVE19;VPS4A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.49519394630219005,-1.1801201648630166,0.256140350877193,0.4116381105453374,1.0,5/12,24.19%,RFWD3;PLK3;WAC;FBXO31;PRKDC
prerank,regulation of proteolysis (GO:0030162),-0.34995910965468546,-1.1799358978145513,0.19932432432432431,0.41171641045635843,1.0,16/48,24.83%,GSAP;OGT;DNAJC1;FBXW11;ASPH;TRAF3;PLAUR;CLN6;LTBP4;CST3;CLN3;CASP8;BAG6;CDK5;FGFR4;SPOP
prerank,receptor catabolic process (GO:0032801),-0.41552278134247916,-1.1799265020577596,0.24601769911504426,0.41145037862846257,1.0,14/24,30.09%,ZNRF3;MYLIP;UVRAG;KIF16B;AP2A2;SNX25;SH3GLB1;RNF43;TGFB1;BECN1;AP2S1;SMURF1;AP2A1;MVB12A
prerank,cellular response to interleukin-4 (GO:0071353),-0.5203046000804288,-1.1793726664595559,0.2846975088967972,0.4122777798087453,1.0,4/10,17.91%,STAT6;XBP1;TCF7;GATA3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3585847752404069,1.17916877924505,0.21479713603818615,0.5346614490703704,1.0,14/37,21.23%,IFT81;DYNLL1;IFT22;TRAF3IP1;KIFAP3;DYNLL2;CEP131;DYNC2H1;DYNC2LI1;KIF3A;KIF3C;TTC21B;PCM1;DYNC2I1
prerank,regulation of T cell migration (GO:2000404),-0.44070452579698005,-1.1791596405643798,0.23861852433281006,0.4124023231325144,1.0,7/18,15.88%,RHOA;LRCH1;DOCK8;RIPOR2;APP;CCL5;SPN
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.35140309370841444,-1.1791434989225906,0.22959183673469388,0.41215977058273134,1.0,17/45,17.16%,FOXO3;RC3H1;ZC3H7B;PUM3;GCNT2;PUM2;PCIF1;LARP4;PARP9;APP;MTPN;NUDT21;YTHDC1;NOLC1;EIF2A;RBM4B;TDRD7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4564661263498457,-1.1788547128270448,0.25402504472271914,0.4124412531212275,1.0,5/15,16.55%,NIPBL;MTHFD1L;TGFBR1;TGFBR2;IRX5
prerank,regulation of cell motility (GO:2000145),-0.29962899823877326,-1.178783183684783,0.15580286168521462,0.41227579472350767,1.0,23/121,11.47%,DIAPH1;PLXNC1;CDK6;RAC1;ROCK1;RHOA;DOCK10;PLXNA1;FLNA;PLXND1;FES;ABL2;MINK1;SGK1;DAPK3;ARHGAP18;MACF1;CYRIB;PIN1;KIF14;CCDC125;OSGIN1;CRK
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4158643928894832,1.1787537058516642,0.2222222222222222,0.5343995554753186,1.0,8/20,14.59%,PDE4D;ADRA1B;GPR101;ADRA2C;ADRA1A;ADRA1D;ADRB1;ZDHHC21
prerank,protein heterotetramerization (GO:0051290),0.473786582922003,1.1785639514176331,0.2619047619047619,0.5336652762712523,1.0,7/13,26.01%,GRIN2B;PKD1;HSD17B8;CPSF6;CPSF7;PKD2;GRIN1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.42757190554102864,-1.1784946223982669,0.24736842105263157,0.41250259888075835,1.0,7/21,19.51%,OSBPL8;OSBPL5;PLAAT3;PLA2G4A;PLA2G5;PLA2G12A;LPCAT3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3313667821902333,-1.1782216123952374,0.1935483870967742,0.41274493333088813,1.0,30/60,34.28%,HGF;CTNNB1;CCT7;PKIB;NVL;PCNA;HSP90AB1;GREM1;TNKS2;RFC2;CHTF18;CCT4;HNRNPA1;PDGFRB;WRAP53;ATM;RFC3;POLG2;MAPK1;MYC;FGFR4;GRHL2;MAPK15;MAP3K4;FGF2;NEK7;TNKS;KLF4;CCT8;CCT5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3393017048191228,-1.178011794662854,0.20361247947454844,0.4128686544383641,1.0,19/53,24.52%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMD4;PSMA5;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,dendritic spine organization (GO:0097061),0.3912131591463881,1.1769831378080229,0.23863636363636365,0.5361579833898515,1.0,11/26,15.62%,CTNND2;MTMR2;PAK3;EPHB1;SHANK3;PRNP;FYN;ARC;LGMN;CHRNA7;EPHB3
prerank,base-excision repair (GO:0006284),-0.34660605106686027,-1.176906488080606,0.2081967213114754,0.41470535063312663,1.0,20/48,25.36%,ERCC6;RFC1;NEIL3;LIG1;PCNA;WRN;FEN1;RPA3;POLD2;RFC2;PRMT6;LIG3;NEIL2;DNA2;HUWE1;ADPRS;RFC3;POLB;POLD4;XRCC1
prerank,regulation of microglial cell activation (GO:1903978),-0.46200680873008215,-1.17641885668208,0.26124567474048443,0.4153616381438273,1.0,7/15,22.42%,PTPRC;STAP1;GRN;CST7;MMP8;LDLR;IL6
prerank,DNA strand elongation (GO:0022616),-0.4335949571079801,-1.1760543685083986,0.2620320855614973,0.41576847832927777,1.0,9/18,31.23%,GINS3;MCM3;POLD2;RFC3;NBN;GINS4;DCLRE1B;MRE11;MCM7
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4437994345335332,1.175425946967037,0.24146341463414633,0.5384737230918527,1.0,4/17,7.46%,CTNNA2;WASF1;ABI2;NCKAP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4645231420806163,1.1753272299178044,0.2446043165467626,0.5374772963661709,1.0,7/13,22.29%,CIAO1;ISCA2;NFU1;CIAO2B;LTO1;CIAO2A;BOLA2
prerank,cell-matrix adhesion (GO:0007160),-0.30642227348669826,-1.175053954507645,0.17637271214642264,0.417398455808975,1.0,19/95,11.97%,ITGA4;CD44;LYVE1;RAC1;ITGB2;SIGLEC1;HPSE;PEAK1;ITGAL;ITGB1;ITGAV;ADAM9;FN1;ITGB7;CD63;ITGB1BP1;ITGB5;ZYX;ITGA3
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.4304845515516112,-1.174904349817942,0.216696269982238,0.4171167874753714,1.0,6/19,21.06%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.4304845515516112,-1.174904349817942,0.216696269982238,0.4171167874753714,1.0,6/19,21.06%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.39262241104883194,-1.1746923106038187,0.2353923205342237,0.41729667168922635,1.0,8/27,17.02%,CREBBP;PHF20;MORF4L1;TAF6;NAA50;KAT7;MRGBP;PHF20L1
prerank,cellular response to organonitrogen compound (GO:0071417),0.2923706314090992,1.1746276468474206,0.15897435897435896,0.5379069443263697,1.0,17/99,9.26%,GABRB3;AKAP6;GABRB1;RYR3;SLIT2;GLRA1;IGFBP5;P2RY12;SLC26A3;WT1;HCN2;RRAGB;GABRB2;GABRG2;SOX9;GLRA2;HCN1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4224636024873092,-1.1744278462301851,0.2465277777777778,0.41754756522336567,1.0,10/19,24.05%,ITGB2;PIK3AP1;TLR4;LY96;TNIP3;LGALS9;TICAM2;NR1H4;TRIL;ITGAM
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3568963719231987,-1.1742400324267603,0.22487223168654175,0.4176350150685731,1.0,12/46,12.10%,LYN;PTPRC;TLR4;DUSP3;SIRPA;ITGB1BP1;SPRY2;SPRED1;PIN1;DUSP6;FLCN;SPRED2
prerank,regulation of fibroblast migration (GO:0010762),-0.4262765825521919,-1.173995695825927,0.2358974358974359,0.4178117056857738,1.0,9/20,22.48%,CORO1C;RAC1;GNA12;ITGB1;ITGB1BP1;CLN3;APPL2;APPL1;TGFB1
prerank,negative regulation of cyclase activity (GO:0031280),-0.4637123016434678,-1.173337605945369,0.2764811490125673,0.41883401252165553,1.0,2/14,2.29%,CCR2;GNAI3
prerank,response to thyroid hormone (GO:0097066),-0.47437852084010623,-1.1732650227138497,0.2557726465364121,0.4186898897611441,1.0,5/13,21.19%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,rRNA modification (GO:0000154),-0.421757320254594,-1.1727343962523826,0.26325088339222613,0.41944269956301217,1.0,8/21,25.32%,NSUN3;NSUN4;DIMT1;GAR1;THUMPD1;BUD23;NHP2;MRM2
prerank,lipoxygenase pathway (GO:0019372),-0.46076373035804347,-1.1726968691562338,0.25493716337522443,0.4192273970234461,1.0,10/14,47.84%,ALOX5AP;GPX4;PON2;PON3;ALOX15;ALOX12;PON1;LTC4S;ALOXE3;GPX1
prerank,embryonic digestive tract development (GO:0048566),0.4231020442242565,1.1725415975499183,0.2678983833718245,0.5416005678148885,1.0,6/18,14.22%,PCSK5;SOX11;RARB;TGFB2;SALL1;GLI3
prerank,sphingoid metabolic process (GO:0046519),-0.47007666092769107,-1.171876719003846,0.2708333333333333,0.4204917509203227,1.0,9/12,41.75%,KDSR;SPHK2;SPTLC3;PLPP3;DEGS2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,amino acid transport (GO:0006865),-0.3495724225577327,-1.1712820742001184,0.21869782971619364,0.42135968281214226,1.0,11/49,14.58%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC16A10;SLC38A7;SLC7A7;SLC36A4;SLC25A45;SLC7A5;SLC25A44
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.3634936560030638,-1.1711872718798195,0.21942446043165467,0.42126952740903256,1.0,15/40,24.66%,FGR;RNASE7;MYD88;GBP2;CHGA;CAMP;HMGB2;RNASE6;DEFA6;ANG;GBP7;GBP6;IL6;RPL39;GBP4
prerank,keratan sulfate catabolic process (GO:0042340),-0.4923948601973257,-1.171150582875417,0.28885135135135137,0.4210667464112231,1.0,5/11,17.32%,HEXA;GNS;GALNS;PRELP;FMOD
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2823505807984438,-1.1710514086396753,0.13099041533546327,0.4209810194242391,1.0,52/171,25.39%,IQGAP1;SDCBP;RB1;PSME4;CDK13;PSMB7;ANAPC1;PSME3;RNF20;KIF20B;DLGAP5;DAPK3;PSMB9;DUSP3;THAP1;NEK6;PSMA8;SIK1;SCRIB;AFAP1L2;APP;PIN1;PSMC3;EIF4EBP1;CDK1;MAEA;PSMD8;BUB1B;PSMC4;MKI67;PSMB10;PSMA1;BTG1;TFAP4;UBE2C;ANAPC7;PSMB8;DYNLT3;RCC1;PSMD4;PSMA5;PSMB3;PSMD3;CDC25C;TGFB1;CCNB1;PIM2;DDB1;PSMB1;CKS2;ANGEL2;RNF40
prerank,nuclear membrane disassembly (GO:0051081),-0.468324367456528,-1.1709546151042929,0.27964601769911507,0.4208945851034611,1.0,7/14,25.04%,PRKCB;NEK6;CDK1;DCTN1;CCNB1;CCNB2;AKAP8L
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4248213497751867,-1.1709353529961,0.26138279932546377,0.4206505733442812,1.0,6/20,17.43%,ZMIZ1;TGFBR1;HIF1A;EGR1;HSP90AB1;HSPA1A
prerank,ERBB signaling pathway (GO:0038127),0.3133845618784281,1.1709343528864609,0.1700507614213198,0.5441488273049984,1.0,19/64,16.04%,NRG1;ERBB4;PTPRR;SHC3;TGFA;EGF;GAB1;SOS1;PLCE1;NRG2;FAM83B;SOX9;AREG;GAREM1;HSP90AA1;BRAF;PRKCA;ADAM17;ERBB3
prerank,epidermal cell differentiation (GO:0009913),-0.3532407080435691,-1.1707562163153566,0.20623916811091855,0.4207351947331119,1.0,17/41,38.00%,CLIC4;ANXA1;ADAM9;JAG1;CTNNB1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3;SPINK5;ERCC2;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,activation of protein kinase B activity (GO:0032148),-0.38465636341168075,-1.17034689682855,0.21853146853146854,0.4212371961771958,1.0,7/29,11.52%,OSBPL8;IGF1;INSR;IL18;GAS6;ITGB1BP1;CCDC88A
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.3917764989929845,-1.1703145022694486,0.21201413427561838,0.4210172144456252,1.0,12/27,28.08%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;RBM4B;FBXL8;FBXL6;PPP1CC;PPP1CB;PML;FBXL3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4960343815194669,-1.170088823198549,0.2719594594594595,0.421139102676831,1.0,3/11,6.72%,ARRB2;GRK3;ARRB1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.314985042864084,-1.1700003436223423,0.1986863711001642,0.42101770908668984,1.0,20/82,12.59%,LYN;VAV3;ARPC2;SDCBP;ITSN1;RAC1;ROCK1;ACTR2;RHOA;CDC42;ACTR3;ACTB;ARPC3;WASL;AP2A2;VAV2;PSENEN;ARPC1B;CRK;ARPC1A
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.473669442816517,-1.1699868776964424,0.2692967409948542,0.42076559047064466,1.0,6/14,27.41%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,positive chemotaxis (GO:0050918),-0.43803041296108997,-1.1699107416893328,0.25654450261780104,0.4206356139171077,1.0,4/17,10.16%,NRP1;PTPRJ;VEGFA;SCRIB
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4018222597797574,1.1697776667804927,0.2296983758700696,0.5456210174462321,1.0,3/22,6.18%,DDX11;NOL11;UTP15
prerank,response to UV (GO:0009411),-0.3069414111719877,-1.1694099942732787,0.18333333333333332,0.4213096926715835,1.0,20/95,15.19%,PRKCD;MAP4K3;DDB2;CREBBP;ERCC6;PRIMPOL;PCLAF;UBE4B;CDC25A;RELA;PCNA;WRN;FEN1;DHX36;RHNO1;TMEM161A;YY1;INO80;ERCC4;NSMCE3
prerank,regulation of gastrulation (GO:0010470),0.43980188094030725,1.1690395087635201,0.2679425837320574,0.5460588085666785,1.0,2/14,4.33%,TENM4;CLASP2
prerank,steroid biosynthetic process (GO:0006694),0.3268415012835712,1.1689714540805194,0.17135549872122763,0.5449839665299304,1.0,18/56,15.25%,OSBPL6;SLC27A2;OSBPL7;INSIG1;CYP51A1;SQLE;DHCR7;ACOX2;SC5D;EBP;HSD3B7;HSD11B1;OSBPL2;ABCB11;ACOT8;LSS;HSD17B4;CYP39A1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.37813596690760276,-1.168558927273316,0.23570190641247835,0.42260334983790776,1.0,8/33,11.54%,JUN;PPARG;SPI1;STAT3;FOXO3;HIF1A;EGR1;RELA
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5132173665505221,-1.1683775708448298,0.271304347826087,0.422691882340565,1.0,4/10,10.24%,PRKCB;ITGA5;HIF1A;ARNT
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.35438666465773755,1.1683256505812398,0.2175,0.545262876004141,1.0,6/37,8.30%,EFNA5;BICD1;MAPRE3;CLASP2;TRAF3IP1;MAP6D1
prerank,regulation of plasminogen activation (GO:0010755),-0.48218933625762456,-1.1681699274569186,0.2730560578661845,0.4227974194296541,1.0,2/12,0.98%,RUNX1;CTSZ
prerank,actin filament bundle organization (GO:0061572),-0.3734646424158479,-1.1680129914616948,0.19966996699669967,0.42279282010567454,1.0,9/33,18.99%,NEDD9;EPS8;BAIAP2;LCP1;LIMA1;MICAL1;BAIAP2L2;ESPN;RFLNB
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.46570411989277266,-1.16787665798311,0.2585616438356164,0.42276135659953523,1.0,5/14,12.10%,XDH;SPRY2;SPRED1;OSR1;SPRED2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3697560180222784,1.167787331907619,0.2525,0.5452946036192406,1.0,9/32,9.67%,ARHGAP6;SEMA3E;MMP12;CLASP2;DLC1;APOD;NEXMIF;CDKN2A;PLET1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4551891550486576,1.167565768294911,0.27102803738317754,0.5445542575105484,1.0,5/13,20.99%,ELOVL7;HACD1;TECRL;ELOVL6;ELOVL2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4945204271129099,-1.166598433399804,0.28741496598639454,0.4248382627083529,1.0,5/10,34.28%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.429981914609324,-1.166472793067171,0.2664298401420959,0.424807928404064,1.0,6/20,12.60%,LYN;TLR4;IL18;PTPN22;TICAM1;CCL5
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4945115584594644,-1.165723093121659,0.29411764705882354,0.4259852129943476,1.0,6/11,29.01%,BLM;TIMELESS;LIG3;TIPIN;ZRANB3;DONSON
prerank,regulation of cellular respiration (GO:0043457),-0.43532593608415815,-1.1655524598331355,0.2645051194539249,0.42601344502850685,1.0,4/17,11.50%,IL10RB;NOA1;CBFA2T3;IFNAR1
prerank,cellular response to lipid (GO:0071396),-0.27660897185286226,-1.165476720670944,0.13629160063391443,0.42586796488982276,1.0,55/191,21.24%,PID1;LYN;MSN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;FES;ABL2;CTR9;TLR4;TFPI;PTK2B;STAP1;CHMP5;NFKB1;ADAM9;MAPK14;PF4;AHR;SIRPA;MYD88;MEF2C;LY96;UBE2L3;SELENOS;LPL;TNIP2;XBP1;RELA;TICAM1;HMGB2;SERPINE1;CASP1;DEFA6;ADAM15;NFKBIL1;SPP1;NFKBIB;NRIP1;TNIP3;SPHK2;TWF2;NR3C1;NOD2;TICAM2;WNT3;ATM;HMGB1;CD274;ZC3H12A;SFRP1;NLRP3
prerank,regulation of interleukin-2 production (GO:0032663),-0.350481081942603,-1.1652243524461274,0.21367521367521367,0.4260714194944006,1.0,9/43,8.84%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;LAPTM5;CD28
prerank,nuclear migration (GO:0007097),-0.47641220088553093,-1.165044359308845,0.26607142857142857,0.4261376322483069,1.0,5/13,11.71%,DYNC1H1;FBXW11;SUN2;SYNE3;DCTN1
prerank,cellular response to virus (GO:0098586),-0.38163326188561336,-1.1650244886557402,0.24394463667820068,0.42589435224189937,1.0,11/30,22.42%,RIOK3;MAPK14;GSDME;HIF1A;CCL5;POU2AF1;LGALS9;DDX3X;ZC3H12A;TOMM70;IL6
prerank,regulation of calcium ion import (GO:0090279),0.40622973776397625,1.164978177150777,0.2465437788018433,0.5494373979763403,1.0,7/21,16.53%,PLPP4;EGF;PRNP;FYN;WNK3;CXCL12;TRIM27
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.437698576191356,-1.1646244400378918,0.27162629757785467,0.42638716365063656,1.0,5/16,19.24%,CDK13;DHX9;DDX5;SCNM1;SLU7
prerank,mismatch repair (GO:0006298),-0.38773117144513203,-1.164595175521966,0.24866785079928952,0.42617396867851914,1.0,7/27,13.91%,MCM9;LIG1;PCNA;EXO1;MLH3;RPA3;POLD2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4755369379312763,-1.1645863470527165,0.2756052141527002,0.425918210473015,1.0,5/13,25.54%,ABL2;ATP7A;NOD2;HP;MT3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3590696893327547,-1.1636791701198195,0.24784853700516352,0.4273543945613497,1.0,10/40,18.72%,IGF1;BCL2L11;HGF;PLAUR;MLLT11;BBC3;GHITM;BID;TNFSF10;PDCD5
prerank,regulation of protein phosphorylation (GO:0001932),-0.27150959694129695,-1.1636732454763399,0.11801242236024845,0.4270860878654109,1.0,86/256,27.04%,PID1;LYN;DAB2;FNIP2;CD74;FGR;CORO1C;XDH;NIBAN1;RAC1;ITGB2;INSR;BRD4;IBTK;ATF3;RAP2A;RIPK1;AKAP8;CCND3;PPP1R15B;AXIN1;HGF;FN1;C3;ARRB1;LRP6;MYADM;CAMKK2;GAS6;VEGFA;SIRPA;SMG8;PLAUR;FNIP1;APP;PIN1;PAQR3;FLCN;WDFY2;CCDC88A;CIB1;ACVR2A;IGFBP3;RB1CC1;CD40;PPIL4;NSD1;IL34;CRKL;MAVS;BST1;RALB;KRAS;PTPN13;HSPB1;RSPO1;AGER;MOB1B;ZC3H12A;PDGFA;RACK1;KDR;CEBPB;ILK;PLPP3;TGFB1;ADTRP;DVL2;FGF9;PPP2R5B;PRKDC;TARDBP;AKAP8L;STAT2;ECT2;INPP5K;MT3;PPP2R5A;CCDC88C;PDE8A;PECAM1;BMP2;PML;CDK2AP1;ENG;PPP2R5E
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.46181103433163395,1.1635907428284602,0.26244343891402716,0.5502622460436932,1.0,4/12,8.27%,EFNA5;MELTF;SPRY4;KANK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.46181103433163395,1.1635907428284602,0.26244343891402716,0.5502622460436932,1.0,4/12,8.27%,EFNA5;MELTF;SPRY4;KANK1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44061844594666527,-1.1635628890130427,0.26607142857142857,0.4270053049670424,1.0,2/16,1.09%,RUNX1;VIM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4196674021078611,-1.1634604527564882,0.25673249551166966,0.4263666312665292,1.0,8/20,19.84%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.4196674021078611,-1.1634604527564882,0.25673249551166966,0.4263666312665292,1.0,8/20,19.84%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.4196674021078611,-1.1634604527564882,0.25673249551166966,0.4263666312665292,1.0,8/20,19.84%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,regulation of protein targeting to membrane (GO:0090313),0.37410471880284324,1.1630866355480647,0.225,0.5502561971914979,1.0,6/28,8.17%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,supramolecular fiber organization (GO:0097435),-0.2602704267459746,-1.162855375097282,0.10778443113772455,0.42731086868776025,1.0,95/333,25.83%,MYO5A;CORO1C;ARHGAP25;VIM;TSPAN14;RAC1;KLHL24;CD36;MYO1F;RHOA;ARHGAP17;MTM1;ARHGEF2;RIPK1;GGA3;CDC42;DYNC1H1;ATP7A;RUFY3;TGFBI;MYO1G;TRIOBP;TPM3;TPM4;USP9X;P4HA1;HIP1;MARCKSL1;SH3BP1;B2M;TUBGCP4;CKAP5;TGFBR1;UBC;RPS27A;CORO7;MYO1E;ARHGAP12;CDC42EP2;APP;PIN1;KIF14;B4GALT7;PSENEN;MYO7A;CCDC88A;P4HA3;DCTN1;WDR73;HSP90AB1;CIB1;PLK3;BIN3;SLAIN2;GREM1;CALCA;COL9A1;COL4A5;KIF2C;MFGE8;CST3;PPP1R9B;STMN2;RND2;CRTAP;COL22A1;KIF18B;PPIB;COL18A1;RHOBTB1;DNAJB6;CAMSAP2;FAT1;FLII;GFAP;BFSP2;SERF1A;RHOF;MPRIP;CLIP2;PLOD3;P4HB;SAMD14;CYP1B1;RND1;ACTN1;COL5A2;DSP;FURIN;COL28A1;P3H1;RND3;CCDC88C;SIAH2;ADAMTS2
prerank,photoreceptor cell development (GO:0042461),0.4560937736409163,1.1622823555075106,0.2740740740740741,0.5508827830759175,1.0,5/14,11.01%,AHI1;RORB;CDHR1;CEP290;MFSD2A
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.41544791015997784,-1.162226409099986,0.2590759075907591,0.4282932746224965,1.0,2/22,0.70%,MDFIC;SP100
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4197217470048658,-1.1622045340874823,0.24,0.42805451152073914,1.0,2/20,1.91%,ITGA4;ANO6
prerank,positive regulation of leukocyte migration (GO:0002687),-0.4030605523263204,-1.1618193598630868,0.2570480928689884,0.4285308095133726,1.0,15/27,36.34%,IL6R;VEGFA;MDK;ADAM8;NCKAP1L;F7;MIA3;CSF1;IL6;PLVAP;TNF;EDN3;TNFRSF18;PRSS56;EDN2
prerank,L-glutamate transmembrane transport (GO:0015813),0.4978206892821282,1.1617491249912635,0.2678132678132678,0.5509488139550747,1.0,3/10,7.97%,SLC1A2;SLC1A6;SLC1A1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3231330586958248,-1.1617314848699707,0.21322314049586777,0.42842783650386773,1.0,22/66,23.96%,SASH1;MAP3K5;TAOK3;PIK3R5;HTR2B;FLT1;PIK3CG;EZH2;VEGFA;ADAM8;TRAF2;CD40;IL34;MAP3K10;ARHGEF5;RPS3;PDGFRB;NOD2;PDGFA;TGFB1;DVL2;FLT3
prerank,response to hydroxyurea (GO:0072710),-0.4950731399859215,-1.1613314827013892,0.281195079086116,0.42888722929817263,1.0,6/11,15.19%,SPIDR;BLM;DDI2;TIMELESS;KAT7;NSMCE3
prerank,acute inflammatory response (GO:0002526),-0.404238960439683,-1.1610256578221478,0.23843416370106763,0.4291881241639608,1.0,13/23,44.32%,ANO6;IL6R;CEBPB;HPR;HP;IL6;SIGIRR;PLSCR1;VNN1;CD6;CTNNBIP1;F3;LBP
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4868631728217076,-1.160672444438558,0.29043478260869565,0.4296143838985108,1.0,2/11,2.56%,PLCG2;P2RX4
prerank,histone monoubiquitination (GO:0010390),-0.4090491716919574,-1.1605369674141708,0.25084745762711863,0.42960543012903907,1.0,13/24,30.10%,DDB2;CTR9;RYBP;RNF20;CUL4B;UHRF1;WAC;DTX3L;DDB1;RNF40;KDM2B;RNF2;UBE2E1
prerank,nuclear membrane organization (GO:0071763),-0.4232589165139406,-1.1604953415202888,0.2609457092819615,0.42939809886088215,1.0,9/19,25.04%,NEMP1;CHMP7;DCTN1;CHMP2A;TOR1AIP1;CHMP4B;VPS4A;TARDBP;AKAP8L
prerank,neurotrophin signaling pathway (GO:0038179),0.4072339399908483,1.1601075980384412,0.24660633484162897,0.5535106014581311,1.0,4/21,7.13%,MAGI2;NTRK2;SOS1;BDNF
prerank,fatty acid elongation (GO:0030497),0.456088618593304,1.1598063620354564,0.26157407407407407,0.5530064746067146,1.0,5/13,20.99%,ELOVL7;HACD1;ABCD1;ELOVL6;ELOVL2
prerank,T cell differentiation in thymus (GO:0033077),-0.45860812259445016,-1.1593015221314469,0.2722602739726027,0.4314630353587069,1.0,1/14,0.13%,PTPRC
prerank,positive regulation of RNA splicing (GO:0033120),-0.39070334297036124,-1.1592570358716603,0.2571428571428571,0.43125636494940284,1.0,12/29,23.15%,ERN1;TRA2B;DYRK1A;HNRNPLL;NCBP1;POLR2A;DAZAP1;NCL;HSPA1A;SLC38A2;RBM3;RBM22
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4589253666211036,-1.1588987058837765,0.26992753623188404,0.43166872189566896,1.0,6/14,16.87%,MYADM;DGKD;VEGFA;CD40;DGKG;SPHK2
prerank,extracellular transport (GO:0006858),-0.48389696202163957,-1.1579341562296075,0.279491833030853,0.433205556365583,1.0,5/12,21.15%,WWP2;TSG101;CCDC40;ARRDC1;ADCY10
prerank,response to glucose (GO:0009749),-0.348465508076569,-1.1576093312339366,0.22705314009661837,0.4335435554520463,1.0,18/46,29.88%,ERN1;IGF1R;TRA2B;EIF2B3;GAS6;SELENOS;LPL;ZBTB20;XBP1;IRS2;EIF2B1;RACK1;KCNB1;GPLD1;EIF2B2;EIF2B4;PAX2;VAMP2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.36953044289066944,-1.1575351981768474,0.2551369863013699,0.43341496088161396,1.0,4/35,4.10%,APOE;XDH;PPARG;FLT1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.33680139635501627,-1.1575236223946204,0.22393162393162394,0.4331607123489342,1.0,17/56,21.06%,NSMCE2;RB1;RAD51B;BRD4;CCND3;DLGAP5;ANXA1;KLHL18;CDC25A;CDK1;EIF4G1;UBE2C;ANAPC7;DDX3X;RAB11A;ADAMTS1;CDC25C
prerank,negative regulation of DNA recombination (GO:0045910),-0.3496850167226721,-1.157411123257923,0.22696245733788395,0.4330723226073586,1.0,13/43,22.53%,CGAS;BLM;RTEL1;POLR2H;POLR2F;POLR2L;RADX;POLR2A;UBQLN4;POLR2G;SHLD2;POLR2I;ZRANB3
prerank,response to peptide (GO:1901652),-0.3686802589106144,-1.1573136491762273,0.23378839590443687,0.4329721176036839,1.0,18/33,28.13%,STAT3;STAT6;IRF5;ANXA1;EIF2B3;STAT5B;STAT4;ERBIN;KAT7;NOD2;AGER;EIF2B1;MMP2;STAT1;CACNA1A;STAT2;EIF2B2;EIF2B4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2654036486639648,-1.157188913758785,0.13946117274167988,0.4329388043013857,1.0,68/259,22.55%,NRP1;RAB8B;MTSS1;SNX10;ASAP1;SDCBP;P2RX7;FGD6;RAC1;RAP1B;ACTR2;ANO6;RAP2B;EMP1;FLNA;RAP2A;EHD4;FXYD5;MINK1;KIF3B;IFT20;PIBF1;RAP1A;PARVB;FGD4;ACTR3;ITGB1;RAB1A;FGD3;CFAP44;EXOC4;PMP22;CEP162;SPAG16;CCDC88A;FOXJ1;ABCC4;CFAP70;SPEF1;ARL3;CFAP20;EHD1;RP2;CFAP43;PPP1R9B;DYNLT2B;NUDCD3;EXOC2;PCNT;RILP;PDE6D;PTPRO;ARFIP2;MAK;EXOC6;PIP5K1A;BBIP1;RAB11A;TMEM17;ATP6V0D1;RILPL1;DISC1;HYLS1;TTLL3;MAP4K4;CEP41;S1PR2;EMP3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4738706623762473,-1.1567861419959604,0.281195079086116,0.4334504069666016,1.0,5/13,21.14%,NAMPT;TLR4;SELENOS;NOD2;KDR
prerank,response to reactive oxygen species (GO:0000302),-0.3379345268177664,-1.1567713858977444,0.20490367775831875,0.4331977494850455,1.0,17/54,23.49%,APOE;JUN;COA8;ADAM9;CAMKK2;HIF1A;PRDX5;APTX;NCF1;PLK3;STK24;MPV17;RPS3;CAT;HP;HMOX1;MAPK1
prerank,neural tube closure (GO:0001843),-0.3707340173292581,-1.156429786884289,0.24917491749174916,0.4335720862775248,1.0,20/34,30.78%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;TGFB1;PHACTR4;DVL2;LRP2;DEAF1;TSC2;KDM2B;GRHL3;CELSR1;IFT122;GRHL2;PAX2;BCL10
prerank,protein K63-linked deubiquitination (GO:0070536),-0.37739527453079347,-1.155726977629089,0.25749559082892415,0.4346546503428595,1.0,17/31,31.02%,USP50;OTUD5;USP8;ABRAXAS1;BABAM2;ATXN3;BABAM1;OTUD4;USP7;STAMBPL1;BRCC3;ZRANB1;USP16;STAMBP;UIMC1;ABRAXAS2;OTUD1
prerank,ganglioside biosynthetic process (GO:0001574),-0.4456716213882823,-1.1553625616541445,0.26570915619389585,0.43506163280828297,1.0,3/15,2.15%,B4GALT5;ST3GAL1;ST8SIA4
prerank,cardiac muscle cell differentiation (GO:0055007),0.3976501741461874,1.1545218382512814,0.25059101654846333,0.5642337761494829,1.0,7/21,12.19%,NRG1;CBY1;ACVR1;WT1;MYOCD;TTN;ALPK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.31398224781643347,-1.1544201854639258,0.21967213114754097,0.4365978757278274,1.0,33/76,34.36%,DAB2;HECTD1;RNF19A;PIAS1;AXIN1;CBFA2T3;NUB1;DET1;LAPTM5;TRIB1;TRIB2;RNF180;ARIH1;GABARAP;SMAD7;HSPA1A;GSK3B;FBXO22;SIRT2;RACK1;SOCS5;RNF19B;SMURF1;VCP;COP1;KEAP1;HSPBP1;STUB1;HSPA1B;USP5;CSNK1D;NOP53;RAD23A
prerank,regulation of activated T cell proliferation (GO:0046006),-0.38302140912758714,-1.1541411020259582,0.24871355060034306,0.43685908473019625,1.0,16/30,31.29%,IGF1;IL18;RC3H1;SCRIB;IL27RA;RPS3;LGALS9;HMGB1;AGER;CD274;TNFSF9;IL12RB1;CRTAM;RIPK3;IL2;IGFBP2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.36570110951798357,-1.1541363116398353,0.2597623089983022,0.4365870246881442,1.0,10/37,14.86%,DDB2;RFC1;UBC;RPS27A;CUL4B;PCNA;RPA3;POLD2;RFC2;ERCC4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.28682567472025333,-1.1535755317298895,0.18284789644012944,0.4373496785680195,1.0,41/129,22.48%,ZEB2;DKK2;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;PSMB9;AXIN1;TBL1XR1;PPM1B;LRRK1;WLS;PSMA8;PIN1;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;TNKS2;GPRC5B;JRK;PSMB8;PLEKHA4;RSPO1;DDX3X;PSMD4;PSMA5;PSMB3;TMEM198;WNK1;PSMD3;SMURF2;SFRP1;JUP;CSNK1G3;ILK;TGFB1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.320007830911134,1.1535414395234105,0.23529411764705882,0.5653707818223729,1.0,13/51,11.85%,CNTNAP2;DCLK1;NYAP2;MYO16;GPM6A;WASF1;EPB41L3;BDNF;NCKAP1;BMP7;SRGAP2;NBL1;TNIK
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.43999377809207607,-1.1533277293383881,0.27239488117001825,0.4375546239527481,1.0,6/16,10.56%,IGF1;ROCK1;MEF2A;SLC9A1;MTPN;AGT
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.48252460218020665,-1.1529194032123988,0.27175843694493784,0.43805445998874837,1.0,4/11,24.74%,TPR;RESF1;SETDB1;TRIM28
prerank,response to axon injury (GO:0048678),0.41679908628594486,1.1528783409583256,0.2995391705069124,0.5657593606860923,1.0,7/18,14.95%,P2RY12;APOD;FLRT3;DPYSL3;RTN4RL1;DHFR;FOLR1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4796625733627482,-1.1527447763507668,0.28186714542190305,0.43811672937886315,1.0,5/12,21.19%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,megakaryocyte differentiation (GO:0030219),0.4796558689881235,1.1526447426740845,0.2903225806451613,0.5651159436665777,1.0,4/11,22.00%,KIT;THPO;UBA5;TAL1
prerank,positive regulation of protein binding (GO:0032092),-0.33162811470038656,-1.1524815544648175,0.23615635179153094,0.43834049374476997,1.0,10/56,10.88%,APOE;LRP1;AMFR;STK3;RPL11;B2M;NVL;APP;PIN1;DERL1
prerank,regulation of kinase activity (GO:0043549),0.29411544048423627,1.152327170254416,0.1951219512195122,0.5646213257259329,1.0,20/89,12.67%,ERBB4;NTRK3;EPHA6;LDB2;NTRK2;EPHA7;EPHA5;CSF1R;TIE1;EPHB1;ALK;PLCE1;EPHA10;ROS1;LTK;EMP2;TTN;TYRO3;RET;EPHB4
prerank,macrophage differentiation (GO:0030225),-0.4751758347850443,-1.1521117056363883,0.2928082191780822,0.43881681205191325,1.0,6/13,19.32%,IL15;CDC42;VEGFA;IL31RA;CASP8;CSF1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4468751822956424,-1.1520631755263664,0.27886323268206037,0.4386313056157114,1.0,6/16,23.23%,SLC27A1;NR1H2;DAGLB;ABHD5;LDLR;GPLD1
prerank,cellular protein localization (GO:0034613),-0.2606422421764772,-1.1517261198407174,0.13230769230769232,0.4390077100072086,1.0,76/285,18.70%,SH3PXD2B;CD74;ITSN1;SNX9;SNX27;SNX8;FLNA;ARHGEF2;STX7;RAP2A;TBC1D15;RAB31;SGSM2;UNC93B1;TLK1;TBC1D2B;RAB20;TBC1D9;GGA3;PACS2;NIPBL;COG7;RAB1A;SNX6;HHEX;TMED10;CTSA;STX8;TBC1D5;ARL11;TBC1D1;STX3;TBC1D22A;RAB32;CTNNB1;TBC1D16;TBC1D22B;LAPTM5;TBC1D8B;SIL1;WLS;RAB5A;TMED3;CD63;RAB21;TBC1D8;VPS26B;TBC1D17;SNX13;RRAGD;RAB24;SAR1A;MYO7A;RAB29;STX5;VPS26A;FOXJ1;TBC1D10B;COPA;SEC31A;ARL5A;EHD1;TBC1D30;AP3B1;ARFIP1;STX16;AP3D1;TBC1D9B;STX4;VPS33A;TMED2;ARL1;TBC1D25;ARFIP2;SNX1;ID1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.4079681302751732,-1.1514398459114386,0.25693160813308685,0.4392900809190098,1.0,6/21,16.26%,PGD;DERA;HK3;RPE;TKT;PGLS
prerank,UV-damage excision repair (GO:0070914),-0.4802822513318795,-1.1513700733421952,0.2828282828282828,0.43915098117347234,1.0,4/12,24.43%,DDB2;CUL4B;INO80;DDB1
prerank,regulation of blood circulation (GO:1903522),0.35402688320624337,1.1512420458968564,0.2433734939759036,0.566017639583965,1.0,12/34,21.74%,KCNMB2;ADORA3;KCNIP2;TNNT2;AGTR1;PER2;KCNJ12;ECE1;TPM1;CELF2;KCNMB4;DMPK
prerank,negative regulation of hormone secretion (GO:0046888),-0.4975231998993648,-1.1510745593949494,0.29347826086956524,0.43943525571322517,1.0,6/10,44.62%,RAB11FIP5;RAB11FIP1;GJA1;FGF23;IL1B;OSM
prerank,organelle assembly (GO:0070925),-0.2520059812254342,-1.1509409168636473,0.1141552511415525,0.43939432217152613,1.0,107/384,25.23%,RAB8B;SH3PXD2B;SNX10;ASAP1;RAB7A;YTHDF3;GOLGA8B;ACTR2;PDCD6IP;FLNA;STX7;EHD4;ATG5;KIF3B;IFT20;PIBF1;PACS2;ATG7;ACTR3;RAB1A;RC3H1;CHMP5;DYNC1H1;CENPF;DLGAP5;HAUS5;CENPA;TSG101;RAB32;HAUS6;PATL1;ULK2;CFAP44;STARD9;EXOC4;CENPE;TUBGCP4;NEK6;CEP162;DHX37;SPAG16;CHMP7;HAUS4;CHMP1A;STAM2;CSDE1;RPS23;FOXJ1;RBM14;HAUS7;ABCC4;CFAP70;ARL3;CFAP20;RB1CC1;GABARAP;CHMP2A;POGZ;INO80;EHD1;RP2;CFAP43;EIF2A;DYNLT2B;NUDCD3;EXOC2;G3BP1;PCNT;RPS3;RILP;PDE6D;MRPL22;RCC1;ATG16L2;MAK;EXOC6;DDX3X;EMC6;BBIP1;DDX6;SYNPO;RAB11A;TMEM17;ATP6V0D1;RILPL1;DISC1;NUP62;LSM14A;FLII;CHMP4B;CHMP4A;VPS4A;HYLS1;TTLL3;CEP41;BECN1;ATXN2L;HPS4;VMP1;IFT140;PRRC2C;RAB19;PKHD1;CHMP2B;RAB1B;DNAAF1;LZTFL1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3817203409428302,-1.1507066924481921,0.25,0.4395918226621719,1.0,12/30,21.04%,OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;GOLGA7;BLZF1
prerank,DNA dealkylation (GO:0035510),-0.5044983827474112,-1.1504997423671073,0.28546712802768165,0.4394370794041453,1.0,8/10,32.85%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;ASCC2;MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5044983827474112,-1.1504997423671073,0.28546712802768165,0.4394370794041453,1.0,8/10,32.85%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;ASCC2;MPG;ALKBH5
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.41811518211983034,-1.1501100195969214,0.27339449541284405,0.43995662938499835,1.0,3/19,5.71%,RUNX1;VIM;CIITA
prerank,hippo signaling (GO:0035329),0.37307624312223686,1.1496291064697088,0.25,0.5688018161585937,1.0,8/26,13.12%,TJP1;TEAD4;DCHS1;FAT4;YAP1;TEAD1;WWC1;AMOTL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.43023681440646644,-1.1492649277355524,0.26902654867256637,0.44127410088482366,1.0,10/18,31.29%,IGF1;IL18;IL27RA;RPS3;HMGB1;AGER;TNFSF9;IL12RB1;IL2;IGFBP2
prerank,tube closure (GO:0060606),-0.37743692952987123,-1.1491767284248924,0.2570480928689884,0.4411446092095672,1.0,19/31,30.78%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;TGFB1;PHACTR4;DVL2;LRP2;DEAF1;TSC2;GRHL3;CELSR1;IFT122;GRHL2;PAX2;BCL10
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.30884827891856137,-1.1489297131906848,0.2126537785588752,0.44131681111616033,1.0,22/84,21.96%,APOE;IGF1;DAPK1;ROCK1;GAPDH;GGA3;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;PIN1;DHX36;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;RACK1;LSM14A;SHMT1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.31432304353989926,-1.1489116097397112,0.20224719101123595,0.44107582115553384,1.0,31/76,32.29%,BIRC3;MALT1;PIAS1;BRCA1;AXIN1;WDR48;LAPTM5;WFS1;UBE2L3;DERL1;DCUN1D4;UBE3A;NSMCE3;TBC1D7;UBA2;SMAD7;HUWE1;NDFIP2;ZC3H12A;SAE1;CUL3;RIPK2;XIAP;PTTG1IP;TRAF6;BCL10;HSPBP1;CAV1;DCUN1D5;STUB1;FANCI
prerank,negative regulation of nuclear division (GO:0051784),0.46803350421790363,1.148824875665009,0.2882882882882883,0.569469223771972,1.0,4/11,20.67%,AURKAIP1;BMP7;TOM1L1;FBXO5
prerank,response to chemokine (GO:1990868),-0.4752198786146009,-1.1485704918243669,0.2895174708818636,0.4414389906504385,1.0,4/13,5.35%,RHOA;LRCH1;DOCK8;RIPOR2
prerank,positive regulation of cell adhesion (GO:0045785),-0.31522162326459524,-1.1480080532487205,0.22975206611570248,0.4422523540239494,1.0,22/74,19.99%,SYK;RSU1;RAC1;PTPRJ;ITGAV;ADAM9;STX3;VEGFA;MDK;ADAM8;NCKAP1L;TGM2;FLCN;CCL5;CIB1;STX4;SMAD7;TFE3;LIMS1;C1QBP;ATM;NDNF
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.39380910521436,-1.1474743301648205,0.2733446519524618,0.4430740373880959,1.0,7/26,17.59%,NSMCE2;RB1;DLGAP5;CENPE;NEK6;UBE2C;ANAPC7
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.31971620404916534,-1.1474370415574318,0.22591362126245848,0.44287459470430024,1.0,12/63,7.89%,MCL1;ROCK1;NUPR1;HTR2B;STAT3;TAB2;BCL2;PTPN22;EIF4G3;HGF;KLHL22;TIMP2
prerank,mRNA methylation (GO:0080009),-0.4531626138128808,-1.147275910563659,0.2979452054794521,0.44291353322250343,1.0,6/15,16.18%,CBLL1;PCIF1;METTL14;VIRMA;TRMT6;WTAP
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4487166844528416,1.1471825732449863,0.29836829836829837,0.5721755053516178,1.0,6/14,17.01%,NME2;AK4;AK5;NMNAT2;ME1;AK3
prerank,negative regulation of vascular permeability (GO:0043116),0.46000669979106557,1.1469762851521788,0.2727272727272727,0.5714494248782592,1.0,6/12,17.13%,SLIT2;SH3GL2;FERMT2;CLDN5;RAMP2;PDE3A
prerank,cellular response to alcohol (GO:0097306),-0.3544170048666131,-1.1466259133512866,0.24912891986062718,0.4438988920784373,1.0,12/42,8.91%,GNB1;ADCY7;SPIDR;BRCA1;GRAMD1B;PTGER4;BLM;LRP6;GNG2;AHR;CTNNB1;RAD51
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.43107679438179447,-1.1464279496467742,0.2807625649913345,0.4440272913765146,1.0,5/16,11.60%,RREB1;METRNL;PIM1;FLCN;FTO
prerank,brain morphogenesis (GO:0048854),0.44860207421549264,1.146307617576246,0.2815734989648033,0.5717815003335063,1.0,2/12,5.31%,CTNNA2;SHANK3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.44270372222642235,-1.146054338892358,0.2727272727272727,0.44444524704128535,1.0,6/15,17.48%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1;TENT4B
prerank,protein import into nucleus (GO:0006606),-0.32153205216351183,-1.1454128433477921,0.22735042735042735,0.44547512482597584,1.0,21/66,22.26%,SYK;KPNA4;IPO5;NUP50;STAT3;NUP88;E2F3;TPR;NUP188;KPNA3;CBLB;APPL2;NUP153;NUP35;FAM53A;APPL1;TNPO3;NUP107;NXT2;NUP62;SPRN
prerank,positive regulation of protein deacetylation (GO:0090312),-0.457960819649415,-1.1453576667019043,0.30084033613445377,0.44531526150356754,1.0,8/14,34.75%,AKAP8;NIPBL;DYRK1A;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,vesicle transport along microtubule (GO:0047496),-0.4028241264271357,-1.145248523775849,0.27413793103448275,0.44524320367429476,1.0,5/23,5.03%,TRAK1;KIF3B;RAB1A;DYNC1H1;FBXW11
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2823307486173193,-1.1450096801142686,0.18914473684210525,0.44542381118754,1.0,58/151,31.82%,PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;CD36;C5AR1;HTR2B;ARRB2;RAP1A;CCR1;PTK2B;PTPN22;ARRB1;GCNT2;GAS6;SPRY2;APP;MAP2K1;CCL5;CIB1;CRKL;PTPN11;PDGFRB;NOD2;LGALS9;PLA2G5;HMGB1;AGER;PDGFA;KDR;TGFB1;P2RY6;SEMA7A;SHC1;CCL7;FGFR4;MT3;CCN2;PDE8A;BMP2;ALOX15;RAPGEF2;CCL24;FPR2;FFAR4;SLC30A10;P2RY1;F2R;MTURN;GLIPR2;CD4;ATP6AP1;CCL4;FGF2;CCL19
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4578355722504047,-1.14476087397622,0.29180887372013653,0.4456274198114679,1.0,5/14,24.07%,CCR2;PTK2B;CCL5;WNK1;CCL7
prerank,response to growth factor (GO:0070848),-0.3503812356887152,-1.144746778722056,0.2459016393442623,0.44536959102368573,1.0,18/41,26.26%,CTNNB1;STAT5B;MAP2K5;TGFBR1;MAPK7;CPNE3;CIB1;ACVR2A;TGFBR2;TBC1D7;TWF2;BMPR2;SFRP1;RACK1;SHC1;LRP2;MYC;URI1
prerank,regulation of inclusion body assembly (GO:0090083),0.48458449890501043,1.143864968006681,0.2989010989010989,0.5762823447836165,1.0,4/11,13.20%,SACS;SNCAIP;DNAJA4;DNAJB2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.381813241702751,1.143706716648196,0.27419354838709675,0.5754583783941926,1.0,6/25,16.32%,ANK3;TMTC2;KCNA1;PRKN;FAM20A;SNCA
prerank,regulation of protein neddylation (GO:2000434),-0.49398060189446164,-1.1436526717187205,0.3174061433447099,0.44714201924340385,1.0,7/10,34.40%,RPL11;HIF1A;DCUN1D4;RPL5;COPS9;DCUN1D5;DCUN1D1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2706799049471725,-1.1433294885583831,0.1567043618739903,0.44747631747255107,1.0,36/214,12.66%,LYN;PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;SYK;CD36;C5AR1;HTR2B;ARRB2;RAP1A;CCR1;TLR4;PTK2B;PTPN22;DUSP3;FN1;ARRB1;GCNT2;GAS6;SIRPA;PTPN6;ITGB1BP1;SPRY2;SPRED1;APP;PIN1;DUSP6;FLCN;MAP2K1;SPRED2;CCL5;CIB1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.449354817559067,-1.1429624779433096,0.2933104631217839,0.4479345422317329,1.0,5/16,16.87%,PID1;DNAJC30;FLCN;TMSB4X;SPHK2
prerank,reticulophagy (GO:0061709),-0.47941776667177827,-1.1427772508973724,0.307426597582038,0.4480070377258318,1.0,5/12,21.95%,ULK2;TEX264;RETREG1;RB1CC1;UFM1
prerank,positive regulation of metabolic process (GO:0009893),-0.2969212359923386,-1.1427676212421733,0.2042833607907743,0.4477454397815425,1.0,16/103,7.75%,CCR2;SYK;CD36;CAMK1D;OGT;INSR;IGF1R;FABP5;KDM3A;IL18;STAT6;DYNC1H1;ADIPOR1;UCP2;PLAC8;VEGFA
prerank,isotype switching (GO:0045190),-0.5073094334753799,-1.1425040144503869,0.3086206896551724,0.44795518046708416,1.0,2/10,10.02%,BATF;RNF8
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.46274809684086304,1.1421291123977366,0.2881773399014778,0.578188998878078,1.0,6/12,21.31%,SORBS1;PRKCZ;IRS1;IGF2;SIRT1;SORL1
prerank,regulation of protein processing (GO:0070613),-0.40293379616882496,-1.142071260508963,0.2750865051903114,0.4485352220478744,1.0,5/21,17.83%,RUNX1;NLRC4;ADAM8;CLN3;TMEM59
prerank,arachidonic acid secretion (GO:0050482),-0.5134546012293966,-1.1411949063328966,0.33560477001703576,0.4496369596597919,1.0,5/10,38.95%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,arachidonate transport (GO:1903963),-0.5134546012293966,-1.1411949063328966,0.33560477001703576,0.4496369596597919,1.0,5/10,38.95%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.44412815650519594,-1.1410871510929128,0.30517241379310345,0.4495943135135332,1.0,9/17,27.79%,COX4I1;COX10;AFG1L;COX8A;COX6C;NDUFA4;CYCS;COX5A;COX6A2
prerank,cellular response to nitrogen compound (GO:1901699),-0.4140068434572475,-1.1410288604081928,0.2977624784853701,0.4494341435663978,1.0,7/20,15.19%,SPIDR;RIOK3;BLM;DDI2;EPG5;TIMELESS;NSMCE3
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.256134236768509,-1.1403601283361486,0.14153846153846153,0.45043385043673395,1.0,55/291,13.49%,PID1;LYN;LILRB1;P2RX7;DAPK1;VIM;GNB1;PRKCD;AXL;JUN;RAP1B;RHOA;TNFRSF1B;IPO5;P2RX4;SBNO2;FES;ABL2;RAP1A;CTR9;TLR4;PTK2B;STAP1;CHMP5;NFKB1;ACTB;ADAM9;MAPK14;PF4;GNG2;AHR;CAMKK2;SIRPA;MYD88;MEF2C;LY96;SELENOS;LPL;PRDX5;EGR1;TGM2;TNIP2;NCF1;XBP1;RRAGD;RELA;HSP90B1;TICAM1;HMGB2;SERPINE1;CASP1;MTR;DEFA6;NFKBIL1;DHX36
prerank,positive regulation of sodium ion transport (GO:0010765),0.467608026801141,1.1397197738166354,0.3119047619047619,0.5828067581524203,1.0,4/12,15.69%,ANK3;AHCYL1;WNK3;CNKSR3
prerank,histone H2A ubiquitination (GO:0033522),-0.43935955607708044,-1.1396930652954549,0.2841918294849023,0.4514307749745265,1.0,9/17,28.14%,DDB2;RYBP;UBR2;RNF8;CUL4B;DTX3L;DDB1;KDM2B;RNF2
prerank,regulation of metal ion transport (GO:0010959),0.4234768461426104,1.1396763865404282,0.3144963144963145,0.5816945917456559,1.0,2/16,1.49%,ANK2;CACNA2D1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.383946305763813,-1.1395573152598553,0.2453781512605042,0.4513955542824869,1.0,15/28,29.01%,MAP3K20;ERCC6;RAD1;E2F1;RHNO1;DOT1L;BRIP1;RAD9A;ATM;CHEK1;NBN;USP28;CLOCK;CEP63;DONSON
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.45695203901237497,1.139525562218452,0.32027649769585254,0.580861986578871,1.0,3/12,10.95%,TMEFF2;EDN1;GSTP1
prerank,protein heterooligomerization (GO:0051291),0.42188449345178064,1.139304627848333,0.30676328502415456,0.5801946428672636,1.0,9/17,26.01%,GRIN2B;KCNC2;PKD1;HSD17B8;TMEM120A;CPSF6;CPSF7;PKD2;GRIN1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.33285743777919463,1.1389648931487784,0.2384428223844282,0.5797856022240689,1.0,9/39,9.67%,SPOCK1;EFNA5;SEMA3E;MELTF;SPRY4;KANK1;NEXMIF;CDKN2A;PLET1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4602590360560809,-1.1381405381225898,0.2849264705882353,0.45386703655033395,1.0,5/13,17.35%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3058550404175439,-1.1380469002943638,0.22016806722689075,0.45377518461797395,1.0,25/85,22.52%,DAB2;HECTD1;RNF19A;NUPR1;PIAS1;CBFA2T3;NUB1;DET1;ATXN3;TRIB1;TRIB2;PSMC3;RNF180;RNF185;ARIH1;GABARAP;TMEM259;SMAD7;HSPA1A;GSK3B;FBXO22;SIRT2;RACK1;BAG6;SOCS5
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3353552279509757,-1.1378561206259379,0.27017543859649124,0.45386566179435556,1.0,16/47,16.97%,APOE;FOXO3;NFKB1;NR1H2;PUM3;PCIF1;APP;MTPN;AGT;WDR91;UHRF1;NOLC1;EIF4G1;SSH1;EIF2A;RBM4B
prerank,positive regulation of histone acetylation (GO:0035066),-0.40886891167936573,-1.137660076024723,0.28547008547008546,0.4539575567014424,1.0,6/23,16.87%,BRD7;BRCA1;ARRB1;WBP2;KAT7;SPHK2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.360264065206411,1.1376179146501422,0.27205882352941174,0.5819212992149414,1.0,6/31,10.09%,NRG1;RYR2;ZFPM2;TGFB2;TNNT2;MYH7
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.49117381431062374,-1.1375812231299174,0.2953020134228188,0.4538222343364122,1.0,2/10,12.29%,DNMT3A;ZFP57
prerank,negative regulation of cell adhesion (GO:0007162),-0.31725012196918995,-1.1374998017564977,0.24473257698541329,0.4537306384350729,1.0,15/72,9.65%,PTPRC;PLXNC1;RHOA;SIPA1;PLXNA1;PLXND1;LPXN;TGFBI;RIPOR2;JAG1;GCNT2;NF2;MDK;CBLL1;ITGB1BP1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.4073333209696347,-1.1374592263123036,0.29310344827586204,0.4535314734997591,1.0,8/21,23.49%,PTK2B;STAP1;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4558568779028145,1.1372221832352025,0.302540415704388,0.5816585938596783,1.0,3/13,7.45%,MGAT3;CHST5;CHST7
prerank,nucleic acid-templated transcription (GO:0097659),-0.35428857656230206,-1.136657236332601,0.25565217391304346,0.45483383628077756,1.0,18/42,22.00%,MEF2A;POLR2H;E2F1;POLR2F;THAP1;POLR2L;EPC1;POLR2A;NFKBIB;POLR2G;DTX1;RNPS1;POLR3A;MED20;MMS19;POLR2I;XAB2;TOPORS
prerank,regulation of protein transport (GO:0051223),-0.3866926627061483,-1.1365395340040163,0.29360967184801384,0.45477915884581455,1.0,17/27,35.05%,SNX3;DNAJC1;WWP2;RHBDF1;RHBDF2;DNAJA1;LCP1;ARFIP1;NDFIP2;PTPN1;P3H1;HSPA8;ATP13A2;GAPVD1;TNF;LLGL2;DISP1
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2958613300717402,-1.136363136038912,0.21993127147766323,0.45486557242547004,1.0,24/105,13.37%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;PTGER4;TNFAIP8L2;DUSP3;IRAK3;PPM1B;SIRPA;TRIB1;MAPK7;SELENOS;OTULIN;PCBP2;CRK;NLRC3;SERPINE1;NFKBIL1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.27984232009328536,-1.136189302682223,0.20132013201320131,0.454917597276326,1.0,41/138,22.86%,RBPJ;NOTCH2;CREBBP;PPARD;PPARG;MAML1;GTF2A1;E2F2;MAML2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;GTF2E2;RXRA;DR1;HDAC5;POLR2A;TAF4B;TAF8;NR4A1;POLR2G;TAF9;RARA;TAF3;NR3C1;TAF4;MAZ;POLR2I;MAML3;GTF2A2;NR1H4;GTF2F2;ESR2
prerank,mitochondrial translational termination (GO:0070126),-0.30105854359811685,-1.1354602961367422,0.22071307300509338,0.4561351761234223,1.0,34/88,33.27%,MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPS25;MRPL54;MRPL39;MRPL53;MRPL11;MTRF1;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPS35;MRPS28
prerank,protein targeting to membrane (GO:0006612),-0.30197333512580365,-1.135436902569162,0.22948073701842547,0.45590330647571625,1.0,26/83,25.10%,RAB8B;SDCBP;PEX14;ABCD2;SEC63;PEX26;SRP14;NACA;ZDHHC7;SIL1;FIS1;ZDHHC2;NCF1;ZDHHC12;GET3;ABCD3;TAOK2;ZDHHC1;NACAD;GOLGA7;SGTA;CHMP4B;CHMP4A;MICALL1;ZDHHC6;YIF1B
prerank,regulation of protein polymerization (GO:0032271),0.34976778921455365,1.135178949447763,0.25925925925925924,0.5852732493119346,1.0,4/35,4.47%,MAP2;MAPRE3;PAK3;TTBK1
prerank,cGMP-mediated signaling (GO:0019934),0.45195877867525225,1.134836935141208,0.2987951807228916,0.5849253568327308,1.0,4/13,3.88%,HTR2C;KCNC2;GUCY1B1;PDE9A
prerank,positive regulation of isotype switching (GO:0045830),-0.43484055683886974,-1.1348366004289723,0.30824372759856633,0.4568047244718439,1.0,5/15,22.48%,KMT5B;KMT5C;CD40;SHLD2;TGFB1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.4961265330730846,-1.134693053769847,0.3083941605839416,0.4567885488743821,1.0,5/10,25.01%,YWHAE;SESTD1;PLN;VDAC1;FKBP1B
prerank,cytoskeleton organization (GO:0007010),-0.2894845871692338,-1.1345606116241618,0.20063694267515925,0.4567450525209407,1.0,23/114,12.60%,DIAPH1;APOE;NEDD9;ARHGAP10;FGD6;RAC1;RHOA;SIPA1;CAPZB;SH3KBP1;FGD4;PLD2;FGD3;SIPA1L3;MDK;LARP4;DIAPH3;PACSIN2;SYNE3;SPRYD3;MICAL1;FMNL2;MICAL2
prerank,heterochromatin assembly (GO:0031507),0.3956933386158457,1.1340789780110896,0.28095238095238095,0.5855988725971056,1.0,7/20,20.07%,SUV39H1;HMGA2;CDKN2A;BAHD1;HMGA1;HELLS;SIRT1
prerank,RNA destabilization (GO:0050779),-0.42636068390794024,-1.1333590684051567,0.2979452054794521,0.4588381838295016,1.0,5/18,13.02%,ROCK1;YTHDF3;FTO;CELF1;METTL14
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4030319619548248,-1.1331495743278566,0.29069767441860467,0.45897552421894655,1.0,9/21,27.73%,SMARCD3;CTNNB1;VEGFA;MDK;NES;DISC1;KDM1A;LRP2;DCT
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.4149422573284052,-1.1329100441024242,0.30017761989342806,0.45913695331107124,1.0,9/19,33.05%,MTHFS;MTHFD1L;GGH;MTHFD2L;SHMT1;MTHFR;FPGS;SLC19A1;MTHFD1
prerank,embryonic heart tube development (GO:0035050),0.43720684959903733,1.1325485893307186,0.3226600985221675,0.5880710426792535,1.0,2/14,4.76%,RYR2;ACVR1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30370027206113903,-1.132348404553555,0.22495894909688013,0.4599739574509456,1.0,25/78,22.48%,PID1;DAB2;PRKCH;LRP1;STX7;ITGB1;ACTB;STX8;STX3;RHOQ;PICALM;ZDHHC7;ZDHHC8;ZDHHC2;ITGA3;CIB1;PPFIA1;CLN3;STX4;TMEM59;ZDHHC5;APPL1;VPS4A;CDK5;TGFB1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.48951477090523376,-1.1321918298334244,0.3111111111111111,0.4599899620322268,1.0,1/10,0.19%,PRKCH
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.40489447785711247,-1.1313316856681164,0.29464285714285715,0.46144284835925525,1.0,8/21,24.46%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C
prerank,negative regulation of axonogenesis (GO:0050771),0.37322477673201937,1.1313032103621319,0.2926829268292683,0.5898452862516925,1.0,3/27,2.16%,MAP2;DCC;LINGO1
prerank,negative regulation of protein modification process (GO:0031400),-0.30320301985548587,-1.130786278969163,0.23770491803278687,0.4622330324610575,1.0,27/79,25.52%,PID1;LYN;CORO1C;MFHAS1;XDH;NIBAN1;IBTK;PPP1R15B;LRP6;MYADM;SIRPA;PAQR3;CIB1;IGFBP3;CRKL;CRTAP;PTPN13;GSK3B;ZC3H12A;PLPP3;TGFB1;CDYL;PRKDC;TARDBP;P3H1;XRCC1;INPP5K
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.43668796065117976,-1.130634771689992,0.31313131313131315,0.46226575749391546,1.0,5/15,12.50%,ITGA5;VEGFA;JAK1;JMJD8;PKM
prerank,response to insulin (GO:0032868),-0.30140744962350574,-1.1305671618887059,0.24046434494195687,0.46210509356919854,1.0,18/80,19.29%,MYO5A;RAB8B;DENND4C;OGT;INSR;RAB31;PPARG;SLC27A1;RHOQ;SELENOS;XBP1;PKM;RAB10;HDAC5;RAB13;IRS2;ENPP1;RAB12
prerank,negative regulation of peptidase activity (GO:0010466),0.3224731385071473,1.130489932888666,0.24,0.5905750743888809,1.0,5/47,4.81%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,negative regulation of cell development (GO:0010721),-0.38593397365775717,-1.1303628320191443,0.2774869109947644,0.4622359816297036,1.0,8/25,23.75%,IGF1;LILRB1;B2M;APPL2;RFLNB;GSK3B;IL6;PAX6
prerank,female gamete generation (GO:0007292),-0.3645123593447896,-1.1303543082122196,0.28192371475953565,0.4619669076499208,1.0,9/29,20.89%,DIAPH2;USP9X;MDK;MCM9;KMT2D;TOB2;MARF1;HORMAD1;DMC1
prerank,mitochondrial translational elongation (GO:0070125),-0.2960704384960947,-1.1302625738345538,0.2303839732888147,0.4618821102129218,1.0,34/88,33.27%,MRPS10;ERAL1;MRPL42;TUFM;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPS25;MRPL54;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPS35;MRPS28
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3271144532726131,-1.1293350800626039,0.2676767676767677,0.46343158169308907,1.0,22/57,26.49%,NPL;ANPEP;GNPDA1;LNPEP;CLN6;CPQ;TRIM24;IL4I1;MPST;PLA2G4A;PLA2G7;TPP1;PLA2G5;GGACT;PLA2G6;PPT1;GNPDA2;AMDHD2;PNPLA8;RENBP;LRSAM1;PLA2G15
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.353144355580831,-1.1290768059602683,0.27702702702702703,0.46369461102718745,1.0,14/39,24.43%,DDB2;RFC1;UBC;RPS27A;CUL4B;PCNA;RPA3;POLD2;RFC2;ERCC4;RFC3;FAN1;POLD4;DDB1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.39576162667699766,-1.1288946989250084,0.28596802841918295,0.46375263941748995,1.0,6/24,4.43%,ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.4034286891834811,-1.128274044466744,0.2798573975044563,0.4646904802523936,1.0,6/21,10.58%,ARHGAP25;CYRIB;SH3BP1;ARHGAP12;SPRY2;RASAL3
prerank,circulatory system development (GO:0072359),0.27494527887177084,1.1280035667154042,0.19387755102040816,0.5952741423046091,1.0,34/118,18.98%,FGF12;CACNA1C;PCSK5;ERBB4;NTRK3;ZFPM2;PRICKLE4;ACVR1;WT1;PLCE1;CACYBP;FLRT3;SOX9;FBXW7;TGFB2;DNAAF4;POU4F2;POPDC2;SALL1;TBX1;EEF1AKMT4-ECE2;PKD1;PDLIM4;CDH5;MKKS;ECE1;ERBB3;RAMP2;PDLIM7;KAT2A;ZDHHC16;RBM20;TEK;FOXC2
prerank,regulation of viral release from host cell (GO:1902186),-0.4027921562484434,-1.1279834076587198,0.28368794326241137,0.4650063721186858,1.0,9/21,26.34%,TSG101;TRIM11;CHMP2A;TRIM25;VPS4A;DDB1;CHMP2B;TRIM28;PML
prerank,embryonic eye morphogenesis (GO:0048048),-0.48246229797346,-1.1279783386988214,0.3205574912891986,0.46473450334609434,1.0,5/11,27.34%,RARG;LRP6;MFAP5;TBX2;KDM2B
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.27045056897457076,1.1272318715626812,0.21761658031088082,0.5959803010928247,1.0,23/138,8.61%,PTPRD;PTPRG;ERBB4;PTPRT;NTRK3;EPHA6;NTRK2;AHI1;SHC3;EPHA7;EPHA5;CSF1R;PTN;SHC4;TIE1;EPHB1;ALK;MPZL1;BDNF;GFRA2;FYN;SHC2;EPHA10
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3556914077848947,-1.1271714733072302,0.25609756097560976,0.4660573693596848,1.0,13/38,21.22%,SNRPG;COIL;SNRPF;PRPF8;SART1;SMN1;SART3;GEMIN7;SNUPN;SRSF10;WDR77;TGS1;GEMIN6
prerank,stress fiber assembly (GO:0043149),-0.4441514072748024,-1.1270620015312576,0.3231292517006803,0.465712777278616,1.0,6/15,11.26%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4441514072748024,-1.1270620015312576,0.3231292517006803,0.465712777278616,1.0,6/15,11.26%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3617547037080692,-1.126385334325314,0.2674616695059625,0.4668318211084321,1.0,11/33,25.10%,SNRPG;SNRPF;SSU72;NUDT21;WDR33;NCBP1;PAPOLA;MAZ;CPSF3;MED18;CPSF1
prerank,mitochondrial gene expression (GO:0140053),-0.34683553884341667,-1.1263111557440113,0.27986348122866894,0.4666982027543419,1.0,16/42,34.07%,FOXO3;NOA1;FASTKD2;MRPS6;MRPS11;TFAM;MRPS16;MRPS15;MRPL51;MRPL47;TWNK;MRPS7;GATB;MRPS17;MRPS28;RARS2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3989591266294135,-1.1260976598720795,0.2842809364548495,0.4668147050488376,1.0,5/24,2.64%,CD44;ITGA5;ARHGAP24;RHOA;FLNA
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.30123007537774454,-1.1259314384667627,0.2440677966101695,0.46686450058854334,1.0,28/82,25.30%,CNTRL;DYNC1H1;CENPF;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;TPX2;CEP70;KIF14;HAUS4;CDK1;DCTN1;HAUS7;NINL;ODF2;AURKA;ATF5;PCNT;PAFAH1B1;CEP192;TUBA4A;CEP41;GTSE1;CETN2;CEP72
prerank,positive regulation of response to stimulus (GO:0048584),-0.3510657349206579,-1.1259192133121716,0.28091872791519434,0.46660254138237645,1.0,15/40,24.44%,PRKCD;CGAS;IL15;DHX9;RSAD2;B2M;EEF1E1;FCGR2B;ARG2;MAVS;TAF9;GATA3;ILK;ECHDC3;MYC
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4308514864779639,-1.1255812174184392,0.3062283737024221,0.46699976695308176,1.0,5/16,11.16%,GPR137B;KLHL22;PIP4P1;FLCN;RRAGD
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3997874183016192,-1.1254026270268964,0.2900355871886121,0.4670508526728867,1.0,8/21,19.84%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,histone acetylation (GO:0016573),-0.31444357140957385,-1.1246019172152457,0.2508650519031142,0.468344146829974,1.0,16/69,18.49%,CREBBP;PHF20;SPI1;MORF4L1;TAF6;ZZZ3;WDR5;JADE2;NAA50;KAT7;DR1;EPC1;MRGBP;TAF9;PHF20L1;TRIM16
prerank,secondary alcohol biosynthetic process (GO:1902653),0.36306083464551825,1.1245168093508748,0.2900763358778626,0.6013302039307401,1.0,9/30,14.61%,DHCR24;HMGCS1;INSIG1;CYP51A1;SQLE;DHCR7;EBP;MVK;LSS
prerank,necroptotic process (GO:0070266),-0.42274885936400475,-1.1242649820425288,0.3315508021390374,0.46873512071695805,1.0,8/16,28.77%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3267962212253358,-1.124258466081631,0.2670157068062827,0.4684594081419006,1.0,10/51,11.52%,NRP1;PLEK;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1;CCDC88A
prerank,phosphate ion transport (GO:0006817),-0.4261324533035432,-1.1241193977666744,0.28596491228070176,0.4684350112646079,1.0,6/16,30.60%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC20A1;SLC37A2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.48738333455477856,-1.123988846838906,0.3207885304659498,0.4683883148191682,1.0,4/10,26.87%,NCKAP1L;TGFBR2;LGALS9;ZBTB7B
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.35537069050710735,-1.123953137867368,0.2672268907563025,0.4681802587636554,1.0,17/35,33.65%,RFC1;LIG1;PCNA;FEN1;RPA3;POLD2;RFC2;LIG3;ADPRS;RFC3;POLB;POLD4;XRCC1;MPG;MUTYH;PARG;POLE
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.44575368715147157,-1.123758464614264,0.3168141592920354,0.4682720457144572,1.0,3/13,4.54%,RREB1;METRNL;PIM1
prerank,smooth muscle contraction (GO:0006939),-0.45333054824329394,-1.1235520234258138,0.31462585034013607,0.4684194433994687,1.0,7/14,23.74%,ROCK1;SLC8A1;EDNRA;PIK3C2A;CHRNB2;TPCN2;SMTN
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3541408843348003,-1.122999239306735,0.2814569536423841,0.4692015059196131,1.0,15/36,31.58%,APOE;SP100;PPARG;MEF2C;ANGPT2;GADD45A;HMGB1;JUP;APOH;TGFB1;DCN;ADAMTS9;AGTR2;CSNK2B;FGF2
prerank,regulation of histone methylation (GO:0031060),-0.4584266445221342,-1.1227858944301434,0.3225806451612903,0.4693511334448409,1.0,7/13,29.75%,CTR9;CHTOP;JARID2;NSD1;MTHFR;TTLL12;FAM47E
prerank,lymphocyte chemotaxis (GO:0048247),-0.3602310337656869,-1.1224101492934824,0.29069767441860467,0.4698090907668819,1.0,8/34,13.42%,CKLF;PIK3CG;GAS6;ADAM8;CH25H;CXCL16;CCL5;PIK3CD
prerank,wound healing (GO:0042060),-0.31536470765125174,-1.1223265628500863,0.2587646076794658,0.4697009880065141,1.0,12/62,9.08%,MYOF;IGF1;MYH9;ARL8B;HPSE;CFLAR;MACF1;FUT10;AHNAK2;PRCP;TGFBR1;JAML
prerank,positive regulation of cytokinesis (GO:0032467),-0.3675277783122882,-1.1221610603756287,0.2913793103448276,0.46974634404616983,1.0,7/32,14.58%,RHOA;SVIL;CDC42;KIF20B;KIF23;KIF14;RACGAP1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.33375439862137607,-1.1219025766043167,0.2945990180032733,0.4699730122341092,1.0,19/47,29.06%,RBPJ;ROCK1;HGF;CTNNB1;TGFBR1;HIF1A;DDX5;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,regulation of actin filament polymerization (GO:0030833),-0.3085668077255472,-1.1218654307531541,0.26138279932546377,0.469765869070808,1.0,32/69,31.68%,PRKCD;SNX9;PTK2B;ARFGEF1;ARHGAP18;CYRIB;MYADM;BAIAP2;NCKAP1L;CDC42EP2;MTPN;BAIAP2L2;SSH3;RASA1;COTL1;SSH1;CDC42EP3;HCLS1;HCK;TWF2;HAX1;PFN1;SSH2;NCK1;ALOX15;DBNL;CCL24;CDC42EP5;NCK2;TWF1;PLEKHG2;BAIAP2L1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4051816599265595,-1.1217253754245047,0.3333333333333333,0.4697519537389174,1.0,11/20,35.09%,AGO2;ZC3H7B;PUM2;TSNAX;PUM1;TSN;ZC3H7A;SNIP1;DROSHA;SPOUT1;AGO3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.45592366965411835,-1.1203899669722348,0.3159722222222222,0.47209379117669703,1.0,5/12,34.28%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,cardiac conduction system development (GO:0003161),-0.387738427809978,-1.119984736483951,0.2906574394463668,0.47257771785500985,1.0,12/24,39.20%,NOTCH2;MAML1;GJB6;SMAD4;GJA5;HEY2;GJA1;SMAD1;HEY1;NPPA;TBX18;SMAD5
prerank,response to interleukin-6 (GO:0070741),-0.49372029078798585,-1.1189773038705144,0.3327702702702703,0.4743349416680721,1.0,4/10,11.54%,PID1;SBNO2;NFKB1;RELA
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40693967178206114,1.1186467767144317,0.30963302752293576,0.6146327919756339,1.0,3/17,7.06%,PRKG1;TAFA5;APLN
prerank,regulation of embryonic development (GO:0045995),-0.36121019186085107,-1.1184002613576505,0.2789473684210526,0.4751643585625727,1.0,11/34,21.36%,B4GALT5;NIBAN2;INSR;NIPBL;RBM19;CDK1;DHX36;RACGAP1;CFL1;TRIP12;BAG6
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3578989835599689,-1.1178723660306913,0.2954954954954955,0.47589473826233525,1.0,7/34,4.43%,ARPC2;RAC1;ACTR2;CAPZB;WASF2;CDC42;ACTR3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3945282702781866,1.1178276353536674,0.2850467289719626,0.6154787619918374,1.0,6/19,12.33%,GRM5;RYR2;VCAM1;PRNP;GPR143;BCAP31
prerank,aorta development (GO:0035904),0.42597788524217606,1.1177427429397917,0.3053435114503817,0.6144439022506305,1.0,2/14,0.73%,ROBO1;ROBO2
prerank,negative regulation of catabolic process (GO:0009895),-0.3355046254841962,-1.1175834246152268,0.27,0.4761667363193704,1.0,13/47,20.16%,SNX3;NUPR1;FLNA;CBFA2T3;IRAK3;ZDHHC7;AZIN1;SF3B3;PIN1;CST3;RILP;MDM4;SIRT2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4711933221745147,-1.1174978642798061,0.30427350427350425,0.476053331636095,1.0,2/12,4.27%,CCR2;IL18
prerank,ribosomal small subunit assembly (GO:0000028),-0.4314038800825927,-1.116494439433031,0.31746031746031744,0.47778482575452164,1.0,8/16,24.97%,ERAL1;RPS14;RPS28;MRPS11;RPS27;RPS15;PRKDC;MRPS7
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2664840730134874,-1.1162628476360807,0.20772946859903382,0.47797504715765887,1.0,42/172,19.51%,PLCG2;INPP4A;PI4K2A;DDHD1;PIK3R5;MTM1;CSNK2A1;DGKZ;PIP4K2A;TAMM41;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;CEPT1;PI4K2B;PLD2;PIK3CB;GPD1;PIK3CG;PI4KB;DGKD;RAB5A;IMPA1;MTMR6;PIK3CA;ABHD5;CPNE3;PIK3CD;AGPAT1;PLEKHA2;PLA2G4A;PIK3C2A;DGKG;CLN3;PTPN13;PLEKHA4;PLA2G5;PLA2G12A;PIP5K1A;LPCAT3
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.48948644236390004,-1.1160713414639407,0.31385642737896496,0.4780592062272644,1.0,4/10,21.38%,BRCA1;JARID2;MYB;KDM1A
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2887927393024387,-1.1159689395664922,0.23645320197044334,0.4779860760383019,1.0,31/104,22.01%,RB1;RHOA;UVRAG;SLC27A1;CCND3;ACTB;INCENP;BLM;TSG101;LRP6;CAB39;EZH2;TRIB1;SLC8A1;TRIB2;CDKN3;CDC25A;MAP2K1;GADD45A;CIB1;KSR1;CCNE1;RALB;CDKN2C;SERTAD1;CNPPD1;ADRB2;DDX3X;CDC25C;CCNK;CCNF
prerank,GTP metabolic process (GO:0046039),-0.429332775390145,-1.1158543837992552,0.3253012048192771,0.4779159694716732,1.0,5/15,10.85%,GNAI3;IMPDH2;RHOQ;EFL1;GTPBP1
prerank,negative regulation of nervous system development (GO:0051961),0.41030372018601524,1.1155142433697784,0.3104265402843602,0.6188530297094874,1.0,4/17,12.91%,ROBO2;SLIT1;HOOK3;REST
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3323649831894151,-1.1153653054854444,0.30413223140495865,0.4785832657314157,1.0,8/47,10.14%,PLEK;BRCA1;SLC27A1;NFKB1;SIRPA;ERLIN1;SIK1;PRMT3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3883160775611958,-1.115164061954625,0.30124777183600715,0.4787277184578793,1.0,9/24,14.64%,CANX;TAPBP;B2M;TAP2;SEC24A;SEC24D;FCER1G;SEC31A;TAPBPL
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.41843836917600674,-1.1151435053569578,0.31802120141342755,0.4784741011773952,1.0,5/18,10.56%,POR;ABL2;ATP7A;SIRT3;AGT
prerank,positive regulation of receptor internalization (GO:0002092),0.3842869178159752,1.1150286748929605,0.29523809523809524,0.6187912574760619,1.0,5/22,8.22%,MAGI2;AHI1;EGF;APLN;FMR1
prerank,protein localization to cell periphery (GO:1990778),0.26539028644155627,1.1143119414016374,0.21428571428571427,0.6192749253150528,1.0,13/133,4.33%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;CLASP2
prerank,cellular response to UV-A (GO:0071492),0.4594477015436297,1.1141307718635827,0.3236009732360097,0.6184721985422208,1.0,3/11,9.78%,MME;OPN3;OPN5
prerank,copper ion transport (GO:0006825),-0.4816325184766901,-1.1132877770479757,0.34915254237288135,0.4820150438751867,1.0,4/11,19.48%,ATP7A;STEAP3;SLC31A1;SLC11A2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3053863162098988,-1.1130767474269778,0.2757417102966841,0.4821681758721008,1.0,15/80,6.45%,NRP1;PLEKHM1;ARPC2;P2RX7;RAC1;ACTR2;EPS8;WASF2;DOCK11;CDC42;ACTR3;ARAP1;RIPOR2;RHOQ;WASL
prerank,ceramide transport (GO:0035627),-0.45962560704082805,-1.1121372280628665,0.33568904593639576,0.4837482238988898,1.0,3/12,5.82%,PSAP;PLTP;GLTP
prerank,protein O-linked glycosylation via serine (GO:0018242),0.47380451728533945,1.1115545723311098,0.34521158129175944,0.6236053294632325,1.0,3/10,10.83%,GALNT13;GALNT16;POGLUT3
prerank,response to interleukin-1 (GO:0070555),-0.30961099313893375,-1.1114512479736751,0.25597269624573377,0.4848380625880747,1.0,19/73,20.84%,IRAK2;RC3H1;NFKB1;ANXA1;YTHDC2;IRAK3;SIRPA;MYD88;HIF1A;GBP2;APP;RELA;CCL5;CD40;TAF9;GBP3;LGALS9;ZC3H12A;SFRP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.44461861152837473,-1.1107025019878611,0.3345008756567426,0.4860347359309418,1.0,6/13,35.57%,BCL2L11;VDAC2;BNIP3L;BNIP3;BLOC1S2;RTL10
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.32732139352298834,-1.110595594689135,0.29015544041450775,0.4859689891810298,1.0,18/52,25.77%,BCL2;RNF31;USP36;E2F1;UBE2L3;YWHAE;UBL5;SH3GLB1;BBC3;BID;CASP8;HUWE1;BAP1;SFN;HPS4;NMT1;SAE1;VPS11
prerank,regulation of calcium ion transport (GO:0051924),-0.32608874480520694,-1.1100099032708937,0.2938230383973289,0.4868519755010385,1.0,10/54,8.38%,CD84;ATP2B1;LILRB1;SARAF;CRACR2A;P2RX4;CCR1;BCL2;CTNNB1;WFS1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3525551176728033,-1.1093291164616335,0.3060200668896321,0.4878994665880572,1.0,14/36,21.04%,RAB7A;OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;RILPL1;GOLGA7;BLZF1
prerank,selective autophagy (GO:0061912),-0.32062460252257224,-1.1088606352719983,0.26949152542372884,0.488520785326189,1.0,17/56,22.73%,VIM;RAB7A;ATG5;DYNC1H1;WDFY3;ULK2;TEX264;UBC;RPS27A;RETREG1;RB1CC1;USP30;DYNC1LI2;PCNT;ATM;UFM1;BECN1
prerank,positive regulation of cell differentiation (GO:0045597),-0.2579481153129106,-1.1088069697950016,0.19776714513556617,0.48835246942138966,1.0,49/237,14.48%,DAB2;PRKCH;MSR1;IGF1;TCF4;SDCBP;CD36;SLC6A6;MEF2A;RHOA;PPARD;ARHGEF2;FES;PPARG;IL6R;RAP1A;CDC42;RIN2;IL18;NFKB1;RUNX2;MEDAG;RIPOR2;PKDCC;MAPK14;PF4;HGF;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1;MEF2C;LPL;AGT;XBP1;WDFY2;NUDT21;HSP90AB1;ACVR2A;SMYD1;DHX36;IGFBP3;TGFBR2;SIN3A;BTG1;ID2;TCF3
prerank,positive regulation of histone deacetylation (GO:0031065),-0.46108172482016496,-1.1083074988910637,0.32642487046632124,0.48908344196101444,1.0,8/12,34.75%,AKAP8;NIPBL;VEGFA;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,anterograde axonal transport (GO:0008089),0.33799587464678565,1.1082769912874761,0.2857142857142857,0.6306323051846916,1.0,12/37,17.71%,DLG2;KIF5C;KIF1B;RAB27B;KIF5A;AP3M2;NEFL;KIF3A;AP3S2;MAP1A;HAP1;BLOC1S6
prerank,regulation of stress fiber assembly (GO:0051492),-0.30056733258087276,-1.1077409759714607,0.25618374558303886,0.48994669654222306,1.0,15/74,9.65%,NRP1;PAK2;RAC1;ROCK1;RHOA;WASF2;CDC42;ARAP1;PTGER4;ARHGEF10;ARHGEF18;NF2;TGFBR1;SLC9A1;ITGB1BP1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3839478259553966,-1.1075198822413825,0.3171171171171171,0.490088328086454,1.0,6/24,10.24%,PRKCB;ITGA5;NIBAN2;HHEX;HIF1A;ARNT
prerank,positive regulation of catabolic process (GO:0009896),-0.3062582251038347,-1.107456727334637,0.26533996683250416,0.4899289312870786,1.0,13/65,12.17%,WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;ATG7;TIPARP;AXIN1;PLK2;NEDD4L;ASB5;STX5
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3498798072036221,-1.1074449567894316,0.3157894736842105,0.48966295827287615,1.0,10/36,18.56%,ATP2B1;P2RX7;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SPHK2;LILRA5;PDGFRB
prerank,negative regulation of leukocyte migration (GO:0002686),0.47553599274917663,1.1071784773847322,0.33176470588235296,0.6322012443839106,1.0,3/10,7.85%,SLIT2;CD200R1;CD200
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4490077124125659,-1.106818143692347,0.3398576512455516,0.49063851965418886,1.0,4/13,5.43%,IGF1;INSR;DYRK2;PHKG2
prerank,amyloid-beta metabolic process (GO:0050435),0.413801036074642,1.1066336942939874,0.3253012048192771,0.6323151348591551,1.0,3/16,5.45%,MME;MGAT3;IDE
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.45791522086562814,1.106597583656615,0.3295964125560538,0.6298947744262492,1.0,4/11,13.42%,CASQ2;CALM1;CALM3;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.45791522086562814,1.106597583656615,0.3295964125560538,0.6298947744262492,1.0,4/11,13.42%,CASQ2;CALM1;CALM3;CALM2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3554849126545665,-1.106357557540258,0.30341113105924594,0.49125819436383134,1.0,10/31,21.23%,DCP1A;PATL1;EXOSC5;DCP2;POLR2G;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,negative regulation of lyase activity (GO:0051350),-0.42600846825504085,-1.1059268134090274,0.34991119005328597,0.49183943852078404,1.0,2/16,2.29%,CCR2;GNAI3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.39564841589473254,-1.1059097865264118,0.31560283687943264,0.49158673388433605,1.0,9/22,26.79%,ERI3;RPS21;NOP14;ERI2;EXOSC10;NOL9;WDR12;RPP40;EXOSC8
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.39692822502234176,-1.1058356819141757,0.36,0.4914516391953509,1.0,11/21,36.49%,AXIN1;LRP6;CTNNB1;PPP1CA;GSK3B;DVL2;FZD1;FRAT1;CAV1;APC;FRAT2
prerank,negative regulation of transport (GO:0051051),-0.32890422587423784,-1.1056912873286184,0.3156089193825043,0.49146000101032233,1.0,10/51,8.32%,MCTP1;LILRB1;RAB7A;SNX3;WWP2;ITGAV;NR1H2;SNX33;SIRPA;BST2
prerank,regulation of cellular localization (GO:0060341),0.3214988790605376,1.105466638748318,0.3065326633165829,0.6314714773112596,1.0,20/46,22.59%,MAP2;EFNA5;EPHA5;ADCY5;TRIM46;NR1D1;STXBP2;GSN;BRSK1;WWC1;CSNK1E;PRKN;HSP90AA1;REEP5;GOSR1;PARD6A;FER;TTL;LRRK2;DVL3
prerank,ceramide catabolic process (GO:0046514),-0.4377907921464026,-1.1048618619249766,0.32068965517241377,0.4928252630915255,1.0,2/14,2.00%,HEXA;ACER3
prerank,cellular response to amyloid-beta (GO:1904646),-0.34682689487891083,-1.1039214308853607,0.31438127090301005,0.4944151806365793,1.0,11/35,12.50%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP;FCGR2B
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.38212426410158745,-1.1038995505194533,0.3053691275167785,0.4941696524184305,1.0,5/26,6.50%,OSBPL8;IGF1;INSR;RHOQ;C3
prerank,respiratory system development (GO:0060541),-0.35130244026885465,-1.1036860103422272,0.3054607508532423,0.4942789272484936,1.0,18/32,42.66%,VEGFA;CCDC40;ITGA3;BAG6;CHD7;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;SMCHD1;DISP1;STRA6;LOXL3;FGF7;BASP1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.4388319410398681,-1.1035453578592636,0.36741767764298094,0.4942740606647894,1.0,5/14,19.74%,FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.31018238517123753,-1.1034120224186175,0.28289473684210525,0.4942627091685395,1.0,20/66,20.25%,CDK6;RB1;BRD7;PSME3;CCND3;PRMT2;ANXA1;E2F1;PTPN6;KIF14;ID2;EIF4G1;INO80;APPL2;WEE1;CDKN2C;CDK2AP2;DDX3X;APPL1;ADAMTS1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3605863708136132,-1.1032917021126156,0.30849220103986136,0.4942383973413299,1.0,7/31,12.13%,EXT1;XYLT1;IGF1;CHST12;CHST11;B4GALT7;XYLT2
prerank,signal peptide processing (GO:0006465),0.457709474041298,1.1030314060125523,0.3256880733944954,0.636324447100885,1.0,2/11,7.42%,PCSK5;SEC11C
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.40900799413908173,-1.1028057850466828,0.33856893542757416,0.4949279662477609,1.0,6/18,25.56%,SLC35F6;BID;HSPA1A;ACAA2;GSK3B;TMEM14A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2909065321255484,-1.1023489168587044,0.26218487394957984,0.4955576952383292,1.0,14/90,7.75%,CCR2;SYK;CD36;OGT;IGF1R;FABP5;KDM3A;IL18;STAT6;DYNC1H1;ADIPOR1;UCP2;PLAC8;VEGFA
prerank,regulation of cellular protein localization (GO:1903827),0.3156564076936896,1.1015693422914428,0.2733485193621868,0.6388063640109334,1.0,7/45,8.47%,MAP2;GPC6;GPC5;EGF;BDNF;TOR1A;TRIM46
prerank,regulation of gluconeogenesis (GO:0006111),-0.3700739531980227,-1.1014965066097868,0.3142857142857143,0.4971090774549002,1.0,8/27,29.58%,OGT;SELENOS;SIK1;USP7;GNMT;DDB1;ZNF692;EP300
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3019707338947069,-1.1013706061946005,0.285,0.49706949652098015,1.0,12/75,10.39%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;HHEX;SARS1;PF4;CTNNB1;KLK3;SPRY2;SPRED1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.42167784304267686,1.1009572181766776,0.3194103194103194,0.6391395063795415,1.0,3/14,10.76%,ANK2;KCNIP2;ATP1B1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.36083839358216374,-1.1008218788816695,0.32653061224489793,0.49790168701377785,1.0,9/32,19.51%,OSBPL8;SLC27A1;ABHD12;OSBPL5;PLAAT3;PLA2G4A;PLA2G5;PLA2G12A;LPCAT3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4097887178970379,-1.1002920556688849,0.33676975945017185,0.4987156683034777,1.0,9/19,21.18%,NFKB1;MAP2K5;WFS1;MAPK7;APP;MTPN;KLF2;GATA3;TMEM106A
prerank,positive regulation of angiogenesis (GO:0045766),-0.2806698162075307,-1.0997461464417806,0.2764900662251656,0.4995437738775131,1.0,22/108,14.12%,SASH1;RUNX1;PRKCB;ITGA5;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;MDK;JAK1;HIF1A;CTSH;ITGAX;XBP1;JMJD8;PKM;SERPINE1;PIK3CD;CD40;BTG1
prerank,mitochondrion organization (GO:0007005),-0.26541867643783784,-1.099721549593026,0.250814332247557,0.499299842788245,1.0,48/165,24.43%,PID1;VPS13C;TRAK1;DNM2;MEF2A;IMMP2L;MTM1;PYROXD2;ATP7A;NRF1;PITRM1;RAB32;HIGD2A;BCS1L;ATAD3A;SIRT3;FIS1;SSBP1;TIMM44;TMEM11;RAB29;TIMM22;CXADR;IFIT2;AFG1L;MPV17;TFAM;SLC25A4;USP30;BID;NIPSNAP2;MIGA2;FBXO7;BNIP3L;COX7A2;TOMM22;MTFR1L;TOMM34;HAX1;TOMM70;TWNK;MTX1;MTFP1;BIK;POLG2;CYCS;PTCD2;ATP5F1B
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.39970333805040426,-1.099095685435294,0.3166089965397924,0.5002614344666405,1.0,11/19,33.11%,PDCD6IP;CHMP5;TPR;CHMP1A;CHMP2A;HSPA1A;CHMP4B;CHMP2B;HSPA1B;VPS4B;DRG1
prerank,regulation of vasculogenesis (GO:2001212),-0.4381568599199872,-1.09892893507601,0.34050179211469533,0.5003068595786494,1.0,3/14,4.27%,XDH;RAP1A;RIN2
prerank,cellular response to glucose stimulus (GO:0071333),-0.36075374618274736,-1.0978362771734227,0.3229706390328152,0.5022557383396831,1.0,8/30,11.27%,ERN1;IGF1R;TRA2B;RAB11FIP5;GAS6;ZBTB20;XBP1;RAB11B
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.47907444270256583,-1.0977984967202876,0.3578767123287671,0.5020351318987277,1.0,4/11,19.21%,ABCG1;AGT;PLA2G7;PLA2G5
prerank,dicarboxylic acid transport (GO:0006835),0.35106959687081113,1.0977892119965293,0.33014354066985646,0.6460997269926361,1.0,7/28,14.95%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC26A8;FOLR2;FOLR1
prerank,histone H2B ubiquitination (GO:0033523),-0.48020681987681163,-1.0976986344547408,0.36713286713286714,0.5019549826757395,1.0,7/10,30.10%,CTR9;RNF20;RNF8;WAC;DTX3L;RNF40;UBE2E1
prerank,chromatin assembly (GO:0031497),-0.34348525365262017,-1.0974641798483196,0.33835845896147404,0.5021115565265587,1.0,11/38,18.73%,SMARCA5;ANP32B;HMGB2;ASF1A;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,muscle tissue development (GO:0060537),0.43113089283246675,1.0973957479057843,0.3477272727272727,0.6457841975244688,1.0,6/13,29.03%,CSRP1;PGM5;SMO;NF1;CSRP2;PTCH1
prerank,piRNA metabolic process (GO:0034587),0.3913339634373433,1.097303364413422,0.33638443935926776,0.6447918350921484,1.0,3/19,9.57%,TDRD12;TDRD9;PIWIL4
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45757407564199537,-1.096809863962415,0.3508771929824561,0.5032210633769363,1.0,1/12,0.16%,APOE
prerank,regulation of cell population proliferation (GO:0042127),-0.23099486133489638,-1.096527625026879,0.1609353507565337,0.5035209616442377,1.0,207/691,27.10%,LYN;RUNX1;IGF1;NAMPT;ABI1;GAB2;SDCBP;ARID2;BCL6;CDK6;JUN;NIBAN2;BIRC6;PTPRJ;RHOA;ACER3;NUPR1;BRD7;INSR;ARHGEF2;CSNK2A1;IGF1R;FES;CDK13;PIAS1;IL6R;SGK1;HTR2B;S100A11;RNF41;STAT3;IL15;FLT1;EAPP;STAT6;TCIRG1;DPP4;PTK2B;HHEX;ITGAV;RARG;BCL2;KIF20B;RPS6;JAG1;CBFA2T3;PF4;SMYD2;STX3;SLC35F6;FN1;CHTOP;GCNT2;CTNNB1;STAT5B;STAT4;IFI35;EZH2;GRK5;NF2;SKI;VEGFA;NME1;CNBP;PRMT1;EIF2AK2;RPS15A;TGFBR1;GSDME;PTPN6;TGFB1I1;CTSH;TBC1D8;ITGB1BP1;RPS4X;INCA1;APP;ITGAX;AGT;KIF14;IL7R;CDKN3;STRN;HP1BP3;XBP1;TIMELESS;XRCC6;OSGIN1;CCDC88A;RELA;MAP2K1;KLF10;KMT2D;CELF1;EEF1E1;CACUL1;HMGB2;CIB1;STK11;SHCBP1;UHRF1;FRK;KSR1;GLP2R;IGFBP3;GREM1;TGFBR2;BTG1;ID2;CAPNS1;DOT1L;TFAP4;IL34;CRKL;TTK;IL31RA;HCLS1;PPP1R9B;BST1;KLF11;RBBP4;STX4;CNOT6L;RPS9;VHL;TOB1;HSPA1A;RARA;HCK;ATF5;CDKN2C;GATA3;SERTAD1;IRS2;KRAS;LIMS1;PDGFRB;PDCD5;MDM4;MEIS3;COL18A1;BMPR2;CSF1;WDR77;IL7;CNOT8;CHP2;SIRT2;PRC1;ADAMTS1;BAP1;MAZ;PDS5B;TIPIN;COPS8;SFRP1;JUP;STAT1;PDGFA;GNRH1;KDR;NUP62;TBX2;IFITM1;INHA;S1PR2;IL6;EID2;TGFB1;BNIPL;SOX7;GPLD1;PIM2;TES;CYP1B1;LMNA;FLT3;FGF9;SHC1;CD47;PRKDC;NUDT6;RNF187;MYC;PKHD1;KITLG;CGRRF1;FGFR4;FTH1;STAT2;P3H1;PRTN3;TPTE;ZFP36L1;CDCA7L;BMP2;PML;VIP;ASH2L;CUL3;RTKN2;RAPGEF2;TBRG4;ENG;STAMBP;PDPN;TSPAN31
prerank,positive regulation of viral genome replication (GO:0045070),-0.3654926470854172,-1.0963835334341534,0.31327433628318585,0.5035222062863506,1.0,12/29,34.36%,TOP2A;CD28;IFIT1;CCL5;VAPB;DDX3X;SRPK1;DDB1;HACD3;PPID;ADARB1;RAD23A
prerank,endoderm formation (GO:0001706),-0.3421559200403914,-1.09626936891125,0.32538330494037476,0.5034592582160067,1.0,11/35,23.90%,ITGA4;ITGB2;ITGA5;ITGAV;FN1;ITGB5;MMP8;DUSP5;MMP2;SOX7;DUSP2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.28065197950876614,-1.0958326584497726,0.2784,0.5040935240743538,1.0,23/107,14.07%,ATP2B1;CCR2;SLC30A5;SLC10A7;HTR2B;CCR1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC8A1;ATP2A3;ATP13A1;TPT1;LCK;CCL5;SLC24A5;MT2A;CD40
prerank,negative regulation of receptor internalization (GO:0002091),-0.44846640994178344,-1.0951180557245008,0.3371212121212121,0.5053219180405184,1.0,2/12,1.07%,SDCBP;RIN3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3147094637525746,-1.094359631499314,0.3085808580858086,0.50655458623896,1.0,21/54,33.22%,OGT;ARRB2;RPL11;ARRB1;CTNNB1;DNAJA1;PRMT3;SPRY2;ISG15;SMAD7;HSPA1A;RPS3;UBXN1;HDAC8;RPL5;U2AF2;COPS9;SQSTM1;CAV1;HSPA1B;PRR7
prerank,regulation of osteoclast differentiation (GO:0045670),-0.351598934835319,-1.094358375200584,0.3333333333333333,0.5062658802873934,1.0,5/33,8.24%,LILRB3;GPR137B;CCR1;TLR4;PRXL2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3213921948970692,1.0941673698735317,0.30296127562642367,0.6514897755182941,1.0,10/43,12.46%,NELL1;SOX11;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;BMP7;FERMT2;ATRAID
prerank,response to nitric oxide (GO:0071731),0.4325015412617661,1.093919155997587,0.3427230046948357,0.6508765234865569,1.0,2/13,2.91%,KCNC2;GUCY1B1
prerank,cellular response to organic cyclic compound (GO:0071407),0.2585787309932738,1.0933746124326196,0.25806451612903225,0.6510958400572533,1.0,23/141,9.26%,RORA;GABRB3;AKAP6;GABRB1;RYR3;ADCY2;ADCY8;IGFBP5;P2RY12;ADCY5;SLC26A3;WT1;RAMP3;GNAI1;HCN2;INSIG1;GABRB2;ADCY3;GABRG2;ATP1A3;SLC1A1;ADCY1;HCN1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.47497636097464757,-1.092992548516042,0.3687821612349914,0.5087795374026461,1.0,5/11,26.31%,EGR1;ASAH1;NR1H4;FGFR4;BMP2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3487514366923712,1.0928070153576512,0.32598039215686275,0.6513575046277101,1.0,5/32,5.53%,NAV3;MAP2;TUBB4A;CLASP2;APC2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4346608406209329,-1.092804309253911,0.3464285714285714,0.5088758245746796,1.0,6/14,20.56%,DHX9;CNBP;PKM;DHX36;UNK;CPEB4
prerank,positive regulation of ossification (GO:0045778),0.33090069456608306,1.0926715157679117,0.3165829145728643,0.6504593329491754,1.0,10/39,9.36%,NELL1;SOX11;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TGFB2;TFAP2A
prerank,sensory perception of pain (GO:0019233),-0.3834932091457479,-1.0924679985181092,0.3366174055829228,0.5092639559443474,1.0,3/21,2.56%,CCR2;P2RX7;P2RX4
prerank,regulation of transmembrane transport (GO:0034762),-0.3536653108901304,-1.0924356167222962,0.3236363636363636,0.5090275987543814,1.0,6/31,5.13%,PRKCB;WWP2;SLC2A1;PIM1;ACTB;BCL2
prerank,regulation of trophoblast cell migration (GO:1901163),-0.426857453491741,-1.0919278287428111,0.3278985507246377,0.5097855718849271,1.0,5/14,20.71%,YTHDF3;AGO2;VEGFA;C1QBP;SMURF2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4075752605643736,-1.0917589148238085,0.35714285714285715,0.5098541104550132,1.0,6/17,15.36%,RB1;KNL1;CENPA;ZWILCH;CDK1;TTK
prerank,positive regulation of secretion by cell (GO:1903532),0.295556079742457,1.0917438130311263,0.2804878048780488,0.6515844226567007,1.0,23/70,20.88%,CADPS;FRMD4A;SOX11;SLC12A2;CADPS2;CLASP2;RAB27B;TGFB2;PLA2G10;EDN1;TTN;MYH10;ARF6;UNC13B;RAB27A;SNCA;IL1A;RAB3A;STX1B;GRK2;TREM2;DNM1L;CD33
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.447996288980772,-1.091445443489373,0.3321678321678322,0.5101855040602212,1.0,5/12,21.70%,SEC63;GET3;SGTA;CHMP4B;CHMP4A
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.35652075064851607,-1.0914306387129342,0.3202846975088968,0.5099179950242307,1.0,10/28,27.14%,ARHGAP18;SH3BP1;WDR1;RASA1;COTL1;BRK1;HCLS1;HAX1;PFN1;DBNL
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.40885399017546886,1.0913958343661974,0.3685393258426966,0.6512098413419694,1.0,4/15,11.36%,PAX8;GDNF;SOX9;SMO
prerank,regulation of mitotic spindle organization (GO:0060236),-0.34507029559354063,-1.0911459660976397,0.32062391681109187,0.5102093280420229,1.0,12/35,21.70%,PDCD6IP;CHMP5;DYNC1H1;RAE1;TPX2;TPR;CHMP1A;DCTN1;CHMP2A;HSPA1A;NUP62;CHMP4B
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4364222240912169,-1.090381953154874,0.3464163822525597,0.511504967969508,1.0,8/13,40.31%,RPS21;NOP14;NOL9;RPP40;RCL1;TBL3;BMS1;KRI1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.4286535112795127,-1.089987684932629,0.3608058608058608,0.5120262717585317,1.0,6/15,21.71%,RTEL1;TNKS2;ERCC4;SLX4;ATM;NBN
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2888420383413429,-1.0895036448034072,0.28452579034941766,0.5127172869572595,1.0,28/91,24.52%,PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;PSMC3;DBF4;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;PSMA1;TFAP4;UBE2C;ANAPC7;PSMB8;TRIM39;PSMD4;PSMA5;PSMB3;PSMD3;TCIM;GTSE1;CCNB1;DDB1;PSMB1
prerank,negative regulation of synaptic transmission (GO:0050805),0.36343359039998924,1.0893382367879674,0.330188679245283,0.6551517522161084,1.0,6/23,19.09%,SLC24A2;MTMR2;SYT11;GRIK3;SHANK2;SLC24A1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3768873019140557,-1.0885560322030006,0.3257042253521127,0.5143927637145461,1.0,8/24,19.77%,IGF1;INSR;DYRK2;SELENOS;PPP1R3E;IRS2;ENPP1;GSK3B
prerank,motile cilium assembly (GO:0044458),0.43147057244711307,1.0884614782690378,0.3616557734204793,0.6561823034813414,1.0,1/12,0.58%,DNAAF3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4469116695321277,-1.0884332490243476,0.3675496688741722,0.5143425816551522,1.0,4/13,13.96%,NRP1;CTNNB1;VEGFA;TGFBR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.44280413988058953,-1.0880728027448934,0.3592057761732852,0.5147728794741279,1.0,5/14,17.43%,TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A
prerank,regulation of angiogenesis (GO:0045765),-0.25756318803450456,-1.0879377486564306,0.2516025641025641,0.5147754167259729,1.0,33/192,14.12%,SASH1;RUNX1;PRKCB;SP100;CCR2;STAB1;ROCK1;NIBAN2;AGO2;PLXND1;PPARG;BRCA1;FLT1;ITGB1;HHEX;SARS1;PF4;GRN;CTNNB1;VEGFA;EGLN1;HIF1A;CTSH;KLK3;SPRY2;SPRED1;ITGAX;XBP1;HTATIP2;SERPINE1;PIK3CD;CD40;BTG1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.32400145203555114,1.087741584923121,0.31894484412470026,0.6568194302354321,1.0,10/39,11.52%,SLIT2;SEMA3E;PAX8;GDNF;TIE1;WT1;FGF10;CITED1;SALL1;PKD1
prerank,regulation of filopodium assembly (GO:0051489),0.3315416574309767,1.0877222897138479,0.3133971291866029,0.6556176178807557,1.0,4/38,1.82%,NLGN1;TENM2;TENM1;GPM6A
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.416938242537511,-1.0867005848257647,0.3647260273972603,0.5170377889016083,1.0,5/16,24.95%,NUDT2;IMPDH2;ADSS1;PFAS;ATIC
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3757448444234816,-1.0866908000359372,0.35172413793103446,0.5167608462530734,1.0,8/24,21.14%,NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,proteoglycan metabolic process (GO:0006029),-0.37141665427285653,-1.0866123613234113,0.36395759717314485,0.5166151368772414,1.0,7/26,10.96%,XYLT1;IGF1;HPSE;CHST12;SULF2;CHST11;B4GALT7
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2416218463052007,-1.0864100318128997,0.23502994011976047,0.5167390151679754,1.0,66/348,14.26%,PID1;RBPJ;MITF;IGF1;CD74;MSN;LILRB1;P2RX7;PLCG2;ROCK1;CD36;AGO2;NFE2L2;INSR;ANXA2;ARRB2;BRCA1;STAT3;TLR4;STAP1;PTPN22;TBC1D5;MAPK14;RPL11;PF4;PIK3CB;FN1;ARRB1;GAS6;VEGFA;LAPTM5;E2F1;MYD88;MAP2K5;WFS1;TGFBR1;CD28;HIF1A;MEF2C;SERPINB9;MAPK7;CD63;CTSH;EGR1;SCRIB;SPRY2;APP;MTPN;ITGAX;MOV10;MYOM1;OSR1;RESF1;MAP2K1;TICAM1;RAB29;CD46;CELF1;TNRC6C;PIK3CD;CALCOCO1;DHX36;SETDB1;GREM1;KLF2;ID2
prerank,protein monoubiquitination (GO:0006513),-0.34147112868752055,-1.0859207038686858,0.335016835016835,0.5174814334513882,1.0,14/36,26.61%,CTR9;RNF20;UBE2R2;KLHL22;MGRN1;UHRF1;WAC;UBE2T;HUWE1;DTX3L;TRIM25;TOPORS;RNF40;CUL3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4573354056149498,-1.085641425526529,0.3769363166953528,0.5177803369349766,1.0,8/12,41.27%,PPARG;ZC3H12A;TGFB1;NCOR1;ESR1;TNF;ZC3H10;ELAVL1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.28852677513378827,-1.0853468631357088,0.31,0.5181076912360484,1.0,13/86,13.29%,RBPJ;DAB2;ZEB2;SDCBP;CREBBP;RNF111;RBPMS;TGFBR1;TGFB1I1;FLCN;HSP90AB1;STK11;ACVR2A
prerank,TOR signaling (GO:0031929),-0.36508977248845353,-1.0852009973743453,0.32405891980360063,0.5181230532888943,1.0,7/26,11.52%,CARD11;RPS6;FNIP1;EIF4EBP1;EIF4EBP2;FLCN;CCDC88A
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.36479325975222787,-1.084801063666715,0.35018050541516244,0.5186308114680702,1.0,8/26,19.95%,B4GALT5;ST3GAL1;SLC35D2;PRELP;B3GNT2;B4GALT3;FMOD;B4GALT1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4220246264585751,-1.0830915258312652,0.36462093862815886,0.5218257946700487,1.0,3/15,14.63%,JUN;NUCKS1;TFAP4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3690694236019215,-1.082942760019267,0.35343383584589616,0.5218418156870523,1.0,6/26,9.52%,ALPK1;IRAK2;TAB2;NOD1;UBC;RPS27A
prerank,cellular response to alkaloid (GO:0071312),0.39674478328819673,1.0829196916125028,0.3438914027149321,0.6666572027808852,1.0,6/17,12.43%,RYR3;RYR2;CASQ2;RYR1;CASP6;HTR1B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3817356084628025,-1.0827639418029686,0.34035087719298246,0.5219306440773951,1.0,6/23,9.28%,MTM1;MTMR10;SYNJ1;MTMR3;PIP4P1;MTMR6
prerank,histone deacetylation (GO:0016575),-0.33414336725028687,-1.0825135146985352,0.33559322033898303,0.5221383455598839,1.0,10/43,14.09%,RCOR1;MIDEAS;MORF4L1;TBL1XR1;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.41232853985533247,1.08204769078866,0.3485576923076923,0.6675769887952968,1.0,8/16,20.07%,ST8SIA2;ST8SIA3;ST6GALNAC3;ST8SIA5;ST8SIA1;B3GALT4;B4GALT6;ST6GALNAC5
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.45400532528288756,-1.0819782809187815,0.3852739726027397,0.5229976983438509,1.0,3/12,8.76%,BRCA1;PIBF1;ERLIN1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.33970951599366583,-1.081797142850067,0.3309982486865149,0.5230808252021074,1.0,11/33,26.81%,RFC1;RTEL1;RAD51;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;DCLRE1B;MRE11
prerank,melanosome organization (GO:0032438),-0.3652542450348478,-1.0813336234024382,0.32013769363166955,0.5237095077425781,1.0,7/26,16.71%,LYST;AP1G1;RAB32;RAB29;DTNBP1;AP3B1;AP3D1
prerank,negative regulation of mRNA processing (GO:0050686),-0.4286075645430707,-1.0809478609540766,0.36115843270868825,0.5241985231064922,1.0,7/15,33.73%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7;BARD1
prerank,carbohydrate homeostasis (GO:0033500),-0.30357759675030627,-1.0807946702817965,0.3133561643835616,0.5242145303910916,1.0,19/67,25.52%,INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;STK11;APPL2;TENT4B;SLC8B1;CYB5R4;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.47829283268577816,-1.0805942476951018,0.3817204301075269,0.5243190978988651,1.0,2/10,0.40%,DSE;XYLT1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.47375098924188025,-1.080202787941483,0.3631578947368421,0.5248264547235875,1.0,3/10,20.26%,CCR2;CCL5;WNK1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2696471752344028,-1.0800219865415244,0.29401993355481726,0.5249187137859332,1.0,39/117,31.38%,AOAH;IGF1;MTHFS;CD36;PPARD;PANK2;KYNU;PPARG;CPT1A;MTHFD1L;ME2;LPL;AGXT;BCO2;PDZD11;NPC1;SLC6A8;DLD;AMACR;ACOT2;SLC16A1;ACOT4;PDHB;AASDHPPT;ECHDC3;VDAC1;PNPLA8;HLCS;HOGA1;ACOT11;ALDH8A1;SCP2;GPAT2;CYP2S1;PTGR1;SCPEP1;UGT1A7;UGT1A8;UGT1A1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.34913462397345313,-1.079879940722642,0.335042735042735,0.5249112999060112,1.0,15/32,22.34%,PRKCD;ROCK1;FOXO3;TMED10;PUM3;PICALM;PCIF1;APP;MTPN;NOLC1;EIF2A;RBM4B;SAMD8;RBM3;NR1H4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.359634299961402,1.079877123005292,0.35926773455377575,0.6720067022569632,1.0,8/23,20.99%,ELOVL7;FAR2;HACD1;ACSL3;ACSL6;ACOT7;ELOVL6;ELOVL2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2752973660575829,-1.0798500459489568,0.30781758957654726,0.5246714673146596,1.0,19/116,14.19%,LYN;FGR;CD163;PLCG2;SYK;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;RHBDF2;CYSLTR1;SELENOS;FCGR2B;GLP2R;CALCA;ADCYAP1R1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.26012764774801655,-1.0796127546669305,0.27450980392156865,0.5248533765317805,1.0,46/166,22.86%,RBPJ;NOTCH2;CREBBP;PPARD;SMARCA5;PPARG;MAML1;GTF2A1;E2F2;MAML2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;GTF2E2;RXRA;HDAC5;TFAM;POLR2A;TAF4B;TAF8;NR4A1;POLR2G;TAF9;RARA;TAF1A;TAF3;POLR1F;NCOA6;NR3C1;RSF1;TAF4;MAZ;POLR2I;MAML3;GTF2A2;NR1H4;GTF2F2;ESR2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.43353373670859474,-1.0795997412660252,0.3655913978494624,0.524583958225193,1.0,7/13,31.77%,ENTPD6;ENTPD3;ENPP1;NUDT15;DCTPP1;SMPDL3A;ENTPD7
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.38517022585440525,-1.0794767625869284,0.34554973821989526,0.524537846311353,1.0,3/22,3.24%,APOE;PPARD;PPARG
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.38544863977878463,-1.079378794585628,0.372972972972973,0.5244341579938832,1.0,6/22,13.63%,MAN1C1;AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,protein localization to organelle (GO:0033365),-0.2692119864473439,-1.0792140053911234,0.2887788778877888,0.5244728416857909,1.0,46/133,26.69%,SNX10;DCP1A;OPTN;IFT20;LAMP2;DHX9;COG7;HHEX;RPL11;LAMP5;GBP5;DNAJA1;SYS1;YWHAE;TRAM2;GBP2;APP;PAQR3;PACSIN2;LAMP1;TSPAN17;SERP1;STX5;ARL3;TOR1AIP1;EHD1;DDX1;UBAC2;ISG15;ARL1;DDX3X;RAB11A;SGTA;LMBRD1;TOPORS;ZBTB7A;HMOX1;MICALL1;IFT140;LMNA;RAB35;CYB5A;TRAM1L1;ARFRP1;OTOF;VAPA
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.40379868418007336,-1.0791887395590254,0.3469750889679715,0.524227825588125,1.0,10/18,45.83%,HHEX;THOC2;ENY2;NUP133;SARNP;ZC3H11A;PABPN1;PCID2;POLDIP3;DDX25
prerank,response to sterol (GO:0036314),0.4409315584481113,1.0791659099606952,0.3695150115473441,0.6725706555149836,1.0,3/11,12.52%,RORA;INSIG1;RORC
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3713783749867627,-1.0788627470922445,0.35714285714285715,0.52456948637238,1.0,4/25,4.64%,PRKCD;ARHGAP24;CAPZB;STAP1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2831915908255096,-1.0787879836706977,0.3198051948051948,0.5244244484791254,1.0,20/91,12.56%,PTPRC;NRP1;RAB8B;FGR;SYK;FES;ABL2;CD22;ITGAV;DNAJC13;PICALM;RINT1;HIP1;RAB5A;RAB21;PACSIN2;RAB3D;RAB11B;MAP2K1;RAB10
prerank,cellular response to organic substance (GO:0071310),0.2603602598260318,1.078546540764407,0.2945945945945946,0.6729712862037625,1.0,13/116,5.86%,IL1RAPL1;AKAP6;ROBO2;NCOA2;SLIT3;SLIT2;BMPR1B;IGFBP5;CSF1R;MME;ACVR1;ACVR1C;RAMP3
prerank,regulation of cartilage development (GO:0061035),0.40092684986623256,1.0781158044791206,0.3558897243107769,0.6727626124352607,1.0,7/18,11.23%,BMPR1B;SOX5;SOX6;SOX9;MBOAT2;BMP1;TAPT1
prerank,positive regulation of histone methylation (GO:0031062),-0.37673808601224484,-1.0779792376642388,0.35760517799352753,0.5258117776426147,1.0,7/24,8.44%,OGT;BRCA1;CTR9;CHTOP;CTNNB1;JARID2;WDR5
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3210192634905311,-1.0779113269681817,0.34429065743944637,0.5256793517319924,1.0,9/44,11.52%,NRP1;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1;CCDC88A
prerank,mitochondrion localization (GO:0051646),-0.39092523116865135,-1.0778405215069997,0.35139573070607555,0.5255297850317338,1.0,3/19,2.65%,TRAK1;MEF2A;MTM1
prerank,placenta development (GO:0001890),-0.44766443444879234,-1.076869586653606,0.3734290843806104,0.5273032995690639,1.0,4/12,18.32%,PPARG;E2F8;ADAM19;ANG
prerank,regulation of axon guidance (GO:1902667),-0.471081536024765,-1.0768512210099312,0.3741258741258741,0.5270479858843754,1.0,3/10,7.75%,NRP1;ZSWIM8;VEGFA
prerank,positive regulation of actin nucleation (GO:0051127),0.443188531037566,1.076777266815299,0.39473684210526316,0.6748181844879074,1.0,4/11,10.89%,WASF1;ABI2;NCKAP1;GSN
prerank,ATP transport (GO:0015867),-0.45946384276501584,-1.076745366262489,0.375,0.5269600409605771,1.0,5/10,25.12%,SLC25A24;SLC25A42;SLC25A4;CD47;SLC17A9
prerank,mesonephros development (GO:0001823),0.4433345368322156,1.076232917641401,0.36009174311926606,0.6750138875997301,1.0,3/11,8.69%,PAX8;FGF10;BMP7
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.27545502183188453,-1.0757567384925242,0.3106312292358804,0.5287090682407886,1.0,14/117,8.25%,LYN;FGR;CD163;PLCG2;SYK;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;RHBDF2;CYSLTR1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.39007350848116695,-1.0755990556118828,0.3664825046040516,0.5287389103268509,1.0,5/19,18.67%,DCP2;TEN1;TENT4B;HNRNPA1;EXOSC10
prerank,ear morphogenesis (GO:0042471),0.3741990626389703,1.074159268970294,0.36363636363636365,0.679045854667765,1.0,5/20,12.92%,PAX8;MYO6;TFAP2A;TBX1;TMIE
prerank,protein localization to cilium (GO:0061512),-0.35115229454669183,-1.074039086039207,0.3394648829431438,0.53164363076292,1.0,15/32,36.02%,SNX10;IFT20;RAB29;RABEP1;ARL3;EHD1;IFT140;IFT122;ODAD4;TULP2;MAPK15;INVS;CSNK1D;WDR19;ROPN1
prerank,neutral amino acid transport (GO:0015804),-0.36222291621674574,-1.0740233920478601,0.348993288590604,0.5313707574959091,1.0,8/28,19.13%,SLC38A6;SLC6A6;SLC43A2;SLC36A4;CTNS;SLC7A5;SLC6A9;SLC38A2
prerank,camera-type eye development (GO:0043010),0.3632362233572327,1.0736504134131815,0.33980582524271846,0.6790909690262518,1.0,6/25,11.95%,CACNA1C;TENM3;WT1;TSKU;CEP290;HES5
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4084684044602478,-1.0736131687767967,0.3739424703891709,0.5319044120942286,1.0,3/18,4.94%,AOAH;SAMHD1;DERA
prerank,cognition (GO:0050890),0.31656757332048363,1.0735412503351107,0.32390745501285345,0.6780885428503722,1.0,13/42,17.95%,GRM5;MGAT3;SHROOM4;HRH3;CUX2;TTC8;SOBP;SLC8A2;MFSD2A;LINS1;CHRNA7;TUSC3;FAM107A
prerank,glial cell development (GO:0021782),-0.3688352440009354,-1.0733605635059498,0.3594548551959114,0.5321477773410507,1.0,10/25,28.13%,CDK6;NRROS;EIF2B3;MDK;APP;SOX10;EIF2B1;MT3;EIF2B2;EIF2B4
prerank,sodium-independent organic anion transport (GO:0043252),0.440223820787535,1.0726628899855901,0.35648148148148145,0.6791175636357025,1.0,4/10,15.50%,SLCO4A1;SLCO2B1;SLC16A2;SLCO3A1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.26705601354539477,-1.071982348409579,0.3212520593080725,0.5347614444102078,1.0,48/144,25.08%,PRKCD;ITGB2;IPO5;FLNA;RUFY3;BCL2;ANP32B;KIF20B;RNF31;USP36;GAS6;E2F1;UBE2L3;YWHAE;ITGB1BP1;FIS1;UBL5;ZDHHC2;TPR;SAR1A;RAB29;CIB1;PLK3;SH3GLB1;BBC3;HCLS1;MAVS;BID;BAG3;CASP8;PCNT;HUWE1;CHP2;GSK3B;BAP1;ZC3H12A;JUP;KCNB1;SFN;TGFB1;GTSE1;HPS4;RBM22;NMT1;SAE1;ITGAM;TRIM28;ECT2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4190156225034015,-1.0719472771128569,0.3867595818815331,0.5345444880652531,1.0,3/15,9.47%,BCL2L11;ANXA1;UBE2L3
prerank,muscle contraction (GO:0006936),0.25659059123993777,1.071878514078757,0.2780487804878049,0.6798856648695729,1.0,21/126,13.10%,SORBS1;DMD;DTNA;GLRA1;GNAO1;CASQ2;TNNI1;ACTA1;KCNIP2;MYL12B;OXTR;TNNT2;RYR1;MYH7;TTN;CALD1;MYLK;DYSF;CALM1;ADRA1A;KCNJ12
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3725284691990457,1.07186991517146,0.3693467336683417,0.6786445788574978,1.0,6/21,15.69%,DMD;PDE4D;MLXIPL;INPP5J;NLRP2B;CNKSR3
prerank,homeostasis of number of cells (GO:0048872),0.4342014881942648,1.0717063777282703,0.3619489559164733,0.6778111310031475,1.0,3/12,8.40%,OCIAD1;CCN3;CX3CR1
prerank,gland development (GO:0048732),0.2972574899800507,1.0715683867148191,0.343980343980344,0.6769256278963623,1.0,16/59,16.96%,NRG1;PAX8;PRKCSH;WT1;FGF10;CDK5RAP3;SOX9;HOXD3;COBL;SALL1;TBX1;ARHGAP35;HES1;EPHB3;IGSF3;TGFBR3
prerank,autophagosome assembly (GO:0000045),-0.313464606514274,-1.0715061767155922,0.36195286195286197,0.5351624217809852,1.0,22/52,34.70%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B;SMURF1;TRAPPC8;ATG101;GABARAPL1;STX17;TP53INP2;UBQLN2;ATG9A
prerank,protein lipidation (GO:0006497),-0.3041738460722248,-1.0714826564319073,0.32896890343698854,0.534909782197651,1.0,19/59,26.75%,ATG5;ATG7;ATG10;DPM3;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;PIGH;PGAP3;ZDHHC1;ZDHHC5;MPPE1;HHAT;ZDHHC13;GPLD1;ZDHHC6;PIGZ;PGAP2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4692485059262112,-1.0710670514908336,0.38204225352112675,0.5354870240806783,1.0,2/10,3.30%,NFE2L2;RIPK1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.38965307186368786,1.070790679113106,0.3515981735159817,0.6777221235565448,1.0,4/17,12.06%,PCSK5;PCSK6;APOC1;ANGPTL3
prerank,negative regulation of histone modification (GO:0031057),-0.4312193867172659,-1.0707764535620579,0.39191564147627417,0.5358249625910074,1.0,6/14,28.38%,BRCA1;JARID2;PRMT6;SPHK2;SET;NOC2L
prerank,mRNA metabolic process (GO:0016071),-0.28389520919586386,-1.0705318223536087,0.3239669421487603,0.5360268109930533,1.0,38/90,35.66%,ERN1;SON;RNASE4;SNRPG;SNRPF;DCP2;DDX5;PRPF8;PCBP2;NUDT21;CELF1;NCBP1;SF3A1;PRPF18;LSM6;HSPA1A;CPSF3;LSM5;NONO;SRSF11;AKAP8L;NUDT16;TBRG4;HIPK3;U2AF2;SRSF7;ZC3H12D;METTL3;HNRNPR;NUDT12;HSPA1B;SRSF5;ALKBH5;SF3B4;KIN;AGO3;SNRPD3;SLFN14
prerank,protein tetramerization (GO:0051262),0.28859899962940355,1.0702483368985836,0.29974811083123426,0.6779388246086704,1.0,18/67,17.53%,RYR3;GRIN2B;CRYZ;CBY1;HOMER1;HCN1;RYR1;PKD1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;HSD17B8;SNCA;ALDH1A3;TRPM2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.37271371178127854,-1.0701113945712375,0.3681506849315068,0.5366483644206249,1.0,9/23,31.11%,PREB;SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;RANGRF;AUP1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.36402972407414236,1.0700907995792177,0.35218508997429304,0.6771115697593967,1.0,5/24,3.42%,DSCAM;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,neuron projection extension (GO:1990138),-0.3454980401826761,-1.0694427143415075,0.36192109777015435,0.537759442099794,1.0,9/32,12.58%,IQGAP1;NRP1;ALCAM;ULK2;USP9X;CTNNB1;NRP2;LLPH;HSP90AB1
prerank,rRNA 3'-end processing (GO:0031125),-0.4681529940830955,-1.0691596069698897,0.3881932021466905,0.5380659409679732,1.0,3/10,7.92%,ERI3;RPS21;ERI2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.3653382734632633,-1.069030320633659,0.3568965517241379,0.5380342534362398,1.0,4/25,6.29%,CBL;PPARG;SNX6;TSG101
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3311548535531581,1.0689078201888764,0.3566265060240964,0.6788375860947339,1.0,5/33,7.06%,PRKG1;IGFBP5;TAFA5;APOD;APLN
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.41081027957797384,1.0688084828057491,0.3744292237442922,0.6778614683741719,1.0,8/14,20.93%,ACOX2;EHHADH;ACOT8;ABCD1;DECR2;HSD17B4;CROT;ACOX3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.38525716895548784,-1.0685012135591596,0.3767361111111111,0.5388481130598713,1.0,5/20,12.95%,AGO2;CNOT1;MOV10;CELF1;TNRC6C
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3838446821636252,-1.0683678641411902,0.3819444444444444,0.5388501833494262,1.0,5/20,10.09%,PACS2;BCL2;WFS1;FIS1;TGM2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3363682858457984,1.068366674904359,0.3473193473193473,0.6777478703693807,1.0,5/32,11.42%,AKAP6;TRPC1;RAMP3;NPSR1;CAPN3
prerank,axonal transport (GO:0098930),-0.33708392645412544,-1.0682472976356074,0.37628865979381443,0.5387983133387669,1.0,14/36,20.61%,KIF3B;DYNC1H1;AP3S1;FBXW11;KIF4A;HIF1A;RAB21;AP3M1;DCTN1;DTNBP1;AP3B1;AP3D1;PAFAH1B1;AP3B2
prerank,cell junction organization (GO:0034330),0.2841518611239691,1.0682243894256125,0.32061068702290074,0.6768775263377512,1.0,13/71,9.22%,GRM5;CTNND2;PPFIA2;SLC8A3;TJP1;PAK3;SEMA3E;SDK1;PRKCI;SLC6A1;OCLN;SLC8A2;TGFB2
prerank,regulation of DNA replication (GO:0006275),-0.3152169339443557,-1.0682018592633857,0.35121107266435986,0.5385806823202438,1.0,11/49,17.36%,BCAR3;S100A11;DHX9;BLM;NUCKS1;CCDC88A;PCNA;ORC5;KAT7;FAF1;DNA2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.43329493905743405,-1.068188447001583,0.39522998296422485,0.5383066863632379,1.0,5/13,19.84%,DDX5;SPRED1;SPRED2;EEF1E1;ATM
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.40042648196349717,-1.0681172721377727,0.38841567291311757,0.5381563680815697,1.0,5/17,19.42%,PLBD1;PLAAT3;PLA2G4A;PLA2G5;PLA2G12A
prerank,negative regulation of cell cycle (GO:0045786),-0.2919890588831972,-1.068064355395843,0.32441471571906355,0.5379639789313712,1.0,17/73,16.16%,LILRB1;CDK6;RB1;RUNX3;NUPR1;IPO5;SIPA1;HHEX;TAF6;INCA1;SCRIB;CDK5RAP1;CHMP1A;BTG1;TFAP4;LATS2;NR4A1
prerank,peptide hormone secretion (GO:0030072),0.3550258796028113,1.0680614991081192,0.36363636363636365,0.6760585211757179,1.0,5/26,10.51%,RIMS2;MAFA;EDN1;GHRH;NEUROD1
prerank,blood circulation (GO:0008015),0.30782436028190624,1.0674952418234287,0.34057971014492755,0.6763593119926345,1.0,7/49,10.12%,SGCZ;SGCD;SERPING1;GUCY1B1;COL4A3;SGCG;AGTR1
prerank,second-messenger-mediated signaling (GO:0019932),-0.2874370957082053,-1.0674738442011613,0.34308943089430893,0.5388680039296689,1.0,13/82,10.76%,APOE;MCTP1;CCR2;PLCG2;CD36;P2RX4;HTR2B;CCR1;HRH1;CAMKK2;DGKD;AGT;INPP5A
prerank,negative regulation of cellular process (GO:0048523),-0.22975657176608882,-1.0666642018427552,0.23760932944606414,0.5402446525362146,1.0,150/521,25.94%,LYN;PLXNC1;VPS13C;SP100;ABI1;LILRB1;ARID2;BCL6;CDK6;MYH9;RB1;SNX3;NIBAN2;PTPRJ;RUNX3;TNFRSF1B;NUPR1;BRD7;APBB2;SIPA1;PLXNA1;PLXND1;LPXN;CD9;ATG5;HTR2B;S100A11;RNF41;PTK2B;RARG;BCL2;ANP32B;CRLF3;TGFBI;RIPOR2;NR1H2;TXNDC12;CBFA2T3;SMYD2;BLM;TNFRSF21;TAF6;UBR2;CTNNB1;IFI35;NF2;SKI;SIRPA;NME1;MDK;CBLL1;BST2;WFS1;EIF2AK2;GSDME;PTPN6;TGFB1I1;ITGB1BP1;INCA1;APP;CDKN3;STRN;FLCN;OSGIN1;CHMP1A;MAP2K1;KLF10;CELF1;EEF1E1;FCGR2B;TMBIM6;CCDC85B;CIB1;STK11;FRK;SPEF1;ADAM15;IGFBP3;ANXA6;BTG1;MIA3;CHMP2A;RASA1;TFAP4;SPN;PPP1R9B;APPL2;EI24;NR4A1;KLF11;RBBP4;SPHK2;VHL;TMEM109;TOB1;HSPA1A;ATF5;BNIP3L;CDKN2C;GATA3;PDCD5;MDM4;ENPP1;COL18A1;BMPR2;DDX3X;LPCAT3;TXNIP;NME6;SIRT2;ADAMTS1;BAP1;PDS5B;PPT1;COPS8;SFRP1;GNRH1;RACK1;NUP62;CHMP4B;IFITM1;INHA;CRYAB;IL6;TGFB1;BECN1;BNIPL;ESR2;SOX7;GPLD1;PIM2;TES;CYP1B1;LMNA;RND1;NUDT6;MYC;PKHD1;SMYD5;ACTN1;CGRRF1;FTH1;CCN4;P3H1;PRTN3;TPTE;MT3;CCN2;CASK;PDE8A
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3928540681534558,-1.065928080821354,0.39655172413793105,0.5415191217445332,1.0,5/20,10.14%,BRCA1;SLC27A1;ERLIN1;SIK1;PRMT3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3791871198178465,-1.0657784710548859,0.3830935251798561,0.5415183465608187,1.0,5/22,13.49%,MED24;PSMC3;MED4;PSMC4;DHX36
prerank,cellular glucan metabolic process (GO:0006073),-0.44746258498078695,-1.0656356446770585,0.3806228373702422,0.5415345563947473,1.0,5/11,21.68%,PRKAG2;PHKG2;GBE1;GSK3B;PYGL
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.43179023777370523,-1.065581776038549,0.3645833333333333,0.5413545197831005,1.0,7/14,28.23%,FLNA;CD63;ITGB1BP1;BST1;LIMS1;PHACTR4;CD177
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.27170334119459094,1.0655737528545068,0.3161764705882353,0.6800255023642756,1.0,21/95,12.82%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;CHSY3;PXYLP1;VCAN;HS3ST1;B4GALT4;DSEL;CHST5;SDC1;GLCE;CHST7;OMD;HAS2;CHST9;CHST14;SDC2;ST3GAL6
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.437245192112458,-1.0642313448193106,0.3854166666666667,0.5438572548711454,1.0,5/12,23.49%,LYN;BST2;IL34;CSF1;MAPK1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.46394178001339403,1.0638842552288292,0.4151898734177215,0.6831969268678295,1.0,3/10,5.48%,SEMA5A;CARMIL1;CARMIL2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.41493376275051064,1.0636258223018906,0.36185819070904646,0.6826580629214855,1.0,3/14,3.07%,SLIT2;PRKG1;IGFBP5
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.44107708446516847,-1.0634918275398417,0.39965095986038396,0.5450767079643578,1.0,5/12,17.51%,CENPE;KIF2C;MAD1L1;NUF2;NDC80
prerank,negative regulation of histone acetylation (GO:0035067),-0.45916331344863986,-1.0627028732105317,0.4088586030664395,0.5464473378857094,1.0,6/11,33.78%,SPI1;BRCA1;SIN3A;SET;NOC2L;CTBP1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.38073259845602725,-1.0623274190896674,0.37800687285223367,0.546918098659772,1.0,8/22,18.19%,PRKCD;ARFGEF1;CYRIB;MYADM;SSH3;TMSB4X;SSH1;TWF2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29066650082190937,1.062326912895945,0.342042755344418,0.6848268997202988,1.0,18/59,17.34%,OSBPL6;SLC27A2;OSBPL7;ACSM5;ACOX2;NDUFAB1;PER2;ACACA;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1;HSD17B8;MLYCD;ACSM3;ALDH1A3
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3684528357113454,-1.0622747592785597,0.3664259927797834,0.546719343642441,1.0,5/24,7.18%,MCL1;NUPR1;FOXO3;GRN;CTNNB1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3768814904322689,-1.061519220820531,0.3710247349823322,0.5476962141297238,1.0,8/23,23.42%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3768814904322689,-1.061519220820531,0.3710247349823322,0.5476962141297238,1.0,8/23,23.42%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.35722113791390314,-1.060955639154507,0.3963210702341137,0.5485674782089333,1.0,9/28,19.19%,IRAK2;TAB2;NOD1;UBC;RPS27A;OTULIN;RELA;CASP8;NOD2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.4499728026767623,-1.0608011533472288,0.4295415959252971,0.5485777010972399,1.0,5/11,25.42%,EXOSC5;TENT4B;EXOSC10;EXOSC4;LARP7
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4401966490098658,-1.0605631100565778,0.39019963702359345,0.5487553784612549,1.0,5/11,32.19%,DHX9;TPR;NUP153;AKAP8L;SETD2
prerank,autophagy of nucleus (GO:0044804),-0.41183488097908666,-1.0597806650244566,0.3783303730017762,0.5500815313262762,1.0,4/16,14.01%,ATG5;ATG7;ULK2;RB1CC1
prerank,positive regulation of hormone secretion (GO:0046887),0.4027420208856177,1.0593417245421675,0.3835616438356164,0.6913244426663482,1.0,5/17,16.10%,SOX11;EDN1;VAMP7;VAMP8;GRP
prerank,membrane repolarization (GO:0086009),0.40710482322268754,1.05927830477523,0.3860045146726862,0.6902824458920074,1.0,5/15,17.36%,KCND3;KCNIP2;ATP1B1;KCNE4;ATP1B2
prerank,regulation of spindle organization (GO:0090224),-0.3948118337168302,-1.0591526325014704,0.3761140819964349,0.5510790857003621,1.0,5/18,11.71%,DYNC1H1;RAE1;RNF4;TPX2;DCTN1
prerank,muscle organ development (GO:0007517),0.2977990010001666,1.0590854036420276,0.3598130841121495,0.6895947409153654,1.0,11/54,13.57%,SGCD;DMD;MKX;SOX6;TEAD4;SGCG;TBX1;SGCE;CAPN3;ITGA11;FKTN
prerank,cellular response to hydroxyurea (GO:0072711),-0.4623341865402137,-1.0588095242997462,0.3960573476702509,0.5514897062699435,1.0,5/10,15.19%,SPIDR;BLM;DDI2;TIMELESS;NSMCE3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4228973202684473,1.058469579626449,0.3768472906403941,0.6899944824759727,1.0,6/13,21.31%,SORBS1;PRKCZ;IRS1;IGF2;SIRT1;SORL1
prerank,cell proliferation in forebrain (GO:0021846),0.45447632587950965,1.0584351092040563,0.3824884792626728,0.6888573830460683,1.0,4/10,19.55%,HOOK3;NUMB;DOCK7;PCM1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4498024767901342,-1.0582177521937788,0.3955637707948244,0.5524442959254326,1.0,5/11,21.14%,HPSE;PRCP;VEGFA;NDNF;KDR
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.42550160874979154,-1.0581475921539896,0.38564273789649417,0.552308925484596,1.0,4/14,14.08%,RHOA;MAP2K5;ITGB1BP1;HDAC5
prerank,proteolysis (GO:0006508),-0.24409627539680814,-1.0579775238982698,0.30537974683544306,0.5523661950233035,1.0,53/252,19.51%,CTSB;FAM111A;ADAM33;CTSD;CTSZ;ANPEP;OGT;PLAU;MALT1;SRGN;DPP4;CTSA;LNPEP;HGF;DDI2;PITRM1;PCSK7;PRCP;ATG4C;RNF123;CASP4;CTSC;RNPEPL1;CNDP2;CTSH;KLK3;PSENEN;CAPN15;F7;FAP;CPQ;CTSS;CASP7;HTRA3;UBE3A;DPP7;CASP1;PSMC4;FBXW2;CTSE;LAP3;HM13;CLN3;TPP1;VHL;CASP8;ADAM19;XPNPEP3;MMP8;CASP2;MMP17;FBXL6;SUFU
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4361224510763,-1.0579507773612773,0.38160136286201024,0.5521146415813842,1.0,1/13,0.03%,PID1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.40486161900477535,-1.0575652667987228,0.3893653516295026,0.5526607261971949,1.0,5/18,11.94%,LILRB1;ITGAV;FN1;HIF1A;CD46
prerank,glucose homeostasis (GO:0042593),-0.2870553363006003,-1.0574242043177775,0.3615257048092869,0.5526169179047528,1.0,22/83,25.52%,LRRC8D;INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;HIF1A;NUCKS1;HK3;STK11;APPL2;SLC8B1;CYB5R4;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4241778151216775,-1.0572048787879211,0.3869346733668342,0.5527511258636093,1.0,6/15,17.59%,ANAPC1;CENPE;NEK6;TPR;UBE2C;ANAPC7
prerank,positive regulation of ERAD pathway (GO:1904294),-0.43426494362058454,-1.0569568590754848,0.39414802065404475,0.5529502950076429,1.0,9/13,33.50%,NFE2L2;ATXN3;RNF185;TMEM259;SGTA;BAG6;RNFT1;CAV1;UBQLN2
prerank,negative regulation of neuron projection development (GO:0010977),0.29371844334017755,1.0569490971363262,0.3309178743961353,0.6915753758798037,1.0,4/56,2.16%,NLGN1;SPOCK1;DCC;LINGO1
prerank,fluid transport (GO:0042044),0.42963609757757726,1.056788471491498,0.3681592039800995,0.6907609678524276,1.0,3/12,20.20%,SLC4A11;AQP11;AQP4
prerank,limb morphogenesis (GO:0035108),-0.3886226427173205,-1.0557351024805408,0.4136690647482014,0.5552295422600928,1.0,4/20,7.73%,MBNL1;NIPBL;LRP6;SKI
prerank,sodium ion import across plasma membrane (GO:0098719),0.3818233531006408,1.055076429063324,0.3815165876777251,0.6940569730662738,1.0,4/17,8.41%,SLC12A2;SLC9A2;HCN2;SLC6A1
prerank,peptidyl-methionine modification (GO:0018206),0.43675723479630785,1.054349676341782,0.38372093023255816,0.6947390359329209,1.0,5/12,19.66%,METAP2;NAA60;METAP1;PDF;NAA30
prerank,phospholipid dephosphorylation (GO:0046839),0.32191155273115724,1.0540024947648494,0.3903061224489796,0.6944895052509483,1.0,5/37,3.08%,PLPP4;MTMR2;PLPPR1;PLPPR4;SYNJ2
prerank,negative regulation of kinase activity (GO:0033673),-0.2989238932064847,-1.0535386271903198,0.34196891191709844,0.5594641098845033,1.0,10/62,10.39%,PTPRC;PAK2;RB1;PRKAG2;CEP85;LRP6;TRIB1;ITGB1BP1;TRIB2;SPRED1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.33754604348772266,-1.0532746932031556,0.38860103626943004,0.5597356904839681,1.0,4/33,4.84%,APOE;SP100;CORO1C;ADIPOR1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2985558413570564,-1.0525196510237695,0.37606837606837606,0.5610002161997013,1.0,22/58,31.90%,SGMS1;SPTLC2;ACER3;SPTSSA;GBGT1;PRKD3;KDSR;VAPB;SPHK2;SPTLC3;SAMD8;PLPP3;ELOVL5;DEGS2;CERS3;VAPA;HACD4;ST3GAL4;HACD3;ST8SIA6;ACER2;ALDH3B1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.3706910718028811,-1.051896522785537,0.3771626297577855,0.5620103377814917,1.0,7/23,24.28%,REXO4;DNASE1L1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4014670408108786,-1.0516821766419613,0.3821428571428571,0.5621342438348385,1.0,7/16,24.19%,KMT5B;KMT5C;PARP9;WRAP53;SHLD2;DTX3L;PRKDC
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.36641159435410486,1.0513388995901944,0.39260969976905313,0.7003423537211099,1.0,6/18,20.99%,ELOVL7;HACD1;ACSL3;ACSL6;ELOVL6;ELOVL2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3659665047844891,-1.0508497840378759,0.4163636363636364,0.5635906527066625,1.0,7/26,7.94%,ITSN1;SIGLEC1;CANX;ITSN2;FCHO2;PICALM;AP2A2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.40040695479517,-1.0506143879701586,0.4129263913824057,0.5637529952076504,1.0,6/16,21.70%,CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP4B;CHMP4A
prerank,mitotic nuclear membrane organization (GO:0101024),-0.31302121991518905,-1.0504940553799411,0.3832752613240418,0.5633795403896414,1.0,21/51,26.00%,CHMP7;NUP205;CDK1;NUP188;CHMP2A;LEMD2;ANKLE2;UBE2I;RCC1;NUP35;SIRT2;REEP3;NUP107;CHMP4B;CHMP4A;VPS4A;CCNB1;LMNA;CHMP2B;CCNB2;NUP37
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.31302121991518905,-1.0504940553799411,0.3832752613240418,0.5633795403896414,1.0,21/51,26.00%,CHMP7;NUP205;CDK1;NUP188;CHMP2A;LEMD2;ANKLE2;UBE2I;RCC1;NUP35;SIRT2;REEP3;NUP107;CHMP4B;CHMP4A;VPS4A;CCNB1;LMNA;CHMP2B;CCNB2;NUP37
prerank,transepithelial transport (GO:0070633),0.39014651933603095,1.050273146478188,0.408675799086758,0.7019151897318653,1.0,3/15,7.97%,SLC12A2;SLC1A2;SLC1A1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29935701352079275,1.0498154415982501,0.385,0.7019041960028227,1.0,9/54,7.09%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;PXYLP1;HS3ST1;SDC1;B3GAT2
prerank,negative regulation of secretion by cell (GO:1903531),-0.32829824056561796,-1.0495633606514605,0.3767123287671233,0.5651256864848074,1.0,9/38,10.38%,APOE;LILRB1;TNFRSF1B;ANXA1;RSAD2;RHBDF1;RHBDF2;SYT4;CHGA
prerank,negative regulation of locomotion (GO:0040013),0.41731107538579837,1.0493576561332638,0.3952941176470588,0.7018526602888259,1.0,2/12,1.72%,SPOCK3;FRMD5
prerank,negative regulation of developmental process (GO:0051093),0.2781674203955616,1.0488322742479352,0.33505154639175255,0.7019859808731033,1.0,16/69,15.71%,OMA1;DCC;GRIN3A;NFIB;RPS6KA6;ARHGEF15;SOX9;KANK1;POU4F2;TBX1;ALPK2;HYAL3;PTPRS;PRKN;KLF7;FUZ
prerank,thymus development (GO:0048538),0.416853463605101,1.048393981699843,0.3918918918918919,0.7019023699411764,1.0,5/13,19.24%,FGF10;TBX1;HES1;EPHB3;FADD
prerank,regulation of protein acetylation (GO:1901983),-0.431762445926011,-1.0477615800723294,0.42287694974003465,0.5686410852963592,1.0,4/12,19.77%,CEP295;TAOK1;DDX3X;GSK3B
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3633850342897712,-1.0476658617397274,0.3934142114384749,0.5685589843687251,1.0,8/25,23.38%,BCL2L11;PLAUR;MLLT11;BBC3;BID;TNFSF10;PDCD5;BIK
prerank,protein glycosylation (GO:0006486),-0.2597524545195131,-1.047627682084179,0.34049586776859503,0.5683310909931085,1.0,42/125,23.74%,B4GALT5;TRAK1;TET3;ST3GAL1;MGAT5;GALNT7;OGT;ST8SIA4;MAN1C1;GALNT10;ALG5;COG7;FUT10;DPM3;GCNT2;POFUT1;ALG12;MPI;GALNT1;MAGT1;POMK;B3GNT2;B4GALT7;SERP1;POMGNT1;TET2;LARGE1;NPC1;PMM2;MGAT2;POMT1;ALG6;STT3B;B4GALT1;MGAT4B;GFPT1;GCNT4;GALNT6;FUT4;PLOD3;DDOST;B3GNT9
prerank,hemidesmosome assembly (GO:0031581),0.43925705213615307,1.047441182637641,0.41959798994974873,0.7032081583006958,1.0,2/11,8.57%,DST;CD151
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4196276488628687,1.0471317547885068,0.40941176470588236,0.7028098094568519,1.0,3/12,5.78%,ANK2;RYR2;CASQ2
prerank,sprouting angiogenesis (GO:0002040),0.2946014234519766,1.0467373639699913,0.37967914438502676,0.7026624914917118,1.0,8/51,7.79%,ROBO1;SLIT2;CDH13;SEMA3E;SEMA5A;VEGFD;PGF;ADGRA2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2914957610689681,-1.0464396327805123,0.3790186125211506,0.5705594492310953,1.0,6/66,2.05%,APOE;MTSS1;XDH;CDK6;RUNX3;NUPR1
prerank,positive regulation of transferase activity (GO:0051347),0.24714233900932547,1.0462084873192252,0.3282828282828283,0.7028062269955032,1.0,34/142,16.40%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;MAGEC2;TIE1;EPHB1;MAP2K7;ALK;XRCC5;CD200;FBXW7;EPHA10;ROS1;CHTF8;LTK;TYRO3;RET;EPHB4;DCUN1D2;NAF1;BMI1;HSP90AA1;RPS2;IGF2;MAPKAPK5;CHRNA7;EPHB3;ERBB3;EPHA3;PNKP
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3713501530175478,-1.04578238591387,0.4024604569420035,0.571303974670806,1.0,8/22,29.60%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6;ZDHHC19
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3713501530175478,-1.04578238591387,0.4024604569420035,0.571303974670806,1.0,8/22,29.60%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6;ZDHHC19
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2801497579577329,-1.045502846621842,0.37886178861788616,0.5716094978508638,1.0,19/86,17.95%,APOE;PLEK;RB1;RAC1;SNX9;FES;PTK2B;BAIAP2;NCKAP1L;WDR1;CDC42EP2;APP;DCTN1;BAIAP2L2;SLAIN2;CDC42EP3;STMN2;HCK;RPS3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4373255246771496,-1.0450272405557628,0.42439862542955326,0.5719758786812769,1.0,6/11,40.67%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4373255246771496,-1.0450272405557628,0.42439862542955326,0.5719758786812769,1.0,6/11,40.67%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,regulation of ruffle assembly (GO:1900027),0.35541623067312894,1.0449414417651626,0.36982968369829683,0.7048276028773853,1.0,5/23,8.27%,NLGN1;FAM98A;P2RY12;CARMIL2;KANK1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.35878674376598496,-1.0448245912212546,0.39414802065404475,0.5721080065182775,1.0,9/26,17.43%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;EYA3;HSPA1A
prerank,neuron remodeling (GO:0016322),0.4303820944715072,1.0447398235409506,0.42010309278350516,0.7041796961934691,1.0,1/10,0.10%,ADGRB3
prerank,epidermis development (GO:0008544),-0.29903083208558967,-1.044573563866517,0.3893653516295026,0.5723361634552865,1.0,29/56,42.55%,EMP1;FABP5;FLOT2;DSP;CERS3;CCN2;ATP2C1;PLOD1;FOXN1;DCT;GRHL3;SPINK5;GRHL2;LAMC2;LAMB3;YBX1;GRHL1;OVOL2;EDAR;OVOL1;EDA2R;GLI1;SPRR1A;NTF4;SVEP1;LAMA3;FGF7;ATP2A2;UGCG
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34328425694069864,-1.044234880837259,0.3905429071803853,0.5727755379600444,1.0,5/32,10.92%,APOE;PRKAG2;ADIPOR1;C3;ZBTB20
prerank,positive regulation of glucose import (GO:0046326),-0.3839707257697529,-1.0440190067077364,0.40709459459459457,0.5729136471022923,1.0,4/21,6.37%,OSBPL8;IGF1;INSR;RHOQ
prerank,negative regulation of angiogenesis (GO:0016525),-0.2819397528077567,-1.0439982070259308,0.38474295190713104,0.5726549610434392,1.0,14/84,10.39%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;E2F2;HHEX;SARS1;PF4;PIK3CB;CTNNB1;KLK3;SPRY2;SPRED1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.346735880249575,-1.0439139428850257,0.4203935599284436,0.5725500966898148,1.0,5/29,8.35%,AGO2;TUT7;ZC3H7B;SRRT;PUM2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.36719782247444405,-1.0436806373357697,0.4010600706713781,0.5727244850849277,1.0,8/23,20.42%,USP50;OTUD5;USP8;MINDY2;ATXN3;OTUD4;MINDY1;BAP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3372007299309404,-1.043470106948812,0.37258347978910367,0.5728722415169427,1.0,16/33,26.25%,IGF1;PIK3R5;IGF1R;HTR2B;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;GATA3;C1QBP;SIRT2;NYAP1;PIK3C2G;TPTE;ZFP36L1
prerank,MAPK cascade (GO:0000165),-0.2355825151915961,-1.0432518969455318,0.3241590214067278,0.5730178569656847,1.0,97/295,24.78%,MAP3K8;MAP3K5;TAOK3;IGF1;GRB2;RASA3;MEF2A;CSF2RA;MAP3K20;PSME4;ABHD17C;MINK1;HTR2B;MAPKAPK2;RASGRP4;PSMB7;PSME3;IL18;NFKB1;ITGAV;RGL2;FBXW11;PTGER4;PSMB9;PIK3CB;HGF;CAMKK2;FRS2;JAK1;MEF2C;PSMA8;UBC;RPS27A;CTSH;YWHAE;TNIP2;SPRED1;PSMC3;RASAL3;PAQR3;IL2RG;TAOK1;DUSP6;CDK1;PIK3CA;CSF2RB;MAP2K1;PSMD8;CCL5;KSR1;PSMC4;PSMB10;PSMA1;RASA1;IKBKB;KARS1;BRAP;IL31RA;IL2RB;PSMB8;PDE6D;RASA4;IRS2;KRAS;NRAS;IL17RD;TAOK2;PDGFRB;DUSP5;LGALS9;PSMD4;PSMA5;PSMB3;RGL3;PSMD3;GOLGA7;PDGFA;KDR;LYPLA1;MAP4K4;PTPN7;TGFB1;PPP1CC;MAP3K3;SPTAN1;MAPK1;PPP1CB;IL2RA;RASA2;FLT3;FGF9;SHC1;MYC;RCE1;PSMB1;KITLG;FGFR4
prerank,arachidonic acid metabolic process (GO:0019369),-0.3288351784722589,-1.0431086532992127,0.3989547038327526,0.5730325560976016,1.0,10/35,29.52%,TBXAS1;DAGLB;CBR1;GPX4;PLA2G4A;CYP1B1;PNPLA8;ALOX15;CYP2S1;PTGES
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4531435688404913,-1.042501031566518,0.425,0.5740049715901901,1.0,4/10,19.80%,PTPN22;IFI35;WDFY1;TICAM2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3619171393892575,-1.0422702413492413,0.4107142857142857,0.5741728347959288,1.0,7/24,16.56%,DNMT3A;SPI1;JARID2;EZH2;EED;EPC1;RBBP4
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.46316261755729626,-1.042202491430135,0.4384057971014493,0.574014143663628,1.0,2/10,9.98%,TLR4;NCKAP1L
prerank,Wnt signaling pathway (GO:0016055),-0.272315027318256,-1.0421576924822278,0.37597503900156004,0.5738042213768125,1.0,30/92,28.40%,PLCG2;SNX3;RARG;AXIN1;LRP6;CTNNB1;WLS;UBC;RPS27A;STRN;VPS26A;TCF7;RYK;DDX3X;GSK3B;WNT3;SFRP1;CSNK1G3;ZRANB1;PLPP3;DVL2;CCDC88C;WNT7B;FZD1;FZD7;USP34;BCL9;WNT6;FRAT1;LEF1
prerank,body fluid secretion (GO:0007589),0.39868497878274073,1.0420997805541448,0.4172494172494173,0.7099783800610411,1.0,3/15,9.32%,ERBB4;APLN;OXTR
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3563732962981463,-1.0420511137889106,0.4003466204506066,0.573744692929303,1.0,5/24,3.56%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,regulation of transposition (GO:0010528),0.40990898795946473,1.0412714018698745,0.42437923250564336,0.7110045098739634,1.0,3/13,9.57%,TDRD9;AICDA;PIWIL4
prerank,mitochondrial transport (GO:0006839),-0.2976470279674155,-1.041270874494572,0.3931034482758621,0.5750886895193582,1.0,21/53,30.01%,SLC25A24;TMEM14C;BCL2;PITRM1;BCS1L;FLVCR1;FIS1;TIMM44;TIMM22;SLC25A4;MAIP1;FBXO7;TOMM22;TOMM34;SLC25A13;TOMM70;TMEM14A;BCL2L1;SLC25A31;BNIP3;TOMM40
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.41116390837083194,-1.040342649471631,0.4430604982206406,0.5766766572806746,1.0,5/15,20.84%,RNF213;ZNRF3;SPEF1;RSPO3;SFRP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.37126852933779086,-1.0400540995354073,0.4013961605584642,0.5769773581834026,1.0,6/22,15.96%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,aminoglycan metabolic process (GO:0006022),-0.4557185256991594,-1.0390890238835209,0.43109540636042404,0.5787473018390682,1.0,4/10,12.13%,XYLT1;B4GALT7;CLN6;XYLT2
prerank,fat cell differentiation (GO:0045444),-0.2975278530765127,-1.0387341241461492,0.4027072758037225,0.5792042268703844,1.0,6/57,9.42%,PID1;OSBPL8;METRNL;PPARG;TMEM120B;OSBPL11
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.39381889192898273,-1.0380605573147337,0.41408934707903783,0.5802948698860959,1.0,5/16,23.15%,PRPF39;SART1;CWC15;WBP11;RBM22
prerank,autophagosome maturation (GO:0097352),-0.33875060225608083,-1.038013784793762,0.40241796200345425,0.5800838059018933,1.0,9/32,17.46%,TECPR1;LAMP2;UVRAG;TSG101;EPG5;LIX1;GABARAP;CLN3;VPS33A
prerank,histone H4 acetylation (GO:0043967),-0.30979620960146065,-1.0379307187676068,0.42434782608695654,0.5799496987671486,1.0,11/47,18.49%,OGT;PHF20;KANSL2;MORF4L1;ZZZ3;WDR5;JADE2;KAT7;EPC1;KMT2A;TRIM16
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.34449180446632793,-1.0379199469613445,0.4028520499108734,0.5796649745315481,1.0,9/28,20.54%,ACTR2;ERCC6;KMT5B;KMT5C;PARP9;TFIP11;WRAP53;SHLD2;DTX3L
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.41153930125881966,-1.0373985144897429,0.42473118279569894,0.5804418628428791,1.0,4/15,22.48%,LILRB1;IRAK3;SMAD7;TGFB1
prerank,membrane repolarization during action potential (GO:0086011),0.41299915866757286,1.0371635388246783,0.3986784140969163,0.7208715933783674,1.0,4/13,16.78%,KCND3;KCNIP2;ATP1B1;KCNE4
prerank,autonomic nervous system development (GO:0048483),0.38012847641997943,1.0371326234600633,0.40963855421686746,0.719715394662915,1.0,3/17,4.74%,PHOX2A;SOX11;GDNF
prerank,macrophage chemotaxis (GO:0048246),-0.45411504014500587,-1.0366522361220751,0.40955631399317405,0.5817784163927548,1.0,7/10,44.44%,CKLF;CCL5;EDNRB;EDN2;TAFA4;CXCL17;CCL3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4034084670677015,1.0359564358147404,0.4164705882352941,0.721683205622922,1.0,2/13,11.97%,SOX11;PER2
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2729863910756148,-1.0356720443923944,0.38917089678510997,0.5835297669994426,1.0,23/85,24.89%,MTSS1;IGF1;CDK6;RUNX3;NUPR1;C5AR1;GRN;VEGFA;NME1;B2M;OSR1;NLRC3;UHRF1;NR4A1;LIMS1;NOD2;SFRP1;TGFB1;FGF9;PRKDC;MYC;PKHD1;DEAF1
prerank,regulation of peptidase activity (GO:0052547),-0.3787591782750078,-1.0349098768812361,0.40540540540540543,0.5848240127497124,1.0,11/19,41.75%,RCN3;CTSH;CST7;CST3;PSMB8;FURIN;ATP13A2;CAV1;ECM1;PSMA3;PINK1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4420696645421501,-1.0348050979800265,0.4200351493848858,0.584715271400208,1.0,3/11,20.26%,CCR2;CCL5;WNK1
prerank,anion transmembrane transport (GO:0098656),-0.2897802158431316,-1.0346156794190229,0.4051863857374392,0.5848150768389753,1.0,19/67,22.12%,LRRC8D;SLC16A7;MFSD12;SLC27A1;LRRC8C;SLC36A4;SFXN2;SLC25A42;ABCC1;SLC7A5;SFXN1;SLC25A4;SLC23A1;SLC23A2;SLC6A9;SLC6A8;SLC25A10;SLC25A22;SLC25A13
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.386987200216572,-1.0345182236209478,0.3975481611208406,0.5847188634826843,1.0,6/17,27.42%,BCL2;FIS1;BBC3;BID;SFN;BCL2L1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3983279966531976,1.0342518366910156,0.413953488372093,0.7249429853218465,1.0,5/14,17.01%,NME2;ENPP3;AK4;AK5;AK3
prerank,protein deneddylation (GO:0000338),-0.44432778712827914,-1.0341964954432104,0.43137254901960786,0.5851096637038945,1.0,5/10,21.21%,GPS1;COPS6;COPS5;COPS8;COPS4
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4319760913285577,-1.0341307234638684,0.4257246376811594,0.5849475087998024,1.0,7/12,23.52%,MDK;LCK;MIA3;ASS1;WNK1;FUT4;ADTRP
prerank,striated muscle cell differentiation (GO:0051146),0.3794812934728914,1.033959192215298,0.38095238095238093,0.7244601692039627,1.0,5/16,10.31%,NRG1;CBY1;SDC1;MYOCD;POPDC2
prerank,negative regulation of cellular component movement (GO:0051271),-0.40252346301019093,-1.0337710196230767,0.44851657940663175,0.5853892820123464,1.0,9/15,25.16%,SP100;CD9;PIN1;CCDC125;CRK;GATA3;PKHD1;ACTN1;SPINT2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3824785456817706,-1.0337536036241532,0.40765391014975044,0.5851137620701571,1.0,4/18,11.54%,ABCG1;GSAP;PICALM;RELA
prerank,cellular response to hormone stimulus (GO:0032870),0.27748058872407355,1.0336724244546236,0.3837837837837838,0.7239755270149073,1.0,9/69,7.78%,ROBO2;NCOA2;SLIT3;SLIT2;THRB;PAX8;WT1;RAMP3;ATP1A3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.33378170851339584,-1.0332442441897078,0.405,0.5858936629615044,1.0,7/33,12.71%,RUNX1;PRMT2;AXIN1;CBFB;DDX5;KLK3;TRIM68
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3010634859453622,-1.0332364462738586,0.3806228373702422,0.5856025444346663,1.0,16/50,18.56%,IGF1;GAB2;RHOA;OGT;IGF1R;PLCL2;PIK3CB;PIK3CG;PI4KB;PIK3CA;PLCB3;PIK3CD;PLCD1;PIK3C2A;IRS2;PDGFRB
prerank,mRNA 3'-end processing (GO:0031124),-0.2806560265944153,-1.032895353611455,0.38704318936877075,0.5860417355246236,1.0,26/78,27.41%,SRRM1;CHTOP;CDC40;SSU72;APP;MTPAP;ALYREF;NUDT21;RPRD2;WDR33;NCBP1;THOC2;TENT4B;RNPS1;THOC6;MAGOH;PAPOLA;SLU7;GRSF1;CPSF3;SRSF11;DDX39B;CPSF1;DHX38;U2AF2;SRSF7
prerank,protein insertion into membrane (GO:0051205),0.3193370312407237,1.032501359204585,0.3833718244803695,0.7258147959204844,1.0,8/32,9.63%,GET4;PRNP;RTP4;COX18;REEP1;UBE2J2;CCDC47;RTP2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.41390991226206586,-1.0322983658982603,0.4288135593220339,0.5869954853287523,1.0,7/13,28.50%,STX3;SNX33;HSP90AB1;STX4;GPD1L;TMEM35A;RANGRF
prerank,phosphate ion transmembrane transport (GO:0035435),-0.42620926808225257,-1.0322015494346852,0.42662116040955633,0.5868738799336387,1.0,6/12,30.60%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC20A1;SLC37A2
prerank,folic acid metabolic process (GO:0046655),-0.38850229889673804,-1.0320207374595092,0.41323792486583183,0.5869323407257186,1.0,8/18,33.05%,MTHFS;MTHFD1L;MTHFD2L;SHMT1;MTHFR;FPGS;SLC19A1;MTHFD1
prerank,lamellipodium organization (GO:0097581),0.3284291506245824,1.0318622045568868,0.4186046511627907,0.7261982722507273,1.0,6/29,4.93%,ARHGEF7;CDH13;WASF1;P2RY12;CARMIL1;ABLIM1
prerank,tRNA metabolic process (GO:0006399),-0.39240044753296494,-1.031835647102256,0.41737649063032367,0.5870193069086189,1.0,6/17,20.55%,FARS2;ADAT1;SARS1;KARS1;AARS1;DARS2
prerank,relaxation of cardiac muscle (GO:0055119),-0.4201896061258642,-1.031601021610954,0.4175824175824176,0.58719183742654,1.0,4/13,11.55%,P2RX4;SLC8A1;CHGA;PIK3CA
prerank,primary alcohol metabolic process (GO:0034308),-0.35374772563379825,-1.031259141150446,0.4084507042253521,0.5876184245301262,1.0,2/25,0.80%,IGF1;DHRS3
prerank,negative regulation of signal transduction (GO:0009968),-0.23833834596016565,-1.030996263337453,0.3704918032786885,0.5878546319474239,1.0,58/249,22.59%,PID1;LYN;PTPRC;PRKCB;LRP1;XDH;PLEK;PRKCD;RB1;NIBAN2;PTPRJ;CSNK2A1;PIP4K2A;WWP2;CNOT1;HERC4;PTPN12;HHEX;PTPRE;BCL2;PIK3CB;MDFI;ARRB1;IRAK3;MGRN1;EZH2;SULF2;TRIB1;ASXL1;SPRY2;AGT;TMBIM6;CCL5;NFKBIL1;IGFBP3;ARRDC1;RNF43;OTUD4;RGS14;BRAP;GPR108;TMEM25;GATA3;NFATC1;ENPP1;SUFU;APPL1;UBASH3B;MAZ;CYP26C1;SFRP1;RACK1;MEGF8;PTPN1;SNAI2;TCIM;SOCS5;PHACTR4
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3133899479061262,-1.0307653015599392,0.39700996677740863,0.5880400556034906,1.0,14/41,24.08%,CD44;PIEZO1;GCNT2;MDK;PLAUR;JAK1;LCK;CCL5;ADAM19;SMAD7;AGER;CD3E;PLPP3;CD47
prerank,regulation of cellular senescence (GO:2000772),-0.343733277602827,-1.0305396847072144,0.4131147540983607,0.5882052102280431,1.0,6/28,15.87%,CDK6;CGAS;B2M;NEK6;EEF1E1;ARG2
prerank,cilium movement (GO:0003341),0.2968636852304988,1.030034023861137,0.38386308068459657,0.7297666794580914,1.0,19/47,26.31%,DNAI4;ODAD3;DNAH17;CFAP91;DNAAF4;CFAP73;GAS8;ZBBX;DNAH5;DNHD1;CFAP53;RSPH4A;DNAAF5;CAMSAP3;DNAH1;SPEF2;CFAP206;CABYR;DNAH9
prerank,negative regulation of insulin secretion (GO:0046676),0.38412985774032354,1.0296234965674798,0.41421568627450983,0.7296463760313724,1.0,6/17,15.19%,CCN3;REST;PRKN;INHBB;IRS1;KLF7
prerank,organic substance transport (GO:0071702),-0.25684694439877764,-1.0295504647516733,0.39195979899497485,0.589996611919303,1.0,36/121,25.27%,ABCA1;ABCG1;PLTP;MYH9;RAB7A;MFSD12;ABCD2;TOM1;CENPF;RCN3;FLVCR1;TAP2;CHMP1A;HSP90B1;ARRDC4;ABCA9;ARRDC1;MIA3;CHMP2A;ABCA13;LMAN2L;SLC50A1;SLC23A1;ABCD3;SNX4;RILP;TXNIP;ABCA4;PPT1;SLC22A18;ATP8A1;ARRDC2;LRP2;CHMP2B;ABCA2;SLC22A3
prerank,positive regulation of transporter activity (GO:0032411),-0.4274174414133935,-1.0294526942840072,0.4225352112676056,0.5899089346450029,1.0,3/13,17.25%,SGK1;RXRA;KMT2A
prerank,response to UV-A (GO:0070141),0.3916161412310852,1.0290784141776714,0.4326241134751773,0.729828024154271,1.0,3/14,9.78%,MME;OPN3;OPN5
prerank,negative regulation of catalytic activity (GO:0043086),-0.3543836724909057,-1.029043671153608,0.41767764298093585,0.5904982587648708,1.0,9/24,25.54%,NES;PARP9;IFIT1;PPP1R12A;CLN3;APBA3;PLN;HP;MT3
prerank,snRNA metabolic process (GO:0016073),-0.3895857884348853,-1.0285962318827857,0.4432624113475177,0.591132196665304,1.0,6/17,23.50%,INTS8;INTS11;INTS6;INTS1;INTS5;MTREX
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4521484275588489,-1.0284881668205634,0.42702702702702705,0.5910614991437536,1.0,5/10,26.82%,RAP1A;RIN2;ASB4;KDR;RAPGEF2
prerank,regulation of epithelial cell migration (GO:0010632),0.29150578372804,1.0284436684640679,0.385,0.7303089369022393,1.0,12/51,12.27%,PTPRG;PTPRR;PRKCE;ENPP2;PTN;CLASP2;FGF10;GLUL;SOX9;TGFB2;EMP2;DUSP10
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3542054185498954,-1.02820355847924,0.43350604490500866,0.5913691417773871,1.0,9/25,23.05%,IGF1;RB1;NIBAN2;SIN3A;DOT1L;NSD1;GATA3;TGFB1;ZBTB7A
prerank,glycerophospholipid catabolic process (GO:0046475),0.3388668330087911,1.0280167177357042,0.39348370927318294,0.7302124136025342,1.0,6/27,10.79%,ENPP2;ABHD16A;GDPD1;PLA2G4E;PLA2G10;ENPP6
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3766428687577293,-1.0276078122422552,0.45132743362831856,0.5923564673380941,1.0,3/18,10.60%,SLC43A2;CAB39;NEDD4L
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.40072005599858473,-1.0274523377374385,0.4242957746478873,0.5923806739339815,1.0,8/15,26.23%,ATF3;DHX36;MKNK2;HNRNPA1;DDX3X;ZC3H12A;GSTO1;VCP
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.43083898017086186,-1.0273002047767354,0.4380305602716469,0.5923764975804816,1.0,7/12,41.20%,CCR2;CLEC6A;IL12RB1;ZBTB1;SLC11A1;IL12B;IL1B
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4119725927622565,1.0269999491405948,0.3912037037037037,0.7317170426416687,1.0,4/12,11.36%,PAX8;GDNF;SOX9;SMO
prerank,DNA replication checkpoint signaling (GO:0000076),-0.39103094270267835,-1.0268895377508678,0.4423076923076923,0.5929237207623511,1.0,7/16,22.46%,TIMELESS;TICRR;TOPBP1;DNA2;RAD9A;TIPIN;CDC45
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.39896291876098927,-1.026787875759804,0.4461805555555556,0.592843938121182,1.0,5/16,10.64%,TNFRSF1B;CD22;PTPN22;AHR;IKZF3
prerank,positive regulation of myelination (GO:0031643),0.41972333605343803,1.026349857497621,0.3927710843373494,0.7322552005894648,1.0,2/11,1.83%,TENM4;PARD3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4107250125445188,1.0253604620449641,0.4392059553349876,0.7337501689389284,1.0,7/13,23.55%,SAR1B;BCAP31;TMEM30A;TM9SF4;CD81;SORL1;SEC16A
prerank,ncRNA 3'-end processing (GO:0043628),-0.4160023938909,-1.024757013276193,0.4265486725663717,0.5969455682477367,1.0,5/14,21.60%,INTS8;INTS6;INTS14;INTS5;ELAC2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3781438471072765,-1.024381814842616,0.4332191780821918,0.5974046499493246,1.0,5/18,13.63%,AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,regulation of phospholipase C activity (GO:1900274),0.3851623004864162,1.0240657450689692,0.42890995260663506,0.7360626779719777,1.0,2/15,1.52%,BICD1;NTRK3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.43743200572035174,1.0239728148058374,0.39675174013921116,0.7350826467881174,1.0,3/10,12.46%,NELL1;CDK5RAP3;ATRAID
prerank,collagen fibril organization (GO:0030199),0.26089578720837026,1.0238164202722217,0.39949748743718594,0.7342569226551762,1.0,15/88,11.64%,P3H2;COL27A1;TLL1;DST;COL11A1;COLGALT2;COL25A1;COL4A3;PLOD2;COL23A1;COL19A1;CD151;TGFB2;BMP1;COL7A1
prerank,chromatin organization (GO:0006325),-0.25697921890406633,-1.0235341894309333,0.4019138755980861,0.598875030213477,1.0,28/132,18.73%,RB1;BPTF;SMARCA5;SPI1;SMARCD3;SMARCC2;JARID2;PWWP3A;EZH2;ARID1A;HIRIP3;NUCKS1;HDAC10;BAZ2B;HP1BP3;BAZ1A;HMGB2;SETDB1;PADI4;DR1;HDAC5;INO80;HMGN1;RBBP4;LRWD1;INO80C;MYB;RSF1
prerank,protein maturation (GO:0051604),0.2623677210294319,1.0235188697934445,0.37965260545905705,0.7338046435921061,1.0,22/95,17.21%,METAP2;PCSK5;MMP16;PCSK2;TESC;MME;ECE2;PCSK6;CIAO1;NAA10;MMEL1;PCSK1;CPE;EEF1AKMT4-ECE2;NDUFAB1;NAA60;LIPT2;ECE1;TASP1;ADAM17;NFU1;PHEX
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3649275918163366,-1.0231924989526098,0.44148936170212766,0.5992587406974895,1.0,10/23,21.84%,NABP1;PLK2;ZWILCH;BUB1;PLK3;BUB1B;WEE1;CHEK1;ZFYVE19;VPS4A
prerank,regulation of neuron death (GO:1901214),0.26669983944241554,1.0228844895410594,0.4314214463840399,0.7342343232578215,1.0,25/82,19.60%,GRID2;TRIM2;GRIN2B;DCC;CD200R1;TSC1;EPHB1;DHCR24;PRNP;FYN;CD200;REST;PRKN;PPARGC1A;CHRNA7;SNCA;LANCL1;UBB;IKBKG;GRM4;FOS;EFNB2;NSMF;NAE1;WNT5A
prerank,aggrephagy (GO:0035973),-0.3360041505237009,-1.0228605823244836,0.43463497453310695,0.5996497562811851,1.0,6/27,9.52%,VIM;ATG5;DYNC1H1;WDFY3;UBC;RPS27A
prerank,triglyceride homeostasis (GO:0070328),-0.35044044373410754,-1.022754733017517,0.44648829431438125,0.5995699237305977,1.0,5/26,10.97%,APOE;IL18;LPL;APOC4;XBP1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.30693887056097463,-1.022555583370223,0.423841059602649,0.5996691435669667,1.0,9/45,11.55%,IQGAP1;GRB2;CBL;PTK2B;KIF16B;DGKD;ERBIN;REPS2;PIK3CA
prerank,peptidyl-amino acid modification (GO:0018193),0.44800129430871344,1.0224520830181305,0.45011600928074247,0.7340694287801578,1.0,3/10,15.48%,METAP2;METAP1;PDF
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3269538881136738,1.0223184571369723,0.4092009685230024,0.733209165630356,1.0,7/29,10.53%,GRIK2;SHISA6;SLC4A10;SHISA9;NETO1;SLC8A2;CAMK2A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2854736555243387,1.0222511450935625,0.3916256157635468,0.732163718276548,1.0,12/52,16.33%,DPP10;SORBS1;PRKCE;RAMP3;GNAI1;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3342266853133939,-1.0218078857789632,0.42857142857142855,0.6009819232220405,1.0,9/29,21.23%,DCP1A;PATL1;EXOSC5;DCP2;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,dephosphorylation (GO:0016311),0.23913432108599172,1.021362020542874,0.3643835616438356,0.7332531502372838,1.0,33/147,17.22%,PTPRD;PTPRG;PTPRN2;PLPP4;PTPRR;PTPRT;PPM1E;MTMR2;PLPPR1;PLPPR4;PXYLP1;PTPRK;PTPN3;ACP6;PTPRB;PPP2R1B;PPP2R2A;PTPRZ1;THTPA;CTDNEP1;MTMR7;DUSP4;DUSP10;DUSP18;PTPRS;PTPN4;PHPT1;PLPPR2;PNKP;DUSP8;THNSL2;PPM1G;CTDSP1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3666779798122119,1.0212844141546913,0.4176904176904177,0.7322559892292233,1.0,10/19,28.40%,ASPA;GOT1;AASS;SDSL;ALDH7A1;SLC25A21;SDS;HYKK;DDO;GOT2
prerank,glucose metabolic process (GO:0006006),0.2814729185339241,1.0208055798395235,0.4362745098039216,0.732314220362145,1.0,13/58,14.43%,OMA1;PFKFB1;GOT1;APOD;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;HECTD4;PPARGC1A
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.36836447592298444,-1.0203491949606915,0.4365217391304348,0.6039030206328881,1.0,5/22,10.47%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.3298113001816221,-1.0201102927854424,0.4304857621440536,0.604113832586732,1.0,12/30,28.60%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;PDCD5;BAP1;HPS4;SAE1;VPS11;MICALL2
prerank,cellular response to hexose stimulus (GO:0071331),-0.35858829112175555,-1.0201066677027717,0.4332784184514003,0.6038084792176897,1.0,6/23,10.97%,ERN1;IGF1R;TRA2B;GAS6;ZBTB20;XBP1
prerank,regulation of lipid kinase activity (GO:0043550),-0.43258274493601,-1.0200683878893018,0.46194690265486726,0.6035763804666205,1.0,4/11,25.55%,RB1;WDR91;RBL2;PPP2R5A
prerank,glycoprotein biosynthetic process (GO:0009101),-0.273711666871537,-1.019997380834408,0.40619621342512907,0.6034225378394776,1.0,18/79,14.81%,B4GALT5;XYLT1;IGF1;ST8SIA4;ALG5;COG7;ATP7A;FUT10;CHST12;GCNT2;CHST11;MPI;B3GNT2;B4GALT7;SERP1;GCNT1;LARGE1;NPC1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3285872445623664,-1.019885914873787,0.4191304347826087,0.6033487467802183,1.0,8/33,18.06%,CDK6;RB1;BRD7;PRMT2;PLK3;WEE1;CDKN2C;CDK2AP2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3569571196466763,-1.0194969565634522,0.4261168384879725,0.6038588973805866,1.0,8/23,13.84%,IGF1;NIBAN2;PIEZO1;MAML1;MAPK14;MEF2C;SMYD1;GREM1
prerank,positive regulation of phosphorylation (GO:0042327),-0.23532674915620821,-1.019301967464341,0.3919523099850969,0.6039535126761318,1.0,42/240,15.05%,LYN;DAB2;NRP1;IGF1;CD74;SDCBP;P2RX7;NIBAN1;AXL;RAC1;INSR;IGF1R;RAP2A;RIPK1;FLT1;CCND3;PFKFB3;AXIN1;HGF;C3;ARRB1;CAMKK2;GAS6;VEGFA;PLAUR;FNIP1;HIF1A;NCKAP1L;ARNT;APP;PIN1;PFKFB4;ZBTB20;FLCN;WDFY2;CCL5;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL
prerank,C4-dicarboxylate transport (GO:0015740),0.38473901876349176,1.0188558667375947,0.43080357142857145,0.7362638161220374,1.0,5/14,11.39%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.31496327642285193,-1.0186535683223983,0.42549668874172186,0.6050620332473566,1.0,7/38,12.66%,BANK1;XDH;PTPRJ;ARRB2;PIK3CB;FLCN;CIB1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.27020072127531714,-1.0185403427352349,0.42589437819420783,0.6049792537714075,1.0,24/88,21.96%,APOE;DAPK1;GAPDH;DNAJC1;CNOT1;NFKB1;DAPK3;PUS7;EIF2AK2;PCIF1;DHX36;CST3;NCL;CLN3;TOB1;RPS3;DDX3X;CNOT8;DDX6;RACK1;BAG6;LSM14A;CDK5;SHMT1
prerank,positive regulation of dephosphorylation (GO:0035306),0.32749073896651865,1.0185087907052472,0.4254807692307692,0.7359679356294612,1.0,13/27,21.68%,CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;MTMR9;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,negative regulation of cell division (GO:0051782),-0.43341337352427445,-1.0182774490718014,0.45471014492753625,0.6052229488460281,1.0,9/11,40.06%,BLM;E2F8;TXNIP;ZFYVE19;VPS4A;MYC;ORC6;SUSD2;AURKB
prerank,negative regulation of immune system process (GO:0002683),-0.39263015676172863,-1.018078378120217,0.43448275862068964,0.6053179360487091,1.0,6/16,28.67%,LYN;FCGR2B;HMOX1;ADTRP;FCRLB;SPINK5
prerank,regulation of nervous system development (GO:0051960),0.31227553462556285,1.0180142234671383,0.4228855721393035,0.736107840780606,1.0,13/37,17.76%,TENM4;PTN;YAP1;CX3CR1;PTPRZ1;GBX2;HES5;PER2;HES1;NPHP3;PRUNE1;HES3;DOCK7
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3638024945223759,-1.017936106223547,0.42784380305602715,0.6053052026538146,1.0,7/21,26.25%,RUNX1;ROCK1;CBFB;GDF3;SFN;MAFF;ZFP36L1
prerank,visual perception (GO:0007601),0.2645054389156473,1.0178883628285351,0.4186046511627907,0.7352388482468463,1.0,16/84,12.01%,GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;ABLIM1;IMPG2;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;EML2;PRPH2;ZIC2
prerank,regulation of feeding behavior (GO:0060259),0.4073567615367576,1.0174417319102853,0.44298245614035087,0.7352428088597257,1.0,2/11,8.36%,SGIP1;LEPR
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4510618608941893,-1.0172812672600566,0.4721254355400697,0.6063515996358703,1.0,2/10,5.66%,ABCD2;NR1H2
prerank,regulation of receptor internalization (GO:0002090),-0.3154394023251991,-1.0172780897768638,0.4172297297297297,0.6060444392051556,1.0,8/35,9.53%,SDCBP;RIN3;INSR;ARRB2;TBC1D5;ARRB1;VEGFA;CD63
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.37486331688459684,1.0170333148613921,0.4268292682926829,0.7351158453700456,1.0,3/16,1.93%,AKAP6;ERBB4;ZFPM2
prerank,regulation of tube diameter (GO:0035296),-0.4098832629630279,-1.0170001936798023,0.4463373083475298,0.606010648484006,1.0,7/13,39.60%,ROCK1;ITGB1BP1;SCPEP1;ACE;ROCK2;ACE2;NPR1
prerank,vascular process in circulatory system (GO:0003018),-0.4098832629630279,-1.0170001936798023,0.4463373083475298,0.606010648484006,1.0,7/13,39.60%,ROCK1;ITGB1BP1;SCPEP1;ACE;ROCK2;ACE2;NPR1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.34835840403922574,-1.016481507486088,0.44666666666666666,0.6068461832320167,1.0,8/24,19.19%,IRAK2;TAB2;NOD1;UBC;RPS27A;RNF34;CASP8;NOD2
prerank,purine-containing compound salvage (GO:0043101),-0.42208413963857194,-1.0162873770925083,0.4506065857885615,0.606990777487466,1.0,6/12,29.95%,DCK;HPRT1;DGUOK;PNP;GMPR2;ADA
prerank,establishment of protein localization to membrane (GO:0090150),-0.282073841868974,-1.0161907614744792,0.4189655172413793,0.6069042576232768,1.0,20/66,20.79%,RFTN1;SDCBP;SEC63;RAB3GAP1;NACA;ZDHHC7;ZDHHC2;NCF1;SYNE3;RAB11B;RAB10;ZDHHC12;NPC1;BID;TAOK2;ZDHHC1;GRIN3B;NACAD;RAB11A;GOLGA7
prerank,hepaticobiliary system development (GO:0061008),-0.37197763131243244,-1.0161210397760705,0.4392361111111111,0.6067322110220633,1.0,5/20,11.30%,ARID5B;NIPBL;CEBPG;XBP1;GFER
prerank,positive regulation of cellular component movement (GO:0051272),-0.3524122443805589,-1.015917867419566,0.44047619047619047,0.6068595261469266,1.0,5/24,13.74%,LYN;VEGFA;TGFBR1;STK11;CFAP20
prerank,ethanol metabolic process (GO:0006067),0.41799088347124186,1.0158520799538509,0.4563106796116505,0.7371003840386688,1.0,4/12,25.67%,ACSS2;ALDH1A1;ACSS1;ALDH2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.34532320238144837,-1.015400477818235,0.43137254901960786,0.6076823359340634,1.0,5/26,3.56%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,amino acid import across plasma membrane (GO:0089718),0.3355480884212781,1.0149724398529667,0.4064039408866995,0.7381252457016819,1.0,7/24,16.85%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC6A13;SLC16A2;SLC6A5
prerank,organelle disassembly (GO:1903008),-0.32848690547847365,-1.0148024915349998,0.4166666666666667,0.6085935817922046,1.0,8/33,14.01%,KLC1;ULK2;TEX264;CDK1;STX5;PLK3;RETREG1;RB1CC1
prerank,regulation of fibrinolysis (GO:0051917),-0.4144136949040879,-1.0143465854597984,0.4456140350877193,0.609233647331942,1.0,6/13,35.91%,FAP;SERPINE1;APOH;F11;F12;HRG
prerank,heterochromatin organization (GO:0070828),0.37818497715395794,1.0141505538162943,0.4152334152334152,0.7390805243991102,1.0,6/14,20.07%,HMGA2;SNAI1;BAHD1;MECOM;PRDM16;SIRT1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3973190361129155,1.0140000705005225,0.4306569343065693,0.7382713937724757,1.0,6/13,19.24%,GRIN2A;TBC1D10A;LGMN;CIDEB;PERP;FADD
prerank,mitochondrion disassembly (GO:0061726),-0.3188349348760351,-1.0132886745379976,0.43898305084745765,0.6111514620653039,1.0,9/34,17.54%,ATG5;ATG7;ULK2;FIS1;MARK2;RB1CC1;GABARAP;USP30;FBXO7
prerank,endocrine system development (GO:0035270),0.35046596177632,1.013182410270763,0.4369158878504673,0.7392563401314047,1.0,5/21,10.68%,PAX8;WT1;HOXD3;SALL1;TBX1
prerank,cellular response to inorganic substance (GO:0071241),0.3534276297853367,1.0118049370993758,0.4375,0.7416311264005382,1.0,4/21,8.22%,DDX11;KCNC2;GUCY1B1;FMR1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.39986591353213985,-1.0117962576421398,0.44424778761061945,0.6140175575610425,1.0,4/14,18.78%,KMT5B;KMT5C;CD226;SHLD2
prerank,smooth muscle tissue development (GO:0048745),0.4311497031071053,1.0117384101799676,0.43427230046948356,0.7405761062343942,1.0,4/10,22.49%,SMO;MYLK;EFEMP2;NF1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3733941394772454,1.0116773238957344,0.43187066974595845,0.7395540668544834,1.0,3/17,11.01%,ALK;APOC1;MFSD2A
prerank,sarcomere organization (GO:0045214),0.33337932869897824,1.0116067307362937,0.42789598108747046,0.7385386095593686,1.0,6/27,16.33%,CSRP1;TNNT2;TTN;CAPN3;FHOD3;TPM1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2820756607790927,-1.0114074044759649,0.42857142857142855,0.6145849726474178,1.0,29/64,35.14%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;NCBP1;POLR2A;POLR2G;ELP4;RTF1;ELOC;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;POLR1E;ELOA;MNAT1;SETD2;NELFA;CDK12;ERCC2;POLR2B;GTF2H1
prerank,response to organonitrogen compound (GO:0010243),-0.3223348132678039,-1.0105709245841554,0.4397810218978102,0.6160499227528616,1.0,14/38,26.23%,KYNU;IRF5;IRAK3;RCN3;DERL1;SEL1L;UBXN6;KAT7;RNF185;ERLEC1;NR1H4;IL6;HLCS;VCP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3236667057917547,-1.010451912416535,0.4521276595744681,0.6159882368321777,1.0,9/35,12.69%,CBL;RAC1;PIK3CB;C3;PICALM;HIP1;B2M;RAB21;SERPINE1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3854378653981397,1.010178003600851,0.45774647887323944,0.7410564114873429,1.0,3/14,8.46%,PPP2R2B;PPTC7;PPP2R2A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.32475235148861414,-1.0096654116624841,0.4571917808219178,0.6173840851803327,1.0,7/29,18.61%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53
prerank,regulation of mitotic nuclear division (GO:0007088),-0.2907560895948012,-1.0091036702180882,0.4219554030874786,0.618269595160451,1.0,17/55,23.11%,IGF1;INSR;CDK13;KIF20B;DAPK3;CD28;PIN1;MKI67;NUSAP1;AURKA;RCC1;PDGFRB;CHEK1;NME6;CDC25C;NUP62;CCNB1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4031259091117883,1.0086688025314787,0.4308390022675737,0.7438843158593661,1.0,3/12,10.90%,DSCAM;RORB;CEP290
prerank,tRNA aminoacylation (GO:0043039),-0.3189749696673174,-1.007428994433568,0.44648829431438125,0.621490695388094,1.0,9/37,23.00%,RARS1;FARS2;SARS1;DARS1;EEF1E1;KARS1;AARS1;DARS2;IARS1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3948754483526846,-1.007188408795243,0.43838028169014087,0.6213929231447004,1.0,9/15,34.21%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3948754483526846,-1.007188408795243,0.43838028169014087,0.6213929231447004,1.0,9/15,34.21%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.27380782534854725,-1.0070793474312107,0.4267515923566879,0.6212965979141956,1.0,34/80,34.40%,BIRC3;MALT1;BRCA1;AXIN1;LAPTM5;WFS1;UBE2L3;PIN1;DERL1;DCUN1D4;ARRDC4;UBE3A;NSMCE3;TBC1D7;SMAD7;HUWE1;NDFIP2;KDM1A;TOPORS;UBE2N;CUL3;RIPK2;XIAP;PTTG1IP;TRAF6;BCL10;HSPBP1;CAV1;DCUN1D5;STUB1;FANCI;TSPYL5;MTA1;DCUN1D1
prerank,sterol biosynthetic process (GO:0016126),0.316458102413216,1.006983435274377,0.44871794871794873,0.7471633566703396,1.0,10/33,14.61%,DHCR24;HMGCS1;INSIG1;CYP51A1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,telomere maintenance via telomerase (GO:0007004),-0.32813632198336035,-1.0069820627632864,0.4488734835355286,0.6212010001801755,1.0,7/28,18.61%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53
prerank,positive regulation of protein maturation (GO:1903319),-0.42094499291373805,-1.0062131660554423,0.4634974533106961,0.6225621586937315,1.0,5/11,33.79%,NLRC4;ADAM8;CCBE1;RHBDD1;TFR2
prerank,activin receptor signaling pathway (GO:0032924),0.3826429532317556,1.0059561835483215,0.45622119815668205,0.7485624065501969,1.0,6/15,19.77%,ACVR1;ACVR1C;INHBB;INHBA;AMHR2;ACVR2B
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.30892702777418063,-1.0059498388422383,0.4420529801324503,0.6228329756226835,1.0,11/42,23.00%,RARS1;FARS2;SARS1;CARS2;DARS1;EEF1E1;KARS1;TARS2;AARS1;DARS2;IARS1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.3107494648999838,-1.0057897728373848,0.44833625218914186,0.6228661165023177,1.0,14/40,20.16%,ROCK1;SNX3;FLNA;CTSA;IRAK3;AZIN1;TIMP2;SF3B3;PIN1;CST3;RILP;SNRNP70;MDM4;SIRT2
prerank,regulation of neuroblast proliferation (GO:1902692),0.37489629551342185,1.0056022504731725,0.423728813559322,0.7482542672668011,1.0,3/15,8.40%,TAFA1;PTN;CX3CR1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.26781805961797506,-1.004971645077339,0.44293015332197616,0.6243141061276083,1.0,15/88,11.90%,PTPRC;CORO1C;PAK2;RB1;PRKAG2;CEP85;DUSP3;LRP6;MVP;TRIB1;SLC8A1;ITGB1BP1;TRIB2;SPRED1;GADD45A
prerank,acylglycerol homeostasis (GO:0055090),-0.3656995791697643,-1.0043231904153442,0.45753899480069327,0.6253891977845315,1.0,4/20,10.45%,APOE;IL18;LPL;APOC4
prerank,establishment of protein localization to organelle (GO:0072594),-0.2721254021419338,-1.0043104137203003,0.4292604501607717,0.6251030551243435,1.0,22/72,22.26%,SYK;IPO5;NUP50;LAMP2;STAT3;NUP88;LAMP5;E2F3;TPR;LAMP1;TSPAN17;NUP188;APPL2;NUP153;FAM53A;RAB11A;APPL1;TNPO3;NUP107;NXT2;NUP62;SPRN
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4016817811316676,1.0042268035361517,0.44731182795698926,0.7494279352148806,1.0,2/12,2.21%,AKAP6;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4016817811316676,1.0042268035361517,0.44731182795698926,0.7494279352148806,1.0,2/12,2.21%,AKAP6;CAMTA1
prerank,regulation of centriole replication (GO:0046599),-0.3755813338554046,-1.0041319702379055,0.45878136200716846,0.625202662272253,1.0,7/17,21.40%,BRCA1;CEP295;PLK2;CEP295NL;RBM14;STIL;NUP62
prerank,smoothened signaling pathway (GO:0007224),0.31324665023352255,1.0039800546570743,0.43705463182897863,0.7488640871318111,1.0,14/32,27.59%,PTCH2;TMEM231;EVC2;ARL13B;SMO;HES5;GLI3;GLI2;ULK3;DISP3;DISP2;CC2D2A;B9D1;HIPK2
prerank,cellular response to leucine (GO:0071233),-0.4323540163603815,-1.0037990302863316,0.4632352941176471,0.6252863657014316,1.0,4/10,11.40%,KLHL22;UBR2;RRAGD;SESN1
prerank,response to leucine (GO:0043201),-0.4323540163603815,-1.0037990302863316,0.4632352941176471,0.6252863657014316,1.0,4/10,11.40%,KLHL22;UBR2;RRAGD;SESN1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3303586955149457,-1.0036519528660055,0.44601769911504424,0.6252968633019249,1.0,4/30,6.72%,AKAP13;RAC1;ARHGEF3;ARRB1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2318689893573024,-1.0036182885999545,0.44565217391304346,0.6250446457454187,1.0,62/248,21.08%,DAB2;APOE;ZEB2;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;NFKB1;HHEX;CCNY;USP8;DAPK3;PSMB9;STK3;AXIN1;BICC1;LRP6;CTNNB1;TBL1XR1;PPM1B;PPP1CA;SDHAF2;MDK;LRRK1;WLS;CDK14;TLE3;PSMA8;OTULIN;PIN1;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;PSMA1;GREM1;TNKS2;LATS2;UBAC2;TLE4;GPRC5B;JRK;PSMB8;PTPRO;PLEKHA4;RSPO1;DDX3X;PSMD4;PSMA5;GSK3B;PSMB3;TMEM198;WNK1;PSMD3;SMURF2;SFRP1;JUP;CSNK1G3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.4092631169120926,-1.003551085303472,0.4517857142857143,0.6248695802990284,1.0,3/13,10.60%,PTK2B;CAB39;NEDD4L
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3968537076693578,-1.0031075457146978,0.4714038128249567,0.6254907535240609,1.0,4/15,9.87%,SLC27A1;NR1H2;C3;SIK1
prerank,autophagosome organization (GO:1905037),-0.2969893863417752,-1.0028811559735995,0.43373493975903615,0.6256610068522698,1.0,14/50,24.71%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B
prerank,cellular protein-containing complex assembly (GO:0034622),-0.24385600255222925,-1.0024555574032643,0.4444444444444444,0.6262436951798869,1.0,45/159,22.48%,TCF4;CYBA;SNX9;IMMP2L;UVRAG;DHX9;CENPF;DLGAP5;CENPA;AXIN1;FCHO2;PICALM;HIGD2A;HIP1;EPS15;CENPE;CCDC40;DNAJB14;NUP205;TPR;HSP90AB1;TBCE;TRAF2;CHMP2A;HSPA4;GPX4;POGZ;PIK3C2A;VAMP4;SHQ1;TESPA1;FMOD;HSPA1A;NUP153;COX7A2;ADRB2;POMP;PSMD4;NUP107;CHMP4B;CHMP4A;VAMP1;CD3E;EID2;TGFB1
prerank,positive regulation of exocytosis (GO:0045921),0.3062733067179146,1.0019301345835716,0.423841059602649,0.7531933414403832,1.0,6/35,6.30%,CADPS;CADPS2;RAB15;CLASP2;RAB27B;SDC1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3565048066753649,1.0018096739572224,0.43488372093023253,0.7523240466088967,1.0,4/19,10.84%,ROBO1;SEMA6A;TSPAN12;SMOC2
prerank,cellular response to light stimulus (GO:0071482),-0.2765881612487563,-1.0017936558604723,0.444636678200692,0.6273436303299916,1.0,30/66,35.52%,GNB1;PRKCD;CREBBP;CDC25A;PCNA;DHX36;RHNO1;TMEM161A;YY1;INO80;ERCC4;NSMCE3;KDM1A;MYC;USP28;GPR52;NOC2L;AQP1;METTL3;ZBTB1;EP300;COPS9;ATF4;CNGB1;RHBDD1;RRH;EIF2S1;SAG;USP47;MAPK13
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.29568929452490894,-1.0014645614751232,0.45302013422818793,0.6277222101346844,1.0,13/50,23.05%,OGT;ARRB2;ARRB1;DNAJA1;PRMT3;SPRY2;ISG15;SMAD7;HSPA1A;RPS3;DTX3L;UBXN1;HDAC8
prerank,regulation of signal transduction (GO:0009966),-0.23806394863137742,-1.0011864470803593,0.44532488114104596,0.6280037997051157,1.0,32/190,11.97%,MDFIC;RUNX1;SP100;DHRS3;CD36;SNX3;CREBBP;OGT;ELF1;IRAK2;RASGRP4;FBXL17;GRK3;AMFR;CDC42SE2;RGS3;AXIN1;RIC8B;POFUT1;ZDHHC7;GRK5;RGS11;CBFB;CD63;ITGB1BP1;NUCKS1;APP;CRK;RGS12;RFNG;CD46;ITGA3
prerank,calcium-mediated signaling (GO:0019722),0.25182454822090033,1.0007893373581755,0.4379746835443038,0.7538766023712786,1.0,15/93,10.76%,GRM5;ANK2;CACNA1C;RYR2;CHRM3;RCAN2;P2RY12;VCAM1;PRNP;PLCE1;CX3CR1;GPR143;AGTR1;EDN1;ATP1B1
prerank,negative regulation of JNK cascade (GO:0046329),-0.33150949170971483,-1.0007801793568336,0.4612736660929432,0.6285473674386557,1.0,6/31,11.96%,TAOK3;PTPN22;DUSP3;SIRPA;DNAJA1;AIDA
prerank,skeletal system development (GO:0001501),-0.24971807101501464,-1.0001061724813318,0.4383116883116883,0.6297155135419126,1.0,19/148,11.29%,EXT1;CD44;AKAP13;XYLT1;SH3PXD2B;IGF1;TRPS1;ANKRD11;SLC10A7;ATP7A;PTGER4;PKDCC;DYM;SULF2;CREB3L2;TGFBR1;TGM2;PRELP;PRDX1
prerank,sympathetic nervous system development (GO:0048485),-0.39184984759391517,-0.9987944176620992,0.4856175972927242,0.6322739922415773,1.0,3/15,7.24%,NRP1;CTNNB1;NRP2
prerank,lipid droplet formation (GO:0140042),0.43009594297245063,0.9987502951723668,0.4745011086474501,0.7579531787792536,1.0,3/10,18.84%,SQLE;ZFYVE1;CDS1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4212014957628884,-0.9986567998347484,0.48484848484848486,0.6322441949862138,1.0,5/12,24.84%,PRKCB;NEK6;CDK1;CCNB1;CCNB2
prerank,regulation of intracellular pH (GO:0051453),0.31111725477450586,0.9985092202859004,0.44711538461538464,0.7574466916443607,1.0,5/34,5.78%,SLC4A10;SLC4A4;SLC26A3;SLC9A2;CA2
prerank,macromolecule catabolic process (GO:0009057),-0.33859577610238384,-0.9983745386623138,0.4758364312267658,0.6325513860573078,1.0,12/26,25.91%,UVRAG;KIF16B;SNX25;CLN6;TRIM24;SH3GLB1;TPP1;PPT1;TGFB1;BECN1;LRSAM1;SMURF1
prerank,neuron projection regeneration (GO:0031102),0.4187062512631814,0.9983663870127797,0.45901639344262296,0.7566478007166134,1.0,4/10,14.95%,PTN;RTN4RL1;DHFR;FOLR1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.416296401875271,-0.9978320111338448,0.478494623655914,0.6334193730945052,1.0,4/13,11.54%,PPARD;PPARG;NFATC3;RELA
prerank,gene silencing by miRNA (GO:0035195),-0.32120620738224265,-0.997697205709947,0.4702702702702703,0.6334008430433401,1.0,7/32,12.95%,AGO2;CNOT1;ZC3H7B;PUM2;XPO5;MOV10;TNRC6C
prerank,regulation of cytoplasmic transport (GO:1903649),-0.4226188886118363,-0.9973526310336354,0.4712041884816754,0.6338162381141734,1.0,4/11,23.49%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,regulation of response to stress (GO:0080134),0.42412490994523244,0.9968875942633405,0.46464646464646464,0.7592735765966122,1.0,4/10,20.36%,ADCY8;DYRK3;OPRM1;STOX1
prerank,regulation of microtubule depolymerization (GO:0031114),0.33952763094166194,0.99650529744088,0.4702842377260982,0.7590626124956615,1.0,4/25,5.53%,NAV3;MAP1B;CLASP2;APC2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4026782910564637,-0.9963694177995617,0.4647887323943662,0.6356749782770543,1.0,4/13,11.54%,ITGB2;RHOA;MDK;RELA
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.33757215874030433,0.9962691361375249,0.4391891891891892,0.7584713773389816,1.0,5/23,13.22%,SLC12A2;SLC12A8;SLC12A1;SLC12A5;CLCN3
prerank,protein methylation (GO:0006479),-0.3144417795420304,-0.9959753091922224,0.46296296296296297,0.6361731456850064,1.0,9/40,15.07%,NSD3;GSPT1;PRMT2;EZH2;PRMT1;METTL22;PRMT3;NSD1;PRMT6
prerank,ameboidal-type cell migration (GO:0001667),0.2798771449372334,0.9959442918180577,0.45202020202020204,0.7581677820284595,1.0,15/51,16.13%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;CCN3;SRGAP2;SEMA3F;TBX1;SEMA5B;AMOTL1;SEMA4G;RADIL;NRTN
prerank,regulation of steroid metabolic process (GO:0019218),-0.350985094717847,-0.9958090642322867,0.4859154929577465,0.6362264038463816,1.0,16/23,36.49%,APOE;ABCG1;PANK2;TTC39B;FMO5;ASAH1;NR1H4;ACADVL;ABCA2;LAMTOR1;UGT1A8;UGT1A1;STUB1;ARV1;DGKQ;GNB3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4427474825285007,-0.9957870352289039,0.5,0.6359531303713414,1.0,3/10,11.82%,PRKCD;CD9;ADAMTS18
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.30925682030228546,-0.9957493041297036,0.47796610169491527,0.6357055187916955,1.0,13/40,25.07%,MCL1;PRKCD;ARMT1;SMYD2;RFWD3;WDR76;RADX;KMT5A;FEM1B;SMG1;MYC;UBE2V2;UBE2N
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.4329979638701902,-0.9951583384073791,0.4831858407079646,0.6366649715564856,1.0,3/10,10.32%,XDH;PIK3CB;SPRY2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.39831984388369934,-0.9951303929013191,0.4689165186500888,0.63639745687817,1.0,4/15,22.40%,APOE;APP;LDLR;CRYAB
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.26669759190573983,0.9948163774389995,0.43838862559241704,0.7599377992414905,1.0,16/69,12.11%,PLCB1;PLCL1;NYAP2;MYO16;PIK3C2B;KCNH1;CSF1R;PLCH2;PLCE1;PLCZ1;PIRT;GPR143;EDN1;LTK;PLCD3;TYRO3
prerank,lamellipodium assembly (GO:0030032),0.3228990411513899,0.9946970172810674,0.4528301886792453,0.7591403930557621,1.0,6/26,9.03%,ARHGEF7;CDH13;P2RY12;CARMIL1;ABLIM1;SRGAP2
prerank,RNA interference (GO:0016246),-0.38023875587754796,-0.9946154127188355,0.49298245614035086,0.6371744481786462,1.0,5/17,24.63%,AGO2;DHX9;CELF1;TSNAX;TSN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.35186960224845204,-0.9942637810516527,0.464041095890411,0.637628708539786,1.0,8/22,27.63%,RPS20;DDX5;SPRED1;SPRED2;EEF1E1;ATM;RPS15;PLA2R1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.33258621296048035,-0.9938239860599085,0.5097345132743363,0.6382597746005574,1.0,15/29,36.29%,PLBD1;NR1H2;TMEM86B;PLAAT3;PLA2G4A;PLA2G5;PLA2G12A;LPCAT3;PLA2G6;PNPLA8;LPCAT4;DBI;PLA2G3;PLA2G4B;PLB1
prerank,protein localization to cell surface (GO:0034394),0.32293711640721956,0.9937302384284443,0.45287958115183247,0.7604856813785511,1.0,7/26,14.50%,ANK2;PIGU;PTPRK;FGF10;EMP2;ARF6;RIC3
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4230100304458677,-0.9936594412749801,0.4698581560283688,0.6383062160593851,1.0,4/11,14.97%,SNX33;PICALM;NEDD4L;LEPROTL1
prerank,cartilage development (GO:0051216),-0.29484579372194725,-0.9930850813929215,0.44554455445544555,0.6392818391170715,1.0,9/49,11.39%,CD44;RUNX1;RUNX3;RUNX2;ATP7A;SULF2;CREB3L2;MEF2C;OSR1
prerank,negative regulation of ion transport (GO:0043271),0.33365857784529995,0.9927307973186563,0.46403712296983757,0.7620611515598282,1.0,11/24,20.88%,GPM6B;HRH3;CASQ2;NEDD4;SYT11;HTR1B;WNK4;WNK3;SNCA;WNK2;CD33
prerank,positive regulation of nuclear division (GO:0051785),-0.34013011847089447,-0.9926764605013051,0.4540727902946274,0.6398081373164177,1.0,8/25,21.40%,IGF1;INSR;CD28;NUSAP1;AURKA;PDGFRB;SIRT2;NUP62
prerank,long-term memory (GO:0007616),0.3580364572966432,0.9923925067240958,0.49056603773584906,0.7617954397614665,1.0,9/19,17.83%,RASGRF1;CAMK4;PRNP;NFATC4;CPEB3;PJA2;ARC;KAT2A;CALB1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.42716407822989544,-0.9922622981241125,0.478494623655914,0.640423902435831,1.0,4/10,17.47%,PPARG;RARG;RXRA;RARA
prerank,neural crest cell migration (GO:0001755),0.3014190863762392,0.9920005108316599,0.4597402597402597,0.7616463271134244,1.0,13/36,16.13%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;SEMA3F;TBX1;SEMA5B;FOLR1;SEMA4G;RADIL;NRTN
prerank,pre-miRNA processing (GO:0031054),-0.39858459314837247,-0.9918141471833095,0.5,0.6410944990071547,1.0,2/14,3.76%,AGO2;TUT7
prerank,tRNA wobble base modification (GO:0002097),-0.38527285220311636,-0.9917066683183804,0.4539249146757679,0.6409977755789571,1.0,4/14,16.47%,ALKBH1;MOCS3;ADAT2;ELP4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.41136393789571596,-0.9913432527994872,0.5043327556325823,0.6414649231695224,1.0,2/13,7.95%,ITGA4;MDK
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4112669677172476,-0.9911763814802377,0.4864376130198915,0.6414929900180042,1.0,3/12,4.04%,IGF1;INSR;DYRK2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.35784123289869135,-0.9911750597246147,0.4836488812392427,0.6411748632517051,1.0,7/20,21.66%,MCL1;ITGAV;BCL2;CASP2;GSK3B;APPL1;BCL2L2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4331051732838348,-0.9907238168784144,0.48704663212435234,0.6418575445920522,1.0,3/10,10.43%,SYNGR1;RAB5A;APP
prerank,RNA transport (GO:0050658),-0.2693772636079468,-0.9904789327438726,0.4782608695652174,0.6420475340571906,1.0,26/71,27.41%,RFTN1;SRRM1;CHTOP;RAE1;CDC40;CKAP5;XPO5;TPR;ALYREF;NUP188;NCBP1;TGFBR2;THOC2;NUP153;RNPS1;THOC6;HNRNPA1;MAGOH;SLU7;NUP62;SRSF11;DDX39B;DHX38;ZFP36L1;U2AF2;SRSF7
prerank,epiboly involved in wound healing (GO:0090505),0.3574137735703239,0.9902246313908187,0.47255369928400953,0.7651209896605388,1.0,6/16,11.93%,TMEFF2;MRTFA;CARMIL2;TOR1A;CD151;ARHGAP35
prerank,positive regulation of protein modification process (GO:0031401),-0.2341862958113986,-0.990089076491869,0.48244274809160304,0.6425516704009302,1.0,37/203,16.05%,LYN;DAB2;CD74;NIBAN1;PRKCD;RAC1;INSR;RAP2A;RIPK1;CEP295;ATG7;CCND3;ATG10;RAB3GAP1;AXIN1;HGF;C3;ARRB1;CAMKK2;GAS6;VEGFA;PLAUR;FNIP1;APP;PIN1;TAOK1;DYRK1A;FLCN;WDFY2;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL;MAVS;ANKLE2
prerank,polyamine metabolic process (GO:0006595),-0.4071537251951718,-0.9900443850626519,0.47594501718213056,0.6423158770029974,1.0,5/13,20.78%,PAOX;SAT1;HDAC10;SAT2;SMS
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.35839261199576294,0.9896805329151107,0.47961630695443647,0.765390017277575,1.0,6/17,13.22%,ADRA1B;GPR101;ADRA2C;ADRA1A;ADRA1D;ADRB1
prerank,chromatin assembly or disassembly (GO:0006333),-0.4229101539368779,-0.9893472307025105,0.48135593220338985,0.6435093690948244,1.0,5/11,28.38%,HIRIP3;CHAF1A;RBBP4;HDAC8;NOC2L
prerank,cellular response to catecholamine stimulus (GO:0071870),0.33994890494993124,0.9893241308000696,0.46875,0.7651595585846807,1.0,2/23,1.18%,PDE4B;RYR2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3560447153563927,-0.9892457317899214,0.47952218430034127,0.6434051329518629,1.0,9/21,37.28%,PPARD;AGXT;ACOX1;CYP26C1;PLA2G15;HOGA1;LPIN3;FAH;HAO1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.32575662732656996,-0.9887836537474839,0.4734042553191489,0.6440858891465848,1.0,4/31,4.96%,CDK6;RB1;BRD7;PRMT2
prerank,replicative senescence (GO:0090399),0.4011643098660506,0.9886561677221207,0.48292682926829267,0.7657017396486463,1.0,5/12,18.84%,MME;ROMO1;CDKN2A;TERT;CHEK2
prerank,anterior/posterior pattern specification (GO:0009952),0.27297162645010875,0.9885519031176364,0.45566502463054187,0.7647905898538069,1.0,15/53,19.77%,PCSK5;HOXC4;WT1;HOXD3;TBX1;HES5;HOXC5;HOXC9;HES1;ATP6AP2;HOXB6;HOXC6;HES3;CELSR2;ACVR2B
prerank,negative regulation of cell differentiation (GO:0045596),-0.23691399354623927,-0.9884070075151461,0.47213622291021673,0.6445908182362223,1.0,46/181,22.48%,ABCA1;ABCG1;XDH;CDK6;RB1;NELFB;PPARG;CTR9;PTK2B;ADIPOR1;ITGAV;ANP32B;NR1H2;JAG1;SKI;SDHAF2;E2F1;TGFBR1;ASXL1;TRIB2;SPRY2;SPRED1;OSR1;CHADL;SPRED2;CCDC85B;METTL14;GREM1;TRIO;ID2;LDLRAD4;VASN;SMAD7;GATA3;MYB;DTX1;IL17RD;PTPN11;ENPP1;SUFU;SIRT2;SFRP1;ANKRD26;SNAI2;IL6;TGFB1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.39376001773889013,-0.987570024561633,0.48633879781420764,0.6461021589542536,1.0,5/14,19.51%,MDFI;TMSB4X;NFKBIB;FAF1;SUFU
prerank,microtubule anchoring (GO:0034453),0.39825745364125203,0.9875278156553409,0.46115288220551376,0.7663650325834748,1.0,2/12,4.33%,BICD1;CLASP2
prerank,protein O-linked glycosylation (GO:0006493),-0.25813883655732245,-0.987412589184823,0.5066666666666667,0.6461332725570131,1.0,22/96,14.65%,B4GALT5;TRAK1;TET3;ST3GAL1;GALNT7;OGT;GALNT10;DPM3;GALNT3;POFUT1;XXYLT1;GALNT1;ST6GAL1;C1GALT1;POMK;B3GNT2;GXYLT1;POMGNT1;GALNT12;GCNT1;TET2;LARGE1
prerank,establishment of vesicle localization (GO:0051650),0.3587932785847714,0.9872119935412429,0.47706422018348627,0.766014760459594,1.0,5/18,9.02%,KIF5C;KIF5A;TOR1A;SYT11;F8A1
prerank,steroid metabolic process (GO:0008202),-0.2715891411693955,-0.9870031825156389,0.4845528455284553,0.6467116453578413,1.0,35/72,39.05%,LIPA;CYP27A1;HSD17B7;NPC1;CYP46A1;FDXR;CYP2R1;SRD5A1;AMACR;CYP26C1;CYP1B1;SRD5A2;LRP2;DHRS4;FDX1;HSD17B10;HSD3B2;SCP2;HSD17B14;FDX2;UGT1A7;UGT1A8;UGT1A1;STARD3;ARV1;DHRS11;BAAT;AKR1C1;NR1I2;HSD17B3;AKR1D1;CYP19A1;SULT2A1;VDR;TSPO
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3571466613922534,0.9868002441130561,0.4567307692307692,0.7659192134635107,1.0,6/17,18.32%,AHI1;SOX9;TMEM100;KDF1;RFX3;SULT2B1
prerank,protein processing (GO:0016485),0.24539753228424876,0.986177372853518,0.4815668202764977,0.7663647319136028,1.0,17/102,12.87%,OMA1;METAP2;PCSK5;MMP16;PCSK2;MME;ECE2;ATP23;PCSK6;PRSS12;SEC11C;MMEL1;PCSK1;CPE;EEF1AKMT4-ECE2;GGT1;F9
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4341324902759139,-0.986025097977702,0.4982517482517482,0.6485222209586816,1.0,5/10,34.04%,NFE2L2;QRICH1;EIF2AK3;ATF4;EIF2S1
prerank,bile acid biosynthetic process (GO:0006699),0.3357555735325253,0.9857660956876901,0.46766169154228854,0.7662720506974076,1.0,10/24,15.25%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.369121057447392,-0.9856890783920189,0.48063380281690143,0.6489131226454737,1.0,2/16,5.43%,AOAH;PHKG2
prerank,regulation of chemotaxis (GO:0050920),-0.32094515685000474,-0.9853968436369263,0.4831649831649832,0.6492303659089512,1.0,11/30,24.42%,P2RX4;STX3;DUSP3;CYRIB;ZSWIM8;CXCR4;ZSWIM6;STX4;PDGFRB;TGFB1;ZSWIM4
prerank,central nervous system neuron development (GO:0021954),0.3675334085233218,0.9853753144212073,0.44680851063829785,0.76614136617506,1.0,2/15,1.99%,MAP2;NTRK2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.23824999307100206,-0.9852466559948073,0.48829953198127923,0.6492262850318228,1.0,50/161,28.32%,DAB2;APOE;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;AXIN1;BICC1;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;PSMA1;GREM1;LATS2;UBAC2;TLE4;PSMB8;PTPRO;PSMD4;PSMA5;GSK3B;PSMB3;PSMD3;SFRP1;SNAI2;TNN;DVL2;PSMB1;CCDC88C;SIAH2;BMP2;TMEM131L;TMEM170B;CUL3;FRMD8;PSMA7;NOTUM;DKK3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.32072872581250833,-0.9850830045583575,0.47285464098073554,0.6492649069054085,1.0,9/31,23.42%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;GSK3B;SFN;NMT1
prerank,positive regulation of axon extension (GO:0045773),-0.35529939202223504,-0.98502520886678,0.5017421602787456,0.6490724220777226,1.0,5/22,7.75%,NRP1;GOLGA4;RUFY3;MACF1;VEGFA
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4126927462078527,0.9847761043936274,0.498812351543943,0.7653911720542407,1.0,4/12,13.85%,FHL2;PRNP;HOMER3;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4126927462078527,0.9847761043936274,0.498812351543943,0.7653911720542407,1.0,4/12,13.85%,FHL2;PRNP;HOMER3;ATP2B4
prerank,protein localization to chromatin (GO:0071168),-0.36258584648697245,-0.9847405428355879,0.49646643109540634,0.6493572703085199,1.0,9/18,32.25%,NIPBL;MCM9;CHMP7;LEMD2;LRWD1;ESR1;FAM47E;RAD21;WAPL
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.38630880798107603,-0.9846340205241175,0.46236559139784944,0.6492587279741072,1.0,4/15,19.14%,PAOX;SAT1;MOXD1;SAT2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.27754472043543504,-0.9845177056588299,0.4602076124567474,0.6491821990293781,1.0,28/62,35.14%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;NCBP1;POLR2A;POLR2G;ELP4;RTF1;ELOC;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;ELOA;MNAT1;SETD2;NELFA;CDK12;ERCC2;POLR2B;GTF2H1
prerank,positive regulation of cyclase activity (GO:0031281),0.3702930291497285,0.9840823956367939,0.448512585812357,0.7660947067270022,1.0,1/14,0.82%,CACNA1C
prerank,organelle transport along microtubule (GO:0072384),-0.3204923424314104,-0.9836709422055011,0.4852941176470588,0.6506749979762075,1.0,11/31,20.89%,TRAK1;PEX14;CDC42;RAB1A;FBXW11;LRPPRC;MAP1S;CLN3;UXT;PAFAH1B1;BORCS5
prerank,muscle filament sliding (GO:0030049),0.29954465072143227,0.983591501559272,0.49635036496350365,0.765009183943182,1.0,6/38,11.17%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,actin-myosin filament sliding (GO:0033275),0.29954465072143227,0.983591501559272,0.49635036496350365,0.765009183943182,1.0,6/38,11.17%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4337026102272904,-0.9832736720153201,0.4767025089605735,0.6512309520223137,1.0,4/10,25.52%,PRKCB;IRS2;OAZ3;INPP5K
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3467037591243347,-0.9826478331878059,0.4716981132075472,0.6522799486645502,1.0,5/24,10.47%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.32231301062516043,0.9819540473711514,0.4593967517401392,0.7680940837280184,1.0,11/28,17.95%,ADCY8;PTN;SHANK3;NSG1;ADCY1;RELN;ARC;LGMN;CHRNA7;CALB1;FAM107A
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2813074623346138,-0.9818376716659849,0.47855917667238423,0.6537149324244583,1.0,17/57,24.98%,DDHD1;BCL2L11;CAMKK2;PLAUR;FIS1;MLLT11;BBC3;BID;TNFSF10;AURKA;FBXO7;PDCD5;GSK3B;KDR;BIK;DCN;ZDHHC6
prerank,cellular response to amino acid stimulus (GO:0071230),0.30199650229981534,0.9812223538792532,0.48642533936651583,0.7688568438889347,1.0,9/33,11.57%,GLRA1;SESN3;RRAGB;UBR1;FYN;GLRA2;CASTOR2;CPEB3;RPTOR
prerank,positive regulation of vasculature development (GO:1904018),-0.25622107929607574,-0.9811299168815847,0.5016722408026756,0.6549189508762344,1.0,17/94,14.12%,SASH1;RUNX1;PRKCB;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;HIF1A;CTSH;ITGAX;XBP1;SERPINE1;PIK3CD;CD40;BTG1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.42897855546802666,-0.9807259280294227,0.5181159420289855,0.6554965999741974,1.0,7/10,43.94%,ACADM;ACAD11;ACADVL;ACADS;GCDH;IVD;ACADL
prerank,regulation of monooxygenase activity (GO:0032768),-0.3363008710271338,-0.9797355776352031,0.4878472222222222,0.6573549725863865,1.0,3/23,6.45%,DNM2;POR;WASL
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.2320203503540253,-0.9791364336694938,0.49686520376175547,0.6583522815567691,1.0,42/186,21.11%,DAB2;APOE;RNF213;LRP1;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;AXIN1;BICC1;MDFI;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;PSMA1;GREM1;RNF43;LATS2;UBAC2;TLE4;PSMB8;PTPRO;NFATC1;PSMD4;PSMA5;GSK3B;PSMB3;PSMD3;SFRP1;RACK1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.33587441249247396,-0.9791106844591583,0.4767857142857143,0.6580843350819597,1.0,6/24,10.24%,HPSE;BRCA1;C3;SULF2;HIF1A;ARNT
prerank,epithelial tube morphogenesis (GO:0060562),0.30472928717793285,0.978668364367439,0.4804177545691906,0.7743044156892858,1.0,8/32,15.31%,RYR2;SLIT2;CSF1R;ACVR1;FGF10;PKD1;HES1;PODXL
prerank,snRNA 3'-end processing (GO:0034472),-0.3657984156046391,-0.9779536778943815,0.5043630017452007,0.6603045777462089,1.0,11/19,33.57%,INTS8;EXOSC5;INTS6;INTS14;INTS1;INTS5;EXOSC4;EXOSC8;TUT1;USB1;EXOSC3
prerank,mucosal immune response (GO:0002385),-0.3813719917886364,-0.9778056096340709,0.49119718309859156,0.6602896297865146,1.0,7/15,44.16%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3;IFNLR1
prerank,organophosphate catabolic process (GO:0046434),-0.41258972870993127,-0.9775747767844267,0.49023090586145646,0.6604508041588231,1.0,3/11,7.25%,PLBD1;ABHD12;PLBD2
prerank,carnitine metabolic process (GO:0009437),-0.40841966479437636,-0.9774869349555977,0.5,0.6602978856102683,1.0,4/12,21.96%,CPT1A;ACADM;TMLHE;SHMT1
prerank,endoderm development (GO:0007492),-0.40456590095300227,-0.977440510887826,0.4879310344827586,0.6600737761933196,1.0,7/13,38.45%,KIF16B;DUSP5;SOX7;DUSP2;DUSP1;EOMES;SOX17
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3434599927915496,-0.977413091263544,0.4931740614334471,0.6598100038407383,1.0,9/24,16.01%,ATXN7;ARHGEF2;LIMA1;TPX2;TAOK1;PIK3CA;CIB1;SPEF1;STMN2
prerank,positive regulation of kinase activity (GO:0033674),-0.25499119927252717,-0.9772714836523393,0.5008183306055647,0.6598164751038825,1.0,15/107,8.24%,IQGAP1;PTPRC;CD74;AXL;SNX9;INSR;IGF1R;PRKAG2;TAB2;RAP1A;FLT1;PTK2B;GAS6;ALS2;CENPE
prerank,cellular response to drug (GO:0035690),0.32501445221385117,0.9766835888707205,0.4975,0.7782902008838619,1.0,2/25,1.63%,PDE4B;PPM1E
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3786428194380448,-0.976609407525459,0.4844827586206897,0.6608926895156887,1.0,5/16,24.28%,HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.355603682092116,0.9761249433497031,0.4776470588235294,0.7786081367196854,1.0,2/17,1.35%,ROBO1;SLIT2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.31062316802177276,-0.976115066981835,0.4982456140350877,0.6616637346821961,1.0,16/35,34.28%,RTEL1;CTNNB1;CCT7;PKIB;DHX36;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.36920053952895077,0.9754688976824767,0.4639423076923077,0.7791683371009657,1.0,6/16,21.34%,HFM1;SHOC1;CORT;MEIOB;MSH4;RMI1
prerank,programmed necrotic cell death (GO:0097300),-0.3553233630495405,-0.9754077626636458,0.5130890052356021,0.6628598155202766,1.0,8/18,28.77%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4173354186521141,-0.9744715102983466,0.5139372822299652,0.6645429993939559,1.0,4/11,20.84%,DAB2;RSPO3;PLEKHA4;SFRP1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.39329078673879625,-0.9743380798352675,0.488013698630137,0.664491103228323,1.0,2/13,6.82%,STX7;CYRIB
prerank,regulation of microtubule-based process (GO:0032886),-0.31013655413650176,-0.9742999731333141,0.5118243243243243,0.6642555811840816,1.0,11/36,19.77%,DIAPH1;ROCK1;MACF1;TAOK1;MARK2;KLHL42;MEMO1;AURKA;ATF5;CDK2AP2;GSK3B
prerank,histone lysine methylation (GO:0034968),-0.3154903460645793,-0.9736497271867258,0.5164644714038128,0.6653619781959798,1.0,15/33,28.24%,SMYD2;SMYD3;EZH2;WDR5;KMT2D;SMYD1;SETDB1;DOT1L;KMT2A;CXXC1;SETD6;RBBP5;ASH2L;KDM6A;WDR5B
prerank,myotube cell development (GO:0014904),-0.4253954911808159,-0.9733596823179782,0.5043327556325823,0.665686979482489,1.0,2/10,7.73%,IGF1;SKI
prerank,negative regulation of protein secretion (GO:0050709),-0.30384090148897536,-0.9726671021296517,0.49146757679180886,0.6668156487887239,1.0,6/38,10.38%,APOE;RAB11FIP5;RSAD2;RHBDF1;RHBDF2;CHGA
prerank,tRNA 5'-leader removal (GO:0001682),0.3822373175934406,0.9726412286706605,0.5169902912621359,0.7854365008867753,1.0,6/13,21.61%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,nuclear membrane reassembly (GO:0031468),-0.2852609301587897,-0.9720789546150792,0.4905335628227194,0.6677472756978545,1.0,21/54,26.00%,CHMP7;NUP205;CDK1;NUP188;CHMP2A;LEMD2;ANKLE2;UBE2I;RCC1;NUP35;SIRT2;REEP3;NUP107;CHMP4B;CHMP4A;VPS4A;CCNB1;LMNA;CHMP2B;CCNB2;NUP37
prerank,gluconeogenesis (GO:0006094),0.2931421396840204,0.9720638938644777,0.5099502487562189,0.7857798331501037,1.0,10/39,14.43%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,regulation of vasculature development (GO:1901342),-0.3294827032990316,-0.9717693263819741,0.5,0.6681084833595744,1.0,11/26,31.58%,SP100;PLXND1;CTNNB1;EGLN1;HTATIP2;SFRP1;IL6;HMOX1;ETS1;VASH2;FGF2
prerank,protein localization to chromosome (GO:0034502),-0.30987128476277315,-0.9717684564030824,0.5078534031413613,0.6677836186362787,1.0,8/34,16.13%,RB1;CENPA;MCM9;CHMP7;TNKS2;XRCC4;LEMD2;TPP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3927085723863759,0.9710039627729998,0.48484848484848486,0.7874411802424804,1.0,6/12,19.51%,HUS1B;CLSPN;STK33;SETMAR;CHEK2;NAE1
prerank,negative regulation of cell projection organization (GO:0031345),0.2797564389862649,0.9709553535654508,0.5371287128712872,0.7864077818193476,1.0,10/48,13.93%,SPOCK1;GRIN2B;DCC;PRNP;FYN;KANK1;TSKU;DPYSL3;RTN4RL1;PTPRS
prerank,base conversion or substitution editing (GO:0016553),-0.4080239328053299,-0.9709003680498564,0.5236427320490368,0.6693249753665815,1.0,1/11,0.05%,APOBEC1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3057424996928846,-0.9704643872735701,0.48986486486486486,0.6698954397041622,1.0,6/37,9.38%,IGF1;JUN;ERN1;PPARG;MEF2D;MEF2C
prerank,atrioventricular valve development (GO:0003171),0.36495717594540544,0.9703653206182035,0.5153664302600472,0.7868410531303819,1.0,3/14,9.22%,SLIT3;ACVR1;TGFB2
prerank,skeletal system morphogenesis (GO:0048705),0.2813977557376245,0.9701018649393729,0.49176470588235294,0.7863865085857056,1.0,8/42,15.71%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;MMP13;HOXC9;FUZ
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.3933511614250533,-0.9694923969602152,0.5344827586206896,0.6716213331091455,1.0,2/13,2.65%,NUPR1;MTM1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.38870307807875365,0.968127387411793,0.47306791569086654,0.7903120110769457,1.0,4/11,14.85%,PTS;CALM1;HSP90AA1;DHFR
prerank,sulfur compound biosynthetic process (GO:0044272),-0.24682423530965222,-0.967482318619677,0.5126050420168067,0.6756779634547244,1.0,21/104,18.55%,DSE;B4GALT5;ST3GAL1;CDO1;SLC10A7;SLC35D2;CHST12;TPK1;CHST11;CNDP2;PRELP;B3GNT2;CHST3;MPST;CSPG4;B4GALT3;AKR1A1;PAPSS1;FMOD;CHAC2;MAT2A
prerank,neuron maturation (GO:0042551),0.3478287984970075,0.967088443761935,0.5012165450121655,0.7919090306963331,1.0,2/18,2.37%,ADGRB3;SRRM4
prerank,positive regulation of wound healing (GO:0090303),-0.30891364604938376,-0.9668044714146501,0.5017667844522968,0.676785392745531,1.0,7/36,12.69%,RREB1;HPSE;ITGB1;ARFGEF1;ANXA1;XBP1;SERPINE1
prerank,negative regulation of protein processing (GO:0010955),-0.40410059603987797,-0.9657198968865092,0.5071174377224199,0.6787850076690252,1.0,3/12,17.83%,CTSZ;SERPINE1;TMEM59
prerank,response to amyloid-beta (GO:1904645),-0.28943104724785645,-0.9655496789973216,0.521594684385382,0.6788360470167393,1.0,10/44,10.43%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3607485604455969,-0.9651478058180355,0.5089605734767025,0.6793792894287517,1.0,3/18,8.93%,MFHAS1;ZCCHC9;GPATCH2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.35774121685979654,-0.9651223663332599,0.5095986038394416,0.6791077604256331,1.0,7/18,34.28%,CEP295;CCT7;CCT4;WRAP53;TNF;CCT8;CCT5
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.36335740833831975,-0.9651128599182155,0.5120274914089347,0.6787982526792169,1.0,3/15,10.36%,PLCG2;EZH2;KLHL18
prerank,Golgi localization (GO:0051645),-0.4005661584312129,-0.9646705899893534,0.5078809106830122,0.6794619638280093,1.0,2/11,4.13%,UVRAG;CDC42
prerank,mitochondrial fission (GO:0000266),0.3631503079843972,0.964552300586304,0.48577680525164113,0.7973710013371649,1.0,3/16,6.17%,DNM3;MIEF1;DNM1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2875443958062605,0.9642161586411999,0.5025125628140703,0.797063963837691,1.0,12/38,20.45%,RORA;OTUD7A;NLRP12;NR1D1;GSTP1;OTUD7B;TNIP1;TRIM59;CCDC22;SIRT1;PER1;TREM2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3760726926720829,-0.9639430894600552,0.5008183306055647,0.6806599062451596,1.0,5/15,27.42%,ERN1;TSEN54;DDX1;CPSF1;ZBTB8OS
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3292608226448858,-0.9635290186669773,0.5287162162162162,0.6811836434590507,1.0,6/26,14.86%,DDB2;RNF111;UBC;RPS27A;CUL4B;ERCC4
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4228714102795428,-0.9628988121478428,0.5077720207253886,0.6818880350189079,1.0,4/10,28.20%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4228714102795428,-0.9628988121478428,0.5077720207253886,0.6818880350189079,1.0,4/10,28.20%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.29003463369526866,0.9625617005241622,0.5110565110565111,0.8002997281536757,1.0,9/40,9.36%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;AMELX;TFAP2A
prerank,cellular response to interferon-beta (GO:0035458),-0.3880536109098834,-0.9625294571862555,0.5219683655536028,0.6823520279512367,1.0,5/14,28.44%,AIM2;IFITM2;CDC34;STAT1;IRGC
prerank,blood vessel morphogenesis (GO:0048514),-0.27788556894016314,-0.962457861366818,0.546572934973638,0.6821962367810612,1.0,19/54,28.11%,RBPJ;NRP1;SYK;FLT1;VEGFA;TGFBR1;TGFBR2;RASA1;SMAD7;ID1;AGGF1;KDR;TGFB1;APLNR;CYP1B1;ADM;ENG;GJA5;CCBE1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.31673981172147836,0.962443386514393,0.49403341288782815,0.7994434782074186,1.0,7/24,10.94%,BMPR1B;SOX5;SOX6;WNT9A;SOX9;MBOAT2;ADAMTS12
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.39630945704361076,-0.9623799443294284,0.5119453924914675,0.6820304775059332,1.0,5/11,34.28%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,negative regulation of neuron death (GO:1901215),-0.25649392818941086,-0.9618824793945687,0.5279187817258884,0.6827596659311267,1.0,28/93,22.96%,APOE;TNFRSF1B;PTK2B;SNX6;BCL2;GRN;MDK;WFS1;MEF2C;ADAM8;CHGA;KIF14;INPP5A;RETREG1;TRAF2;RASA1;EIF4G1;CLN3;FBXO7;CSF1;GSK3B;NDNF;CPEB4;PPT1;CHMP4B;CHMP4A;CDK5;SET
prerank,alpha-amino acid metabolic process (GO:1901605),0.2844264494415316,0.9614720867546963,0.5061124694376528,0.8007397634842046,1.0,12/45,17.50%,ASPA;GOT1;GLUL;ALDH18A1;FOLH1;GPT;ASNS;CBS;GLS2;GLS;RIMKLB;GPT2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3321053142131368,0.961168929514289,0.4858490566037736,0.8003697727494928,1.0,3/22,2.27%,MAP2;MAP1B;MAPRE3
prerank,cellular component maintenance (GO:0043954),0.38296707014287024,0.9608145062537563,0.515625,0.8001601040839124,1.0,4/12,7.73%,MTMR2;LNPK;PRNP;FYN
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.29915079363664954,0.9606252148822009,0.4953051643192488,0.79947007607189,1.0,9/29,20.99%,ELOVL7;HACD1;ACACA;HSD17B8;ACSL3;ACSL6;ELOVL6;FASN;ELOVL2
prerank,negative regulation of GTPase activity (GO:0034260),-0.34113474436733243,-0.960540730283211,0.5128205128205128,0.6853161062801298,1.0,5/22,20.26%,LRCH1;ARFGEF1;TMED2;RASA4;WNK1
prerank,negative regulation of cell activation (GO:0050866),-0.38526390338753624,-0.960066451402849,0.5391459074733096,0.6860091241896533,1.0,1/14,0.16%,APOE
prerank,positive regulation of cellular senescence (GO:2000774),-0.4189836080846227,-0.9600417155119723,0.5087412587412588,0.6857355042689182,1.0,4/10,15.87%,CGAS;B2M;EEF1E1;ARG2
prerank,meiosis I (GO:0007127),0.31877306375650266,0.9596780111619215,0.4927536231884058,0.8006584978972924,1.0,6/23,14.28%,ZCWPW1;TDRD9;PTTG1;MEIKIN;BRDT;MEIOB
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2960287065491941,0.9595194390947027,0.49640287769784175,0.7999231912592939,1.0,8/35,16.50%,PAM;FAR2;HMGCLL1;GGT1;ACACA;ACAT1;HSD17B8;GGT5
prerank,positive regulation of chemotaxis (GO:0050921),-0.28948518893194836,-0.95942618185793,0.5058626465661642,0.6867512663230997,1.0,16/43,22.48%,NRP1;CCR2;P2RX4;IL6R;STX3;VEGFA;MDK;F7;TMSB4X;STX4;PDGFRB;HSPB1;KDR;MEGF8;IL6;TGFB1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2744430944494848,-0.9591223541172255,0.5346020761245674,0.6870900479490651,1.0,18/60,24.74%,NFKB1;RUNX2;MED24;CTNNB1;CBFB;MOV10;CDK1;RELA;MED4;TNRC6C;MED31;DHX36;MED6;MED20;CEBPB;IL6;CCNB1;TRIM28
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.30591304518063,-0.9588471825906408,0.5261437908496732,0.6873650286308488,1.0,7/35,8.18%,NRP1;RAC1;FLNA;PLXND1;SEMA4A;NRP2;SH3BP1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22693494585115193,0.9587188630805307,0.5492227979274611,0.8007809764633305,1.0,23/140,13.58%,HTR2C;CACNA1C;RYR2;CACNA2D1;ADCY8;GRM1;ADCY5;PLCE1;ADRA1B;CX3CR1;TRPM1;JPH4;CCKBR;PLCZ1;AGTR1;EDN1;LPAR2;FFAR1;BCAP31;F2RL2;ADRA1A;ADRA1D;TAC1
prerank,protein localization to nucleus (GO:0034504),-0.2499723489345223,-0.95870691853874,0.5242070116861436,0.6873503937458421,1.0,29/102,23.66%,SYK;IPO5;NUP50;STAT3;HHEX;RPL11;NUP88;E2F3;MORC3;YWHAE;GBP2;TPR;WRN;NUP188;TOR1AIP1;TAF8;APPL2;TAF3;NUP153;FAM53A;APPL1;TNPO3;NUP107;NXT2;NUP62;TOPORS;SPRN;ZBTB7A;LMNA
prerank,regulation of neuron apoptotic process (GO:0043523),0.24514051014803168,0.9587015776277654,0.5637755102040817,0.7996662902422591,1.0,21/96,14.43%,GRID2;TRIM2;NTRK2;EPHA7;GDNF;PRKCI;PRNP;BDNF;PTPRZ1;TGFB2;TFAP2A;NFATC4;FOXQ1;CITED1;TOX3;CDK5R1;TYRO3;VSTM2L;PRKN;LGMN;PPARGC1A
prerank,zymogen activation (GO:0031638),0.28372254221545257,0.9584285792026033,0.5081585081585082,0.7991684612868266,1.0,14/39,21.55%,GRIN2A;OMA1;PRSS12;TBC1D10A;GGT1;F9;LGMN;CIDEB;PERP;KLK1;FADD;KLKB1;MMP14;KLK2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3387808054053459,-0.958016971848673,0.5341506129597198,0.6884612073182138,1.0,8/23,24.60%,PLBD1;PLAAT3;PLA2G4A;PLA2G5;PLA2G12A;LPCAT3;PLA2G6;PNPLA8
prerank,regulation of cell death (GO:0010941),-0.24967114307998148,-0.9579210427836977,0.5247524752475248,0.6883536505244908,1.0,32/94,26.65%,CTSZ;LRP1;CD36;ACER3;TNFRSF1B;ATG5;HTR2B;SLC25A24;NOA1;TXNDC12;RAB29;CELF1;CCL5;SPEF1;CHMP2A;EIF4G1;FAF1;TMEM109;HSPA1A;BNIP3L;ZC3H12A;RILPL1;CHMP4B;HPR;HP;CRYAB;BECN1;CCN4;MT3;CCN2;PDE8A;NCK1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.39834901450963806,-0.9577207470343404,0.5076400679117148,0.6884451345818174,1.0,2/12,5.75%,NELFB;JAG1
prerank,dorsal/ventral pattern formation (GO:0009953),0.33641795588671,0.9572097676693959,0.5136986301369864,0.8011682520182923,1.0,4/20,11.06%,BMPR1B;ACVR1;DSCAML1;NBL1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.41739453656030706,-0.9570655769178148,0.5267857142857143,0.6895171276603544,1.0,4/10,29.58%,CREBBP;KAT7;BAG6;EP300
prerank,female gonad development (GO:0008585),-0.3459292126472484,-0.956904814307959,0.512280701754386,0.689516872450657,1.0,10/19,37.99%,VEGFA;ANG;NUP107;CEBPB;INHA;EIF2B2;EIF2B4;CYP19A1;FSHR;LHCGR
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.32817567895443156,-0.9556241959066679,0.5085910652920962,0.6919962019120843,1.0,7/23,22.37%,BCL2L11;TIMM22;HSPA4;TIMM29;MAIP1;TOMM22;TOMM70
prerank,icosanoid biosynthetic process (GO:0046456),-0.4190555473994508,-0.9554843365269946,0.5340136054421769,0.6919557543298531,1.0,3/10,19.21%,ALOX5AP;PLA2G4A;PLA2G5
prerank,regulation of osteoblast differentiation (GO:0045667),0.2501136079249015,0.955258821295945,0.5384615384615384,0.80501343876204,1.0,25/82,20.67%,NELL1;SOX11;RORB;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;SOX9;BMP7;CITED1;FERMT2;MEN1;ATRAID;REST;NOCT;RIOX1;TMEM64;SMOC1;RANBP3L;PTK2;ACVR2B;LRP3;WWTR1;FBXO5
prerank,lipid oxidation (GO:0034440),-0.39829552825385933,-0.955246570428276,0.5371621621621622,0.692109080155568,1.0,4/12,26.65%,ADIPOR1;PLA2G7;ACOX1;ALOX15
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3769571974070669,0.9549715716385613,0.5034168564920274,0.8045974335312857,1.0,4/13,14.57%,ASPA;GOT1;GLUL;ACOT8
prerank,organic cation transport (GO:0015695),0.32910985952238936,0.9548028331551613,0.5128205128205128,0.8038648587117532,1.0,3/20,5.87%,SLC25A19;SLC47A1;SLC5A7
prerank,positive regulation of phospholipase activity (GO:0010518),-0.33522742121211,-0.9543847250071101,0.5192307692307693,0.6936756064344816,1.0,7/22,19.21%,ABL2;FLT1;GNA13;CCL5;ARL1;PDGFRB;PLA2G5
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3755703247835748,-0.954085560491966,0.5337954939341422,0.693968401166732,1.0,6/14,23.49%,MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,mammary gland epithelium development (GO:0061180),0.3600146045186593,0.9536768357155204,0.5301204819277109,0.8056729284123153,1.0,2/14,3.27%,ERBB4;CSF1R
prerank,negative regulation of cell communication (GO:0010648),0.3324654913343332,0.9522857354818393,0.4927536231884058,0.8081720754600616,1.0,5/21,16.04%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3
prerank,regulation of cell differentiation (GO:0045595),-0.23488521128106193,-0.9521901544718131,0.5793780687397708,0.6977189402977835,1.0,29/148,17.91%,RUNX1;PRKCB;TRPS1;BCL6;CDK6;ROCK1;SLC6A6;CREBBP;RUNX3;FES;RUNX2;ANP32B;MDK;EIF2AK2;CBFB;TGFBR1;DDX5;SIK1;CDK5RAP1;LTBP4;HSP90AB1;GREM1;ID2;TAF8;FLOT2;VHL;SMAD7;PLEKHB1;GATA3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.33614871340860447,0.9521710177027449,0.5049019607843137,0.8072871262111609,1.0,5/20,13.76%,SLC8A3;SLC25A23;LETM1;PMPCB;MICU3
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.24948464330695116,-0.9518313841166908,0.5460420032310178,0.6981209367310641,1.0,21/102,19.29%,MYO5A;RAB8B;DENND4C;PRKCD;ADCY7;INSR;RAB31;PPARG;NFKB1;RHOQ;SELENOS;XBP1;RELA;PKM;RAB10;HDAC5;RAB13;NR4A1;IRS2;ENPP1;RAB12
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3848511959416367,0.9517024918062592,0.5023696682464455,0.8073515836405641,1.0,2/11,9.22%,ZFPM2;TGFB2
prerank,protein complex oligomerization (GO:0051259),-0.25355995950083166,-0.9515186826899805,0.5733113673805601,0.6984777658869102,1.0,28/85,25.43%,LRRC8D;RNF213;PDCD6IP;EHD4;CARD11;NLRC4;LRRC8C;BLM;FUS;ALS2;TMEM120B;PRMT1;SLC9A1;NUDT21;CHMP2A;EHD1;IKZF4;CLDN1;MAT2A;HGSNAT;ZC3H12A;RNF135;TWNK;TRIM72;UPB1;PRF1;ECT2;MS4A1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.24128405986632712,0.9511552804284457,0.5558659217877095,0.8076291029424121,1.0,22/93,16.32%,DMD;NTRK3;TENM1;PDE4D;OPRD1;RAMP3;MLXIPL;BDNF;PRKD1;INPP5J;CREBL2;SPTBN4;CAPRIN2;SH2D3C;RPTOR;NLRP2B;CNOT9;ATP2B4;HSP90AA1;BRAF;CNKSR3;SNCA
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.38290010520840345,0.9511518721029754,0.5174825174825175,0.8064774672990845,1.0,3/12,9.60%,SNAP25;STX2;PRRT2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2846434694533949,-0.9509616949097307,0.5267857142857143,0.6993590147386659,1.0,13/45,26.92%,DAB2;SDCBP;RBPMS;TGFBR1;ACVR2A;TTK;BMPR2;GDF3;INHA;TGFB1;BMP2;SMAD4;ENG
prerank,carbohydrate catabolic process (GO:0016052),-0.29536350533027356,-0.9507420602419183,0.5445378151260504,0.6995388959506518,1.0,15/38,31.22%,GAPDH;DERA;HK3;TPI1;PKM;NEU1;MAN2C1;MAN2B1;PGK1;MANBA;PGM1;PGAM2;ALDOA;PGAM1;PGAM4
prerank,myelin assembly (GO:0032288),0.4043492809308445,0.9504405719880828,0.513715710723192,0.8071991631352741,1.0,2/10,3.87%,TENM4;EPB41L3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.27398492145139397,0.9503704245300598,0.5279069767441861,0.8062259617538754,1.0,7/48,8.83%,ADCY2;ADCY8;PANK3;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,substantia nigra development (GO:0021762),-0.3017351423163488,-0.9502992051087479,0.5383244206773619,0.7001669616327798,1.0,7/37,9.96%,RHOA;ZNF148;CDC42;ACTB;RAD1;YWHAE;SUDS3
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3109886280491345,-0.95021476057477,0.5188834154351396,0.7000028265996754,1.0,4/29,4.56%,FGR;DGKZ;FLT1;PTK2B
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23934234573902483,0.949841800928413,0.5637755102040817,0.8064667132103921,1.0,12/98,8.17%,DPP10;ANK3;SORBS1;PRKCE;TCAF1;TFDP2;RAMP3;MIEF1;PRKCI;PRNP;FYN;MTCL1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.35802191179957166,-0.9484503112557989,0.511864406779661,0.7034346175923363,1.0,6/16,14.12%,RIPOR2;MAPK14;MEF2C;SMYD1;IGFBP3;BTG1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.28023597562467023,-0.9481916156619875,0.5383304940374787,0.7036938785142111,1.0,19/48,29.73%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G5;PLA2G12A;PLA2G6;GPD1L;DGKA;LIPH;LCLAT1;GPAT2;LPCAT4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.38068233483433084,-0.9479272071458665,0.5164075993091537,0.7039611137250804,1.0,4/12,12.52%,RB1;CTNNB1;BUB1;FEN1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3246957456543742,0.94778895489297,0.49635036496350365,0.8105825858537244,1.0,5/20,13.46%,SPRY4;APLN;SMOC2;CREB3L1;SPRY1
prerank,mitochondrial membrane organization (GO:0007006),-0.3041452951730593,-0.947439272382787,0.5376532399299475,0.7046882947077356,1.0,13/32,29.98%,HSPA9;BCL2;MICOS13;TMEM11;GHITM;SLC25A4;MAIP1;MTX1;BCL2L1;SLC25A31;DNAJC11;BNIP3;CHCHD6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3375218789792333,0.9474079663209822,0.5349887133182845,0.8104312418081683,1.0,3/18,7.13%,SOX6;CCN3;BDNF
prerank,secretion (GO:0046903),0.3625584228869726,0.9467732012604053,0.5045045045045045,0.8108934473560768,1.0,4/14,18.29%,RIMS1;PRKCI;ABCB11;FBLN5
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.27428628108653014,-0.9467643860775908,0.525963149078727,0.7057497940446216,1.0,10/55,10.63%,CD44;HEXA;LYVE1;HPSE;GNS;GALNS;GUSB;SLC9A1;SDC4;PRELP
prerank,artery development (GO:0060840),0.3244758728104608,0.9461497937329162,0.5348258706467661,0.8113995825663702,1.0,2/23,0.73%,ROBO1;ROBO2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.24081522659950858,-0.9459161767981594,0.5747899159663865,0.7072418948312547,1.0,28/113,21.14%,NRP1;IGF1;NOTCH2;RREB1;C5AR1;HTR2B;GRN;NRP2;VEGFA;NME1;MDK;TGFBR1;JAML;HIF1A;ARNT;XBP1;OSR1;HMGB2;PIK3CD;NR4A1;CLDN1;NRAS;ANG;BMPR2;NOD2;AGGF1;SFRP1;KDR
prerank,bicarbonate transport (GO:0015701),0.3101440585526399,0.9456079697901715,0.543778801843318,0.8115659079377314,1.0,4/25,10.11%,SLC4A10;SLC4A4;CA2;SLC4A11
prerank,regulation of isotype switching (GO:0045191),-0.3735744550570413,-0.9453707925109359,0.5478723404255319,0.708080773072273,1.0,4/14,23.13%,KMT5B;KMT5C;SHLD2;SLC15A4
prerank,tRNA methylation (GO:0030488),-0.30103869821279106,-0.9450845405388979,0.5273972602739726,0.7084138301169529,1.0,13/34,34.22%,METTL1;PRORP;DALRD3;TRMT44;METTL6;BCDIN3D;METTL2A;METTL2B;THADA;HSD17B10;FTSJ1;TRMT61A;TRMT61B
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.22452788081838765,-0.9448808176072954,0.5880452342487884,0.7085252156429062,1.0,43/199,19.88%,RBPJ;ATP2B1;PAEP;CORO1C;RB1;ROCK1;SPI1;RAB11FIP5;IL15;TLR4;SRGN;ADIPOR1;PTGER4;NR1H2;LNPEP;PLCL2;GRN;GAS6;SDHAF2;MDK;TLE3;MEF2C;SPRY2;SPRED1;FLCN;ACOT13;SPRED2;FCGR2B;STK11;LDLRAD4;IL18R1;VASN;SMAD7;TFE3;GATA3;PTPRO;IL17RD;ID1;RHEB;BMPR2;WDR77;GSK3B;AGER
prerank,regulation of endopeptidase activity (GO:0052548),0.2548548695408614,0.944702425678787,0.5731414868105515,0.8128087921968312,1.0,5/59,4.81%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.3020157855470467,-0.9445916291671571,0.5313588850174216,0.7087898477848213,1.0,14/31,33.23%,RTEL1;PKIB;DHX36;TNKS2;SLX4;ATM;NBN;MAPK1;PML;MRE11;MAPK15;MAP3K4;NEK7;TNKS
prerank,regulation of axon extension (GO:0030516),-0.29882506891930183,-0.9445404261128394,0.5429553264604811,0.7085592870130426,1.0,5/37,5.68%,APOE;DNM2;GOLGA4;RUFY3;MACF1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.26100976889936683,-0.9440450242912186,0.5647058823529412,0.7093060774779758,1.0,18/72,16.01%,APOE;PRKCD;ATXN7;ARHGEF2;ARFGEF1;CYRIB;MYADM;LIMA1;TPX2;TAOK1;DYRK1A;PIK3CA;CHADL;SSH3;CIB1;SPEF1;SSH1;STMN2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.3987758687537408,-0.9433717074093274,0.5654362416107382,0.710491103690778,1.0,3/12,27.61%,DR1;GTF2A2;POLR1E
prerank,regulation of neurogenesis (GO:0050767),0.2627652338542515,0.9431104726418803,0.5679611650485437,0.8157035900018278,1.0,17/55,19.55%,SOX11;MME;YAP1;HOOK3;NUMB;CX3CR1;RASSF10;HES5;PER2;REST;HES1;OPRM1;PRUNE1;HES3;DOCK7;SNW1;PCM1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.31912668181307335,-0.9427680323076653,0.5617597292724196,0.7114588492113323,1.0,13/27,30.90%,ERN1;RNASE4;KHNYN;NYNRIN;RNASE6;CPSF3;ZC3H12A;NHP2;NUDT16;LACTB2;ZC3H12D;ZC3H12C;POP1
prerank,regulation of ERAD pathway (GO:1904292),-0.40783825818938874,-0.9426918785694356,0.5555555555555556,0.7113062894605389,1.0,5/11,21.36%,ATXN3;RNF185;TMEM259;UBXN1;BAG6
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2891482418590252,-0.9424255852741111,0.5536028119507909,0.7115892768095456,1.0,19/37,41.01%,ENTPD6;DNASE1L1;RNASE6;NCBP1;ENTPD3;XRN2;NUDT15;MTREX;SND1;RNASEH2B;NUDT16;ISG20;ENTPD7;NUDT1;DNASE1;RNASE3;NUDT5;DNASE1L2;RNASEH2A
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3646028105390341,-0.9419622722138715,0.558974358974359,0.7122395204900971,1.0,1/15,0.19%,PRKCH
prerank,organelle fission (GO:0048285),-0.32183639609998793,-0.941718647354684,0.5428051001821493,0.7124320005235176,1.0,3/24,1.66%,TMCC1;CORO1C;DNM2
prerank,regulation of fat cell differentiation (GO:0045598),-0.25939145448423456,-0.9414700375824805,0.5792079207920792,0.7126237153780037,1.0,30/74,26.31%,PPARD;PPARG;MEDAG;E2F1;LPL;ASXL1;TRIB2;XBP1;WDFY2;FTO;CCDC85B;TRIO;ID2;TAF8;GATA3;CMKLR1;ENPP1;GDF3;SIRT2;ZC3H12A;SFRP1;ANKRD26;CEBPB;IL6;TGFB1;ADIG;ZBTB16;GPS2;ZFP36L1;BMP2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.22299543061756316,0.9412404276558002,0.596816976127321,0.8193396903324618,1.0,24/142,13.85%,CACNA1C;TRPC5;RYR2;ADCY8;HCRTR2;TRPC1;ADCY5;PLCE1;ADRA1B;CX3CR1;CCKBR;SLC8A2;PLCZ1;RYR1;AGTR1;EDN1;CALCB;LPAR2;FFAR1;BCAP31;ADRA1A;ADRA1D;TAC1;ATP2B4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.27353321830840016,-0.9407505271386211,0.5606326889279437,0.71385159423743,1.0,8/53,12.58%,APOE;NUPR1;GNA12;UCHL5;PSME3;RHBDF1;PSMC3;HSP90AB1
prerank,embryonic digit morphogenesis (GO:0042733),-0.3500384346955017,-0.940444292366303,0.5505226480836237,0.7141728838638864,1.0,3/18,11.39%,CREBBP;MAP3K20;OSR1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2743316550115815,-0.9403870297116944,0.5372881355932203,0.7139462143534042,1.0,18/54,25.39%,RPL7;RPL11;RPL10A;NVL;RPL14;RPL6;PAK1IP1;SURF6;RPL23A;GTF3A;NIP7;BRIX1;SNU13;RPL7A;WDR12;RPLP0;NHP2;RPL5
prerank,inositol phosphate metabolic process (GO:0043647),0.2737398018691722,0.9402836551575743,0.541371158392435,0.8206351496287381,1.0,12/46,12.54%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,protein secretion (GO:0009306),0.26134720277017714,0.9396648212107993,0.556930693069307,0.8210860358601743,1.0,6/56,5.56%,RIMS2;OLFM2;PCSK5;RAB3C;RAB15;MAFA
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.3938089553270022,-0.9394527717910086,0.5481099656357389,0.7157103967167223,1.0,6/12,35.01%,BRCA1;YTHDC1;CDYL;RBM15B;METTL3;SMCHD1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3356481063810063,-0.9393738155765177,0.536283185840708,0.7155384518892215,1.0,4/21,10.63%,MFHAS1;MASTL;YWHAE;STYXL1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3316930778686658,0.939328548968431,0.5393518518518519,0.8207836084054746,1.0,6/20,15.91%,MAPRE3;TTBK1;CCNYL1;PKD1;SPDYA;ADAM17
prerank,protein dephosphorylation (GO:0006470),0.2220643475320232,0.9389612892847251,0.5879265091863517,0.8205914909430622,1.0,18/135,8.86%,PTPRD;PTPRG;PPP2R2B;PTPRN2;PTPRR;PTPRT;PPM1E;MTMR2;EYA2;PTPRK;PTPN3;TNS2;PPTC7;RPRD1A;PTPRB;PPP2R1B;PPP2R2A;PTPRZ1
prerank,positive regulation of ion transport (GO:0043270),-0.2808808316572591,-0.9381244575398535,0.5721649484536082,0.7179116041909465,1.0,13/48,17.90%,ATP2B1;P2RX7;ANO6;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SCN4B;SCN3B;CHRNB2;LILRA5;SNX4
prerank,regulation of lipid metabolic process (GO:0019216),-0.251820155039843,-0.937761871516932,0.5853658536585366,0.7183533678809295,1.0,18/88,14.88%,PSAP;CREBBP;PPARD;PANK2;NFYA;PRKAG2;PPARG;ADIPOR1;SMARCD3;TBL1XR1;EDF1;HELZ2;NPC2;IDI1;RXRA;SIN3A;ID2;ACACB
prerank,skin development (GO:0043588),-0.26060977344473035,-0.9376780699954569,0.5804794520547946,0.7181949347003859,1.0,16/65,25.66%,CLIC4;ATP7A;ANXA1;ADAM9;JAG1;ITGA3;CLDN1;PIP5K1A;TXNIP;PDGFA;SFN;ASAH1;LSR;COL5A2;DSP;CERS3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3054825800095919,0.9376232097612676,0.5210643015521065,0.8217142245251636,1.0,12/29,23.00%,GLYAT;ACSM5;ACAT1;ACOT8;MLYCD;ACSM3;ACOT12;CROT;ACSL6;ACOT7;GPAT4;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3054825800095919,0.9376232097612676,0.5210643015521065,0.8217142245251636,1.0,12/29,23.00%,GLYAT;ACSM5;ACAT1;ACOT8;MLYCD;ACSM3;ACOT12;CROT;ACSL6;ACOT7;GPAT4;OXSM
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.3471366958456541,-0.9375814979113476,0.5746924428822495,0.7180581237721566,1.0,3/18,9.47%,BCL2L11;ANXA1;UBE2L3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3801621463175994,-0.93699548555206,0.5502555366269165,0.7190015358713008,1.0,3/13,9.38%,RBPJ;PIM1;MEF2C
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3022480112324529,-0.9369180815181518,0.5515463917525774,0.7188279464618713,1.0,10/33,16.84%,RAB11FIP5;STX3;SNX33;PICALM;CTNNB1;NEDD4L;RAB11B;HSP90AB1;LEPROTL1;STX4
prerank,apoptotic nuclear changes (GO:0030262),-0.32483297715292997,-0.9363070794245664,0.577054794520548,0.7197828567577683,1.0,9/24,26.04%,TOP2A;ACIN1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2;DEDD2;ERN2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.35846506625993724,-0.9356501178717084,0.5623869801084991,0.7208515599193699,1.0,7/16,28.05%,RC3H1;MOV10;DHX36;ZC3H12A;TARDBP;ZFP36L1;ZC3H12D
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.30945658286207745,-0.9350704197835683,0.561525129982669,0.7217791440640963,1.0,13/29,29.87%,CREBBP;CTNNB1;TLE3;KMT2D;TCF7;TLE4;MYC;RBBP5;ASH2L;BCL9;LEF1;EP300;TLE2
prerank,chondrocyte differentiation (GO:0002062),0.29136797323333424,0.9350509968425359,0.5526315789473685,0.8270587788502762,1.0,9/32,11.95%,NFIB;BMPR1B;SOX5;SOX6;CCN3;HMGA2;SOX9;AMELX;HES5
prerank,rRNA transcription (GO:0009303),-0.3530019375124006,-0.9345958290250826,0.541095890410959,0.7224790021635111,1.0,7/17,27.61%,SPIN1;NIFK;ANG;GTF3C5;GTF3A;BRF1;POLR1E
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.34399450106294754,-0.93448648691471,0.5694682675814752,0.7223741766153994,1.0,4/20,9.99%,IMPDH2;HPRT1;ADSS1;NT5C2
prerank,response to cholesterol (GO:0070723),-0.35515388696469247,-0.9344273342201009,0.5452991452991452,0.7221515041630432,1.0,7/17,24.70%,GRAMD1B;LRP6;TGFBR1;TGFBR2;TGFB1;GPLD1;ABCA2
prerank,cellular response to gamma radiation (GO:0071480),-0.35709262521085333,-0.9340124052338313,0.5420393559928444,0.7227109291453748,1.0,7/17,22.40%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;CRYAB
prerank,vitamin D metabolic process (GO:0042359),0.3713261434327265,0.9336178904867722,0.508557457212714,0.8295328080229598,1.0,4/13,15.22%,CUBN;CYP1A1;LGMN;GC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3922573068561601,-0.9328705385386509,0.5498281786941581,0.724799946792173,1.0,1/11,0.70%,SP100
prerank,positive regulation of bone mineralization (GO:0030501),0.28749309645367954,0.9323910430570657,0.6009732360097324,0.8315056009902257,1.0,8/35,9.36%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TFAP2A
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.29950771693667966,-0.932320224315044,0.5741379310344827,0.7256197207827533,1.0,9/33,18.00%,IGF1;SLC35F6;HGF;VAT1;FLCN;GHITM;HSPA1A;ACAA2;HUWE1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3196295250894328,0.9321047835750933,0.5558035714285714,0.8310877699051136,1.0,6/22,12.34%,EPB41L4B;PTPRK;FGF10;PRKD1;AREG;KLF9
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2917789687412271,0.9319299465347779,0.5920745920745921,0.8303676047298496,1.0,13/32,21.68%,MAGI2;CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3637936297396144,-0.9313661184610953,0.5460869565217391,0.7273510878281243,1.0,6/15,31.85%,LILRB1;TMBIM6;PLN;INPP5K;PACSIN3;SLC30A1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.277906838529662,-0.9308927240193776,0.5846153846153846,0.7280529586052235,1.0,18/46,29.73%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G5;PLA2G12A;GPD1L;DGKA;LIPH;LCLAT1;GPAT2;LPCAT4
prerank,regulation of mRNA processing (GO:0050684),-0.3055750926988732,-0.9308700984631806,0.5851979345955249,0.7277648319165753,1.0,14/32,28.45%,RBM39;SON;DHX9;CWC22;YTHDC1;NCBP1;SRSF10;PAPOLA;SRPK1;HNRNPK;PTCD2;LARP7;ZFP36L1;SAFB
prerank,glutamate metabolic process (GO:0006536),0.32529095920085993,0.9308523040438762,0.5252293577981652,0.8320476952042011,1.0,7/19,17.37%,GOT1;GLUL;ALDH18A1;GGT1;GLS2;GLS;ALDH5A1
prerank,xenobiotic transport (GO:0042908),-0.3495876171248421,-0.9301262480256336,0.5519031141868512,0.7289994757899939,1.0,10/17,38.46%,ABCC1;SLC7A5;SLC22A18;SLC22A3;ABCC3;ABCA3;GJA1;NR1I2;SLC22A2;SLC29A4
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.33184410006295506,-0.9298438679952511,0.5618181818181818,0.7292203583759785,1.0,11/24,35.42%,SLC27A1;PLA2G4A;PLA2G5;PLA2G12A;PNPLA8;PLA2G15;LPCAT4;ABCA3;PGS1;PLA2G3;PLA2G4B
prerank,endothelial cell proliferation (GO:0001935),-0.3459637127997854,-0.929610387017426,0.554806070826307,0.7293817341629463,1.0,5/17,23.10%,ERN1;THAP1;ITGB1BP1;BMPR2;HMOX1
prerank,mRNA stabilization (GO:0048255),-0.28274506247897196,-0.9293459315181424,0.5896551724137931,0.7296154669022109,1.0,8/40,13.09%,MAPKAPK2;DHX9;MAPK14;FUS;E2F1;MYD88;TENT5A;BOLL
prerank,ovarian follicle development (GO:0001541),-0.37019615556628893,-0.9290998228987718,0.5508021390374331,0.7298213719494137,1.0,6/13,28.13%,VEGFA;ANG;CEBPB;INHA;EIF2B2;EIF2B4
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.31920098613161463,-0.9290725847518967,0.5551537070524413,0.7295435753237229,1.0,5/25,12.60%,NRP1;SDCBP;NCKAP1L;APP;CCL5
prerank,visual system development (GO:0150063),-0.28972509808364444,-0.9288195515785042,0.5794701986754967,0.7297579414038237,1.0,6/37,7.87%,SH3PXD2B;C1QA;C3;SMG9;ATF6;SIPA1L3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3741461286656601,-0.9281650505004098,0.5602836879432624,0.7308509163741216,1.0,4/13,10.85%,GNAI3;RHOQ;EFL1;GTPBP1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3327662203333385,0.9281285408487057,0.5606407322654462,0.8378521965313732,1.0,5/17,15.91%,MAPRE3;CCNYL1;PKD1;SPDYA;ADAM17
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3008514372655219,0.9271331641423483,0.5536992840095465,0.8391277190511555,1.0,4/27,8.73%,FGF12;SCN2B;PTPN3;FXYD6
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2294656622026769,0.9271297706805882,0.6184538653366584,0.8379711162040732,1.0,29/101,20.88%,ROBO1;TENM1;MAPRE3;ETAA1;PDGFD;CSF1R;EGF;CCNYL1;HMGA2;SLC8A2;EDN1;PKD1;RPTOR;FERMT2;SPDYA;CALM1;CALM3;CALM2;ATP2B4;ADAM17;SNCA;PIH1D1;TELO2;TPD52L1;IRAK1;WNT5A;SIRT1;KIT;HRAS
prerank,apoptotic cell clearance (GO:0043277),0.2946650850317574,0.9268616399516196,0.5727482678983834,0.8374532717530202,1.0,5/30,6.44%,XKR4;XKR6;RHOBTB2;ITGB3;XKR8
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29091198007411523,-0.9266364578424617,0.5824742268041238,0.733765692677258,1.0,16/35,29.06%,ZMIZ1;KDM3A;PMEPA1;ARID1A;WBP2;DDX5;UBE3A;CALCOCO1;PPARGC1B;NR3C1;DDX54;ESR2;TADA3;SAFB;ESR1;DDX17
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2832812897738711,0.9259054055343288,0.5652173913043478,0.8386988222723316,1.0,16/36,22.63%,TGFA;EGF;SHANK3;FBXW7;AREG;ADRA2C;EDN1;RELN;ARC;JAK2;ADAM17;CCL2;NCOA3;HDAC2;NLGN3;HDAC6
prerank,fatty acid metabolic process (GO:0006631),-0.2345868829951261,-0.9258983600310235,0.6174496644295302,0.7349837471637493,1.0,29/115,27.87%,AOAH;CD36;PPARD;ABCD2;PPARG;CPT1A;ADIPOR1;ALOX5AP;ACADM;LPL;XBP1;ACSL5;GPX4;PON2;ACOX1;MCAT;ABCD3;ACOT2;ACOT4;ACSBG1;ACAD9;ECHDC3;PNPLA8;PON3;SLC27A3;PLA2G15;ALOX15;LIPH;ACOT11
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34930160013132133,-0.9255639745962762,0.5684039087947883,0.7353861799761313,1.0,5/18,22.37%,NFE2L2;HIF1A;MAPK7;HSPB1;NONO
prerank,polyol metabolic process (GO:0019751),0.26884520409526813,0.9254288369354561,0.5870069605568445,0.838783471344784,1.0,12/46,12.54%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,regulation of phospholipase activity (GO:0010517),-0.4038892501757402,-0.9250333554700321,0.5471698113207547,0.7361683451697772,1.0,1/10,1.16%,LRP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2624787338787766,-0.9244974996185344,0.5983471074380166,0.7369933333499294,1.0,18/59,24.19%,PRKCD;ROCK1;CSNK2A1;DYRK2;TGFBR1;DYRK1A;CDK1;MAP2K1;MARK2;TGFBR2;MAP3K10;GSK3B;CHEK1;CDC42BPG;WNK1;CDK5;MAPK1;PRKDC
prerank,protein depolymerization (GO:0051261),-0.31611813785201104,-0.9242934594550267,0.6017094017094017,0.737075802547107,1.0,10/27,19.62%,CKAP5;WDR1;KIF14;MICAL1;MICAL2;KIF2C;STMN2;KIF18B;TWF2;CFL1
prerank,positive regulation of cell development (GO:0010720),0.2955262961689866,0.9237321707611654,0.5566265060240964,0.8418992525053266,1.0,9/31,19.24%,SOX11;MME;NUMB;CX3CR1;RASSF10;RFX3;OPRM1;PDE3A;SNW1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.35425525560881554,-0.9232837274820861,0.5801801801801801,0.7390108504135653,1.0,6/16,19.84%,RTEL1;DHX36;TNKS2;ERCC4;SLX4;ATM
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3395543438369546,-0.9227844050488864,0.5813559322033899,0.7397469559416461,1.0,7/18,32.10%,FLNA;POLR2L;MAF1;RASL11A;UBTF;EIF2AK3;ATF4
prerank,regulation of DNA metabolic process (GO:0051052),-0.28225495055410416,-0.9223149665070722,0.5782537067545305,0.7403965797818782,1.0,15/44,25.07%,NUCKS1;IL7R;ALYREF;KAT7;TICRR;RADX;MPV17;WDR70;PDGFA;NBN;HDAC8;SMG1;MYC;UBE2V2;UBE2N
prerank,negative regulation of glycolytic process (GO:0045820),-0.40785433938742377,-0.9219551835511273,0.5661641541038526,0.740459684268692,1.0,2/10,5.92%,NUPR1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.40785433938742377,-0.9219551835511273,0.5661641541038526,0.740459684268692,1.0,2/10,5.92%,NUPR1;CBFA2T3
prerank,dopamine metabolic process (GO:0042417),0.335461229681468,0.9208599129079174,0.5767441860465117,0.8481025421680556,1.0,6/18,16.32%,SNCAIP;MAOA;TGFB2;MAOB;PRKN;SNCA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32345324730418085,-0.9201499701152176,0.5843270868824532,0.7439662825971679,1.0,13/23,30.39%,LTBP4;ITGA3;LATS2;SMAD7;SMURF2;EID2;TGFB1;SMAD4;ENG;BCL9;DKK3;NREP;SMAD2
prerank,positive regulation of protein secretion (GO:0050714),-0.2564601616764701,-0.9200156235175202,0.5962199312714777,0.7438950962379207,1.0,9/69,11.07%,IGF1;ABCG1;TLR4;TMED10;ADAM9;GOLPH3L;WLS;ADAM8;MYOM1
prerank,negative regulation of histone methylation (GO:0031061),-0.4075346291427934,-0.9197623621768146,0.5782073813708261,0.7440841946964925,1.0,3/10,8.44%,BRCA1;JARID2;WDR5
prerank,positive regulation of response to wounding (GO:1903036),-0.320805276084483,-0.9196857299192287,0.5706984667802385,0.7439017934977743,1.0,5/24,7.95%,ITGB1;ARFGEF1;ANXA1;GRN;MDK
prerank,oligodendrocyte development (GO:0014003),-0.347315573696637,-0.9196693114375994,0.576592082616179,0.7435975543066723,1.0,6/15,28.13%,B4GALT5;EIF2B3;SOX10;EIF2B1;EIF2B2;EIF2B4
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.34095092844004216,-0.9195810247116082,0.580267558528428,0.7434263748603356,1.0,2/18,1.40%,RUNX1;RB1
prerank,positive regulation of protein transport (GO:0051222),-0.25401676279118396,-0.9195570171500382,0.6314907872696818,0.7431385862301568,1.0,16/67,18.32%,IGF1;ABCG1;TMED10;RUFY3;KIF20B;ADAM9;GOLPH3L;ADAM8;MYOM1;TPR;RAB29;PLK3;CLN3;ARHGEF5;PCNT;ANG
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3042331152653652,-0.919268284171065,0.5916230366492147,0.7434363401984089,1.0,13/29,33.89%,PAK2;RIPK1;AGT;TRAF2;BID;TNFSF10;SFRP1;DEDD2;PML;AGTR2;BCL10;CAV1;TNF
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.37937255540284553,-0.9189750831236774,0.5776293823038398,0.7437201610066897,1.0,4/12,24.95%,IMPDH2;ADSS1;PFAS;ATIC
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.28324537487509394,-0.9186477178741385,0.6113989637305699,0.7440679947365356,1.0,10/38,17.49%,PTPRC;NEDD9;RAP2B;MVP;GAS6;APP;AGT;IL34;GPRC5B;LILRA5
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3146103428640225,0.9184882809311141,0.5548245614035088,0.8527382282310882,1.0,7/21,17.63%,PDE4D;PDE9A;NUDT11;NUDT7;ACAT1;MLYCD;NUDT3
prerank,import into cell (GO:0098657),-0.28206077005593017,-0.9182778490786112,0.6020236087689713,0.7445019259235778,1.0,13/41,25.71%,LRRC8D;SLC6A6;SLC27A1;LRRC8C;SLC12A7;SLC12A6;SLC7A5;SLC5A3;SLC29A1;SLC11A2;LRP2;LRSAM1;NEURL1B
prerank,modulation by host of symbiont process (GO:0051851),-0.2986503186700681,-0.9179375132152235,0.5889464594127807,0.7448791962348472,1.0,12/31,31.43%,JUN;SAP30;NUCKS1;CCL5;TFAP4;LRRC19;TARDBP;INPP5K;LEF1;AQP1;EP300;CCL4
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3814687244130933,-0.9177223059102743,0.5697478991596638,0.7449897165185334,1.0,6/12,25.52%,JUN;PSMC3;CCL5;TFAP4;TARDBP;INPP5K
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.34947911301933365,-0.9173739616351024,0.5762411347517731,0.7454129697311316,1.0,9/16,29.06%,ARID1A;DDX5;PPARGC1B;DDX54;ESR2;TADA3;SAFB;ESR1;DDX17
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2878691323055086,0.9169357619586349,0.592964824120603,0.85550920171274,1.0,3/34,2.63%,RORA;ZFPM2;RUNX1T1
prerank,response to iron ion (GO:0010039),-0.38415578498739295,-0.9165370677511384,0.5899814471243042,0.7469106710793412,1.0,3/12,9.13%,BCL2;B2M;HIF1A
prerank,amino acid import (GO:0043090),0.31539357375601507,0.9165127194742666,0.5569948186528497,0.8553801985574178,1.0,7/21,13.92%,SLC47A1;SLC1A1;SLC6A1;SLC6A13;SFXN3;SLC25A38;SLC16A2
prerank,in utero embryonic development (GO:0001701),-0.31665014539312564,-0.9164797675987442,0.6,0.7466814626236405,1.0,5/25,11.09%,MBNL1;ZNF568;VEGFA;TGFBR1;FLCN
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.39836473343323736,-0.9161454659536153,0.5736568457538995,0.7470608280687291,1.0,2/10,14.63%,SP100;TFAP4
prerank,ganglion development (GO:0061548),-0.40074610168354324,-0.9161425878699482,0.5857664233576643,0.7467195525437398,1.0,3/11,7.24%,NRP1;CTNNB1;NRP2
prerank,heart morphogenesis (GO:0003007),0.25890564010393474,0.9155378927270084,0.6043689320388349,0.8566300321842311,1.0,11/50,14.06%,RYR2;ACVR1;DLC1;SOX9;TGFB2;TBX1;TTN;ALPK2;EPHB4;FLRT2;HES1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31278954187277364,0.9154518197642548,0.5892857142857143,0.8556899764483188,1.0,8/21,16.22%,SLC8A3;SLC25A23;LETM1;FATE1;BCAP31;MICU3;ATP2A1;PDZD8
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.30851580860302985,-0.9151470771596086,0.5753176043557169,0.7485226102056387,1.0,9/27,24.78%,NIBAN2;PARP4;HGF;PDGFRB;BMPR2;ATM;PDGFA;MYC;FGFR4
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.3600359809522223,-0.9149851533027704,0.6144781144781145,0.7485263524871709,1.0,8/15,27.03%,LRP1;DPP4;FAP;CST3;IL6;TGFB1;FGFR4;PDPN
prerank,regulation of TORC1 signaling (GO:1903432),-0.29012346895708396,-0.914925896764607,0.6098807495741057,0.74831390591775,1.0,7/33,12.77%,GPR137B;KLHL22;PIP4P1;FLCN;RRAGD;SESN1;STK11
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3892140303394658,-0.9141785187016457,0.5884353741496599,0.7495231838891101,1.0,2/11,2.68%,IGF1;IGF1R
prerank,extracellular matrix organization (GO:0030198),0.19613300869307465,0.9141563788794982,0.7888888888888889,0.8577179719391258,1.0,71/276,20.74%,ADAM12;MMP16;TNR;P3H2;ADAMTS17;COL27A1;SCUBE1;LAMC3;TLL1;MMP12;DST;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;GPM6B;VCAM1;MMP15;ITGB3;ITGA9;VIT;COLGALT2;COL25A1;THSD4;COL4A3;PLOD2;COL23A1;COL19A1;CD151;TGFB2;MMP13;HAS2;SMOC2;GSN;ADAMTS12;CTSK;TTR;HTRA1;BMP1;COL7A1;ADAMTS5;ITGA11;CREB3L1;FLRT2;ADAMTS6;CDH1;CAPNS2;COL24A1;NID2;SPARC;CAPN2;ADAMTSL2;ST7;FBLN5;COL1A1;LAMA2;LOXL1;LAMA5;COL26A1;TNC;SMOC1;KLKB1;LOX;SH3PXD2A;COL4A4;JAM3;NID1;ITGA2B;MMP14
prerank,autophagy of mitochondrion (GO:0000422),-0.28307710375068657,-0.9137676919822096,0.6051724137931035,0.7500822594461795,1.0,9/38,17.54%,ATG5;ATG7;ULK2;FIS1;MARK2;RB1CC1;GABARAP;USP30;FBXO7
prerank,cellular response to hypoxia (GO:0071456),-0.22946035533999926,-0.9137355644210988,0.6501650165016502,0.7498100501312808,1.0,47/126,27.58%,CREBBP;BACH1;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;ADAM8;UBC;RPS27A;ARNT;PSMC3;HP1BP3;PSMD8;PLK3;PSMC4;PSMB10;CUL2;PSMA1;VHL;PGK1;PSMB8;BNIP3L;ACAA2;HYOU1;MDM4;PSMD4;PSMA5;NDNF;PSMB3;SIRT2;ELOC;PSMD3;SFRP1;P4HB;HMOX1;LMNA;MYC;PSMB1;MT3;ZFP36L1;HIGD1A;CARD16;PSMA7
prerank,protein targeting to mitochondrion (GO:0006626),-0.26500499343635103,-0.9132648922340126,0.6382608695652174,0.750498405530049,1.0,15/52,22.68%,IMMP2L;PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;HSPA4;TIMM29;FBXO7;GRPEL2;TOMM22;TOMM34;TOMM70;TOMM20L
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.30075019291308847,-0.9127684027788393,0.6093189964157706,0.751178788907054,1.0,10/30,24.54%,MGAT5;ALG5;DPM3;MAGT1;ST6GAL1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,cardiac myofibril assembly (GO:0055003),-0.3549762527979096,-0.9126797463879455,0.578125,0.7510379500550224,1.0,2/15,7.45%,MEF2A;NRAP
prerank,negative regulation of macrophage activation (GO:0043031),-0.3487339978786482,-0.9121781386251696,0.5893470790378007,0.7517174621292861,1.0,7/16,20.67%,PTPRC;GRN;FCGR2B;CST7;IL31RA;LDLR;ZC3H12A
prerank,peptidyl-arginine modification (GO:0018195),-0.35547109800753013,-0.9115366349882349,0.6161971830985915,0.7527374839364521,1.0,7/15,38.96%,PRMT1;PADI4;ART4;PRMT5;KRTCAP2;PADI1;PRMT8
prerank,protein localization to microtubule organizing center (GO:1905508),-0.34957674206776557,-0.9113694194450664,0.5590828924162258,0.7527787301070774,1.0,2/15,3.83%,SNX10;PIBF1
prerank,epithelium development (GO:0060429),-0.2375940990518987,-0.9113189570074628,0.6507413509060955,0.7525365789232986,1.0,33/107,29.49%,CTSB;ANXA4;TAGLN2;PPARG;CPT1A;VEGFA;RCN3;TIMELESS;CDK1;OSR1;PCNA;FOXJ1;CBR1;TPP1;SOX10;STIL;PGK1;WNT3;EHF;STAT1;KDR;TBX2;SNAI2;ANXA7;TGFB1;ACADVL;VDAC1;WNT7B;BMP2;SPINK5;IFT122;GRHL2;PAX2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3489843677104342,-0.9112659165386854,0.6020761245674741,0.7522907078190273,1.0,3/16,10.99%,CREBBP;NAA25;NAA50
prerank,regulation of protein localization to centrosome (GO:1904779),0.39716184229782864,0.9109421216481404,0.5474452554744526,0.8644545990633492,1.0,4/10,18.57%,BICD1;NSFL1C;UBXN2B;PARD6A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.35872168801879495,-0.9103059619258119,0.5759162303664922,0.7539614764498878,1.0,4/14,13.42%,NRP1;VEGFA;PIK3CA;PIK3CD
prerank,extracellular matrix assembly (GO:0085029),0.30734444789822174,0.91007865971745,0.5845771144278606,0.8653989346072967,1.0,9/23,22.23%,NTNG2;NTNG1;GPM6B;HAS2;RAMP2;FBLN5;EFEMP2;TNXB;NTN4
prerank,Rac protein signal transduction (GO:0016601),0.32929293458923964,0.909869834746566,0.5808080808080808,0.864769297307989,1.0,5/18,11.03%,CDH13;WASF1;ABI2;NCKAP1;FARP2
prerank,modulation by symbiont of entry into host (GO:0052372),0.34275769388419236,0.9096047030110832,0.5857461024498887,0.8642543123499058,1.0,1/16,0.53%,HS3ST5
prerank,protein palmitoylation (GO:0018345),-0.3012515717518246,-0.9094625254376086,0.6041666666666666,0.7553651858423509,1.0,10/30,24.98%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,bone morphogenesis (GO:0060349),0.3491160890549787,0.9091526938634023,0.533175355450237,0.8642973402956954,1.0,3/14,10.28%,BMPR1B;TFAP2A;MMP13
prerank,response to ATP (GO:0033198),-0.3354996495950216,-0.9089045292825487,0.5918727915194346,0.7561963059273311,1.0,4/18,15.27%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,cellular response to ATP (GO:0071318),-0.35801951050740266,-0.9088343714179205,0.5676625659050967,0.7560003590029503,1.0,4/14,15.27%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3158453709155862,0.9085004608322585,0.5938967136150235,0.8647019755329735,1.0,5/22,13.92%,TAFA1;TOX;PTPRZ1;RASSF10;SLC16A2
prerank,polyol biosynthetic process (GO:0046173),-0.3526728354634969,-0.9076259812418018,0.6096256684491979,0.7581506500219938,1.0,7/16,26.14%,ACER3;ITPKB;CYP27A1;CYP2R1;IP6K3;ITPKC;IP6K1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.36481558007015147,0.9070209664285306,0.5660377358490566,0.8672180555820862,1.0,2/12,3.07%,PRKG1;IGFBP5
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.35424934499049054,-0.9065853982615782,0.592057761732852,0.7599772161673946,1.0,3/15,14.89%,IGF1;HGF;GHITM
prerank,negative regulation of chemokine production (GO:0032682),-0.3571533988951504,-0.9065354492583827,0.5785714285714286,0.7597298583504465,1.0,7/14,28.55%,SIRPA;MAP2K5;OAS3;LGALS9;IL6;MEFV;SIGIRR
prerank,regulation of multicellular organism growth (GO:0040014),-0.357954885436526,-0.9064192789722021,0.6033898305084746,0.7596145675154988,1.0,3/15,10.43%,IGF1;STAT5B;APP
prerank,spliceosomal complex assembly (GO:0000245),-0.2719465862000941,-0.9063014994232781,0.6024518388791593,0.7595139618359376,1.0,16/46,24.92%,CRNKL1;SNRPG;GCFC2;CELF1;SMN1;YTHDC1;NCBP1;ZRSR2;DDX1;SF3A1;SRSF10;TXNL4A;SF3B1;SRPK1;DDX39B;PRPF6
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.26961656004691775,-0.9059046204024123,0.6360485268630849,0.76002497080198,1.0,15/49,22.97%,PMEPA1;CDC42;RIOK3;PTGER4;KIF14;AIDA;NLRC3;LDLRAD4;TFIP11;DDX3X;GSK3B;HMGB1;TMC8;CRYAB;MEFV
prerank,establishment of spindle localization (GO:0051293),-0.35306302059020694,-0.905772326626282,0.5993150684931506,0.7599573252477426,1.0,4/14,19.62%,DYNC1H1;MAP4;NUSAP1;CFL1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.33350177415988935,-0.9048787265476627,0.6313131313131313,0.7615047978966369,1.0,6/18,25.09%,CCT7;DCP2;SHQ1;CCT4;EXOSC10;NHP2
prerank,glycoprotein metabolic process (GO:0009100),-0.26466725715415224,-0.9048739288515509,0.6401326699834162,0.7611661809081887,1.0,25/53,32.96%,B4GALT5;HPSE;ST8SIA4;MAN1C1;MAN2A1;HIF1A;B4GALT7;GCNT1;LARGE1;GANC;MAN2B1;STT3B;MGAT4B;ERP44;MANBA;MAN1B1;GANAB;AGA;GAL3ST4;ST3GAL4;ADAMTS9;ST8SIA6;CNMD;OGA;FBXO6
prerank,Golgi inheritance (GO:0048313),-0.3825600400543332,-0.9038757700313549,0.5833333333333334,0.7629147936006693,1.0,3/11,12.77%,CDK1;STX5;PLK3
prerank,cellular amino acid catabolic process (GO:0009063),0.23172157895312098,0.9034966698037721,0.6741854636591479,0.8748937957346358,1.0,24/87,21.05%,GLDC;ASPA;GOT1;SARDH;MCCC2;GLUL;HMGCLL1;GSTZ1;MCCC1;BCAT1;AASS;SDSL;ABAT;CBS;ACAT1;DBT;GLS2;GLS;ALDH5A1;ALDH7A1;BCAT2;CARNS1;SLC25A21;BCKDHB
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3507960461878258,-0.9033018128421938,0.6087719298245614,0.7638134463496392,1.0,3/16,17.42%,CLDN10;CLDN18;CLDN1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.29307117369438723,-0.9018777851533539,0.637137989778535,0.7664111651248804,1.0,9/31,22.68%,PEX14;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM70;TOMM20L
prerank,leukotriene metabolic process (GO:0006691),-0.33194306211995517,-0.9015111777907053,0.6094276094276094,0.7668799821951475,1.0,5/19,19.21%,MAPKAPK2;ALOX5AP;ABCC1;PLA2G4A;PLA2G5
prerank,positive regulation of cell aging (GO:0090343),-0.3795096661141664,-0.9011871653718142,0.5852372583479789,0.7672070780679683,1.0,4/11,15.87%,CGAS;B2M;EEF1E1;ARG2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.30405227239650223,0.9010712043008654,0.6033254156769596,0.8796831735632706,1.0,6/26,11.13%,ANK2;CASQ2;NETO1;NEDD4;ATP1B1;KCNG1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3431500278129917,-0.9001555954739185,0.6199649737302977,0.7690036892361244,1.0,5/17,13.97%,PTPRC;CD300A;PPP1R15B;HSP90AB1;PPP1R12A
prerank,bile acid metabolic process (GO:0008206),0.2970098592871487,0.8996201135861283,0.6052631578947368,0.8820395940251098,1.0,10/27,15.25%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,regulation of protein dephosphorylation (GO:0035304),0.27214098524221575,0.8995842778148594,0.6309794988610479,0.880945017139273,1.0,16/37,22.85%,CAMTA1;TSC1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;TIPRL;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK;HTT;ENSA
prerank,rRNA methylation (GO:0031167),-0.3192823170062679,-0.8994754624221972,0.6174377224199288,0.7699974201653046,1.0,6/22,25.32%,NSUN3;NSUN4;DIMT1;EMG1;BUD23;MRM2
prerank,microtubule depolymerization (GO:0007019),-0.3406491581597753,-0.8993026141080792,0.5933682373472949,0.769971851500115,1.0,11/17,40.02%,CKAP5;KIF14;KIF2C;STMN2;KIF18B;KIF19;NCKAP5L;KIF18A;KATNB1;CCSAP;KIF24
prerank,negative regulation of cell growth (GO:0030308),0.222362070915843,0.8991931351741275,0.6950904392764858,0.880735416750103,1.0,16/121,9.22%,MAP2;SLIT3;SLIT2;DCC;RERG;CDA;CCN3;MSX1;WT1;RBBP7;ENO1;IP6K2;TRIM46;CDKN2A;CAPRIN2;TGFB2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24460427782772087,-0.8989760832681865,0.6605960264900662,0.7703014133486997,1.0,21/78,23.11%,IPO5;CCND3;HHEX;ACTB;CCNY;BLM;INCA1;CDK5RAP1;CDKN3;CDC25A;GADD45A;TFAP4;CCNE1;LATS2;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1
prerank,regulation of cellular pH (GO:0030641),0.2868612030298903,0.8979675070262243,0.6359447004608295,0.8826246472774737,1.0,4/29,5.78%,SLC4A10;SLC4A4;SLC9A2;CA2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3887265724655392,0.8978647780014849,0.5632183908045977,0.881671387328274,1.0,2/10,3.77%,PDE4D;PDE11A
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.26065142286495846,-0.8977787550920417,0.6563039723661486,0.7724249118152046,1.0,16/52,26.75%,MTHFS;IDH1;MTHFD1L;ME2;DGLUCY;MTHFD2L;OGDH;ASS1;ACOT4;SHMT1;MTHFR;MDH1;MDH2;D2HGDH;FPGS;HOGA1
prerank,response to light stimulus (GO:0009416),0.24984951051157744,0.8974782198445695,0.6511627906976745,0.8813974201120924,1.0,11/55,12.14%,MAPK10;MAP2K7;GTF2H2;TRPM1;OPN3;OPN1MW;OPN1MW3;OPN5;OPN4;BRSK1;MEN1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3556454368358149,0.897459607635627,0.5928411633109619,0.8802658310271381,1.0,2/12,7.13%,CCN3;BDNF
prerank,response to retinoic acid (GO:0032526),0.2443598874497692,0.8973826322838984,0.6628175519630485,0.8792771199210657,1.0,17/59,20.52%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;TBX1;LTK;RET;EPHA3;BRINP2;FZD4;ADNP2;SNW1;WNT5A;WNT5B;FZD10
prerank,regulation of cholesterol transport (GO:0032374),-0.3256544050881584,-0.8966101419305575,0.5989110707803993,0.774482993839628,1.0,5/20,15.09%,LRP1;NFKB1;NR1H2;TTC39B;ABCA13
prerank,positive regulation of protein acetylation (GO:1901985),-0.36606896911958364,-0.8964024817274332,0.5834797891036907,0.7745712377965961,1.0,3/12,19.23%,CEP295;TAOK1;DDX3X
prerank,B cell activation involved in immune response (GO:0002312),-0.3661413110305691,-0.8961406326750722,0.6313043478260869,0.7747545565602231,1.0,6/13,33.57%,BATF;RNF8;FCGR2B;GAPT;CD19;EXOSC3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.32938080575432893,-0.8959008187143406,0.6056105610561056,0.774900999829587,1.0,9/19,30.91%,IGF1;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.26043906328883865,0.8958500453480077,0.6363636363636364,0.8817621704156393,1.0,8/44,11.74%,TENM1;PRKCE;CARMIL1;CARMIL2;SPIRE1;NCKAP1;GSN;ARF6
prerank,response to organic cyclic compound (GO:0014070),-0.26214296762455536,-0.8958362151389816,0.6587436332767402,0.7746842708821763,1.0,16/52,24.87%,KYNU;STAT3;IL18;ANXA1;TIPARP;CTNNB1;STAT5B;CCL5;SPP1;CHRNB2;SFRP1;TGFB1;CYP1B1;ABCA2;FGFR4;HLCS
prerank,lipid biosynthetic process (GO:0008610),0.23140543810111724,0.8952210955334737,0.6837209302325581,0.8820924897755555,1.0,24/77,26.43%,PAM;CYP51A1;GPAM;AGPAT3;ACSM5;OLAH;NDUFAB1;ACSS2;ACACA;MVK;LSS;HSD17B8;MLYCD;ACSM3;CLN8;ACSL6;GPAT4;MVD;OXSM;PDSS1;PRKAA2;PRLR;MBOAT1;FDFT1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3659016847049949,-0.8951760793243403,0.589041095890411,0.7756880676739999,1.0,8/12,33.89%,STAT3;BCDIN3D;ZC3H12A;IL6;TGFB1;NCOR1;ESR1;TNF
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2930989798285246,0.895138735414429,0.6024096385542169,0.8811358487458407,1.0,4/26,11.57%,PLCB1;UBE2E2;FGF10;RPTOR
prerank,pharyngeal system development (GO:0060037),0.33902873135462586,0.8949601693671969,0.6085011185682326,0.8803980519658325,1.0,5/15,14.95%,BMP7;TGFB2;TBX1;HES1;FOLR1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.24701821025208923,-0.8947514265514988,0.6588050314465409,0.7762160441404202,1.0,21/68,28.40%,RARG;AXIN1;LRP6;CTNNB1;PPP1CA;RAB5A;TCF7;GATA3;RYK;GSK3B;WNT3;SFRP1;PLPP3;DVL2;WNT7B;FZD1;FZD7;BCL9;WNT6;FRAT1;LEF1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3369467858085191,-0.8946349589633685,0.6037099494097807,0.7760767437649427,1.0,4/17,15.32%,ROCK1;VEGFA;PPP1R12A;IKBKB
prerank,protein localization to condensed chromosome (GO:1903083),-0.37013606894934026,-0.894520335279269,0.602112676056338,0.7759486681319182,1.0,4/12,15.36%,KNL1;ZWILCH;CDK1;TTK
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3065780893887457,0.8944318560436352,0.6106194690265486,0.8804904365978149,1.0,3/22,7.35%,APOD;ALK;APOC1
prerank,organelle fusion (GO:0048284),-0.31369155094236856,-0.8941996491684655,0.6308243727598566,0.7762583691547406,1.0,9/22,28.52%,EEA1;FIS1;USP30;STX4;MIGA2;VPS18;CYP26C1;VPS11;THG1L
prerank,histone H4 deacetylation (GO:0070933),-0.3897971977284945,-0.893791910879474,0.6010016694490818,0.7767385627680422,1.0,1/10,0.80%,RCOR1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3950079397409858,-0.8937073145786816,0.6143106457242583,0.7765760014515795,1.0,6/10,39.37%,BRCA1;SET;NOC2L;KLF15;CTBP1;THAP7
prerank,acidic amino acid transport (GO:0015800),0.3260999161290259,0.8932918412507305,0.6342042755344418,0.8821159925894834,1.0,5/17,9.49%,SLC1A2;SLC1A6;SLC1A1;SLC6A1;SLC6A13
prerank,regulation of myelination (GO:0031641),0.29280816411895383,0.8929836127368197,0.6177884615384616,0.8817052341576912,1.0,5/25,11.95%,TENM4;PARD3;PTN;PTPRZ1;HES5
prerank,hexose biosynthetic process (GO:0019319),0.26605882544642184,0.8927147555156428,0.6593137254901961,0.8811669960344449,1.0,10/42,14.43%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3597987032497979,-0.8920699774777359,0.6347826086956522,0.7795606013162341,1.0,6/14,17.93%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2895900789261443,0.8917013445341647,0.6327433628318584,0.8824241271106857,1.0,6/27,17.15%,HTR2C;GRM1;AGTR1;F2RL2;OPRL1;GPR157
prerank,positive regulation of translational initiation (GO:0045948),-0.33225491117349204,-0.891464042623631,0.6240875912408759,0.7804760874547672,1.0,5/18,19.23%,YTHDF3;CCL5;BOLL;POLR2G;DDX3X
prerank,regulation of protein secretion (GO:0050708),-0.22418444884416933,-0.8912389893560517,0.706953642384106,0.7805721885364368,1.0,19/119,12.63%,APOE;IGF1;ABCG1;ITPR1;DNAJC1;RAP1A;SLC2A1;DPP4;TMED10;ADAM9;RSAD2;GOLPH3L;RHBDF1;RHBDF2;ADAM8;MYOM1;EIPR1;CCL5;ITPR3
prerank,regulation of phospholipid metabolic process (GO:1903725),0.37779569254196915,0.8909266672453183,0.5916473317865429,0.8831089507916603,1.0,4/10,18.68%,MTMR2;MFSD2A;MTMR9;MTMR4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2462117974595183,0.8907238341488033,0.6442786069651741,0.8824651653260888,1.0,11/52,16.33%,DPP10;SORBS1;PRKCE;RAMP3;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.30257423735865613,0.8904340745193089,0.6105990783410138,0.8819864828136693,1.0,10/24,23.15%,PEX5L;PDE4D;PDE11A;GNAI1;PRKAR1A;PDE3A;GPR61;PRKAR2B;PRKAR1B;RNF157
prerank,positive regulation of macrophage migration (GO:1905523),-0.32629837429988295,-0.8900649769681472,0.6102292768959435,0.7826431526604098,1.0,7/19,23.49%,P2RX4;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,regulation of cellular component organization (GO:0051128),0.21201789056845777,0.8889034363428125,0.7777777777777778,0.8844732465803974,1.0,18/135,10.12%,NRG3;SPOCK1;RIT2;TJP1;PAK5;SNCAIP;CDH13;MELTF;PTCH2;STON1;MLLT3;PLCE1;ANGPTL7;CHPT1;NEDD4;TMEM97;ROS1;AGTR1
prerank,peptidyl-asparagine modification (GO:0018196),-0.29089014435054017,-0.888785853848075,0.647912885662432,0.7848980492997293,1.0,10/31,24.54%,MGAT5;ALG5;DPM3;MAGT1;ST6GAL1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,heart trabecula morphogenesis (GO:0061384),0.3143521446730991,0.8885527003333242,0.5975609756097561,0.8841854053142596,1.0,3/18,9.22%,NRG1;BMP7;TGFB2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3045028901377478,-0.8877360035628342,0.631484794275492,0.7867098573233025,1.0,13/25,42.83%,CSNK2A1;RPL11;HSP90AB1;TRIM39;SGTA;RPL5;PML;PSMF1;PSME3IP1;LAMP3;HFE;OPHN1;RPS7
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3739941388854413,-0.8876532303155094,0.5969387755102041,0.7865234408917873,1.0,4/10,29.05%,PSMC3;PSMC4;HMGB1;ESR1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.28875312110448514,-0.887600742828285,0.6288135593220339,0.7862891491869999,1.0,8/30,20.00%,CGAS;ERCC6;RNF169;RADX;UBQLN4;TFIP11;SHLD2;TRIP12
prerank,fatty acid beta-oxidation (GO:0006635),-0.25967730426732805,-0.8867888134550677,0.6661016949152543,0.787565247231159,1.0,20/51,33.03%,PPARD;ABCD2;ACADM;ACAD11;ACAT2;ACOX1;MCAT;ABCD3;ACAA2;AMACR;ACADVL;ACOXL;HSD17B10;ACAD10;SCP2;ECHDC2;ACADS;HADH;ECHS1;SLC25A17
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.20891741168439193,-0.8867046251212853,0.7799043062200957,0.7874002150298044,1.0,35/198,15.16%,PTPRC;PLCG2;INPP4A;PAK2;PLBD1;ITPKB;PANK2;PIP4K2A;NADK;HTR2B;STAT3;SYNJ1;PFKFB3;PIK3CB;DUSP3;PIK3CG;LGALS13;PPP1CA;COQ8A;IMPA1;PIP4P1;LPL;HK3;PFKFB4;INPP5A;TAOK1;PIK3CA;PLCB3;PIK3CD;PLCD1;AGPAT1;GPX4;PLAAT3;PLA2G4A;NUDT14
prerank,vasoconstriction (GO:0042310),-0.3748788517371011,-0.886498971890681,0.6209386281588448,0.7875044488096823,1.0,4/11,15.30%,HTR2B;SLC8A1;EDNRA;PIK3C2A
prerank,positive regulation of cell growth (GO:0030307),-0.2317122280999429,-0.8864083373871148,0.6996805111821086,0.7873373868288344,1.0,20/96,14.82%,IGF1;SDCBP;CSNK2A1;GOLGA4;ITSN2;CDC42;RUFY3;BCL2;MACF1;DDX49;KLHL22;SYT4;TGFBR1;MTPN;NEDD4L;CXCL16;CIB1;NCBP1;EIF4G1;INO80
prerank,positive regulation of embryonic development (GO:0040019),-0.3252663622801399,-0.886060938741121,0.6386554621848739,0.7876939030630187,1.0,4/19,11.39%,B4GALT5;NIBAN2;RBM19;OSR1
prerank,cellular copper ion homeostasis (GO:0006878),-0.3615317711930537,-0.8857674358032231,0.6394557823129252,0.7879250842269012,1.0,4/14,13.35%,ATP7A;SLC31A1;APP;MT2A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2822524876632343,-0.8852030310299921,0.6301369863013698,0.7887384710263642,1.0,13/34,23.90%,PTPRJ;PTPN12;PTPN22;DUSP3;PTPN6;DUSP6;PTPRO;PTPN13;PTPN11;DUSP5;UBASH3B;PTPN1;DUSP2
prerank,cGMP biosynthetic process (GO:0006182),0.3753981648507835,0.8847468283752447,0.5879732739420935,0.8921820158811343,1.0,1/10,2.91%,GUCY1B1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3571490173752152,-0.8847350804630262,0.6225165562913907,0.7893403890495879,1.0,3/14,13.94%,ERN1;NUDT21;NCBP1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3175211450868759,0.884108146513698,0.6261467889908257,0.8924511716898016,1.0,6/18,14.06%,TENM4;PTN;PTPRZ1;DAAM2;HES5;HES1
prerank,protein alkylation (GO:0008213),-0.31721546258103217,-0.8835298942254517,0.6013513513513513,0.791449847674924,1.0,5/22,10.14%,GSPT1;PRMT2;PRMT1;METTL22;PRMT3
prerank,negative regulation of transposition (GO:0010529),-0.3316705660920983,-0.8832473906719716,0.6155202821869489,0.7916607957524979,1.0,3/16,10.53%,TUT7;UBR2;MOV10
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3396286319898266,-0.8831669771943008,0.6492411467116358,0.7914588801738194,1.0,2/16,1.67%,APOE;CD36
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3432723412710128,-0.8827440360755846,0.6284153005464481,0.7919294337965371,1.0,5/15,16.75%,RAB3GAP1;SRP14;ZFAND2A;RAB10;SRPRB
prerank,glutathione derivative metabolic process (GO:1901685),0.3150903258179132,0.8826764206321416,0.6118721461187214,0.8935196114146376,1.0,6/20,20.33%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3150903258179132,0.8826764206321416,0.6118721461187214,0.8935196114146376,1.0,6/20,20.33%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2430275089625225,-0.8820291421113553,0.7165605095541401,0.7930380667500261,1.0,12/73,15.86%,FNIP2;CD44;BCAR3;AXIN1;GAS6;VEGFA;FNIP1;SPRY2;APP;HSP90AB1;EIF4G1;HCLS1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.324129391435924,-0.8819087857278868,0.6329787234042553,0.7929181219007163,1.0,1/19,0.16%,APOE
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2734912519366894,0.8815941310975011,0.6465116279069767,0.8950021807735536,1.0,9/33,17.37%,GOT1;GLUL;ALDH18A1;GGT1;GLS2;GLS;RIMKLB;CAD;ALDH5A1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3094910962207706,-0.8815444192819161,0.62,0.7933023748255214,1.0,10/23,30.91%,IGF1;GAS6;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,negative regulation of DNA binding (GO:0043392),-0.2950443860182567,-0.8810465642895554,0.6382978723404256,0.7940048339765167,1.0,9/28,23.76%,SP100;JUN;MDFI;E2F1;SIN3A;TFAP4;RSF1;KDM1A;SUMO3
prerank,negative regulation of ATPase activity (GO:0032780),0.3288533483055047,0.8800369269665284,0.6123853211009175,0.8974309774410233,1.0,5/16,20.07%,TSC1;TNNT2;PPIF;VCPKMT;SIRT1
prerank,negative regulation of cellular component organization (GO:0051129),-0.24089411386615683,-0.8798332815304573,0.6983842010771992,0.7961408680325223,1.0,22/74,22.40%,MCTP1;LILRB1;DNM2;CDC42;RIOK3;RTEL1;WASL;SNX33;IRAK3;VEGFA;SPRY2;FAP;AIDA;TFIP11;HSPA1A;DDX3X;HSPA2;GSK3B;DNAJB6;TMC8;NR1H4;CRYAB
prerank,response to glucocorticoid (GO:0051384),0.28597541322440445,0.8796641403976854,0.6355353075170843,0.8971956519921795,1.0,3/26,4.85%,SLIT3;SLIT2;GOT1
prerank,regulation of hippo signaling (GO:0035330),0.325215585238532,0.8791569864965615,0.6466346153846154,0.8972318090808639,1.0,8/17,17.75%,SOX11;WWC1;WTIP;SCHIP1;MARK3;SHANK2;CIT;DLG5
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2372672656788408,-0.8791194501990138,0.7064516129032258,0.7972057171254742,1.0,30/84,25.42%,MBNL1;RBM39;MBNL2;TRA2B;SON;SMU1;MBNL3;HNRNPL;CWC22;DDX5;CELF1;YTHDC1;NCBP1;DAZAP1;NCL;SRSF10;WTAP;RNPS1;NSRP1;HNRNPA1;MAGOH;C1QBP;RBM11;RBM3;SRPK1;HNRNPK;ZBTB7A;PCBP4;RBM15B;LARP7
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.22841420134936416,-0.879065070715484,0.7335526315789473,0.7969724853204647,1.0,35/104,26.68%,PPARG;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRY2;SPRED1;PIN1;SPRED2;HTRA3;ACVR2A;GREM1;TGFBR2;LEMD2;LDLRAD4;VASN;SMAD7;HSPA1A;IL17RD;BMPR2;RBPMS2;GDF3;SMURF2;EID2;TGFB1;ZBTB7A;LRP2;SKIL;SMURF1;BMP2;SMAD4
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.33414877715028946,0.8786472486241265,0.6094527363184079,0.8972985143230532,1.0,7/14,22.84%,PKIA;ATP2B4;PRKAR1A;SIRT1;PRKAR2B;HTT;PRKAR1B
prerank,aspartate family amino acid metabolic process (GO:0009066),0.32077075489859225,0.8784325572318545,0.6465116279069767,0.8966463346761011,1.0,5/18,14.25%,ASPA;GOT1;ADI1;FOLH1;ASNS
prerank,outer dynein arm assembly (GO:0036158),0.3353490121689559,0.8770812105875306,0.621867881548975,0.8987691782759372,1.0,5/14,17.71%,ODAD3;DNAH17;DNAAF4;LRRC49;DNAH5
prerank,ubiquinone biosynthetic process (GO:0006744),-0.34113899443677076,-0.8765712656245453,0.6429809358752167,0.8016317847171954,1.0,3/15,14.99%,COQ8A;NDUFA9;FDXR
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3372649270904561,0.8760967780625659,0.621867881548975,0.8999333533443052,1.0,4/14,7.97%,ELAVL4;DAZL;TIRAP;YBX3
prerank,skeletal muscle organ development (GO:0060538),-0.2960537002505521,-0.8760599099788045,0.6567425569176882,0.8023054550686479,1.0,4/26,14.65%,SVIL;CFLAR;MEF2C;LARGE1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.2829433237825577,-0.8760434417308783,0.6693944353518821,0.8019876986971061,1.0,8/33,14.22%,ITGA5;E2F2;PIK3CB;VEGFA;JAK1;JMJD8;PKM;KLF2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.36599567069470257,-0.8757196104095032,0.627318718381113,0.8022408453967798,1.0,6/12,45.87%,PPP1R3E;INPP5K;PPP1R3A;AKT1;PPP1R3D;PPP1R3B
prerank,fatty acid oxidation (GO:0019395),-0.2504682176588169,-0.8749984378301778,0.7022375215146299,0.8033553279387009,1.0,21/57,33.03%,PPARD;ABCD2;ADIPOR1;ACADM;ACAD11;ACAT2;ACOX1;MCAT;ABCD3;ACAA2;ACADVL;ALOX15;HSD17B10;ACAD10;SCP2;ECHDC2;ACADS;HADH;ECHS1;ADH5;SLC25A17
prerank,histone H3-K36 demethylation (GO:0070544),-0.38265575430215265,-0.8744050610349814,0.6558219178082192,0.8042356422549921,1.0,2/10,7.70%,KDM7A;KDM2A
prerank,sulfur compound catabolic process (GO:0044273),0.2665501526734489,0.8738375308415075,0.6888888888888889,0.9041202825850005,1.0,13/38,16.91%,HEXB;VCAN;NUDT7;OMD;GLB1;GGT1;CTH;ACAT1;MLYCD;IDUA;GGT5;ADO;IDS
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.35374786877024034,-0.8734525269174119,0.6406779661016949,0.8057347085430211,1.0,5/13,26.31%,NRROS;CD46;GREM1;GREM2;BMP2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.31030442051701296,-0.8734032781207018,0.6483704974271012,0.805472333010819,1.0,3/22,4.64%,PLEK;ROCK1;STAP1
prerank,protein oxidation (GO:0018158),0.36940556148389914,0.872711160012621,0.6098765432098765,0.905544240632209,1.0,11/11,63.08%,LOXL1;LOX;TMX3;SUMF1;APOA1;LOXL4;LOXL2;PRDX3;CHCHD4;LOXL3;APOA2
prerank,tRNA 5'-end processing (GO:0099116),0.32838537065831086,0.8724017752782892,0.6059113300492611,0.9051219576673407,1.0,6/15,21.61%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,aminoglycan catabolic process (GO:0006026),0.2818626473137823,0.8718543816567959,0.662004662004662,0.9052039773095392,1.0,7/28,16.91%,GPC6;GPC5;SDC1;GLB1;SDC2;IDUA;IDS
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3093336360946607,-0.8710361879883916,0.6491228070175439,0.8097961241973128,1.0,3/22,6.07%,CCR2;GNAI3;CAP1
prerank,atrial septum morphogenesis (GO:0060413),-0.382415435002774,-0.8700120822976609,0.6523235800344234,0.8114351906957928,1.0,1/10,0.56%,NOTCH2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.33520146014634333,-0.8698743208545888,0.6442477876106195,0.8113449998831317,1.0,1/16,0.56%,NOTCH2
prerank,protein export from nucleus (GO:0006611),-0.2986921559207444,-0.8694999206355436,0.671304347826087,0.8117461505684737,1.0,13/27,32.65%,NUP42;XPO6;XPO5;TPR;STRADA;CCHCR1;EGR2;TGFB1;SMURF1;XPO7;CSE1L;STYX;ANKLE1
prerank,regulation of lipase activity (GO:0060191),0.34066411282592624,0.8693541856773315,0.6555023923444976,0.9097630414354052,1.0,4/13,16.32%,PCSK5;PCSK6;ANGPTL3;SNCA
prerank,protein homotetramerization (GO:0051289),0.24830904272811732,0.8691917269736734,0.7031630170316302,0.9089830344156203,1.0,13/49,17.53%,RYR3;CRYZ;CBY1;HCN1;RYR1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;ALDH1A3;TRPM2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.35975027202606225,0.8690242634838086,0.6363636363636364,0.9082119341203776,1.0,3/11,8.59%,POMT2;TOR1A;UGGT2
prerank,cellular component disassembly (GO:0022411),0.2416269670016881,0.8688469551207297,0.7160194174757282,0.9074600647929703,1.0,14/53,16.08%,MMP16;SCUBE1;TLL1;MMP12;MMP15;MMP13;GSN;CTSK;HTRA1;BMP1;ADAMTS5;DYRK3;CAPNS2;CAPN2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3667714404609234,0.868518075471408,0.627906976744186,0.9070592591879231,1.0,2/10,8.69%,SOX11;BMP7
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.34093343160115935,-0.868321424046939,0.6485568760611206,0.8137360352109034,1.0,4/15,25.39%,RPL11;SMAD7;DTX3L;RPL5
prerank,regulation of cell development (GO:0060284),-0.2754197220537342,-0.8682770661780572,0.6748366013071896,0.8134566690892618,1.0,11/36,23.77%,NOTCH2;GRN;CTNNB1;BHLHE40;HMGB2;RHEB;WNT3;FBXO22;HEYL;HES7;HES6
prerank,protein homooligomerization (GO:0051260),0.21131206302602384,0.8680917397217388,0.7659033078880407,0.9068411438833096,1.0,26/114,18.55%,MPP2;RYR3;KCNC2;ADCY8;CRYZ;SLC1A2;CBY1;LETM1;HCN1;RYR1;GSDMD;SCARA5;ACACA;KCNJ12;GOLGA2;OSBPL2;GLRA3;ARC;CTH;RS1;GLS;AQP11;ALDH1A3;TRPM2;TMEM120A;RBMX
prerank,protein localization to centrosome (GO:0071539),-0.326601633499532,-0.8675026025094256,0.6460176991150443,0.8146265359240625,1.0,5/17,20.84%,SNX10;PIBF1;NUDCD3;STIL;CEP192
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.36035545476950387,0.8672650724698835,0.6275862068965518,0.9075514185521317,1.0,3/11,15.40%,PCBP3;NOVA1;NOVA2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.31151783067055955,-0.8672550502581788,0.6527777777777778,0.8147656516328798,1.0,4/21,5.60%,BIRC3;USP50;AIM2;PSMB9
prerank,regulation of telomere capping (GO:1904353),-0.2991917656776395,-0.8669575749891753,0.6829268292682927,0.8150068098811392,1.0,11/23,33.23%,RTEL1;PKIB;TNKS2;USP7;ATM;NBN;MAPK1;MAPK15;MAP3K4;NEK7;TNKS
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2874961271508699,0.8665592053062712,0.6650485436893204,0.9079824941953875,1.0,4/25,8.59%,OMA1;POMT2;TOR1A;UGGT2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2099217155810562,-0.8664458365894948,0.8003072196620584,0.8156426566635161,1.0,58/173,26.69%,CTSZ;VTI1A;CAPZB;COG7;RAB1A;DYNC1H1;TMED10;TRAPPC11;TFG;PREB;PROS1;GAS6;CTSC;TMED3;SEC24A;SAR1A;DCTN1;F7;RAB29;STX5;SEC24D;CAPZA1;MIA2;COG5;COG2;COPA;SEC31A;MIA3;TRAPPC5;VAMP4;DYNC1LI2;LMAN2L;VAPB;TMED2;HYOU1;F10;CNIH4;TICAM2;F5;MPPE1;TMED4;DCTN4;BET1L;COG4;SPTAN1;TMED5;DCTN5;ARCN1;PGAP1;MCFD2;TRIP11;RAB1B;YIF1B;TRAPPC2L;TRAPPC3;COPB2;CUL3;VAPA
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2552773555601105,-0.8659396073826533,0.6996527777777778,0.816295316752011,1.0,12/49,22.19%,ZCCHC9;LRCH1;ARFGEF1;EGLN1;GPATCH2;MAPK7;CST7;CST3;TMED2;RASA4;WNK1;SH2D4A
prerank,regulation of cell growth (GO:0001558),0.1941537409975917,0.8657241070527067,0.845108695652174,0.9087710055838096,1.0,25/204,10.12%,NRG3;AKAP6;SPOCK1;SLIT3;SLIT2;PAK5;RERG;CDA;CCN3;MELTF;PTCH2;MSX1;WT1;PLCE1;RBBP7;ENO1;IP6K2;CHPT1;TMEM97;CDKN2A;CAPRIN2;TGFB2;ROS1;EIF4G2;AGTR1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3681832324158214,-0.8654927932963314,0.6458684654300169,0.8168328883922708,1.0,6/11,26.38%,FRS2;MEF2C;GREM1;TGFB1;BMP2;FZD7
prerank,ether lipid biosynthetic process (GO:0008611),0.36299171030020394,0.8648367431873436,0.6327944572748267,0.9096680270248456,1.0,2/10,7.25%,LPCAT2;CHPT1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.28736265686035173,0.8645872854891563,0.6578947368421053,0.9090672704672653,1.0,4/26,6.36%,AKAP6;CAMTA1;FHL2;PRNP
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24305687480339014,-0.8645871586443892,0.7009966777408638,0.818208109424785,1.0,19/69,22.96%,APOE;PTK2B;SNX6;BCL2;GRN;MDK;WFS1;HIF1A;MEF2C;ADAM8;KIF14;RETREG1;RASA1;CLN3;NDNF;CPEB4;PPT1;NONO;SET
prerank,negative regulation of hippo signaling (GO:0035331),0.34978325239178254,0.8645315207645504,0.6276849642004774,0.9080433570789173,1.0,7/12,22.07%,WWC1;WTIP;MARK3;SHANK2;CIT;DLG5;AJUBA
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.28775879737578564,-0.8641150406964057,0.6643717728055077,0.8187541244550788,1.0,9/29,18.19%,PRKCD;ARFGEF1;CYRIB;MYADM;LIMA1;PIK3CA;SSH3;SSH1;TWF2
prerank,regulation of keratinocyte migration (GO:0051547),0.3424673435364182,0.8639504335647026,0.6210045662100456,0.9082133684378733,1.0,3/12,11.74%,EPB41L4B;FGF10;ARF6
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3362016480335867,-0.8639119617602864,0.62708719851577,0.8187831354949515,1.0,8/14,42.78%,ENTPD6;ENTPD3;NUDT15;NUDT16;ENTPD7;NUDT1;NUDT5;ENTPD1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3500175219906062,-0.8634863318630015,0.6380789022298456,0.819268281312667,1.0,7/13,33.63%,GEN1;TPR;XRCC3;NDC80;CCNB1;ANAPC15;DUSP1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3012490253756423,-0.8630261592408597,0.64,0.8197909064414747,1.0,6/23,13.83%,IL10RB;PIBF1;PTK2B;CRLF3;CCL5;OCIAD2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.30938326075508515,0.8623927939139288,0.6634146341463415,0.9105947279363221,1.0,3/19,9.22%,SLIT3;ACVR1;TGFB2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3784227761474958,0.86235660894645,0.6563876651982379,0.9095216820298839,1.0,3/10,13.20%,SACS;DNAJA4;DNAJB2
prerank,central nervous system myelination (GO:0022010),0.3525636392366288,0.8616097813635354,0.6438356164383562,0.9101338400040483,1.0,2/11,3.29%,TENM4;PLP1
prerank,regulation of muscle cell differentiation (GO:0051147),0.26858695689089884,0.8615099979159249,0.685785536159601,0.9091905830841587,1.0,2/31,1.33%,CTNNA2;CDH2
prerank,membrane lipid catabolic process (GO:0046466),0.3593520060011544,0.8615097533473594,0.6256038647342995,0.9080520945638899,1.0,1/10,2.31%,ENPP2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.3507242440815642,0.8613640471677673,0.6292682926829268,0.907218830765494,1.0,3/11,10.41%,SLC25A19;ENPP3;THTPA
prerank,response to metal ion (GO:0010038),-0.2403826624435759,-0.8612677637176415,0.7543859649122807,0.8228430210636186,1.0,13/67,13.58%,SLC30A5;ANXA11;MT1A;MT1X;BCL2;ADAM9;CRIP1;PPP1CA;HIF1A;NEDD4L;ITPR3;MT2A;SEC31A
prerank,response to purine-containing compound (GO:0014074),-0.3181061000627641,-0.8604409545666816,0.6504201680672269,0.8241015977152204,1.0,2/17,2.56%,P2RX7;P2RX4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.23713266157367444,-0.86030985645876,0.7345276872964169,0.8240173293157738,1.0,31/69,34.20%,AMFR;RHBDD2;WFS1;ERLIN1;DNAJB9;SELENOS;UBE4B;DNAJB14;DERL1;SEL1L;HSP90B1;RNF185;RNF121;STT3B;FOXRED2;SGTA;FAF2;BAG6;TRIM25;EDEM1;MAN1B1;VCP;UBE4A;AUP1;STUB1;SEL1L2;DNAJB12;FBXO6;UBQLN2;UBXN4;DNAJC18
prerank,regulation of telomere maintenance (GO:0032204),-0.289140082155694,-0.8602151499591383,0.6798623063683304,0.8238358327341618,1.0,10/26,26.81%,RTEL1;DHX36;ERCC4;USP7;NBN;HDAC8;SMG1;MYC;PML;MRE11
prerank,protein destabilization (GO:0031648),-0.2838192755050344,-0.8601371506666661,0.6814946619217082,0.8236274790423147,1.0,6/32,10.88%,CREBBP;GGA3;FBXW11;SERF2;CTSH;DERL1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.33496179618035915,0.8594483025013078,0.6263982102908278,0.9103034595736577,1.0,5/12,17.01%,IRS1;PPARGC1A;ABCD1;MLYCD;AKT2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.33972262556149657,-0.85943606594958,0.6661045531197302,0.8246642234612935,1.0,4/14,24.95%,IMPDH2;ADSS1;PFAS;ATIC
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3315238344395619,0.8581846903229267,0.654627539503386,0.9119711369475273,1.0,6/14,24.18%,XRCC5;NABP2;PINX1;TERT;BRCA2;TINF2
prerank,pseudouridine synthesis (GO:0001522),-0.35246786073415526,-0.8577841868857183,0.6599326599326599,0.827529631288494,1.0,3/13,13.99%,PUS7;PUS1;GAR1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3321874683754183,-0.8573183884188221,0.6909090909090909,0.828064606692251,1.0,7/16,21.38%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB;KDM1A
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2481046854350911,0.856083170702983,0.7304964539007093,0.9154016153089349,1.0,9/43,18.57%,RYR2;AHI1;ACVR1;SMO;HES1;MKKS;FOLR1;NPHP3;BBS7
prerank,negative regulation of protein polymerization (GO:0032272),0.2856229428177549,0.8557482935320586,0.6782407407407407,0.9149914765921551,1.0,8/27,17.05%,MAP2;SLIT2;TUBB4A;KANK1;EML2;CDH5;SNCA;KANK4
prerank,membrane fusion (GO:0061025),0.27170988987081834,0.8556438177688838,0.6995305164319249,0.9140697498610373,1.0,5/33,11.91%,DNM3;RIMS1;DNM1;DYSF;NSFL1C
prerank,COPII-coated vesicle budding (GO:0090114),-0.241106048074207,-0.8551432464990147,0.7516447368421053,0.8319184761159985,1.0,24/68,26.69%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;PPP6R3;SEC24A;SAR1A;STX5;SEC24D;SEC31A;MIA3;TRAPPC5;VAPB;TMED2;TRAPPC9;F5;MCFD2;RAB1B;TRAPPC2L;TRAPPC3;CUL3;VAPA
prerank,defense response to tumor cell (GO:0002357),-0.37957533320173065,-0.855001318418438,0.6783831282952548,0.8318132489183504,1.0,4/10,14.77%,DAPK1;SPI1;LAPTM5;PRDX2
prerank,integrated stress response signaling (GO:0140467),0.3239116650364999,0.8548277180284881,0.6605922551252847,0.9147223766261428,1.0,1/14,0.58%,OMA1
prerank,positive regulation of protein polymerization (GO:0032273),0.23215025789565427,0.8547981944244794,0.7358024691358025,0.9136429010943922,1.0,12/65,14.92%,NAV3;TENM1;PRKCE;CARMIL1;TTBK1;NCKAP1;OCLN;CDK5R1;ARF6;CDK5RAP2;HSP90AA1;ARL2
prerank,sodium ion homeostasis (GO:0055078),0.3012048369472078,0.8547385954834972,0.6768149882903981,0.9126172549672893,1.0,4/21,10.76%,SLC12A2;SLC12A1;ATP1A3;ATP1B1
prerank,negative regulation of coagulation (GO:0050819),-0.3439216184021681,-0.8542272637110757,0.6703296703296703,0.8330025769164184,1.0,2/14,4.33%,APOE;TFPI
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.22603599579667608,-0.8538623372333226,0.7867768595041322,0.8333139013102969,1.0,31/88,32.20%,APOE;NRP1;XDH;HTR2B;NRP2;VEGFA;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;NR4A1;NRAS;ANG;BMPR2;AGGF1;STAT1;KDR;APOH;BMP2;VIP;CCL24;FGF18;GHRL;VASH2;NRARP;FGF16;TNMD;FGF2;CAV1;CNMD
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.32415842977318954,0.853849391256144,0.6220095693779905,0.9133605496788644,1.0,7/14,22.34%,SPRY4;APLN;CREB3L1;SPRY1;FUZ;SULF1;GPC1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3076958780213549,-0.853734787793948,0.6881533101045296,0.8332044325055394,1.0,6/22,13.83%,MGAT5;IL10RB;CRLF3;IL7R;CCL5;OCIAD2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2718182546988546,-0.8535065468987142,0.6979522184300341,0.83328558342976,1.0,15/36,27.04%,RAP2A;MVP;VEGFA;TAOK2;ENPP1;DDX3X;MOB1B;PDGFA;NBN;PPP2R5B;PPP2R5A;RASSF2;MRE11;ENG;PPP2R5E
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3433100562929331,-0.8532524674383105,0.6695804195804196,0.833393561783504,1.0,2/13,6.24%,NFE2L2;HGF
prerank,peroxisome organization (GO:0007031),-0.2897444424497298,-0.8531860195707817,0.699288256227758,0.8331513816929457,1.0,6/25,17.21%,PEX14;ABCD2;FIS1;PLAAT3;PEX7;ABCD3
prerank,cellular sodium ion homeostasis (GO:0006883),-0.33161000921685113,-0.8529000316730242,0.6579406631762653,0.8333227490809002,1.0,4/15,10.60%,ATP1B3;SLC8A1;SLC9A1;NEDD4L
prerank,synaptic vesicle transport (GO:0048489),0.34850900540079977,0.8523476880051952,0.6355555555555555,0.9155199066121825,1.0,3/11,8.25%,KIF5C;KIF5A;TOR1A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3065653032050294,-0.851698021434252,0.6992753623188406,0.8353308695873266,1.0,3/20,9.21%,MTHFS;SLC27A1;CNDP2
prerank,striated muscle cell development (GO:0055002),0.3365918174499739,0.8515388456422085,0.6566125290023201,0.9161617015821838,1.0,3/14,11.42%,SDC1;PGM5;CAPN3
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.37309223064332875,-0.8515182903235594,0.66,0.8352884726988226,1.0,3/10,11.96%,PTPN22;DNAJA1;AIDA
prerank,peptide catabolic process (GO:0043171),-0.30178577644028276,-0.8514194258743456,0.6809269162210339,0.8351162085717672,1.0,6/23,18.12%,ANPEP;LNPEP;CTSH;CPQ;TPP1;CHAC2
prerank,regulation of receptor binding (GO:1900120),-0.37306736763315307,-0.8513240133037208,0.6655052264808362,0.8349242419674808,1.0,3/10,13.27%,B2M;ATP2A3;ADAM15
prerank,positive regulation of chromosome organization (GO:2001252),-0.32606702223449346,-0.8503617374404924,0.674502712477396,0.8363628748531099,1.0,7/15,26.81%,RTEL1;FEN1;DHX36;SHCBP1L;NBN;PML;MRE11
prerank,chordate embryonic development (GO:0043009),-0.24680664263001822,-0.8501261226847663,0.7331136738056013,0.8364471561447837,1.0,8/55,11.09%,MBNL1;XYLT1;ZNF568;BRCA1;VEGFA;SULF2;TGFBR1;FLCN
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.269611601009722,-0.8498568649192493,0.7149837133550488,0.8365945954032235,1.0,10/35,18.22%,PTPRC;IL10RB;ADIPOR1;CRLF3;NF2;CCL5;OCIAD2;DOT1L;VHL;SOCS3
prerank,regulation of response to oxidative stress (GO:1902882),-0.3640334651018753,-0.8498385950165049,0.6851520572450805,0.8362646636204862,1.0,1/11,0.63%,MCTP1
prerank,positive regulation of ATPase activity (GO:0032781),0.25086057162940845,0.8494973860418165,0.7203791469194313,0.9194337884153356,1.0,13/41,17.91%,RYR2;DYNLL1;FGF10;DYNLL2;TNNT2;ALDOB;ATP1B1;DNAJB2;ATP2A1;TPM1;GABARAPL2;ATP1B2;SETMAR
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2456213328801425,0.8491703247908863,0.7075471698113207,0.9190040609860228,1.0,11/45,17.47%,BRINP3;BRINP1;AURKAIP1;PTPN3;ZW10;BMP7;TOM1L1;TRIM35;NABP2;CDKN1C;BRINP2
prerank,modulation by host of viral genome replication (GO:0044827),-0.3424797700111783,-0.8489611659996702,0.65625,0.8375572591804773,1.0,6/13,26.69%,YTHDC2;NUCKS1;PPIB;ZC3H12A;CCNK;VAPA
prerank,autophagy of peroxisome (GO:0030242),-0.3562091412284959,-0.8489214286049528,0.671280276816609,0.8372555591641373,1.0,7/12,36.04%,RB1CC1;USP30;ATM;TRAPPC8;SQSTM1;PEX5;PJVK
prerank,negative regulation of cell population proliferation (GO:0008285),-0.1881357291882378,-0.8485338552087456,0.9209726443768997,0.8376083375162057,1.0,92/351,24.88%,LYN;MTSS1;ABI1;ARID2;CD300A;CDK6;NIBAN2;PTPRJ;RUNX3;NUPR1;BRD7;PPARG;S100A11;RNF41;PTK2B;RARG;CBFA2T3;SMYD2;CTNNB1;IFI35;NF2;SKI;NME1;E2F1;B2M;EIF2AK2;TRIB1;E2F3;GSDME;PTPN6;TGFB1I1;MORC3;ITGB1BP1;INCA1;APP;CDKN3;STRN;B4GALT7;FLCN;MAP2K1;KLF10;FAP;CELF1;EEF1E1;NLRC3;CIB1;STK11;FRK;IGFBP3;GREM1;BTG1;TFAP4;APPL2;KLF11;RBBP4;VHL;PARP10;TOB1;HSPA1A;ATF5;CDKN2C;GATA3;ANG;PDCD5;MDM4;COL18A1;BMPR2;SIRT2;ADAMTS1;BAP1;PDS5B;COPS8;SFRP1;GNRH1;NUP62;IFITM1;IL6;TGFB1;BNIPL;SOX7;HMOX1;GPLD1;PIM2;TES;TNN;CYP1B1;LMNA;NUDT6;MYC;RBP4;CGRRF1;FTH1
prerank,carbohydrate transport (GO:0008643),0.36103532133455196,0.848098434509531,0.6721311475409836,0.9201328173325597,1.0,1/11,1.12%,SLC2A5
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3081437712960696,0.8479807460158775,0.6935483870967742,0.9192676434871513,1.0,6/18,18.81%,CCN3;REST;PRKN;INHBB;IRS1;CRH
prerank,axonal transport of mitochondrion (GO:0019896),-0.3637162729888631,-0.8475858354762065,0.675,0.8389975823948185,1.0,2/11,9.13%,TRAK1;HIF1A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.362278970618969,-0.8473993442257286,0.6788830715532286,0.8389906731721436,1.0,4/11,23.23%,SLC27A1;NR1H2;LDLR;GPLD1
prerank,endoplasmic reticulum organization (GO:0007029),-0.23482257834483708,-0.8467774387681387,0.7512437810945274,0.839836935934642,1.0,32/72,37.20%,TMCC1;TRAM2;APP;SERP1;STX5;RAB10;SEC31A;MIA3;LMAN2L;VAPB;DOP1B;LPCAT3;REEP3;SGTA;HMOX1;CYB5A;TRAM1L1;OTOF;VAPA;EIF2AK3;GAK;VAMP2;MAPK15;REEP6;MOSPD3;TOR1AIP2;LMAN2;CAV2;SEC31B;TLE6;LMAN1L;SEC16B
prerank,respiratory tube development (GO:0030323),-0.2769234011003256,-0.8467440253631835,0.7220338983050848,0.8395375711989637,1.0,15/28,41.58%,VEGFA;CCDC40;ITGA3;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;HECA;STRA6;LOXL3;FGF7
prerank,nitrogen compound transport (GO:0071705),-0.21084519264247717,-0.8465550366808263,0.8427876823338736,0.8395277678658971,1.0,27/141,18.03%,LRRC8D;MYH9;RAB7A;SLC6A6;SLC43A2;SLC15A3;TOM1;CENPF;SLC16A10;SLC7A7;RCN3;FLVCR1;ABCC1;CHMP1A;HSP90B1;SLC25A45;ARRDC4;SEC14L1;SLC7A5;ARRDC1;MIA3;CHMP2A;LMAN2L;SLC23A1;SLC6A8;SNX4;RILP
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3502721868636951,-0.8460030352123211,0.6783216783216783,0.8402195721039507,1.0,5/12,14.90%,ACTB;ZDHHC7;SCRIB;RAB10;VANGL2
prerank,sulfate transport (GO:0008272),-0.3330701297467022,-0.8458370191982747,0.6834782608695652,0.8401636174907416,1.0,6/14,33.58%,SLC26A11;RACGAP1;SLC25A10;SLC26A4;SLC13A4;SLC26A7
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2627196852767121,-0.8456331257624798,0.6993006993006993,0.8401727462805472,1.0,14/37,25.52%,PRKAG2;AXIN1;CAB39;SPRY2;SPRED1;APP;SPRED2;EIF4G1;SMAD7;SIRT2;S1PR2;TGFB1;MAPK1;INPP5K
prerank,intestinal absorption (GO:0050892),0.33166510416658174,0.8450628011825969,0.6630196936542669,0.9243275551080513,1.0,1/13,1.12%,SLC2A5
prerank,ruffle organization (GO:0031529),-0.327751606274768,-0.8448064885431927,0.6900175131348512,0.8413104269644397,1.0,5/16,19.46%,PLEK;RAC1;LIMA1;ARFIP2;PIP5K1A
prerank,negative regulation of macroautophagy (GO:0016242),-0.287049247549543,-0.8445256062357557,0.6987951807228916,0.8414404868279232,1.0,10/26,27.25%,NUPR1;MTM1;USP36;PIK3CA;UBQLN4;CHMP4B;CHMP4A;SMG1;QSOX1;TSC2
prerank,protein targeting (GO:0006605),-0.21245517627295246,-0.8442285107315992,0.8195615514333895,0.8416305931956188,1.0,37/118,26.19%,SDCBP;TRAK1;KIF13B;LAMP2;SEC63;FUT10;RPL11;PITRM1;SRP14;ZFAND2A;NACA;ZDHHC7;AP1S3;ZFAND6;FIS1;ZDHHC2;NCF1;TIMM44;TIMM22;ZDHHC12;GABARAP;SRPRB;FBXO7;TAOK2;TOMM22;ZDHHC1;NACAD;GOLGA7;TOMM34;TOMM70;HPS4;MICALL1;EDEM1;ZDHHC6;YIF1B;AP4E1;LONP2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2727453312231805,0.8439669182901254,0.7092731829573935,0.9255791619524899,1.0,7/27,18.06%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC25A38;SLC6A5;SLC38A1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3435013401179042,0.8431778614045949,0.6627634660421545,0.9261244544848599,1.0,5/12,14.23%,MYCBP2;EPHB1;SPTBN4;ARHGAP35;HSP90AA1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.33929301993168637,-0.8418365133767727,0.6883561643835616,0.8456802249070506,1.0,1/13,0.06%,RBPJ
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3504664197245563,-0.8415646722830243,0.6738351254480287,0.8458449293776418,1.0,3/12,10.32%,XDH;PIK3CB;SPRY2
prerank,blood vessel endothelial cell migration (GO:0043534),0.2855635153316885,0.8414318291054596,0.6536697247706422,0.9286498339102442,1.0,2/22,1.35%,ROBO1;SLIT2
prerank,glycine metabolic process (GO:0006544),0.3412088054551048,0.8409443468998694,0.654292343387471,0.9285620536363421,1.0,6/12,26.68%,GLDC;GLYAT;SDSL;RIDA;SHMT2;SDS
prerank,protein localization to kinetochore (GO:0034501),-0.3351876921283047,-0.8402538331559752,0.6994727592267135,0.8479150715563539,1.0,4/14,15.36%,KNL1;ZWILCH;CDK1;TTK
prerank,detection of mechanical stimulus (GO:0050982),0.3052161858873109,0.8401101339340789,0.6909547738693468,0.9290819063844294,1.0,4/19,11.52%,CDH2;PKD1L3;TTN;PKD1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.3484006224914249,-0.8393375468162313,0.6882453151618398,0.8492191840787853,1.0,5/12,24.21%,DSE;CHST12;CSPG4;BGN;DCN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3554671808306188,-0.8393343352543198,0.6824324324324325,0.8484893367019284,1.0,5/11,25.52%,SYNJ1;IMPA1;INPP5A;INPP5B;INPP5K
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.3554671808306188,-0.8393343352543198,0.6824324324324325,0.8484893367019284,1.0,5/11,25.52%,SYNJ1;IMPA1;INPP5A;INPP5B;INPP5K
prerank,tyrosine metabolic process (GO:0006570),-0.3517104787262731,-0.8393314866595191,0.676271186440678,0.848131785358491,1.0,7/11,43.03%,IL4I1;DCT;HGD;FAH;TAT;TH;THAP4
prerank,acute-phase response (GO:0006953),-0.346013722725363,-0.839201219357738,0.6613756613756614,0.8479931267101796,1.0,5/12,33.39%,IL6R;CEBPB;IL6;SIGIRR;PLSCR1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.31978925551586435,0.8391284031148935,0.6403712296983759,0.9300274761114317,1.0,4/15,16.50%,ABHD16A;SARDH;GGT1;GGT5
prerank,external encapsulating structure organization (GO:0045229),0.18747306217636953,0.8389463120292787,0.9182058047493403,0.9292731223821087,1.0,51/205,20.74%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;ADAMTS12;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ADAMTSL2;ST7;FBLN5;COL1A1;LAMA2;LOXL1;LAMA5;TNC;SMOC1;LOX;SH3PXD2A;COL4A4;JAM3;NID1;ITGA2B;TGM1;MMP14
prerank,extracellular matrix disassembly (GO:0022617),0.23394029532112823,0.8389346827716179,0.7383863080684596,0.9281637283741486,1.0,11/53,12.24%,MMP16;SCUBE1;TLL1;MMP12;MMP15;MMP13;GSN;CTSK;HTRA1;BMP1;ADAMTS5
prerank,amide transport (GO:0042886),-0.2814607077947442,-0.8386899321437982,0.6970227670753065,0.8485561954027908,1.0,5/26,15.09%,PLTP;SLC27A1;GLTP;TAP2;ABCA13
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3489820225343422,0.8384418502661575,0.6466512702078522,0.9280737855168327,1.0,3/10,11.74%,EPB41L4B;FGF10;ARF6
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.22743970792205215,-0.8382687208954427,0.7826825127334465,0.8489788358487342,1.0,20/75,23.10%,ITGA4;NRP1;HTR2B;NRP2;VEGFA;MDK;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;NR4A1;NRAS;ANG;BMPR2;AGGF1;HMGB1;KDR;APLNR;HMOX1
prerank,ceramide biosynthetic process (GO:0046513),-0.25759269754454195,-0.8380219828103201,0.7232472324723247,0.8490673010755486,1.0,3/40,2.15%,SGMS1;SPTLC2;ST8SIA4
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.35451774909254147,-0.8371913369485818,0.6733212341197822,0.8502514965434598,1.0,5/11,22.79%,P4HA1;EGLN1;P4HA3;CRTAP;P4HB
prerank,glycine transport (GO:0015816),0.34986825715390935,0.836779830711864,0.6666666666666666,0.9303694804472773,1.0,3/10,16.85%,SLC6A17;SLC25A38;SLC6A5
prerank,cellular response to osmotic stress (GO:0071470),-0.29761673992740434,-0.8367611883078265,0.7096188747731398,0.850651685815129,1.0,4/21,9.83%,LRRC8D;ARHGEF2;CAB39;RCSD1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.23214421745885097,-0.8363119924579341,0.7804054054054054,0.8510827521829682,1.0,17/68,20.53%,SNRPG;SNRPF;POLR2H;SSU72;POLR2F;POLR2L;NUDT21;SMN1;WDR33;NCBP1;POLR2A;TTF1;TAF1A;POLR1F;PAPOLA;MAZ;CPSF3
prerank,regulation of endocytic recycling (GO:2001135),-0.3535897732406297,-0.8353035491838071,0.703150912106136,0.8525718725175643,1.0,3/11,15.34%,RAB11B;EIPR1;EHD1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.27447818010286773,-0.8350278959795217,0.7244897959183674,0.8526892693866962,1.0,10/29,25.07%,AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4;SMAD7;DTX3L;FEM1B;TOPORS;UBE2N
prerank,DNA catabolic process (GO:0006308),-0.3531379487432555,-0.8344698513850274,0.6800699300699301,0.8533387582653984,1.0,6/11,40.40%,REXO4;DNASE1L1;XRN2;ISG20;DNASE1;DNASE1L2
prerank,muscle cell migration (GO:0014812),-0.36302359149211777,-0.8343126070486904,0.6920353982300885,0.8532290987188695,1.0,2/10,9.65%,ROCK1;ITGB1BP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.282342874009649,0.8340548386233844,0.729490022172949,0.934721801322835,1.0,5/23,11.36%,EGF;PAX8;GDNF;SOX9;SMO
prerank,positive regulation of cellular protein localization (GO:1903829),-0.23097410409570357,-0.8337505982179662,0.7712765957446809,0.8539031443189248,1.0,25/69,31.18%,GPR137B;STX3;SNX33;PARP9;CDK1;CCDC88A;HSP90AB1;KAT7;SLC5A3;STX4;NDC80;GSK3B;DTX3L;NUP62;TGFB1;GTSE1;CARD10;GPD1L;TMEM35A;MARK4;EIF2AK3;RANGRF;NGFR;CENPQ;ORMDL3
prerank,amino sugar metabolic process (GO:0006040),-0.36628059201329866,-0.833702382301864,0.6872791519434629,0.8536254921280744,1.0,2/10,9.77%,ST3GAL1;ST6GAL1
prerank,sodium ion export across plasma membrane (GO:0036376),0.3339358395880743,0.8335295053522509,0.6746411483253588,0.9347093592179064,1.0,4/13,17.36%,SLC4A4;ATP1A3;ATP1B1;ATP1B2
prerank,C-terminal protein amino acid modification (GO:0018410),0.34787275216327873,0.8334628391147525,0.6867469879518072,0.933703899038118,1.0,3/11,12.14%,AGBL4;AGBL1;FOLH1
prerank,cellular response to ketone (GO:1901655),-0.2619498386602114,-0.8333143091467959,0.7534965034965035,0.8539748513044926,1.0,10/35,20.84%,MSN;GNB1;PTGER4;GNG2;AHR;ADAM15;SPP1;SPHK2;NR3C1;SFRP1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3379204567566375,0.8332971679693477,0.648590021691974,0.9329359698189226,1.0,6/12,20.91%,BICD1;HOOK3;CCDC68;KIF3A;PCM1;BBS4
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.31421001723776965,-0.8325884355414328,0.691768826619965,0.8549240475373048,1.0,6/17,26.26%,TFPI;UBE2L3;NR3C1;ADTRP;ATP1A1;URI1
prerank,copper ion homeostasis (GO:0055070),-0.3224234623313482,-0.8319622964688581,0.7186440677966102,0.855701638724959,1.0,4/17,13.35%,ATP7A;SLC31A1;APP;MT2A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3133861983716181,0.8319345352284165,0.7111111111111111,0.9346045383980123,1.0,4/15,10.68%,EDA;MSX1;AMELX;TBX1
prerank,transport along microtubule (GO:0010970),-0.34420293232004345,-0.8317964843205449,0.6872791519434629,0.8556228635624225,1.0,7/13,30.50%,CDC42;APP;BAG3;APBA1;BORCS5;COPG1;SPG11
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3327506316956916,0.831668723808109,0.6793893129770993,0.9340377093242394,1.0,4/13,20.29%,CAMK4;TOX;ZC3H8;GLI2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2447046317944609,-0.8314591210873974,0.768270944741533,0.8558348851381171,1.0,17/51,26.68%,PPARG;SKI;HTRA3;ACVR2A;GREM1;LEMD2;SMAD7;BMPR2;RBPMS2;GDF3;SMURF2;GREM2;LRP2;SKIL;SMURF1;BMP2;SMAD4
prerank,establishment of spindle orientation (GO:0051294),-0.277548581264849,-0.83104712445998,0.7122557726465364,0.8562362501950541,1.0,13/28,36.58%,ITGB1;FBXW11;CENPA;DCTN1;MAP4;NDC80;PAFAH1B1;PKHD1;SPDL1;GJA1;NUMA1;LLGL2;MISP
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.30711063221225965,-0.8309175054056164,0.7241379310344828,0.8560941994954827,1.0,6/20,26.92%,RBPJ;TGFBR1;HEYL;SNAI2;BMP2;ENG
prerank,hexose metabolic process (GO:0019318),-0.2535343816833005,-0.8306102476102593,0.7457044673539519,0.8563367820914762,1.0,16/39,32.71%,PPARD;GALT;SORD;AKR1A1;FUOM;GALM;IRS2;PMM2;GALK2;PGM1;PMM1;GALK1;GHRL;ALDOA;SLC35A2;GDPGP1
prerank,RNA polyadenylation (GO:0043631),-0.2851797954275428,-0.8305837157445413,0.7336769759450171,0.8556619432890248,1.0,8/26,20.53%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;GRSF1;CPSF3
prerank,mRNA polyadenylation (GO:0006378),-0.2851797954275428,-0.8305837157445413,0.7336769759450171,0.8556619432890248,1.0,8/26,20.53%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;GRSF1;CPSF3
prerank,positive regulation of calcium ion import (GO:0090280),0.3219444595474099,0.8303425964111608,0.6875,0.935517929037549,1.0,4/12,19.83%,RAMP3;ATP2A1;CXCL12;CCL2
prerank,neuron projection organization (GO:0106027),-0.3247231557059627,-0.8303207544765587,0.7013888888888888,0.8557389194458447,1.0,4/15,11.71%,INSR;ABCD2;APP;DCTN1
prerank,ganglioside metabolic process (GO:0001573),0.2880063383740694,0.8302422489110712,0.6967592592592593,0.9346036496326701,1.0,3/20,3.46%,ST8SIA2;ST8SIA3;HEXB
prerank,protein kinase A signaling (GO:0010737),-0.3483371739554496,-0.8299567493859845,0.7021276595744681,0.8560678826816683,1.0,6/12,36.35%,LCP1;MYOM1;RAB13;GAL;EZR;TCP11
prerank,synaptic vesicle membrane organization (GO:0048499),0.3027622656625357,0.8292397480389401,0.6993006993006993,0.9355010818312348,1.0,4/17,9.60%,SNAP25;STX2;TOR1A;PRRT2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.32053644628065814,0.8290405153869415,0.7341176470588235,0.9347997351479349,1.0,5/14,23.84%,SLC5A7;CHAT;SLC6A4;NOS1;ALDH9A1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.320282785773515,0.8281599201373029,0.7054794520547946,0.9354559826536151,1.0,3/15,7.13%,NTRK2;SOS1;BDNF
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.26877975522728204,-0.8276878641781878,0.7422680412371134,0.8597605592763204,1.0,14/32,34.28%,CTNNB1;CCT7;PKIB;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5
prerank,determination of bilateral symmetry (GO:0009855),0.27471396490690936,0.8272781542767325,0.7022727272727273,0.9361147047405817,1.0,8/24,20.27%,ODAD3;DNAAF4;TBX1;MKKS;NPHP3;DNAH5;BBS7;CFAP53
prerank,cardiac muscle cell development (GO:0055013),0.29192468404457317,0.8271644061685383,0.704954954954955,0.9352172818750413,1.0,4/20,12.96%,SORBS2;TTN;ALPK2;FHOD3
prerank,negative regulation of heart contraction (GO:0045822),0.34102269172371275,0.8266648042302238,0.6930455635491607,0.9350810161783778,1.0,3/11,8.31%,PDE4D;SPX;SPTBN4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2740806906334257,-0.8265722850007083,0.7344827586206897,0.8613745231334469,1.0,5/29,13.44%,VTI1A;GOLGA5;COG5;COG2;COPA
prerank,mesenchyme morphogenesis (GO:0072132),0.29484496209509103,0.826500733880974,0.7139364303178484,0.9342796100793852,1.0,3/17,9.22%,ACVR1;SOX9;TGFB2
prerank,regulation of histone modification (GO:0031056),-0.33848928281641094,-0.8262897004051827,0.725557461406518,0.8615045234922472,1.0,5/13,25.07%,AKAP8;FLCN;MTHFR;AKAP8L;UBE2N
prerank,glycolipid biosynthetic process (GO:0009247),0.2528191882873265,0.8253595175174762,0.7622549019607843,0.9354282632163006,1.0,19/38,28.95%,ST8SIA3;PIGU;B3GNT5;PIGA;PGAP4;ST8SIA5;DPM2;ST8SIA1;B4GALT6;ST6GALNAC5;PIGO;PIGL;PIGN;DPM1;PIGB;PIGW;PIGP;PIGQ;PIGF
prerank,positive regulation of intracellular transport (GO:0032388),0.24958119497453932,0.8252016151857533,0.7766990291262136,0.9346114698762842,1.0,10/38,14.54%,TENM1;PLA2G4E;ZFAND1;PRR5L;NEDD4;CEP131;CEP290;CAPN10;ICE1;ATP2A1
prerank,protein N-linked glycosylation (GO:0006487),-0.23116059474694256,-0.8247671170172419,0.7931654676258992,0.863797848478669,1.0,17/66,20.50%,ST3GAL1;MGAT5;MAN1C1;ALG5;DPM3;ALG12;MAGT1;ST6GAL1;B4GALT7;NUDT14;PMM2;MGAT2;ALG6;STT3B;B4GALT1;MGAT4B;GFPT1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3012907582568837,-0.824357209365269,0.7221269296740995,0.8641431146227804,1.0,4/18,17.25%,ASH1L;SMYD2;KMT2D;KMT2A
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.27750644063931174,0.8235997601988614,0.742152466367713,0.9366898350617319,1.0,6/23,19.74%,GSTP1;CYP1A1;LTA4H;ASAH2;ACOT7;ELOVL6
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.31771312054814266,0.8230374728621116,0.6981566820276498,0.936653662383918,1.0,3/13,12.33%,YOD1;UBE2J1;BCAP31
prerank,positive regulation of vascular permeability (GO:0043117),0.33360794733306587,0.8227561427175928,0.708029197080292,0.9360954013230044,1.0,2/12,8.76%,TJP1;OCLN
prerank,sulfur amino acid metabolic process (GO:0000096),-0.28630609027316545,-0.8226587252482827,0.7211221122112211,0.8667465774089443,1.0,7/24,22.06%,CDO1;MSRA;MTR;MPST;MMUT;SMS;MTHFR
prerank,response to estradiol (GO:0032355),-0.26952007357867924,-0.822417688647086,0.7578253706754531,0.8667646494348272,1.0,4/31,7.36%,STAT3;ANXA1;CTNNB1;STAT5B
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3243660869624885,-0.8222234896512514,0.7197986577181208,0.866730897097577,1.0,6/14,21.75%,TGFBR1;CHADL;GREM1;PTPN11;RFLNB;SNAI2
prerank,cortical cytoskeleton organization (GO:0030865),-0.2529523209039048,-0.8221950056691122,0.7719869706840391,0.8664068526159823,1.0,11/41,16.11%,PLEK;RAC1;ROCK1;RHOA;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13;RND2
prerank,eye development (GO:0001654),0.2321401760926948,0.8220865717928982,0.7917675544794189,0.9363783904124777,1.0,10/54,12.26%,CACNA1C;MEIS1;BMPR1B;SALL2;WT1;TGFB2;TSKU;CEP290;HES5;PBX1
prerank,gliogenesis (GO:0042063),-0.32668801186959834,-0.8220334053768669,0.7106690777576854,0.8663220389529703,1.0,5/15,15.59%,CDK6;CD9;ANXA1;METTL14;METRN
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.34966539172722955,-0.8214689384911679,0.7164948453608248,0.8669522910124826,1.0,3/10,12.36%,HTR2B;DGKD;PRKD3
prerank,regulation of chromatin binding (GO:0035561),0.3532664111336685,0.8201644591149992,0.6997635933806147,0.9390608750466176,1.0,1/10,1.15%,DDX11
prerank,regulation of cell morphogenesis (GO:0022604),0.2617233975529179,0.8200219620260392,0.7437185929648241,0.9382232318466253,1.0,10/30,16.22%,EFNA5;NTNG2;NTNG1;MFSD2A;SH3D19;FERMT2;WTIP;ARC;SPARC;PDZD8
prerank,myelination (GO:0042552),0.2375255873538,0.8197141337344301,0.7925407925407926,0.9376920567972529,1.0,6/46,5.29%,SLC8A3;PARD3;SCN2A;PLP1;EPB41L3;MAL
prerank,skeletal muscle tissue development (GO:0007519),-0.26781522728913426,-0.8196158534608052,0.7736185383244206,0.8696884627300016,1.0,5/32,14.53%,SVIL;CFLAR;SKI;MEF2C;LEMD2
prerank,alanine transport (GO:0032328),-0.3611199495520534,-0.819566387894518,0.6950596252129472,0.8694138454759017,1.0,2/10,8.52%,SLC6A6;SLC36A4
prerank,glycerolipid metabolic process (GO:0046486),0.33556218681859673,0.8194014299794047,0.6504629629629629,0.9371971630209656,1.0,1/11,0.90%,DGKB
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.24724928247080025,-0.8188964896330411,0.7873754152823921,0.8701855311033929,1.0,11/40,18.56%,C5AR1;ABL2;HTR2B;RASGRP4;FLT1;GNA15;ITK;EDNRA;TXK;ANG;PDGFRB
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.2796148804816069,0.8188126105427564,0.7542997542997543,0.937233853234422,1.0,5/22,15.22%,CUBN;RBP2;CYP1A1;LGMN;GC
prerank,vasculogenesis (GO:0001570),-0.26414425267590763,-0.8183870347387372,0.769090909090909,0.8706659365507509,1.0,15/32,32.14%,VEGFA;SPRED1;TGFBR2;RASA1;PDGFRB;AGGF1;KDR;TGFB1;APLNR;ADM;WNT7B;ENG;HEY2;RASIP1;CAV1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2503455410105519,-0.8178434051959534,0.7621527777777778,0.8712340763809894,1.0,10/42,22.68%,PEX14;SEC63;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM70;TOMM20L
prerank,negative regulation of T cell differentiation (GO:0045581),-0.3550308440123403,-0.8170393332811943,0.6949458483754513,0.8722219246209818,1.0,2/10,12.23%,MDK;FOXJ1
prerank,regulation of lipid storage (GO:0010883),-0.2853276023696364,-0.8168219186285849,0.7102966841186736,0.8722412411149489,1.0,5/22,11.60%,NFKB1;ITGAV;C3;LPL;FTO
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2967021904832307,-0.8153562119507403,0.7268041237113402,0.8743753382949073,1.0,6/19,30.31%,TPST1;SULT6B1;PAPSS1;ENPP1;SLC35B3;TPST2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2542666416559705,0.8148717560206479,0.7577937649880095,0.9436010312169854,1.0,9/30,20.99%,ELOVL7;SLC27A2;ACOX2;HACD1;ABCD1;TECRL;ACSL6;ELOVL6;ELOVL2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.27962819573386566,-0.8147437469765163,0.7379310344827587,0.8750643443461169,1.0,6/26,14.41%,CBL;SNX6;TSG101;APP;NCF1;CBLB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.26481172909293815,0.8145575156741941,0.7293064876957495,0.9431065042804125,1.0,6/27,10.91%,CHSY3;PXYLP1;VCAN;B3GAT2;CHST7;CHST9
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.34699137721118556,-0.8141454279978286,0.7308970099667774,0.8757329905609007,1.0,4/11,22.48%,MEF2C;DHX36;GREM1;TGFB1
prerank,stabilization of membrane potential (GO:0030322),0.30503661630958684,0.8139130289735221,0.7105882352941176,0.9431535796860375,1.0,2/16,5.88%,KCNK10;KCNK2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32655760313013205,-0.8138648922410165,0.7450980392156863,0.8758517134839496,1.0,2/14,5.53%,SLC27A1;CEPT1
prerank,regulation of cell projection organization (GO:0031344),0.32490887174021466,0.8135484390761685,0.693069306930693,0.9427604635541627,1.0,3/13,11.01%,NTNG2;NTNG1;MFSD2A
prerank,acyl-CoA metabolic process (GO:0006637),0.2538762558861555,0.8132133881464255,0.7754629629629629,0.9422591646801564,1.0,13/35,23.00%,HMGCS1;GLYAT;ACSM5;ACACA;MCEE;ACOT8;MLYCD;ACSM3;ACOT12;ACSL6;ACOT7;GPAT4;OXSM
prerank,endothelial cell differentiation (GO:0045446),0.32160471299311993,0.8127431231356997,0.7213930348258707,0.942010939207455,1.0,2/12,4.99%,SCUBE1;TIE1
prerank,embryonic hemopoiesis (GO:0035162),-0.3414475026149627,-0.8125976316144238,0.7301587301587301,0.8776525533639595,1.0,8/12,41.11%,TGFBR2;KMT2A;KDR;KITLG;TPO;ATF4;SH2B3;ZFPM1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.3408627743197612,-0.8122047023096185,0.7166064981949458,0.8779673637693786,1.0,5/11,27.42%,FAP;DFFA;SIRT2;ZC3H12A;BCL2L1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.26276480339801783,0.8110928070563395,0.7560386473429952,0.9439686256488038,1.0,8/25,21.06%,SOX11;BMPR1B;HES5;CDH5;ZNF423;UBE2O;ACVR2B;SULF1
prerank,anion transport (GO:0006820),-0.25627262008499135,-0.8108760937610694,0.7851099830795262,0.879843204593982,1.0,3/33,4.87%,LRRC8D;LRRC8C;VDAC2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.27090410132266285,-0.8106343751432447,0.7478559176672385,0.8798613161570621,1.0,5/28,10.49%,NUPR1;AXIN1;LAPTM5;CTSC;PSMC3
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.197509925242987,-0.8104036266166105,0.8887070376432079,0.8798690298820012,1.0,39/151,26.83%,APOE;B4GALT5;SGMS1;SPTLC2;ACER3;CDO1;CSNK2A1;SLC27A1;MOCS1;CEPT1;SPTSSA;PRKD3;GCNT1;MOCS3;GCH1;LARGE1;PLA2G4A;AKR1A1;KDSR;ARG2;ASS1;VAPB;SPHK2;TYW5;LPCAT3;SPTLC3;SAMD8;INHA;PLPP3;GSTO1;ELOVL5;TYW1;DEGS2;FURIN;CERS3;GAL3ST4;ESD;VAPA;HACD4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3048801698412347,0.8102970900593043,0.7386091127098321,0.9443445231728643,1.0,2/16,5.97%,SLC2A5;SPX
prerank,cochlea morphogenesis (GO:0090103),0.34366688763590003,0.809851781326887,0.6976190476190476,0.9440797874485843,1.0,2/10,10.68%,SOX9;TBX1
prerank,histone H3 acetylation (GO:0043966),-0.25036364640333614,-0.8097574305802874,0.7885615251299827,0.8805777828312209,1.0,14/40,34.51%,SPI1;WDR5;JADE2;KAT7;DR1;TAF9;TRIM16;TADA1;TADA3;LEF1;TAF5;TAF5L;JADE3;KAT6A
prerank,SNARE complex assembly (GO:0035493),-0.35590010557522245,-0.8094920573039621,0.7280858676207513,0.8806733652992672,1.0,7/10,40.48%,UVRAG;VAMP4;VAMP1;VAMP2;VAMP3;CLTRN;STXBP1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.258079254303509,-0.8091725847348498,0.7783417935702199,0.8808481933351854,1.0,5/36,11.96%,TAOK3;PTPN22;DUSP3;SIRPA;AIDA
prerank,cell junction maintenance (GO:0034331),-0.3210006662712747,-0.8083714261140496,0.7279151943462897,0.8818147646961094,1.0,7/14,30.37%,MYADM;DCTN1;CBLN2;CLDN1;PRTN3;CD177;F2R
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3262215575381083,0.8083412013394699,0.7014218009478673,0.9458309644487242,1.0,4/12,14.46%,GGT1;PSAT1;CTH;CBS
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2536229030423314,-0.8083100244745403,0.7775891341256367,0.8815470812299953,1.0,7/36,13.19%,GNB1;AGO2;GNG2;CTNNB1;MOV10;TNRC6C;PLCB3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.23807649244785453,-0.8079267780659655,0.7959183673469388,0.8818238485198316,1.0,16/50,24.84%,CCND3;ACTB;BLM;CDKN3;CDC25A;GADD45A;HSP90AB1;CCNE1;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1;CCNB2
prerank,relaxation of muscle (GO:0090075),-0.33010598145050896,-0.8071011841061759,0.7285974499089253,0.8828260566424282,1.0,7/13,35.27%,P2RX4;SLC8A1;PIK3CA;PLN;ATP1A1;RGS2;KCNJ2
prerank,clathrin coat assembly (GO:0048268),-0.3130301693680748,-0.8069926658002662,0.7119565217391305,0.8826265799341009,1.0,4/15,7.77%,FCHO2;PICALM;HIP1;EPS15
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2275546989816774,0.8067251133691357,0.8233766233766234,0.947571797707243,1.0,5/50,6.26%,RORA;IFT81;PTCH2;DCDC2;MOSMO
prerank,extracellular structure organization (GO:0043062),0.18096598434060235,0.8063202528511676,0.9565217391304348,0.9472422927637026,1.0,50/204,20.74%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;ADAMTS12;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ADAMTSL2;ST7;FBLN5;COL1A1;LAMA2;LOXL1;LAMA5;TNC;SMOC1;LOX;SH3PXD2A;COL4A4;JAM3;NID1;ITGA2B;MMP14
prerank,acylglycerol biosynthetic process (GO:0046463),0.27837890314469504,0.8057050994255811,0.748780487804878,0.9472331240759653,1.0,5/23,14.21%,MOGAT3;PLCE1;GPAM;DGAT2L6;GPAT3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.26974619167503033,-0.8056403777017711,0.7602739726027398,0.8845538484402383,1.0,3/29,5.66%,APOE;SLC27A1;NR1H2
prerank,vascular transport (GO:0010232),0.20838750875137474,0.8055741630282348,0.8529411764705882,0.9463696362992864,1.0,18/81,15.50%,SLC12A2;SLC2A13;SLC4A4;SLC1A2;SLC24A3;SLC6A17;SLC1A1;LEPR;SLC6A1;SLC8A2;SLC6A13;SLC38A3;SLCO2B1;MFSD2A;ATP2B4;SLC16A2;SLC22A5;SLCO3A1
prerank,positive regulation of secretion (GO:0051047),-0.33949849967677825,-0.8055595700003592,0.7238421955403087,0.8843072882117075,1.0,6/11,39.60%,XBP1;GPLD1;AQP1;SCIN;TRH;NPR1
prerank,ncRNA metabolic process (GO:0034660),-0.25358094596478686,-0.8047563738661376,0.7986230636833046,0.885246829025974,1.0,8/37,20.35%,AGO2;TUT7;EXD1;XPO5;NIFK;TDRKH;TENT4B;BCDIN3D
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.3312028620607088,-0.8042857663970256,0.7277486910994765,0.8856830143561552,1.0,3/12,9.84%,IQGAP1;JAG1;MYO1E
prerank,regulation of chromatin organization (GO:1902275),-0.3270773843220183,-0.8041935933965269,0.7419354838709677,0.8854760454536206,1.0,3/14,13.21%,TLK1;METTL4;MKI67
prerank,cobalamin metabolic process (GO:0009235),-0.3072550541647515,-0.8039143467608174,0.7482758620689656,0.8855696082406368,1.0,4/17,21.20%,ABCC1;MTR;MMUT;LMBRD1
prerank,proton transmembrane transport (GO:1902600),-0.25079265369215253,-0.8037633089848649,0.7715827338129496,0.8854521047027498,1.0,15/36,40.47%,ATP6V1A;UCP2;SLC9A1;ATP6V0E1;NNT;ATP5MF;ATP6V0D1;ATP5F1B;ATP1A1;SLC36A3;ATP6V0A4;ATP6V1B1;ATP1A4;ATP6V1F;ATP5PO
prerank,cardiac ventricle development (GO:0003231),-0.30005478674847696,-0.8030981002008692,0.7696245733788396,0.8861850008165727,1.0,9/20,34.85%,HECTD1;TMEM65;GATA3;MDM4;HEYL;ENG;GJA5;HEY2;HEY1
prerank,positive regulation of telomerase activity (GO:0051973),-0.2582954810214766,-0.7999721354884679,0.7978910369068541,0.890941248966732,1.0,15/33,34.06%,CTNNB1;PKIB;NVL;HSP90AB1;GREM1;CCT4;WRAP53;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3159244512662041,0.7996996718281496,0.7452380952380953,0.9559242161287692,1.0,3/13,14.52%,PLCB1;GOLGA2;SOAT1
prerank,regulation of mitochondrial fission (GO:0090140),-0.27321158374594323,-0.799209772146464,0.7736842105263158,0.8917722147059861,1.0,8/24,25.05%,DDHD1;CYRIB;FIS1;INF2;AURKA;KDR;DCN;STAT2
prerank,glycerolipid catabolic process (GO:0046503),0.2808359416469865,0.7987187506336364,0.7292682926829268,0.9565849315563502,1.0,5/19,18.61%,GDPD1;PLA2G4E;ENPP6;PNPLA6;GDE1
prerank,transport across blood-brain barrier (GO:0150104),-0.21869915009593538,-0.7981698355257292,0.8347529812606473,0.8930809188767164,1.0,19/83,20.05%,SLC16A7;LRP1;CD36;SLC6A6;INSR;FABP5;SLC2A1;SLC27A1;ABCC1;ATP2A3;SLC28A2;ABCC4;SLC7A5;SLC5A3;SLC29A1;SLC6A9;SLC38A2;AGER;SLC16A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2781054401029295,-0.7979611093039469,0.762063227953411,0.8930650194131885,1.0,8/23,28.70%,HERC4;MGRN1;ENPP1;SUFU;RACK1;MEGF8;VCP;IFT122
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.27398665345541323,0.7979429273853896,0.7471264367816092,0.9568979560545204,1.0,4/21,10.91%,CHSY3;VCAN;CHST7;CHST9
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.28798456880557893,-0.7978353585143343,0.7491638795986622,0.8929024813005035,1.0,7/21,16.01%,ATXN7;ARHGEF2;TPX2;TAOK1;CIB1;SPEF1;STMN2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.27967071377315195,0.7977644564636057,0.7692307692307693,0.9560880645310971,1.0,6/20,20.44%,FAR2;ACACA;HSD17B4;HSD17B8;ACSL3;FASN
prerank,retinoid metabolic process (GO:0001523),0.21276617686397062,0.7973168745847112,0.8590078328981723,0.9557607563630698,1.0,10/71,12.80%,GPC6;GPC5;DHRS13;RETSAT;SDC1;OPN1MW;RBP2;TTR;CYP1A1;SDC2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.30573159617504153,-0.797267836727155,0.7124183006535948,0.8934313696827184,1.0,9/15,31.58%,P2RX4;VEGFA;TMSB4X;HSPB1;KDR;FGF18;MET;FGF16;FGF2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.34659976173575363,-0.7966037943067376,0.7061855670103093,0.8940868081656806,1.0,4/10,32.14%,MVP;ENPP1;ENG;CAV1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.2867513018330839,-0.7956689478766964,0.7555938037865749,0.8952556224992733,1.0,12/21,31.06%,CD300A;PLEK;PPP1R15B;MEF2C;HSP90AB1;PDGFRB;CHP2;GPLD1;BMP2;RIPK3;AGTR2;PTPA
prerank,regulation of protein localization to membrane (GO:1905475),0.2612444782945395,0.7954597226475701,0.7697841726618705,0.957874673495233,1.0,6/28,14.45%,GPC6;GPC5;FYN;GSN;PRKN;VAMP8
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.30254667936887797,0.793674601872993,0.7636761487964989,0.9598471516797379,1.0,3/15,7.45%,MGAT3;CHST5;CHST7
prerank,protein K11-linked ubiquitination (GO:0070979),-0.271001788715875,-0.7936294636740813,0.7738693467336684,0.898078630658638,1.0,7/27,17.59%,ANAPC1;RNF4;UBE2L3;UBE2H;UBE2T;UBE2C;ANAPC7
prerank,amide biosynthetic process (GO:0043604),0.22751744110638275,0.7935774016244155,0.8158508158508159,0.9589120114244809,1.0,3/47,3.49%,DMD;PCSK5;PAM
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2756587873510028,0.7929402610887313,0.7894736842105263,0.957802229375013,1.0,9/20,25.18%,MCCC2;MCCC1;BCAT1;ACAT1;DBT;BCAT2;BCKDHB;ACADSB;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2756587873510028,0.7929402610887313,0.7894736842105263,0.957802229375013,1.0,9/20,25.18%,MCCC2;MCCC1;BCAT1;ACAT1;DBT;BCAT2;BCKDHB;ACADSB;AUH
prerank,vasculature development (GO:0001944),-0.30117592577115343,-0.7922999299497964,0.7296819787985865,0.8998024582732256,1.0,9/16,39.84%,PIK3CA;STK11;PDGFRB;BMPR2;APLNR;FLT4;STRA6;PDGFRA;NOTCH4
prerank,regulation of protein localization (GO:0032880),-0.2259411622493881,-0.7915310537284893,0.8526863084922011,0.9006799883412371,1.0,15/58,22.61%,CTSD;PLEKHM2;USP8;PICALM;ZDHHC7;TPR;HSP90AB1;TRIM68;TRIM14;DNAJB6;RACK1;KDM1A;TRIM25;VPS4A;TRIM67
prerank,regulation of mitochondrial fusion (GO:0010635),-0.34050988494226464,-0.7908141503682357,0.7712305025996534,0.9014362159755417,1.0,2/11,8.29%,PID1;VAT1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.24420756293057472,-0.7905034726421004,0.8157453936348409,0.9015553634554002,1.0,12/42,27.52%,CCDC40;MEF2C;MICAL2;TGFBR2;VANGL2;STIL;MEGF8;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,aerobic electron transport chain (GO:0019646),-0.21734523511628587,-0.7904933722217973,0.8433734939759037,0.9012002209316834,1.0,26/68,33.98%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA4;NDUFA3;CYCS;COX5A;NDUFB8;NDUFC2;NDUFC1;COX6A2;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.30002207623025884,0.7901725908137104,0.7420814479638009,0.9614785018278048,1.0,5/14,17.01%,MFSD2A;IRS1;ABCB11;ABCD1;AKT2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.26301569230870964,-0.7900500607820922,0.7794117647058824,0.9015007659387881,1.0,16/27,39.81%,FGR;FLT1;PTK2B;PDGFRB;NOD2;TGFB1;FLT3;FPR2;CD19;FGF2;CCL19;EPHA8;PDGFB;CCR7;PDGFRA;ATG14
prerank,coenzyme A metabolic process (GO:0015936),0.31040623226870406,0.7881214541471985,0.7182448036951501,0.9639387460440313,1.0,6/14,19.70%,PANK3;NUDT7;ACAT1;COASY;CROT;ACOT7
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.21854321293907283,-0.7880817642859768,0.8482293423271501,0.904174650026685,1.0,17/64,26.65%,CPT1A;DAGLB;ACSL5;AIG1;GPX4;PLA2G4A;ACOX1;ACOT2;ACOT4;ACSBG1;ACAD9;ELOVL5;ADTRP;CYP1B1;PNPLA8;SLC27A3;ALOX15
prerank,cilium-dependent cell motility (GO:0060285),-0.2804382982601445,-0.7879482209130186,0.7713787085514834,0.9039970363868025,1.0,7/22,31.21%,EFHC2;CFAP44;DNAH8;DNAH3;TEKT5;DRC1;CFAP54
prerank,endochondral bone morphogenesis (GO:0060350),0.3163650962975137,0.7874729533927028,0.7249417249417249,0.9639430798079479,1.0,1/11,2.95%,BMPR1B
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3136435735821521,-0.7872143386561243,0.7419898819561551,0.9047310607256013,1.0,8/14,41.15%,MALT1;TRAF2;COPS8;CARD10;TRAF6;CARD14;TNFSF15;TLR3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.21579322746742263,-0.7865549272875193,0.8490566037735849,0.9054010396178569,1.0,26/69,33.98%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA4;NDUFA3;CYCS;COX5A;NDUFB8;NDUFC2;NDUFC1;COX6A2;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.30277624128007297,-0.7862025202855384,0.7564322469982847,0.9055514309743231,1.0,9/15,30.90%,KHNYN;NYNRIN;ZC3H12A;RPP40;NUDT16;LACTB2;ZC3H12D;ZC3H12C;POP1
prerank,nuclear envelope organization (GO:0006998),-0.2824316038948021,-0.7859037482168584,0.7562604340567612,0.9056556940705414,1.0,6/20,21.84%,NEMP1;SUN2;TOR1AIP1;LEMD2;REEP3;VPS4A
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3192455432556317,-0.7855777195080051,0.7674418604651163,0.9057670236663837,1.0,2/13,2.04%,PTPRC;MGAT5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2715086166364583,0.7855480201154461,0.762589928057554,0.966039997506826,1.0,6/22,17.09%,PPM1E;DUSP4;DUSP10;DUSP18;DUSP8;PPM1G
prerank,regulation of acute inflammatory response (GO:0002673),-0.2917773285318434,-0.7852364164645428,0.7801047120418848,0.9058951147062692,1.0,8/18,44.62%,ADAM8;NLRP3;IL6;PTGES;F12;DNASE1;IL6ST;OSM
prerank,regulation of hormone secretion (GO:0046883),0.30103765964403234,0.7851083682338058,0.745679012345679,0.9656804908656129,1.0,3/15,14.44%,SOX11;EDN1;SCG5
prerank,aerobic respiration (GO:0009060),-0.2799037035427833,-0.7841962031718537,0.7804428044280443,0.9071023207122514,1.0,7/20,30.30%,SIRT3;UQCRC1;MTFR1L;MDH2;UQCRC2;ATP5F1D;UQCRB
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.25689852427482107,-0.7841828095150533,0.7764505119453925,0.9067464978113069,1.0,14/29,41.27%,FUS;E2F1;TENT5A;TENT5C;TENT5D;VIP;DHX34;SLC11A1;YBX1;PKP3;RBM24;PKP1;TAF15;ELAVL1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.26914789824394003,-0.7840637210140812,0.787085514834206,0.9065587889617935,1.0,12/25,40.21%,DCK;HPRT1;SHMT1;DGUOK;PRPSAP1;PNP;GMPR2;ADA;MTHFD1;AMPD3;PRPS1;PRPS1L1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.34257100124427786,-0.7840224041079773,0.7614840989399293,0.9062452961296219,1.0,6/10,34.79%,SMYD2;KMT5A;SETD6;SETD7;SETD2;SETD4
prerank,filopodium assembly (GO:0046847),-0.298923594121798,-0.7840187737545838,0.7905759162303665,0.9058765094802823,1.0,5/16,15.88%,FGD6;FGD4;FGD3;SPEF1;PPP1R9B
prerank,regulation of pH (GO:0006885),-0.3298819142627798,-0.7836996443678487,0.765625,0.905946668585172,1.0,7/11,41.12%,SLC9A1;SLC26A4;ATP6AP1;ATP6V0A4;ATP6V1B1;ATP1A4;LACC1
prerank,response to gamma radiation (GO:0010332),-0.2733781493597748,-0.7836753751786204,0.7885304659498208,0.9056083562023813,1.0,9/24,24.44%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;FANCD2;CRYAB;MYC
prerank,protein prenylation (GO:0018342),0.3361040869686727,0.7833213106474959,0.7257281553398058,0.9674749367691893,1.0,3/10,12.08%,FNTB;AIPL1;FNTA
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3106663335911658,0.7831494037872652,0.7764976958525346,0.9666803360476731,1.0,1/12,1.62%,ADCY8
prerank,regulation of cellular protein catabolic process (GO:1903362),0.29158749682982016,0.7828413278376793,0.7524038461538461,0.9660730073845626,1.0,4/18,14.23%,NELL1;CDK5RAP3;ATRAID;HSP90AA1
prerank,regulation of cell communication (GO:0010646),0.23854003119381179,0.7821673899634213,0.8173076923076923,0.9660366200405547,1.0,4/35,7.57%,ANK2;RYR2;CASQ2;GRK4
prerank,oogenesis (GO:0048477),0.2957235242649169,0.7819778903411521,0.7751196172248804,0.9652524555565191,1.0,6/15,23.52%,PTN;FMN2;IHO1;NANOS3;MEI4;NANOS1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3031928707270766,-0.7816855951333402,0.7796610169491526,0.9082191516986526,1.0,5/15,24.21%,DSE;CHST12;CSPG4;BGN;DCN
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.27655732336517924,-0.7816115528182414,0.8069883527454242,0.9079458174197609,1.0,4/22,11.52%,DDB2;UBC;RPS27A;CUL4B
prerank,cilium assembly (GO:0060271),-0.1758355471385841,-0.7804399764015852,0.9904610492845787,0.9093348534643352,1.0,64/296,22.20%,RAB8B;SNX10;ASAP1;ACTR2;FLNA;EHD4;KIF3B;IFT20;PIBF1;CNTRL;ACTR3;RAB1A;DYNC1H1;HAUS5;SDCCAG8;HAUS6;CFAP44;EXOC4;CEP57;CKAP5;CEP162;CCDC40;YWHAE;SPAG16;CEP70;HAUS4;CDK1;SPATA6;DCTN1;FOXJ1;HAUS7;ABCC4;CFAP70;TMEM80;GORAB;ARL3;CFAP20;VANGL2;EHD1;RP2;CFAP43;NINL;DYNLT2B;NUDCD3;ODF2;EXOC2;PCNT;RILP;PDE6D;IFT57;MAK;EXOC6;BBIP1;RAB11A;PAFAH1B1;TMEM17;ATP6V0D1;RILPL1;DISC1;CEP192;HYLS1;TUBA4A;TTLL3;CEP41
prerank,serine family amino acid metabolic process (GO:0009069),-0.3010308558085659,-0.780322963962461,0.7972270363951474,0.9091380527387334,1.0,2/16,5.11%,CDO1;SARS1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3267063640340523,-0.7802863932121347,0.7418803418803419,0.9088189403359642,1.0,7/11,41.75%,HIF1A;FBXO7;RACK1;NONO;ATF4;NR4A3;PINK1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27764279597042973,-0.780246096587305,0.7749077490774908,0.9084975515341399,1.0,10/23,33.73%,ITGB1;FBXW11;CENPA;DCTN1;NDC80;PAFAH1B1;PKHD1;SPDL1;GJA1;NUMA1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.32163610374242235,0.7802236532833614,0.7360178970917226,0.9670441322738401,1.0,2/11,4.13%,TJP1;AFDN
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.28862528224276357,-0.7798798346973632,0.795774647887324,0.9086466253092403,1.0,5/19,13.49%,PRDX5;POLR3G;MAF1;CHD8;DHX36
prerank,retinol metabolic process (GO:0042572),-0.31620573052969164,-0.7798762941124618,0.7690972222222222,0.9082763391576978,1.0,5/14,28.60%,DHRS3;CYP1B1;RBP4;RDH12;RDH10
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2314840286127672,-0.7796145453692052,0.8432055749128919,0.9082944839586438,1.0,12/46,22.68%,PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;FBXO7;GRPEL2;TOMM22;TOMM34;TOMM70;TOMM20L
prerank,neurogenesis (GO:0022008),-0.2401663843253842,-0.7794404914335548,0.8175675675675675,0.908158949004188,1.0,9/43,17.91%,TRAK1;CDK6;ERCC6;ANXA1;DAGLB;METTL14;THOC2;CXCR4;RYK
prerank,lung development (GO:0030324),-0.24945464739201081,-0.7789343202722608,0.8260162601626017,0.90853299600136,1.0,13/33,31.58%,VEGFA;RCN3;CCDC40;ITGA3;FOXJ1;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24110060559207303,0.7784597969343582,0.8226950354609929,0.9688165099701611,1.0,7/35,13.42%,MAGI2;TSC1;BOD1;CALM1;CALM3;CALM2;PPP4R4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2255513013862353,-0.7770487080179677,0.8359240069084629,0.9109731667659313,1.0,11/51,19.84%,CTNNB1;CCT7;PKIB;DCP2;TNKS2;TEN1;TENT4B;CCT4;HNRNPA1;EXOSC10;ATM
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3421831112422456,-0.7769455790799435,0.7580372250423012,0.9107384318877876,1.0,4/10,31.95%,AGO2;TSNAX;TSN;DROSHA
prerank,dermatan sulfate metabolic process (GO:0030205),-0.3180815149237203,-0.776918888679972,0.7753378378378378,0.9103995904010435,1.0,5/13,24.21%,DSE;CHST12;CSPG4;BGN;DCN
prerank,primary miRNA processing (GO:0031053),-0.3404261462888505,-0.7768501566183232,0.7539823008849558,0.910122265958825,1.0,5/10,32.63%,SRRT;METTL3;SMAD2;DROSHA;SMAD1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2743119564222085,0.7766461228178081,0.7807881773399015,0.9706077587947433,1.0,3/18,9.22%,ACVR1;SOX9;TGFB2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.31619867826688103,-0.7763968200612329,0.7653429602888087,0.9104304882026295,1.0,2/13,4.72%,NIBAN2;HHEX
prerank,protein insertion into ER membrane (GO:0045048),-0.24759839633212172,-0.7763345701865155,0.8089500860585198,0.9101513562883311,1.0,16/37,30.99%,TRAM2;APP;SERP1;STX5;GET3;EMC6;SGTA;BAG6;EMC9;HMOX1;CYB5A;TRAM1L1;OTOF;VAPA;VAMP2;UBL4A
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2588946927138116,-0.774831037630662,0.7979094076655052,0.9119484505500008,1.0,7/28,17.95%,RAC1;FES;CKAP5;DCTN1;SLAIN2;HSPA1A;RPS3
prerank,monoacylglycerol metabolic process (GO:0046462),0.30546455782654813,0.7747631517501369,0.7654320987654321,0.9725510323705334,1.0,2/13,4.15%,MOGAT3;ABHD16A
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.20362920314811547,0.7746208146487973,0.9101941747572816,0.9716939981903234,1.0,17/79,15.84%,SLIT2;BMPR1B;VWC2;PDCD6;SPRY4;VWC2L;APLN;NEDD4;EPN2;ADAMTS12;NBL1;CREB3L1;SPRY1;ATP2B4;TRIM33;BMPER;SPART
prerank,peptidyl-threonine modification (GO:0018210),-0.21445922476772758,-0.7743826739969041,0.8617200674536256,0.9122272479558295,1.0,20/66,24.19%,PRKCD;ROCK1;CSNK2A1;DYRK2;GALNT3;TGFBR1;GALNT1;DYRK1A;CDK1;MAP2K1;MARK2;TGFBR2;MAP3K10;GSK3B;CHEK1;CDC42BPG;WNK1;CDK5;MAPK1;PRKDC
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2642949830833097,-0.7741804284120303,0.8056042031523643,0.9121542928458454,1.0,8/24,24.70%,FLVCR1;RSAD1;HMBS;COX10;PGRMC1;PPOX;UROD;SUCLA2
prerank,regulation of rRNA processing (GO:2000232),-0.28705198428654144,-0.7737009445538415,0.7828467153284672,0.9124908353559747,1.0,5/16,25.84%,USP36;DIMT1;SHQ1;BUD23;NUDT16
prerank,glycerophospholipid metabolic process (GO:0006650),-0.20794619187866958,-0.7736356158040021,0.9080645161290323,0.9122250563105561,1.0,18/75,20.48%,PLEK;SYNJ1;ABHD12;CPNE3;PLCB3;PLCD1;PLA2G4A;PIGH;PIGX;PLA2G7;CLN3;PLAAT1;PDGFRB;IP6K3;GPCPD1;PIP5K1A;PAFAH1B1;PLA2G6
prerank,negative regulation of cell death (GO:0060548),0.19559415415209502,0.7731855629459311,0.9253731343283582,0.9729374774676358,1.0,21/88,18.83%,SOX11;CD200R1;TIGAR;CCN3;PRKD1;FYN;CD200;BMP7;PACRG;SRGAP2;AGR3;AMIGO2;FERMT2;PRKN;PPARGC1A;MECOM;SNCA;IKBKG;ADNP2;DUS2;RAD18
prerank,regulation of ossification (GO:0030278),-0.24673086529346655,-0.7727008648849052,0.8412698412698413,0.9132316965087294,1.0,9/36,20.84%,RBPJ;LRP6;MDK;MEF2C;ANKH;PTPN11;ENPP1;BMPR2;SFRP1
prerank,response to amino acid (GO:0043200),0.2411673326576396,0.7726404536017398,0.8228438228438228,0.9726752205975037,1.0,9/31,19.99%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;GLRA3;CAPN2;NSMF;RRAGA
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3309559950316364,-0.7724101928871003,0.7345575959933222,0.9132759360227015,1.0,4/11,42.57%,SIK1;EP300;C1QTNF12;CLK2
prerank,histone H2A monoubiquitination (GO:0035518),-0.29412090739231744,-0.7723410185659015,0.7932773109243697,0.9130096579620457,1.0,3/17,11.52%,DDB2;RYBP;CUL4B
prerank,inositol phosphate catabolic process (GO:0071545),-0.32182326817577944,-0.772059477642514,0.788135593220339,0.9130605018511786,1.0,3/12,10.76%,SYNJ1;IMPA1;INPP5A
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.264774396237061,-0.7711478627621977,0.8180300500834724,0.9139860842374473,1.0,6/24,17.93%,CKAP5;PIN1;KIF14;KIF2C;STMN2;KIF18B
prerank,determination of left/right symmetry (GO:0007368),0.23664855980285557,0.7709414554565328,0.8217592592592593,0.9742497778446839,1.0,11/36,20.27%,ODAD3;DNAAF4;TBX1;SMO;ENKUR;MKKS;RFX3;NPHP3;DNAH5;BBS7;CFAP53
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3341258697780356,0.7709036011084294,0.7772727272727272,0.9732235996685806,1.0,4/10,16.30%,CDC73;CPEB3;HSF1;LEO1
prerank,glutathione metabolic process (GO:0006749),-0.2399171110066879,-0.7708273494044543,0.8373702422145328,0.9140772631640923,1.0,4/38,9.21%,ETHE1;GSR;CTNS;CNDP2
prerank,lipid phosphorylation (GO:0046834),0.32527731225226275,0.7706869362279457,0.7093023255813954,0.9724885595146325,1.0,1/10,0.90%,DGKB
prerank,diacylglycerol metabolic process (GO:0046339),0.2624533038599465,0.7699977054025195,0.8356807511737089,0.9724696687120375,1.0,3/23,7.95%,DGKB;PLCE1;GPAM
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.23724190885323454,-0.7693529051767185,0.8306878306878307,0.9157776124382292,1.0,2/40,5.13%,PID1;BCL2
prerank,microtubule-based transport (GO:0099111),0.32060613142800165,0.7692824152772436,0.7570093457943925,0.9724870337503202,1.0,6/12,25.76%,DYNC1I1;DNAAF4;DYNC1I2;HTT;SPEF2;CABYR
prerank,regulation of wound healing (GO:0061041),-0.23497952581894238,-0.7685982302368781,0.8523489932885906,0.9164745997483473,1.0,6/42,12.69%,PLAU;ITGB1;ARFGEF1;ANXA1;CRK;SERPINE1
prerank,endocardial cushion development (GO:0003197),0.26191629152091844,0.7685618034925161,0.8048780487804879,0.9725382726704029,1.0,3/21,9.22%,ACVR1;SOX9;TGFB2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29385247979662044,-0.768074652203167,0.806070826306914,0.9168436996295822,1.0,4/17,22.79%,NFE2L2;MAPK7;HSPB1;P4HB
prerank,proteasome assembly (GO:0043248),0.3212518286819293,0.7680136533943257,0.7416481069042317,0.9722792546732383,1.0,6/11,27.22%,PSMG2;PSMD5;ADRM1;PSMG1;PSMD11;PSMD13
prerank,protein acylation (GO:0043543),-0.23681366765089906,-0.7670642153333,0.8235294117647058,0.9179136066454762,1.0,12/38,29.58%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;HHAT;ZDHHC13;ZDHHC6;CLOCK;EP300
prerank,negative regulation of organelle assembly (GO:1902116),-0.24102282020957522,-0.7663607381718345,0.8447971781305115,0.9185088940143328,1.0,9/35,21.70%,NUPR1;MTM1;BRCA1;STYXL1;RBM14;TBC1D30;TBC1D7;CHMP4B;CHMP4A
prerank,serine family amino acid catabolic process (GO:0009071),0.3204684991449142,0.766347438008047,0.7339667458432304,0.9737239511108441,1.0,5/10,26.68%,GLDC;CBS;THNSL2;SHMT2;SDS
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2357603759629332,0.7659211024556294,0.8181818181818182,0.9733019538385131,1.0,4/33,6.91%,PLCB1;UBE2E2;FGF10;CDC73
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3067060065586483,-0.7658501391285686,0.7953410981697171,0.9188711876697693,1.0,3/13,8.74%,ATG7;ATG10;UBA7
prerank,negative regulation of viral transcription (GO:0032897),-0.308438041961901,-0.764555659364586,0.7846975088967971,0.9202727691091864,1.0,3/13,15.94%,UBP1;TRIM11;TRIM14
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3037607044272618,-0.764287479140079,0.801358234295416,0.9202642456213469,1.0,7/14,38.72%,CCR1;CSF1;TRAF6;ATP6AP1;TNF;IL12B;POU4F1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.27426225930743114,0.7642808630385627,0.8286384976525821,0.9747198050329602,1.0,3/18,11.40%,NAV3;PRNP;HOMER3
prerank,cellular response to leucine starvation (GO:1990253),0.3263727126224564,0.7642275322753411,0.7511520737327189,0.9737198216989482,1.0,2/10,6.77%,SESN3;RRAGB
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.29351260225725234,-0.7641482494413048,0.7912280701754386,0.9200887087906913,1.0,7/17,40.23%,PLA2G4A;PLA2G5;PLA2G12A;LPCAT4;PLA2G3;PLA2G4B;SERAC1
prerank,ERAD pathway (GO:0036503),-0.20594228549717716,-0.7636058834531935,0.9151103565365025,0.9204853645609202,1.0,23/83,21.46%,AMFR;RHBDD2;ATXN3;WFS1;ERLIN1;RCN3;DNAJB9;SELENOS;UBE4B;DNAJB14;DERL1;SEL1L;HSP90B1;UBXN6;RNF185;RNF121;STT3B;ERLEC1;FOXRED2;SGTA;FAF2;BAG6;TRIM25
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.25046648516529296,-0.7635253146619284,0.8338983050847457,0.9202251856669699,1.0,6/31,11.91%,RAB1A;AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4
prerank,melanosome transport (GO:0032402),-0.2853293578050579,-0.7633955406615585,0.8177083333333334,0.919656390138879,1.0,1/18,0.10%,MYO5A
prerank,pigment granule transport (GO:0051904),-0.2853293578050579,-0.7633955406615585,0.8177083333333334,0.919656390138879,1.0,1/18,0.10%,MYO5A
prerank,protein autoprocessing (GO:0016540),-0.287745528195589,-0.7633893844936062,0.798941798941799,0.9192932538201058,1.0,3/17,12.94%,FAM111A;CASP4;CASP1
prerank,negative regulation of proteolysis (GO:0045861),-0.2413381366093797,-0.7628431577016153,0.830155979202773,0.919696931618017,1.0,9/34,21.94%,ROCK1;DNAJC1;TIMP2;CST7;CST3;CLN3;TMEM59;BAG6;CDK5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.2906726588594433,0.7622364679543113,0.7896039603960396,0.9755967151123095,1.0,4/15,14.38%,SEMA5A;PRKD1;SMOC2;LGMN
prerank,negative regulation of wound healing (GO:0061045),-0.25725599404645605,-0.7621803486411346,0.8227848101265823,0.9202138119195826,1.0,4/28,12.69%,APOE;TFPI;CRK;SERPINE1
prerank,transition metal ion transport (GO:0000041),-0.24501583642928426,-0.7621724932718458,0.8522920203735145,0.9198498919038768,1.0,16/35,35.59%,IREB2;SLC30A5;ATP7A;SLC31A1;CP;SLC11A2;FTH1;MT3;ATP2C1;SLC30A10;ATOX1;SLC30A1;SLC11A1;TFR2;LTF;SLC30A8
prerank,diterpenoid metabolic process (GO:0016101),-0.22329207385423544,-0.7621348891689801,0.8883161512027491,0.9195287444781051,1.0,3/55,1.16%,APOE;DHRS3;LRP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2475996196539795,0.7619034833871099,0.8337349397590361,0.9750062624205558,1.0,7/29,20.87%,TNNT2;MYH7;TTN;TPM1;TGFBR3;TNNC1;ISL1
prerank,peptidyl-lysine methylation (GO:0018022),-0.2602687633174857,-0.7618775358502651,0.8247787610619469,0.919494086256948,1.0,12/26,34.79%,SMYD2;SMYD3;SMYD1;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;ETFBKMT;SETD2;ANTKMT;SETD4
prerank,regulation of telomerase activity (GO:0051972),-0.2293648302481742,-0.7616607796061756,0.856637168141593,0.9194145170685579,1.0,18/45,34.06%,PARP4;CTNNB1;PKIB;NVL;HSP90AB1;GREM1;ERCC4;CCT4;WRAP53;ATM;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2253389599894066,-0.7611524170390999,0.8776508972267537,0.919736804647873,1.0,21/47,34.68%,ATP5MC1;HSPA9;MICOS13;TMEM11;TIMM22;GHITM;TIMM29;MAIP1;ATP5MC2;ATP5MF;TOMM70;MTX1;ATP5F1B;ATP5F1D;DNAJC11;CHCHD6;ATP5F1C;SAMM50;UQCC3;ATP5F1A;MICOS10
prerank,cellular response to BMP stimulus (GO:0071773),0.20702876201573875,0.7607544051910162,0.9292452830188679,0.9755868493180461,1.0,17/66,21.58%,BMPR1B;ACVR1;VSTM2A;SOX9;TMEM100;BMP7;TGFB2;BMP15;ADAMTS12;RGMA;GDF15;TGFBR3;RGMB;AMHR2;ACVR2B;SMAD9;SCX
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.31140825952523565,-0.7606501576138521,0.794425087108014,0.9200348827612512,1.0,2/13,6.85%,ABCE1;NUP88
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3170611683177511,0.7605964789455707,0.7575757575757576,0.9747470083325148,1.0,3/11,11.06%,SLIT2;CCN3;NBL1
prerank,odontogenesis (GO:0042476),0.2319747138472612,0.7603146011325063,0.8542199488491049,0.9740677688169408,1.0,6/35,14.73%,EDA;MSX1;TGFB2;AMELX;TBX1;INHBA
prerank,7-methylguanosine RNA capping (GO:0009452),-0.24699554983502003,-0.7600956523209155,0.8330404217926186,0.9200455573499127,1.0,11/31,26.33%,POLR2H;POLR2F;POLR2L;CMTR2;NCBP1;POLR2A;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.24699554983502003,-0.7600956523209155,0.8330404217926186,0.9200455573499127,1.0,11/31,26.33%,POLR2H;POLR2F;POLR2L;CMTR2;NCBP1;POLR2A;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC
prerank,organic anion transport (GO:0015711),-0.20875845214846997,-0.7600795956579877,0.897133220910624,0.9196913559530697,1.0,34/76,38.04%,LRRC8D;CYB5R1;LRRC8C;SLC25A24;SLC25A42;ABCC4;SLC25A4;SLC23A1;SLCO5A1;CYB5R4;SLC52A2;CYB5R2;CA4;SLC17A9;SLC22A3;SLC52A1;SLC4A1;SLC35B1;SLC4A5;CPTP;AQP1;SLC2A2;SLC4A8;SLC35A2;SLCO1B1;SLC19A1;RHAG;SLC25A17;SLC26A7;SLC2A6;SLC52A3;CA1;SLC22A6;CA3
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.20942278102497608,-0.7600224187836403,0.8947368421052632,0.9193987089369509,1.0,30/70,37.35%,PLBD1;CSNK2A1;SLC27A1;CEPT1;NR1H2;TMEM86B;PLAAT3;PLA2G4A;PLA2G7;PLAAT1;PLA2G5;PLA2G12A;LPCAT3;PLA2G6;GPLD1;PNPLA8;PLA2G15;PCYT1A;LPCAT4;LPIN3;ABCA3;CSNK2B;DBI;PCTP;PLA2G3;PLA2G4B;PLB1;LCAT;APOA2;PON1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.28488696704296534,0.7590128985929184,0.8059360730593608,0.974911766958466,1.0,5/15,24.75%,LNPK;REEP1;RAB18;ATL2;TMEM170A
prerank,hexose transmembrane transport (GO:0008645),0.2619673214481269,0.7584810678628559,0.8107476635514018,0.974632448823072,1.0,6/21,18.15%,SLC2A5;SLC2A9;SLC5A10;SLC2A12;SLC2A8;SLC45A1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.3330260808605014,-0.758285802508896,0.7944078947368421,0.9213608298665186,1.0,4/10,14.23%,LRCH1;RIPOR2;WASL;MIA3
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2573222068204858,-0.7582223700677471,0.805414551607445,0.9210687396810817,1.0,5/28,13.16%,APOE;PANK2;ADIPOR1;TTC39B;FMO5
prerank,digestive tract morphogenesis (GO:0048546),0.2884357188851106,0.7579500922690059,0.7813953488372093,0.9743418581670599,1.0,1/14,1.30%,SOX11
prerank,positive regulation of protein processing (GO:0010954),-0.27635332116354727,-0.757934684258784,0.8163265306122449,0.9210768819163426,1.0,3/19,9.47%,MYH9;NLRC4;ADAM8
prerank,regulation of osteoblast proliferation (GO:0033688),-0.2833021346099653,-0.7576388904516083,0.8106312292358804,0.9210894933146997,1.0,10/17,34.39%,RHOA;HPSE;EIF2AK2;GREM1;SFRP1;TNN;BMP2;SOX8;MN1;LTF
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.26752584643818234,-0.7573191035353973,0.8153846153846154,0.9211617470147975,1.0,9/22,26.81%,RAP2A;VEGFA;GREM1;TAOK2;DDX3X;PDGFA;NBN;RASSF2;MRE11
prerank,COPII vesicle coating (GO:0048208),-0.2161606196722865,-0.7571024193084853,0.9032258064516129,0.9203528809987592,1.0,20/61,26.61%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;PPP6R3;SEC24A;STX5;SEC24D;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;MCFD2;RAB1B;TRAPPC2L;TRAPPC3;CUL3
prerank,vesicle coating (GO:0006901),-0.2161606196722865,-0.7571024193084853,0.9032258064516129,0.9203528809987592,1.0,20/61,26.61%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;PPP6R3;SEC24A;STX5;SEC24D;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;MCFD2;RAB1B;TRAPPC2L;TRAPPC3;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2161606196722865,-0.7571024193084853,0.9032258064516129,0.9203528809987592,1.0,20/61,26.61%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;PPP6R3;SEC24A;STX5;SEC24D;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;MCFD2;RAB1B;TRAPPC2L;TRAPPC3;CUL3
prerank,nucleoside salvage (GO:0043174),0.32410708711310166,0.7564292801345022,0.7583732057416268,0.9754239436845206,1.0,2/10,4.22%,UPP2;CDA
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.29157181685351563,-0.7559364846539054,0.823321554770318,0.9215439799674173,1.0,2/16,4.82%,NUPR1;ATP7A
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.3270176232285459,-0.7557960168411741,0.7848537005163512,0.9213470175148126,1.0,2/10,20.50%,HK3;GFPT1
prerank,urogenital system development (GO:0001655),0.31087191801167796,0.7552530461105945,0.7827102803738317,0.9760552140471538,1.0,4/11,21.72%,PAX8;SOX9;EPHB3;LHX1
prerank,phospholipid catabolic process (GO:0009395),0.2570553327201981,0.7552317378249956,0.8120649651972158,0.9750206388413397,1.0,6/24,15.09%,ENPP2;GDPD1;PLA2G4E;ENPP6;ANGPTL3;PNPLA6
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.23295734956859313,-0.7548216573164441,0.8664440734557596,0.9222183865744261,1.0,11/38,25.77%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;BAP1;HAX1;HPS4;SAE1;VPS11
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2929747610847404,-0.7540527457195567,0.8098591549295775,0.9228421938272388,1.0,4/16,18.78%,CGAS;RADX;UBQLN4;SHLD2
prerank,establishment of melanosome localization (GO:0032401),-0.27894875009110237,-0.7540032884652138,0.8377425044091711,0.9225339539509136,1.0,1/19,0.10%,MYO5A
prerank,negative regulation of signaling (GO:0023057),0.24931571877090697,0.7538886380318454,0.823960880195599,0.9758306955801003,1.0,6/25,18.21%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3;AP1AR
prerank,regulation of glucose metabolic process (GO:0010906),0.23397056385146753,0.7537769599052366,0.8647959183673469,0.9749101836922252,1.0,7/34,17.01%,RORA;PDK3;RORC;PRKN;IRS1;MLYCD;AKT2
prerank,skeletal muscle contraction (GO:0003009),0.2674016494479598,0.7537260487786738,0.8177570093457944,0.9739186176895439,1.0,3/19,12.08%,TNNI1;MYH7;STAC
prerank,glucan catabolic process (GO:0009251),0.2839771340783783,0.7533544104165479,0.8018648018648019,0.9733818489553971,1.0,3/15,12.85%,PHKG1;CALM1;PHKA1
prerank,response to UV-B (GO:0010224),-0.3131640210616033,-0.7527520277053742,0.8246205733558178,0.9237584297510106,1.0,3/12,12.77%,CRIP1;RELA;STK11
prerank,response to interleukin-4 (GO:0070670),-0.322723182884027,-0.7516022307630142,0.7989690721649485,0.9248774531794487,1.0,3/10,17.91%,XBP1;TCF7;GATA3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.20214902727548206,0.7514128345519293,0.9132530120481928,0.9749869388531834,1.0,24/68,23.00%,RAN;PDE9A;MFN1;GLYAT;ACSM5;AK4;SULT4A1;ACAT1;ACOT8;MLYCD;ACSM3;AK3;ABHD14B;SULT2B1;ACOT12;CROT;ACSL6;ACOT7;BPNT2;EPHA2;GPAT4;PTHLH;LRRK2;OXSM
prerank,blood vessel diameter maintenance (GO:0097746),-0.23934954044818765,-0.7513496197739722,0.8675721561969439,0.9248320557959603,1.0,6/34,14.22%,ROCK1;HTR2B;ITGB1BP1;AGT;EDNRA;KLF2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2538178592858548,-0.7510282705779238,0.825136612021858,0.9248579325171331,1.0,7/28,19.95%,ITGB1;FBXW11;CENPA;DCTN1;NUSAP1;NDC80;PAFAH1B1
prerank,phospholipid metabolic process (GO:0006644),-0.2066831184010557,-0.7506111561147137,0.9125874125874126,0.9250306569262401,1.0,12/71,15.04%,PLBD1;PIP4K2A;ABHD12;PLBD2;LGALS13;PIP4P1;LPL;PLCD1;AGPAT1;GPX4;PLAAT3;PLA2G4A
prerank,epithelial structure maintenance (GO:0010669),0.3059973799848743,0.7501228261636752,0.7723004694835681,0.9756844978327913,1.0,2/11,9.57%,STRAP;PIWIL4
prerank,nucleotide metabolic process (GO:0009117),0.2599551485428301,0.7496959642295146,0.8073170731707318,0.9751923825237763,1.0,6/23,16.93%,NME2;ENPP3;AK4;AK5;NMNAT2;ME1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2727023687951089,-0.7495370248122408,0.8058925476603119,0.9260583954208508,1.0,5/20,15.42%,PLEK;GRK3;MGRN1;CCL5;RGS14
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3366539409808101,-0.7489580180814821,0.7800338409475466,0.9264409896303093,1.0,6/10,26.49%,PLA2G4A;PLA2G7;PLA2G5;PLA2G6;PNPLA8;PLA2G15
prerank,steroid catabolic process (GO:0006706),-0.3223866698682931,-0.7480818802379031,0.8069565217391305,0.9271759292164158,1.0,4/10,37.77%,SPP1;HSD17B14;FGF23;CYP19A1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.30323427012221144,0.747929299615728,0.8111380145278451,0.9765869693128557,1.0,2/12,4.22%,UPP2;CDA
prerank,glutamine family amino acid catabolic process (GO:0009065),0.30167297250924985,0.7477424381435744,0.7976744186046512,0.9758339232642,1.0,3/13,15.21%,GLUL;GLS2;GLS
prerank,renal absorption (GO:0070293),0.32333294604108004,0.747395151030533,0.7595238095238095,0.9752165376349802,1.0,6/10,27.63%,HAS2;GSN;WNK4;KCNQ1;SLC15A2;HYAL2
prerank,negative regulation of cell aging (GO:0090344),-0.2888719084791397,-0.7471198626492572,0.8330550918196995,0.9279700182299285,1.0,1/16,1.36%,CDK6
prerank,sensory organ development (GO:0007423),0.21204585144910237,0.747077840296461,0.8987951807228916,0.974613655964281,1.0,12/51,19.46%,AHI1;MEIS1;BMPR1B;PAX8;SALL2;TGFB2;PBX1;ECE1;MAB21L1;RAB18;ZDHHC16;SMOC1
prerank,N-glycan processing (GO:0006491),-0.27609079536861914,-0.746951125796581,0.8257042253521126,0.9278297399842629,1.0,3/18,2.47%,ST8SIA4;MAN1C1;MAN2A1
prerank,zinc ion transport (GO:0006829),-0.26334991313540346,-0.7461864291862393,0.8388214904679376,0.9284211633810495,1.0,9/21,39.91%,SLC30A5;SLC30A6;SLC39A3;MT3;SLC30A10;SLC30A1;SLC30A8;SLC39A4;SLC39A11
prerank,positive regulation of cell cycle (GO:0045787),-0.21023434156551582,-0.7457232659436971,0.9210084033613445,0.928615644770563,1.0,8/62,10.55%,NUPR1;CCND3;CCNY;DUSP3;LRP6;RPS15A;APP;EIF4EBP1
prerank,heart looping (GO:0001947),-0.2319173322324572,-0.7444820475838574,0.8818493150684932,0.929827360797266,1.0,11/39,27.52%,CCDC40;MEF2C;MICAL2;TGFBR2;VANGL2;STIL;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,sulfur amino acid catabolic process (GO:0000098),0.3193132652871623,0.7441613973135476,0.7447306791569087,0.9775141896048788,1.0,3/10,16.65%,CTH;CBS;ADO
prerank,negative regulation of centrosome duplication (GO:0010826),0.3140487073693566,0.7440184120402977,0.8035714285714286,0.9766757883186263,1.0,5/11,19.73%,TRIM37;TMEM67;CDK5RAP2;KAT2A;NPM1
prerank,glycerol metabolic process (GO:0006071),0.31744480429616484,0.7436766191604388,0.8038740920096852,0.9760791171496572,1.0,4/10,24.02%,GOT1;ANGPTL3;COQ3;PDXP
prerank,negative regulation of TOR signaling (GO:0032007),0.2287821350941024,0.7431488088956544,0.8954869358669834,0.9757350509227314,1.0,6/36,9.13%,TSC1;PDCD6;SESN3;UBR1;NPRL3;CASTOR2
prerank,embryonic organ development (GO:0048568),0.20363558547956656,0.7429539062659165,0.9158415841584159,0.9749216422945546,1.0,11/61,12.26%,PCSK5;GDNF;TEAD4;RARB;COBL;TGFB2;NEUROD1;SALL1;MFSD2A;TEAD1;PBX1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.27164734839024085,-0.742815326541751,0.8528428093645485,0.9315002817123118,1.0,5/19,17.91%,LRP6;CTNNB1;VEGFA;MANF;RYK
prerank,chemical homeostasis (GO:0048878),0.20293160746263197,0.7426095972433502,0.9325,0.9743302317564663,1.0,18/61,20.93%,SLC4A10;SLC4A4;FBXW7;SLC4A11;ACOX2;ANGPTL3;WNK4;ABCB11;EIF5A2;TM6SF2;WNK3;AQP11;CLN8;WNK2;ADCK1;AQP4;TREM2;ACOX3
prerank,cellular respiration (GO:0045333),-0.2250695472141445,-0.7421928752250486,0.8989169675090253,0.9318794721427602,1.0,12/41,25.64%,SIRT3;COX10;LYRM7;SDHAF4;UQCRC1;MTFR1L;SLC25A13;MDH2;UQCRC2;CYCS;ATP5F1D;COQ10B
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.32546349763965116,-0.7420733465174555,0.8027923211169284,0.9316567318427147,1.0,4/10,24.44%,TGFBR2;STAT1;PDGFA;MYC
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.24433935912513594,-0.7418795262473817,0.8610634648370498,0.9315271828842604,1.0,6/30,15.20%,DSE;HEXA;CHST12;CHST11;CHST3;CSPG4
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.30574020235010774,0.7414260507814738,0.8018433179723502,0.9748721115361685,1.0,4/12,23.08%,INSIG1;TAPT1;HSPA5;INSIG2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.27580560698195267,-0.740953918854385,0.8225255972696246,0.932267480885727,1.0,4/18,21.20%,ABCC1;MTR;MMUT;LMBRD1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.29133753604064827,-0.7408973761562782,0.8080808080808081,0.931968141191865,1.0,2/15,3.24%,PPARD;PPARG
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.24206271646970995,0.7405457592467302,0.8611111111111112,0.974958040414591,1.0,5/26,14.92%,NAV3;OCLN;CDK5R1;CDK5RAP2;ARL2
prerank,DNA packaging (GO:0006323),0.2661246120660669,0.740050291820473,0.8337236533957846,0.9745648476848565,1.0,5/16,19.56%,NAA10;H1-0;BANF1;BANF2;CHAF1B
prerank,miRNA metabolic process (GO:0010586),-0.2704502806887048,-0.7397961282015066,0.8003597122302158,0.9329293574821337,1.0,8/20,31.95%,AGO2;TUT7;XPO5;TENT4B;BCDIN3D;SND1;DDX17;DROSHA
prerank,mesoderm development (GO:0007498),-0.2771025350320493,-0.7387829256766194,0.8456140350877193,0.9337728654631118,1.0,6/18,27.37%,IKZF1;VEGFA;IKZF3;HCK;HES7;MESD
prerank,apical junction assembly (GO:0043297),-0.21560937759304682,-0.7387581088931069,0.9040404040404041,0.9334276062869385,1.0,21/53,36.36%,PAK2;RHOA;PDCD6IP;WDR1;STRN;CLDN10;RAB13;CLDN18;CLDN1;CTNNA1;ECT2;PECAM1;MARVELD2;MICALL2;GRHL2;VCL;APC;RHOC;POF1B;CLDN16;PARD6B
prerank,protein import into mitochondrial matrix (GO:0030150),0.27106388479494675,0.7383603738563713,0.8265060240963855,0.9757214072033098,1.0,5/18,12.64%,TIMM17B;ROMO1;GRPEL1;DNLZ;TIMM17A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.29637336595103514,0.7381675078601327,0.7949308755760369,0.9749059971396546,1.0,4/13,20.57%,UPP2;OGG1;UNG;NT5M
prerank,myelin maintenance (GO:0043217),-0.3149211184703855,-0.7380657095992186,0.8142857142857143,0.933883369893014,1.0,2/10,15.66%,ABCD2;CXCR4
prerank,response to steroid hormone (GO:0048545),0.2351037632953485,0.7378692175412375,0.8853932584269663,0.9742461658090594,1.0,5/31,9.22%,PAQR8;YAP1;ATP1A3;CATSPERD;TGFB2
prerank,regulation of BMP signaling pathway (GO:0030510),0.1945992561701071,0.7376593380898019,0.9504716981132075,0.9734715838315684,1.0,19/73,21.31%,SOX11;TWSG1;BMPR1B;VWC2;PCSK6;VWC2L;NBL1;HES5;TRIM33;CDH5;BMPER;SPART;ZNF423;UBE2O;ACVR2B;SKOR2;SMAD9;SULF1;SORL1
prerank,atrial septum development (GO:0003283),0.2877993213134317,0.7375536458390235,0.8056872037914692,0.9725646001466919,1.0,1/13,0.69%,ANK2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.30852961410189644,-0.736437455999599,0.8272884283246977,0.9354729138173369,1.0,3/12,24.45%,TLR4;NOD2;RBP4
prerank,regulation of myoblast differentiation (GO:0045661),-0.24275479544977524,-0.7364147529478066,0.8593481989708405,0.9351259180905989,1.0,9/32,22.48%,RIPOR2;MAPK14;MEF2C;SMYD1;IGFBP3;BTG1;FLOT2;BOC;TGFB1
prerank,regulation of membrane depolarization (GO:0003254),0.26710326583724453,0.7361837843248215,0.8108108108108109,0.973278692015129,1.0,4/18,15.92%,SCN2B;PTPN3;ABCD1;SCN10A
prerank,membrane lipid metabolic process (GO:0006643),-0.2564340485940274,-0.7355568937211094,0.8508771929824561,0.9358084808540468,1.0,9/22,38.74%,TEX2;AGMO;SPHK2;CYP1B1;CERK;SERINC1;ARV1;MGST2;SPHK1
prerank,cellular response to misfolded protein (GO:0071218),-0.26891368075069005,-0.7352692295031236,0.8557046979865772,0.9357763185911748,1.0,11/20,34.20%,ATXN3;DNAJB14;DERL1;RNF185;BAG6;VCP;CUL3;AUP1;STUB1;DNAJB12;DNAJC18
prerank,magnesium ion transport (GO:0015693),0.2967376150662364,0.7349877728562414,0.8181818181818182,0.9737402739917533,1.0,6/12,20.28%,NIPA1;MMGT1;NIPAL4;TUSC3;NIPAL2;MRS2
prerank,phospholipid biosynthetic process (GO:0008654),-0.2298087255379418,-0.7349604599232784,0.8852173913043478,0.9357721106438495,1.0,7/36,21.20%,SGMS1;CPNE3;IDI1;CLN3;SPHK2;PIP5K1A;SAMD8
prerank,alpha-amino acid catabolic process (GO:1901606),-0.24101320025857675,-0.7345984956662532,0.8738738738738738,0.9358252105538131,1.0,15/29,41.29%,KYNU;KMO;KYAT1;IL4I1;IDO2;HOGA1;HSD17B10;HGD;DAO;FAH;HAAO;TAT;OTC;BLMH;ALDH4A1
prerank,bile acid and bile salt transport (GO:0015721),0.23936906236431416,0.7345046676903788,0.8620689655172413,0.9732949586923801,1.0,4/24,14.38%,NCOA2;SLCO2B1;NCOA1;ABCB11
prerank,protein import into peroxisome matrix (GO:0016558),-0.3069127022185715,-0.7344921432817082,0.8138747884940778,0.9355747241322557,1.0,2/12,4.83%,PEX14;PEX26
prerank,cilium organization (GO:0044782),0.16612640979934573,0.7338907958464702,0.997289972899729,0.9730357415470705,1.0,31/209,12.05%,SCLT1;RAB3IP;AHI1;IFT81;RPGR;ABLIM1;DYNLL1;CPLANE1;TTC8;DCDC2;TRAF3IP1;KIFAP3;CEP126;DYNLL2;TMEM231;TMEM67;DZIP1;ARL13B;CFAP298;FAM161A;TMEM216;EXOC3;TMEM138;CEP131;CCNO;GSN;CEP290;PKD1;DYNC2H1;BBS1;NEK1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.23384635987679467,-0.7335309400244779,0.8765652951699463,0.9363389475690985,1.0,10/32,29.58%,DYRK2;DDX5;STK11;TMEM109;BAG6;RRP8;PML;USP28;MYBBP1A;EP300
prerank,glycogen metabolic process (GO:0005977),-0.244776263340788,-0.7329099813129211,0.8715753424657534,0.9366730475366306,1.0,4/27,10.75%,PRKAG2;GYG1;PHKG2;GBE1
prerank,actin filament depolymerization (GO:0030042),-0.3138087589823816,-0.7324775934306759,0.8023648648648649,0.9367956324363913,1.0,5/11,19.62%,WDR1;MICAL1;MICAL2;TWF2;CFL1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.26283731487869577,-0.7315839863524081,0.8485915492957746,0.9374489666816527,1.0,4/20,10.60%,ATP1B3;SLC8A1;SLC9A1;NEDD4L
prerank,activation of phospholipase C activity (GO:0007202),-0.24131433059310098,-0.7315572252837007,0.8762711864406779,0.9371079390103955,1.0,7/29,14.85%,C5AR1;HTR2B;RASGRP4;GNA15;ITK;EDNRA;TXK
prerank,monocarboxylic acid transport (GO:0015718),-0.21622926481865312,-0.731329454719537,0.8942148760330578,0.9369996705305271,1.0,10/51,20.05%,SLC16A7;CD36;SLC27A1;STARD5;ABCC4;RXRA;SLC16A6;SLC6A8;SLC10A6;SLC16A1
prerank,organophosphate biosynthetic process (GO:0090407),-0.22696924238840116,-0.7307006530362343,0.8956521739130435,0.9373679977714576,1.0,13/37,29.31%,ITPKB;MOCS1;TPK1;TPI1;MOCS3;TKT;IP6K3;PIP5K1A;PNPO;ITPKC;IP6K1;GK5;GPAT2
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.32110994263268344,-0.7299018199530672,0.8324697754749568,0.9379053804585242,1.0,4/10,20.28%,RC3H1;SCRIB;LGALS9;CD274
prerank,iron ion transmembrane transport (GO:0034755),-0.32406863892175675,-0.7297420187820238,0.8173598553345389,0.9377276512830938,1.0,1/10,2.62%,ABCB7
prerank,camera-type eye morphogenesis (GO:0048593),-0.31746492772855706,-0.729438927171659,0.831918505942275,0.9377109864109785,1.0,3/10,7.75%,LRP6;SKI;VEGFA
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.27939497476436165,-0.72936490116325,0.8373702422145328,0.9374150238818232,1.0,5/16,25.89%,BRCA1;ERLIN1;APPL2;ACADVL;NCOR1
prerank,organic hydroxy compound transport (GO:0015850),-0.22746826531900452,-0.7292037223071365,0.8831385642737897,0.9372391618517762,1.0,19/36,39.69%,NPC2;STARD5;ABCC4;RXRA;SLC5A3;SLC10A6;SLC16A1;NR1H4;RBP4;GHRL;ABCC3;SLC51A;SLCO1B1;ABCG8;AKR1C1;SLC27A5;SLC10A2;STRA6;SLCO1C1
prerank,triglyceride biosynthetic process (GO:0019432),0.2671464216438326,0.7290487709758372,0.8524590163934426,0.9778705751561798,1.0,3/18,14.21%,MOGAT3;GPAM;GPAT3
prerank,melanosome localization (GO:0032400),-0.26003879108200656,-0.7290236838399407,0.8544520547945206,0.9370692838739939,1.0,1/21,0.10%,MYO5A
prerank,sphingolipid biosynthetic process (GO:0030148),-0.20098753730146957,-0.7288135224511364,0.9422066549912435,0.9369297265852042,1.0,22/71,31.90%,SGMS1;SPTLC2;ACER3;SPTSSA;PRKD3;LARGE1;KDSR;VAPB;SPHK2;SPTLC3;SAMD8;ASAH1;PLPP3;ELOVL5;DEGS2;CERS3;VAPA;HACD4;HACD3;ST3GAL5;ACER2;ALDH3B1
prerank,vitamin transport (GO:0051180),0.23577975666362497,0.7273393906872766,0.8602941176470589,0.9788595780275473,1.0,7/29,17.39%,CUBN;SLC35F3;FOLR2;FOLR1;AMN;GC;SLC2A8
prerank,cellular response to heat (GO:0034605),-0.23043578323099165,-0.7269319367447483,0.886986301369863,0.9387165679499799,1.0,10/35,23.10%,ATXN3;YWHAE;TPR;HSP90AB1;DHX36;BAG3;HSPA1A;SLU7;TCIM;HMOX1
prerank,synaptonemal complex organization (GO:0070193),-0.2844818093141709,-0.7259345274630816,0.8284671532846716,0.9391109767635791,1.0,7/15,42.18%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,synaptonemal complex assembly (GO:0007130),-0.2844818093141709,-0.7259345274630816,0.8284671532846716,0.9391109767635791,1.0,7/15,42.18%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2804729627077971,-0.7255231869552302,0.8368794326241135,0.9392056222455027,1.0,5/16,21.26%,TRA2B;NCBP1;DAZAP1;NCL;RBM3
prerank,protein hydroxylation (GO:0018126),0.27726659053976926,0.7255113700314813,0.8416289592760181,0.9800124567776568,1.0,2/15,7.70%,P3H2;PLOD2
prerank,glucose transmembrane transport (GO:1904659),0.26254339641055835,0.724931170644124,0.8484848484848485,0.9796829253964758,1.0,5/18,18.15%,SLC2A5;SLC2A9;RAB4B;SLC2A8;SLC45A1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.18452065855285257,0.7235278039647303,0.9801488833746899,0.980317092957115,1.0,16/94,14.23%,SCLT1;RAB3IP;AHI1;TUBB4A;DYNLL1;SFI1;TMEM67;TMEM216;CEP131;CEP97;CEP290;NPHP1;CDK5RAP2;DYNC1I2;CSNK1E;HSP90AA1
prerank,regulation of stem cell proliferation (GO:0072091),-0.2694474387808775,-0.7229942405334319,0.8542372881355932,0.9415796126061486,1.0,3/17,12.62%,PTPRC;EIF2AK2;HMGB2
prerank,organic acid transport (GO:0015849),-0.18930932940730397,-0.7221805381955482,0.9607201309328969,0.9420637288873406,1.0,38/94,38.23%,LRRC8D;SLC6A6;PPARD;SLC43A2;SLC27A1;SLC16A10;SLC7A7;STARD5;SLC25A45;ABCC4;RXRA;SLC23A1;SLC23A2;SLC38A2;SLC10A6;SLC25A10;SLC16A1;NR1H4;SLC27A3;PDPN;SLC7A4;ABCC3;SLC7A2;SLC51A;SLC7A1;SLCO1B1;SLC19A1;SLC25A17;SLC26A7;SLC7A8;SLC6A12;AKR1C1;SLC38A5;SLC27A5;SLC6A19;SLC6A14;SLC22A6;SLC10A2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.23049539430422805,-0.7209372139720225,0.8946488294314381,0.94304221799861,1.0,3/34,4.56%,FGR;FLT1;PTK2B
prerank,negative regulation of cellular senescence (GO:2000773),-0.2933689162467565,-0.7209056503582804,0.8336221837088388,0.9427022415638109,1.0,1/13,1.36%,CDK6
prerank,catecholamine metabolic process (GO:0006584),0.28009833743320045,0.7182538071972144,0.8436018957345972,0.9853655175812659,1.0,3/14,13.97%,SNCAIP;DDC;PRKN
prerank,negative regulation of phosphatase activity (GO:0010923),-0.24665788081055676,-0.7177058693959331,0.8909710391822828,0.9457115026401086,1.0,10/25,31.06%,ZCCHC9;GPATCH2;MASTL;STYXL1;GSK3B;SH2D4A;FKBP1B;URI1;BOD1L1;PTPA
prerank,negative regulation of blood pressure (GO:0045776),-0.2972994991170316,-0.7174856598871228,0.8464223385689355,0.9455608447201975,1.0,5/13,37.05%,PRCP;BMPR2;SCPEP1;NOS2;NPPA
prerank,ribosomal large subunit assembly (GO:0000027),-0.2509341644908367,-0.7171638543750164,0.867003367003367,0.9455334357413172,1.0,7/24,25.39%,RPL11;FASTKD2;RPL6;RPL23A;BRIX1;RPLP0;RPL5
prerank,negative regulation of transferase activity (GO:0051348),-0.23890716207527743,-0.7166639224342738,0.9035087719298246,0.9457003624126817,1.0,7/28,25.52%,EIF4A2;ERCC4;SMAD7;IRS2;GSK3B;DTX3L;INPP5K
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2505430428123312,-0.7160557845781839,0.862708719851577,0.9459727531262795,1.0,3/22,8.88%,TSG101;UBAP1;MVB12B
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3053716137938695,-0.7155677001300336,0.8405017921146953,0.9461243655578595,1.0,2/11,10.60%,CAB39;NEDD4L
prerank,inorganic anion transport (GO:0015698),0.19882523487882908,0.7152301945706431,0.9362186788154897,0.9877326687670696,1.0,8/53,13.15%,GLRA1;SLC4A10;ANO4;ENPP3;ANO5;SLC4A11;SLC25A11;SLC26A8
prerank,cellular macromolecule catabolic process (GO:0044265),0.2044457891093808,0.714284274719748,0.9401913875598086,0.9877991783600029,1.0,7/49,9.97%,EXOSC7;MAGEC2;IDE;FBXO44;FBXO2;RNASEH1;FBXO27
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.28779943299425204,-0.7130114575649044,0.8578856152512998,0.948354162580968,1.0,3/13,18.94%,TPST1;SULT6B1;ENPP1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2623515203152838,0.712545502761491,0.8652482269503546,0.9886610066668896,1.0,6/16,20.44%,ACACA;ACAT1;HSD17B8;MLYCD;ACSS1;FASN
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.27000275929239137,-0.7119099305331767,0.851782363977486,0.949103194151469,1.0,8/17,26.31%,TNFRSF1B;MDK;ID2;IL34;CXCR4;EGR2;TGFB1;BMP2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.24850584205070841,-0.7116071462151563,0.8850174216027874,0.9486730176645852,1.0,10/24,34.19%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;ALDOA;PGAM1;FOXK2;FOXK1
prerank,canonical glycolysis (GO:0061621),-0.24850584205070841,-0.7116071462151563,0.8850174216027874,0.9486730176645852,1.0,10/24,34.19%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;ALDOA;PGAM1;FOXK2;FOXK1
prerank,positive regulation of telomere capping (GO:1904355),-0.26787117649010717,-0.7115232319263488,0.8611111111111112,0.9483883544780453,1.0,10/17,40.06%,RTEL1;PKIB;TNKS2;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;NEK2;AURKB
prerank,bicellular tight junction assembly (GO:0070830),0.20473358903004624,0.7104715968128565,0.9358669833729216,0.9898725354760326,1.0,11/46,19.57%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,DNA modification (GO:0006304),-0.24922336729540823,-0.7103140389127504,0.8805704099821747,0.9492400524028636,1.0,11/22,44.04%,EXOSC5;NEIL3;NEIL2;EXOSC4;MPG;MUTYH;EXOSC3;SMUG1;PARP2;TERF2;TDG
prerank,leukotriene biosynthetic process (GO:0019370),-0.28114591294838404,-0.7099997435872812,0.8666666666666667,0.9491871639298459,1.0,3/14,19.21%,ALOX5AP;PLA2G4A;PLA2G5
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2801999368220276,-0.7083619669023683,0.8581436077057794,0.9504964192594912,1.0,2/13,6.61%,FLNA;MDFI
prerank,positive regulation of protein sumoylation (GO:0033235),-0.31135895285157345,-0.7075968755789217,0.8469565217391304,0.9509096410200313,1.0,3/10,23.99%,PIAS1;UBA2;SAE1
prerank,negative regulation of complement activation (GO:0045916),0.30304223672492875,0.7074570294395623,0.8193069306930693,0.9920647183744011,1.0,1/10,2.29%,SERPING1
prerank,negative regulation of cholesterol transport (GO:0032375),0.29674244482330975,0.7073319821587263,0.8365384615384616,0.9911555868739685,1.0,2/10,9.66%,APOC1;PLA2G10
prerank,inner dynein arm assembly (GO:0036159),0.29969700421701917,0.7071754756780282,0.8216704288939052,0.9902830439871054,1.0,5/10,27.74%,DNAAF4;CFAP73;DNAAF5;DNAH1;CFAP100
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.28625757095951065,0.7069842158632239,0.8620689655172413,0.9894540465301709,1.0,5/12,22.96%,ACOT8;ABCD1;HSD17B4;ELOVL2;FADS2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2614923766271362,-0.7058378462441406,0.8743455497382199,0.9522316634967374,1.0,7/19,32.39%,USP36;CAMKK2;FBXO7;HAX1;VDAC1;ATP13A2;SREBF1
prerank,regulation of axon regeneration (GO:0048679),0.28113810308697257,0.7049490425296737,0.844059405940594,0.9906442960469325,1.0,3/12,13.93%,PTN;RTN4RL1;PTPRS
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.28582790145338804,0.7044849619720528,0.8313817330210773,0.9900932760200569,1.0,5/12,25.93%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,positive regulation of chromatin organization (GO:1905269),-0.2912232219091846,-0.7036827108763212,0.8460144927536232,0.9539296562312041,1.0,3/12,25.07%,SIN3A;MIER1;UBE2N
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.2886995151125504,0.7035842090554967,0.8491484184914841,0.9900051406815751,1.0,2/11,8.35%,PTPRT;LEPROT
prerank,regulation of biosynthetic process (GO:0009889),0.2867018046663698,0.7035011117258,0.8211009174311926,0.9890622802279974,1.0,4/11,27.24%,GSTP1;SNCA;CCN6;ALOX5
prerank,regulation of transport (GO:0051049),-0.22694949412385487,-0.7034645064917661,0.915,0.9537791330690071,1.0,5/36,10.86%,NRP1;FES;ACTB;DNAJA1;CLDN10
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2323543609453778,0.7034143352772022,0.8982300884955752,0.9881333390752209,1.0,7/23,15.46%,EGF;BMP7;RPTOR;CALM1;CALM3;CALM2;WNK3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.2882015754126663,-0.7029897567563069,0.8569023569023569,0.9538512859979624,1.0,4/13,17.11%,HIF1A;LRPPRC;MAP1S;UXT
prerank,response to hexose (GO:0009746),0.23291377954876052,0.7020778912586816,0.8956310679611651,0.9884108329623216,1.0,3/25,10.51%,SLC2A5;MAFA;NEUROD1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.29179275458946535,-0.7017200060166381,0.8460176991150442,0.9547424806312395,1.0,6/12,40.21%,HPRT1;PRPSAP1;ADA;MTHFD1;PRPS1;PRPS1L1
prerank,response to nutrient levels (GO:0031667),-0.2619234823910485,-0.7009096395021908,0.8717504332755632,0.9551333357911796,1.0,8/17,42.20%,EIF4G1;KCNB1;SCTR;CD68;ATF4;RPS6KB1;MTOR;ULK1
prerank,ncRNA catabolic process (GO:0034661),-0.23406504527297395,-0.700770133331494,0.908273381294964,0.954889231821941,1.0,13/28,35.66%,EXOSC5;TENT4B;EXOSC10;EXOSC4;MTREX;SND1;DEDD2;NUDT16;ERN2;EXOSC8;POP1;EXOSC3;SLFN14
prerank,embryonic axis specification (GO:0000578),-0.27650489724196503,-0.698604932603583,0.8467023172905526,0.9565557492549152,1.0,3/15,19.06%,STIL;RIPPLY2;HOXD8
prerank,maturation of 5.8S rRNA (GO:0000460),-0.26110075665447785,-0.6975425935782826,0.8827586206896552,0.9571627531173726,1.0,7/17,24.19%,EXOSC10;NOL9;EXOSC4;WDR12;MTREX;C1D;PRKDC
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25087936083072815,0.6966539036552966,0.8729411764705882,0.9927776992868673,1.0,4/17,12.11%,SOX11;HMGA2;CITED1;FERMT2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.29104518567927357,0.6962644976592319,0.8264058679706602,0.9921002599080435,1.0,7/10,33.18%,MMGT1;EMC8;EMC2;EMC3;EMC4;EMC7;EMC10
prerank,eosinophil chemotaxis (GO:0048245),-0.27495086487408954,-0.6961057139162246,0.8696428571428572,0.9577339899993436,1.0,5/14,35.99%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,eosinophil migration (GO:0072677),-0.27495086487408954,-0.6961057139162246,0.8696428571428572,0.9577339899993436,1.0,5/14,35.99%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,regulation of viral life cycle (GO:1903900),-0.24778327641293588,-0.6960887623790016,0.8911070780399274,0.9573764948083036,1.0,6/21,21.84%,AXL;TSG101;TRIM68;TRIM14;TRIM25;VPS4A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24923478687608264,-0.6960670160553567,0.8961267605633803,0.9570221588003935,1.0,6/19,29.58%,DYRK2;TMEM109;BAG6;PML;USP28;EP300
prerank,receptor recycling (GO:0001881),-0.2990066245935836,-0.695864583149833,0.8476357267950964,0.9568302881248689,1.0,5/10,36.70%,RAB11B;ARFGEF2;PHETA1;REP15;PHETA2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.26949810335135893,-0.6947704520443395,0.8818342151675485,0.9574650244358337,1.0,1/16,0.53%,IGF1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.19902437333270914,-0.6946936048834955,0.9553264604810997,0.9567851864376545,1.0,19/56,32.77%,BCS1L;NDUFA9;TIMM21;NDUFAF2;NDUFB2;NDUFS5;NDUFAF8;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;TIMMDC1;NDUFB11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.19902437333270914,-0.6946936048834955,0.9553264604810997,0.9567851864376545,1.0,19/56,32.77%,BCS1L;NDUFA9;TIMM21;NDUFAF2;NDUFB2;NDUFS5;NDUFAF8;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;TIMMDC1;NDUFB11
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2617172808574466,-0.694615571689522,0.8683760683760684,0.9564839926605536,1.0,2/18,4.58%,CNOT1;CNOT2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.2278201617267903,-0.6920668530549915,0.9264448336252189,0.9584363284937019,1.0,9/30,26.75%,DPM3;PIGH;PIGX;PGAP3;MPPE1;PGAP1;PIGS;PIGZ;PGAP2
prerank,negative regulation by host of viral process (GO:0044793),-0.30224897472229295,-0.6911806494088276,0.84375,0.9588805858975487,1.0,6/10,35.99%,PSMC3;ZC3H12A;CCNK;VAPA;LTF;CCL8
prerank,mitochondrial transcription (GO:0006390),-0.3033077676716963,-0.6910022865002375,0.8494983277591973,0.9586684159982861,1.0,3/10,22.49%,FOXO3;TFAM;TWNK
prerank,microtubule polymerization (GO:0046785),-0.22640358295748914,-0.6896916214027184,0.9172535211267606,0.9594614378818962,1.0,11/28,33.24%,TUBGCP4;CKAP5;TPX2;PIN1;SLAIN2;RANBP9;TUBGCP2;TPPP3;FGF13;CSNK1D;CCDC57
prerank,glutathione biosynthetic process (GO:0006750),0.2858441674574042,0.6895255411602211,0.8680555555555556,0.9975611554433674,1.0,5/11,25.93%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,calcineurin-mediated signaling (GO:0097720),0.28905835594188356,0.6885327525373439,0.8408551068883611,0.9964508759043204,1.0,4/10,20.99%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.28905835594188356,0.6885327525373439,0.8408551068883611,0.9964508759043204,1.0,4/10,20.99%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2482804143909956,-0.6881652359409285,0.9033898305084745,0.9604393734964124,1.0,2/21,5.95%,RAB1A;RPL11
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.22323803764572195,0.6869899350137236,0.9170616113744076,0.9968877777066809,1.0,3/30,6.63%,SOX11;TWSG1;PCSK6
prerank,microtubule anchoring at centrosome (GO:0034454),-0.2936588881924619,-0.6866549091168161,0.8629629629629629,0.9614026876973829,1.0,3/10,16.18%,NIN;DCTN1;NINL
prerank,lysine catabolic process (GO:0006554),-0.2862792712011446,-0.6863002024973192,0.8490230905861457,0.9609600192961839,1.0,3/12,17.74%,OGDH;PHYKPL;DLD
prerank,lysine metabolic process (GO:0006553),-0.2862792712011446,-0.6863002024973192,0.8490230905861457,0.9609600192961839,1.0,3/12,17.74%,OGDH;PHYKPL;DLD
prerank,epithelial cell development (GO:0002064),0.24433351313390075,0.6858309961735493,0.9048780487804878,0.996951220693223,1.0,6/20,20.17%,DACT2;ROS1;PDZD7;TMEM79;ACTA2;WNT5B
prerank,regulation of actin nucleation (GO:0051125),-0.2901675654927419,-0.6857857387252425,0.8812056737588653,0.9610397225734763,1.0,7/12,41.12%,ARFIP1;ARFIP2;ARF1;WHAMM;PICK1;SCIN;CORO1A
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.21145218609768263,-0.6847107297824356,0.9431438127090301,0.9615808580768852,1.0,9/41,22.48%,RBPJ;JAG1;MEF2C;TGFBR2;SMAD7;GATA3;MYBPC3;HEYL;TGFB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.250110457024107,-0.6846440385896939,0.9026086956521739,0.9608950556996635,1.0,4/21,14.86%,DDB2;CUL4B;RPA3;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.250110457024107,-0.6846440385896939,0.9026086956521739,0.9608950556996635,1.0,4/21,14.86%,DDB2;CUL4B;RPA3;ERCC4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2226870490626226,0.6844467345754021,0.9198113207547169,0.9971588028180958,1.0,4/29,14.28%,ZCWPW1;IHO1;SYCP2;MEIOB
prerank,regulation of intracellular transport (GO:0032386),0.20422004074665567,0.6839644616249335,0.9447115384615384,0.9965722458264855,1.0,9/38,18.58%,MAP2;NEFH;CAPN10;WWC1;SCFD1;GRIPAP1;REEP5;HAP1;TTC21B
prerank,calcium import into the mitochondrion (GO:0036444),-0.2906025651806505,-0.6836228685044352,0.8526315789473684,0.9614084470335843,1.0,5/10,29.99%,MCUB;MAIP1;MICU2;SMDT1;MCUR1
prerank,regulation of astrocyte differentiation (GO:0048710),0.27295276324429324,0.6833122007082955,0.8896713615023474,0.9961385185227287,1.0,5/12,23.64%,HES5;HES1;SERPINE2;BIN1;EPHA4
prerank,respiratory chain complex IV assembly (GO:0008535),-0.24251629637718547,-0.6828129390432198,0.9151943462897526,0.9616931954052961,1.0,5/21,14.99%,COA8;BCS1L;TIMM21;COX10;FASTKD3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.19800716891171277,-0.6816229135954583,0.9595278246205734,0.9623287705970477,1.0,9/54,13.43%,RHOA;DYNC1H1;TUBGCP4;CCDC88A;DCTN1;WDR73;CIB1;PLK3;SLAIN2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.2581454073316601,-0.6813174407042399,0.8807829181494662,0.962196800482654,1.0,5/16,27.42%,TPT1;TMEM161A;RPS3;SNAI2;BCL2L1
prerank,neuron apoptotic process (GO:0051402),0.24320973561785658,0.6803275350240525,0.9174528301886793,0.9977324395136142,1.0,2/19,2.76%,TRPC5;SCN2A
prerank,water transport (GO:0006833),0.2703703703703705,0.6785881156084245,0.8682352941176471,0.9982534884976147,1.0,12/12,72.98%,AQP11;AQP4;CFTR;AQP9;MIP;UPK3A;AQP6;AQP5;AQP7;SLC5A1;AQP1;PDPN
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.22366742234824977,-0.677922393830322,0.9238249594813615,0.9646602918590181,1.0,5/29,13.30%,DDB2;UBC;RPS27A;CUL4B;RPA3
prerank,regulation of aerobic respiration (GO:1903715),-0.2613599187689769,-0.6774645901026539,0.890625,0.9646826221573185,1.0,2/15,5.92%,ATP7A;CBFA2T3
prerank,protein localization to mitochondrion (GO:0070585),-0.2896767577154713,-0.6773807004568666,0.8684654300168634,0.964376783070878,1.0,3/11,16.57%,DNAJA1;ISG15;MAIP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2681690375230496,-0.6768262424328274,0.9016666666666666,0.9644505487539684,1.0,5/14,33.86%,TSEN54;DDX1;CPSF1;ZBTB8OS;RTCB
prerank,myelination in peripheral nervous system (GO:0022011),0.27404045443166286,0.6761661613808061,0.8660287081339713,0.9992276370337013,1.0,1/13,1.83%,PARD3
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2866121246845387,-0.6756768077310886,0.8816254416961131,0.964605034713142,1.0,2/11,12.95%,AGO2;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2866121246845387,-0.6756768077310886,0.8816254416961131,0.964605034713142,1.0,2/11,12.95%,AGO2;TNRC6C
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.2560146017897785,-0.6749988547719883,0.8972125435540069,0.9647792947906527,1.0,6/17,20.16%,SPRY2;SPRED1;SPRED2;EIF4G1;SMAD7;SIRT2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.2798923346242528,0.6748195078885715,0.8655256723716381,0.9993290983727869,1.0,5/11,23.05%,ST18;GSN;PIH1D1;FAS;CAAP1
prerank,glycogen catabolic process (GO:0005980),0.25526801183283976,0.6748083827104413,0.888095238095238,0.9983190529209369,1.0,3/15,12.85%,PHKG1;CALM1;PHKA1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.29273945023184406,-0.674121332393271,0.8688811188811189,0.9650910733682497,1.0,3/11,14.22%,E2F2;PIK3CB;KLF2
prerank,protein trimerization (GO:0070206),-0.2705093326456627,-0.6740086481509103,0.8966789667896679,0.9644290322749681,1.0,3/14,17.67%,ALOX5AP;ASIC1;MLKL
prerank,protein homotrimerization (GO:0070207),-0.2705093326456627,-0.6740086481509103,0.8966789667896679,0.9644290322749681,1.0,3/14,17.67%,ALOX5AP;ASIC1;MLKL
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.21779593835434752,-0.6739125911844662,0.9424703891708968,0.9641318196336868,1.0,3/32,5.53%,CSNK2A1;SLC27A1;CEPT1
prerank,regulation of intracellular protein transport (GO:0033157),-0.21691109399760025,-0.6735904380384317,0.9313893653516295,0.9640125612196965,1.0,9/32,22.48%,RUFY3;KIF20B;LCP1;TPR;RAB29;PLK3;PCNT;PTPN1;TGFB1
prerank,positive regulation of mRNA processing (GO:0050685),-0.2411367742621004,-0.6725432334710937,0.9005328596802842,0.9644401038878634,1.0,5/21,15.44%,TRA2B;DHX36;NCBP1;DAZAP1;NCL
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.22974038222197088,-0.6701279831827704,0.9206081081081081,0.9659309537448687,1.0,5/25,17.46%,GAPDH;HK3;TPI1;PKM;PGK1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2572158502906287,-0.668276055705932,0.9074380165289256,0.9669477427975548,1.0,6/15,34.28%,CCT7;SHQ1;CCT4;NHP2;CCT8;CCT5
prerank,mitochondrial fusion (GO:0008053),0.24102721507439234,0.6679827944484296,0.9072847682119205,1.0,1.0,2/18,6.00%,MFN1;MIEF1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24288864035464522,0.6678701536910798,0.9262672811059908,1.0,1.0,9/18,27.44%,COX16;COX18;COX19;SCO1;COX20;COA3;COX14;COA5;PET100
prerank,signal transduction by p53 class mediator (GO:0072331),-0.218159362819219,-0.6674295593854795,0.9541595925297114,0.9672283893360146,1.0,7/30,22.83%,BATF;DDX5;STK11;GREM1;MDM4;NBN;RRP8
prerank,negative regulation of cartilage development (GO:0061037),-0.26858541480076964,-0.6670524001474591,0.897822445561139,0.9671412812522067,1.0,5/13,21.75%,TGFBR1;CHADL;GREM1;PTPN11;SNAI2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24951883856565177,0.6668597819741517,0.8839907192575406,1.0,1.0,4/15,18.84%,ATF2;HUS1B;NEK11;CHEK2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.27979092985640025,-0.6664955222192701,0.8877005347593583,0.9671856899618597,1.0,5/11,26.31%,TGFBR1;TGFBR2;SMAD7;TGFB1;BMP2
prerank,regulation of cilium movement (GO:0003352),-0.2874273018212685,-0.6662024515517058,0.8800738007380073,0.9670400554336733,1.0,4/10,29.49%,CCDC40;CFAP43;DNAAF1;DRC1
prerank,negative regulation of cilium assembly (GO:1902018),-0.2721121448993146,-0.6648118604484929,0.8888888888888888,0.9676986902841812,1.0,3/12,16.60%,MAP4;TBC1D30;TBC1D7
prerank,regulation of mitochondrion organization (GO:0010821),-0.1980799050784092,-0.6641995955262101,0.9696969696969697,0.9677740054508867,1.0,7/47,15.82%,PID1;CYRIB;USP36;FIS1;FLCN;PRMT6;INF2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.1752318870493126,-0.6641581798250928,0.9895470383275261,0.9674427714796419,1.0,14/87,14.99%,IMMP2L;COA8;SDHAF2;BCS1L;NDUFA9;TIMM21;NDUFAF2;NDUFB2;UQCC1;LYRM7;NDUFS5;NDUFAF8;SDHAF4;FASTKD3
prerank,fatty acid catabolic process (GO:0009062),0.17588310483558123,0.6618651150630324,0.9929245283018868,1.0,1.0,13/67,15.22%,PECR;ABHD3;SLC27A2;PCCB;NUDT7;PCCA;PEX13;MCEE;EHHADH;ACAT1;ACOT8;ABCD1;HSD17B4
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.266076773056213,-0.6615244853482527,0.8949211908931699,0.9689759320186657,1.0,4/13,23.23%,SESN1;STK11;ATM;KPTN
prerank,RNA stabilization (GO:0043489),-0.21034956292925278,-0.6614443735493726,0.9512987012987013,0.9686652483459497,1.0,8/33,26.41%,FUS;E2F1;TENT5A;DHX36;TENT5C;PHAX;TENT5D;VIP
prerank,gas transport (GO:0015669),0.2755051080831618,0.6608979434725306,0.8938271604938272,1.0,1.0,1/10,5.78%,CA2
prerank,heterocycle biosynthetic process (GO:0018130),0.25392538587252816,0.660801621745801,0.919431279620853,1.0,1.0,1/14,1.52%,GPHN
prerank,mesoderm formation (GO:0001707),0.24178355498315307,0.6607248721322655,0.8943488943488943,1.0,1.0,3/17,10.06%,ITGB3;HMGA2;SNAI1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.27523218551919554,-0.6605382508183235,0.91005291005291,0.9689480410465071,1.0,4/12,22.79%,APOC4;DGAT1;LPCAT3;P4HB
prerank,regulation of phosphatase activity (GO:0010921),-0.22841827484494598,-0.6601882933368879,0.927689594356261,0.9688355906982872,1.0,10/24,31.06%,ZCCHC9;GPATCH2;PPP6R3;HSP90B1;CHP2;SH2D4A;URI1;BMP2;RIPK3;PTPA
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2797791587356735,0.6557459652047599,0.8894348894348895,1.0,1.0,4/10,19.50%,ZNHIT3;NAF1;PIH1D1;RUVBL1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21859052633492582,-0.6555450288106403,0.9420035149384886,0.9716866742530381,1.0,3/28,6.72%,NIBAN2;WWP2;ARRB1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.2325996979478095,-0.6523246804099553,0.9275618374558304,0.9734766973198968,1.0,5/21,20.84%,UCHL5;TUBD1;RAB34;TTC23;SFRP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.208461717801608,-0.6521416832774652,0.967266775777414,0.9732209169154562,1.0,3/31,7.73%,CDK6;PPARG;SKI
prerank,regulation of fatty acid oxidation (GO:0046320),0.2413152396535189,0.6518983023946104,0.924892703862661,1.0,1.0,5/16,16.20%,SOX9;ABCB11;PPARGC1A;ABCD1;MLYCD
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2647052547405697,-0.6517614818055391,0.9211908931698775,0.9731065333586904,1.0,1/13,1.90%,IDH1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.19447382406674893,0.6514390116579519,0.9590361445783132,1.0,1.0,7/38,15.68%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFAB1;NDUFA8;NDUFV3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.2699968338467138,0.6511216815323635,0.8896713615023474,1.0,1.0,2/11,15.32%,CD200;ATP6AP2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2614755357000548,-0.650834672845315,0.9128113879003559,0.973341811727737,1.0,3/13,15.54%,PRPF8;SART3;SRSF10
prerank,negative regulation of defense response to virus (GO:0050687),-0.28603783159120666,-0.6507426768096806,0.9064124783362218,0.9730219436520133,1.0,4/10,27.73%,PPM1B;PCBP2;C1QBP;RNF26
prerank,glycolytic process (GO:0006096),-0.21918268519839318,-0.6506796514027626,0.9366197183098591,0.9726924472806154,1.0,10/28,31.22%,GAPDH;HK3;TPI1;PKM;PGK1;PGM1;PGAM2;ALDOA;PGAM1;PGAM4
prerank,oxoacid metabolic process (GO:0043436),-0.21894805974271464,-0.6491479198019389,0.9464594127806563,0.9733186137424423,1.0,5/27,18.94%,TPST1;AGXT;SULT6B1;GNMT;ENPP1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.2689586372599304,0.6490209047521303,0.9153318077803204,1.0,1.0,3/11,16.50%,ROMO1;TIMM10;AGK
prerank,L-amino acid transport (GO:0015807),-0.2158256439864803,-0.6487698181754593,0.9366883116883117,0.9731809226590586,1.0,11/28,31.12%,SLC36A4;CTNS;SLC7A5;SFXN1;SLC38A2;SLC25A22;SLC25A13;SLC25A18;SLC7A2;SLC7A1;SLC36A3
prerank,pyruvate metabolic process (GO:0006090),-0.18795415564871024,-0.6487305538070434,0.9775086505190311,0.9728357767455053,1.0,17/52,32.69%,GAPDH;ME2;HK3;TPI1;PKM;PGK1;DLD;SLC16A1;PDHB;VDAC1;PGM1;HOGA1;PGAM2;ALDOA;PGAM1;PGAM4;PCK2
prerank,peptidyl-proline modification (GO:0018208),0.21326800348921476,0.6486194721495984,0.9479638009049773,1.0,1.0,7/25,22.20%,P3H2;PPIL3;PPIF;PPIH;FKBP4;PPIL2;CWC27
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.2868554970013269,-0.6455621962873331,0.8892857142857142,0.9744901261028933,1.0,1/10,7.75%,VEGFA
prerank,nuclear transport (GO:0051169),0.24583819566069914,0.6453077098634401,0.9138321995464853,1.0,1.0,7/16,20.93%,NXT1;CITED1;BANF1;XPO1;HMGA1;NPM1;NUTF2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.2088758694716663,-0.6446107989813822,0.9557522123893806,0.9747303487066069,1.0,14/31,37.77%,MOCS1;MOCS3;GCH1;FDXR;SRD5A1;SRD5A2;PYCR3;HSD3B2;SCP2;DHRS11;PYCR2;HDC;HSD17B3;CYP19A1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.21916743167782118,-0.6439305555024022,0.9553571428571429,0.9747860493195033,1.0,9/27,30.05%,SLC27A1;CEPT1;PLAAT3;PLAAT1;PLA2G6;PNPLA8;PLA2G15;ALOX15;LPIN3
prerank,non-motile cilium assembly (GO:1905515),-0.21190535628041665,-0.6436379133760975,0.94,0.9745866385108672,1.0,8/30,20.83%,PIBF1;DCTN1;TMEM80;GORAB;VANGL2;IFT57;TMEM17;DISC1
prerank,cristae formation (GO:0042407),0.2093885657617124,0.6435043658060347,0.9536585365853658,1.0,1.0,5/27,12.01%,ATP5MG;APOO;LETM1;ATP5MC3;ATP5ME
prerank,covalent chromatin modification (GO:0016569),0.24874434957307856,0.6434012099963076,0.8870192307692307,1.0,1.0,14/14,75.15%,AURKC;HELLS;SIRT1;SIRT7;UFL1;PARK7;HDAC1;MBD2;SETD5;PARP2;AURKB;CHD1;MT3;HLCS
prerank,tight junction assembly (GO:0120192),0.1830231117870323,0.6433281075182028,0.9721577726218097,1.0,1.0,11/49,19.57%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,catecholamine biosynthetic process (GO:0042423),-0.27038924555660776,-0.6431039391199124,0.8992932862190812,0.9745668910285891,1.0,3/11,17.91%,GCH1;MOXD1;GATA3
prerank,cellular response to acid chemical (GO:0071229),0.20858903996709513,0.6427159669708935,0.9641148325358851,1.0,1.0,8/27,19.99%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;CAPN2;NSMF;RRAGA
prerank,monosaccharide transmembrane transport (GO:0015749),-0.24716056136583484,-0.6417555470081471,0.9407665505226481,0.9750245801338748,1.0,4/16,17.03%,SLC5A3;SLC50A1;SLC23A1;SLC23A2
prerank,L-serine metabolic process (GO:0006563),0.27296152168059334,0.6414648625126663,0.8980582524271845,1.0,1.0,5/10,26.68%,PSAT1;CBS;PHGDH;SHMT2;SDS
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.21080489574908917,0.6404206171193191,0.9457013574660633,1.0,1.0,7/27,17.02%,NME2;RRM2B;AK4;GLRX;CTPS1;AK5;AK6
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.23519981035260243,0.6396782341759277,0.9119804400977995,1.0,1.0,9/16,28.95%,PIGA;DPM2;PIGL;PIGN;PIGB;PIGW;PIGP;PIGQ;PIGF
prerank,T cell homeostasis (GO:0043029),0.275634586499856,0.6395251821978181,0.8928571428571429,1.0,1.0,4/10,20.44%,ZC3H8;JAK3;FADD;FAS
prerank,positive regulation of glucose metabolic process (GO:0010907),0.24224771391740318,0.6392547925055523,0.9238095238095239,1.0,1.0,4/14,20.07%,IRS1;PPARGC1A;AKT2;SIRT1
prerank,GPI anchor metabolic process (GO:0006505),-0.2166026094060629,-0.6388861052508399,0.9545454545454546,0.9764012748120549,1.0,8/26,26.75%,DPM3;PIGH;PGAP3;MPPE1;GPLD1;PGAP1;PIGZ;PGAP2
prerank,phasic smooth muscle contraction (GO:0014821),-0.2732932840520861,-0.6385729867255485,0.9280701754385965,0.9762132569769066,1.0,6/10,36.34%,HTR2B;TIFAB;PTGER3;EDNRB;EDN3;EDN2
prerank,tRNA wobble uridine modification (GO:0002098),-0.24859179536012727,-0.6381306482965828,0.9243986254295533,0.9761096194822217,1.0,3/14,16.47%,ELP1;MOCS3;ELP4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.19440919890098868,0.6364230068835885,0.9758454106280193,1.0,1.0,8/39,20.87%,GHRH;CAPN10;NLGN2;GRP;MYRIP;CRH;LRRC8A;ISL1
prerank,genitalia development (GO:0048806),0.25931862364323577,0.6363745676131178,0.8995327102803738,1.0,1.0,3/12,19.60%,WT1;PKD1;WNT5A
prerank,regulation of transferase activity (GO:0051338),-0.24284505157459185,-0.6355796332613224,0.9391143911439115,0.9772307797775378,1.0,5/17,21.90%,NLRC5;PARP4;JMJD8;ATM;FEM1B
prerank,development of primary male sexual characteristics (GO:0046546),-0.20798498971268808,-0.6344167954961251,0.9660194174757282,0.977521513442137,1.0,14/34,37.99%,LHFPL2;CSDE1;GATA3;BIK;SRD5A2;FGF9;LRP2;KITLG;SOX8;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.24290620564055954,0.6328326098143278,0.9285714285714286,1.0,1.0,3/15,15.12%,NME2;AK4;AK5
prerank,chondroitin sulfate catabolic process (GO:0030207),0.25093824537737497,0.6327223824889623,0.9334916864608076,1.0,1.0,2/13,3.69%,HEXB;VCAN
prerank,male meiosis I (GO:0007141),-0.24000806761868893,-0.6310509447072755,0.9294320137693631,0.97905030552541,1.0,6/16,35.12%,FOXJ3;FOXJ2;ZSCAN21;SLC25A31;ING2;HSF2BP
prerank,regulation of chromosome organization (GO:0033044),0.21368889796367058,0.6298325237630829,0.9570707070707071,1.0,1.0,6/22,17.91%,YLPM1;XRCC5;SMG5;CDT1;UPF1;SETMAR
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.25369977599966215,-0.6289343621511129,0.9163822525597269,0.9798209523375727,1.0,4/13,25.29%,MTHFD1L;GCH1;QDPR;FPGS
prerank,glycogen biosynthetic process (GO:0005978),-0.2603607598756268,-0.6268882897568993,0.9134275618374559,0.9801866557544616,1.0,5/12,32.57%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,glucan biosynthetic process (GO:0009250),-0.2603607598756268,-0.6268882897568993,0.9134275618374559,0.9801866557544616,1.0,5/12,32.57%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.21299322930862477,-0.6266197591986306,0.9619377162629758,0.9799613666044408,1.0,4/26,10.55%,DUSP3;KLHL18;APP;EIF4EBP1
prerank,thyroid hormone generation (GO:0006590),-0.2701197734671673,-0.6261550022597874,0.9288194444444444,0.9798323607714298,1.0,5/10,35.57%,CPQ;TG;SLC5A5;TPO;DUOX1
prerank,cellular amide metabolic process (GO:0043603),-0.1589955311839435,-0.6244100259391759,1.0,0.9803755184636608,1.0,31/102,33.58%,MTHFS;ST3GAL1;PANK2;MTHFD1L;ST6GAL1;ACOT9;PDZD11;ACOT13;MTHFD2L;PLAAT3;PLAAT1;ACOT2;ACOT4;SHMT1;MTHFR;PLPP3;AASDHPPT;ABCA2;HLCS;FPGS;ORMDL2;PLA2G15;ACOT11;CERK;GNE;ORMDL3;ATF4;DBI;SLC19A1;MTHFD1;ACOT6
prerank,regulation of TOR signaling (GO:0032006),-0.17494786386067301,-0.6240135929918447,0.9868852459016394,0.9802222104560804,1.0,18/67,27.25%,GNA12;UBR2;GAS6;FNIP1;FLCN;RRAGD;PIK3CA;TBC1D7;DEPTOR;FAM83D;RHEB;HTR6;WDR24;PKHD1;LAMTOR1;LAMTOR3;MIOS;TSC2
prerank,microtubule bundle formation (GO:0001578),-0.1894408054005602,-0.6205139967737984,0.9750445632798574,0.98168150003611,1.0,16/42,33.73%,NAV1;CCDC40;SPAG16;FOXJ1;SPEF1;MAP1S;KIF20A;GAS2L1;TTLL3;RP1;LRGUK;MARK4;AAAS;TPPP3;CFAP46;NUMA1
prerank,linoleic acid metabolic process (GO:0043651),0.22850863422291995,0.6197452377978122,0.9282407407407407,1.0,1.0,17/17,77.17%,GSTP1;ABCD1;ELOVL2;FADS2;ALOX5;FADS1;ALOX12B;GSTA1;ELOVL3;GSTM2;ACSL1;ALOXE3;ELOVL1;ALOX12;ALOX15;PNPLA8;ELOVL5
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.25807253832849875,-0.6182201333898424,0.9466911764705882,0.9824763018115938,1.0,3/11,31.93%,VAPB;LPCAT3;MOSPD3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.23165360185256048,0.6161371667716738,0.9347319347319347,1.0,1.0,3/14,11.91%,ZNHIT3;RPF2;DDX18
prerank,response to progesterone (GO:0032570),0.22895770354386652,0.6157239289235775,0.9417249417249417,1.0,1.0,3/18,9.22%,YAP1;CATSPERD;TGFB2
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24960103571420206,-0.6146579102022125,0.9267461669505963,0.9838623841365092,1.0,4/14,26.62%,FOXO3;TFAM;TWNK;EARS2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2010656163514953,0.6136547336055956,0.9635036496350365,1.0,1.0,5/26,14.10%,GPR37;FYN;REST;PRKN;NOL3
prerank,myofibril assembly (GO:0030239),0.18158457850701235,0.6128794020241203,0.9855421686746988,1.0,1.0,7/42,16.33%,CSRP1;TNNT2;TTN;PGM5;CAPN3;FHOD3;TPM1
prerank,mRNA splice site selection (GO:0006376),-0.2017251797241703,-0.6124510059809035,0.9721254355400697,0.9845505549359909,1.0,6/30,19.24%,PRPF39;CELF1;YTHDC1;SF3A1;SRSF10;SLU7
prerank,positive regulation of insulin secretion (GO:0032024),0.18812921395940438,0.6110673515353118,0.9645390070921985,1.0,1.0,8/36,20.87%,ADCY8;CAPN10;NLGN2;MYRIP;PPP3CB;LRRC8A;ANO1;ISL1
prerank,rRNA catabolic process (GO:0016075),-0.23535516069676568,-0.6104523252211093,0.9437386569872959,0.9851204766789549,1.0,9/16,38.51%,EXOSC5;EXOSC10;EXOSC4;DEDD2;ERN2;EXOSC8;EXOSC3;SLFN14;PELO
prerank,negative regulation of DNA replication (GO:0008156),-0.24698739501382827,-0.6096168984053077,0.9414802065404475,0.9851275961408203,1.0,1/13,3.60%,S100A11
prerank,cranial nerve development (GO:0021545),0.24629614970991842,0.6085192919874788,0.9255583126550868,1.0,1.0,4/11,20.87%,TFAP2A;SALL1;ERBB3;ISL1
prerank,homocysteine metabolic process (GO:0050667),-0.25677592629227336,-0.6081302101440973,0.9285714285714286,0.9854439208113859,1.0,3/11,22.06%,MPST;MMUT;MTHFR
prerank,eye photoreceptor cell development (GO:0042462),0.23345909781161428,0.607912557039543,0.9379652605459057,1.0,1.0,2/15,10.90%,RORB;CEP290
prerank,pancreas development (GO:0031016),-0.24971079098563975,-0.6075383346823807,0.9447415329768271,0.985340289666172,1.0,4/12,38.06%,CCDC40;DNAAF1;MET;NKX6-1
prerank,heme biosynthetic process (GO:0006783),-0.2123463637238567,-0.6050714849249634,0.9644128113879004,0.9861144174572892,1.0,6/22,23.07%,FLVCR1;HMBS;COX10;PGRMC1;PPOX;UROD
prerank,prostanoid metabolic process (GO:0006692),-0.24611429880170183,-0.6023236410191807,0.9444444444444444,0.9869590218969204,1.0,5/13,36.06%,ACOX1;CYP2S1;PTGES;PTGR1;AKR1C1
prerank,transcription by RNA polymerase III (GO:0006383),-0.20224180735057462,-0.6013001093817592,0.9759450171821306,0.9870318256713654,1.0,8/27,26.25%,POLR2L;SNAPC2;POLR3G;SNAPC3;GTF3C5;GTF3A;POLR3GL;BRF1
prerank,lung epithelium development (GO:0060428),-0.2615858015738407,-0.6006768908677329,0.9408783783783784,0.9869282160095103,1.0,4/10,28.84%,RCN3;FOXJ1;WNT7B;GRHL2
prerank,modified amino acid transport (GO:0072337),0.23243947749805766,0.6004827896387847,0.9341176470588235,1.0,1.0,3/15,14.95%,SLC6A13;FOLR2;FOLR1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.23392336559043744,0.5999034793762498,0.9436936936936937,1.0,1.0,4/14,18.77%,GSTP1;NLRP2B;PELI3;CCDC3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2165900172907116,-0.5980485817550558,0.9625668449197861,0.987635627733365,1.0,6/20,25.01%,PIN1;PPIL6;PPIG;PPIB;PPIL1;FKBP1B
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.26681112041349486,-0.5975071574310976,0.9410745233968805,0.9874841021849415,1.0,6/10,35.91%,SERPINE1;WNK1;SNAI2;CYP1B1;ACER2;HRG
prerank,morphogenesis of an epithelium (GO:0002009),-0.20962313925937057,-0.5953032370504012,0.9662162162162162,0.988008122130728,1.0,4/25,11.03%,ACTB;LRP6;ARHGAP12;TIMELESS
prerank,regulation of epithelial cell differentiation (GO:0030856),0.21726052231948184,0.5946606802327841,0.9619047619047619,1.0,1.0,4/17,15.19%,APOLD1;SOX9;AJAP1;KLF7
prerank,regulation of microtubule nucleation (GO:0010968),0.24761560311627276,0.5946328327203967,0.9184149184149184,1.0,1.0,2/10,10.63%,ARHGEF7;EML2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.24799859234788957,-0.5911939255261771,0.947098976109215,0.9892361185768676,1.0,1/11,3.94%,PACS2
prerank,quinone biosynthetic process (GO:1901663),-0.23456492890282166,-0.59022009539659,0.9536878216123499,0.9892416589890425,1.0,3/14,25.64%,COQ8A;FDXR;COQ10B
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.25644477916614633,-0.5896650199213428,0.9485420240137221,0.9890721610769495,1.0,4/10,24.06%,RFWD3;WDR76;FEM1B;DDX39B
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.2501237049009303,-0.5895864816316173,0.9501779359430605,0.9887324511918326,1.0,1/11,2.56%,P2RX4
prerank,protein acetylation (GO:0006473),-0.19210301987399575,-0.5894657609788073,0.9792387543252595,0.9884068779745124,1.0,11/30,41.35%,CREBBP;NAA50;ESCO2;NAA16;CLOCK;EP300;KAT6A;NAA11;FOXO1;SPHK1;NAA15
prerank,estrogen metabolic process (GO:0008210),-0.2302198607319839,-0.5893437845884598,0.9612141652613828,0.9880732239897088,1.0,6/15,31.38%,HSD17B7;CYP1B1;HSD17B10;HSD17B14;UGT1A7;UGT1A1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.24424178899666707,-0.5890451268463383,0.9522998296422487,0.9877976154355294,1.0,2/12,16.45%,RAB1A;UBE2C
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.21758028579124203,-0.5886119456769113,0.9571917808219178,0.987596163321338,1.0,3/19,10.76%,NFATC3;HRH1;INPP5A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.21796842823415022,-0.5886086140176883,0.9623287671232876,0.9872262288496916,1.0,7/19,29.95%,DCK;HPRT1;POLD2;DGUOK;PNP;GMPR2;ADA
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.2496792767372355,-0.5881996107877338,0.9460869565217391,0.987012672872476,1.0,4/11,24.44%,TGFBR2;STAT1;PDGFA;MYC
prerank,endodermal cell fate commitment (GO:0001711),-0.25755111397653613,-0.5854561237187724,0.9642857142857143,0.9876468909597668,1.0,1/10,3.97%,CTR9
prerank,positive regulation of locomotion (GO:0040017),0.18901770948105234,0.5847182771957761,0.9903381642512077,1.0,1.0,2/27,3.93%,CSF1R;P2RY12
prerank,regulation of urine volume (GO:0035809),0.24479035902585988,0.5842330749545042,0.9493392070484582,1.0,1.0,10/10,75.54%,HAS2;HYAL2;ADCY6;TRPV5;NPPB;TFAP2B;NPR3;NPR1;INPP5K;ADM
prerank,BMP signaling pathway (GO:0030509),-0.1647135313846427,-0.5834777814038489,0.9930675909878682,0.9879691274326718,1.0,15/62,26.92%,RUNX2;USP9X;SLC33A1;DDX5;ACVR2A;SMAD7;BMPR2;GDF3;USP9Y;MEGF8;TGFB1;SMURF1;BMP2;SMAD4;ENG
prerank,retinal metabolic process (GO:0042574),0.2322231965823685,0.5820860647275006,0.9532019704433498,1.0,1.0,3/12,17.34%,DHRS13;RDH11;ALDH1A3
prerank,regulation of phosphate metabolic process (GO:0019220),0.21708294238147163,0.5817722450433545,0.96,1.0,1.0,2/16,8.64%,TIGAR;SMG5
prerank,mesenchyme development (GO:0060485),0.22270168665682386,0.5809419175636282,0.9579439252336449,1.0,1.0,2/15,8.69%,HMGA2;BMP7
prerank,spermatid development (GO:0007286),-0.1902535887237645,-0.5801593214497589,0.9829059829059829,0.9887635109525771,1.0,5/32,12.66%,YTHDC2;CEP57;ACRBP;RNF8;CIB1
prerank,negative regulation of neurogenesis (GO:0050768),0.18253568723627686,0.578822333568572,0.9899749373433584,1.0,1.0,9/34,22.49%,LINGO1;PTN;HOOK3;REST;PCM1;LRP4;SORL1;OMG;NF1
prerank,negative regulation of response to wounding (GO:1903035),-0.21333800525779503,-0.5763813608819002,0.9642248722316865,0.9896712015942265,1.0,3/19,12.69%,MDK;CRK;SERPINE1
prerank,sphingolipid catabolic process (GO:0030149),-0.22659417157264133,-0.5759263160046965,0.9694793536804309,0.9894386907652337,1.0,11/15,47.04%,ACER3;PPT1;ASAH1;SMPDL3A;ACER2;SPHK1;PDXDC1;SMPD1;GLA;SMPD2;SMPD4
prerank,histone H2A acetylation (GO:0043968),-0.22286712839870323,-0.5757615569464817,0.9655765920826161,0.9891280183141001,1.0,3/16,16.87%,MORF4L1;EPC1;SPHK2
prerank,ubiquinone metabolic process (GO:0006743),-0.2244201778173644,-0.5729971738958541,0.9692832764505119,0.9896218318888571,1.0,4/15,30.86%,COQ8A;FDXR;COQ10B;AIFM2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.2248100947956557,0.5724472624617928,0.9575,1.0,1.0,13/13,77.54%,SOX9;SRA1;MSTN;TBX3;SOSTDC1;BMP4;EID2B;DLL1;NOTCH1;PRICKLE1;ANKRD2;SOX8;TGFB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.20643000090080088,-0.5716285617565917,0.9698581560283688,0.9896971837549715,1.0,6/20,29.61%,HSP90AB1;HSPA4;HSPA1A;TMEM35A;BBS10;LONP1
prerank,zinc ion transmembrane transport (GO:0071577),-0.20010883018962644,-0.5702792880078957,0.9853747714808044,0.9897494651620881,1.0,3/22,16.23%,SLC30A5;SLC30A6;SLC39A3
prerank,maintenance of protein localization in organelle (GO:0072595),-0.20918715112502573,-0.5700165780470162,0.9630931458699473,0.9894547849420549,1.0,5/19,26.34%,MORC3;TAF8;TAF3;TOPORS;PML
prerank,secondary palate development (GO:0062009),-0.22673515245546666,-0.5693302661842916,0.9627118644067797,0.9892757693421887,1.0,5/14,30.39%,TGFBR2;CHD7;SMAD4;LEF1;SMAD2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.20851979899678608,-0.5693253970388249,0.972027972027972,0.9889070043556358,1.0,5/18,24.21%,DDHD1;FIS1;AURKA;KDR;DCN
prerank,nuclear body organization (GO:0030575),0.2356361760270328,0.5688393340401237,0.9732739420935412,1.0,1.0,1/12,1.74%,AFF2
prerank,smooth muscle cell differentiation (GO:0051145),-0.23555194009073022,-0.5667602826593721,0.9634782608695652,0.9893313142193982,1.0,7/12,38.56%,MEF2C;MRTFB;APLNR;EDNRB;HEY2;HEY1;TBX18
prerank,ketone body metabolic process (GO:1902224),-0.24965552245793907,-0.566735172133497,0.9617391304347827,0.9889683169613952,1.0,1/10,4.79%,OXCT1
prerank,regulation of exit from mitosis (GO:0007096),-0.1789413028037833,-0.5666809235645902,0.9879101899827288,0.9886143164615556,1.0,8/38,20.16%,ANAPC1;UBC;RPS27A;BUB1B;PPP1R9B;UBE2C;ANAPC7;SIRT2
prerank,lipid droplet organization (GO:0034389),0.1941193704181309,0.5633627692340526,0.9739336492890995,1.0,1.0,4/22,18.84%,SQLE;ZFYVE1;RAB18;CDS1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.23812029471408902,0.5611224065368854,0.9607843137254902,1.0,1.0,2/10,8.58%,ATP5MG;ATP5MC3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.23533170457361133,0.5598640227032569,0.9519450800915332,1.0,1.0,3/11,12.54%,IP6K2;ITPKA;PPIP5K2
prerank,maturation of LSU-rRNA (GO:0000470),0.17995066942658694,0.5586075550381049,0.9861431870669746,1.0,1.0,4/26,11.91%,ZNHIT3;LAS1L;RPF2;DDX18
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.21709728667940076,-0.557813753047886,0.9707317073170731,0.9907501674671185,1.0,2/16,10.38%,C3;CHGA
prerank,respiratory electron transport chain (GO:0022904),0.21377448518332476,0.557429175359145,0.9732739420935412,1.0,1.0,14/14,78.64%,PPARGC1A;ETFB;ETFRF1;SDHA;SDHB;ETFDH;GPD2;ETFA;SLC25A12;NDUFA5;UQCRFS1;SLC25A18;SLC25A13;SLC25A22
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.18250545400935717,-0.5555946554742045,0.9865546218487395,0.990960223411309,1.0,13/30,35.14%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;UBTF;POLR1E;POLR1C;MNAT1;TAF1D;ERCC2;GTF2H1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.23244955862691197,0.5545979324455257,0.9721577726218097,1.0,1.0,2/11,6.91%,AHCYL1;CDC73
prerank,nucleotide biosynthetic process (GO:0009165),0.19751271621249483,0.5542371515378103,0.9837587006960556,1.0,1.0,5/18,18.04%,RRM2B;NMNAT2;ADSL;ME1;PPAT
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.21929618717615745,-0.5509792041836381,0.9691252144082333,0.9917628109323791,1.0,8/13,47.00%,ALG12;ALG6;ALG11;SRD5A3;ALG1;ALG2;ALG9;ALG13
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.21587136675158994,-0.54953132863532,0.980701754385965,0.9917476355085458,1.0,9/16,40.47%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A;ATP5F1E;ATP5PO
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.23532121177533705,-0.5483442674953437,0.9792387543252595,0.9916522522362617,1.0,2/10,20.84%,BATF;SFRP1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.2241482807068206,-0.5460787703454012,0.9825174825174825,0.9918195026260475,1.0,3/12,29.64%,TPR;TGFB1;AAAS
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22598366658362024,0.5459846545740119,0.9618834080717489,1.0,1.0,4/11,19.70%,PANK3;ACAT1;COASY;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.22598366658362024,0.5459846545740119,0.9618834080717489,1.0,1.0,4/11,19.70%,PANK3;ACAT1;COASY;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22598366658362024,0.5459846545740119,0.9618834080717489,1.0,1.0,4/11,19.70%,PANK3;ACAT1;COASY;ACOT7
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.1860795732567564,0.545786026048109,0.9903614457831326,1.0,1.0,6/23,20.87%,TNNT2;MYH7;TPM1;TGFBR3;TNNC1;ISL1
prerank,erythrocyte development (GO:0048821),-0.23355309568960364,-0.5440944526102159,0.9587813620071685,0.9919037207325682,1.0,2/10,23.05%,NCKAP1L;ZBTB7A
prerank,gastrulation (GO:0007369),0.21202988635650133,0.5422571168468826,0.9822784810126582,1.0,1.0,15/15,78.82%,MKKS;NPHP3;LHX1;UGDH;WNT8B;TASOR;LRP5;GPC3;APELA;FGF8;NR4A3;EOMES;SMAD2;MEGF8;LMBRD1
prerank,intraciliary retrograde transport (GO:0035721),0.21474781181228397,0.5395414737690588,0.9714285714285714,1.0,1.0,4/12,21.23%,DYNC2H1;DYNC2LI1;TTC21B;DYNC2I1
prerank,microtubule nucleation (GO:0007020),-0.19473516228791066,-0.5387045783697874,0.9893805309734514,0.9927172843904629,1.0,7/19,33.24%,TUBGCP4;TPX2;SLAIN2;RANBP9;TUBGCP2;CSNK1D;CCDC57
prerank,apoptotic mitochondrial changes (GO:0008637),0.16736572813563877,0.538262909223205,0.9886363636363636,1.0,1.0,12/32,28.38%,ERBB4;BOK;CAMK2A;ATP2A1;ATG3;DNM1L;HK2;BAK1;CCAR2;GGCT;BAD;MFF
prerank,rRNA pseudouridine synthesis (GO:0031118),0.22874996298728795,0.537301282900464,0.9789719626168224,1.0,1.0,6/10,30.50%,NAF1;NOP10;RPUSD4;RPUSD3;RPUSD1;TSR3
prerank,DNA biosynthetic process (GO:0071897),-0.20684339305129296,-0.5367401365340697,0.993127147766323,0.9927754739080229,1.0,4/16,24.38%,WRN;POLD2;RFC3;POLD4
prerank,gonad development (GO:0008406),0.15786252952147362,0.5367175705402568,0.9974293059125964,1.0,1.0,6/41,14.73%,WT1;SOX9;TGFB2;SALL1;MKKS;INHBA
prerank,positive regulation of rRNA processing (GO:2000234),0.22508646588397804,0.5358903181143154,0.9673202614379085,1.0,1.0,1/10,6.18%,UTP15
prerank,histone H3 deacetylation (GO:0070932),0.20167011992214467,0.5354183233046802,0.9753694581280788,1.0,1.0,15/15,79.85%,PER2;SIRT1;PER1;HDAC2;SIRT7;SFPQ;HDAC1;HDAC4;ELK4;SIRT6;SMARCAD1;HDAC3;HDAC9;HDAC8;SIRT2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2071884816777047,-0.534934047648852,0.9653916211293261,0.9927681915215674,1.0,8/16,36.78%,VEGFA;APLNR;HMOX1;NGFR;FGF2;GATA2;IL12A;IL12B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2001428194164827,-0.5327594672855639,0.9805996472663139,0.9928606218062599,1.0,7/18,37.58%,BCL2;SLC25A4;BCL2L1;SLC25A31;BNIP3;ALKBH7;HEBP2
prerank,male gonad development (GO:0008584),-0.17400624884852334,-0.5315450537257154,0.993517017828201,0.9927403841054309,1.0,14/34,37.99%,CSDE1;GATA3;BIK;SRD5A2;FGF9;LRP2;KITLG;SOX8;ING2;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,cellular response to estradiol stimulus (GO:0071392),0.18972354061220323,0.5291153042686535,0.9717223650385605,1.0,1.0,2/18,10.15%,RAMP3;POU4F2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.19379278749438777,-0.5246657682870105,0.9748322147651006,0.993629364456657,1.0,7/20,42.57%,SIK1;NCOR1;EP300;UGT1A8;BCKDK;C1QTNF12;CLK2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.21891412503018925,-0.5243954417829767,0.9822064056939501,0.9933106519533204,1.0,5/12,34.80%,MBTPS2;LPCAT3;ABCA2;SREBF1;DGKQ
prerank,apical protein localization (GO:0045176),0.22083525582135927,0.5225077099072979,0.9930875576036866,1.0,1.0,5/10,23.93%,MAL;GOPC;JAM3;ATP8B1;INSC
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.20161221756727601,-0.5198400083166334,0.991304347826087,0.9937416103206608,1.0,9/17,40.47%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A;ATP5F1E;ATP5PO
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.19550962944719932,-0.518452165137886,0.9832775919732442,0.9936057023607351,1.0,5/17,21.97%,GET3;EMC6;SGTA;BAG6;EMC9
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1863280451818141,0.5138178665495475,0.9933184855233853,1.0,1.0,9/18,29.87%,DNAAF4;RFX3;NPHP3;AQP4;CFAP53;SPEF2;CABYR;NEK10;DNAAF2
prerank,diol metabolic process (GO:0034311),0.17980262630758137,0.5105897952605032,0.9907192575406032,1.0,1.0,4/19,17.61%,PTS;CALM1;HSP90AA1;ASAH2
prerank,vasodilation (GO:0042311),0.2003234013912848,0.5090541499638497,0.9743589743589743,1.0,1.0,2/13,13.22%,KCNMA1;ADRB1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.20314300263109292,0.5071453097855945,0.9861751152073732,1.0,1.0,6/12,27.77%,FUT8;B4GALNT2;SLC35A3;GMDS;CSGALNACT1;GFPT2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2174240522219434,0.5064141258887758,0.9883177570093458,0.9998656239459744,1.0,10/10,78.27%,PRKN;SNCA;HDAC6;DRD5;OXA1L;AOC3;GZMA;ETFBKMT;MT3;HP
prerank,transcription by RNA polymerase I (GO:0006360),-0.1614203521517627,-0.5010999258760904,0.9982964224872232,0.9957361533853183,1.0,13/34,35.14%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;UBTF;POLR1E;POLR1C;MNAT1;TAF1D;ERCC2;GTF2H1
prerank,negative regulation of viral release from host cell (GO:1902187),0.20074686697451008,0.49862554526039965,0.9929411764705882,1.0,1.0,2/13,15.86%,TRIM13;TRIM35
prerank,metanephric mesenchyme development (GO:0072075),-0.21624051938229133,-0.48856562615095067,0.9838998211091234,0.9968559419132637,1.0,5/10,42.66%,OSR1;STAT1;PAX2;SIX4;BASP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.1483650823127546,-0.4775173531225021,1.0,0.9975708696862772,1.0,10/41,29.83%,DAGLB;GPX4;PLA2G4A;ACOX1;ELOVL5;CYP1B1;PNPLA8;ALOX15;SCP2;PTGR1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.19677381363130536,-0.47744548721743874,0.9881956155143339,0.9972053647304728,1.0,4/13,31.76%,NUDT21;NCBP1;CPSF1;TUT1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.20026158810945605,-0.4709135401422561,0.9930915371329879,0.9973650724554531,1.0,6/11,37.38%,ITGB5;JUP;DSP;VCL;PLEKHA7;THBS4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.14779696386189353,0.46964174799891206,1.0,1.0,1.0,10/32,24.58%,CCNH;GTF2H2;GTF2H3;GTF2H5;POLR2K;CAVIN1;RRN3;POLR2E;POLR1H;TBP
prerank,cellular biogenic amine metabolic process (GO:0006576),0.1920578106544384,0.4642376803276683,0.9950124688279302,1.0,1.0,6/12,24.86%,MAOA;DDC;ODC1;HNMT;SRM;AMD1
prerank,regulation of water loss via skin (GO:0033561),0.17423243548690914,0.4633854604219847,0.9952038369304557,0.9998256817284258,1.0,15/15,82.59%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,establishment of skin barrier (GO:0061436),0.17423243548690914,0.4633854604219847,0.9952038369304557,0.9998256817284258,1.0,15/15,82.59%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,UV protection (GO:0009650),-0.20262207599578083,-0.4597580525987008,0.9967105263157895,0.9977710928629346,1.0,2/10,20.03%,FEN1;CAT
prerank,protein neddylation (GO:0045116),0.1713185834352331,0.44477578890612335,0.9952038369304557,1.0,1.0,3/13,19.51%,UBA3;DCUN1D2;NAE1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.1530298273155416,-0.40670160455574245,1.0,0.9994672504751488,1.0,17/17,84.72%,NEIL3;NEIL2;MPG;MUTYH;SMUG1;TERF2;TDG;NEIL1;ACD;MBD4;TERF2IP;NTHL1;TINF2;ERCC5;UNG;TERF1;OGG1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.1681840577725323,0.40478021441467704,1.0,1.0,1.0,4/10,28.96%,MYOCD;SIRT1;PRKAA2;DIP2A
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.13594161048588443,0.3718455624436049,1.0,0.9998907240712505,1.0,8/17,29.49%,DPAGT1;DHDDS;DOLK;MPDU1;MVD;ALG3;ALG8;ALG14
